Citrus Sinensis ID: 023282

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280----
Protein Sequence
MTALRDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRRL
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccccEEEEEccccEEEEEEEcccccccHHHHHHHHHHHHHHcccccccccccEEccccccEEEEcccccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccEEEEccccccccccccccEcccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccHcccccccccccccccccccEEcHHHHHHHHcccccccEEccccccEEEEEEcccccEEEEEEcccccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEccccccHHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEcccHHHHHHHHHHcc
Coil and Loop (DISEMBL)
mtalrdlsnnrlsgpvpdngsfsqftpisfennlnlcgpntkkpcsgsppfsppppfgptsspgrnksnaaiPVGVALGAALLFAVPvigfaywrrtrphefffdvpaeddselqlgqlkRFSLRELQVAtdgfsnknilgrggfgkvykgrladgKLVAVKRLKEertsggelqfqTEVKIISMAVHRNLLRLYGFCTTVTEKLLVypymtngsvASRLRerqsslppldwptrkkiALGSARGlsylhehcdpkiihRDVKAANIlldedadqsskTILRRL
Flexible Loop (DISEMBL)
mtalrdlsnnrlsgpvpdnGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVAtdgfsnknilgrggfgkvykgrlaDGKLVAVKrlkeertsggelqfqteVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRlrerqsslppldwptrkKIALGSARGLSYLHEHCDPKIIHRDVKAANilldedadqssktilrrl
Low Complexity Region (SEG)
MTALRDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKpcsgsppfsppppfgptsspgRNKSNaaipvgvalgaallfavpvIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRRL
Disordered region (IsUnstruct)
**********************************************************************AIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV**************DWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL***************
Disordered Region (DISOPRED)
MTALRDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPN********************************PVGVALGAALLFAVPVIGFAYWR**********************QLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAV*****************EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRRL
Disordered Region (DISEMBL)
MTALRDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNT************************NKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRRL
Disordered Region (DISPRO)
MTALRDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTK************************KSNAAIPVGVALGAALLFAVPVIGFAYWRRTRP**FFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRRL
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MTALRDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILRRL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	284	2.2.26 [Sep-21-2011]
Q94AG2	625	Somatic embryogenesis rec	yes	no	0.940	0.427	0.796	1e-101
Q94F62	615	BRASSINOSTEROID INSENSITI	no	no	0.908	0.419	0.719	1e-97
Q9SKG5	620	Somatic embryogenesis rec	no	no	0.904	0.414	0.700	5e-95
Q9XIC7	628	Somatic embryogenesis rec	no	no	0.633	0.286	0.833	3e-84
Q8LPS5	601	Somatic embryogenesis rec	no	no	0.855	0.404	0.632	1e-77
Q8RY65	635	Protein NSP-INTERACTING K	no	no	0.908	0.406	0.526	1e-74
Q9LFS4	638	Protein NSP-INTERACTING K	no	no	0.919	0.409	0.536	1e-73
Q93ZS4	632	Protein NSP-INTERACTING K	no	no	0.936	0.420	0.538	8e-71
Q8W4S5	614	Probable LRR receptor-lik	no	no	0.908	0.420	0.483	9e-69
Q0WVM4	634	Probable LRR receptor-lik	no	no	0.883	0.395	0.525	8e-68

>sp|Q94AG2|SERK1_ARATH Somatic embryogenesis receptor kinase 1 OS=Arabidopsis thaliana GN=SERK1 PE=1 SV=2

 Score =  367 bits (941), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 215/270 (79%), Positives = 229/270 (84%), Gaps = 3/270 (1%)

Query: 6   DLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGP---TSS 62
           DLSNNRLSG VPDNGSFS FTPISF NNL+LCGP T  PC GSPPFSPPPPF      S+
Sbjct: 171 DLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGPVTSHPCPGSPPFSPPPPFIQPPPVST 230

Query: 63  PGRNKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRF 122
           P       AI  GVA GAALLFA P I FA+WRR +P + FFDVPAE+D E+ LGQLKRF
Sbjct: 231 PSGYGITGAIAGGVAAGAALLFAAPAIAFAWWRRRKPLDIFFDVPAEEDPEVHLGQLKRF 290

Query: 123 SLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKI 182
           SLRELQVA+DGFSNKNILGRGGFGKVYKGRLADG LVAVKRLKEERT GGELQFQTEV++
Sbjct: 291 SLRELQVASDGFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEM 350

Query: 183 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 242
           ISMAVHRNLLRL GFC T TE+LLVYPYM NGSVAS LRER  S PPLDWPTRK+IALGS
Sbjct: 351 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQPPLDWPTRKRIALGS 410

Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           ARGLSYLH+HCDPKIIHRDVKAANILLDE+
Sbjct: 411 ARGLSYLHDHCDPKIIHRDVKAANILLDEE 440

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Phosphorylates BRI1 on 'Ser-887' and CDC48 on at least one threonine residue and on 'Ser-41'. Confers embryogenic competence. Acts redundantly with SERK2 as a control point for sporophytic development controlling male gametophyte production. Involved in the brassinolide signaling pathway.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2

 Score =  356 bits (914), Expect = 1e-97,   Method: Compositional matrix adjust.
 Identities = 192/267 (71%), Positives = 209/267 (78%), Gaps = 9/267 (3%)

Query: 6   DLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGR 65
           DLSNN L+G +P NGSFS FTPISF N          K         PP    P S  G 
Sbjct: 170 DLSNNPLTGDIPVNGSFSLFTPISFANT---------KLTPLPASPPPPISPTPPSPAGS 220

Query: 66  NKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLR 125
           N+   AI  GVA GAALLFAVP I  A+WRR +P + FFDVPAE+D E+ LGQLKRFSLR
Sbjct: 221 NRITGAIAGGVAAGAALLFAVPAIALAWWRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLR 280

Query: 126 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 185
           ELQVA+D FSNKNILGRGGFGKVYKGRLADG LVAVKRLKEERT GGELQFQTEV++ISM
Sbjct: 281 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISM 340

Query: 186 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 245
           AVHRNLLRL GFC T TE+LLVYPYM NGSVAS LRER  S PPLDWP R++IALGSARG
Sbjct: 341 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARG 400

Query: 246 LSYLHEHCDPKIIHRDVKAANILLDED 272
           L+YLH+HCDPKIIHRDVKAANILLDE+
Sbjct: 401 LAYLHDHCDPKIIHRDVKAANILLDEE 427

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2

 Score =  347 bits (891), Expect = 5e-95,   Method: Compositional matrix adjust.
 Identities = 187/267 (70%), Positives = 204/267 (76%), Gaps = 10/267 (3%)

Query: 6   DLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGR 65
           D+SNNRLSG +P NGSFS FTPISF NN            +  P   P         P  
Sbjct: 176 DISNNRLSGDIPVNGSFSLFTPISFANN----------SLTDLPEPPPTSTSPTPPPPSG 225

Query: 66  NKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLR 125
            +  AAI  GVA GAALLFAVP I FA+W R +P + FFDVPAE+D E+ LGQLKRF+LR
Sbjct: 226 GQMTAAIAGGVAAGAALLFAVPAIAFAWWLRRKPQDHFFDVPAEEDPEVHLGQLKRFTLR 285

Query: 126 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 185
           EL VATD FSNKN+LGRGGFGKVYKGRLADG LVAVKRLKEERT GGELQFQTEV++ISM
Sbjct: 286 ELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVKRLKEERTKGGELQFQTEVEMISM 345

Query: 186 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 245
           AVHRNLLRL GFC T TE+LLVYPYM NGSVAS LRER    P LDWP RK IALGSARG
Sbjct: 346 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPKRKHIALGSARG 405

Query: 246 LSYLHEHCDPKIIHRDVKAANILLDED 272
           L+YLH+HCD KIIHRDVKAANILLDE+
Sbjct: 406 LAYLHDHCDQKIIHRDVKAANILLDEE 432

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XIC7|SERK2_ARATH Somatic embryogenesis receptor kinase 2 OS=Arabidopsis thaliana GN=SERK2 PE=1 SV=1

 Score =  311 bits (797), Expect = 3e-84,   Method: Compositional matrix adjust.
 Identities = 150/180 (83%), Positives = 161/180 (89%)

Query: 93  YWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR 152
           +WRR +P EFFFDVPAE+D E+ LGQLKRFSLRELQVATD FSNKNILGRGGFGKVYKGR
Sbjct: 264 WWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR 323

Query: 153 LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT 212
           LADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM 
Sbjct: 324 LADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 383

Query: 213 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           NGSVAS LRER  S  PL W  R++IALGSARGLSYLH+HCDPKIIHRDVKAANILLDE+
Sbjct: 384 NGSVASCLRERPPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 443

Serine/threonine-kinase involved in brassinosteroid-dependent and -independent signaling pathways. Acts redundantly with SERK1 as a control point for sporophytic development controlling male gametophyte production.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8LPS5|SERK5_ARATH Somatic embryogenesis receptor kinase 5 OS=Arabidopsis thaliana GN=SERK5 PE=1 SV=2

 Score =  289 bits (740), Expect = 1e-77,   Method: Compositional matrix adjust.
 Identities = 169/267 (63%), Positives = 191/267 (71%), Gaps = 24/267 (8%)

Query: 6   DLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGR 65
           D+SNNRLSG +P NGSFSQFT +SF NN                      P   + SP  
Sbjct: 171 DISNNRLSGDIPVNGSFSQFTSMSFANN-------------------KLRPRPASPSPSP 211

Query: 66  NKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLR 125
           + ++AAI VGVA GAALLFA+         R +    F DVPAE+D E+ LGQ KRFSLR
Sbjct: 212 SGTSAAIVVGVAAGAALLFALAWW-----LRRKLQGHFLDVPAEEDPEVYLGQFKRFSLR 266

Query: 126 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 185
           EL VAT+ FS +N+LG+G FG +YKGRLAD  LVAVKRL EERT GGELQFQTEV++ISM
Sbjct: 267 ELLVATEKFSKRNVLGKGRFGILYKGRLADDTLVAVKRLNEERTKGGELQFQTEVEMISM 326

Query: 186 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 245
           AVHRNLLRL GFC T TE+LLVYPYM NGSVAS LRER    P LDWP RK IALGSARG
Sbjct: 327 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPKRKHIALGSARG 386

Query: 246 LSYLHEHCDPKIIHRDVKAANILLDED 272
           L+YLH+HCD KIIH DVKAANILLDE+
Sbjct: 387 LAYLHDHCDQKIIHLDVKAANILLDEE 413

Serine/threonine-kinase of unknown function.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1

 Score =  279 bits (714), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 149/283 (52%), Positives = 189/283 (66%), Gaps = 25/283 (8%)

Query: 1   MTALR--DLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFG 58
           MT L   DLS N LSGPVP     S     +   N  +C   T+K C+G+ P     P  
Sbjct: 176 MTQLTFLDLSYNNLSGPVPR----SLAKTFNVMGNSQICPTGTEKDCNGTQP----KPMS 227

Query: 59  PTSSPGRNKSN--------AAIPVGVALGAALLFAVPVIGFAYWRRTRPHE--FFFDVPA 108
            T +  +NKS+         A+  GV+L    L  +   GF  W R R ++   FFD+  
Sbjct: 228 ITLNSSQNKSSDGGTKNRKIAVVFGVSLTCVCLLIIG-FGFLLWWRRRHNKQVLFFDINE 286

Query: 109 EDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEER 168
           ++  E+ LG L+RF+ +ELQ AT  FS+KN++G+GGFG VYKG L DG ++AVKRLK+  
Sbjct: 287 QNKEEMCLGNLRRFNFKELQSATSNFSSKNLVGKGGFGNVYKGCLHDGSIIAVKRLKDIN 346

Query: 169 TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP 228
             GGE+QFQTE+++IS+AVHRNLLRLYGFCTT +E+LLVYPYM+NGSVASRL+ +    P
Sbjct: 347 NGGGEVQFQTELEMISLAVHRNLLRLYGFCTTSSERLLVYPYMSNGSVASRLKAK----P 402

Query: 229 PLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 271
            LDW TRK+IALG+ RGL YLHE CDPKIIHRDVKAANILLD+
Sbjct: 403 VLDWGTRKRIALGAGRGLLYLHEQCDPKIIHRDVKAANILLDD 445

Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1

 Score =  276 bits (706), Expect = 1e-73,   Method: Compositional matrix adjust.
 Identities = 147/274 (53%), Positives = 179/274 (65%), Gaps = 13/274 (4%)

Query: 3   ALRDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSS 62
           A  DLS N LSGPVP    F+  T  S   N  +C   T+  C+G+           T  
Sbjct: 180 AFLDLSYNNLSGPVP---RFAAKT-FSIVGNPLICPTGTEPDCNGTTLIPMSMNLNQTGV 235

Query: 63  P----GRNKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVP-AEDDSELQLG 117
           P    G      AI VG ++G   L  + V  F +WR+      FFDV       E+ LG
Sbjct: 236 PLYAGGSRNHKMAIAVGSSVGTVSLIFIAVGLFLWWRQRHNQNTFFDVKDGNHHEEVSLG 295

Query: 118 QLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQ 177
            L+RF  RELQ+AT+ FS+KN+LG+GG+G VYKG L D  +VAVKRLK+    GGE+QFQ
Sbjct: 296 NLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKGILGDSTVVAVKRLKDGGALGGEIQFQ 355

Query: 178 TEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKK 237
           TEV++IS+AVHRNLLRLYGFC T TEKLLVYPYM+NGSVASR++ +    P LDW  RK+
Sbjct: 356 TEVEMISLAVHRNLLRLYGFCITQTEKLLVYPYMSNGSVASRMKAK----PVLDWSIRKR 411

Query: 238 IALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 271
           IA+G+ARGL YLHE CDPKIIHRDVKAANILLD+
Sbjct: 412 IAIGAARGLVYLHEQCDPKIIHRDVKAANILLDD 445

Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1

 Score =  267 bits (682), Expect = 8e-71,   Method: Compositional matrix adjust.
 Identities = 146/271 (53%), Positives = 177/271 (65%), Gaps = 5/271 (1%)

Query: 3   ALRDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSS 62
            L D+S N LSG +P   S   F  I    N  +CGP     CS  P     P  GP  S
Sbjct: 173 TLVDISYNNLSGSLP-KVSARTFKVIG---NALICGPKAVSNCSAVPEPLTLPQDGPDES 228

Query: 63  PGRNKSNAAIPVGVALGAALLFAVPVIG-FAYWRRTRPHEFFFDVPAEDDSELQLGQLKR 121
             R   +       A  +A  F     G F +WR  R  + FFDV  + D E+ LG LKR
Sbjct: 229 GTRTNGHHVALAFAASFSAAFFVFFTSGMFLWWRYRRNKQIFFDVNEQYDPEVSLGHLKR 288

Query: 122 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVK 181
           ++ +EL+ AT+ F++KNILGRGG+G VYKG L DG LVAVKRLK+   +GGE+QFQTEV+
Sbjct: 289 YTFKELRSATNHFNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVE 348

Query: 182 IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALG 241
            IS+A+HRNLLRL GFC++  E++LVYPYM NGSVASRL++     P LDW  RKKIA+G
Sbjct: 349 TISLALHRNLLRLRGFCSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVG 408

Query: 242 SARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           +ARGL YLHE CDPKIIHRDVKAANILLDED
Sbjct: 409 TARGLVYLHEQCDPKIIHRDVKAANILLDED 439

Involved in defense response to geminivirus infection.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8W4S5|Y5371_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g63710 OS=Arabidopsis thaliana GN=At5g63710 PE=2 SV=1

 Score =  260 bits (664), Expect = 9e-69,   Method: Compositional matrix adjust.
 Identities = 129/267 (48%), Positives = 170/267 (63%), Gaps = 9/267 (3%)

Query: 6   DLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGR 65
           DLS+N L+G +P    F       F     +CG +  +PCS S          P +S  +
Sbjct: 170 DLSSNNLTGSIPTQ--FFSIPTFDFSGTQLICGKSLNQPCSSSSRL-------PVTSSKK 220

Query: 66  NKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLR 125
              +  +         L     V+   +  R   ++ FFDV  EDD ++  GQLKRFSLR
Sbjct: 221 KLRDITLTASCVASIILFLGAMVMYHHHRVRRTKYDIFFDVAGEDDRKISFGQLKRFSLR 280

Query: 126 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 185
           E+Q+ATD F+  N++G+GGFGKVY+G L D   VAVKRL +  + GGE  FQ E+++IS+
Sbjct: 281 EIQLATDSFNESNLIGQGGFGKVYRGLLPDKTKVAVKRLADYFSPGGEAAFQREIQLISV 340

Query: 186 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 245
           AVH+NLLRL GFCTT +E++LVYPYM N SVA RLR+ ++    LDWPTRK++A GSA G
Sbjct: 341 AVHKNLLRLIGFCTTSSERILVYPYMENLSVAYRLRDLKAGEEGLDWPTRKRVAFGSAHG 400

Query: 246 LSYLHEHCDPKIIHRDVKAANILLDED 272
           L YLHEHC+PKIIHRD+KAANILLD +
Sbjct: 401 LEYLHEHCNPKIIHRDLKAANILLDNN 427

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q0WVM4|Y2239_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g23950 OS=Arabidopsis thaliana GN=At2g23950 PE=2 SV=1

 Score =  257 bits (656), Expect = 8e-68,   Method: Compositional matrix adjust.
 Identities = 143/272 (52%), Positives = 183/272 (67%), Gaps = 21/272 (7%)

Query: 6   DLSNNRLSGPVPDNGSFSQFTPISFENNLN--LCGPNTKKPCSGSPPFSPPPPFGPTSSP 63
           DLS N L GPVP      +F   +F    N  +C  +  + CSGS   SP       SS 
Sbjct: 176 DLSYNNLRGPVP------KFPARTFNVAGNPLICKNSLPEICSGSISASPLS-VSLRSSS 228

Query: 64  GRNKSNAAIPVGVALGAALLFAVPVI---GFAYWRRTRPHEFFFDVP-AEDDSELQLGQL 119
           GR  +  A+ +GV+LG    FAV VI   GF ++R+ +       +   +++  L LG L
Sbjct: 229 GRRTNILAVALGVSLG----FAVSVILSLGFIWYRKKQRRLTMLRISDKQEEGLLGLGNL 284

Query: 120 KRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTE 179
           + F+ REL VATDGFS+K+ILG GGFG VY+G+  DG +VAVKRLK+   + G  QF+TE
Sbjct: 285 RSFTFRELHVATDGFSSKSILGAGGFGNVYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTE 344

Query: 180 VKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA 239
           +++IS+AVHRNLLRL G+C + +E+LLVYPYM+NGSVASRL+ +    P LDW TRKKIA
Sbjct: 345 LEMISLAVHRNLLRLIGYCASSSERLLVYPYMSNGSVASRLKAK----PALDWNTRKKIA 400

Query: 240 LGSARGLSYLHEHCDPKIIHRDVKAANILLDE 271
           +G+ARGL YLHE CDPKIIHRDVKAANILLDE
Sbjct: 401 IGAARGLFYLHEQCDPKIIHRDVKAANILLDE 432

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	284
449462838	626	PREDICTED: somatic embryogenesis recepto	0.940	0.426	0.774	1e-107
218200553	624	hypothetical protein OsI_28003 [Oryza sa	0.957	0.435	0.783	1e-106
115475023	624	Os08g0174700 [Oryza sativa Japonica Grou	0.957	0.435	0.783	1e-106
242078341	530	hypothetical protein SORBIDRAFT_07g00475	0.957	0.513	0.787	1e-106
418204460	624	somatic embryogenesis receptor-like kina	0.957	0.435	0.805	1e-105
413917200	631	putative leucine-rich repeat receptor-li	0.957	0.431	0.784	1e-105
357139703	615	PREDICTED: somatic embryogenesis recepto	0.957	0.442	0.787	1e-105
242065530	626	hypothetical protein SORBIDRAFT_04g02381	0.936	0.424	0.789	1e-105
413917199	564	putative leucine-rich repeat receptor-li	0.957	0.482	0.784	1e-105
357163915	630	PREDICTED: somatic embryogenesis recepto	0.936	0.422	0.766	1e-104

>gi|449462838|ref|XP_004149147.1| PREDICTED: somatic embryogenesis receptor kinase 2-like [Cucumis sativus] gi|449521625|ref|XP_004167830.1| PREDICTED: somatic embryogenesis receptor kinase 2-like [Cucumis sativus]

 Score =  395 bits (1015), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 209/270 (77%), Positives = 224/270 (82%), Gaps = 3/270 (1%)

Query: 6   DLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPF---GPTSS 62
           DLSNN LSG VP+NGSFS FTPISF NNL+LCG  T KPC G PPFSPPPPF      SS
Sbjct: 172 DLSNNLLSGKVPNNGSFSLFTPISFANNLDLCGLVTGKPCPGDPPFSPPPPFVPQSTVSS 231

Query: 63  PGRNKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRF 122
              N  N AI  GVA GAALLFA P I F YW R +  E FFDVPAE+DSE+ LGQLKRF
Sbjct: 232 HELNNPNGAIVGGVAAGAALLFATPAIIFVYWHRRKSREIFFDVPAEEDSEINLGQLKRF 291

Query: 123 SLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKI 182
           SLR+LQVATD F NKNILGRGGFGKVY+GRLADG LVAVKRLKEERT GGELQFQTEV++
Sbjct: 292 SLRDLQVATDNFCNKNILGRGGFGKVYRGRLADGSLVAVKRLKEERTPGGELQFQTEVEM 351

Query: 183 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 242
           ISMAVHRNLLRL+GFCTT +E+LLVYPYM NGSVAS LRER  S  PLDWPTRKK+ALGS
Sbjct: 352 ISMAVHRNLLRLHGFCTTSSERLLVYPYMANGSVASCLRERPQSEAPLDWPTRKKVALGS 411

Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           ARGLSYLH+ CDPKIIHRDVKAANILLDE+
Sbjct: 412 ARGLSYLHDGCDPKIIHRDVKAANILLDEE 441

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|218200553|gb|EEC82980.1| hypothetical protein OsI_28003 [Oryza sativa Indica Group]

 Score =  390 bits (1001), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 217/277 (78%), Positives = 235/277 (84%), Gaps = 5/277 (1%)

Query: 1   MTALR--DLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFG 58
           +TAL+  DLSNN LSG VP  GSFS FTPISF NN +LCGP T KPC G+PPFSPPPP+ 
Sbjct: 163 ITALQVLDLSNNNLSGEVPSTGSFSLFTPISFANNPSLCGPGTTKPCPGAPPFSPPPPYN 222

Query: 59  P---TSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQ 115
           P     SPG + S  AI  GVA GAALLFA+P IGFA++RR +P E FFDVPAE+D E+ 
Sbjct: 223 PPTPVQSPGSSSSTGAIAGGVAAGAALLFAIPAIGFAWYRRRKPQEHFFDVPAEEDPEVH 282

Query: 116 LGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ 175
           LGQLKRFSLRELQVATD FSNKNILGRGGFGKVYKGRLADG LVAVKRLKEERT GGELQ
Sbjct: 283 LGQLKRFSLRELQVATDTFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQ 342

Query: 176 FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR 235
           FQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NGSVASRLRER  S PPLDW TR
Sbjct: 343 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASRLRERPPSEPPLDWRTR 402

Query: 236 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           ++IALGSARGLSYLH+HCDPKIIHRDVKAANILLDED
Sbjct: 403 RRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDED 439

Source: Oryza sativa Indica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|115475023|ref|NP_001061108.1| Os08g0174700 [Oryza sativa Japonica Group] gi|40253600|dbj|BAD05545.1| putative somatic embryogenesis receptor kinase 1 [Oryza sativa Japonica Group] gi|57753893|dbj|BAD86793.1| SERK-family receptor-like protein kinase [Oryza sativa Japonica Group] gi|113623077|dbj|BAF23022.1| Os08g0174700 [Oryza sativa Japonica Group] gi|215736920|dbj|BAG95849.1| unnamed protein product [Oryza sativa Japonica Group] gi|222639998|gb|EEE68130.1| hypothetical protein OsJ_26221 [Oryza sativa Japonica Group]

 Score =  390 bits (1001), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 217/277 (78%), Positives = 235/277 (84%), Gaps = 5/277 (1%)

Query: 1   MTALR--DLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFG 58
           +TAL+  DLSNN LSG VP  GSFS FTPISF NN +LCGP T KPC G+PPFSPPPP+ 
Sbjct: 163 ITALQVLDLSNNNLSGEVPSTGSFSLFTPISFANNPSLCGPGTTKPCPGAPPFSPPPPYN 222

Query: 59  P---TSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQ 115
           P     SPG + S  AI  GVA GAALLFA+P IGFA++RR +P E FFDVPAE+D E+ 
Sbjct: 223 PPTPVQSPGSSSSTGAIAGGVAAGAALLFAIPAIGFAWYRRRKPQEHFFDVPAEEDPEVH 282

Query: 116 LGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ 175
           LGQLKRFSLRELQVATD FSNKNILGRGGFGKVYKGRLADG LVAVKRLKEERT GGELQ
Sbjct: 283 LGQLKRFSLRELQVATDTFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQ 342

Query: 176 FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR 235
           FQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NGSVASRLRER  S PPLDW TR
Sbjct: 343 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASRLRERPPSEPPLDWRTR 402

Query: 236 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           ++IALGSARGLSYLH+HCDPKIIHRDVKAANILLDED
Sbjct: 403 RRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDED 439

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|242078341|ref|XP_002443939.1| hypothetical protein SORBIDRAFT_07g004750 [Sorghum bicolor] gi|241940289|gb|EES13434.1| hypothetical protein SORBIDRAFT_07g004750 [Sorghum bicolor]

 Score =  390 bits (1001), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 219/278 (78%), Positives = 236/278 (84%), Gaps = 6/278 (2%)

Query: 1   MTALR--DLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFG 58
           +TAL+  DLSNN LSG VP  GSFS FTPISF NN NLCGP T KPC G+PPFSPPPP+ 
Sbjct: 169 ITALQVLDLSNNNLSGEVPSTGSFSLFTPISFANNPNLCGPGTTKPCPGAPPFSPPPPYN 228

Query: 59  P---TSSPGRNKS-NAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSEL 114
           P     SPG + S   AI  GVA GAALLFA+P IGFAYWRR +P E FFDVPAE+D E+
Sbjct: 229 PTTPAQSPGSSSSSTGAIAGGVAAGAALLFAIPAIGFAYWRRRKPQEHFFDVPAEEDPEV 288

Query: 115 QLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGEL 174
            LGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADG LVAVKRLKEERT GGEL
Sbjct: 289 HLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGEL 348

Query: 175 QFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPT 234
           QFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NGSVASRLR+R  + PPLDW T
Sbjct: 349 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASRLRDRPPAEPPLDWQT 408

Query: 235 RKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           R++IALGSARGLSYLH+HCDPKIIHRDVKAANILLDED
Sbjct: 409 RRRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDED 446

Source: Sorghum bicolor

Species: Sorghum bicolor

Genus: Sorghum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|418204460|gb|AFX61784.1| somatic embryogenesis receptor-like kinase [Camellia nitidissima]

 Score =  389 bits (998), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 223/277 (80%), Positives = 237/277 (85%), Gaps = 5/277 (1%)

Query: 1   MTALR--DLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFG 58
           +TAL+  DLSNNRLSGPVPDNGSFS FTPISF NN NLCGP T KPC GSPPF+PPPPF 
Sbjct: 163 ITALQVLDLSNNRLSGPVPDNGSFSLFTPISFANNFNLCGPVTGKPCPGSPPFAPPPPFV 222

Query: 59  ---PTSSPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQ 115
                SSP  N +  AI  GVA GAALLFA P IGFA+WRR +PHE FFDVPAE+D E+ 
Sbjct: 223 PPSTISSPSGNSATGAIAGGVAAGAALLFAAPAIGFAWWRRRKPHEHFFDVPAEEDPEVH 282

Query: 116 LGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ 175
           LGQLKRFSLRELQVATD FSNKNILGRGGFGKVYKGRLADG LVAVKRLKEERT GGELQ
Sbjct: 283 LGQLKRFSLRELQVATDTFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQ 342

Query: 176 FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR 235
           FQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NGSVAS LRER  S  PLDWPTR
Sbjct: 343 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSEQPLDWPTR 402

Query: 236 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           K+IALGSARGLSYLH+HCDPKIIHRDVKAANILLDE+
Sbjct: 403 KRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 439

Source: Camellia nitidissima

Species: Camellia nitidissima

Genus: Camellia

Family: Theaceae

Order: Ericales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|413917200|gb|AFW57132.1| putative leucine-rich repeat receptor-like protein kinase family protein [Zea mays]

 Score =  388 bits (996), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 218/278 (78%), Positives = 235/278 (84%), Gaps = 6/278 (2%)

Query: 1   MTALR--DLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFG 58
           +TAL+  DLSNN LSG VP  GSFS FTPISF NN NLCGP T KPC G+PPFSPPPP+ 
Sbjct: 169 ITALQVLDLSNNNLSGEVPSTGSFSLFTPISFGNNPNLCGPGTTKPCPGAPPFSPPPPYN 228

Query: 59  P---TSSPGRNKS-NAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSEL 114
           P     SPG + S   AI  GVA GAALLFA+P I FAYWRR +P E FFDVPAE+D E+
Sbjct: 229 PTTPVQSPGSSSSSTGAIAGGVAAGAALLFAIPAISFAYWRRRKPQEHFFDVPAEEDPEV 288

Query: 115 QLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGEL 174
            LGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADG LVAVKRLKEERT GGEL
Sbjct: 289 HLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGEL 348

Query: 175 QFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPT 234
           QFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NGSVASRLR+R  + PPLDW T
Sbjct: 349 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASRLRDRPPAEPPLDWQT 408

Query: 235 RKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           R++IALGSARGLSYLH+HCDPKIIHRDVKAANILLDED
Sbjct: 409 RQRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDED 446

Source: Zea mays

Species: Zea mays

Genus: Zea

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357139703|ref|XP_003571417.1| PREDICTED: somatic embryogenesis receptor kinase 1-like, partial [Brachypodium distachyon]

 Score =  387 bits (994), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 219/278 (78%), Positives = 234/278 (84%), Gaps = 6/278 (2%)

Query: 1   MTALR--DLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFG 58
           +TAL+  DLSNN+LSG VP  GSFS FTPISF NN  LCGP T KPC G+PPFSPPPP+ 
Sbjct: 153 ITALQVLDLSNNKLSGEVPSTGSFSSFTPISFGNNPALCGPGTSKPCPGAPPFSPPPPYN 212

Query: 59  P---TSSPGRNKS-NAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSEL 114
           P     SPG + S   AI  GVA GAALLFAVP IGFAYWRR +P E FFDVPAE+D E+
Sbjct: 213 PPTPVQSPGSSSSSTGAIAGGVAAGAALLFAVPAIGFAYWRRRKPEEHFFDVPAEEDPEV 272

Query: 115 QLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGEL 174
            LGQLKRFSLRELQVATD FSNKNILGRGGFGKVYKGRL DG LVAVKRLKEERT GGEL
Sbjct: 273 HLGQLKRFSLRELQVATDTFSNKNILGRGGFGKVYKGRLTDGTLVAVKRLKEERTPGGEL 332

Query: 175 QFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPT 234
           QFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NGSVASRLRER  S PPLDW T
Sbjct: 333 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASRLRERGPSEPPLDWQT 392

Query: 235 RKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           R++IALGSARGLSYLH+HCDPKIIHRDVKAANILLDED
Sbjct: 393 RRRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDED 430

Source: Brachypodium distachyon

Species: Brachypodium distachyon

Genus: Brachypodium

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|242065530|ref|XP_002454054.1| hypothetical protein SORBIDRAFT_04g023810 [Sorghum bicolor] gi|241933885|gb|EES07030.1| hypothetical protein SORBIDRAFT_04g023810 [Sorghum bicolor]

 Score =  385 bits (990), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 214/271 (78%), Positives = 227/271 (83%), Gaps = 5/271 (1%)

Query: 6   DLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGP----TS 61
           DLSNN LSG VP  GSFS FTPISF NN  LCGP T KPC G+PPFSPPPPF P    T 
Sbjct: 173 DLSNNNLSGQVPSTGSFSLFTPISFANNPGLCGPGTTKPCPGAPPFSPPPPFNPPSPPTQ 232

Query: 62  SPGRNKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKR 121
           S G + S  AI  GVA GAAL+FAVP I FA WRR +P E FFDVPAE+D E+ LGQLK+
Sbjct: 233 STGAS-STGAIAGGVAAGAALVFAVPAIAFAMWRRRKPEEHFFDVPAEEDPEVHLGQLKK 291

Query: 122 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVK 181
           FSLRELQVATD FSNKNILGRGGFGKVYKGRLADG LVAVKRLKEERT GGELQFQTEV+
Sbjct: 292 FSLRELQVATDNFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGELQFQTEVE 351

Query: 182 IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALG 241
           +ISMAVHRNLLRL GFC T TE+LLVYPYM NGSVASRLRERQ S PPL W TR++IALG
Sbjct: 352 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASRLRERQQSEPPLKWETRRRIALG 411

Query: 242 SARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           SARGLSYLH+HCDPKIIHRDVKAANILLDED
Sbjct: 412 SARGLSYLHDHCDPKIIHRDVKAANILLDED 442

Source: Sorghum bicolor

Species: Sorghum bicolor

Genus: Sorghum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|413917199|gb|AFW57131.1| putative leucine-rich repeat receptor-like protein kinase family protein [Zea mays]

 Score =  385 bits (990), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 218/278 (78%), Positives = 235/278 (84%), Gaps = 6/278 (2%)

Query: 1   MTALR--DLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFG 58
           +TAL+  DLSNN LSG VP  GSFS FTPISF NN NLCGP T KPC G+PPFSPPPP+ 
Sbjct: 169 ITALQVLDLSNNNLSGEVPSTGSFSLFTPISFGNNPNLCGPGTTKPCPGAPPFSPPPPYN 228

Query: 59  P---TSSPGRNKS-NAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSEL 114
           P     SPG + S   AI  GVA GAALLFA+P I FAYWRR +P E FFDVPAE+D E+
Sbjct: 229 PTTPVQSPGSSSSSTGAIAGGVAAGAALLFAIPAISFAYWRRRKPQEHFFDVPAEEDPEV 288

Query: 115 QLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGEL 174
            LGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADG LVAVKRLKEERT GGEL
Sbjct: 289 HLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGSLVAVKRLKEERTPGGEL 348

Query: 175 QFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPT 234
           QFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NGSVASRLR+R  + PPLDW T
Sbjct: 349 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASRLRDRPPAEPPLDWQT 408

Query: 235 RKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           R++IALGSARGLSYLH+HCDPKIIHRDVKAANILLDED
Sbjct: 409 RQRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDED 446

Source: Zea mays

Species: Zea mays

Genus: Zea

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357163915|ref|XP_003579889.1| PREDICTED: somatic embryogenesis receptor kinase 1-like [Brachypodium distachyon]

 Score =  384 bits (987), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 207/270 (76%), Positives = 225/270 (83%), Gaps = 4/270 (1%)

Query: 6   DLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTS---S 62
           DLSNN LSG VP  GSF  FTPISF NNLNLCGP T KPC G+PPFSPPPPF P +   +
Sbjct: 178 DLSNNNLSGEVPSTGSFQLFTPISFANNLNLCGPATTKPCPGAPPFSPPPPFNPPATPVA 237

Query: 63  PGRNKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRF 122
            G +K+ A      A  AAL+FAVP IGFA WRR +P + FFDVPAE+D E+ LGQLKRF
Sbjct: 238 QGDSKTGAIAGGVAAG-AALIFAVPAIGFALWRRRKPEDHFFDVPAEEDPEVHLGQLKRF 296

Query: 123 SLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKI 182
           SLRELQVA+D FSNKNILGRGGFGKVYKGRL DG LVAVKRLKEERT GGELQFQTEV++
Sbjct: 297 SLRELQVASDNFSNKNILGRGGFGKVYKGRLTDGTLVAVKRLKEERTPGGELQFQTEVEM 356

Query: 183 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 242
           ISMAVHRNLLRL GFC T TE+LLVYPYM NGSVASRLRERQ + PPL+WP R +IALGS
Sbjct: 357 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASRLRERQPNEPPLEWPKRTRIALGS 416

Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           ARGLSYLH+HCDPKIIHRDVKAANILLDED
Sbjct: 417 ARGLSYLHDHCDPKIIHRDVKAANILLDED 446

Source: Brachypodium distachyon

Species: Brachypodium distachyon

Genus: Brachypodium

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	284
TAIR|locus:2013021	625	SERK1 "somatic embryogenesis r	0.647	0.294	0.847	5.4e-96
TAIR|locus:2026097	628	SERK2 "somatic embryogenesis r	0.647	0.292	0.826	3.8e-93
TAIR|locus:2040461	620	SERK4 "somatic embryogenesis r	0.647	0.296	0.798	3.5e-86
TAIR|locus:2040471	601	SERK5 "somatic embryogenesis r	0.637	0.301	0.734	2.2e-76
TAIR|locus:2146102	638	NIK1 "NSP-interacting kinase 1	0.623	0.277	0.648	3.3e-63
TAIR|locus:2036636	632	NIK3 "NSP-interacting kinase 3	0.933	0.419	0.503	7.9e-62
TAIR|locus:2160644	614	AT5G63710 [Arabidopsis thalian	0.623	0.288	0.629	3.3e-61
TAIR|locus:2145407	613	AT5G10290 [Arabidopsis thalian	0.605	0.280	0.668	6.9e-61
TAIR|locus:2061466	634	AT2G23950 [Arabidopsis thalian	0.901	0.403	0.471	1.1e-58
TAIR|locus:2118811	648	SARK "SENESCENCE-ASSOCIATED RE	0.901	0.395	0.470	2.3e-58

TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 813 (291.2 bits), Expect = 5.4e-96, Sum P(2) = 5.4e-96
 Identities = 156/184 (84%), Positives = 168/184 (91%)

Query:    89 IGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKV 148
             I FA+WRR +P + FFDVPAE+D E+ LGQLKRFSLRELQVA+DGFSNKNILGRGGFGKV
Sbjct:   257 IAFAWWRRRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKV 316

Query:   149 YKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY 208
             YKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVY
Sbjct:   317 YKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 376

Query:   209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL 268
             PYM NGSVAS LRER  S PPLDWPTRK+IALGSARGLSYLH+HCDPKIIHRDVKAANIL
Sbjct:   377 PYMANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANIL 436

Query:   269 LDED 272
             LDE+
Sbjct:   437 LDEE 440

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0042802 "identical protein binding" evidence=IPI

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=IDA

GO:0009793 "embryo development ending in seed dormancy" evidence=RCA;IMP

GO:0005515 "protein binding" evidence=IPI

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=TAS

GO:0009556 "microsporogenesis" evidence=IGI;IMP

GO:0010152 "pollen maturation" evidence=IMP

GO:0043234 "protein complex" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI;IMP

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0007030 "Golgi organization" evidence=IGI

GO:0010227 "floral organ abscission" evidence=IGI

GO:0000226 "microtubule cytoskeleton organization" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0007062 "sister chromatid cohesion" evidence=RCA

GO:0009880 "embryonic pattern specification" evidence=RCA

GO:0010072 "primary shoot apical meristem specification" evidence=RCA

GO:0010228 "vegetative to reproductive phase transition of meristem" evidence=RCA

GO:0010431 "seed maturation" evidence=RCA

GO:0016310 "phosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0045595 "regulation of cell differentiation" evidence=RCA

GO:0051301 "cell division" evidence=RCA

TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 784 (281.0 bits), Expect = 3.8e-93, Sum P(2) = 3.8e-93
 Identities = 152/184 (82%), Positives = 164/184 (89%)

Query:    89 IGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKV 148
             + FA+WRR +P EFFFDVPAE+D E+ LGQLKRFSLRELQVATD FSNKNILGRGGFGKV
Sbjct:   260 LAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKV 319

Query:   149 YKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY 208
             YKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVY
Sbjct:   320 YKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 379

Query:   209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL 268
             PYM NGSVAS LRER  S  PL W  R++IALGSARGLSYLH+HCDPKIIHRDVKAANIL
Sbjct:   380 PYMANGSVASCLRERPPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANIL 439

Query:   269 LDED 272
             LDE+
Sbjct:   440 LDEE 443

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009556 "microsporogenesis" evidence=IGI;IMP

GO:0010152 "pollen maturation" evidence=IMP

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 765 (274.4 bits), Expect = 3.5e-86, Sum P(2) = 3.5e-86
 Identities = 147/184 (79%), Positives = 160/184 (86%)

Query:    89 IGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKV 148
             I FA+W R +P + FFDVPAE+D E+ LGQLKRF+LREL VATD FSNKN+LGRGGFGKV
Sbjct:   249 IAFAWWLRRKPQDHFFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKV 308

Query:   149 YKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY 208
             YKGRLADG LVAVKRLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVY
Sbjct:   309 YKGRLADGNLVAVKRLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 368

Query:   209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL 268
             PYM NGSVAS LRER    P LDWP RK IALGSARGL+YLH+HCD KIIHRDVKAANIL
Sbjct:   369 PYMANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANIL 428

Query:   269 LDED 272
             LDE+
Sbjct:   429 LDEE 432

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0060548 "negative regulation of cell death" evidence=IMP

GO:1900140 "regulation of seedling development" evidence=IMP

GO:0010200 "response to chitin" evidence=IEP;RCA

GO:0008219 "cell death" evidence=IGI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI

GO:0010150 "leaf senescence" evidence=IGI

GO:0000165 "MAPK cascade" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2040471 SERK5 "somatic embryogenesis receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 676 (243.0 bits), Expect = 2.2e-76, Sum P(2) = 2.2e-76
 Identities = 133/181 (73%), Positives = 148/181 (81%)

Query:    92 AYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKG 151
             A+W R +    F DVPAE+D E+ LGQ KRFSLREL VAT+ FS +N+LG+G FG +YKG
Sbjct:   233 AWWLRRKLQGHFLDVPAEEDPEVYLGQFKRFSLRELLVATEKFSKRNVLGKGRFGILYKG 292

Query:   152 RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM 211
             RLAD  LVAVKRL EERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM
Sbjct:   293 RLADDTLVAVKRLNEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 352

Query:   212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 271
              NGSVAS LRER    P LDWP RK IALGSARGL+YLH+HCD KIIH DVKAANILLDE
Sbjct:   353 ANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHLDVKAANILLDE 412

Query:   272 D 272
             +
Sbjct:   413 E 413

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2146102 NIK1 "NSP-interacting kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 610 (219.8 bits), Expect = 3.3e-63, Sum P(2) = 3.3e-63
 Identities = 118/182 (64%), Positives = 142/182 (78%)

Query:    91 FAYWRRTRPHEFFFDVP-AEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVY 149
             F +WR+      FFDV       E+ LG L+RF  RELQ+AT+ FS+KN+LG+GG+G VY
Sbjct:   268 FLWWRQRHNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVY 327

Query:   150 KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP 209
             KG L D  +VAVKRLK+    GGE+QFQTEV++IS+AVHRNLLRLYGFC T TEKLLVYP
Sbjct:   328 KGILGDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYP 387

Query:   210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 269
             YM+NGSVASR++ +    P LDW  RK+IA+G+ARGL YLHE CDPKIIHRDVKAANILL
Sbjct:   388 YMSNGSVASRMKAK----PVLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILL 443

Query:   270 DE 271
             D+
Sbjct:   444 DD 445

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0051607 "defense response to virus" evidence=IMP

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0009736 "cytokinin mediated signaling pathway" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 632 (227.5 bits), Expect = 7.9e-62, P = 7.9e-62
 Identities = 136/270 (50%), Positives = 166/270 (61%)

Query:     4 LRDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKXXXXXXXXXXXXXXXXXXXX 63
             L D+S N LSG +P   S   F  I    N  +CGP                        
Sbjct:   174 LVDISYNNLSGSLP-KVSARTFKVIG---NALICGPKAVSNCSAVPEPLTLPQDGPDESG 229

Query:    64 XRNKSNXXXXXXXXXXXXXXXXXXXIG-FAYWRRTRPHEFFFDVPAEDDSELQLGQLKRF 122
              R   +                    G F +WR  R  + FFDV  + D E+ LG LKR+
Sbjct:   230 TRTNGHHVALAFAASFSAAFFVFFTSGMFLWWRYRRNKQIFFDVNEQYDPEVSLGHLKRY 289

Query:   123 SLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKI 182
             + +EL+ AT+ F++KNILGRGG+G VYKG L DG LVAVKRLK+   +GGE+QFQTEV+ 
Sbjct:   290 TFKELRSATNHFNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVET 349

Query:   183 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 242
             IS+A+HRNLLRL GFC++  E++LVYPYM NGSVASRL++     P LDW  RKKIA+G+
Sbjct:   350 ISLALHRNLLRLRGFCSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGT 409

Query:   243 ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
             ARGL YLHE CDPKIIHRDVKAANILLDED
Sbjct:   410 ARGLVYLHEQCDPKIIHRDVKAANILLDED 439

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0048653 "anther development" evidence=RCA

TAIR|locus:2160644 AT5G63710 [Arabidopsis thaliana (taxid:3702)]

 Score = 595 (214.5 bits), Expect = 3.3e-61, Sum P(2) = 3.3e-61
 Identities = 112/178 (62%), Positives = 142/178 (79%)

Query:    95 RRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLA 154
             RRT+ ++ FFDV  EDD ++  GQLKRFSLRE+Q+ATD F+  N++G+GGFGKVY+G L 
Sbjct:   251 RRTK-YDIFFDVAGEDDRKISFGQLKRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLP 309

Query:   155 DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG 214
             D   VAVKRL +  + GGE  FQ E+++IS+AVH+NLLRL GFCTT +E++LVYPYM N 
Sbjct:   310 DKTKVAVKRLADYFSPGGEAAFQREIQLISVAVHKNLLRLIGFCTTSSERILVYPYMENL 369

Query:   215 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
             SVA RLR+ ++    LDWPTRK++A GSA GL YLHEHC+PKIIHRD+KAANILLD +
Sbjct:   370 SVAYRLRDLKAGEEGLDWPTRKRVAFGSAHGLEYLHEHCNPKIIHRDLKAANILLDNN 427

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

TAIR|locus:2145407 AT5G10290 [Arabidopsis thaliana (taxid:3702)]

 Score = 592 (213.5 bits), Expect = 6.9e-61, Sum P(2) = 6.9e-61
 Identities = 115/172 (66%), Positives = 136/172 (79%)

Query:   101 EFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVA 160
             + F DV  E D  +  GQLKRF+ RELQ+ATD FS KN+LG+GGFGKVYKG L D   VA
Sbjct:   257 DVFVDVAGEVDRRIAFGQLKRFAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVA 316

Query:   161 VKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL 220
             VKRL +  + GG+  FQ EV++IS+AVHRNLLRL GFCTT TE+LLVYP+M N S+A RL
Sbjct:   317 VKRLTDFESPGGDAAFQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRL 376

Query:   221 RERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
             RE ++  P LDW TRK+IALG+ARG  YLHEHC+PKIIHRDVKAAN+LLDED
Sbjct:   377 REIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLLDED 428

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2061466 AT2G23950 [Arabidopsis thaliana (taxid:3702)]

 Score = 576 (207.8 bits), Expect = 1.1e-58, Sum P(2) = 1.1e-58
 Identities = 126/267 (47%), Positives = 163/267 (61%)

Query:     6 DLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKXXXXXXXXXXXXXXXXXXXXXR 65
             DLS N L GPVP    F   T  +   N  +C  N+                       R
Sbjct:   176 DLSYNNLRGPVP---KFPART-FNVAGNPLIC-KNSLPEICSGSISASPLSVSLRSSSGR 230

Query:    66 NKSNXXXXXXXXXXXXXXXXXXXIGFAYWRRTRPHEFFFDVP-AEDDSELQLGQLKRFSL 124
              ++N                   +GF ++R+ +       +   +++  L LG L+ F+ 
Sbjct:   231 -RTNILAVALGVSLGFAVSVILSLGFIWYRKKQRRLTMLRISDKQEEGLLGLGNLRSFTF 289

Query:   125 RELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIIS 184
             REL VATDGFS+K+ILG GGFG VY+G+  DG +VAVKRLK+   + G  QF+TE+++IS
Sbjct:   290 RELHVATDGFSSKSILGAGGFGNVYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTELEMIS 349

Query:   185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
             +AVHRNLLRL G+C + +E+LLVYPYM+NGSVASRL+ +    P LDW TRKKIA+G+AR
Sbjct:   350 LAVHRNLLRLIGYCASSSERLLVYPYMSNGSVASRLKAK----PALDWNTRKKIAIGAAR 405

Query:   245 GLSYLHEHCDPKIIHRDVKAANILLDE 271
             GL YLHE CDPKIIHRDVKAANILLDE
Sbjct:   406 GLFYLHEQCDPKIIHRDVKAANILLDE 432

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2118811 SARK "SENESCENCE-ASSOCIATED RECEPTOR-LIKE KINASE" [Arabidopsis thaliana (taxid:3702)]

 Score = 570 (205.7 bits), Expect = 2.3e-58, Sum P(2) = 2.3e-58
 Identities = 126/268 (47%), Positives = 161/268 (60%)

Query:     6 DLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKXXXXXXXXXXXXXXXXXXXXXR 65
             DLS N LSGPVP    F   T  +   N  +C  N  +                     R
Sbjct:   179 DLSYNNLSGPVP---KFPART-FNVAGNPLICRSNPPEICSGSINASPLSVSLSSSSGRR 234

Query:    66 NKSNXXXXXXXXXXXXXXXXXXXIG-FAYWRRTRPHEFFFDVPAEDDSELQ-LGQLKRFS 123
               SN                   +G F ++R+ +      ++  + +  LQ LG L+ F+
Sbjct:   235 --SNRLAIALSVSLGSVVILVLALGSFCWYRKKQRRLLILNLNDKQEEGLQGLGNLRSFT 292

Query:   124 LRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKII 183
              REL V TDGFS+KNILG GGFG VY+G+L DG +VAVKRLK+   + G+ QF+ E+++I
Sbjct:   293 FRELHVYTDGFSSKNILGAGGFGNVYRGKLGDGTMVAVKRLKDINGTSGDSQFRMELEMI 352

Query:   184 SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 243
             S+AVH+NLLRL G+C T  E+LLVYPYM NGSVAS+L+ +    P LDW  RK+IA+G+A
Sbjct:   353 SLAVHKNLLRLIGYCATSGERLLVYPYMPNGSVASKLKSK----PALDWNMRKRIAIGAA 408

Query:   244 RGLSYLHEHCDPKIIHRDVKAANILLDE 271
             RGL YLHE CDPKIIHRDVKAANILLDE
Sbjct:   409 RGLLYLHEQCDPKIIHRDVKAANILLDE 436

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010150 "leaf senescence" evidence=IMP

GO:0007267 "cell-cell signaling" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0009616 "virus induced gene silencing" evidence=RCA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009887 "organ morphogenesis" evidence=RCA

GO:0009944 "polarity specification of adaxial/abaxial axis" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010051 "xylem and phloem pattern formation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010267 "production of ta-siRNAs involved in RNA interference" evidence=RCA

GO:0035196 "production of miRNAs involved in gene silencing by miRNA" evidence=RCA

GO:0048438 "floral whorl development" evidence=RCA

GO:0048439 "flower morphogenesis" evidence=RCA

GO:0048519 "negative regulation of biological process" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q94AG2	SERK1_ARATH	2, ., 7, ., 1, 1, ., 1	0.7962	0.9401	0.4272	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: BISERK1 Os08g0174700 (624 aa) (Oryza sativa Indica)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	284
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-36
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-35
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-34
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-33
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-32
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-32
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-32
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-26
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-21
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-19
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-18
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-18
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	8e-18
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-17
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-17
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	6e-17
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-16
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-16
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-16
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-16
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-16
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-16
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-16
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	7e-16
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-15
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-15
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-15
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-15
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-15
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-15
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-15
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-14
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-14
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-14
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-14
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-13
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-13
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-13
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-13
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-13
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-13
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-13
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-13
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	8e-13
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	9e-13
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	9e-13
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-12
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-12
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-12
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-12
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-12
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	6e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-11
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-11
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-11
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-11
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-11
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-11
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-11
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-11
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	6e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-11
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-11
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-11
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-11
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	9e-11
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-10
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-10
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-10
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-10
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-10
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-10
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-10
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-10
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-10
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-10
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-10
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	8e-10
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-09
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-09
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-09
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-09
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-09
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-09
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-09
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-09
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-09
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-09
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-09
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-09
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-09
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	7e-09
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	8e-09
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	8e-09
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	9e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-08
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-08
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-08
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-08
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-08
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-08
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-08
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-08
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-08
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	6e-08
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	6e-08
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-08
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-08
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	7e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-08
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	8e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-07
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-07
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-07
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-07
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-07
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-07
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-07
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-07
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-07
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-07
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-07
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-07
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	6e-07
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	7e-07
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	9e-07
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-06
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-06
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-06
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-06
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-06
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-06
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-06
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-06
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-06
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-06
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	8e-06
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	8e-06
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-05
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-05
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-05
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-05
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-05
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-05
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-05
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-05
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-05
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-05
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-05
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-05
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-05
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-05
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	6e-05
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	7e-05
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	7e-05
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-05
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	8e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	9e-05
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-04
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-04
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-04
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-04
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-04
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-04
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-04
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-04
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-04
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-04
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-04
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	6e-04
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-04
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-04
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	0.001
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	0.001
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	0.001
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	0.001
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	0.002
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	0.002
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	0.002
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	0.002
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	0.002
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	0.002
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	0.002
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	0.002
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	0.003
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	0.003
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	0.003
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	0.003
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  129 bits (326), Expect = 1e-36
 Identities = 51/137 (37%), Positives = 69/137 (50%), Gaps = 7/137 (5%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 198
           LG GGFG VY  R    GK VA+K +K+E +S    +   E++I+    H N+++LYG  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 258
                  LV  Y   GS+   L+E +     L      +I L    GL YLH +    II
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHSN---GII 114

Query: 259 HRDVKAANILLDEDADQ 275
           HRD+K  NILLD D  +
Sbjct: 115 HRDLKPENILLDSDNGK 131

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  126 bits (320), Expect = 3e-35
 Identities = 49/143 (34%), Positives = 68/143 (47%), Gaps = 11/143 (7%)

Query: 135 SNKNILGRGGFGKVYKGRLADGK-----LVAVKRLKEERTSGGELQFQTEVKIISMAVHR 189
           +    LG G FG+VYKG+L          VAVK LKE+ +     +F  E +I+    H 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           N+++L G CT      +V  YM  G + S LR+ +  L           AL  ARG+ YL
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLS---LSDLLSFALQIARGMEYL 118

Query: 250 HEHCDPKIIHRDVKAANILLDED 272
                   IHRD+ A N L+ E+
Sbjct: 119 ESK---NFIHRDLAARNCLVGEN 138

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  124 bits (315), Expect = 2e-34
 Identities = 48/143 (33%), Positives = 67/143 (46%), Gaps = 10/143 (6%)

Query: 135 SNKNILGRGGFGKVYKGRLADGK-----LVAVKRLKEERTSGGELQFQTEVKIISMAVHR 189
           +    LG G FG+VYKG L          VAVK LKE+ +     +F  E +I+    H 
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           N+++L G CT     ++V  YM  G +   LR+ +     L        AL  ARG+ YL
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYL 119

Query: 250 HEHCDPKIIHRDVKAANILLDED 272
                   IHRD+ A N L+ E+
Sbjct: 120 ESK---NFIHRDLAARNCLVGEN 139

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  120 bits (304), Expect = 7e-33
 Identities = 47/140 (33%), Positives = 65/140 (46%), Gaps = 8/140 (5%)

Query: 134 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
           +     LG G FGKVY  R    GKLVA+K +K+++      +   E+KI+    H N++
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
           RLY       +  LV  Y   G +   L++R   L        +         L YLH  
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-RLSE---DEARFYLRQILSALEYLHSK 116

Query: 253 CDPKIIHRDVKAANILLDED 272
               I+HRD+K  NILLDED
Sbjct: 117 ---GIVHRDLKPENILLDED 133

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  119 bits (302), Expect = 2e-32
 Identities = 49/144 (34%), Positives = 67/144 (46%), Gaps = 12/144 (8%)

Query: 138 NILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
             LG G FG+VYKG+L         VAVK LKE+ +      F  E +++    H N++R
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP-----PLDWPTRKKIALGSARGLSY 248
           L G CT      LV  YM  G +   LR+ +   P      L        A+  A+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 249 LHEHCDPKIIHRDVKAANILLDED 272
           L      K +HRD+ A N L+ ED
Sbjct: 121 LASK---KFVHRDLAARNCLVGED 141

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  118 bits (299), Expect = 4e-32
 Identities = 47/138 (34%), Positives = 64/138 (46%), Gaps = 11/138 (7%)

Query: 140 LGRGGFGKVYKGRLADGK-----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           LG G FG+VYKG L          VAVK LKE  +     +F  E  I+    H N++RL
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 195 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 254
            G CT      +V  YM  G +   LR+       L      ++AL  A+G+ YL     
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHG---EKLTLKDLLQMALQIAKGMEYLESK-- 121

Query: 255 PKIIHRDVKAANILLDED 272
              +HRD+ A N L+ E+
Sbjct: 122 -NFVHRDLAARNCLVTEN 138

Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  118 bits (299), Expect = 4e-32
 Identities = 53/136 (38%), Positives = 66/136 (48%), Gaps = 9/136 (6%)

Query: 139 ILGRGGFGKVYKGR-LADGKLVAVKRL-KEERTSGGELQFQTEVKIISMAVHRNLLRLYG 196
            LG G FG VYK +    GK+VAVK L K    S  +   + E++I+    H N++RL  
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 197 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 256
                    LV  Y   G +   L        PL     KKIAL   RGL YLH +    
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSRGG----PLSEDEAKKIALQILRGLEYLHSN---G 118

Query: 257 IIHRDVKAANILLDED 272
           IIHRD+K  NILLDE+
Sbjct: 119 IIHRDLKPENILLDEN 134

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  102 bits (256), Expect = 7e-26
 Identities = 51/139 (36%), Positives = 77/139 (55%), Gaps = 11/139 (7%)

Query: 138 NILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVHRNLLRLY 195
            +LGRG FG VY     D G+L+AVK ++    S  EL   + E++I+S   H N++R Y
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 196 GFCTTVTEK-LLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           G      +  L ++  Y++ GS++S L ++   LP    P  +K       GL+YLH + 
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSS-LLKKFGKLPE---PVIRKYTRQILEGLAYLHSN- 120

Query: 254 DPKIIHRDVKAANILLDED 272
              I+HRD+K ANIL+D D
Sbjct: 121 --GIVHRDIKGANILVDSD 137

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 89.2 bits (222), Expect = 5e-21
 Identities = 51/145 (35%), Positives = 74/145 (51%), Gaps = 16/145 (11%)

Query: 134 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
           F     +G+GGFG+VYK R    GK VA+K +K E     E     E++I+    H N++
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN-EIQILKKCKHPNIV 60

Query: 193 RLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA---LGSARGLSY 248
           + YG      ++L +V  + + GS+   L+    +L      T  +IA       +GL Y
Sbjct: 61  KYYG-SYLKKDELWIVMEFCSGGSLKDLLKSTNQTL------TESQIAYVCKELLKGLEY 113

Query: 249 LHEHCDPKIIHRDVKAANILLDEDA 273
           LH +    IIHRD+KAANILL  D 
Sbjct: 114 LHSN---GIIHRDIKAANILLTSDG 135

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 86.9 bits (216), Expect = 4e-20
 Identities = 44/141 (31%), Positives = 70/141 (49%), Gaps = 9/141 (6%)

Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNL 191
           +   +++GRG FG VYKG  L  G  VA+K++  E+     L+    E+ ++    H N+
Sbjct: 2   YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61

Query: 192 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 251
           ++  G   T     ++  Y  NGS+   + ++    P           L   +GL+YLHE
Sbjct: 62  VKYIGSIETSDSLYIILEYAENGSLRQII-KKFGPFPESLVAVYVYQVL---QGLAYLHE 117

Query: 252 HCDPKIIHRDVKAANILLDED 272
                +IHRD+KAANIL  +D
Sbjct: 118 Q---GVIHRDIKAANILTTKD 135

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 85.3 bits (212), Expect = 2e-19
 Identities = 42/146 (28%), Positives = 68/146 (46%), Gaps = 17/146 (11%)

Query: 134 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNL 191
           +     +G G +G+VYK R    G+LVA+K+++ E    G  +    E+K++    H N+
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60

Query: 192 LRLYGFCTTVTEKL-----LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
           +RL      VT K      +V+ YM +  +   L   +           K        GL
Sbjct: 61  VRLKE---IVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTE---SQIKCYMKQLLEGL 113

Query: 247 SYLHEHCDPKIIHRDVKAANILLDED 272
            YLH +    I+HRD+K +NIL++ D
Sbjct: 114 QYLHSN---GILHRDIKGSNILINND 136

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 84.8 bits (208), Expect = 1e-18
 Identities = 49/146 (33%), Positives = 68/146 (46%), Gaps = 9/146 (6%)

Query: 133 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGEL--QFQTEVKII-SMAVHR 189
            +     LG G FG+VY  R  D KLVA+K L ++  S  +   +F  E++I+ S+    
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           N+++LY F        LV  Y+  GS+   L++     P L       I       L YL
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGP-LSESEALFILAQILSALEYL 117

Query: 250 HEHCDPKIIHRDVKAANILLDEDADQ 275
           H      IIHRD+K  NILLD D   
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRV 140

Length = 384

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 82.8 bits (205), Expect = 1e-18
 Identities = 45/139 (32%), Positives = 65/139 (46%), Gaps = 10/139 (7%)

Query: 138 NILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
            ++G G FG+V +GRL         VA+K LK   +    L F TE  I+    H N++R
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           L G  T     +++  YM NGS+   LRE               +  G A G+ YL E  
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQL---VGMLRGIASGMKYLSEMN 126

Query: 254 DPKIIHRDVKAANILLDED 272
               +HRD+ A NIL++ +
Sbjct: 127 ---YVHRDLAARNILVNSN 142

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 80.8 bits (200), Expect = 5e-18
 Identities = 43/145 (29%), Positives = 68/145 (46%), Gaps = 16/145 (11%)

Query: 134 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
           F     LG G +G VYK      G++VA+K +          +   E+ I+       ++
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PVEEDLQEIIKEISILKQCDSPYIV 61

Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL---GSARGLSYL 249
           + YG     T+  +V  Y   GSV+  ++    +L      T ++IA     + +GL YL
Sbjct: 62  KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTL------TEEEIAAILYQTLKGLEYL 115

Query: 250 HEHCDPKIIHRDVKAANILLDEDAD 274
           H +   K IHRD+KA NILL+E+  
Sbjct: 116 HSN---KKIHRDIKAGNILLNEEGQ 137

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 81.0 bits (200), Expect = 8e-18
 Identities = 45/152 (29%), Positives = 68/152 (44%), Gaps = 19/152 (12%)

Query: 137 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
           K  LG G FGKV+ G     +      LVAVK LKE  ++     F+ E ++++   H N
Sbjct: 10  KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK----------KIAL 240
           +++ YG CT     ++V+ YM +G +   LR        L  P             +IA+
Sbjct: 70  IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 241 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
             A G+ YL        +HRD+   N L+  D
Sbjct: 130 QIASGMVYLASQ---HFVHRDLATRNCLVGYD 158

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 80.1 bits (198), Expect = 1e-17
 Identities = 44/136 (32%), Positives = 64/136 (47%), Gaps = 8/136 (5%)

Query: 137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 196
              +G+G FG V  G    G+ VAVK LK++  S     F  E  +++   H NL++L G
Sbjct: 11  GATIGKGEFGDVMLGDYR-GQKVAVKCLKDD--STAAQAFLAEASVMTTLRHPNLVQLLG 67

Query: 197 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 256
                    +V  YM  GS+   LR R  ++  L    +   AL    G+ YL E     
Sbjct: 68  VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLA--QQLGFALDVCEGMEYLEEK---N 122

Query: 257 IIHRDVKAANILLDED 272
            +HRD+ A N+L+ ED
Sbjct: 123 FVHRDLAARNVLVSED 138

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 79.6 bits (197), Expect = 2e-17
 Identities = 57/180 (31%), Positives = 83/180 (46%), Gaps = 39/180 (21%)

Query: 130 ATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVK--RLKEERTSGGELQFQTEVKII-SM 185
            T  F    ++G G +GKVYK R    G+LVA+K   + E+     E + + E  I+   
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE----EEEIKEEYNILRKY 59

Query: 186 AVHRNLLRLYGF-----CTTVTEKL-LVYPYMTNGSV---ASRLRERQSSLPPLDWPTRK 236
           + H N+   YG           ++L LV      GSV      LR++   L   +W    
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKE-EW---- 114

Query: 237 KIAL---GSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 283
            IA     + RGL+YLHE+   K+IHRD+K  NILL ++A+          Q   T+ RR
Sbjct: 115 -IAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR 170

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 79.0 bits (195), Expect = 3e-17
 Identities = 41/135 (30%), Positives = 68/135 (50%), Gaps = 10/135 (7%)

Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           +G+G FG VYKG L     VAVK  +       + +F  E +I+    H N+++L G C 
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62

Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK--KIALGSARGLSYLHEHCDPKI 257
                 +V   +  GS+ + LR++++ L       +K  +++L +A G+ YL        
Sbjct: 63  QKQPIYIVMELVPGGSLLTFLRKKKNRL-----TVKKLLQMSLDAAAGMEYLESKN---C 114

Query: 258 IHRDVKAANILLDED 272
           IHRD+ A N L+ E+
Sbjct: 115 IHRDLAARNCLVGEN 129

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 77.9 bits (193), Expect = 6e-17
 Identities = 44/143 (30%), Positives = 69/143 (48%), Gaps = 21/143 (14%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QTEVKIISMAVHRNLLRLYGF 197
           +G+G FGKVY  R  +DGKL  +K +     S  E +    EVKI+    H N+++ Y  
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE- 66

Query: 198 CTTVTEKLL--VYPYMTNGSVASRLRERQSSLPP------LDWPTRKKIALGSARGLSYL 249
            +   +  L  V  Y   G ++ ++++++    P      LDW    ++ L     L YL
Sbjct: 67  -SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV--QLCLA----LKYL 119

Query: 250 HEHCDPKIIHRDVKAANILLDED 272
           H     KI+HRD+K  NI L  +
Sbjct: 120 HSR---KILHRDIKPQNIFLTSN 139

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 77.6 bits (192), Expect = 1e-16
 Identities = 42/134 (31%), Positives = 65/134 (48%), Gaps = 13/134 (9%)

Query: 140 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG-F 197
           LG+G  G VYK R    GK+ A+K++  +       Q   E+K +       +++ YG F
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68

Query: 198 CT--TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
                ++   +V  YM  GS+A  L+ +   +P    P    IA    +GL YLH     
Sbjct: 69  YKEGEIS---IVLEYMDGGSLADLLK-KVGKIPE---PVLAYIARQILKGLDYLHT--KR 119

Query: 256 KIIHRDVKAANILL 269
            IIHRD+K +N+L+
Sbjct: 120 HIIHRDIKPSNLLI 133

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 77.4 bits (191), Expect = 1e-16
 Identities = 47/146 (32%), Positives = 72/146 (49%), Gaps = 17/146 (11%)

Query: 140 LGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
           LG+G FG VY+G LA G +       VA+K + E  +    ++F  E  ++      +++
Sbjct: 14  LGQGSFGMVYEG-LAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72

Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---SLPPLDWPTRKKI---ALGSARGL 246
           RL G  +T    L+V   M  G + S LR R+    + P L  PT +K    A   A G+
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 247 SYLHEHCDPKIIHRDVKAANILLDED 272
           +YL      K +HRD+ A N ++ ED
Sbjct: 133 AYLAAK---KFVHRDLAARNCMVAED 155

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 77.1 bits (190), Expect = 1e-16
 Identities = 45/141 (31%), Positives = 71/141 (50%), Gaps = 10/141 (7%)

Query: 134 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
           F+ +  LG G FG+V++G   +   VA+K LK +     +  FQ EV+ +    H++L+ 
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQ-DFQKEVQALKRLRHKHLIS 66

Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLR--ERQSSLPPLDWPTRKKIALGSARGLSYLHE 251
           L+  C+      ++   M  GS+ + LR  E Q     L   +   +A   A G++YL E
Sbjct: 67  LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV----LPVASLIDMACQVAEGMAYLEE 122

Query: 252 HCDPKIIHRDVKAANILLDED 272
                 IHRD+ A NIL+ ED
Sbjct: 123 Q---NSIHRDLAARNILVGED 140

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 76.5 bits (189), Expect = 3e-16
 Identities = 48/162 (29%), Positives = 69/162 (42%), Gaps = 21/162 (12%)

Query: 134 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
           F+    +G+G FG+VYK       ++VA+K +  E         Q E++ +S      + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 193 RLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 251
           + YG       KL ++  Y   GS    L+        LD      I      GL YLHE
Sbjct: 63  KYYG-SFLKGSKLWIIMEYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHE 116

Query: 252 HCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 283
                 IHRD+KAANILL E+ D          Q + T+ +R
Sbjct: 117 E---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 75.9 bits (187), Expect = 3e-16
 Identities = 45/139 (32%), Positives = 71/139 (51%), Gaps = 14/139 (10%)

Query: 140 LGRGGFGKVYKG-RLADGKLVAVKRLK---EERTSGGEL-QFQTEVKIISMAVHRNLLRL 194
           LG G FG VY+G  L DG   AVK +    + +T    + Q + E+ ++S   H N+++ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 195 YGFCTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
            G      + L ++   +  GS+A  L++  S   P+     ++I LG    L YLH   
Sbjct: 68  LG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLH--- 119

Query: 254 DPKIIHRDVKAANILLDED 272
           D   +HRD+K ANIL+D +
Sbjct: 120 DRNTVHRDIKGANILVDTN 138

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 78.0 bits (192), Expect = 4e-16
 Identities = 71/274 (25%), Positives = 116/274 (42%), Gaps = 42/274 (15%)

Query: 6   DLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGR 65
           ++S+N L G +P  G+F      +   N++LCG +T    SG PP              +
Sbjct: 577 NISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTT---SGLPP---------CKRVRK 624

Query: 66  NKSNAAIPVGVALGAALLFAVPVIGFAYWRRTRPHEFFFDVPAEDDS-ELQLGQLKRFSL 124
             S     +   LGA L+ A+   GF + R     E    V  ED + ELQ    K    
Sbjct: 625 TPSWWFY-ITCTLGAFLVLALVAFGFVFIRGRNNLELK-RVENEDGTWELQFFDSKVSKS 682

Query: 125 RELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKE-------ERTSGGELQF 176
             +         +N++ RG  G  YKG+ + +G    VK + +       E    G+LQ 
Sbjct: 683 ITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQ- 741

Query: 177 QTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK 236
                      H N+++L G C +     L++ Y+   +++  LR        L W  R+
Sbjct: 742 -----------HPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRR 783

Query: 237 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 270
           KIA+G A+ L +LH  C P ++  ++    I++D
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID 817

Length = 968

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 76.0 bits (188), Expect = 4e-16
 Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 15/144 (10%)

Query: 134 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT----EVKIISMAVH 188
           +     LG G +G VYK R    G++VA+K+++ +    G     +    E+ ++    H
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG---IPSTALREISLLKELKH 57

Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 248
            N+++L     T  +  LV+ Y     +   L +R   L P      K I     RGL+Y
Sbjct: 58  PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSP---NLIKSIMYQLLRGLAY 113

Query: 249 LHEHCDPKIIHRDVKAANILLDED 272
            H H   +I+HRD+K  NIL++ D
Sbjct: 114 CHSH---RILHRDLKPQNILINRD 134

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 75.6 bits (186), Expect = 6e-16
 Identities = 51/151 (33%), Positives = 67/151 (44%), Gaps = 12/151 (7%)

Query: 128 QVATDGFSNKNILGRGGFGKVYKG--RLADGKL----VAVKRLKEERTSGGELQFQTEVK 181
           +V  D  +    LG G FG+VY+G  R  DG      VAVK L E  +   E  F  E  
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 182 IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE---RQSSLPPLDWPTRKKI 238
           I+S   H+N++RL G       + ++   M  G + S LRE   R      L        
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121

Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 269
           A   A+G  YL E+     IHRD+ A N LL
Sbjct: 122 ARDVAKGCKYLEEN---HFIHRDIAARNCLL 149

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 75.0 bits (184), Expect = 7e-16
 Identities = 48/137 (35%), Positives = 77/137 (56%), Gaps = 12/137 (8%)

Query: 139 ILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 198
           +LG+G FG+V+KG L D   VAVK  KE+     +++F +E +I+    H N+++L G C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK--KIALGSARGLSYLH-EHCDP 255
           T      +V   +  G   S LR+++  L      T++  K AL +A G++YL  ++C  
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDEL-----KTKQLVKFALDAAAGMAYLESKNC-- 114

Query: 256 KIIHRDVKAANILLDED 272
             IHRD+ A N L+ E+
Sbjct: 115 --IHRDLAARNCLVGEN 129

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 73.7 bits (182), Expect = 2e-15
 Identities = 51/139 (36%), Positives = 67/139 (48%), Gaps = 16/139 (11%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRL-Y 195
           LG+G FGKV   R    GKL A+K LK+++           TE  I+S   H  +++L Y
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 196 GFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-LGSARGLSYLHEHC 253
            F T   EKL LV  Y   G + S L  ++      +   R   A +  A  L YLH   
Sbjct: 61  AFQTE--EKLYLVLEYAPGGELFSHLS-KEGRFS--EERARFYAAEIVLA--LEYLHSL- 112

Query: 254 DPKIIHRDVKAANILLDED 272
              II+RD+K  NILLD D
Sbjct: 113 --GIIYRDLKPENILLDAD 129

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 73.1 bits (179), Expect = 3e-15
 Identities = 40/133 (30%), Positives = 67/133 (50%), Gaps = 8/133 (6%)

Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           +G G FG V+ G   + + VA+K ++E   S  E  F  E +++    H  L++LYG CT
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
             +   LV+ +M +G ++  LR ++         T   + L    G++YL       +IH
Sbjct: 70  ERSPICLVFEFMEHGCLSDYLRAQRGKFSQ---ETLLGMCLDVCEGMAYLESSN---VIH 123

Query: 260 RDVKAANILLDED 272
           RD+ A N L+ E+
Sbjct: 124 RDLAARNCLVGEN 136

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 73.1 bits (180), Expect = 3e-15
 Identities = 46/137 (33%), Positives = 71/137 (51%), Gaps = 13/137 (9%)

Query: 138 NILGRGGFGKVYKG-RLADGKLVAVK--RLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           N +G G FGKVY    L  G+L+AVK  R+++      + +   E+K++ +  H NL++ 
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIK-EIADEMKVLELLKHPNLVKY 64

Query: 195 YGFCTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           YG      EK+ ++  Y + G++   L   +     LD    +   L    GL+YLH H 
Sbjct: 65  YGV-EVHREKVYIFMEYCSGGTLEELLEHGRI----LDEHVIRVYTLQLLEGLAYLHSH- 118

Query: 254 DPKIIHRDVKAANILLD 270
              I+HRD+K ANI LD
Sbjct: 119 --GIVHRDIKPANIFLD 133

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 73.6 bits (181), Expect = 4e-15
 Identities = 40/146 (27%), Positives = 65/146 (44%), Gaps = 19/146 (13%)

Query: 138 NILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQ---FQTEVKIISMAVHR 189
             LG G FGKV   R        G+ VAVK L     SG E     F+ E++I+    H 
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLN---HSGEEQHRSDFEREIEILRTLDHE 66

Query: 190 NLLRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           N+++  G C     +   L+  Y+ +GS+   L+  +     ++       +    +G+ 
Sbjct: 67  NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMD 123

Query: 248 YLHEHCDPKIIHRDVKAANILLDEDA 273
           YL      + IHRD+ A NIL++ + 
Sbjct: 124 YLGSQ---RYIHRDLAARNILVESED 146

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 73.2 bits (180), Expect = 5e-15
 Identities = 41/139 (29%), Positives = 72/139 (51%), Gaps = 18/139 (12%)

Query: 139 ILGRGGFGKVYKGR-LADG---KL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
           +LG G FG VYKG  + +G   K+ VA+K L+EE +     +   E  +++   H +++R
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYLH 250
           L G C +     L+   M  G +   +R  + ++     L+W       +  A+G+SYL 
Sbjct: 74  LLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYLE 126

Query: 251 EHCDPKIIHRDVKAANILL 269
           E    +++HRD+ A N+L+
Sbjct: 127 EK---RLVHRDLAARNVLV 142

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 72.5 bits (178), Expect = 5e-15
 Identities = 46/137 (33%), Positives = 64/137 (46%), Gaps = 16/137 (11%)

Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG V+ G+      VA+K ++E   S  E  F  E K++    H NL++LYG CT
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS--EDDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA----RGLSYLHEHCDP 255
                 +V  YM NG + + LRER+  L         +  L         + YL  +   
Sbjct: 70  KQRPIFIVTEYMANGCLLNYLRERKGKL-------GTEWLLDMCSDVCEAMEYLESNG-- 120

Query: 256 KIIHRDVKAANILLDED 272
             IHRD+ A N L+ ED
Sbjct: 121 -FIHRDLAARNCLVGED 136

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 72.7 bits (179), Expect = 5e-15
 Identities = 46/141 (32%), Positives = 66/141 (46%), Gaps = 6/141 (4%)

Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
           D       LG G  G V K      GK++AVK ++ E     + Q   E+ I+       
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
           ++  YG      +  +   YM  GS+   L+E Q  +P        KIA+   +GL+YLH
Sbjct: 61  IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPE---RILGKIAVAVLKGLTYLH 117

Query: 251 EHCDPKIIHRDVKAANILLDE 271
           E    KIIHRDVK +NIL++ 
Sbjct: 118 E--KHKIIHRDVKPSNILVNS 136

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 71.8 bits (176), Expect = 2e-14
 Identities = 48/158 (30%), Positives = 73/158 (46%), Gaps = 27/158 (17%)

Query: 140 LGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
           +G+G FG+V++ R           +VAVK LKEE ++  +  FQ E  +++   H N+++
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRER----QSSL--------------PPLDWPTR 235
           L G C       L++ YM  G +   LR R    Q SL               PL    +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 236 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA 273
             IA   A G++YL E    K +HRD+   N L+ E+ 
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENM 167

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 70.7 bits (173), Expect = 3e-14
 Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 13/138 (9%)

Query: 139 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-----FQTEVKIISMAVHRNLL 192
            LG G F   Y+ R +  G L+AVK++   R +  E +      + E+++++   H +++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
           R+ G     +   L   +M  GSV+  L    S                  RGLSYLHE+
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLL----SKYGAFKEAVIINYTEQLLRGLSYLHEN 122

Query: 253 CDPKIIHRDVKAANILLD 270
              +IIHRDVK AN+L+D
Sbjct: 123 ---QIIHRDVKGANLLID 137

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 70.4 bits (173), Expect = 3e-14
 Identities = 44/132 (33%), Positives = 61/132 (46%), Gaps = 7/132 (5%)

Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG+V+ G       VAVK LK    S     F  E +I+    H  L++LY  C+
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA--FLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 +V  YM+ GS+   L+  +     L  P    +A   A G++YL        IH
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYLESR---NYIH 126

Query: 260 RDVKAANILLDE 271
           RD+ A NIL+ E
Sbjct: 127 RDLAARNILVGE 138

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 70.0 bits (172), Expect = 5e-14
 Identities = 38/135 (28%), Positives = 65/135 (48%), Gaps = 9/135 (6%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGF 197
           +G G  G V+K +    G+ VA+K++   R  GG   Q   E+K +    H  +++L   
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 198 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
               +  +LV  YM    ++  LR+ +  LP       K       +G++Y+H +    I
Sbjct: 68  FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPE---AQVKSYMRMLLKGVAYMHAN---GI 120

Query: 258 IHRDVKAANILLDED 272
           +HRD+K AN+L+  D
Sbjct: 121 MHRDLKPANLLISAD 135

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 69.3 bits (170), Expect = 7e-14
 Identities = 49/134 (36%), Positives = 63/134 (47%), Gaps = 10/134 (7%)

Query: 140 LGRGGFGKVYKGRL--ADGKL--VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           LG G FG V +G    + GK+  VAVK LK ++ S     F  E  I+    H NL+RLY
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G   T     +V      GS+  RLR+    L      T    A+  A G+ YL      
Sbjct: 63  GVVLTHPLM-MVTELAPLGSLLDRLRKDA--LGHFLISTLCDYAVQIANGMRYLESK--- 116

Query: 256 KIIHRDVKAANILL 269
           + IHRD+ A NILL
Sbjct: 117 RFIHRDLAARNILL 130

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 69.1 bits (169), Expect = 1e-13
 Identities = 42/137 (30%), Positives = 65/137 (47%), Gaps = 10/137 (7%)

Query: 137 KNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           K+ LG G +G+VY+G        VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 68

Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRE-RQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 254
           G CT      ++  +MT G++   LRE  +  +  +       +A   +  + YL +   
Sbjct: 69  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKK-- 123

Query: 255 PKIIHRDVKAANILLDE 271
              IHRD+ A N L+ E
Sbjct: 124 -NFIHRDLAARNCLVGE 139

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 69.3 bits (170), Expect = 1e-13
 Identities = 45/140 (32%), Positives = 68/140 (48%), Gaps = 9/140 (6%)

Query: 138 NILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 196
            ++G G    VY    L + + VA+KR+  E+      + + EV+ +S   H N+++ Y 
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 197 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP--LDWPTRKKIALGSARGLSYLHEHCD 254
                 E  LV PY++ GS+   ++   SS P   LD      +     +GL YLH +  
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLDIMK---SSYPRGGLDEAIIATVLKEVLKGLEYLHSN-- 121

Query: 255 PKIIHRDVKAANILLDEDAD 274
              IHRD+KA NILL ED  
Sbjct: 122 -GQIHRDIKAGNILLGEDGS 140

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 1e-13
 Identities = 52/158 (32%), Positives = 76/158 (48%), Gaps = 24/158 (15%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 198
           +G G +G VYK R +A G+LVA+K +K E     E   Q E+ ++    H N++  +G  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFE-IIQQEISMLKECRHPNIVAYFGSY 69

Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL---GSARGLSYLHEHCDP 255
               +  +V  Y   GS+    +  +  L  L      +IA     + +GL+YLHE    
Sbjct: 70  LRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL------QIAYVCRETLKGLAYLHET--- 120

Query: 256 KIIHRDVKAANILLDEDAD----------QSSKTILRR 283
             IHRD+K ANILL ED D          Q + TI +R
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR 158

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 69.1 bits (169), Expect = 1e-13
 Identities = 45/147 (30%), Positives = 71/147 (48%), Gaps = 16/147 (10%)

Query: 139 ILGRGGFGKVYKGRLA--DGKL--VAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLR 193
           ILG G FG V +G+L+  DG    VAVK +K +  +  E++ F +E   +    H N+++
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 194 LYGFCTTVTEK------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRK--KIALGSARG 245
           L G C   +        +++ P+M +G + S L   +    P   P +   K  +  A G
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 246 LSYLHEHCDPKIIHRDVKAANILLDED 272
           + YL        IHRD+ A N +L ED
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLRED 149

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 68.9 bits (168), Expect = 1e-13
 Identities = 44/150 (29%), Positives = 65/150 (43%), Gaps = 21/150 (14%)

Query: 140 LGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
           LG G FGKV+           D  LVAVK LKE  +      FQ E +++++  H++++R
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVR 71

Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRE-----------RQSSLPPLDWPTRKKIALGS 242
            YG CT     L+V+ YM +G +   LR               +   L       IA   
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           A G+ YL        +HRD+   N L+ + 
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQG 158

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 68.4 bits (167), Expect = 1e-13
 Identities = 44/133 (33%), Positives = 64/133 (48%), Gaps = 8/133 (6%)

Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 +V  YM+NG + + LRE      P       ++      G++YL      + IH
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL---LEMCKDVCEGMAYLESK---QFIH 123

Query: 260 RDVKAANILLDED 272
           RD+ A N L+D+ 
Sbjct: 124 RDLAARNCLVDDQ 136

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 67.3 bits (164), Expect = 3e-13
 Identities = 46/134 (34%), Positives = 67/134 (50%), Gaps = 9/134 (6%)

Query: 140 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 198
           +GRG FG+V+ GRL AD   VAVK  +E      + +F  E +I+    H N++RL G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH-EHCDPKI 257
           T      +V   +  G   + LR   +  P L      ++   +A G+ YL  +HC    
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYLESKHC---- 115

Query: 258 IHRDVKAANILLDE 271
           IHRD+ A N L+ E
Sbjct: 116 IHRDLAARNCLVTE 129

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 67.7 bits (165), Expect = 4e-13
 Identities = 42/140 (30%), Positives = 67/140 (47%), Gaps = 10/140 (7%)

Query: 135 SNKNILGRGGFGKVYKGRL-ADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
           + + ++G G FG+V++G L   G+    VA+K LK   T      F +E  I+    H N
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
           ++RL G  T     +++  YM NG++   LR+              +   G A G+ YL 
Sbjct: 68  IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYL- 123

Query: 251 EHCDPKIIHRDVKAANILLD 270
              D   +HRD+ A NIL++
Sbjct: 124 --SDMNYVHRDLAARNILVN 141

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 67.2 bits (164), Expect = 5e-13
 Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 10/138 (7%)

Query: 139 ILGRGGFGKVYKGRL-ADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           ++G G FG+V +GRL   GK    VA+K LK   T      F +E  I+    H N++ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 195 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 254
            G  T     +++  +M NG++ S LR+       +       +  G A G+ YL E   
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYLSEM-- 125

Query: 255 PKIIHRDVKAANILLDED 272
              +HRD+ A NIL++ +
Sbjct: 126 -NYVHRDLAARNILVNSN 142

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 67.1 bits (164), Expect = 6e-13
 Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 27/153 (17%)

Query: 140 LGRGGFGKVYKGRL---ADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
           LG G FGKVYKG L    +      VA+K LKE      + +F+ E +++S   H N++ 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 194 LYGFCTTVTEKLLVYPYMTNGSV---------------ASRLRERQSSLPPLDWPTRKKI 238
           L G CT      +++ Y+ +G +                S     +SSL   D+     I
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF---LHI 129

Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 271
           A+  A G+ YL  H     +HRD+ A N L+ E
Sbjct: 130 AIQIAAGMEYLSSH---HFVHRDLAARNCLVGE 159

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 66.9 bits (164), Expect = 7e-13
 Identities = 43/150 (28%), Positives = 69/150 (46%), Gaps = 25/150 (16%)

Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
           + N   +G G  G+VYK    A GK VA+K+++  + +  +     E+ I+    H N++
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQN--KELIINEILIMKDCKHPNIV 78

Query: 193 RLYGFCTTVTEKL-LVYPYMTNGSVA-------SRLRERQSSLPPLDWPTRKKIALGSAR 244
             Y     V ++L +V  YM  GS+         R+ E Q +           +     +
Sbjct: 79  DYYD-SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA----------YVCREVLQ 127

Query: 245 GLSYLHEHCDPKIIHRDVKAANILLDEDAD 274
           GL YLH      +IHRD+K+ NILL +D  
Sbjct: 128 GLEYLHSQ---NVIHRDIKSDNILLSKDGS 154

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 66.4 bits (162), Expect = 8e-13
 Identities = 42/138 (30%), Positives = 68/138 (49%), Gaps = 14/138 (10%)

Query: 139 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEER----TSGGELQFQTEVKIISMAVHRNLLR 193
           +LG+G FG+VY     D G+ +AVK++  +     T       + E++++    H  +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 194 LYGFCTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
            YG C    E L ++  YM  GSV  +L+    +   L     +K       G+ YLH +
Sbjct: 69  YYG-CLRDDETLSIFMEYMPGGSVKDQLK----AYGALTETVTRKYTRQILEGVEYLHSN 123

Query: 253 CDPKIIHRDVKAANILLD 270
               I+HRD+K ANIL D
Sbjct: 124 ---MIVHRDIKGANILRD 138

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 66.3 bits (162), Expect = 9e-13
 Identities = 42/132 (31%), Positives = 60/132 (45%), Gaps = 7/132 (5%)

Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG+V++G   +   VAVK LK       +  F  E +I+    H  L++LY  CT
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKD--FLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 +V   M  GS+   L+        L  P    +A   A G++YL        IH
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRA--LKLPQLIDMAAQVASGMAYLEAQ---NYIH 126

Query: 260 RDVKAANILLDE 271
           RD+ A N+L+ E
Sbjct: 127 RDLAARNVLVGE 138

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 66.5 bits (162), Expect = 9e-13
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 12/137 (8%)

Query: 138 NILGRGGFGKVYKGRLADGKLVAVKR--LKEERTSGGELQF---QTEVKIISMAVHRNLL 192
            +LG+G +G VY G    G+L+AVK+  L        E ++   Q EV ++    H N++
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
           +  G C       +   ++  GS++S L        PL  P   K       G++YLH +
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN 121

Query: 253 CDPKIIHRDVKAANILL 269
           C   ++HRD+K  N++L
Sbjct: 122 C---VVHRDIKGNNVML 135

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 66.3 bits (162), Expect = 1e-12
 Identities = 49/139 (35%), Positives = 70/139 (50%), Gaps = 14/139 (10%)

Query: 140 LGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 197
           LG G FGKVYK +  + G   A K ++ E  S  EL+ F  E+ I+S   H N++ LY  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYE- 69

Query: 198 CTTVTE-KLLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
                E KL +   +   G++ S + E +     L  P  + +       L++LH H   
Sbjct: 70  -AYFYENKLWILIEFCDGGALDSIMLELER---GLTEPQIRYVCRQMLEALNFLHSH--- 122

Query: 256 KIIHRDVKAANILLDEDAD 274
           K+IHRD+KA NILL  D D
Sbjct: 123 KVIHRDLKAGNILLTLDGD 141

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 64.9 bits (158), Expect = 3e-12
 Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 13/153 (8%)

Query: 138 NILGRGGFGKVYKGRLAD------GKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
           N LG G FG+VY+G   D      G + VAVK L++  T   + +F  E  ++S   H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE-RQSSLPP--LDWPTRKKIALGSARGLS 247
           +++L G C     + ++   M  G + S LR+ R     P  L       I L  A+G  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 248 YLHEHCDPKIIHRDVKAANILLDEDADQSSKTI 280
           YL        IHRD+ A N L+ E    + + +
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVV 150

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 65.0 bits (158), Expect = 3e-12
 Identities = 50/159 (31%), Positives = 72/159 (45%), Gaps = 29/159 (18%)

Query: 139 ILGRGGFGKVYKGR------LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
            LG G FGKV K         A    VAVK LKE  +S       +E  ++    H +++
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP------------PLDWPTRKKIAL 240
           +LYG C+     LL+  Y   GS+ S LRE +   P             LD P  + + +
Sbjct: 67  KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 241 GS--------ARGLSYLHEHCDPKIIHRDVKAANILLDE 271
           G         +RG+ YL E    K++HRD+ A N+L+ E
Sbjct: 127 GDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAE 162

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 65.1 bits (159), Expect = 3e-12
 Identities = 46/156 (29%), Positives = 69/156 (44%), Gaps = 28/156 (17%)

Query: 139 ILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRNL 191
            LG G FG+V K              VAVK LK++ T        +E++++ M   H+N+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 192 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP-------LDWPTRKKI------ 238
           + L G CT      +V  Y  +G++   LR R+   PP          P  + +      
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARR---PPGEYASPDDPRPPEETLTQKDLV 135

Query: 239 --ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
             A   ARG+ +L      K IHRD+ A N+L+ ED
Sbjct: 136 SFAYQVARGMEFLASK---KCIHRDLAARNVLVTED 168

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 64.6 bits (158), Expect = 4e-12
 Identities = 41/137 (29%), Positives = 62/137 (45%), Gaps = 13/137 (9%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---EVKIISMAVHRNLLRLY 195
           +G G +G V K R  A G++VA+K+ KE      E   +T   EVK++    H N++ L 
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLRHENIVNLK 66

Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
                     LV+ Y+   ++   L      LPP      +       + ++Y H H   
Sbjct: 67  EAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPD---AVRSYIWQLLQAIAYCHSH--- 119

Query: 256 KIIHRDVKAANILLDED 272
            IIHRD+K  NIL+ E 
Sbjct: 120 NIIHRDIKPENILVSES 136

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 64.4 bits (157), Expect = 5e-12
 Identities = 35/142 (24%), Positives = 64/142 (45%), Gaps = 14/142 (9%)

Query: 139 ILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
            LGRG FG+V+  +           LV VK L++ +    + +F+ E+ +     H+N++
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 193 RLYGFCTTVTEKLLVYPYMTNGS-----VASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           RL G C       ++  Y   G       A++ ++ +   PPL    +  +    A G+ 
Sbjct: 72  RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131

Query: 248 YLHEHCDPKIIHRDVKAANILL 269
           +L      + +HRD+ A N L+
Sbjct: 132 HLSNA---RFVHRDLAARNCLV 150

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 64.0 bits (156), Expect = 6e-12
 Identities = 40/144 (27%), Positives = 69/144 (47%), Gaps = 17/144 (11%)

Query: 139 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGG---ELQ------FQTEVKIISMAVH 188
           ++G+G +G+VY       G+++AVK+++   T  G     Q       ++E++ +    H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 248
            N+++  GF TT     +   Y+  GS+ S LR         +    +        GL+Y
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAY 123

Query: 249 LHEHCDPKIIHRDVKAANILLDED 272
           LH      I+HRD+KA N+L+D D
Sbjct: 124 LHSK---GILHRDLKADNLLVDAD 144

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 64.3 bits (157), Expect = 7e-12
 Identities = 50/150 (33%), Positives = 71/150 (47%), Gaps = 35/150 (23%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRL-- 194
           LG G FG+VYK R +  G++VA+K++    E+  G  +    E+KI+    H N++ L  
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKHPNVVPLID 74

Query: 195 --YGFCTTVTEKL----LVYPYM--------TNGSVASRLRERQSSLPPLDWPTRKKIAL 240
                      K     +V PYM         N SV  +L E Q           K   L
Sbjct: 75  MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV--KLTESQI----------KCYML 122

Query: 241 GSARGLSYLHEHCDPKIIHRDVKAANILLD 270
               G++YLHE+    I+HRD+KAANIL+D
Sbjct: 123 QLLEGINYLHEN---HILHRDIKAANILID 149

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 16/154 (10%)

Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FGKVYK +  +  ++A  ++ + ++      +  E+ I++   H N+++L     
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 ++  +   G+V + + E +    PL  P  + +   +   L+YLHE+   KIIH
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELER---PLTEPQIRVVCKQTLEALNYLHEN---KIIH 126

Query: 260 RDVKAANILLDEDAD----------QSSKTILRR 283
           RD+KA NIL   D D          ++++TI RR
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 160

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 62.7 bits (152), Expect = 2e-11
 Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 25/163 (15%)

Query: 139 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLLRLYG 196
           ++G G +G+VYKGR +  G+L A+K +  + T   E + + E+ ++   + HRN+   YG
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTEDEEEEIKLEINMLKKYSHHRNIATYYG 80

Query: 197 FCTTVT------EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
                +      +  LV  +   GSV   ++  + +    DW     I     RGL++LH
Sbjct: 81  AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLH 138

Query: 251 EHCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 283
            H   K+IHRD+K  N+LL E+A+          Q  +T+ RR
Sbjct: 139 AH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 178

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 62.5 bits (152), Expect = 2e-11
 Identities = 47/142 (33%), Positives = 65/142 (45%), Gaps = 17/142 (11%)

Query: 138 NILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
            ++G+G FG VY G L D        AVK L          QF  E  I+    H N+L 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 194 LYGFC-TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYL 249
           L G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHN------PTVKDLIGFGLQVAKGMEYL 114

Query: 250 HEHCDPKIIHRDVKAANILLDE 271
                 K +HRD+ A N +LDE
Sbjct: 115 ASK---KFVHRDLAARNCMLDE 133

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 62.6 bits (152), Expect = 2e-11
 Identities = 44/136 (32%), Positives = 63/136 (46%), Gaps = 16/136 (11%)

Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG V+ G+      VA+K + E   S  E  F  E K++    H  L++LYG CT
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMS--EEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR----GLSYLHEHCDP 255
                 +V  +M NG + + LR+RQ  L        K + L   +    G+ YL  +   
Sbjct: 70  QQKPLYIVTEFMENGCLLNYLRQRQGKL-------SKDMLLSMCQDVCEGMEYLERN--- 119

Query: 256 KIIHRDVKAANILLDE 271
             IHRD+ A N L+  
Sbjct: 120 SFIHRDLAARNCLVSS 135

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 62.2 bits (152), Expect = 2e-11
 Identities = 42/144 (29%), Positives = 61/144 (42%), Gaps = 23/144 (15%)

Query: 139 ILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISM--------AVHR 189
           I+G G F  V   +     K  A+K L + +     L  + +VK + +          H 
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQ-----LIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 190 NLLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 248
            +++LY +     E L  V  Y  NG +   +R+  S    LD    +  A      L Y
Sbjct: 63  GIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGS----LDEKCTRFYAAEILLALEY 117

Query: 249 LHEHCDPKIIHRDVKAANILLDED 272
           LH      IIHRD+K  NILLD+D
Sbjct: 118 LHSK---GIIHRDLKPENILLDKD 138

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 62.4 bits (151), Expect = 3e-11
 Identities = 46/144 (31%), Positives = 78/144 (54%), Gaps = 15/144 (10%)

Query: 139 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLLRLYG 196
           ++G G +G+VYKGR +  G+L A+K +  + T   E + + E+ ++   + HRN+   YG
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70

Query: 197 FCTT-----VTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
                    + ++L LV  +   GSV   ++  + +    +W     I     RGLS+LH
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLH 128

Query: 251 EHCDPKIIHRDVKAANILLDEDAD 274
           +H   K+IHRD+K  N+LL E+A+
Sbjct: 129 QH---KVIHRDIKGQNVLLTENAE 149

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 61.9 bits (150), Expect = 3e-11
 Identities = 45/135 (33%), Positives = 71/135 (52%), Gaps = 12/135 (8%)

Query: 139 ILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 198
           I+G G FG V +G    G+ VAVK +K + T+     F  E  +++   H+NL+RL G  
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLG-- 66

Query: 199 TTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
             +   L +V   M+ G++ + LR R  +L  +      + +L  A G+ YL      K+
Sbjct: 67  VILHNGLYIVMELMSKGNLVNFLRTRGRALVSV--IQLLQFSLDVAEGMEYLESK---KL 121

Query: 258 IHRDVKAANILLDED 272
           +HRD+ A NIL+ ED
Sbjct: 122 VHRDLAARNILVSED 136

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 3e-11
 Identities = 38/138 (27%), Positives = 69/138 (50%), Gaps = 11/138 (7%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKE-ERTSGGELQFQTEVKIISMAVHRNLLRLYGF 197
           +G G +G VYK R    G++VA+K++K    + G       E+K++    H N+++L   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 198 CTTVTEKLLVYPYM-TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 256
                +  LV+ +M T+  +   +++RQ  LP       K       +GL++ H H    
Sbjct: 67  FRHKGDLYLVFEFMDTD--LYKLIKDRQRGLPE---SLIKSYLYQLLQGLAFCHSH---G 118

Query: 257 IIHRDVKAANILLDEDAD 274
           I+HRD+K  N+L++ +  
Sbjct: 119 ILHRDLKPENLLINTEGV 136

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 61.7 bits (150), Expect = 3e-11
 Identities = 44/140 (31%), Positives = 68/140 (48%), Gaps = 7/140 (5%)

Query: 133 GFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGE-LQFQTEVKIISMAVHRN 190
            F     LG+G +G VYK  RL+D +  A+K +     S  E      E++I++   H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 191 LLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           ++  Y        KL +V  Y   G ++  + +R+     +      +I +   RGL  L
Sbjct: 61  IIS-YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119

Query: 250 HEHCDPKIIHRDVKAANILL 269
           HE    KI+HRD+K+ANILL
Sbjct: 120 HEQ---KILHRDLKSANILL 136

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 61.5 bits (149), Expect = 5e-11
 Identities = 44/140 (31%), Positives = 64/140 (45%), Gaps = 15/140 (10%)

Query: 140 LGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           LG G FGKV            G++VAVK LK E        ++ E+ I+    H N+++ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 195 YGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
            G C+    K   L+  Y+  GS+   L + + +L  L        A     G++YLH  
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL-----LLFAQQICEGMAYLHSQ 126

Query: 253 CDPKIIHRDVKAANILLDED 272
                IHRD+ A N+LLD D
Sbjct: 127 ---HYIHRDLAARNVLLDND 143

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 61.3 bits (149), Expect = 6e-11
 Identities = 41/149 (27%), Positives = 64/149 (42%), Gaps = 18/149 (12%)

Query: 132 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVHR 189
           +     + LG G  G V K RL +  ++   +         +LQ Q   E++I       
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTIT-TDPNPDLQKQILRELEINKSCKSP 59

Query: 190 NLLRLYGFCTTVTEKLL--VYPYMTNGSVAS---RLRER--QSSLPPLDWPTRKKIALGS 242
            +++ YG     +   +     Y   GS+ S   ++++R  +     L      KIA   
Sbjct: 60  YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESV 114

Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDE 271
            +GLSYLH     KIIHRD+K +NILL  
Sbjct: 115 LKGLSYLHSR---KIIHRDIKPSNILLTR 140

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 61.3 bits (149), Expect = 6e-11
 Identities = 45/161 (27%), Positives = 79/161 (49%), Gaps = 23/161 (14%)

Query: 127 LQVATDGFSNKNILGRGGFGKVYKGRLADGKL-----VAVKRLKEERTSGGELQ---FQT 178
           + ++ D  +  ++L  G FG+++ G L D K      V VK +K+  +   E+Q      
Sbjct: 1   IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS---EIQVTLLLQ 57

Query: 179 EVKIISMAVHRNLLRLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPLDWP---- 233
           E  ++    H+N+L +   C    E   V YPYM  G++   L+  Q  L   + P    
Sbjct: 58  ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQ--QCRLGEANNPQALS 115

Query: 234 TRKKIALGS--ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           T++ + +    A G+SYLH+     +IH+D+ A N ++DE+
Sbjct: 116 TQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEE 153

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 60.8 bits (148), Expect = 6e-11
 Identities = 47/135 (34%), Positives = 69/135 (51%), Gaps = 14/135 (10%)

Query: 140 LGRGGFGKVYKG--RLADGKL--VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           LG G FG V KG   +  GK   VAVK LK+E  + G+ +F  E  +++   H  ++RL 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 196 GFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 254
           G C    E L LV      G +   L++R+  +P  D    K++A   A G++YL     
Sbjct: 63  GVC--KGEPLMLVMELAPLGPLLKYLKKRR-EIPVSDL---KELAHQVAMGMAYLESK-- 114

Query: 255 PKIIHRDVKAANILL 269
              +HRD+ A N+LL
Sbjct: 115 -HFVHRDLAARNVLL 128

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 61.0 bits (149), Expect = 7e-11
 Identities = 40/135 (29%), Positives = 67/135 (49%), Gaps = 14/135 (10%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVK-IISMAVHRNLLRLYGF 197
           LG G FG VY  R    G+LVA+K++K++  S  E     EVK +  +  H N+++L   
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK-- 64

Query: 198 CTTVTEK---LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 254
                E      V+ YM  G++   +++R+    P      + I     +GL+++H+H  
Sbjct: 65  -EVFRENDELYFVFEYM-EGNLYQLMKDRKGK--PFSESVIRSIIYQILQGLAHIHKH-- 118

Query: 255 PKIIHRDVKAANILL 269
               HRD+K  N+L+
Sbjct: 119 -GFFHRDLKPENLLV 132

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 60.7 bits (148), Expect = 7e-11
 Identities = 35/146 (23%), Positives = 58/146 (39%), Gaps = 16/146 (10%)

Query: 138 NILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGE-LQFQTEVKIISMAVHRNLLRLY 195
             +G+G FG V K  R +DGK++  K +     +  E  Q  +EV I+    H N++R Y
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 196 GFCTTVTEKLLVYPYMTN------GSVASRLRERQSSLP-PLDWPTRKKIALGSARGLSY 248
                      +Y  M          +  + ++ +  +     W    +I       L  
Sbjct: 66  DR-IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW----RILTQLLLALYE 120

Query: 249 LH--EHCDPKIIHRDVKAANILLDED 272
            H        ++HRD+K ANI LD +
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDAN 146

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 60.6 bits (147), Expect = 8e-11
 Identities = 40/144 (27%), Positives = 70/144 (48%), Gaps = 13/144 (9%)

Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQT-EVKIISMAVHRNL 191
           F   N +G+G FG V+K  R AD ++ A+K++   + +  E +    E ++++      +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 192 LRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLD--WPTRKKIALGSARGLSY 248
           +R Y        KL +V  Y  NG +   L+ ++    P D  W    +  +    GL++
Sbjct: 62  IRYYE-SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAH 116

Query: 249 LHEHCDPKIIHRDVKAANILLDED 272
           LH     KI+HRD+K+ N+ LD  
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAY 137

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 60.7 bits (147), Expect = 9e-11
 Identities = 46/137 (33%), Positives = 66/137 (48%), Gaps = 7/137 (5%)

Query: 140 LGRGGFGKVYKGRLADG---KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 196
           +G G FGKV  G +  G     V VK L+   +   +++F  E +      H NLL+  G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 197 FCTTVTEKLLVYPYMTNGSVASRLRE-RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
            CT VT  LLV  +   G +   LR  R++ L   D  T +++A   A GL +LH++   
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119

Query: 256 KIIHRDVKAANILLDED 272
             IH D+   N LL  D
Sbjct: 120 NFIHSDLALRNCLLTAD 136

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 60.7 bits (148), Expect = 1e-10
 Identities = 40/144 (27%), Positives = 65/144 (45%), Gaps = 24/144 (16%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG----------ELQFQTEVKIISMAVH 188
           LG G +  VYK R    G++VA+K++K                 E++   E+K      H
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK------H 61

Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 248
            N++ L       +   LV+ +M    +   ++++   L P D    K   L + RGL Y
Sbjct: 62  PNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPAD---IKSYMLMTLRGLEY 117

Query: 249 LHEHCDPKIIHRDVKAANILLDED 272
           LH +    I+HRD+K  N+L+  D
Sbjct: 118 LHSN---WILHRDLKPNNLLIASD 138

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 60.3 bits (146), Expect = 1e-10
 Identities = 40/138 (28%), Positives = 58/138 (42%), Gaps = 7/138 (5%)

Query: 140 LGRGGFGKVYKGRLADGKLVA---VKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 196
           +G G FGKV  G    G   A   VK L+   T   +L F  EV+      H N+L+  G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 197 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWP-TRKKIALGSARGLSYLHEHCDP 255
            C      LLV  +   G + + LR  +  +  +      +++A   A GL +LH+    
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119

Query: 256 KIIHRDVKAANILLDEDA 273
             IH D+   N  L  D 
Sbjct: 120 DFIHSDLALRNCQLTADL 137

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 60.4 bits (147), Expect = 1e-10
 Identities = 35/121 (28%), Positives = 53/121 (43%), Gaps = 10/121 (8%)

Query: 158 LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVA 217
           LVAVK L+ + +      F  EVKI+S     N+ RL G CT      ++  YM NG + 
Sbjct: 48  LVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107

Query: 218 SRLRERQ-------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 270
             L++          +   L + T   +A   A G+ YL        +HRD+   N L+ 
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVG 164

Query: 271 E 271
           +
Sbjct: 165 K 165

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 59.9 bits (145), Expect = 2e-10
 Identities = 45/138 (32%), Positives = 66/138 (47%), Gaps = 10/138 (7%)

Query: 139 ILGRGGFGKVYKGRLA-DGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           ++G G FG+V  GRL   GK    VA+K LK   T      F +E  I+    H N++ L
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 195 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 254
            G  T     ++V  YM NGS+ + LR+       +       +  G A G+ YL    D
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL---VGMLRGIASGMKYL---SD 124

Query: 255 PKIIHRDVKAANILLDED 272
              +HRD+ A NIL++ +
Sbjct: 125 MGYVHRDLAARNILVNSN 142

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 59.8 bits (145), Expect = 2e-10
 Identities = 47/144 (32%), Positives = 66/144 (45%), Gaps = 12/144 (8%)

Query: 134 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQ---TEVKIISMAVHR 189
           F++   +G G FG VY  R +   ++VA+K++        E ++Q    EV+ +    H 
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQQLRHP 75

Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           N +   G         LV  Y   GS AS + E      PL       I  G+ +GL+YL
Sbjct: 76  NTIEYKGCYLREHTAWLVMEYCL-GS-ASDILEVHKK--PLQEVEIAAICHGALQGLAYL 131

Query: 250 HEHCDPKIIHRDVKAANILLDEDA 273
           H H     IHRD+KA NILL E  
Sbjct: 132 HSHE---RIHRDIKAGNILLTEPG 152

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 59.2 bits (143), Expect = 2e-10
 Identities = 45/137 (32%), Positives = 65/137 (47%), Gaps = 14/137 (10%)

Query: 139 ILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 198
            +G+G FG V  G    G  VAVK +K + T+     F  E  +++   H NL++L G  
Sbjct: 13  TIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLG-- 66

Query: 199 TTVTEK---LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
             V EK    +V  YM  GS+   LR R  S+  L      K +L     + YL  +   
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEAN--- 121

Query: 256 KIIHRDVKAANILLDED 272
             +HRD+ A N+L+ ED
Sbjct: 122 NFVHRDLAARNVLVSED 138

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 59.2 bits (144), Expect = 3e-10
 Identities = 42/146 (28%), Positives = 62/146 (42%), Gaps = 26/146 (17%)

Query: 138 NILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-------ELQFQTEVKIISMAVHR 189
             +G G +G VYK R L  G+ VA+K+++   +  G       E+     +K +    H 
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIAL---LKQLESFEHP 61

Query: 190 NLLRLYGFCTTVTEK-----LLVYPYMTNGSVASRLRERQSSLPP--LDWPTRKKIALGS 242
           N++RL   C            LV+ +     V   L    S  P   L   T K +    
Sbjct: 62  NIVRLLDVCHGPRTDRELKLTLVFEH-----VDQDLATYLSKCPKPGLPPETIKDLMRQL 116

Query: 243 ARGLSYLHEHCDPKIIHRDVKAANIL 268
            RG+ +LH H    I+HRD+K  NIL
Sbjct: 117 LRGVDFLHSHR---IVHRDLKPQNIL 139

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 58.7 bits (142), Expect = 3e-10
 Identities = 42/134 (31%), Positives = 64/134 (47%), Gaps = 12/134 (8%)

Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG+V+ G       VA+K LK+   S     F  E  ++    H  L+RLY    
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE--AFLAEANLMKQLQHPRLVRLYA--- 68

Query: 200 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
            VT++   ++  YM NGS+   L+  +     L       +A   A G++++        
Sbjct: 69  VVTQEPIYIITEYMENGSLVDFLKTPEGI--KLTINKLIDMAAQIAEGMAFIERK---NY 123

Query: 258 IHRDVKAANILLDE 271
           IHRD++AANIL+ E
Sbjct: 124 IHRDLRAANILVSE 137

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 58.9 bits (142), Expect = 4e-10
 Identities = 45/142 (31%), Positives = 66/142 (46%), Gaps = 9/142 (6%)

Query: 134 FSNKNILGRGGFGKVYKGRLADGK-LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
           F+    +G+G FG+VYKG     K +VA+K +  E         Q E+ ++S      + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
           R YG     T+  ++  Y+  GS    L+       PL+      I     +GL YLH  
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE 120

Query: 253 CDPKIIHRDVKAANILLDEDAD 274
              + IHRD+KAAN+LL E  D
Sbjct: 121 ---RKIHRDIKAANVLLSEQGD 139

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 58.9 bits (143), Expect = 5e-10
 Identities = 42/140 (30%), Positives = 66/140 (47%), Gaps = 11/140 (7%)

Query: 134 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNL 191
           F   N +G G +G VY+ R    G++VA+K+++ +    G  +    E+ ++    H N+
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68

Query: 192 LRLYGFCT--TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           + L        +    LV  Y     +AS L    +   P      K + L   RGL YL
Sbjct: 69  VELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPT---PFSESQVKCLMLQLLRGLQYL 124

Query: 250 HEHCDPKIIHRDVKAANILL 269
           HE+    IIHRD+K +N+LL
Sbjct: 125 HENF---IIHRDLKVSNLLL 141

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 58.5 bits (141), Expect = 5e-10
 Identities = 44/145 (30%), Positives = 67/145 (46%), Gaps = 15/145 (10%)

Query: 140 LGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLY 195
           LG G FG V +G+L        VAVK +K    +  E++ F +E   +    H N++RL 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 196 GFCTTVTEK------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRK--KIALGSARGLS 247
           G C    E       +++ P+M +G + S L   +    P   PT+   K     A G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           YL        IHRD+ A N +L+E+
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNEN 148

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 58.3 bits (141), Expect = 5e-10
 Identities = 42/138 (30%), Positives = 70/138 (50%), Gaps = 15/138 (10%)

Query: 139 ILGRGGFGKVYK-GRLADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHRNLLRLYG 196
           ++GRG FG V+   R AD KLV +K++  E+ T    L  Q E +++ +  H N++  Y 
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 197 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP----LDWPTRKKIALGSARGLSYLHEH 252
                   ++V  Y   G++A  +++R +SL      L +  +  +AL       ++H  
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL------HHVHTK 120

Query: 253 CDPKIIHRDVKAANILLD 270
               I+HRD+K  NILLD
Sbjct: 121 ---LILHRDLKTQNILLD 135

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 58.1 bits (140), Expect = 7e-10
 Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 19/152 (12%)

Query: 137 KNILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLL 192
           ++++G G FG+V K R+    L    A+KR+KE  +      F  E++++  +  H N++
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ--SSLPPLDWPTRKKIALGS-------- 242
            L G C       L   Y  +G++   LR+ +   + P           L S        
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 243 --ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
             ARG+ YL +    + IHRD+ A NIL+ E+
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGEN 160

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 57.9 bits (140), Expect = 8e-10
 Identities = 36/134 (26%), Positives = 66/134 (49%), Gaps = 6/134 (4%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 198
           LG G +  VYKGR    G++VA+K +  +   G       E+ ++    H N++RL+   
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 258
            T  + +LV+ YM       +  +       LD  T K       +G+++ HE+   +++
Sbjct: 68  HTENKLMLVFEYMDKD--LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVL 122

Query: 259 HRDVKAANILLDED 272
           HRD+K  N+L+++ 
Sbjct: 123 HRDLKPQNLLINKR 136

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 57.3 bits (138), Expect = 1e-09
 Identities = 40/132 (30%), Positives = 60/132 (45%), Gaps = 7/132 (5%)

Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG+V+ G   +   VAVK LK    S     F  E  ++    H  L+RLY   T
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS--VQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 ++  YM  GS+   L+  +     +  P     +   A G++Y+        IH
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGG--KVLLPKLIDFSAQIAEGMAYIERK---NYIH 126

Query: 260 RDVKAANILLDE 271
           RD++AAN+L+ E
Sbjct: 127 RDLRAANVLVSE 138

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 57.0 bits (137), Expect = 1e-09
 Identities = 43/139 (30%), Positives = 70/139 (50%), Gaps = 14/139 (10%)

Query: 139 ILGRGGFGKVYKGRLAD-GKLVAVKRLK----EERTSGGELQFQTEVKIISMAVHRNLLR 193
           +LG+G FG+VY    AD G+ +AVK+++       TS      + E++++   +H  +++
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 194 LYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 251
            YG      E+ L     +M  GS+  +L+    S   L     +K       G+SYLH 
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLHS 124

Query: 252 HCDPKIIHRDVKAANILLD 270
           +    I+HRD+K ANIL D
Sbjct: 125 N---MIVHRDIKGANILRD 140

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 57.1 bits (138), Expect = 2e-09
 Identities = 41/137 (29%), Positives = 63/137 (45%), Gaps = 10/137 (7%)

Query: 140 LGRGGFGKVYKGRLAD-GKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRL-Y 195
           LG+GGFG+V   ++   GK+ A K+L ++R     GE     E KI+     R ++ L Y
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
            F  T  +  LV   M  G +  +        P          A     GL +LH+    
Sbjct: 61  AF-ETKDDLCLVMTLMNGGDL--KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR--- 114

Query: 256 KIIHRDVKAANILLDED 272
           +I++RD+K  N+LLD+ 
Sbjct: 115 RIVYRDLKPENVLLDDH 131

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 57.0 bits (137), Expect = 2e-09
 Identities = 44/142 (30%), Positives = 65/142 (45%), Gaps = 9/142 (6%)

Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
           F+    +G+G FG+V+KG      K+VA+K +  E         Q E+ ++S      + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
           + YG     T+  ++  Y+  GS    L        PLD      I     +GL YLH  
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE 120

Query: 253 CDPKIIHRDVKAANILLDEDAD 274
              K IHRD+KAAN+LL E  +
Sbjct: 121 ---KKIHRDIKAANVLLSEHGE 139

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 40/146 (27%), Positives = 64/146 (43%), Gaps = 30/146 (20%)

Query: 140 LGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVH-RNLLRLYG- 196
           +GRG FG V K      G ++AVKR++       + +   ++ ++  +     +++ YG 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 197 --------FC----TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
                    C        +K   Y Y     + S + E              KIA+ + +
Sbjct: 72  LFREGDCWICMELMDISLDKFYKYVYE---VLKSVIPEEILG----------KIAVATVK 118

Query: 245 GLSYLHEHCDPKIIHRDVKAANILLD 270
            L+YL E  + KIIHRDVK +NILLD
Sbjct: 119 ALNYLKE--ELKIIHRDVKPSNILLD 142

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 57.0 bits (137), Expect = 2e-09
 Identities = 43/139 (30%), Positives = 72/139 (51%), Gaps = 18/139 (12%)

Query: 139 ILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
           +LG G FG VYKG  + +G+ V    A+K L E       ++F  E  I++   H +L+R
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYLH 250
           L G C + T + LV   M +G +   + E + ++     L+W       +  A+G+ YL 
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 126

Query: 251 EHCDPKIIHRDVKAANILL 269
           E    +++HRD+ A N+L+
Sbjct: 127 ER---RLVHRDLAARNVLV 142

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 56.9 bits (137), Expect = 2e-09
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)

Query: 134 FSNKNILGRGGFGKVYKGR-LADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 188
           F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 245
            ++ RL G C T T + L+   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 69  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 121

Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           ++YL E    +++HRD+ A N+L+
Sbjct: 122 MNYLEER---RLVHRDLAARNVLV 142

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 56.7 bits (137), Expect = 2e-09
 Identities = 37/135 (27%), Positives = 63/135 (46%), Gaps = 12/135 (8%)

Query: 139 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH---RNLLRL 194
           ++GRG +G VY+G+ +  G++VA+K +  +         Q EV ++S        N+ + 
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 195 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 254
           YG         ++  Y   GSV + ++       P+       I       L Y+H+   
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV-- 120

Query: 255 PKIIHRDVKAANILL 269
             +IHRD+KAANIL+
Sbjct: 121 -GVIHRDIKAANILV 134

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 56.6 bits (136), Expect = 2e-09
 Identities = 44/144 (30%), Positives = 66/144 (45%), Gaps = 13/144 (9%)

Query: 134 FSNKNILGRGGFGKVYKGRLADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
           F+    +G+G FG+V+KG   D +   +VA+K +  E         Q E+ ++S      
Sbjct: 6   FTKLERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
           + + YG     T+  ++  Y+  GS    LR       P D      +     +GL YLH
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLH 118

Query: 251 EHCDPKIIHRDVKAANILLDEDAD 274
                K IHRD+KAAN+LL E  D
Sbjct: 119 SE---KKIHRDIKAANVLLSEQGD 139

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 56.4 bits (136), Expect = 2e-09
 Identities = 39/146 (26%), Positives = 69/146 (47%), Gaps = 6/146 (4%)

Query: 126 ELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS 184
           E +   D    + +LG+G +G VY  R L+    +A+K +  ER S        E+ + S
Sbjct: 2   EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEI-PERDSRYVQPLHEEIALHS 60

Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              HRN+++  G  +      +    +  GS+++ LR +   L   +  T          
Sbjct: 61  YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE-QTIIFYTKQILE 119

Query: 245 GLSYLHEHCDPKIIHRDVKAANILLD 270
           GL YLH++   +I+HRD+K  N+L++
Sbjct: 120 GLKYLHDN---QIVHRDIKGDNVLVN 142

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 56.4 bits (136), Expect = 3e-09
 Identities = 40/154 (25%), Positives = 68/154 (44%), Gaps = 21/154 (13%)

Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKR----LKEERTSGGELQFQTEVKIISMA 186
           D +     +G G +GKVYK R    GKLVA+K+    + EE      L+   E+ ++ M 
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR---EISLLQML 57

Query: 187 VHRN-LLRLYGFCTTVTEK-------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI 238
                ++RL        E+        LV+ Y+ +          +    PL   T K  
Sbjct: 58  SESIYIVRL--LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF 115

Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
                +G+++ H+H    ++HRD+K  N+L+D+ 
Sbjct: 116 MYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQ 146

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 56.6 bits (137), Expect = 3e-09
 Identities = 42/150 (28%), Positives = 64/150 (42%), Gaps = 27/150 (18%)

Query: 138 NILGRGGFGKVYKGR-LADGKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
             +G+G FG+V+K R     ++VA+K+ L E    G  +    E+KI+ +  H N++ L 
Sbjct: 18  AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77

Query: 196 GFCTTVTEKLLVYPYMTNGSVAS-------------RLRERQSSLPPLDWPTRKKIALGS 242
             C T            N    S              L    +          KK+    
Sbjct: 78  EICRTK-------ATPYNRYKGSFYLVFEFCEHDLAGLL--SNKNVKFTLSEIKKVMKML 128

Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
             GL Y+H +   KI+HRD+KAANIL+ +D
Sbjct: 129 LNGLYYIHRN---KILHRDMKAANILITKD 155

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 56.2 bits (135), Expect = 3e-09
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 17/158 (10%)

Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEV 180
           +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  E 
Sbjct: 2   EVAREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60

Query: 181 KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTRKK 237
            ++      +++RL G  +     L++   MT G + S LR  +  +   P    P+ KK
Sbjct: 61  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120

Query: 238 ---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
              +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 121 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 155

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 56.2 bits (135), Expect = 3e-09
 Identities = 44/139 (31%), Positives = 70/139 (50%), Gaps = 14/139 (10%)

Query: 139 ILGRGGFGKVYKGRLAD-GKLVAVKRL----KEERTSGGELQFQTEVKIISMAVHRNLLR 193
           +LGRG FG+VY    AD G+ +AVK++      + TS      + E++++    H  +++
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 194 LYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 251
            YG      EK L     YM  GS+  +L+    +   L     ++      +G+SYLH 
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHS 124

Query: 252 HCDPKIIHRDVKAANILLD 270
           +    I+HRD+K ANIL D
Sbjct: 125 N---MIVHRDIKGANILRD 140

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 56.0 bits (135), Expect = 3e-09
 Identities = 44/139 (31%), Positives = 66/139 (47%), Gaps = 8/139 (5%)

Query: 140 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRL-Y 195
           LG+GGFG+V   ++ A GKL A K+L ++R     G      E +I++    R ++ L Y
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
            F  T T+  LV   M  G +   +       P    P           GL +LH+    
Sbjct: 61  AF-QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116

Query: 256 KIIHRDVKAANILLDEDAD 274
           +II+RD+K  N+LLD D +
Sbjct: 117 RIIYRDLKPENVLLDNDGN 135

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 56.1 bits (135), Expect = 4e-09
 Identities = 43/158 (27%), Positives = 69/158 (43%), Gaps = 28/158 (17%)

Query: 137 KNILGRGGFGKVYKGRLADG----------------KLVAVKRLKEERTSGGELQFQTEV 180
           K  LG G FG+V+    A+G                 LVAVK L+ + T      F  E+
Sbjct: 10  KEKLGEGQFGEVHLCE-AEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68

Query: 181 KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ--------SSLPPLDW 232
           KI+S   + N++RL G C +     ++  YM NG +   L +R+        +++P +  
Sbjct: 69  KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128

Query: 233 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 270
                +A+  A G+ YL        +HRD+   N L+ 
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVG 163

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 56.2 bits (135), Expect = 4e-09
 Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 16/154 (10%)

Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FGKVYK +  +   +A  ++ E ++      +  E++I++   H  +++L G   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
              +  ++  +   G+V + + E    L     P  + I       L YLH     KIIH
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGLTE---PQIQVICRQMLEALQYLHSM---KIIH 133

Query: 260 RDVKAANILLDEDAD----------QSSKTILRR 283
           RD+KA N+LL  D D          ++ KT+ RR
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR 167

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 55.7 bits (134), Expect = 5e-09
 Identities = 45/144 (31%), Positives = 74/144 (51%), Gaps = 22/144 (15%)

Query: 139 ILGRGGFGKVYKG-RLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAV--HRNL 191
           +LG G FG V+KG  + +G      VA+K + ++R+     Q  T+  +++M    H  +
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI-QDRSGRQTFQEITD-HMLAMGSLDHAYI 71

Query: 192 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSY 248
           +RL G C   + +L V      GS+   +R+ + SL P   L+W       +  A+G+ Y
Sbjct: 72  VRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYY 124

Query: 249 LHEHCDPKIIHRDVKAANILLDED 272
           L EH    ++HR++ A NILL  D
Sbjct: 125 LEEHR---MVHRNLAARNILLKSD 145

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 55.8 bits (134), Expect = 5e-09
 Identities = 48/152 (31%), Positives = 69/152 (45%), Gaps = 10/152 (6%)

Query: 124 LRELQVATDGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKI 182
           L  L   TD +     +G+G +GKVYK     DG L AVK L        E++ +  + +
Sbjct: 14  LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI-L 72

Query: 183 ISMAVHRNLLRLYGFCTTVTEKL-----LVYPYMTNGSVASRLRERQSSLPPLDWPTRKK 237
            S+  H N+++ YG      + +     LV      GSV   ++        LD      
Sbjct: 73  QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132

Query: 238 IALGSARGLSYLHEHCDPKIIHRDVKAANILL 269
           I  G+  GL +LH +   +IIHRDVK  NILL
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILL 161

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 55.2 bits (133), Expect = 7e-09
 Identities = 44/144 (30%), Positives = 69/144 (47%), Gaps = 22/144 (15%)

Query: 139 ILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQ----------FQTEVKIISMAV 187
           ++G G FG VY G  A  G+L+AVK++  E  S                  E+ ++    
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQV--ELPSVSASSKDRKRSMLDALAREIALLKELQ 64

Query: 188 HRNLLRLYGFCTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
           H N+++  G  +   + L ++  Y+  GSVA+ L    +    L     ++I     +GL
Sbjct: 65  HENIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGL 119

Query: 247 SYLHEHCDPKIIHRDVKAANILLD 270
           +YLH      IIHRD+K ANIL+D
Sbjct: 120 NYLHNR---GIIHRDIKGANILVD 140

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 55.4 bits (133), Expect = 7e-09
 Identities = 44/154 (28%), Positives = 66/154 (42%), Gaps = 24/154 (15%)

Query: 140 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRN 190
           LG G FG+V         K R      VAVK LK+  T        +E++++  +  H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP------------PLDWPTRKKI 238
           ++ L G CT      ++  Y   G++   LR R+   P             L +      
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           A   ARG+ YL      + IHRD+ A N+L+ ED
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTED 170

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 54.6 bits (132), Expect = 8e-09
 Identities = 44/145 (30%), Positives = 61/145 (42%), Gaps = 14/145 (9%)

Query: 133 GFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL-KEERTSGGELQ-FQTEVKIISMAVHR 189
            F    ++G+G FGKV   +  D K + A+K + K++    G ++    E +I+    H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 190 NLLRL-YGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
            L+ L Y F     E + LV   +  G     LR   S          K         L 
Sbjct: 61  FLVNLWYSFQDE--ENMYLVVDLLLGGD----LRYHLSQKVKFSEEQVKFWICEIVLALE 114

Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           YLH      IIHRD+K  NILLDE 
Sbjct: 115 YLHSK---GIIHRDIKPDNILLDEQ 136

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 55.0 bits (132), Expect = 8e-09
 Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 21/148 (14%)

Query: 140 LGRGGFGKVYKGRLAD---GKL---VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
           LG+G FG VY+G   D   G+    VAVK + E  +    ++F  E  ++      +++R
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWPTRKKI---ALGSAR 244
           L G  +     L+V   M +G + S LR      E     PP   PT +++   A   A 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP---PTLQEMIQMAAEIAD 130

Query: 245 GLSYLHEHCDPKIIHRDVKAANILLDED 272
           G++YL+     K +HRD+ A N ++  D
Sbjct: 131 GMAYLNAK---KFVHRDLAARNCMVAHD 155

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 55.1 bits (132), Expect = 9e-09
 Identities = 45/142 (31%), Positives = 69/142 (48%), Gaps = 12/142 (8%)

Query: 134 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQ---TEVKIISMAVHR 189
           FS+   +G G FG VY  R + + ++VA+K++        E ++Q    EV+ +    H 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKLRHP 75

Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           N ++  G         LV  Y   GS +  L   +  L  ++      +  G+ +GL+YL
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA---VTHGALQGLAYL 131

Query: 250 HEHCDPKIIHRDVKAANILLDE 271
           H H    +IHRDVKA NILL E
Sbjct: 132 HSH---NMIHRDVKAGNILLSE 150

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 54.6 bits (131), Expect = 1e-08
 Identities = 45/139 (32%), Positives = 68/139 (48%), Gaps = 18/139 (12%)

Query: 139 ILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
           +LG G FG VYKG    DG+     VA+K L+E  +     +   E  +++      + R
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRE---RQSSLPPLDWPTRKKIALGSARGLSYLH 250
           L G C T T + LV   M  G +   +RE   R  S   L+W       +  A+G+SYL 
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLE 126

Query: 251 EHCDPKIIHRDVKAANILL 269
           E    +++HRD+ A N+L+
Sbjct: 127 E---VRLVHRDLAARNVLV 142

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 54.1 bits (130), Expect = 1e-08
 Identities = 40/161 (24%), Positives = 70/161 (43%), Gaps = 41/161 (25%)

Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEV------------------- 180
           LG+G F K++KG            ++ E    GEL  +TEV                   
Sbjct: 3   LGQGTFTKIFKG------------IRREVGDYGELH-KTEVLLKVLDKSHRNYSESFFEA 49

Query: 181 -KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA 239
             ++S   H++L+  YG C    E ++V  Y+  GS+ + L++ ++ +    W       
Sbjct: 50  ASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINIS-W------K 102

Query: 240 LGSARGLSY-LHEHCDPKIIHRDVKAANILLDEDADQSSKT 279
           L  A+ L++ LH   D  + H +V A N+LL  + D+ +  
Sbjct: 103 LEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGN 143

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 45/153 (29%), Positives = 68/153 (44%), Gaps = 27/153 (17%)

Query: 140 LGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           LG   FGK+YKG L        +LVA+K LK+        +FQ E  +++   H N++ L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 195 YGFCTTVTEKLLVYPYMTNGSVASRLRER----------------QSSLPPLDWPTRKKI 238
            G  T      +++ Y+  G +   L  R                +SSL   D+     I
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF---LHI 129

Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 271
           A+  A G+ YL  H     +H+D+ A NIL+ E
Sbjct: 130 AIQIAAGMEYLSSHF---FVHKDLAARNILIGE 159

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 53.9 bits (129), Expect = 2e-08
 Identities = 41/141 (29%), Positives = 68/141 (48%), Gaps = 17/141 (12%)

Query: 140 LGRGGFGKVYKGR--LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMA---VHRNLLR 193
           +G G +GKV+K R     G+ VA+KR++ +    G  L    EV ++       H N++R
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 194 LYGFCTTV-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 248
           L+  CT       T+  LV+ ++         +  +  +P     T K +     RGL +
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT---ETIKDMMFQLLRGLDF 125

Query: 249 LHEHCDPKIIHRDVKAANILL 269
           LH H   +++HRD+K  NIL+
Sbjct: 126 LHSH---RVVHRDLKPQNILV 143

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 53.9 bits (129), Expect = 2e-08
 Identities = 41/151 (27%), Positives = 64/151 (42%), Gaps = 19/151 (12%)

Query: 137 KNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
           K  LG G FGKV+           D  LVAVK LK+  +      F  E ++++   H +
Sbjct: 10  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEH 68

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL-------PPLDWPTRK--KIALG 241
           +++ YG C      ++V+ YM +G +   LR              P +    +   IA  
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 242 SARGLSYLHEHCDPKIIHRDVKAANILLDED 272
            A G+ YL        +HRD+   N L+ E+
Sbjct: 129 IAAGMVYLASQ---HFVHRDLATRNCLVGEN 156

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 53.9 bits (129), Expect = 2e-08
 Identities = 47/156 (30%), Positives = 72/156 (46%), Gaps = 28/156 (17%)

Query: 140 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 190
           LG G FG+V         K +      VAVK LK++ T        +E++++ M   H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWP-----------TRKKI- 238
           ++ L G CT      ++  Y + G++   LR R+   P +D+            T K + 
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRP--PGMDYSFDTCKLPEEQLTFKDLV 137

Query: 239 --ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
             A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 138 SCAYQVARGMEYLASQ---KCIHRDLAARNVLVTED 170

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 53.6 bits (129), Expect = 2e-08
 Identities = 31/142 (21%), Positives = 62/142 (43%), Gaps = 6/142 (4%)

Query: 131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK--EERTSGGELQFQTEVKIISMAV 187
              F  +  +G+G F  VYK   L DG++VA+K+++  E   +        E+ ++    
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           H N+++         E  +V      G ++  ++  +     +   T  K  +     L 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 248 YLHEHCDPKIIHRDVKAANILL 269
           ++H     +I+HRD+K AN+ +
Sbjct: 121 HMHSK---RIMHRDIKPANVFI 139

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 53.6 bits (129), Expect = 3e-08
 Identities = 44/141 (31%), Positives = 68/141 (48%), Gaps = 14/141 (9%)

Query: 139 ILGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNL 191
            LG G FGKV +        +D  + VAVK LK    S       +E+KI+S +  H N+
Sbjct: 42  TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101

Query: 192 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL-H 250
           + L G CT     L++  Y   G + + LR ++ S   L        +   A+G+++L  
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF--LTLEDLLSFSYQVAKGMAFLAS 159

Query: 251 EHCDPKIIHRDVKAANILLDE 271
           ++C    IHRD+ A N+LL  
Sbjct: 160 KNC----IHRDLAARNVLLTH 176

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 43/131 (32%), Positives = 58/131 (44%), Gaps = 10/131 (7%)

Query: 142 RGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRLYGFC 198
           RG FGKVY GR   + KL AVK +K+       +  Q Q E   ++++    ++ LY   
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73

Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 258
            +     LV  Y+  G V S L          D     K     A  L YLH H    II
Sbjct: 74  QSANNVYLVMEYLIGGDVKSLL----HIYGYFDEEMAVKYISEVALALDYLHRH---GII 126

Query: 259 HRDVKAANILL 269
           HRD+K  N+L+
Sbjct: 127 HRDLKPDNMLI 137

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 53.2 bits (127), Expect = 3e-08
 Identities = 52/162 (32%), Positives = 72/162 (44%), Gaps = 15/162 (9%)

Query: 117 GQLKRFSLRELQVATDG---FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG 172
           G LK   + EL    D    F++   +G G FG VY  R     ++VA+K++        
Sbjct: 7   GSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN 66

Query: 173 ELQFQ---TEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP 229
           E ++Q    EVK +    H N +   G         LV  Y   GS +  L   +    P
Sbjct: 67  E-KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKK---P 121

Query: 230 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 271
           L       I  G+ +GL+YLH H    +IHRD+KA NILL E
Sbjct: 122 LQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTE 160

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 53.2 bits (128), Expect = 3e-08
 Identities = 50/155 (32%), Positives = 70/155 (45%), Gaps = 27/155 (17%)

Query: 132 DGFSNKNILGRGGFGKVYKGRLAD-GKLVAVK--RLKEERTSGGELQFQTEVKIISMAVH 188
           D F     +G G +G+VYK R  D G+LVA+K  RL  E+  G  +    E+KI+    H
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNH 65

Query: 189 RNLLRLYGFCTTVTEK-------------LLVYPYMTNGSVASRLRERQSSLPPLDWPTR 235
           RN++ L      VT+K              LV+ YM +  +   L E  S L        
Sbjct: 66  RNIVNL---KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMG--LLE--SGLVHFSEDHI 118

Query: 236 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 270
           K        GL+Y H       +HRD+K +NILL+
Sbjct: 119 KSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLN 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 52.6 bits (127), Expect = 4e-08
 Identities = 39/137 (28%), Positives = 65/137 (47%), Gaps = 12/137 (8%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRLYG 196
           + +G +G+V+  +  + G + A+K +K+          Q  TE  I+S A    +++LY 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 197 FCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           +     + L LV  Y+  G +AS L     ++  LD    +         L YLH +   
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLE----NVGSLDEDVARIYIAEIVLALEYLHSN--- 112

Query: 256 KIIHRDVKAANILLDED 272
            IIHRD+K  NIL+D +
Sbjct: 113 GIIHRDLKPDNILIDSN 129

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 52.8 bits (126), Expect = 5e-08
 Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 10/145 (6%)

Query: 132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
           D +     LG G +  VYKG+   +GKLVA+K ++ +   G       E  ++    H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS-ARGLSYL 249
           ++ L+    T     LV+ Y     V + L +     P    P   K+ L    RGLSY+
Sbjct: 65  IVLLHDIIHTKETLTLVFEY-----VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYI 119

Query: 250 HEHCDPKIIHRDVKAANILLDEDAD 274
           H+     I+HRD+K  N+L+ +  +
Sbjct: 120 HQR---YILHRDLKPQNLLISDTGE 141

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 52.4 bits (126), Expect = 5e-08
 Identities = 37/137 (27%), Positives = 64/137 (46%), Gaps = 9/137 (6%)

Query: 139 ILGRGGFGK--VYKGRLADGKLVAVKRLKEERTSGGELQF-QTEVKIISMAVHRNLLRLY 195
           +LG+G FG+  +Y+ R  D  LV  K +   R S  E +    E+ I+S+  H N++  Y
Sbjct: 7   VLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
                    L+   Y   G++  ++  ++  L   +        + SA  +SY+H+    
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA--VSYIHKA--- 120

Query: 256 KIIHRDVKAANILLDED 272
            I+HRD+K  NI L + 
Sbjct: 121 GILHRDIKTLNIFLTKA 137

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 52.7 bits (126), Expect = 5e-08
 Identities = 45/136 (33%), Positives = 62/136 (45%), Gaps = 12/136 (8%)

Query: 140 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQ---TEVKIISMAVHRNLLRLY 195
           +G G FG VY    +   ++VAVK++        E ++Q    EVK +    H N +   
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE-KWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G         LV  Y   GS +  L   +    PL       I  G+ +GL+YLH H   
Sbjct: 88  GCYLKEHTAWLVMEYCL-GSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSHN-- 141

Query: 256 KIIHRDVKAANILLDE 271
            +IHRD+KA NILL E
Sbjct: 142 -MIHRDIKAGNILLTE 156

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 52.7 bits (127), Expect = 5e-08
 Identities = 39/143 (27%), Positives = 68/143 (47%), Gaps = 24/143 (16%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-------ELQFQTEVKIISMAVHRNL 191
           +G G +G VYK R    G++VA+K+++ E    G       E+    E+       H N+
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN------HPNI 60

Query: 192 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP--PLDWPTRKKIALGSARGLSYL 249
           +RL     +  +  LV+ ++        L++   S P   LD P  K       +G++Y 
Sbjct: 61  VRLLDVVHSENKLYLVFEFLD-----LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115

Query: 250 HEHCDPKIIHRDVKAANILLDED 272
           H H   +++HRD+K  N+L+D +
Sbjct: 116 HSH---RVLHRDLKPQNLLIDRE 135

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 52.2 bits (125), Expect = 6e-08
 Identities = 39/138 (28%), Positives = 63/138 (45%), Gaps = 10/138 (7%)

Query: 139 ILGRGGFGKVYKGRLA-DGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           ILG G FG++ +G L    K    VA+  L+   +      F  E   +    H N++RL
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 195 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 254
            G  T     ++V  YM+NG++ S LR+ +  L          +  G A G+ YL E   
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL---MGMLPGLASGMKYLSEM-- 126

Query: 255 PKIIHRDVKAANILLDED 272
              +H+ + A  +L++ D
Sbjct: 127 -GYVHKGLAAHKVLVNSD 143

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 52.4 bits (125), Expect = 6e-08
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)

Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYA--- 68

Query: 200 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 69  VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 123

Query: 258 IHRDVKAANILLDED 272
           +HRD++AANIL+ E+
Sbjct: 124 VHRDLRAANILVGEN 138

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 52.4 bits (125), Expect = 6e-08
 Identities = 43/139 (30%), Positives = 67/139 (48%), Gaps = 14/139 (10%)

Query: 139 ILGRGGFGKVYKGRLAD-GKLVAVKRLK----EERTSGGELQFQTEVKIISMAVHRNLLR 193
           +LG+G FG+VY     D G+ +A K+++       TS      + E++++    H  +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 194 LYGFCTTVTEKLLV--YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 251
            YG      EK L     YM  GSV  +L+    +   L     +K       G+SYLH 
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLK----AYGALTESVTRKYTRQILEGMSYLHS 124

Query: 252 HCDPKIIHRDVKAANILLD 270
           +    I+HRD+K ANIL D
Sbjct: 125 N---MIVHRDIKGANILRD 140

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 52.5 bits (126), Expect = 6e-08
 Identities = 44/145 (30%), Positives = 69/145 (47%), Gaps = 22/145 (15%)

Query: 140 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLR 193
           LG+G FG V   R   L D  G++VAVK+L+        L+ F+ E++I+    H N+++
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAE--HLRDFEREIEILKSLQHDNIVK 69

Query: 194 LYGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSY 248
             G C +   +   LV  Y+  GS+   L   RER      LD       A    +G+ Y
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER------LDHRKLLLYASQICKGMEY 123

Query: 249 LHEHCDPKIIHRDVKAANILLDEDA 273
           L      + +HRD+   NIL++ + 
Sbjct: 124 LGSK---RYVHRDLATRNILVESEN 145

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 52.3 bits (125), Expect = 7e-08
 Identities = 42/136 (30%), Positives = 65/136 (47%), Gaps = 9/136 (6%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 198
           +G G +G VYK R L  G+L AVK +K E      L  Q E+ ++    H N++  +G  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-IQQEIFMVKECKHCNIVAYFGSY 75

Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 258
            +  +  +   Y   GS    L++      PL       +   + +GL+YLH       +
Sbjct: 76  LSREKLWICMEYCGGGS----LQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK---M 128

Query: 259 HRDVKAANILLDEDAD 274
           HRD+K ANILL ++ D
Sbjct: 129 HRDIKGANILLTDNGD 144

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 52.3 bits (126), Expect = 7e-08
 Identities = 40/141 (28%), Positives = 56/141 (39%), Gaps = 19/141 (13%)

Query: 139 ILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQF-QTEVKIISMAVHRNLLRLYGF 197
                    + K +     LVAVK++  +  S  +L+  Q E+       H N+L  Y  
Sbjct: 9   CFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP-YVT 66

Query: 198 CTTVTEKL-LVYPYMTNGSVASRLRER-QSSLPPLDWPTRKKIAL---GSARGLSYLH-E 251
              V  +L +V P M  GS    L+      LP L       IA         L Y+H +
Sbjct: 67  SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPEL------AIAFILKDVLNALDYIHSK 120

Query: 252 HCDPKIIHRDVKAANILLDED 272
                 IHR VKA++ILL  D
Sbjct: 121 GF----IHRSVKASHILLSGD 137

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 52.2 bits (125), Expect = 8e-08
 Identities = 39/135 (28%), Positives = 61/135 (45%), Gaps = 10/135 (7%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---EVKIISMAVHRNLLRLY 195
           LG+G +G VYK      G  +A   +KE R    E +F     E+ I+  AV   ++  Y
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMA---MKEIRLELDESKFNQIIMELDILHKAVSPYIVDFY 65

Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G         +   YM  GS+  +L     +   +     ++I     +GL +L E  + 
Sbjct: 66  GAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EH 122

Query: 256 KIIHRDVKAANILLD 270
            IIHRDVK  N+L++
Sbjct: 123 NIIHRDVKPTNVLVN 137

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 51.9 bits (124), Expect = 8e-08
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 24/154 (15%)

Query: 140 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 190
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ----------SSLP--PLDWPTRKKI 238
           ++ L G CT      ++  Y + G++   LR R+          + +P   + +      
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
               ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTEN 173

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 51.3 bits (123), Expect = 1e-07
 Identities = 39/147 (26%), Positives = 62/147 (42%), Gaps = 16/147 (10%)

Query: 140 LGRGGFGKVYKGRL-------ADGKLVAVKRLKEERTSGGE--LQFQTEVKIISMAVHRN 190
           LG+G F  +YKG L         G    V  + +   S     L F     ++S   H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
           L++LYG C    E ++V  Y+  G +   L  R+ +   L W  +  +A   A  L YL 
Sbjct: 63  LVKLYGVCVR-DENIMVEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQLASALHYLE 118

Query: 251 EHCDPKIIHRDVKAANILLDEDADQSS 277
           +    K++H +V   NIL+        
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEG 142

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 51.6 bits (123), Expect = 1e-07
 Identities = 42/137 (30%), Positives = 65/137 (47%), Gaps = 10/137 (7%)

Query: 140 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 198
           LG G +  V+KGR      LVA+K ++ E   G       EV ++    H N++ L+   
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS-ARGLSYLHEHCDPKI 257
            T     LV+ Y+      S L++   +   L      KI +    RGLSY H+    KI
Sbjct: 73  HTERCLTLVFEYLD-----SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KI 124

Query: 258 IHRDVKAANILLDEDAD 274
           +HRD+K  N+L++E  +
Sbjct: 125 LHRDLKPQNLLINEKGE 141

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 51.7 bits (124), Expect = 1e-07
 Identities = 34/122 (27%), Positives = 57/122 (46%), Gaps = 19/122 (15%)

Query: 156 GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS 215
           G+ VAVK++   +    EL F  EV I+    H N++ +Y       E  +V  ++  G+
Sbjct: 44  GRQVAVKKMDLRKQQRRELLFN-EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA 102

Query: 216 V-----ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 270
           +      +R+ E Q +           + L   + LS+LH      +IHRD+K+ +ILL 
Sbjct: 103 LTDIVTHTRMNEEQIA----------TVCLAVLKALSFLHAQ---GVIHRDIKSDSILLT 149

Query: 271 ED 272
            D
Sbjct: 150 SD 151

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 51.3 bits (123), Expect = 1e-07
 Identities = 38/143 (26%), Positives = 64/143 (44%), Gaps = 23/143 (16%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH-RNLLRLYG- 196
           LGRG +G V K R +  G ++AVKR++    S  + +   ++ I   +V     +  YG 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68

Query: 197 --------FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 248
                    C  V +  L   Y        ++ ++  ++P        KIA+   + L Y
Sbjct: 69  LFREGDVWICMEVMDTSLDKFY-------KKVYDKGLTIPE---DILGKIAVSIVKALEY 118

Query: 249 LHEHCDPKIIHRDVKAANILLDE 271
           LH      +IHRDVK +N+L++ 
Sbjct: 119 LHSKL--SVIHRDVKPSNVLINR 139

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 51.3 bits (123), Expect = 1e-07
 Identities = 33/138 (23%), Positives = 68/138 (49%), Gaps = 11/138 (7%)

Query: 140 LGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT-EVKIISMAVHRNLLRLYGF 197
           +G G +G V+K +  +  ++VA+KR++ +    G       E+ ++    H+N++RLY  
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 198 CTTVTEKLLVYPYMTNGSVASRLRERQSSLP-PLDWPTRKKIALGSARGLSYLHEHCDPK 256
             +  +  LV+ Y         L++   S    +D    K       +GL++ H H    
Sbjct: 68  LHSDKKLTLVFEYCDQD-----LKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---N 119

Query: 257 IIHRDVKAANILLDEDAD 274
           ++HRD+K  N+L++++ +
Sbjct: 120 VLHRDLKPQNLLINKNGE 137

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 50.9 bits (122), Expect = 2e-07
 Identities = 37/141 (26%), Positives = 60/141 (42%), Gaps = 21/141 (14%)

Query: 137 KNILGRGGFGKVYKG---RLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
              +G G FG VY+G      + K+ VAVK  K   +     +F  E  I+    H +++
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 193 RLYGFCT-----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           +L G  T      V E   + P    G + S L+  + SL      +    +   +  L+
Sbjct: 71  KLIGVITENPVWIVME---LAPL---GELRSYLQVNKYSLDLA---SLILYSYQLSTALA 121

Query: 248 YLHEHCDPKIIHRDVKAANIL 268
           YL      + +HRD+ A N+L
Sbjct: 122 YLESK---RFVHRDIAARNVL 139

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 50.8 bits (121), Expect = 2e-07
 Identities = 43/132 (32%), Positives = 65/132 (49%), Gaps = 12/132 (9%)

Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG+V+ G       VAVK LK    S     F  E +I+    H  L++LY    
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS--PESFLEEAQIMKKLRHDKLVQLYA--- 68

Query: 200 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
            V+E+   +V  YM+ GS+   L++ +     L  P    +A   A G++Y+        
Sbjct: 69  VVSEEPIYIVTEYMSKGSLLDFLKDGEGR--ALKLPNLVDMAAQVAAGMAYIERM---NY 123

Query: 258 IHRDVKAANILL 269
           IHRD+++ANIL+
Sbjct: 124 IHRDLRSANILV 135

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 50.9 bits (122), Expect = 2e-07
 Identities = 35/139 (25%), Positives = 66/139 (47%), Gaps = 11/139 (7%)

Query: 134 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRN 190
           + N  ++G G +G V K +  + G++VA+K+    E+     ++  + E++++    H N
Sbjct: 3   YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHEN 61

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
           L+ L           LV+ ++ +    + L + +     LD    +K      RG+ + H
Sbjct: 62  LVNLIEVFRRKKRLYLVFEFVDH----TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH 117

Query: 251 EHCDPKIIHRDVKAANILL 269
            H    IIHRD+K  NIL+
Sbjct: 118 SH---NIIHRDIKPENILV 133

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 43/152 (28%), Positives = 65/152 (42%), Gaps = 24/152 (15%)

Query: 137 KNILGRGGFGKVYKGR------LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
           K  LG G FGKV+           D  LVAVK LK+   +  +  FQ E ++++   H +
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK-DFQREAELLTNLQHEH 68

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE-------------RQSSLPPLDWPTRKK 237
           +++ YG C      ++V+ YM +G +   LR              RQ+    L       
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK-GELGLSQMLH 127

Query: 238 IALGSARGLSYLHEHCDPKIIHRDVKAANILL 269
           IA   A G+ YL        +HRD+   N L+
Sbjct: 128 IASQIASGMVYLASQ---HFVHRDLATRNCLV 156

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 50.7 bits (121), Expect = 2e-07
 Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 22/155 (14%)

Query: 134 FSNKNILGRGGFGKVYKGRL----ADGKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVH 188
           F+   +LG+G FG V + +L       + VAVK LK +  S  ++ +F  E   +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 189 RNLLRLYGFCTTVTEK------LLVYPYMTNGSV-----ASRLRERQSSLPPLDWPTRKK 237
            N+++L G       K      +++ P+M +G +      SR+ E   +LP     T  +
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLP---LQTLVR 117

Query: 238 IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
             +  A G+ YL        IHRD+ A N +L+E+
Sbjct: 118 FMIDIASGMEYLSSK---NFIHRDLAARNCMLNEN 149

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 50.8 bits (122), Expect = 2e-07
 Identities = 44/144 (30%), Positives = 62/144 (43%), Gaps = 22/144 (15%)

Query: 139 ILGRGGFGKV----YKGRLADGKLVAVKRLKE----ERTSGGELQFQTEV-KIISMAVHR 189
           +LGRG FGKV    YK     G+L A+K LK+     R     L  +  + +  +   H 
Sbjct: 6   VLGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP 62

Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI-ALGSARGLSY 248
            L+ L+    T      V  Y   G +   +     S P      R    A     GL Y
Sbjct: 63  FLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP------RAVFYAACVVLGLQY 116

Query: 249 LHEHCDPKIIHRDVKAANILLDED 272
           LHE+   KI++RD+K  N+LLD +
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTE 137

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 50.8 bits (121), Expect = 2e-07
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 33/184 (17%)

Query: 112 SELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVY--------KGRLADGKLVAVKR 163
           SE +L +  R+     +V  D       LG G FG+V         K +      VAVK 
Sbjct: 3   SEYELPEDPRW-----EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKM 57

Query: 164 LKEERTSGGELQFQTEVKIISM-AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE 222
           LK + T        +E++++ M   H+N++ L G CT      ++  Y + G++   LR 
Sbjct: 58  LKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA 117

Query: 223 RQSSLPPLDW---PTRKKIALGS-----------ARGLSYLHEHCDPKIIHRDVKAANIL 268
           R+   P +++   PT+      S           ARG+ YL      K IHRD+ A N+L
Sbjct: 118 RRP--PGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVL 172

Query: 269 LDED 272
           + ED
Sbjct: 173 VTED 176

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 50.7 bits (121), Expect = 3e-07
 Identities = 46/171 (26%), Positives = 65/171 (38%), Gaps = 41/171 (23%)

Query: 137 KNILGRGGFGKVY--------------------KGRLADGKLVAVKRLKEERTSGGELQF 176
           K  LG G FG+V+                    KGR     LVAVK L+ +        F
Sbjct: 10  KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGR---PLLVAVKILRPDANKNARNDF 66

Query: 177 QTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ------------ 224
             EVKI+S     N++RL G C       ++  YM NG +   L                
Sbjct: 67  LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126

Query: 225 ---SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
                LP + + +   +AL  A G+ YL        +HRD+   N L+ E+
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGEN 174

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 50.0 bits (119), Expect = 4e-07
 Identities = 47/142 (33%), Positives = 66/142 (46%), Gaps = 20/142 (14%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-ELQFQTEV---KIISMAVHRNLLRL 194
           +G G +G VYK R    G  VA+K ++ +    G  L    EV   K +    H N++RL
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 195 YGFCTTV-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWP--TRKKIALGSARGLS 247
              C T      T+  LV+ +     V   LR     +PP   P  T K +     RGL 
Sbjct: 68  MDVCATSRTDRETKVTLVFEH-----VDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122

Query: 248 YLHEHCDPKIIHRDVKAANILL 269
           +LH +C   I+HRD+K  NIL+
Sbjct: 123 FLHANC---IVHRDLKPENILV 141

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 49.9 bits (119), Expect = 4e-07
 Identities = 46/143 (32%), Positives = 70/143 (48%), Gaps = 21/143 (14%)

Query: 139 ILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQ------FQTEVKIISMAV-HRN 190
           +LG+G FGKV   RL   G+L AVK LK++      LQ        TE +I+S+A  H  
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVI----LQDDDVECTMTEKRILSLARNHPF 57

Query: 191 LLRLYGFCTTVTEKLL-VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           L +LY  C    ++L  V  ++  G +   +++ +      D    +  A      L +L
Sbjct: 58  LTQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRR----FDEARARFYAAEITSALMFL 112

Query: 250 HEHCDPKIIHRDVKAANILLDED 272
           H   D  II+RD+K  N+LLD +
Sbjct: 113 H---DKGIIYRDLKLDNVLLDHE 132

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 49.8 bits (119), Expect = 4e-07
 Identities = 34/137 (24%), Positives = 67/137 (48%), Gaps = 12/137 (8%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHRNLLRLYGF 197
           +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H N+++L   
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 198 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR--KKIALGSARGLSYLHEHCDP 255
             T  +  LV+ ++        L++   + P    P    K       +GL++ H H   
Sbjct: 68  IHTENKLYLVFEFLHQD-----LKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH--- 119

Query: 256 KIIHRDVKAANILLDED 272
           +++HRD+K  N+L++ +
Sbjct: 120 RVLHRDLKPQNLLINTE 136

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 49.8 bits (119), Expect = 5e-07
 Identities = 51/147 (34%), Positives = 69/147 (46%), Gaps = 29/147 (19%)

Query: 139 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL----- 192
           ++G+G FGKV   +  ADGK  AVK L+++      +  + E K I MA  RN+L     
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKK-----AILKKKEQKHI-MA-ERNVLLKNVK 54

Query: 193 ------RLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 245
                   Y F T   +KL  V  Y+  G +   L +R+ S P    P  +  A   A  
Sbjct: 55  HPFLVGLHYSFQTA--DKLYFVLDYVNGGELFFHL-QRERSFPE---PRARFYAAEIASA 108

Query: 246 LSYLHEHCDPKIIHRDVKAANILLDED 272
           L YLH      II+RD+K  NILLD  
Sbjct: 109 LGYLHSL---NIIYRDLKPENILLDSQ 132

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 49.7 bits (119), Expect = 5e-07
 Identities = 47/168 (27%), Positives = 74/168 (44%), Gaps = 31/168 (18%)

Query: 117 GQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ 175
           GQ     L +L+   +       +G G  G+VYK R    G ++AVK+++  RT   E  
Sbjct: 7   GQKYPADLNDLENLGE-------IGSGTCGQVYKMRFKKTGHVMAVKQMR--RTGNKE-- 55

Query: 176 FQTEVKIISMAVH--------RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL 227
              E K I M +           +++ YG+  T ++  +    M   +   +L +R    
Sbjct: 56  ---ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGP 110

Query: 228 PPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDAD 274
            P D     K+ +   + L YL E H    +IHRDVK +NILLD   +
Sbjct: 111 IPED--ILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGN 153

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 49.5 bits (119), Expect = 6e-07
 Identities = 41/143 (28%), Positives = 62/143 (43%), Gaps = 21/143 (14%)

Query: 137 KNILGRGGFGKVY----KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
           K I G+  FGKV     K      KL   K +K +  +  E      V  + M  + N +
Sbjct: 23  KLIDGK--FGKVSVLKHKP---TQKLFVQKIIKAKNFNAIEPM----VHQL-MKDNPNFI 72

Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
           +LY   TT+   +L+  Y+ +G +   L++       L     KKI       L+ LH+H
Sbjct: 73  KLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH 128

Query: 253 CDPKIIHRDVKAANILLDEDADQ 275
               IIH D+K  N+L D   D+
Sbjct: 129 ---NIIHNDIKLENVLYDRAKDR 148

Length = 267

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 49.2 bits (117), Expect = 7e-07
 Identities = 41/142 (28%), Positives = 69/142 (48%), Gaps = 17/142 (11%)

Query: 140 LGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGE--LQFQTEVKIISMAVHRNLL 192
           LG G FGKV   R        G+ VAVK LK E  SGG      + E++I+    H N++
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIV 69

Query: 193 RLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
           +  G CT        L+  ++ +GS+   L   ++    ++   + K A+   +G+ YL 
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMDYLG 126

Query: 251 EHCDPKIIHRDVKAANILLDED 272
                + +HRD+ A N+L++ +
Sbjct: 127 SR---QYVHRDLAARNVLVESE 145

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 49.1 bits (117), Expect = 9e-07
 Identities = 43/157 (27%), Positives = 65/157 (41%), Gaps = 27/157 (17%)

Query: 137 KNILGRGGFGKVY------------KGRLADGK-----LVAVKRLKEERTSGGELQFQTE 179
           K  LG G FG+V+            K    D       LVAVK L+E+        F  E
Sbjct: 10  KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKE 69

Query: 180 VKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV---ASRLRER----QSSLPPLDW 232
           +KI+S     N++RL   C T     ++  YM NG +    SR   +    ++ +  + +
Sbjct: 70  IKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129

Query: 233 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 269
            T   +A   A G+ YL        +HRD+   N L+
Sbjct: 130 STLIFMATQIASGMKYLSSL---NFVHRDLATRNCLV 163

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 36/144 (25%), Positives = 65/144 (45%), Gaps = 12/144 (8%)

Query: 141 GRGGFGKVYKGRL---ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA---VHRNLLRL 194
           GRG +G+VYK +     DGK  A+K+ K ++     +  Q+  + I++     H N++ L
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGIS-QSACREIALLRELKHENVVSL 67

Query: 195 YGFCTTVTEKL--LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
                   +K   L++ Y  +         RQ+    +     K +      G+ YLH +
Sbjct: 68  VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN 127

Query: 253 CDPKIIHRDVKAANILLDEDADQS 276
               ++HRD+K ANIL+  +  + 
Sbjct: 128 W---VLHRDLKPANILVMGEGPER 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 48.4 bits (116), Expect = 1e-06
 Identities = 38/138 (27%), Positives = 60/138 (43%), Gaps = 16/138 (11%)

Query: 140 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRLYG 196
           LG GGFG+V   ++    +  A+K +K+        Q    +E +I+    H  +++LY 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59

Query: 197 FCTTVTEKLLVY---PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
              T  +K  +Y    Y   G + + LR+R       D  T +           YLH   
Sbjct: 60  --RTFKDKKYIYMLMEYCLGGELWTILRDRGL----FDEYTARFYIACVVLAFEYLHNR- 112

Query: 254 DPKIIHRDVKAANILLDE 271
              II+RD+K  N+LLD 
Sbjct: 113 --GIIYRDLKPENLLLDS 128

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 48.1 bits (114), Expect = 1e-06
 Identities = 42/135 (31%), Positives = 64/135 (47%), Gaps = 12/135 (8%)

Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG+G FG+V+ G       VA+K LK          F  E +I+    H  L+ LY    
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM--PEAFLQEAQIMKKLRHDKLVPLYA--- 68

Query: 200 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
            V+E+   +V  +M  GS+   L+E       L  P    +A   A G++Y+        
Sbjct: 69  VVSEEPIYIVTEFMGKGSLLDFLKEGDGKY--LKLPQLVDMAAQIADGMAYIERM---NY 123

Query: 258 IHRDVKAANILLDED 272
           IHRD++AANIL+ ++
Sbjct: 124 IHRDLRAANILVGDN 138

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 48.4 bits (116), Expect = 1e-06
 Identities = 37/146 (25%), Positives = 71/146 (48%), Gaps = 19/146 (13%)

Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 189
           D +   N +  G +G VY+ R    G++VA+K+LK E+   G  +    E+ I+    H 
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64

Query: 190 NLLRL----YGFCTTVTEKLLVYPYMTNG--SVASRLRERQSSLPPLDWPTRKKIALGSA 243
           N++ +     G  + + +  +V  Y+ +   S+   ++       P      K + L   
Sbjct: 65  NIVTVKEVVVG--SNLDKIYMVMEYVEHDLKSLMETMK------QPFLQSEVKCLMLQLL 116

Query: 244 RGLSYLHEHCDPKIIHRDVKAANILL 269
            G+++LH++    I+HRD+K +N+LL
Sbjct: 117 SGVAHLHDN---WILHRDLKTSNLLL 139

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 41/137 (29%), Positives = 66/137 (48%), Gaps = 10/137 (7%)

Query: 140 LGRGGFGKVYKGR--LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 197
           LG G +  VYKGR  L D  LVA+K ++ E   G       EV ++    H N++ L+  
Sbjct: 14  LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 198 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
             T     LV+ Y+ +  +   L +  +S   ++    K       RGL+Y H     K+
Sbjct: 73  IHTEKSLTLVFEYL-DKDLKQYLDDCGNS---INMHNVKLFLFQLLRGLNYCHRR---KV 125

Query: 258 IHRDVKAANILLDEDAD 274
           +HRD+K  N+L++E  +
Sbjct: 126 LHRDLKPQNLLINERGE 142

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 40/138 (28%), Positives = 64/138 (46%), Gaps = 12/138 (8%)

Query: 140 LGRGGFGKVYKGR--LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 197
           LG G +  V+KGR  L +  LVA+K ++ E   G       EV ++    H N++ L+  
Sbjct: 14  LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 198 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA-RGLSYLHEHCDPK 256
             T     LV+ Y+        L++       +      KI L    RGL+Y H     K
Sbjct: 73  VHTDKSLTLVFEYLDKD-----LKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---K 124

Query: 257 IIHRDVKAANILLDEDAD 274
           ++HRD+K  N+L++E  +
Sbjct: 125 VLHRDLKPQNLLINERGE 142

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 37/134 (27%), Positives = 62/134 (46%), Gaps = 10/134 (7%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 198
           LG G +  VYKGR    G+LVA+K ++ E   G       E  ++    H N++ L+   
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72

Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS-ARGLSYLHEHCDPKI 257
            T     LV+ Y+      + L++              ++ L    RGL+Y H+    ++
Sbjct: 73  HTKKTLTLVFEYLD-----TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RV 124

Query: 258 IHRDVKAANILLDE 271
           +HRD+K  N+L+ E
Sbjct: 125 LHRDLKPQNLLISE 138

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 47.9 bits (115), Expect = 2e-06
 Identities = 39/163 (23%), Positives = 62/163 (38%), Gaps = 45/163 (27%)

Query: 134 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EVKII 183
           +     +G G +G V        G+ VA+K++           F           E+K++
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNV------FDDLIDAKRILREIKLL 53

Query: 184 SMAVHRNLLRLYGFCT-TVTEKL----LVYPYM-TNGSVASRLRERQSSLPPLDWPTRKK 237
               H N++ L         E      +V   M T+  +   ++  Q    PL   T   
Sbjct: 54  RHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETD--LHKVIKSPQ----PL---TDDH 104

Query: 238 I------ALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 274
           I       L   RGL YLH      +IHRD+K +NIL++ + D
Sbjct: 105 IQYFLYQIL---RGLKYLHS---ANVIHRDLKPSNILVNSNCD 141

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 42/149 (28%), Positives = 74/149 (49%), Gaps = 29/149 (19%)

Query: 139 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL---QFQTEVKIISMAVHRNLLRL 194
           ++G+GG G+VY        + VA+K+++E+  S   L   +F  E KI +  +H  ++ +
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIRED-LSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 195 YGFCTTVTEKLLVY---PYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARG--LS 247
           Y  C+   +   VY   PY+   ++ S L+   ++ SL        K++A  ++ G  LS
Sbjct: 68  YSICS---DGDPVYYTMPYIEGYTLKSLLKSVWQKESLS-------KELAEKTSVGAFLS 117

Query: 248 YLHEHC-------DPKIIHRDVKAANILL 269
             H+ C          ++HRD+K  NILL
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILL 146

Length = 932

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 47.2 bits (112), Expect = 3e-06
 Identities = 37/136 (27%), Positives = 59/136 (43%), Gaps = 6/136 (4%)

Query: 140 LGRGGFGKVYKGRLADGKLVA---VKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 196
           +G G FGKV    +     VA   VK LK   +S  + +F  +     +  H N+L+  G
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 197 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 256
            C      LLV+ Y   G + S L + Q           +++A   A G++++H+H    
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---N 119

Query: 257 IIHRDVKAANILLDED 272
            +H D+   N  L  D
Sbjct: 120 FLHSDLALRNCFLTSD 135

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 47.5 bits (113), Expect = 3e-06
 Identities = 35/98 (35%), Positives = 50/98 (51%), Gaps = 8/98 (8%)

Query: 140 LGRGGFGKVYK------GRLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 192
           LGRG FGKV +       + A  + VAVK LKE  T+       TE+KI I +  H N++
Sbjct: 15  LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74

Query: 193 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPP 229
            L G CT     L+V   Y   G++++ LR ++    P
Sbjct: 75  NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSP 112

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 47.0 bits (112), Expect = 3e-06
 Identities = 37/135 (27%), Positives = 66/135 (48%), Gaps = 15/135 (11%)

Query: 140 LGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT----EVKIISMAVHRNLLRL 194
           +G G +G V+K R  + G++VA+K+  E   S  +   +     E++++    H NL+ L
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVE---SEDDPVIKKIALREIRMLKQLKHPNLVNL 65

Query: 195 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 254
                   +  LV+ Y  + +V + L +    +P       KKI   + + +++ H+H  
Sbjct: 66  IEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEH---LIKKIIWQTLQAVNFCHKH-- 119

Query: 255 PKIIHRDVKAANILL 269
              IHRDVK  NIL+
Sbjct: 120 -NCIHRDVKPENILI 133

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 46.5 bits (110), Expect = 5e-06
 Identities = 36/141 (25%), Positives = 66/141 (46%), Gaps = 17/141 (12%)

Query: 139 ILGRGGFGKVY--KGRLADGKLVAVKRLKEERTSGGELQF-QTEVKIISMAVHRNLLRLY 195
            +G G FGK+Y  K + +D +   +K +   +    E +  + EV +++   H N++  +
Sbjct: 7   KIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSL----PPLDWPTRKKIALGSARGLSYLHE 251
                     +V  Y   G +  R+  ++  L      L W    +I+LG    L ++H 
Sbjct: 66  ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV--QISLG----LKHIH- 118

Query: 252 HCDPKIIHRDVKAANILLDED 272
             D KI+HRD+K+ NI L ++
Sbjct: 119 --DRKILHRDIKSQNIFLSKN 137

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 46.4 bits (110), Expect = 6e-06
 Identities = 37/135 (27%), Positives = 64/135 (47%), Gaps = 12/135 (8%)

Query: 137 KNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           + ILG G  G VYK   L   +++AVK +  + T   + Q  +E++I+       ++  Y
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G         +   +M  GS+     +    +P        +IA+   +GL+YL      
Sbjct: 66  GAFFVENRISICTEFMDGGSL-----DVYRKIPE---HVLGRIAVAVVKGLTYL---WSL 114

Query: 256 KIIHRDVKAANILLD 270
           KI+HRDVK +N+L++
Sbjct: 115 KILHRDVKPSNMLVN 129

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 46.6 bits (111), Expect = 6e-06
 Identities = 43/141 (30%), Positives = 66/141 (46%), Gaps = 17/141 (12%)

Query: 139 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEE---RTSGGELQFQTEVKIISMA-VHRNLLR 193
           +LG+G FGKV    L    +L AVK LK++   +    E    TE +++++A  H  L +
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECT-MTEKRVLALAGKHPFLTQ 60

Query: 194 LYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 251
           L       T+  L  V  Y+  G +   ++         D P  +  A     GL +LHE
Sbjct: 61  L--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR----FDEPRARFYAAEIVLGLQFLHE 114

Query: 252 HCDPKIIHRDVKAANILLDED 272
                II+RD+K  N+LLD +
Sbjct: 115 R---GIIYRDLKLDNVLLDSE 132

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 46.2 bits (109), Expect = 8e-06
 Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 29/165 (17%)

Query: 126 ELQVATDGFSNKNILGRGGFGKVYKGRL---ADG---KLVAVKRLKEERTSGGELQFQTE 179
           E+ ++T  F  +  LG   FGKVYKG L   A G   + VA+K LK++       +F+ E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 180 VKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER---------------Q 224
             + S   H N++ L G  T      +++ Y ++  +   L  R               +
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 225 SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 269
           S+L P D+     I    A G+ +L  H    ++H+D+   N+L+
Sbjct: 119 STLEPADF---VHIVTQIAAGMEFLSSH---HVVHKDLATRNVLV 157

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 46.0 bits (109), Expect = 8e-06
 Identities = 37/141 (26%), Positives = 64/141 (45%), Gaps = 24/141 (17%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-------ELQFQTEVKIISMAVHRNL 191
           +G G +G VYK R     + +A+K+++ E+   G       E+    E++      H N+
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ------HGNI 63

Query: 192 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR--KKIALGSARGLSYL 249
           +RL     +     LV+ Y+        L++   S P      R  K       RG++Y 
Sbjct: 64  VRLQDVVHSEKRLYLVFEYLD-----LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118

Query: 250 HEHCDPKIIHRDVKAANILLD 270
           H H   +++HRD+K  N+L+D
Sbjct: 119 HSH---RVLHRDLKPQNLLID 136

Length = 294

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 45.4 bits (107), Expect = 1e-05
 Identities = 37/130 (28%), Positives = 60/130 (46%), Gaps = 8/130 (6%)

Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG+V+         VAVK +K    S     F  E  ++    H  L++L+   T
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE--AFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 ++  +M  GS+   L+  + S  PL  P     +   A G++++ +      IH
Sbjct: 72  K-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NYIH 125

Query: 260 RDVKAANILL 269
           RD++AANIL+
Sbjct: 126 RDLRAANILV 135

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 45.7 bits (108), Expect = 1e-05
 Identities = 42/138 (30%), Positives = 66/138 (47%), Gaps = 11/138 (7%)

Query: 140 LGRG--GFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLY 195
           +GRG      VY  R    G LV V+    E  +   L+  Q EV +     H N++  +
Sbjct: 6   IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65

Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP-LDWPTRKKIALGSARGLSYLHEHCD 254
              TT +   ++ P+M  GS  S L+   +  P  +       I  G+ RGL+YLH++  
Sbjct: 66  TVFTTGSWLWVISPFMAYGSANSLLK---TYFPEGMSEALIGNILFGALRGLNYLHQN-- 120

Query: 255 PKIIHRDVKAANILLDED 272
              IHR++KA++IL+  D
Sbjct: 121 -GYIHRNIKASHILISGD 137

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 45.5 bits (108), Expect = 1e-05
 Identities = 42/153 (27%), Positives = 62/153 (40%), Gaps = 34/153 (22%)

Query: 138 NILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE-----------LQFQT--EVKII 183
             LG G +GKV K      GK+VA+K++K    S              + F T  E+KI+
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 184 SMAVHRNLLRLY------GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKK 237
           +   H N++ L        F   V +       M     AS L++       L     K 
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMD------IM-----ASDLKKVVDRKIRLTESQVKC 123

Query: 238 IALGSARGLSYLHEHCDPKIIHRDVKAANILLD 270
           I L    GL+ LH+      +HRD+  ANI ++
Sbjct: 124 ILLQILNGLNVLHKW---YFMHRDLSPANIFIN 153

Length = 335

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 45.4 bits (107), Expect = 1e-05
 Identities = 42/151 (27%), Positives = 68/151 (45%), Gaps = 19/151 (12%)

Query: 138 NILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLR 193
           +++G G FG+V K R+    L    A+KR+KE  +      F  E++++  +  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------------RQSSLPPLDWPTRKKIALG 241
           L G C       L   Y  +G++   LR+              S+   L        A  
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 242 SARGLSYLHEHCDPKIIHRDVKAANILLDED 272
            ARG+ YL +    + IHRD+ A NIL+ E+
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGEN 148

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 45.2 bits (108), Expect = 1e-05
 Identities = 44/139 (31%), Positives = 61/139 (43%), Gaps = 16/139 (11%)

Query: 140 LGRGGFGKVYKGRLAD-GKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYG 196
           LG G FG+V   R    GK  A+K L + +            E +I+    H  L+ LYG
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 197 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR---KKIALGSARGLSYLHEHC 253
                +   LV  Y+  G + S LR  +S   P     R    ++ L     L YLH   
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFSHLR--KSGRFPEPV-ARFYAAQVVLA----LEYLH-SL 120

Query: 254 DPKIIHRDVKAANILLDED 272
           D  I++RD+K  N+LLD D
Sbjct: 121 D--IVYRDLKPENLLLDSD 137

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 45.4 bits (107), Expect = 1e-05
 Identities = 32/98 (32%), Positives = 49/98 (50%), Gaps = 8/98 (8%)

Query: 140 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 192
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 15  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74

Query: 193 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPP 229
            L G CT     L+V   +   G++++ LR ++    P
Sbjct: 75  NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVP 112

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 45.2 bits (107), Expect = 1e-05
 Identities = 39/147 (26%), Positives = 69/147 (46%), Gaps = 12/147 (8%)

Query: 131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRL-KEERTSGGELQFQTEVKIISMAVH 188
           T+ + +   +G G FG V   R    G+ VA+K++ K   T     +   E+K++    H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 189 RNLLRLYG-FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
            N++ L   F + + +   V   +  G+   RL   +    PL+    +       RGL 
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSR----PLEKQFIQYFLYQILRGLK 122

Query: 248 YLHEHCDPKIIHRDVKAANILLDEDAD 274
           Y+H      ++HRD+K +NIL++E+ D
Sbjct: 123 YVHS---AGVVHRDLKPSNILINENCD 146

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 37/123 (30%), Positives = 57/123 (46%), Gaps = 19/123 (15%)

Query: 156 GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS 215
           GK VAVK++   +    EL F  EV I+    H N++ +Y       E  +V  ++  G+
Sbjct: 47  GKQVAVKKMDLRKQQRRELLFN-EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105

Query: 216 VA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 270
           +      +R+ E Q +           + L   R LSYLH      +IHRD+K+ +ILL 
Sbjct: 106 LTDIVTHTRMNEEQIA----------TVCLSVLRALSYLHNQ---GVIHRDIKSDSILLT 152

Query: 271 EDA 273
            D 
Sbjct: 153 SDG 155

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 48/139 (34%), Positives = 68/139 (48%), Gaps = 17/139 (12%)

Query: 139 ILGRGGFGKVY-KGRLADGKLVAVKRLKEE----RTSGGELQFQTEVKIISMAVHRNLLR 193
           ++G+G FGKV    R  DGK  AVK L+++    R     +  +  V ++    H  L+ 
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVG 60

Query: 194 L-YGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 251
           L Y F TT  EKL  V  ++  G +   L +R+ S P    P  +  A   A  L YLH 
Sbjct: 61  LHYSFQTT--EKLYFVLDFVNGGELFFHL-QRERSFPE---PRARFYAAEIASALGYLHS 114

Query: 252 HCDPKIIHRDVKAANILLD 270
                I++RD+K  NILLD
Sbjct: 115 ---INIVYRDLKPENILLD 130

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 44.7 bits (105), Expect = 2e-05
 Identities = 37/135 (27%), Positives = 63/135 (46%), Gaps = 9/135 (6%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 198
           +G G +G VYK R +  G+L A+K +K E      +  Q E+ ++    H N++  +G  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIMMKDCKHSNIVAYFGSY 75

Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 258
               +  +   +   GS    L++      PL       ++  + +GL YLH       +
Sbjct: 76  LRRDKLWICMEFCGGGS----LQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK---M 128

Query: 259 HRDVKAANILLDEDA 273
           HRD+K ANILL ++ 
Sbjct: 129 HRDIKGANILLTDNG 143

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 44.6 bits (105), Expect = 2e-05
 Identities = 37/152 (24%), Positives = 67/152 (44%), Gaps = 19/152 (12%)

Query: 137 KNILGRGGFGKVYKGRLA-DGKLV--AVKRLKEERTSGGELQFQTEVKII-SMAVHRNLL 192
           ++++G G FG+V +  +  DG  +  A+K LKE  +      F  E++++  +  H N++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRE------------RQSSLPPLDWPTRKKIAL 240
            L G C       +   Y   G++   LR+               +   L      + A 
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 241 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
             A G+ YL    + + IHRD+ A N+L+ E+
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGEN 155

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 44.8 bits (106), Expect = 2e-05
 Identities = 33/134 (24%), Positives = 58/134 (43%), Gaps = 12/134 (8%)

Query: 138 NILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 196
           N +G G  G VYK      G+L A+K +          Q   E++I+    H N+++ + 
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139

Query: 197 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 256
                 E  ++  +M  GS+       +  L          +A     G++YLH      
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFL--------ADVARQILSGIAYLHRR---H 188

Query: 257 IIHRDVKAANILLD 270
           I+HRD+K +N+L++
Sbjct: 189 IVHRDIKPSNLLIN 202

Length = 353

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 44.6 bits (105), Expect = 2e-05
 Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 30/160 (18%)

Query: 140 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 198
           +G G  G V    + + GKLVAVK++   +    EL F  EV I+    H N++ +Y   
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHENVVEMYNSY 86

Query: 199 TTVTEKLLVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
               E  +V  ++  G++      +R+ E Q +           + L   + LS LH   
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----------AVCLAVLKALSVLHAQ- 135

Query: 254 DPKIIHRDVKAANILLDEDAD----------QSSKTILRR 283
              +IHRD+K+ +ILL  D            Q SK + RR
Sbjct: 136 --GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 173

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 44.5 bits (105), Expect = 2e-05
 Identities = 44/144 (30%), Positives = 69/144 (47%), Gaps = 23/144 (15%)

Query: 139 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRN----L 191
           I+GRGGFG+VY  R AD GK+ A+K L ++R     GE     E  ++S+    +    +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 192 LRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR---GLS 247
              Y F T   +KL  +   M  G +   L +           +  ++   +A    GL 
Sbjct: 61  CMSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGVF-------SEAEMRFYAAEIILGLE 111

Query: 248 YLHEHCDPKIIHRDVKAANILLDE 271
           ++H      +++RD+K ANILLDE
Sbjct: 112 HMHNRF---VVYRDLKPANILLDE 132

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 44.6 bits (106), Expect = 2e-05
 Identities = 35/140 (25%), Positives = 66/140 (47%), Gaps = 17/140 (12%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLRLYGF 197
           +G G F +V K +    GK  A+K +K+   S  ++    E++ +  ++ H N+LRL   
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRL--- 63

Query: 198 CTTVTEKL-----LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
              + ++      LV+  M + ++   ++ R+  LP       K       + L ++H +
Sbjct: 64  IEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEK---RVKSYMYQLLKSLDHMHRN 119

Query: 253 CDPKIIHRDVKAANILLDED 272
               I HRD+K  NIL+ +D
Sbjct: 120 ---GIFHRDIKPENILIKDD 136

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 44.8 bits (106), Expect = 2e-05
 Identities = 39/124 (31%), Positives = 54/124 (43%), Gaps = 20/124 (16%)

Query: 154 ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL---YGFCTTVTEKLLVYPY 210
              K V VK +   +T G E+     +K IS   HR ++ L   Y + +TV   +  Y  
Sbjct: 117 EQRKKVIVKAVTGGKTPGREIDI---LKTIS---HRAIINLIHAYRWKSTVCMVMPKYKC 170

Query: 211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 270
                V     +R   LP     T ++  L +   L+YLH      IIHRDVK  NI LD
Sbjct: 171 DLFTYV-----DRSGPLPLEQAITIQRRLLEA---LAYLHGR---GIIHRDVKTENIFLD 219

Query: 271 EDAD 274
           E  +
Sbjct: 220 EPEN 223

Length = 392

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 44.3 bits (104), Expect = 3e-05
 Identities = 35/136 (25%), Positives = 65/136 (47%), Gaps = 9/136 (6%)

Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           +GRG +G VYK +  DGK      LK+   +G  +    E+ ++    H N++ L     
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 200 TVTEK--LLVYPYMTNG--SVASRLRERQSSLPPLDWPTR--KKIALGSARGLSYLHEHC 253
           + +++   L++ Y  +    +    R  +++  P+  P    K +      G+ YLH + 
Sbjct: 69  SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128

Query: 254 DPKIIHRDVKAANILL 269
              ++HRD+K ANIL+
Sbjct: 129 ---VLHRDLKPANILV 141

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 44.0 bits (104), Expect = 3e-05
 Identities = 45/154 (29%), Positives = 69/154 (44%), Gaps = 32/154 (20%)

Query: 140 LGRGGFGKVYKGRLADG--KLVAVKRL-----------KEERTSGGELQFQTEVKIISMA 186
           LG G FG VYK R  +    L+A+K +           +E   S G++   +EV II   
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIV--SEVTIIKEQ 65

Query: 187 V-HRNLLRLYGFCTTVTEKLLVYPYM------TNGSVASRLRERQSSLPPLD-WPTRKKI 238
           + H N++R Y    T  E   +Y  M        G   + L+E++        W    ++
Sbjct: 66  LRHPNIVRYY---KTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQM 122

Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
            L     L YLH+  + +I+HRD+   NI+L ED
Sbjct: 123 VLA----LRYLHK--EKRIVHRDLTPNNIMLGED 150

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 43.9 bits (103), Expect = 4e-05
 Identities = 40/147 (27%), Positives = 66/147 (44%), Gaps = 16/147 (10%)

Query: 134 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRN 190
           F    +LG+GGFG+V   ++ A GK+ A K+L+++R     GE     E +I+     R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-QSSLPPLDWPTRKKIALGSAR---GL 246
           ++ L     T     LV   M  G +   +    ++           +    +A    GL
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE------EGRAVFYAAEICCGL 115

Query: 247 SYLHEHCDPKIIHRDVKAANILLDEDA 273
             LH+    +I++RD+K  NILLD+  
Sbjct: 116 EDLHQE---RIVYRDLKPENILLDDHG 139

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 43.8 bits (103), Expect = 5e-05
 Identities = 39/142 (27%), Positives = 65/142 (45%), Gaps = 10/142 (7%)

Query: 130 ATDGFSNKNILGRGGFGKVYKG--RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV 187
           A   + N   LG G +  VYKG  R+ +G+LVA+K +  +   G       E  ++    
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGISRI-NGQLVALKVISMKTEEGVPFTAIREASLLKGLK 61

Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           H N++ L+    T      V+ YM +  +A  + +    L P +    +       RGL+
Sbjct: 62  HANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYN---VRLFMFQLLRGLA 117

Query: 248 YLHEHCDPKIIHRDVKAANILL 269
           Y+H      I+HRD+K  N+L+
Sbjct: 118 YIHGQ---HILHRDLKPQNLLI 136

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 43.6 bits (103), Expect = 5e-05
 Identities = 37/138 (26%), Positives = 68/138 (49%), Gaps = 17/138 (12%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV---HRNLLRLY 195
           +G G +G VYKGR    G++VA+K+++ E  S  E    T ++ IS+     H N++ L 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLE--SEEEGVPSTAIREISLLKELQHPNIVCLQ 65

Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYLHEH 252
                 +   L++ +++       L++   SLP    +D    K       +G+ + H  
Sbjct: 66  DVLMQESRLYLIFEFLS-----MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120

Query: 253 CDPKIIHRDVKAANILLD 270
              +++HRD+K  N+L+D
Sbjct: 121 ---RVLHRDLKPQNLLID 135

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 43.4 bits (102), Expect = 6e-05
 Identities = 40/151 (26%), Positives = 65/151 (43%), Gaps = 30/151 (19%)

Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKI-------ISMAV----- 187
           LGRG   ++Y G L        K   E+     E + +  +K+       IS+A      
Sbjct: 3   LGRGTRTQIYAGILNY------KDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETAS 56

Query: 188 ------HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALG 241
                 H++++ LYG C    E ++V  ++  G +   +  R+S    L  P + K+A  
Sbjct: 57  MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH-RKSD--VLTTPWKFKVAKQ 113

Query: 242 SARGLSYLHEHCDPKIIHRDVKAANILLDED 272
            A  LSYL    D  ++H +V   NILL  +
Sbjct: 114 LASALSYLE---DKDLVHGNVCTKNILLARE 141

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 43.1 bits (101), Expect = 7e-05
 Identities = 44/144 (30%), Positives = 69/144 (47%), Gaps = 23/144 (15%)

Query: 139 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRN----L 191
           I+GRGGFG+VY  R AD GK+ A+K L ++R     GE     E  ++S+    +    +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 192 LRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR---GLS 247
              Y F T   +KL  +   M  G +   L +           + K++   +     GL 
Sbjct: 61  CMTYAFHT--PDKLCFILDLMNGGDLHYHLSQHGVF-------SEKEMRFYATEIILGLE 111

Query: 248 YLHEHCDPKIIHRDVKAANILLDE 271
           ++H      +++RD+K ANILLDE
Sbjct: 112 HMHNRF---VVYRDLKPANILLDE 132

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 43.3 bits (102), Expect = 7e-05
 Identities = 42/143 (29%), Positives = 65/143 (45%), Gaps = 21/143 (14%)

Query: 139 ILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQ------FQTEVKIISMAV-HRN 190
           +LG+G FGKV         ++ A+K LK++      LQ        TE +I+++A  H  
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI----LQDDDVDCTMTEKRILALAAKHPF 57

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRL-RERQSSLPPLDWPTRKKIALGSARGLSYL 249
           L  L+    T      V  Y+  G +  ++ R R+      D P  +  A      L +L
Sbjct: 58  LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK-----FDEPRSRFYAAEVTLALMFL 112

Query: 250 HEHCDPKIIHRDVKAANILLDED 272
           H H    +I+RD+K  NILLD +
Sbjct: 113 HRH---GVIYRDLKLDNILLDAE 132

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 43.0 bits (101), Expect = 7e-05
 Identities = 45/140 (32%), Positives = 67/140 (47%), Gaps = 15/140 (10%)

Query: 139 ILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQT--EVKIISMA-VHRNLLRL 194
           +LG+G FGKV+   L    +  A+K LK++     +    T  E +++S+A  H  L  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 195 YGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
           Y  CT  T++ L  V  Y+  G +   ++    S    D P     A     GL +LH  
Sbjct: 62  Y--CTFQTKENLFFVMEYLNGGDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLHSK 115

Query: 253 CDPKIIHRDVKAANILLDED 272
               I++RD+K  NILLD D
Sbjct: 116 ---GIVYRDLKLDNILLDTD 132

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 42.9 bits (101), Expect = 7e-05
 Identities = 40/140 (28%), Positives = 65/140 (46%), Gaps = 17/140 (12%)

Query: 140 LGRGGFGK--VYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYG 196
           +G G FGK  + K +  DGK   +K +   + S  E +  + EV ++S   H N+++   
Sbjct: 8   IGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66

Query: 197 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP----LDWPTRKKIALGSARGLSYLHEH 252
                    +V  Y   G +  ++  ++  L P    LDW  +  +AL         H H
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK--------HVH 118

Query: 253 CDPKIIHRDVKAANILLDED 272
            D KI+HRD+K+ NI L +D
Sbjct: 119 -DRKILHRDIKSQNIFLTKD 137

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 43.1 bits (101), Expect = 8e-05
 Identities = 43/139 (30%), Positives = 64/139 (46%), Gaps = 11/139 (7%)

Query: 139 ILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRLY 195
           ++GRG + KV   RL  + ++ A+K +K+E     E     QTE  +   A     L   
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 196 GFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 254
             C   T +L LV  Y+  G +   + +RQ  LP       +  A      L++LHE   
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDLMFHM-QRQRKLPE---EHARFYAAEICIALNFLHER-- 115

Query: 255 PKIIHRDVKAANILLDEDA 273
             II+RD+K  N+LLD D 
Sbjct: 116 -GIIYRDLKLDNVLLDADG 133

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 42.7 bits (100), Expect = 9e-05
 Identities = 38/136 (27%), Positives = 62/136 (45%), Gaps = 10/136 (7%)

Query: 140 LGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF- 197
           +G+G +GKV+K     +G   AVK L        E++ +  + + +++ H N+++ YG  
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNI-LKALSDHPNVVKFYGMY 84

Query: 198 ----CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
                    +  LV      GSV   ++        ++ P    I   +  GL +LH + 
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143

Query: 254 DPKIIHRDVKAANILL 269
             K IHRDVK  NILL
Sbjct: 144 --KTIHRDVKGNNILL 157

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 42.7 bits (100), Expect = 1e-04
 Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 8/143 (5%)

Query: 134 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRN 190
           F    +LG+GGFG+V   ++ A GK+ A KRL+++R     GE     E +I+     + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
           ++ L     T     LV   M  G +   +    +  P  +       A     GL  LH
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLH 119

Query: 251 EHCDPKIIHRDVKAANILLDEDA 273
                  ++RD+K  NILLD+  
Sbjct: 120 RE---NTVYRDLKPENILLDDYG 139

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 42.5 bits (100), Expect = 1e-04
 Identities = 46/140 (32%), Positives = 68/140 (48%), Gaps = 16/140 (11%)

Query: 139 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE--LQFQTEVKIISMAVHRNLLRL- 194
           +LG+G FGKV   R  A GK  A+K LK+E     +      TE +++    H  L  L 
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 195 YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
           Y F T   ++L  V  Y   G +   L RER  S     +   + ++      L YLH  
Sbjct: 62  YSFQTH--DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS-----ALGYLHS- 113

Query: 253 CDPKIIHRDVKAANILLDED 272
           CD  +++RD+K  N++LD+D
Sbjct: 114 CD--VVYRDLKLENLMLDKD 131

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 42.4 bits (99), Expect = 1e-04
 Identities = 37/136 (27%), Positives = 65/136 (47%), Gaps = 9/136 (6%)

Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG-FC 198
           +GRG +G VYK +  DGK      LK+   +G  +    E+ ++    H N++ L   F 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 199 TTVTEKL-LVYPYMTNG--SVASRLRERQSSLPPLDWP--TRKKIALGSARGLSYLHEHC 253
           +    K+ L++ Y  +    +    R  +++  P+  P    K +      G+ YLH + 
Sbjct: 69  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128

Query: 254 DPKIIHRDVKAANILL 269
              ++HRD+K ANIL+
Sbjct: 129 ---VLHRDLKPANILV 141

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 42.3 bits (99), Expect = 1e-04
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 8/99 (8%)

Query: 139 ILGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNL 191
           +LG G FGKV +       + +    VAVK LKE  T+       +E+KI I +  H N+
Sbjct: 14  VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV 73

Query: 192 LRLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPP 229
           + L G CT     L+V   +   G++++ LR ++    P
Sbjct: 74  VNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSP 112

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 48/144 (33%), Positives = 66/144 (45%), Gaps = 24/144 (16%)

Query: 140 LGRGGFGKVYKGRLAD-GKLVAVKRL-KEERTSGGEL-QFQTEVKIISMAVHRNLLRLYG 196
           LG+G  G+V+  RL   GKL A+K L K+E     ++ +  TE +I++   H  L  LY 
Sbjct: 9   LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68

Query: 197 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR--------GLSY 248
              T T   LV  Y   G +  RL +RQ           K ++   AR         L Y
Sbjct: 69  SFQTETYLCLVMDYCPGGEL-FRLLQRQP---------GKCLSEEVARFYAAEVLLALEY 118

Query: 249 LHEHCDPKIIHRDVKAANILLDED 272
           LH      I++RD+K  NILL E 
Sbjct: 119 LHLL---GIVYRDLKPENILLHES 139

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 17/32 (53%), Positives = 20/32 (62%), Gaps = 4/32 (12%)

Query: 244 RGLSYLHEHCDPKIIHRDVKAANILLDEDADQ 275
            GL YLH     +IIHRDVK  NI ++ D DQ
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFIN-DVDQ 195

Length = 357

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 42.0 bits (98), Expect = 2e-04
 Identities = 43/142 (30%), Positives = 66/142 (46%), Gaps = 17/142 (11%)

Query: 139 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV-HRNLLRL 194
           ++GRG + KV   RL    ++ A+K +K+E  +  E     QTE  +   A  H  L+ L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 195 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR---GLSYLHE 251
           +    T +    V  Y+  G +   + +RQ  LP       +     SA     L+YLHE
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLP------EEHARFYSAEISLALNYLHE 114

Query: 252 HCDPKIIHRDVKAANILLDEDA 273
                II+RD+K  N+LLD + 
Sbjct: 115 R---GIIYRDLKLDNVLLDSEG 133

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 41.8 bits (98), Expect = 2e-04
 Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 7/96 (7%)

Query: 139 ILGRGGFGKV-----YKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNL 191
            LG G FGKV     Y    +D  + VAVK LK            +E+K++S +  H N+
Sbjct: 42  TLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINI 101

Query: 192 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL 227
           + L G CT     L++  Y   G + + LR ++ S 
Sbjct: 102 VNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSF 137

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 41.5 bits (97), Expect = 2e-04
 Identities = 41/136 (30%), Positives = 60/136 (44%), Gaps = 11/136 (8%)

Query: 139 ILGRGGFGKVYKGR-LADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLY 195
           ++G+G FGKV   R  A+ K  AVK L+++       E    +E  ++   V    L   
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 196 GFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 254
            F     +KL  V  Y+  G +   L+  +  L P      +  A   A  L YLH    
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP----RARFYAAEIASALGYLHSL-- 115

Query: 255 PKIIHRDVKAANILLD 270
             I++RD+K  NILLD
Sbjct: 116 -NIVYRDLKPENILLD 130

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 41.1 bits (96), Expect = 3e-04
 Identities = 38/151 (25%), Positives = 67/151 (44%), Gaps = 42/151 (27%)

Query: 139 ILGRGGFGKVYKGR-LADGKLVAVKRL-------KEERTSGGELQFQTEVKIISMAVHRN 190
           ++G+G +G+V   R   DGK   +K+L       +E + +  E Q  +++K  ++  +R 
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 191 --------LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP----LDWPTRKKI 238
                   L  + GFC               G +  +L+E++  L P    ++W  +  +
Sbjct: 67  SWEGEDGLLYIVMGFCE-------------GGDLYHKLKEQKGKLLPENQVVEWFVQIAM 113

Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 269
           AL       YLHE     I+HRD+K  N+ L
Sbjct: 114 AL------QYLHEK---HILHRDLKTQNVFL 135

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 41.1 bits (96), Expect = 3e-04
 Identities = 41/141 (29%), Positives = 64/141 (45%), Gaps = 8/141 (5%)

Query: 134 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRN 190
           F +  +LG+GGFG+V   ++ A GK+ A K+L+++R     GE     E +I+     R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
           ++ L     T     LV   M  G +   +    +  P  D       A     GL  L 
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQ 119

Query: 251 EHCDPKIIHRDVKAANILLDE 271
                +I++RD+K  NILLD+
Sbjct: 120 RE---RIVYRDLKPENILLDD 137

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 41.4 bits (97), Expect = 4e-04
 Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 7/93 (7%)

Query: 139 ILGRGGFGKVYK------GRLADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNL 191
            LG G FGKV +      G+  +   VAVK LK    +       +E+KI+S +  H+N+
Sbjct: 45  TLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNI 104

Query: 192 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ 224
           + L G CT     L++  Y   G + + LR++ 
Sbjct: 105 VNLLGACTHGGPVLVITEYCCYGDLLNFLRKKA 137

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 40.9 bits (96), Expect = 4e-04
 Identities = 39/136 (28%), Positives = 58/136 (42%), Gaps = 15/136 (11%)

Query: 142 RGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVK-----IISMAVHRNLLRLY 195
           +G FG VY  +  + G   A+K LK  ++        T VK     ++       + +LY
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLK--KSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
               +     LV  Y+  G  AS L +    LP  DW   K+       G+  LH     
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCAS-LIKTLGGLP-EDWA--KQYIAEVVLGVEDLH---QR 116

Query: 256 KIIHRDVKAANILLDE 271
            IIHRD+K  N+L+D+
Sbjct: 117 GIIHRDIKPENLLIDQ 132

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 40.7 bits (95), Expect = 4e-04
 Identities = 48/140 (34%), Positives = 66/140 (47%), Gaps = 19/140 (13%)

Query: 139 ILGRGGFGKVY-KGRLADGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAV-HRNLLRL 194
           ++G+G FGKV    R +DG   AVK L+++     + Q     E  ++   + H  L+ L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 195 -YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKKI-ALGSARGLSYLH 250
            Y F T   EKL  V  Y+  G +   L RER    P      R +  A   A  + YLH
Sbjct: 62  HYSFQTA--EKLYFVLDYVNGGELFFHLQRERCFLEP------RARFYAAEVASAIGYLH 113

Query: 251 EHCDPKIIHRDVKAANILLD 270
                 II+RD+K  NILLD
Sbjct: 114 SL---NIIYRDLKPENILLD 130

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 40.9 bits (96), Expect = 4e-04
 Identities = 28/131 (21%), Positives = 61/131 (46%), Gaps = 13/131 (9%)

Query: 148 VYKGRLADGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRLYGFCTTVTEKL 205
           +YKG   + K V ++  K+       L    + E+K +      N+L++YGF   + + L
Sbjct: 36  IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 206 ----LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRD 261
               L+  Y T G +   L + +     L + T+  +A+   +GL  L+++      +++
Sbjct: 95  PRLSLILEYCTRGYLREVLDKEKD----LSFKTKLDMAIDCCKGLYNLYKYT--NKPYKN 148

Query: 262 VKAANILLDED 272
           + + + L+ E+
Sbjct: 149 LTSVSFLVTEN 159

Length = 283

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 40.3 bits (94), Expect = 5e-04
 Identities = 41/144 (28%), Positives = 65/144 (45%), Gaps = 26/144 (18%)

Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKE-ERTSGGEL------QFQTEVKIISMAVHRNLL 192
           LG+G FG VY   + D K VA +RLK  +    GEL      Q   E +++S   H  ++
Sbjct: 8   LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 193 RLYG-------FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 245
           + +        FC  +TE      Y     +  +L E + +   L      +  +    G
Sbjct: 66  KFHASFLERDAFCI-ITE------YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118

Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           + Y+H+    +I+HRD+KA NI L
Sbjct: 119 VHYMHQR---RILHRDLKAKNIFL 139

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 40.5 bits (95), Expect = 6e-04
 Identities = 18/38 (47%), Positives = 26/38 (68%), Gaps = 2/38 (5%)

Query: 237 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 274
           KI++   RGL+YL E    KI+HRDVK +NIL++   +
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGE 138

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 40.0 bits (93), Expect = 6e-04
 Identities = 34/141 (24%), Positives = 67/141 (47%), Gaps = 10/141 (7%)

Query: 134 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK--EERTSGGELQFQTEVKIISMAVHRN 190
           F  +  +GRG F +VY+   L DG  VA+K+++  +   +        E+ ++    H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLR--ERQSSLPPLDWPTRKKIALGSARGLSY 248
           +++ Y       E  +V      G ++  ++  ++Q  L P     +  + L SA  L +
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA--LEH 121

Query: 249 LHEHCDPKIIHRDVKAANILL 269
           +H     +++HRD+K AN+ +
Sbjct: 122 MHSR---RVMHRDIKPANVFI 139

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 40.4 bits (94), Expect = 6e-04
 Identities = 31/103 (30%), Positives = 47/103 (45%), Gaps = 7/103 (6%)

Query: 132 DGFSNKNILGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKIIS- 184
           DG     ILG G FGKV +G      R      VAVK LK    S  +    +E+KI++ 
Sbjct: 37  DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTH 96

Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL 227
           +  H N++ L G CT      ++  Y   G + + L + + + 
Sbjct: 97  LGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNF 139

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 40.2 bits (94), Expect = 7e-04
 Identities = 41/141 (29%), Positives = 69/141 (48%), Gaps = 17/141 (12%)

Query: 139 ILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV-HRNLLRL 194
           ++GRG + KV    L    ++ A+K +K+E  +  E     QTE  +   A  H  L+ L
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61

Query: 195 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR---KKIALGSARGLSYLHE 251
           +    T +    V  +++ G +   + +RQ  LP  +   R    +I+L     L++LHE
Sbjct: 62  HSCFQTESRLFFVIEFVSGGDLMFHM-QRQRKLP--EEHARFYSAEISLA----LNFLHE 114

Query: 252 HCDPKIIHRDVKAANILLDED 272
                II+RD+K  N+LLD +
Sbjct: 115 R---GIIYRDLKLDNVLLDAE 132

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 39.5 bits (92), Expect = 0.001
 Identities = 40/142 (28%), Positives = 68/142 (47%), Gaps = 22/142 (15%)

Query: 140 LGRGGFGKVYKGRLAD-GKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRL-Y 195
           LG+GGFG+V   ++ + GK+ A K+L ++R     GE     E +I+       ++ L Y
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLR---ERQSSLPPLDWPTRKKIALGSAR---GLSYL 249
            F  + T   LV   M  G +   +    ER   +        +++   SA+   G+ +L
Sbjct: 61  AF-ESKTHLCLVMSLMNGGDLKYHIYNVGERGLEM--------ERVIHYSAQITCGILHL 111

Query: 250 HEHCDPKIIHRDVKAANILLDE 271
           H      I++RD+K  N+LLD+
Sbjct: 112 HSM---DIVYRDMKPENVLLDD 130

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 39.4 bits (92), Expect = 0.001
 Identities = 41/143 (28%), Positives = 67/143 (46%), Gaps = 12/143 (8%)

Query: 134 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRN 190
           F +  +LG+GGFG+V   ++ A GK+ A K+L+++R     GE     E +I+     R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI--ALGSARGLSY 248
           ++ L     T     LV   M  G     L+    ++    +   + +  A     GL  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGD----LKFHIYNMGNPGFDEERAVFYAAEITCGLED 117

Query: 249 LHEHCDPKIIHRDVKAANILLDE 271
           LH     +I++RD+K  NILLD+
Sbjct: 118 LHRE---RIVYRDLKPENILLDD 137

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 39.4 bits (92), Expect = 0.001
 Identities = 46/155 (29%), Positives = 66/155 (42%), Gaps = 19/155 (12%)

Query: 123 SLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL-KEERTSGGELQFQTEV 180
            + +L++  + F    ++GRG FG+V   R    K V A+K L K E     +  F  E 
Sbjct: 34  KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE 93

Query: 181 KIISMAVHRN---LLRLYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTR 235
           + I MA H N   +++L        +K L  V  YM  G + + +        P  W  R
Sbjct: 94  RDI-MA-HANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDI---PEKW-AR 145

Query: 236 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 270
              A      L  +H       IHRDVK  N+LLD
Sbjct: 146 FYTA-EVVLALDAIHSM---GFIHRDVKPDNMLLD 176

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 39.3 bits (91), Expect = 0.001
 Identities = 43/139 (30%), Positives = 63/139 (45%), Gaps = 12/139 (8%)

Query: 139 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE--LQFQTEVKIISMAVHRNLLRLY 195
           +LG+G FGKV   R  A GK  A+K LK+E     +      TE +++    H  L  L 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 196 GFCTTVTEKLLVYPYMTNGSVASRL-RERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 254
               T      V  Y+  G +   L RER  S     +   + ++      L YLH    
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVS-----ALDYLHSG-- 114

Query: 255 PKIIHRDVKAANILLDEDA 273
            KI++RD+K  N++LD+D 
Sbjct: 115 -KIVYRDLKLENLMLDKDG 132

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 39.0 bits (91), Expect = 0.002
 Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 35/152 (23%)

Query: 139 ILGRGGFGKVY----KGRLADGKLVAVKRLKE----ERTSGGELQFQTEVKIISMAVHRN 190
           +LG G +GKV+     G    GKL A+K LK+    ++    E   +TE +++  AV R 
Sbjct: 7   VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAE-HTRTERQVLE-AVRRC 64

Query: 191 --LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR---- 244
             L+ L+    T T+  L+  Y+  G + + L +R+                   R    
Sbjct: 65  PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE------------HFTESEVRVYIA 112

Query: 245 ----GLSYLHEHCDPKIIHRDVKAANILLDED 272
                L +LH+     II+RD+K  NILLD +
Sbjct: 113 EIVLALDHLHQL---GIIYRDIKLENILLDSE 141

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 39.2 bits (92), Expect = 0.002
 Identities = 43/151 (28%), Positives = 67/151 (44%), Gaps = 24/151 (15%)

Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVH 188
           D F    ++GRG FG+V+  R    G++ A+K L++            + E  I++ A  
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 189 RNLLRLYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKI-----ALG 241
             +++LY   +   E+ L  V  YM  G + + L  R+   P  +   R  I     AL 
Sbjct: 61  PWIVKLY--YSFQDEEHLYLVMEYMPGGDLMNLL-IRKDVFPE-ET-ARFYIAELVLALD 115

Query: 242 SARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           S   L +         IHRD+K  NIL+D D
Sbjct: 116 SVHKLGF---------IHRDIKPDNILIDAD 137

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 38.7 bits (90), Expect = 0.002
 Identities = 40/154 (25%), Positives = 66/154 (42%), Gaps = 30/154 (19%)

Query: 140 LGRGGFGKVYKGRL--------ADGKLVAVKRLKEERTSGGELQ---------------- 175
           LG+G    +Y GRL         + ++     L E   +G EL+                
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 176 FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR 235
           F     ++S   H +L  ++G C   +E ++V  ++ +G +   LR+ +  + P+ W   
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRV-PVAWKIT 121

Query: 236 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 269
               L SA  LSYL    D  ++H +V A NILL
Sbjct: 122 VAQQLASA--LSYLE---DKNLVHGNVCAKNILL 150

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 38.9 bits (90), Expect = 0.002
 Identities = 38/140 (27%), Positives = 60/140 (42%), Gaps = 20/140 (14%)

Query: 140 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 198
           +G G  G V   R    G+ VAVK +   +    EL F  EV I+    H+N++ +Y   
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN-EVVIMRDYQHQNVVEMYKSY 87

Query: 199 TTVTEKLLVYPYMTNGSVAS-----RLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
               E  ++  ++  G++       RL E Q +           +     + L YLH   
Sbjct: 88  LVGEELWVLMEFLQGGALTDIVSQTRLNEEQIA----------TVCESVLQALCYLHSQ- 136

Query: 254 DPKIIHRDVKAANILLDEDA 273
              +IHRD+K+ +ILL  D 
Sbjct: 137 --GVIHRDIKSDSILLTLDG 154

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 38.8 bits (90), Expect = 0.002
 Identities = 29/98 (29%), Positives = 49/98 (50%), Gaps = 10/98 (10%)

Query: 178 TEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP-YMTNGSVASRLRERQSSLPPLDWPTRK 236
           TE  I+    H ++++L G  T      L+ P Y T+  +   L  +++ +   D    +
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD--LYCYLAAKRN-IAICDILAIE 188

Query: 237 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 274
           +  L   R + YLHE+   +IIHRD+KA NI ++   D
Sbjct: 189 RSVL---RAIQYLHEN---RIIHRDIKAENIFINHPGD 220

Length = 391

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 38.8 bits (91), Expect = 0.002
 Identities = 14/30 (46%), Positives = 21/30 (70%), Gaps = 3/30 (10%)

Query: 244 RGLSYLHEHCDPKIIHRDVKAANILLDEDA 273
           RGL Y+H      +IHRD+K +N+L++ED 
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDC 144

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 38.5 bits (89), Expect = 0.002
 Identities = 38/144 (26%), Positives = 67/144 (46%), Gaps = 7/144 (4%)

Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKE-ERTSGGELQFQTEVKIISMA 186
           ++  D F   + LG G  G V K +     L+  ++L   E       Q   E++++   
Sbjct: 1   ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 187 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
               ++  YG   +  E  +   +M  GS+   L+E +  +P        K+++   RGL
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR-IPE---EILGKVSIAVLRGL 116

Query: 247 SYLHEHCDPKIIHRDVKAANILLD 270
           +YL E    +I+HRDVK +NIL++
Sbjct: 117 AYLRE--KHQIMHRDVKPSNILVN 138

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 38.6 bits (90), Expect = 0.002
 Identities = 36/152 (23%), Positives = 62/152 (40%), Gaps = 42/152 (27%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVK--------RLKEERTSGGELQFQTEVKIISMAVHRN 190
           +G G FG+V+  R        A+K        RLK+E+          E +++    H  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQ------HVHNEKRVLKEVSHPF 62

Query: 191 LLRLYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR---- 244
           ++RL+   T   ++ L  +  Y+  G + S LR               + +  +      
Sbjct: 63  IIRLF--WTEHDQRFLYMLMEYVPGGELFSYLR------------NSGRFSNSTGLFYAS 108

Query: 245 ----GLSYLHEHCDPKIIHRDVKAANILLDED 272
                L YLH     +I++RD+K  NILLD++
Sbjct: 109 EIVCALEYLHSK---EIVYRDLKPENILLDKE 137

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 38.2 bits (89), Expect = 0.003
 Identities = 42/148 (28%), Positives = 67/148 (45%), Gaps = 31/148 (20%)

Query: 139 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT--EVKIISMAV-HRNLLRL 194
           +LG+G FGKV    L    +  A+K LK++     +    T  E +++++A  H  L  L
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 195 YGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR-------- 244
             FCT  T++ L  V  Y+  G +   ++               +     AR        
Sbjct: 62  --FCTFQTKEHLFFVMEYLNGGDLMFHIQSS------------GRFDEARARFYAAEIIC 107

Query: 245 GLSYLHEHCDPKIIHRDVKAANILLDED 272
           GL +LH+     II+RD+K  N+LLD+D
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKD 132

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 38.4 bits (89), Expect = 0.003
 Identities = 38/140 (27%), Positives = 65/140 (46%), Gaps = 15/140 (10%)

Query: 140 LGRGGFGKVYKGRLAD-GKLVAVKRL-KEERTSGGELQFQT-EVKIISMAVHRNLLRLYG 196
           +G+G FG+VY+ R  D  ++ A+K L K+E  +  E+     E  I+   +      + G
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 197 F---CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS-ARGLSYLHEH 252
                 T ++  LV  YM+ G +   L +++          R K  +      L +LH++
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHL-QKEGRFSE----DRAKFYIAELVLALEHLHKY 115

Query: 253 CDPKIIHRDVKAANILLDED 272
               I++RD+K  NILLD  
Sbjct: 116 ---DIVYRDLKPENILLDAT 132

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 37.9 bits (88), Expect = 0.003
 Identities = 20/62 (32%), Positives = 34/62 (54%), Gaps = 8/62 (12%)

Query: 210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH-EHCDPKIIHRDVKAANIL 268
           +M  GS+    ++      P+      KIA+    GL+YL+  H   +I+HRD+K +NIL
Sbjct: 84  FMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNIL 136

Query: 269 LD 270
           ++
Sbjct: 137 VN 138

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 38.1 bits (88), Expect = 0.003
 Identities = 43/153 (28%), Positives = 67/153 (43%), Gaps = 15/153 (9%)

Query: 124 LRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK--EERTSGGELQFQTEV 180
           +R+LQ+  + +    ++GRG FG+V   R  +  K+ A+K L   E         F  E 
Sbjct: 35  IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 181 KIISMAVHRNLLRLYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKI 238
            I++ A    +++L  FC    +K L  V  YM  G + + +        P  W   K  
Sbjct: 95  DIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV---PEKWA--KFY 147

Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 271
                  L  +H      +IHRDVK  N+LLD+
Sbjct: 148 TAEVVLALDAIHSM---GLIHRDVKPDNMLLDK 177

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 37.8 bits (87), Expect = 0.004
 Identities = 34/135 (25%), Positives = 62/135 (45%), Gaps = 10/135 (7%)

Query: 140 LGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 198
           +G+G  G VY    +A G+ VA+K++  ++    EL    E+ ++    + N++      
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 85

Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 258
               E  +V  Y+  GS+   + E       +D      +     + L +LH +   ++I
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVI 137

Query: 259 HRDVKAANILLDEDA 273
           HRD+K+ NILL  D 
Sbjct: 138 HRDIKSDNILLGMDG 152

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	284
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.98
KOG0581	364	consensus Mitogen-activated protein kinase kinase	99.97
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.97
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.96
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.96
KOG0575	592	consensus Polo-like serine/threonine protein kinas	99.96
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.96
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.96
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.96
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.96
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.96
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.96
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.96
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.95
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.95
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.95
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.95
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.95
KOG0198	313	consensus MEKK and related serine/threonine protei	99.95
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.95
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.95
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.95
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.95
KOG0605	550	consensus NDR and related serine/threonine kinases	99.95
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.95
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.95
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.95
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.95
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.94
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.94
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.94
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.94
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.94
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.94
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.94
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.94
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.94
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.94
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.94
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.94
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.94
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.94
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.94
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.94
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.94
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.94
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.94
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.94
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.94
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.94
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.94
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.94
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.94
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.94
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.94
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.94
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.93
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.93
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.93
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.93
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.93
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.93
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.93
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.93
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.93
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.93
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.93
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.93
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.93
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.93
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.93
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.93
KOG0610	459	consensus Putative serine/threonine protein kinase	99.93
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.93
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.93
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.93
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.93
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.93
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.93
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.93
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.93
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.93
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.93
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.93
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.93
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.93
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.93
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.93
KOG0578	550	consensus p21-activated serine/threonine protein k	99.93
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.93
PTZ00267	478	NIMA-related protein kinase; Provisional	99.93
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.93
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.93
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.93
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.93
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.93
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.93
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.93
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.93
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.93
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.93
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.93
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.92
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.92
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.92
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.92
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.92
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.92
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.92
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.92
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.92
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.92
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.92
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.92
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.92
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.92
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.92
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.92
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.92
PHA02988	283	hypothetical protein; Provisional	99.92
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.92
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.92
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.92
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.92
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.92
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.92
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.92
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.92
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.92
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.92
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.92
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.92
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.92
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.92
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.92
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.92
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.92
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.92
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.92
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.92
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.92
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.92
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.92
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.92
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.92
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.92
PTZ00283	496	serine/threonine protein kinase; Provisional	99.92
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.92
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.92
PHA03212	391	serine/threonine kinase US3; Provisional	99.92
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.92
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.92
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.92
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.92
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.92
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.92
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.92
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.92
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.92
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.92
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.92
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.92
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.92
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.92
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.92
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.92
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.92
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.92
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.92
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.92
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.92
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.92
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.92
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.92
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.92
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.92
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.92
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.92
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.92
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.91
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.91
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.91
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.91
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.91
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.91
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.91
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.91
KOG0586	596	consensus Serine/threonine protein kinase [General	99.91
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.91
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.91
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.91
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.91
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.91
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.91
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.91
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.91
PTZ00036	440	glycogen synthase kinase; Provisional	99.91
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.91
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.91
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.91
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.91
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.91
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.91
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.91
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.91
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.91
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.91
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.91
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.91
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.91
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.91
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.91
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.91
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.91
PHA03211	461	serine/threonine kinase US3; Provisional	99.91
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.91
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.91
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.91
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.91
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.91
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.91
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.91
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.91
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.91
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.91
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.91
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.91
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.91
PHA03209	357	serine/threonine kinase US3; Provisional	99.91
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.91
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.91
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.91
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.91
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.91
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.91
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.91
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.91
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.91
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.91
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.91
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.9
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.9
KOG0589	426	consensus Serine/threonine protein kinase [General	99.9
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.9
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.9
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.9
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.9
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.9
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.9
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.9
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.9
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.9
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.9
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.9
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.9
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.9
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.9
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.9
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.9
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.9
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.9
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.9
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.9
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.9
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.9
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.9
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.9
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.9
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.9
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.9
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.9
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.9
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.9
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.9
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.9
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.9
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.9
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.9
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.9
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.9
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.9
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.89
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.89
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.89
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.89
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.89
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.89
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.89
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.89
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.89
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.89
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.89
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.89
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.89
PHA03207	392	serine/threonine kinase US3; Provisional	99.89
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.89
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.89
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.89
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.89
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.89
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.89
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.89
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.89
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.89
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.89
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.89
KOG0584	632	consensus Serine/threonine protein kinase [General	99.89
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.89
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.89
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.89
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.89
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.89
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.88
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.88
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.88
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.88
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.88
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.88
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.88
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.88
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.88
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.88
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.88
PLN00009	294	cyclin-dependent kinase A; Provisional	99.88
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.88
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.88
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.88
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.88
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.88
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.88
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.88
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.88
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.88
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.88
PTZ00284	467	protein kinase; Provisional	99.88
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.88
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.87
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.87
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.87
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.87
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.87
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.87
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.87
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.87
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.87
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.87
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.87
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.87
PHA03210	501	serine/threonine kinase US3; Provisional	99.87
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.87
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.87
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.86
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.86
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.86
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.86
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.86
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.86
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.86
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.86
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.86
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.86
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.86
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.86
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.86
PRK10345	210	hypothetical protein; Provisional	99.86
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.85
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.85
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.85
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.85
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.84
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.84
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.84
PHA02882	294	putative serine/threonine kinase; Provisional	99.83
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.83
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.82
KOG1152	772	consensus Signal transduction serine/threonine kin	99.82
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.82
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.8
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.8
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.8
smart00090	237	RIO RIO-like kinase.	99.79
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.79
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.79
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.78
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.78
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.78
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.77
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.77
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.75
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.75
PRK12274	218	serine/threonine protein kinase; Provisional	99.75
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.75
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.74
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.74
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.73
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.72
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.69
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.69
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.69
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.67
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.66
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.66
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.65
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.63
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.63
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.59
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.54
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.54
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.53
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.53
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.37
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.37
PLN00181	793	protein SPA1-RELATED; Provisional	99.35
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.28
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.26
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.22
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.19
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.16
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.13
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.08
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.05
KOG3087	229	consensus Serine/threonine protein kinase [General	99.03
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.96
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.94
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.84
KOG1243	690	consensus Protein kinase [General function predict	98.83
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.76
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.65
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.63
KOG0590	601	consensus Checkpoint kinase and related serine/thr	98.62
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.61
PRK09902	216	hypothetical protein; Provisional	98.55
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.51
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.48
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.36
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.35
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	98.31
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.29
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.13
PLN02876	822	acyl-CoA dehydrogenase	98.12
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.11
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.1
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.03
PRK10593	297	hypothetical protein; Provisional	98.01
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.94
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	97.92
PF01636	239	APH: Phosphotransferase enzyme family This family	97.91
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.85
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.8
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.75
PLN03150	623	hypothetical protein; Provisional	97.72
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.57
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.49
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.34
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.18
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.11
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.99
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.88
PRK05231	319	homoserine kinase; Provisional	96.86
PF00560	22	LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le	96.72
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.72
KOG0606	1205	consensus Microtubule-associated serine/threonine	96.5
KOG2270	520	consensus Serine/threonine protein kinase involved	96.29
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.2
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.02
KOG0576	829	consensus Mitogen-activated protein kinase kinase	96.01
PLN02756	418	S-methyl-5-thioribose kinase	95.87
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	95.78
PLN02236	344	choline kinase	95.55
KOG2268	465	consensus Serine/threonine protein kinase [Signal	95.4
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.25
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.21
KOG4258	1025	consensus Insulin/growth factor receptor (contains	95.1
PF08693	40	SKG6: Transmembrane alpha-helix domain; InterPro:	94.53
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	94.51
COG2334	331	Putative homoserine kinase type II (protein kinase	94.5
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	94.5
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	94.48
PF13504	17	LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OO	94.41
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	94.27
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.09
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	94.04
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	93.62
PRK06148	1013	hypothetical protein; Provisional	93.56
PF12191	129	stn_TNFRSF12A: Tumour necrosis factor receptor stn	93.15
PRK11768	325	serine/threonine protein kinase; Provisional	93.07

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=296.13  Aligned_cols=160  Identities=53%  Similarity=0.915  Sum_probs=147.8

Q ss_pred             ccccccHHHHHHHhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeE
Q 023282          118 QLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF  197 (284)
Q Consensus       118 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~  197 (284)
                      ....|++.++..+|++|...++||+|+||.||+|.++++..||||++....... .++|..|++++.+++|||+|+|+||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence            456799999999999999999999999999999999999999999886544332 5579999999999999999999999


Q ss_pred             EeeCC-eeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcc
Q 023282          198 CTTVT-EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  276 (284)
Q Consensus       198 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~  276 (284)
                      |.+.+ +.+||||||++|+|.++|+.....  +++|..|++||.++|+||+|||+.|.|+|+||||||+|||||++++||
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence            99988 599999999999999999976443  789999999999999999999999999999999999999999999999


Q ss_pred             hhhh
Q 023282          277 SKTI  280 (284)
Q Consensus       277 ~~df  280 (284)
                      |+||
T Consensus       218 lsDF  221 (361)
T KOG1187|consen  218 LSDF  221 (361)
T ss_pred             ccCc
Confidence            9998

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=9.4e-35  Score=285.64  Aligned_cols=249  Identities=27%  Similarity=0.517  Sum_probs=171.4

Q ss_pred             CccEEEccCCCCcccCCCCCCCCccCcccccCCcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcchhhhhHHHH
Q 023282            1 MTALRDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGA   80 (284)
Q Consensus         1 ~~~~~dlS~N~lsG~iP~~~~~~~~~~~s~~gN~~lcg~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~   80 (284)
                      .|+.||+|+|+|+|.||+.+.|..+..+++.||+++||.....   +.+     ++.  .   .......++++++++++
T Consensus       572 ~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~---~~~-----~c~--~---~~~~~~~~~~~~~~~~~  638 (968)
T PLN00113        572 SLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTS---GLP-----PCK--R---VRKTPSWWFYITCTLGA  638 (968)
T ss_pred             ccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCcccc---CCC-----CCc--c---ccccceeeeehhHHHHH
Confidence            3788999999999999999899999999999999999854211   000     000  0   00111222233333333


Q ss_pred             HHHHHHhheeEEEEeccCCCccccCCCCC-Chhhhhh---cccccccHHHHHHHhcCCCCCCeecccCceEEEEEEe-CC
Q 023282           81 ALLFAVPVIGFAYWRRTRPHEFFFDVPAE-DDSELQL---GQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRL-AD  155 (284)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~  155 (284)
                      +++++++++++++++++++.+.. ..+.. ...+...   .....++++++   ...+...++||+|+||.||+|+. .+
T Consensus       639 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~  714 (968)
T PLN00113        639 FLVLALVAFGFVFIRGRNNLELK-RVENEDGTWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKN  714 (968)
T ss_pred             HHHHHHHHHHHHHHHhhhccccc-ccccccccccccccccccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCC
Confidence            33333332223333333221110 00000 0011000   00112333333   34577888999999999999986 57


Q ss_pred             CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHH
Q 023282          156 GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR  235 (284)
Q Consensus       156 ~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~  235 (284)
                      +..||||.++....     ....|++.+++++|||||+++|+|...+..++||||+++|+|.++++.       ++|.++
T Consensus       715 ~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-------l~~~~~  782 (968)
T PLN00113        715 GMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERR  782 (968)
T ss_pred             CcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-------CCHHHH
Confidence            88999998854321     123568899999999999999999999999999999999999999963       789999


Q ss_pred             HHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchh
Q 023282          236 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  278 (284)
Q Consensus       236 ~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~  278 (284)
                      .+++.|+++||+|||+.+.++++||||||+||++|.++++++.
T Consensus       783 ~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~  825 (968)
T PLN00113        783 RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR  825 (968)
T ss_pred             HHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE
Confidence            9999999999999998878899999999999999999888764

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-32  Score=232.46  Aligned_cols=142  Identities=30%  Similarity=0.429  Sum_probs=126.1

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-CcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      .+|...+.||.|+||+||+|+++ ++..||||.+.... .....+.+..|+.+|+.++|||||++++++..++..+||||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            46777788999999999999964 67899999996554 22334458899999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCC------CCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED------ADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~------~~~~~~df  280 (284)
                      ||.+|+|.++++.++    .+++.....++.|+|.||++||++   +||||||||.||||...      -..||+||
T Consensus        90 yC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF  159 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADF  159 (429)
T ss_pred             eCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence            999999999999864    488999999999999999999999   99999999999999886      34689998

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.98  E-value=7.8e-32  Score=233.98  Aligned_cols=140  Identities=35%  Similarity=0.586  Sum_probs=123.8

Q ss_pred             CCCeecccCceEEEEEEeCCCcEEEEEEeecccCcc-cHHHHHHHHHHHhcCCCCCceeeeeEEeeCC-eeeEEEeCCCC
Q 023282          136 NKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVT-EKLLVYPYMTN  213 (284)
Q Consensus       136 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~-~~~lv~e~~~~  213 (284)
                      ..+.+|+|+||+||+|.+.....||||.+....... ...+|.+|+.+|.+++|||||+++|+|..+. ..++|||||++
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            345699999999999999755559999997543222 2458999999999999999999999999987 79999999999


Q ss_pred             CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-eeeeCCCCCCeeeCCCC-Ccchhhh
Q 023282          214 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK-IIHRDVKAANILLDEDA-DQSSKTI  280 (284)
Q Consensus       214 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~-ivHrdlk~~NiLld~~~-~~~~~df  280 (284)
                      |+|.++++..  ....++|..++.+|.|||+||.|||++   + ||||||||+|||++.++ .+||+||
T Consensus       125 GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DF  188 (362)
T KOG0192|consen  125 GSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADF  188 (362)
T ss_pred             CcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCC
Confidence            9999999874  233699999999999999999999998   6 99999999999999998 9999998

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-31  Score=222.04  Aligned_cols=140  Identities=31%  Similarity=0.452  Sum_probs=126.3

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC-eeeEEEeCC
Q 023282          134 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-EKLLVYPYM  211 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~-~~~lv~e~~  211 (284)
                      ++..+.||+|+.|+|||++++ ++..+|+|.+.........+++.+|+++++.++||+||+++|.|.... ...++||||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM  160 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM  160 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence            344678999999999999965 688999999966555555678999999999999999999999999988 599999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .+|+|.+.+...    +.+++...-+++.+|++||.|||+ .   +||||||||+|||++..|++|||||
T Consensus       161 DgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDF  223 (364)
T KOG0581|consen  161 DGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDF  223 (364)
T ss_pred             CCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccc
Confidence            999999999864    248899999999999999999996 5   9999999999999999999999999

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=233.36  Aligned_cols=140  Identities=35%  Similarity=0.520  Sum_probs=126.6

Q ss_pred             CCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCC
Q 023282          134 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  213 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~  213 (284)
                      +...+.||+|.||.||.|.+.....||+|.++...  ....+|.+|+++|++++|+|||+++|+|......+||||||+.
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~  285 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK  285 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence            34457799999999999999888899999997652  2345799999999999999999999999998899999999999


Q ss_pred             CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          214 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       214 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+|.++|+...  ...+...+.+.++.|||+||+||+++   ++|||||.++|||++++..+||+||
T Consensus       286 GsLl~yLr~~~--~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDF  347 (468)
T KOG0197|consen  286 GSLLDYLRTRE--GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDF  347 (468)
T ss_pred             CcHHHHhhhcC--CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccc
Confidence            99999999733  23578899999999999999999999   9999999999999999999999999

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.97  E-value=1.1e-30  Score=238.07  Aligned_cols=150  Identities=31%  Similarity=0.526  Sum_probs=132.6

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeC
Q 023282          128 QVATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV  201 (284)
Q Consensus       128 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~  201 (284)
                      .....+....+.||+|+||+||+|+..      +.+.||||.++.....+...+|++|++++..++|||||+|+|.|...
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~  561 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG  561 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence            344555666788999999999999753      34579999998877666777999999999999999999999999999


Q ss_pred             CeeeEEEeCCCCCChHHHHhhcCCC----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC
Q 023282          202 TEKLLVYPYMTNGSVASRLRERQSS----------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE  271 (284)
Q Consensus       202 ~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~  271 (284)
                      +..++|+|||..|||.++|+.....          ..+++..+.+.||.|||.||+||.++   .+|||||..+|+|+.+
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE  638 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence            9999999999999999999864321          23488999999999999999999999   9999999999999999


Q ss_pred             CCCcchhhh
Q 023282          272 DADQSSKTI  280 (284)
Q Consensus       272 ~~~~~~~df  280 (284)
                      +..+||+||
T Consensus       639 ~l~VKIsDf  647 (774)
T KOG1026|consen  639 NLVVKISDF  647 (774)
T ss_pred             ceEEEeccc
Confidence            999999998

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=4.7e-30  Score=219.99  Aligned_cols=139  Identities=37%  Similarity=0.553  Sum_probs=120.0

Q ss_pred             cCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHh--cCCCCCceeeeeEEeeCC----eee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIIS--MAVHRNLLRLYGFCTTVT----EKL  205 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~--~~~h~niv~l~g~~~~~~----~~~  205 (284)
                      +.....+++|+|+||.||||.+. ++.||||++..    .+...|..|-++.+  .++|+||++++++-....    +.+
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            34455678999999999999984 58999999853    23446777777765  678999999999876555    889


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc------CCCCCeeeeCCCCCCeeeCCCCCcchhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE------HCDPKIIHRDVKAANILLDEDADQSSKT  279 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~------~~~~~ivHrdlk~~NiLld~~~~~~~~d  279 (284)
                      ||+||.+.|+|.++|...     ..+|....+++..+++||+|||+      +.+|+|+|||||++|||+..|++..|+|
T Consensus       285 LVt~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             EEeeeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence            999999999999999875     48999999999999999999997      3478999999999999999999999999


Q ss_pred             h
Q 023282          280 I  280 (284)
Q Consensus       280 f  280 (284)
                      |
T Consensus       360 F  360 (534)
T KOG3653|consen  360 F  360 (534)
T ss_pred             c
Confidence            8

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=6.3e-30  Score=215.93  Aligned_cols=142  Identities=27%  Similarity=0.420  Sum_probs=122.8

Q ss_pred             cCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccCcc------cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCee
Q 023282          132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSG------GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  204 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~------~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~  204 (284)
                      +.|...+.||+|+||.|-+|. ..+|+.||||+++......      ......+|+++|++++|||||++++++..++..
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            446667899999999999997 5589999999997543322      223467999999999999999999999999999


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCC---CCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED---ADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~---~~~~~~df  280 (284)
                      |+||||+++|+|.+.+-...    .+.+.....++.|++.|+.|||++   +|+||||||+|||+..+   .-.||+||
T Consensus       252 YmVlE~v~GGeLfd~vv~nk----~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVANK----YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             EEEEEEecCccHHHHHHhcc----ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence            99999999999999997654    366667788999999999999999   99999999999999877   56788887

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.4e-29  Score=223.30  Aligned_cols=142  Identities=28%  Similarity=0.493  Sum_probs=129.0

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc--ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ..|+..++||+|+|+.+|.++. .+|+.||+|++......  .......+||++.+.++|||||+++++|.+.+..|+|+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4578889999999999999996 78999999999653322  22346889999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+|++++|..+++.+.    ++++.+...+..||+.||.|||++   +|+|||||..|++|++++++||+||
T Consensus        98 ELC~~~sL~el~Krrk----~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDF  162 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRK----PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDF  162 (592)
T ss_pred             EecCCccHHHHHHhcC----CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEeccc
Confidence            9999999999998533    699999999999999999999999   9999999999999999999999998

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.96  E-value=4.3e-30  Score=231.46  Aligned_cols=142  Identities=30%  Similarity=0.458  Sum_probs=131.8

Q ss_pred             CCCCCCeecccCceEEEEEEeC-C---CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-D---GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ..++.++||.|.||.||+|+++ .   ...||||.++.....+...+|+.|+.+|++++||||++|.|........++|.
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            4566789999999999999864 2   34799999998888888889999999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||++|+|..+|+.+++   .++|.+...+..+||.||.||.+.   +.|||||.++|||++.+...||+||
T Consensus       710 EyMENGsLDsFLR~~DG---qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDF  775 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQNDG---QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDF  775 (996)
T ss_pred             hhhhCCcHHHHHhhcCC---ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccc
Confidence            99999999999998754   489999999999999999999999   9999999999999999999999998

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1e-29  Score=219.43  Aligned_cols=142  Identities=30%  Similarity=0.507  Sum_probs=124.9

Q ss_pred             cCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccCccc-HHHHHHHHHHHhcCCCCCceeeeeEEeeC--CeeeEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLLV  207 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~~~h~niv~l~g~~~~~--~~~~lv  207 (284)
                      +.|+..+.||+|.||.||+|+ ..+|+.||+|++..+..... .....+||.+|++++||||++|.+.....  ...|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            446667889999999999998 56899999999976654333 34568999999999999999999998876  689999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +|||+. ||.-++....   -.++..++..++.|++.||+|+|+.   +|+|||||.+|||||.+|..||+||
T Consensus       197 FeYMdh-DL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDF  262 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADF  262 (560)
T ss_pred             Eecccc-hhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccc
Confidence            999986 8998887532   2589999999999999999999999   9999999999999999999999999

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.5e-30  Score=225.54  Aligned_cols=153  Identities=28%  Similarity=0.471  Sum_probs=134.6

Q ss_pred             ccHHHHHHHhcCCCCCCeecccCceEEEEEEeC--CC--cE-EEEEEeecc--cCcccHHHHHHHHHHHhcCCCCCceee
Q 023282          122 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLA--DG--KL-VAVKRLKEE--RTSGGELQFQTEVKIISMAVHRNLLRL  194 (284)
Q Consensus       122 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~--~~-vavK~~~~~--~~~~~~~~~~~e~~~l~~~~h~niv~l  194 (284)
                      +.-+.|+...++....+.||+|+||.||+|++.  ++  .. ||||..+..  .......+|.+|+++|++++|||||++
T Consensus       147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~  226 (474)
T KOG0194|consen  147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF  226 (474)
T ss_pred             ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence            345667777888888899999999999999864  22  23 899998752  233445689999999999999999999


Q ss_pred             eeEEeeCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCC
Q 023282          195 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  274 (284)
Q Consensus       195 ~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~  274 (284)
                      +|++......++|||+|++|+|.++|+....   .++..+++.++.+.|.||+|||+.   +++||||.++|+|++.++.
T Consensus       227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~  300 (474)
T KOG0194|consen  227 YGVAVLEEPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGV  300 (474)
T ss_pred             EEEEcCCCccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCe
Confidence            9999999999999999999999999997643   489999999999999999999999   9999999999999999999


Q ss_pred             cchhhh
Q 023282          275 QSSKTI  280 (284)
Q Consensus       275 ~~~~df  280 (284)
                      +||+||
T Consensus       301 vKISDF  306 (474)
T KOG0194|consen  301 VKISDF  306 (474)
T ss_pred             EEeCcc
Confidence            999998

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-29  Score=210.89  Aligned_cols=143  Identities=29%  Similarity=0.404  Sum_probs=128.8

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcc--cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      .++|+..++||+|+||+||.++. ++++.+|+|++++.....  +......|..++..++||.||++.-.+.+...+++|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            46788999999999999999985 468899999997654333  344688999999999999999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +||+.||.|..+|.+..    .+++.....++..|+.||.|||+.   +||||||||+|||||++|.++++||
T Consensus       104 ld~~~GGeLf~hL~~eg----~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDF  169 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREG----RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDF  169 (357)
T ss_pred             EeccCCccHHHHHHhcC----CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEecc
Confidence            99999999999998643    478888999999999999999999   9999999999999999999999998

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.96  E-value=3.2e-29  Score=200.83  Aligned_cols=141  Identities=27%  Similarity=0.464  Sum_probs=126.6

Q ss_pred             CCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccCccc-HHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          133 GFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +|...+.+|+|.||.||+|+ ..+|+.||||+++.....+. .....+|+..|+.++|+||+.+++.+...+...||+||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            46667889999999999998 56899999999986544433 34688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+. +|+..++....   .++-.+...++.++.+|++|||.+   .|+||||||.|+|+++++..|++||
T Consensus        83 m~t-dLe~vIkd~~i---~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADF  145 (318)
T KOG0659|consen   83 MPT-DLEVVIKDKNI---ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADF  145 (318)
T ss_pred             ccc-cHHHHhccccc---ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecc
Confidence            985 99999986533   588889999999999999999999   9999999999999999999999998

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2.1e-29  Score=199.02  Aligned_cols=145  Identities=30%  Similarity=0.444  Sum_probs=128.1

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      .++|+.++.||+|.||.||.|+. +++-.||+|++-...-  ..-..++.+|+++-+.++||||+++|+++.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            46788899999999999999985 4678999999854331  22245799999999999999999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +||.+.|++...|++...  ..++......+..|+|.||.|+|..   +++||||||+|+|++.+++.|++||
T Consensus       101 lEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdf  168 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADF  168 (281)
T ss_pred             EEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCC
Confidence            999999999999986432  3577778889999999999999998   9999999999999999999999998

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-29  Score=221.32  Aligned_cols=150  Identities=31%  Similarity=0.482  Sum_probs=133.8

Q ss_pred             ccHHHHHHHhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCccc-HHHHHHHHHHHhcCCCCCceeeeeEEee
Q 023282          122 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTT  200 (284)
Q Consensus       122 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~~~h~niv~l~g~~~~  200 (284)
                      .+..++.+..+.+...+.||+|+||+||+|++-+  .||||+++.+....+ .+.|..|+..+++-+|.||+-+.|||..
T Consensus       382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             ccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            3446777777888889999999999999999843  499999986655443 3579999999999999999999999999


Q ss_pred             CCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          201 VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       201 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +.. .+|+.||++-+|+.++|..+.   .++..+...||.|||+||.|||.+   +|||||||+.||++++++.+||+||
T Consensus       460 p~~-AIiTqwCeGsSLY~hlHv~et---kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDF  532 (678)
T KOG0193|consen  460 PPL-AIITQWCEGSSLYTHLHVQET---KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDF  532 (678)
T ss_pred             Cce-eeeehhccCchhhhhccchhh---hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecc
Confidence            877 999999999999999997643   488899999999999999999999   9999999999999999999999998

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=7.1e-29  Score=209.48  Aligned_cols=140  Identities=23%  Similarity=0.469  Sum_probs=127.6

Q ss_pred             CCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccCcccH--HHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          134 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE--LQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~--~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      |++.+.||+|.||.|-+++ ...|+.||||.++.+...+..  ..+.+|+++|+.++||||+.++.+|...+...+||||
T Consensus        55 yE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEY  134 (668)
T KOG0611|consen   55 YEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEY  134 (668)
T ss_pred             HHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEe
Confidence            4555779999999999998 468999999999876654433  3589999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ..+|.|++++.+++    .+++.+...++.||..|+.|+|.+   +++|||||.+|||+|.++++||+||
T Consensus       135 aS~GeLYDYiSer~----~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADF  197 (668)
T KOG0611|consen  135 ASGGELYDYISERG----SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADF  197 (668)
T ss_pred             cCCccHHHHHHHhc----cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeecc
Confidence            99999999998764    489999999999999999999999   9999999999999999999999998

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.95  E-value=9.4e-29  Score=201.53  Aligned_cols=141  Identities=23%  Similarity=0.356  Sum_probs=120.5

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCccc-HHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      .|+....+|+|+||.||+++.+ +|+.||||++.+...... .+-.++|++++++++|+|+|.|++.|.....++||+||
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~   82 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY   82 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence            4666788999999999999964 799999999965433222 23478999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |.. ++.+.|.....   .++.....++..|+++|+.|+|++   ++|||||||+|||+..++.+|+|||
T Consensus        83 ~dh-TvL~eLe~~p~---G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDF  145 (396)
T KOG0593|consen   83 CDH-TVLHELERYPN---GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDF  145 (396)
T ss_pred             cch-HHHHHHHhccC---CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccc
Confidence            986 44455544333   367888999999999999999999   9999999999999999999999998

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=8.2e-28  Score=205.03  Aligned_cols=145  Identities=26%  Similarity=0.410  Sum_probs=133.1

Q ss_pred             hcCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      .+.|+..++||.|..++||+|+ .+.++.||||++.-+....+...+.+|+..|+.++||||++++-.|......|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            4568888999999999999998 567899999999877766666789999999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||.+|++.+.++.....  .+++..+..|..++++||.|||++   +-||||+|+.|||||++|.++|+||
T Consensus       105 fMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadF  170 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADF  170 (516)
T ss_pred             hhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCc
Confidence            99999999999875432  388889999999999999999999   9999999999999999999999999

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-28  Score=216.02  Aligned_cols=147  Identities=26%  Similarity=0.391  Sum_probs=131.8

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          129 VATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       129 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      .+.+.....+.||+|.||.|..+....+..||||+++.+.......+|.+|+++|.+++|||||+|+|.|..++..++|+
T Consensus       535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            34455666789999999999999998889999999998877766779999999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||++|+|.+++..+....  ..-...++|+.||+.||+||.+.   ++|||||.++|||+|.++++||+||
T Consensus       615 EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadf  681 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADF  681 (807)
T ss_pred             HHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCc
Confidence            9999999999998764322  34456778999999999999998   9999999999999999999999999

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.95  E-value=4.6e-28  Score=211.64  Aligned_cols=150  Identities=30%  Similarity=0.447  Sum_probs=125.8

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEe------CCCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEee
Q 023282          128 QVATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  200 (284)
Q Consensus       128 ~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~  200 (284)
                      +.+.++|...+.||+|+||.||+|..      .++..||+|.++..........+.+|+.++..+ +||||++++++|..
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            34456788889999999999999973      234689999987543333445689999999999 89999999999876


Q ss_pred             CC-eeeEEEeCCCCCChHHHHhhcCCC-----------------------------------------------------
Q 023282          201 VT-EKLLVYPYMTNGSVASRLRERQSS-----------------------------------------------------  226 (284)
Q Consensus       201 ~~-~~~lv~e~~~~g~L~~~l~~~~~~-----------------------------------------------------  226 (284)
                      .+ ..+++|||+++|+|.+++......                                                     
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            54 578999999999999999753210                                                     


Q ss_pred             -----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          227 -----LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       227 -----~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                           ..++++.....++.|+++||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~Df  218 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDF  218 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeec
Confidence                 13478889999999999999999998   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=9.9e-28  Score=202.81  Aligned_cols=142  Identities=31%  Similarity=0.512  Sum_probs=123.8

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC--eeeEEEe
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT--EKLLVYP  209 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~--~~~lv~e  209 (284)
                      ++...+.||+|+||.||.+... +|...|||......... .+.+.+|+.+|++++|||||+++|......  ...+.||
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            4566789999999999999854 58999999886542222 456899999999999999999999855544  5889999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC-CCCcchhhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTIL  281 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~-~~~~~~~df~  281 (284)
                      |+++|+|.+++...++   .+++.....+..|+++||+|||++   +|+||||||+|||++. ++++||+||-
T Consensus        97 y~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG  163 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFG  163 (313)
T ss_pred             ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCc
Confidence            9999999999987543   489999999999999999999999   9999999999999999 7999999994

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-28  Score=212.56  Aligned_cols=144  Identities=27%  Similarity=0.372  Sum_probs=126.7

Q ss_pred             HhcCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccCccc--HHHHHHHHHHHhcC-CCCCceeeeeEEeeCCeee
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG--ELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKL  205 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~~  205 (284)
                      ...+|..++.||+|+|++|++|+ ..++..+|||++.+..-..+  .+-...|-++|.++ .||.|++|+-.|.+...+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            44678889999999999999998 45788999999865443222  22466777888888 7999999999999999999


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +|+||+++|+|.++|+..+    .++......+|.+|..||+|||+.   +||||||||+|||||.||..+|.||
T Consensus       151 FvLe~A~nGdll~~i~K~G----sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDF  218 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKYG----SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDF  218 (604)
T ss_pred             EEEEecCCCcHHHHHHHhC----cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeec
Confidence            9999999999999998764    488889999999999999999999   9999999999999999999999998

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=2.9e-29  Score=202.62  Aligned_cols=147  Identities=25%  Similarity=0.377  Sum_probs=125.7

Q ss_pred             CCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeE-EeeCCe-eeEEE
Q 023282          133 GFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGF-CTTVTE-KLLVY  208 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~-~~~~~~-~~lv~  208 (284)
                      +|.+.++||.|+||.|||+. ..+|..+|.|.++-+... ...+++..|+.+|++++|||||+++++ +....+ ..+||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            35557889999999999997 678999999999733322 233468999999999999999999994 445555 78999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK--IIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~--ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||..|+|...++..+.....+++....++..|++.||..+|+. .++  |+||||||.||+++.+|.+|++||
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDf  172 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDF  172 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccc
Confidence            99999999999987655566789999999999999999999994 335  999999999999999999999998

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=6.4e-29  Score=213.19  Aligned_cols=143  Identities=26%  Similarity=0.391  Sum_probs=126.2

Q ss_pred             hcCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCC-CCCceeeeeEEeeCC-eeeEE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVT-EKLLV  207 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~~~-~~~lv  207 (284)
                      .++|...+.||.|.||.||+|+ ..++..||||+++.....-++-.=.+|+..|++++ |||||++.+.+.+.+ .+++|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            3567777899999999999998 56789999999976544333333568999999999 999999999999888 89999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||||+ .+|+++++.+.   ..+++..+..|+.||++||+|+|.+   ++.|||+||+|||+.....+||+||
T Consensus        89 fE~Md-~NLYqLmK~R~---r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDF  154 (538)
T KOG0661|consen   89 FEFMD-CNLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADF  154 (538)
T ss_pred             HHhhh-hhHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccc
Confidence            99996 49999998763   3699999999999999999999999   9999999999999999999999998

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.95  E-value=3.3e-27  Score=203.20  Aligned_cols=146  Identities=29%  Similarity=0.469  Sum_probs=125.4

Q ss_pred             cCCCCCCeecccCceEEEEEEeCC-----------------CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLAD-----------------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL  194 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l  194 (284)
                      ++|...+.||+|+||.||++...+                 +..||+|.+..........+|.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            457778899999999999997532                 336999998754433344579999999999999999999


Q ss_pred             eeEEeeCCeeeEEEeCCCCCChHHHHhhcCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeee
Q 023282          195 YGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH  259 (284)
Q Consensus       195 ~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH  259 (284)
                      ++++...+..+++|||+++|+|.+++.....               ....++|.....++.|++.||.|||+.   +|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence            9999998999999999999999999865321               113478899999999999999999998   9999


Q ss_pred             eCCCCCCeeeCCCCCcchhhh
Q 023282          260 RDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       260 rdlk~~NiLld~~~~~~~~df  280 (284)
                      |||||+|||++.++.+||+||
T Consensus       162 ~dlkp~Nill~~~~~~kl~Df  182 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADF  182 (304)
T ss_pred             cCcchhheEEcCCccEEECCC
Confidence            999999999999999999998

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.95  E-value=2.7e-27  Score=206.01  Aligned_cols=146  Identities=21%  Similarity=0.334  Sum_probs=130.3

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc--ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCee
Q 023282          128 QVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  204 (284)
Q Consensus       128 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~  204 (284)
                      ....++|+.+.+||+|+||.||.++. .+|..+|+|++++....  .+......|-.+|...++|+||+|+-.|.+.+.+
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            44667899999999999999999984 57999999999754322  2233578888999999999999999999999999


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||||||+|||++..+|...+    .|+......++.+++.|++-+|..   ++|||||||+|+|||..|..||+||
T Consensus       217 YLiMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDF  285 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDF  285 (550)
T ss_pred             EEEEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccc
Confidence            99999999999999998654    588888999999999999999999   9999999999999999999999998

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.1e-27  Score=206.08  Aligned_cols=144  Identities=26%  Similarity=0.395  Sum_probs=126.8

Q ss_pred             HhcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc----ccHHHHHHHHHHHhcCC-CCCceeeeeEEeeCCe
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS----GGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTE  203 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~~~~  203 (284)
                      ....|...+.||+|+||+|+.|.. .++..||+|.+......    .....+.+|+.+++.++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            345688889999999999999974 57899999977553211    22345778999999999 9999999999999999


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCC-CCcchhhh
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTI  280 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~-~~~~~~df  280 (284)
                      .++||||+.+|+|.+++.+..    .+.+....+++.|++.|++|+|+.   +|+||||||+|+|+|.+ ++.||+||
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DF  165 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDF  165 (370)
T ss_pred             EEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecc
Confidence            999999999999999998732    478899999999999999999999   99999999999999999 99999998

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.95  E-value=4.4e-27  Score=198.68  Aligned_cols=143  Identities=27%  Similarity=0.385  Sum_probs=126.7

Q ss_pred             cCCCCCCeecccCceEEEEEEeC----CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      ++|+..+.||+|+||.||+|.+.    .+..||+|.++..........+.+|+.++++++||||++++|++...+..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            45777899999999999999753    35689999997654444445789999999999999999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||+++|+|.+++....   ..++|..++.++.|++.||+|||+.   +++||||||+|||++.++.++++||
T Consensus        85 ~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~df  151 (266)
T cd05064          85 TEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGF  151 (266)
T ss_pred             EEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCC
Confidence            99999999999997642   2589999999999999999999998   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-27  Score=225.38  Aligned_cols=147  Identities=32%  Similarity=0.498  Sum_probs=130.9

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC--CCc----EEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCee
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA--DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  204 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~  204 (284)
                      .+..+..+.||+|+||.||+|...  .+.    .||||.++.........+|.+|..+|++++|||||+++|.|......
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            445666789999999999999854  233    49999998776666677899999999999999999999999999999


Q ss_pred             eEEEeCCCCCChHHHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQS---SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++++|||++|+|.++|++.+.   ....++..+.+.++.|||+|+.||+++   ++|||||.++|+||++...+||+||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEccc
Confidence            999999999999999997522   234688999999999999999999999   9999999999999999999999998

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.95  E-value=1.6e-27  Score=196.65  Aligned_cols=142  Identities=27%  Similarity=0.431  Sum_probs=122.8

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCccc-HHHHHHHHHHHhcCCCCCceeeeeEEee--CCeeeEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEKLLV  207 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~~~h~niv~l~g~~~~--~~~~~lv  207 (284)
                      +.|+..+.|++|+||.||+|+. ++++.||+|+++-+..... -..-.+||.++.+++|||||.+..+...  -+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            4566678899999999999995 4788999999975543332 2246799999999999999999998764  4579999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||||+. +|.+++....   +++...+...+..|+++|++|||.+   .|+|||||++|+|+...|..||+||
T Consensus       156 Me~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDF  221 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADF  221 (419)
T ss_pred             HHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEeccc
Confidence            999986 9999998654   3588889999999999999999999   9999999999999999999999999

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.94  E-value=2.7e-27  Score=192.40  Aligned_cols=143  Identities=27%  Similarity=0.416  Sum_probs=127.4

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcc--cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      .++|+..+.||.|+||.|..++.+ +|..+|+|++......+  ..+...+|..+|+.+.||.++++.+.+.+.+..++|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            356777899999999999999865 68899999996543322  233577899999999999999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||+++|.|.++++..+    .++......+|.+|+.||+|||+.   .|++|||||+|||+|.+|..||.||
T Consensus       123 meyv~GGElFS~Lrk~~----rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDF  188 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSG----RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDF  188 (355)
T ss_pred             EeccCCccHHHHHHhcC----CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEec
Confidence            99999999999998754    488899999999999999999999   9999999999999999999999998

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.94  E-value=3.7e-27  Score=208.77  Aligned_cols=149  Identities=29%  Similarity=0.391  Sum_probs=127.0

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEe------CCCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEeeC
Q 023282          129 VATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  201 (284)
Q Consensus       129 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~  201 (284)
                      ...++|...+.||+|+||.||+|+.      .++..||||+++..........+.+|+.++..+ +||||++++++|...
T Consensus        32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            3345677889999999999999963      235689999997544334445688999999999 899999999999999


Q ss_pred             CeeeEEEeCCCCCChHHHHhhcCC--------------------------------------------------------
Q 023282          202 TEKLLVYPYMTNGSVASRLRERQS--------------------------------------------------------  225 (284)
Q Consensus       202 ~~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------  225 (284)
                      +..++||||+++|+|.++++....                                                        
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            999999999999999999975321                                                        


Q ss_pred             ---------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          226 ---------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       226 ---------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                                     ....++|.....++.|+++||+|||+.   +++||||||+|||++.++.++++||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Df  258 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDF  258 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecC
Confidence                           012478999999999999999999998   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.6e-26  Score=197.00  Aligned_cols=138  Identities=33%  Similarity=0.463  Sum_probs=118.2

Q ss_pred             CCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHh--cCCCCCceeeeeEEeeC----CeeeE
Q 023282          133 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIIS--MAVHRNLLRLYGFCTTV----TEKLL  206 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~--~~~h~niv~l~g~~~~~----~~~~l  206 (284)
                      .....+.||+|.||.||+|.++ |+.||||++.    ..++..+.+|.++.+  .++|+||+.+++.=...    .++||
T Consensus       212 qI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~----srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL  286 (513)
T KOG2052|consen  212 QIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFS----SRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL  286 (513)
T ss_pred             eeEEEEEecCccccceeecccc-CCceEEEEec----ccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence            4556689999999999999994 7889999984    344556778887775  67999999988765433    37899


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-----CCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-----HCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-----~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |++|-+.|||+|+|...     .++-...++++..+|.||++||.     +.+|.|.|||||+.|||+..++...|+|+
T Consensus       287 vTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  287 VTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             eeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            99999999999999863     48888999999999999999996     45899999999999999999999999986

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.94  E-value=9.8e-28  Score=200.31  Aligned_cols=138  Identities=29%  Similarity=0.457  Sum_probs=113.5

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC-----eeeEE
Q 023282          134 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-----EKLLV  207 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~-----~~~lv  207 (284)
                      |...+++|.|+||.||+|... +++.||||+...+...     -.+|+++|++++|||||+|.-++....     ...+|
T Consensus        26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            455689999999999999964 5789999988544321     247899999999999999999886532     24589


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCC-CCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~-~~~~~~df  280 (284)
                      |||||. +|+..++........++.....-+..|+.+||+|||+.   +|+||||||.|+|+|.+ +..|||||
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDF  170 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDF  170 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccC
Confidence            999986 89999985322233466667788999999999999998   99999999999999988 79999998

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.94  E-value=1.7e-27  Score=208.33  Aligned_cols=141  Identities=26%  Similarity=0.419  Sum_probs=126.3

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc-CcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      ++|...+.||+|+||.||||+. .+.+.||+|.+.+.. ...+.+.+.+|+++++.++|||||.++++|....+.|+|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            4567778999999999999985 478899999985443 33344579999999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+.+ +|..+|....    .+++.....++.++..||.|||+.   +|+|||+||+|||++..+.+|+|||
T Consensus        82 ~a~g-~L~~il~~d~----~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdF  144 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG----KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDF  144 (808)
T ss_pred             hhhh-hHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechh
Confidence            9976 9999997643    489999999999999999999999   9999999999999999999999998

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=5.1e-27  Score=201.54  Aligned_cols=146  Identities=28%  Similarity=0.388  Sum_probs=122.5

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc-------------ccHHHHHHHHHHHhcCCCCCcee
Q 023282          128 QVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-------------GGELQFQTEVKIISMAVHRNLLR  193 (284)
Q Consensus       128 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-------------~~~~~~~~e~~~l~~~~h~niv~  193 (284)
                      ....+.|++.+.||+|.||.|-+|+. .+++.||||++.+....             ...+...+||.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            34567788999999999999999985 47899999999532110             11235789999999999999999


Q ss_pred             eeeEEeeC--CeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC
Q 023282          194 LYGFCTTV--TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE  271 (284)
Q Consensus       194 l~g~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~  271 (284)
                      |+++..++  +..|||+|||..|.+...--.    ...++..+..++..++..||+|||.+   +||||||||+|+||++
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d----~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPD----KPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSS  245 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCCCC----cccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcC
Confidence            99999764  578999999999887543322    11288999999999999999999999   9999999999999999


Q ss_pred             CCCcchhhh
Q 023282          272 DADQSSKTI  280 (284)
Q Consensus       272 ~~~~~~~df  280 (284)
                      ++.+||+||
T Consensus       246 ~g~VKIsDF  254 (576)
T KOG0585|consen  246 DGTVKISDF  254 (576)
T ss_pred             CCcEEeecc
Confidence            999999998

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.94  E-value=7e-27  Score=195.04  Aligned_cols=143  Identities=26%  Similarity=0.406  Sum_probs=121.4

Q ss_pred             CCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcc-cHHHHHHHHHHHhcCCCCC-ceeeeeEEeeCC------ee
Q 023282          134 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRN-LLRLYGFCTTVT------EK  204 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~n-iv~l~g~~~~~~------~~  204 (284)
                      |...+.||+|+||+||+|+. .+|+.||+|+++.+...+ .-....+|+.+++.++|+| ||+|++++...+      ..
T Consensus        13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l   92 (323)
T KOG0594|consen   13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL   92 (323)
T ss_pred             HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence            44456799999999999984 578999999997554322 2235689999999999999 999999998877      78


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++|+||+.. +|.+++.........++-.....++.|+++||+|||++   +|+||||||.|||+++++..|++||
T Consensus        93 ~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDF  164 (323)
T KOG0594|consen   93 YLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADF  164 (323)
T ss_pred             EEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeecc
Confidence            899999964 99999987542213466678999999999999999999   9999999999999999999999998

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.94  E-value=8.9e-27  Score=205.52  Aligned_cols=142  Identities=20%  Similarity=0.327  Sum_probs=125.8

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|+..+.||+|+||+||+++.. +++.+|+|+++....  ......+..|+.++..++|+||+++++.+......++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            36788899999999999999854 688999999964322  122345788999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus        81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DF  145 (363)
T cd05628          81 EFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDF  145 (363)
T ss_pred             cCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeec
Confidence            9999999999997642    488999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.1e-26  Score=205.94  Aligned_cols=142  Identities=19%  Similarity=0.314  Sum_probs=125.1

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|...+.||+|+||.||++.. .+++.||+|.+.....  ......+.+|+++++.++||||+++++++......++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            3677889999999999999985 4788999999864321  222346888999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.++++||
T Consensus        81 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~Df  145 (377)
T cd05629          81 EFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDF  145 (377)
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeec
Confidence            9999999999997532    478888899999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=8.9e-27  Score=205.55  Aligned_cols=142  Identities=22%  Similarity=0.365  Sum_probs=126.2

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|+..+.||+|+||.||+++.. +++.||||+++....  ......+.+|+.++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            36788899999999999999864 688999999964321  122345788999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.++++||
T Consensus        81 E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df  145 (364)
T cd05599          81 EYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDF  145 (364)
T ss_pred             CCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeec
Confidence            9999999999997642    488999999999999999999999   9999999999999999999999998

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.94  E-value=1.6e-26  Score=205.25  Aligned_cols=141  Identities=23%  Similarity=0.283  Sum_probs=124.8

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc--ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          133 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      .|+..+.||+|+||+||+|+. .+++.+|+|++......  .....+.+|+.++..++||||+++++++...+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            477789999999999999985 46889999999654322  223468899999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++|+|.+++....    .+++.....++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus        82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DF  145 (381)
T cd05626          82 YIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDF  145 (381)
T ss_pred             cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeC
Confidence            999999999997642    478888899999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.94  E-value=2.8e-26  Score=196.06  Aligned_cols=142  Identities=27%  Similarity=0.449  Sum_probs=124.6

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ++|...+.||+|+||.||+|+.. ++..||+|.++..........+.+|+.+++.++||||+++++++......++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46788899999999999999864 68899999986544333344678999999999999999999999988899999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++ |+|.+++.....   .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        85 ~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Df  147 (288)
T cd07871          85 LD-SDLKQYLDNCGN---LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADF  147 (288)
T ss_pred             CC-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcC
Confidence            97 599998875432   478889999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.94  E-value=1.4e-26  Score=204.54  Aligned_cols=148  Identities=24%  Similarity=0.332  Sum_probs=128.7

Q ss_pred             HHHHHHhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeC
Q 023282          125 RELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTV  201 (284)
Q Consensus       125 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~  201 (284)
                      +++....++|+..+.||+|+||.||+++.. +++.+|+|.+.....  ......+.+|+.+++.++||||+++++++...
T Consensus        36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (370)
T cd05621          36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD  115 (370)
T ss_pred             HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            344455678899999999999999999864 678999999864321  22234578999999999999999999999999


Q ss_pred             CeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          202 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       202 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ...++||||+++|+|.+++...     .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DF  186 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADF  186 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEec
Confidence            9999999999999999999653     367888999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.94  E-value=1.8e-26  Score=200.98  Aligned_cols=142  Identities=22%  Similarity=0.322  Sum_probs=125.8

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|+..+.||+|+||.||+++.. +++.||+|.++....  ......+.+|+.+++.++||||+++++++...+..+++|
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            46777899999999999999865 688999999864321  122346889999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus        98 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Df  162 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDF  162 (329)
T ss_pred             cCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeec
Confidence            9999999999997642    478888899999999999999999   9999999999999999999999998

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.1e-26  Score=198.79  Aligned_cols=142  Identities=24%  Similarity=0.314  Sum_probs=125.6

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|+..+.||+|+||.||++... +++.+|+|.+.....  ......+.+|+++++.++||||+++++++......++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            35778899999999999999864 688999999864322  122346889999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||+.   +++||||||+|||++.++.++++||
T Consensus        81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Df  145 (291)
T cd05612          81 EYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDF  145 (291)
T ss_pred             eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEec
Confidence            9999999999997643    478899999999999999999999   9999999999999999999999998

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.94  E-value=1.1e-26  Score=205.66  Aligned_cols=150  Identities=29%  Similarity=0.423  Sum_probs=127.1

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEee
Q 023282          128 QVATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  200 (284)
Q Consensus       128 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~  200 (284)
                      ....++|+..+.||+|+||.||+++..      ++..||+|.++..........+.+|+++++.+ +|+||++++++|..
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            344557888899999999999998731      23579999997544333345688999999999 89999999999999


Q ss_pred             CCeeeEEEeCCCCCChHHHHhhcCC-------------------------------------------------------
Q 023282          201 VTEKLLVYPYMTNGSVASRLRERQS-------------------------------------------------------  225 (284)
Q Consensus       201 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  225 (284)
                      .+..++||||+++|+|.++++....                                                       
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            9999999999999999999864311                                                       


Q ss_pred             -----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          226 -----------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       226 -----------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                                 ...++++....+++.|+++||+|||+.   +++||||||+|||++.++.++|+||
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~Df  256 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDF  256 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeec
Confidence                       112478889999999999999999998   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.94  E-value=3.4e-26  Score=198.67  Aligned_cols=136  Identities=27%  Similarity=0.340  Sum_probs=120.7

Q ss_pred             CeecccCceEEEEEEe-CCCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCC
Q 023282          138 NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  214 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g  214 (284)
                      ++||+|+||.||+++. .+++.+|+|+++....  ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999985 4788999999975432  222345788999999999999999999999999999999999999


Q ss_pred             ChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          215 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       215 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus        81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~Df  139 (323)
T cd05571          81 ELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDF  139 (323)
T ss_pred             cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeC
Confidence            9999997542    478999999999999999999999   9999999999999999999999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.94  E-value=4.1e-26  Score=198.21  Aligned_cols=136  Identities=26%  Similarity=0.346  Sum_probs=120.5

Q ss_pred             CeecccCceEEEEEEe-CCCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCC
Q 023282          138 NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  214 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g  214 (284)
                      +.||+|+||.||+++. .++..||+|.++....  ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999985 4688999999975432  122345778999999999999999999999999999999999999


Q ss_pred             ChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          215 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       215 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +|..++....    .+++.....++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus        81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  139 (323)
T cd05595          81 ELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF  139 (323)
T ss_pred             cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEeccc
Confidence            9999887542    478999999999999999999999   9999999999999999999999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.94  E-value=2.5e-26  Score=204.02  Aligned_cols=141  Identities=24%  Similarity=0.309  Sum_probs=124.5

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          133 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      .|+..+.||+|+||.||+|+. .+++.+|+|.+.....  ......+.+|+.+++.++||||+++++.+...+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            477789999999999999985 4688999999864322  1223468899999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus        82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DF  145 (382)
T cd05625          82 YIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDF  145 (382)
T ss_pred             CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeEC
Confidence            999999999997542    478888899999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.94  E-value=3.2e-26  Score=200.15  Aligned_cols=143  Identities=24%  Similarity=0.304  Sum_probs=125.2

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-C-CcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-D-GKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~l  206 (284)
                      .++|+..+.||+|+||.||+|... + +..||+|.+.....  ......+.+|+.+++.++||||+++++++...+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            356888899999999999999854 3 36899999864322  2233468899999999999999999999999999999


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||||+++|+|.+++....    .+++.....++.|++.||.|||+.   +|+||||||+|||++.++.++++||
T Consensus       109 v~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DF  175 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDF  175 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecC
Confidence            999999999999997643    478899999999999999999998   9999999999999999999999998

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.94  E-value=5.8e-26  Score=195.45  Aligned_cols=142  Identities=27%  Similarity=0.459  Sum_probs=124.8

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ++|...+.||+|+||.||+|+.. +++.+|+|.++..........+.+|+.+++.++||||+++++++......++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY   84 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence            56888899999999999999865 68899999986543333344678899999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++ ++|.+++....   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        85 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Df  147 (303)
T cd07869          85 VH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADF  147 (303)
T ss_pred             CC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCC
Confidence            96 68888886542   2478889999999999999999999   9999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.94  E-value=3.8e-26  Score=202.40  Aligned_cols=141  Identities=23%  Similarity=0.306  Sum_probs=124.5

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          133 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      +|+..+.||+|+||.||+++. .+++.+|+|.+.....  ......+.+|+++++.++|+||+++++.+...+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            578889999999999999985 4688999999864321  1223458899999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus        82 ~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DF  145 (376)
T cd05598          82 YIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDF  145 (376)
T ss_pred             CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeC
Confidence            999999999997642    477888889999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.94  E-value=2.2e-26  Score=204.97  Aligned_cols=150  Identities=28%  Similarity=0.393  Sum_probs=127.5

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccCcccHHHHHHHHHHHhcCC-CCCceeeeeEEee
Q 023282          128 QVATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTT  200 (284)
Q Consensus       128 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~  200 (284)
                      ....++|...++||+|+||.||+|...      .+..||||+++..........+.+|+++++.+. ||||++++++|..
T Consensus        33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            344667888899999999999999752      134699999965443334457899999999996 9999999999999


Q ss_pred             CCeeeEEEeCCCCCChHHHHhhcCC-------------------------------------------------------
Q 023282          201 VTEKLLVYPYMTNGSVASRLRERQS-------------------------------------------------------  225 (284)
Q Consensus       201 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  225 (284)
                      .+..++||||+++|+|.++++....                                                       
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            9999999999999999999875311                                                       


Q ss_pred             -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCee
Q 023282          226 -------------------------------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL  268 (284)
Q Consensus       226 -------------------------------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiL  268 (284)
                                                           ....++|..+..++.|+++||+|||+.   +++||||||+|||
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil  269 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence                                                 012478889999999999999999998   9999999999999


Q ss_pred             eCCCCCcchhhh
Q 023282          269 LDEDADQSSKTI  280 (284)
Q Consensus       269 ld~~~~~~~~df  280 (284)
                      ++.++.++++||
T Consensus       270 l~~~~~~kL~Df  281 (400)
T cd05105         270 LAQGKIVKICDF  281 (400)
T ss_pred             EeCCCEEEEEeC
Confidence            999999999997

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=3.9e-26  Score=199.15  Aligned_cols=141  Identities=23%  Similarity=0.316  Sum_probs=125.8

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc--ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      +|+..+.||+|+||.||+|+.. +++.||+|+++.....  .....+..|++++..++||||+++++++...+..++|||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            5778899999999999999965 5889999999754322  233468899999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++|+|.+++....    .+++.....++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        82 ~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Df  145 (333)
T cd05600          82 YVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDF  145 (333)
T ss_pred             CCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeC
Confidence            999999999997542    478899999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.94  E-value=5.6e-26  Score=193.89  Aligned_cols=142  Identities=29%  Similarity=0.406  Sum_probs=123.9

Q ss_pred             CCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc--ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          134 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      |...+.||+|+||.||++.. .+++.||+|.+......  .....+.+|+.+++.++|+|++++.+++...+..+++|||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            56678999999999999985 57899999998643322  2233578899999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++|+|.+++.....  ..+++.....++.|++.||+|||+.   +|+||||||+|||++.++.++++||
T Consensus        82 ~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Df  146 (285)
T cd05631          82 MNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDL  146 (285)
T ss_pred             cCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeC
Confidence            999999988865322  2588999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.94  E-value=6.3e-26  Score=197.43  Aligned_cols=136  Identities=29%  Similarity=0.358  Sum_probs=120.8

Q ss_pred             CeecccCceEEEEEEe-CCCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCC
Q 023282          138 NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  214 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g  214 (284)
                      +.||+|+||.||+++. .++..||+|++.....  ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999985 4688999999975432  223346888999999999999999999999999999999999999


Q ss_pred             ChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          215 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       215 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +|.+++....    .+++.+...++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~Df  139 (328)
T cd05593          81 ELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDF  139 (328)
T ss_pred             CHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecC
Confidence            9999886532    488999999999999999999999   9999999999999999999999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.94  E-value=5.4e-26  Score=196.81  Aligned_cols=142  Identities=27%  Similarity=0.483  Sum_probs=122.8

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCc----EEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~l  206 (284)
                      .+|+..+.||+|+||.||+|.+. ++.    .||+|.++.........++.+|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            45888899999999999999853 343    48999986543334455788999999999999999999999764 5779


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++||+++|+|.++++....   .+++...+.++.|++.||+|||+.   +++||||||+|||++.++.+||+||
T Consensus        86 v~e~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~Df  153 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDF  153 (316)
T ss_pred             eeecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccc
Confidence            9999999999999986432   478899999999999999999998   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.94  E-value=2.7e-26  Score=202.88  Aligned_cols=144  Identities=22%  Similarity=0.285  Sum_probs=125.7

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeee
Q 023282          129 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  205 (284)
Q Consensus       129 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~  205 (284)
                      ...++|+..+.||+|+||.||+++.. ++..+|+|.+.....  ......+.+|+.+++.++||||+++++++...+..+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            34567888899999999999999864 688999999864321  122335788999999999999999999999999999


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +||||+++|+|.+++...     .++......++.|++.||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus       120 lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~Df  186 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF  186 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEec
Confidence            999999999999998753     367778888999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.93  E-value=4e-26  Score=192.17  Aligned_cols=139  Identities=35%  Similarity=0.592  Sum_probs=120.1

Q ss_pred             CCeecccCceEEEEEEeC-----CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCC
Q 023282          137 KNILGRGGFGKVYKGRLA-----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      .+.||.|+||.||+|.+.     .+..|+||.++..........|.+|++.+++++||||++++|++...+..++|+||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            467999999999999865     256899999965444444568999999999999999999999999888899999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++|+|.++|....  ...+++..+..++.|+++||.|||+.   +++|+||+++||+++.++.+||+||
T Consensus        84 ~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f  147 (259)
T PF07714_consen   84 PGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDF  147 (259)
T ss_dssp             TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEEST
T ss_pred             ccccccccccccc--cccccccccccccccccccccccccc---ccccccccccccccccccccccccc
Confidence            9999999998752  23589999999999999999999999   9999999999999999999999998

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.93  E-value=1.6e-25  Score=194.63  Aligned_cols=136  Identities=26%  Similarity=0.335  Sum_probs=119.7

Q ss_pred             CeecccCceEEEEEEe-CCCcEEEEEEeecccCc--ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCC
Q 023282          138 NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  214 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g  214 (284)
                      +.||+|+||.||+++. .++..||+|.++.....  .....+..|++++..++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999985 47889999999754322  22345778999999999999999999999999999999999999


Q ss_pred             ChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          215 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       215 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +|.+++....    .+++.....++.|++.||.|||+ .   +|+||||||+|||++.++.++|+||
T Consensus        81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Df  140 (325)
T cd05594          81 ELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDF  140 (325)
T ss_pred             cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecC
Confidence            9999886532    48899999999999999999997 6   8999999999999999999999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.93  E-value=1.4e-25  Score=195.47  Aligned_cols=144  Identities=26%  Similarity=0.357  Sum_probs=127.0

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      .++|+..+.||+|+||.||+++.. ++..+|+|.+...........+.+|+++++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            467888899999999999999865 6889999998654332334568999999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++|+|.+++....    .+++.....++.|++.||.|||+.+  +|+||||||+|||++.++.++|+||
T Consensus        84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Df  148 (331)
T cd06649          84 HMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDF  148 (331)
T ss_pred             cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccC
Confidence            999999999997643    4788899999999999999999852  5999999999999999999999998

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.93  E-value=9.5e-26  Score=196.41  Aligned_cols=143  Identities=23%  Similarity=0.307  Sum_probs=126.4

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|...+.||+|+||.||+++.. +++.+|+|.++....  ......+.+|+.+++.++|+||+++++++...+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            35778899999999999999854 788999999975432  223346889999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++.....   .+++.....++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus        81 e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Df  146 (330)
T cd05601          81 EYQPGGDLLSLLNRYED---QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADF  146 (330)
T ss_pred             CCCCCCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccC
Confidence            99999999999976422   488999999999999999999999   9999999999999999999999998

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.93  E-value=8.7e-26  Score=199.00  Aligned_cols=142  Identities=20%  Similarity=0.346  Sum_probs=125.5

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|+..+.||+|+||.||++... +++.+|+|.++....  ......+..|+.++..++||||+++++.+...+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            35778899999999999999864 688999999964321  222346888999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++....    .+++.....++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus        81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~Df  145 (360)
T cd05627          81 EFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDF  145 (360)
T ss_pred             eCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeec
Confidence            9999999999997642    478889999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=9.5e-26  Score=194.96  Aligned_cols=134  Identities=21%  Similarity=0.302  Sum_probs=119.2

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCCCh
Q 023282          140 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  216 (284)
Q Consensus       140 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g~L  216 (284)
                      ||+|+||.||+++.. ++..||+|.++....  ......+..|+.+++.++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999864 678999999864321  22334678899999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          217 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       217 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .+++....    .+++.....++.|+++||.|||+.   +|+||||||+|||++.++.++++||
T Consensus        81 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Df  137 (312)
T cd05585          81 FHHLQREG----RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDF  137 (312)
T ss_pred             HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEEC
Confidence            99997532    478999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.93  E-value=1.4e-25  Score=195.71  Aligned_cols=144  Identities=26%  Similarity=0.361  Sum_probs=126.5

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      .++|+..+.||+|+||.||++... ++..+|+|.+...........+.+|+++++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            467888999999999999999865 6788999988654333334568999999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++|+|.+++....    .+++.....++.+++.||.|||+.+  +++||||||+|||++.++.++++||
T Consensus        84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Df  148 (333)
T cd06650          84 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDF  148 (333)
T ss_pred             cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeC
Confidence            999999999997542    4788889999999999999999742  6999999999999999999999998

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.93  E-value=1.8e-25  Score=188.63  Aligned_cols=143  Identities=31%  Similarity=0.466  Sum_probs=126.6

Q ss_pred             cCCCCCCeecccCceEEEEEEeCC----CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      ++|+..+.||+|+||.||+|.+..    ...||+|.++.........+|..|+.++++++||||+++++++...+..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            467888999999999999998642    3579999986554444445789999999999999999999999998999999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||+++++|.+++.....   .++|.....++.|++.||+|||+.   +|+||||||+||++++++.++++||
T Consensus        84 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~df  150 (266)
T cd05033          84 TEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDF  150 (266)
T ss_pred             EEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECcc
Confidence            999999999999976432   589999999999999999999998   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=1.2e-25  Score=196.00  Aligned_cols=143  Identities=22%  Similarity=0.309  Sum_probs=125.1

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|+..+.||+|+||.||+++.. +++.||+|.+.....  ......+.+|..++..++|+||+++++++...+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            36778899999999999999854 688999999864221  122345888999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++.....   .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus        81 e~~~g~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Df  146 (331)
T cd05597          81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADF  146 (331)
T ss_pred             ecCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEEC
Confidence            99999999999975322   478889999999999999999999   9999999999999999999999998

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.93  E-value=8.1e-26  Score=199.89  Aligned_cols=149  Identities=23%  Similarity=0.325  Sum_probs=129.8

Q ss_pred             HHHHHHHhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEee
Q 023282          124 LRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTT  200 (284)
Q Consensus       124 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~  200 (284)
                      +.++....++|+..+.||+|+||.||+++.. +++.+|+|.+.....  ......+.+|+.+++.++||||+++++.+..
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            4555666788999999999999999999865 678999999864221  1223357889999999999999999999999


Q ss_pred             CCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          201 VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       201 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ....++||||+++|+|.+++...     .++......++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence            99999999999999999999753     367788889999999999999999   9999999999999999999999998

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=3.3e-26  Score=209.64  Aligned_cols=143  Identities=27%  Similarity=0.402  Sum_probs=122.7

Q ss_pred             CCCCCeecccCceEEEEEEeCCC-cEEEEEEeecccCcccHHHHHHHHHHHhcCC-CCCceeeeeE-Eee------CCee
Q 023282          134 FSNKNILGRGGFGKVYKGRLADG-KLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGF-CTT------VTEK  204 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~g~-~~~------~~~~  204 (284)
                      +++.++|.+|+|+.||.+....+ ..+|+|++-.. .........+|+++|+.+. |+|||.+++. ...      ..+.
T Consensus        39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            44568899999999999997655 89999998543 3334457899999999998 9999999993 221      2367


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +|+||||.+|.|-+++..+...  .|++.++++|+.++++|+++||.. .|+|||||||.+||||+.++.-|||||
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence            8999999999999999876543  389999999999999999999985 889999999999999999999999999

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.93  E-value=1.5e-25  Score=195.30  Aligned_cols=143  Identities=20%  Similarity=0.275  Sum_probs=125.0

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|...+.||+|+||.||+++.. +++.+|+|.+.....  ......+.+|..++..++|+||+++++++...+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46778899999999999999864 678999999864221  122335788999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++.....   .+++.....++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus        81 Ey~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~Df  146 (331)
T cd05624          81 DYYVGGDLLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADF  146 (331)
T ss_pred             eCCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEec
Confidence            99999999999976322   478889999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.93  E-value=1.9e-25  Score=187.50  Aligned_cols=141  Identities=29%  Similarity=0.443  Sum_probs=125.4

Q ss_pred             cCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      ++|+..+.||+|+||.||++...++..+|+|.+....  ....++..|+.+++.++||||+++++++......+++|||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            3466778899999999999998877889999875332  22456889999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++|+|.++++....   .++|..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        82 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~  144 (256)
T cd05114          82 ENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDF  144 (256)
T ss_pred             CCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCC
Confidence            99999999975432   478999999999999999999998   9999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.93  E-value=7.4e-26  Score=205.22  Aligned_cols=141  Identities=30%  Similarity=0.467  Sum_probs=125.6

Q ss_pred             CCCCeecccCceEEEEEEe-CCCc----EEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          135 SNKNILGRGGFGKVYKGRL-ADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       135 ~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      ...++||+|+||+||+|.+ +.|+    +||+|++......+...++.+|+..|.+++|||+++|+|+|.... ..||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            3457899999999999974 4443    799999987776667778999999999999999999999998865 889999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  282 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df~~  282 (284)
                      |||.|+|.++++..++   .+.....+.+..|||+||.|||.+   +++||||.++|||+.+-..+|+.||..
T Consensus       778 ~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgl  844 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGL  844 (1177)
T ss_pred             hcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecch
Confidence            9999999999998654   467778999999999999999999   999999999999999999999999953

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.93  E-value=1.2e-25  Score=190.87  Aligned_cols=148  Identities=26%  Similarity=0.419  Sum_probs=126.5

Q ss_pred             HhcCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCe
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  203 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~  203 (284)
                      ..++|+..+.||+|+||.||+|...      .+..+|+|.++.........++.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567888999999999999998753      2457999988644333334568899999999999999999999998889


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcch
Q 023282          204 KLLVYPYMTNGSVASRLRERQSS------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS  277 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~  277 (284)
                      .+++|||+++|+|.++++.....      ...++|..+..++.|+++||.|||+.   +++||||||+||++++++.+++
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence            99999999999999999753221      23468889999999999999999998   9999999999999999999999


Q ss_pred             hhh
Q 023282          278 KTI  280 (284)
Q Consensus       278 ~df  280 (284)
                      +||
T Consensus       161 ~df  163 (277)
T cd05062         161 GDF  163 (277)
T ss_pred             CCC
Confidence            997

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.93  E-value=9e-26  Score=201.00  Aligned_cols=150  Identities=26%  Similarity=0.390  Sum_probs=126.7

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccCcccHHHHHHHHHHHhcCC-CCCceeeeeEEee
Q 023282          128 QVATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTT  200 (284)
Q Consensus       128 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~  200 (284)
                      ....++|...+.||+|+||.||+|++.      .+..||+|+++..........+..|+.++..+. ||||++++++|..
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            344456777899999999999999853      245799999975433333446889999999997 9999999999999


Q ss_pred             CCeeeEEEeCCCCCChHHHHhhcCC-------------------------------------------------------
Q 023282          201 VTEKLLVYPYMTNGSVASRLRERQS-------------------------------------------------------  225 (284)
Q Consensus       201 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  225 (284)
                      .+..++|+||+++|+|.++++....                                                       
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            8999999999999999999975321                                                       


Q ss_pred             ---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCC
Q 023282          226 ---------------------------------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN  266 (284)
Q Consensus       226 ---------------------------------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~N  266 (284)
                                                             ....++|.....++.|++.||+|||+.   +++||||||+|
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~N  269 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARN  269 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcce
Confidence                                                   112467888999999999999999998   99999999999


Q ss_pred             eeeCCCCCcchhhh
Q 023282          267 ILLDEDADQSSKTI  280 (284)
Q Consensus       267 iLld~~~~~~~~df  280 (284)
                      ||++.++.++++||
T Consensus       270 iLl~~~~~~kL~Df  283 (401)
T cd05107         270 VLICEGKLVKICDF  283 (401)
T ss_pred             EEEeCCCEEEEEec
Confidence            99999999999998

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=5.4e-26  Score=192.37  Aligned_cols=143  Identities=29%  Similarity=0.315  Sum_probs=126.1

Q ss_pred             CCCCCCeecccCceEEEEEEeCC-CcEEEEEEeecccCcc--cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          133 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      .|...+.||.|.-|+||.+++.+ +...|+|++.+.....  ...+.+.|-++|+.++||.+..||..+......+++||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            34556789999999999999764 5899999996554332  23367889999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+||+|..+++.+..  ..++...+..+|.+|.-||+|||..   +||.|||||+|||+-++|.+-++||
T Consensus       158 yCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDF  223 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDF  223 (459)
T ss_pred             cCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeec
Confidence            9999999999987544  4588899999999999999999999   9999999999999999999999998

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.93  E-value=1.6e-25  Score=190.54  Aligned_cols=138  Identities=30%  Similarity=0.413  Sum_probs=120.1

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEeecccCcc--cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCCCh
Q 023282          140 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  216 (284)
Q Consensus       140 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g~L  216 (284)
                      ||+|+||+||++... +++.+|+|.+.......  ....+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999854 68899999986433221  224577899999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          217 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       217 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .+++.........+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~df  141 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDL  141 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeC
Confidence            988865433344689999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=1.1e-25  Score=197.43  Aligned_cols=142  Identities=26%  Similarity=0.362  Sum_probs=126.6

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc--ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|...+.||+|+||+||+++.. +++.||+|+++.....  .....+..|+.++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            35778899999999999999865 6889999999754321  23346889999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++...    ..+++.....++.|++.||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus        81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Df  145 (350)
T cd05573          81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADF  145 (350)
T ss_pred             cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecC
Confidence            999999999999764    2478899999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.93  E-value=2.4e-25  Score=186.28  Aligned_cols=137  Identities=32%  Similarity=0.508  Sum_probs=121.8

Q ss_pred             CeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCCCh
Q 023282          138 NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  216 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g~L  216 (284)
                      +.||+|+||.||+|.. .+++.+|+|.+......+....+.+|+++++.++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            3689999999999986 478899999886443333345789999999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          217 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       217 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .++++...   ..++|..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df  138 (252)
T cd05084          81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDF  138 (252)
T ss_pred             HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECcc
Confidence            99997532   2478999999999999999999998   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.93  E-value=2.3e-25  Score=193.05  Aligned_cols=136  Identities=29%  Similarity=0.373  Sum_probs=120.1

Q ss_pred             CeecccCceEEEEEEe----CCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCC
Q 023282          138 NILGRGGFGKVYKGRL----ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  212 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~  212 (284)
                      +.||+|+||.||+++.    .+++.+|+|+++..... .....+..|++++++++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    35789999999754322 223457789999999999999999999999999999999999


Q ss_pred             CCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          213 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       213 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +|+|.+++....    .+++.....++.|+++||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus        82 ~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Df  142 (318)
T cd05582          82 GGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDF  142 (318)
T ss_pred             CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeec
Confidence            999999996532    478999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.93  E-value=2.4e-25  Score=188.17  Aligned_cols=139  Identities=28%  Similarity=0.367  Sum_probs=118.4

Q ss_pred             eecccCceEEEEEEeCC---CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCCC
Q 023282          139 ILGRGGFGKVYKGRLAD---GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS  215 (284)
Q Consensus       139 ~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g~  215 (284)
                      .||+|+||.||+|...+   ...+++|.+...........+.+|++.++.++|+||+++++.+......+++|||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997533   346888877544333334568899999999999999999999999999999999999999


Q ss_pred             hHHHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          216 VASRLRERQSS-LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       216 L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |.+++...... ....++.....++.|++.||+|||+.   +|+||||||+|||++.++.++++||
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~df  144 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDY  144 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEecc
Confidence            99999764322 22356788899999999999999998   9999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.93  E-value=8.4e-26  Score=198.59  Aligned_cols=136  Identities=24%  Similarity=0.360  Sum_probs=118.4

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCC
Q 023282          134 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  212 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~  212 (284)
                      |+..+.||+|+||.||+++.. +++.||+|.+...........+.+|+++++.++|+||+++++++...+..++||||++
T Consensus        76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  155 (353)
T PLN00034         76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD  155 (353)
T ss_pred             HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence            445678999999999999854 6889999998654333334568999999999999999999999999999999999999


Q ss_pred             CCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          213 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       213 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +|+|.+..        ...+.....++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       156 ~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~Df  212 (353)
T PLN00034        156 GGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADF  212 (353)
T ss_pred             CCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccc
Confidence            99986432        245667888999999999999998   9999999999999999999999998

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.93  E-value=2.7e-25  Score=189.34  Aligned_cols=146  Identities=29%  Similarity=0.454  Sum_probs=125.1

Q ss_pred             cCCCCCCeecccCceEEEEEEe-----CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~l  206 (284)
                      ++|+..+.||+|+||.||+|..     ..+..+|+|.++..........+.+|+++++.++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4567778999999999999974     24578999998654333334578899999999999999999999999999999


Q ss_pred             EEeCCCCCChHHHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC
Q 023282          207 VYPYMTNGSVASRLRERQS-------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  273 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~  273 (284)
                      +|||+++|+|.+++.....             ....+++.+.+.++.|++.||+|||+.   +++||||||+|||++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence            9999999999999964321             012478899999999999999999998   999999999999999999


Q ss_pred             Ccchhhh
Q 023282          274 DQSSKTI  280 (284)
Q Consensus       274 ~~~~~df  280 (284)
                      .++++||
T Consensus       162 ~~kl~df  168 (283)
T cd05090         162 HVKISDL  168 (283)
T ss_pred             cEEeccc
Confidence            9999997

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.93  E-value=2.2e-25  Score=190.40  Aligned_cols=149  Identities=27%  Similarity=0.434  Sum_probs=126.4

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC
Q 023282          129 VATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT  202 (284)
Q Consensus       129 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~  202 (284)
                      ...++|+..+.||+|+||.||+|...      .+..||+|.++..........+.+|+.+++.++||||+++++++....
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            34567888999999999999999643      245799998864433333446889999999999999999999999989


Q ss_pred             eeeEEEeCCCCCChHHHHhhcCC------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcc
Q 023282          203 EKLLVYPYMTNGSVASRLRERQS------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  276 (284)
Q Consensus       203 ~~~lv~e~~~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~  276 (284)
                      ..+++|||+++|+|.++++....      .....++.....++.|++.||.|||+.   +++||||||+||+++.++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence            99999999999999999975321      123457788899999999999999998   999999999999999999999


Q ss_pred             hhhh
Q 023282          277 SKTI  280 (284)
Q Consensus       277 ~~df  280 (284)
                      ++||
T Consensus       160 L~Df  163 (288)
T cd05061         160 IGDF  163 (288)
T ss_pred             ECcC
Confidence            9998

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.93  E-value=1.6e-25  Score=196.05  Aligned_cols=148  Identities=30%  Similarity=0.422  Sum_probs=124.2

Q ss_pred             HhcCCCCCCeecccCceEEEEEEe------CCCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEeeC-
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV-  201 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~-  201 (284)
                      ..++|...+.||+|+||.||+|..      .+++.||||.++..........+.+|+.++..+ +||||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            446788899999999999999973      346789999997544333445688999999999 689999999988654 


Q ss_pred             CeeeEEEeCCCCCChHHHHhhcCCC-------------------------------------------------------
Q 023282          202 TEKLLVYPYMTNGSVASRLRERQSS-------------------------------------------------------  226 (284)
Q Consensus       202 ~~~~lv~e~~~~g~L~~~l~~~~~~-------------------------------------------------------  226 (284)
                      ...+++|||+++|+|.++++.....                                                       
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            4578999999999999999753210                                                       


Q ss_pred             --------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          227 --------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       227 --------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                              ...++|.+...++.|+++||+|||+.   +++||||||+|||++.+++++++||
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~df  223 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDF  223 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEec
Confidence                    12368889999999999999999998   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.93  E-value=3.3e-25  Score=192.50  Aligned_cols=136  Identities=27%  Similarity=0.366  Sum_probs=119.1

Q ss_pred             CeecccCceEEEEEEe----CCCcEEEEEEeecccC---cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          138 NILGRGGFGKVYKGRL----ADGKLVAVKRLKEERT---SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +.||+|+||.||+++.    .+++.||+|.++....   ......+..|+++++.++||||+++++++...+..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999975    3578999999865322   12233578899999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++|+|.+++....    .+.+.....++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus        82 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df  144 (323)
T cd05584          82 LSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDF  144 (323)
T ss_pred             CCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeC
Confidence            99999999997542    467888889999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.93  E-value=3.8e-25  Score=192.58  Aligned_cols=136  Identities=25%  Similarity=0.355  Sum_probs=119.7

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEEeecccCc--ccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCCeeeEEEeCCCC
Q 023282          138 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  213 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~~lv~e~~~~  213 (284)
                      ++||+|+||.||+++.. +++.||+|.++.....  .....+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999864 6889999999754322  2233578899999888 699999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          214 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       214 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+|.+++....    .+++..+..++.|++.||.|||+.   +++||||||+|||++.++.++|+||
T Consensus        81 g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Df  140 (329)
T cd05588          81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDY  140 (329)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcC
Confidence            99999886532    489999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.93  E-value=3.3e-25  Score=187.20  Aligned_cols=143  Identities=29%  Similarity=0.434  Sum_probs=125.1

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-C---CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-D---GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      .+|+..+.||+|+||.||+|... +   +..+|+|.++..........+..|+.+++.++||||+++++++...+..+++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            35677899999999999999853 2   3379999886544333445789999999999999999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||+++++|.+++....   ..+++.+...++.|++.||.|||+.   +++||||||+|||++.++.++++||
T Consensus        84 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~df  150 (267)
T cd05066          84 TEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDF  150 (267)
T ss_pred             EEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCC
Confidence            99999999999997643   2479999999999999999999998   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.93  E-value=2.9e-25  Score=192.94  Aligned_cols=139  Identities=29%  Similarity=0.416  Sum_probs=119.1

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHH---hcCCCCCceeeeeEEeeCCeeeEE
Q 023282          134 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKII---SMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l---~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      |...+.||+|+||.||++... +++.||||.++....  ......+..|++++   +.++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            455788999999999999854 688999999974421  12233566666554   677899999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||+++|+|...++..     .+++.....++.|++.||.|||+.   +++||||||+|||++.++.+||+||
T Consensus        81 ~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Df  145 (324)
T cd05589          81 MEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADF  145 (324)
T ss_pred             EcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcc
Confidence            9999999999888642     489999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=3.2e-25  Score=189.24  Aligned_cols=142  Identities=30%  Similarity=0.402  Sum_probs=123.8

Q ss_pred             CCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcc--cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          134 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      |+..++||+|+||.||++.. .++..||+|.+.......  ....+.+|+.+++.++||||+++++++...+..+++|||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence            66778999999999999985 468899999986433221  223577899999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++|+|.+++....  ...+++.....++.|++.||.|||+.   +++||||||+||++++++.++++||
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Df  146 (285)
T cd05605          82 MNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDL  146 (285)
T ss_pred             cCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeC
Confidence            99999999886532  23588999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.93  E-value=4.4e-25  Score=190.45  Aligned_cols=142  Identities=25%  Similarity=0.435  Sum_probs=124.4

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ++|...+.||+|+||.||+|+.. ++..+|+|.++..........+.+|+++++.++||||+++++++...+..+++|||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            45777899999999999999864 67889999987554444444678899999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++ +|.+++....   ..+++.....++.|++.||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus        86 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Df  148 (309)
T cd07872          86 LDK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADF  148 (309)
T ss_pred             CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcc
Confidence            975 8888886542   2478889999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=6.5e-26  Score=198.67  Aligned_cols=140  Identities=25%  Similarity=0.392  Sum_probs=125.2

Q ss_pred             cCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ..|..-..||+|+.|.||.++ ..+++.||||++..... ...+-+.+|+.+|+..+|+|||.+++.+...++.|+||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q-~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ-PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC-CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            356777889999999999997 56788999999965432 2333588999999999999999999999988999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |++|+|.+.+...     .+++.++..|+.++++||+|||.+   +|+|||||++|||++.++++||+||
T Consensus       352 m~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDF  413 (550)
T KOG0578|consen  352 MEGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDF  413 (550)
T ss_pred             cCCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeee
Confidence            9999999999754     388999999999999999999999   9999999999999999999999998

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.93  E-value=4.9e-25  Score=186.36  Aligned_cols=139  Identities=26%  Similarity=0.363  Sum_probs=117.9

Q ss_pred             eecccCceEEEEEEeCCC---cEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCCC
Q 023282          139 ILGRGGFGKVYKGRLADG---KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS  215 (284)
Q Consensus       139 ~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g~  215 (284)
                      .||+|+||.||+|...++   ..+++|.++..........+.+|+.+++.++||||+++++.+......+++|||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999975433   34667766544333344579999999999999999999999999899999999999999


Q ss_pred             hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          216 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       216 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |.++++.........++.....++.|+++||+|||+.   +++||||||+|||++.++.++++||
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Df  143 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDY  143 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEeccc
Confidence            9999986533333466777889999999999999998   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.93  E-value=2.8e-25  Score=202.53  Aligned_cols=143  Identities=17%  Similarity=0.235  Sum_probs=123.7

Q ss_pred             CCCCCeecccCceEEEEEEeC-C-CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCC
Q 023282          134 FSNKNILGRGGFGKVYKGRLA-D-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      |...+.||+|+||.||++... + +..||+|.+.... ......+..|+.+++.++||||+++++++...+..++||||+
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            677889999999999999743 3 5778888764322 222345788999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++|+|.++++.......++++.....++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DF  213 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDF  213 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeC
Confidence            99999999875433344688999999999999999999998   9999999999999999999999998

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.93  E-value=3.9e-25  Score=192.10  Aligned_cols=141  Identities=25%  Similarity=0.349  Sum_probs=121.7

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCC-CceeeeeEEeeCCeeeEEE
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHR-NLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~-niv~l~g~~~~~~~~~lv~  208 (284)
                      +|+..+.||+|+||.||+|+.. +++.||+|+++....  ......+..|.+++..++|+ +|+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4677889999999999999864 578999999875432  22334678899999988765 5888999998889999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus        81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Df  145 (324)
T cd05587          81 EYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADF  145 (324)
T ss_pred             cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeec
Confidence            9999999999997542    478999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.93  E-value=3.9e-25  Score=186.09  Aligned_cols=144  Identities=29%  Similarity=0.416  Sum_probs=128.1

Q ss_pred             HhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      ..++|...+.||+|++|.||+|...++..||+|.++...  ....++.+|+.++++++||||+++++++...+..+++||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            345678889999999999999998777889999986432  234568899999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++++|.+++....  ...++|.....++.|++.||.|||+.   +++||||||+||++++++.++++||
T Consensus        82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~df  147 (261)
T cd05068          82 LMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADF  147 (261)
T ss_pred             cccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCc
Confidence            999999999997643  23589999999999999999999998   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.93  E-value=4.1e-25  Score=192.56  Aligned_cols=141  Identities=26%  Similarity=0.314  Sum_probs=122.4

Q ss_pred             CCCCCCeecccCceEEEEEEe----CCCcEEEEEEeecccCc---ccHHHHHHHHHHHhcCC-CCCceeeeeEEeeCCee
Q 023282          133 GFSNKNILGRGGFGKVYKGRL----ADGKLVAVKRLKEERTS---GGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEK  204 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~~~~~  204 (284)
                      +|+..+.||+|+||.||+++.    .++..+|+|.++.....   .....+..|+.++..++ |+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            367788999999999999875    35789999998643221   22335788999999994 99999999999999999


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++||||+++|+|.+++....    .+++.....++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Df  149 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDF  149 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeC
Confidence            99999999999999997643    478899999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.93  E-value=6.1e-25  Score=185.78  Aligned_cols=140  Identities=31%  Similarity=0.407  Sum_probs=120.2

Q ss_pred             CeecccCceEEEEEEeCC---CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCC
Q 023282          138 NILGRGGFGKVYKGRLAD---GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  214 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g  214 (284)
                      +.||+|+||.||+|...+   +..+|+|.++..........+.+|+.+++.++||||+++++++......++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999998543   45799998865543334457889999999999999999999999988999999999999


Q ss_pred             ChHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          215 SVASRLRERQS-SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       215 ~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +|.++++.... .....++.....++.|++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~df  144 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDY  144 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCc
Confidence            99999976432 223467788889999999999999998   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.93  E-value=4e-25  Score=192.72  Aligned_cols=143  Identities=21%  Similarity=0.287  Sum_probs=124.6

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|+..+.||+|+||.||+++.. +++.+|+|.+.....  ......+..|+.++..++|+||+++++++...+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            35778899999999999999865 577899999864221  122335788999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.++++....   .+++.....++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus        81 ey~~~g~L~~~l~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~Df  146 (332)
T cd05623          81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF  146 (332)
T ss_pred             eccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeec
Confidence            99999999999976322   478889999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.93  E-value=5.5e-25  Score=184.79  Aligned_cols=140  Identities=30%  Similarity=0.461  Sum_probs=124.7

Q ss_pred             CCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCC
Q 023282          133 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  212 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~  212 (284)
                      +|+..+.||+|+||.||++...++..+|+|.++...  ....++.+|+.++++++||||+++++++......+++|||++
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            466678899999999999988777779999886432  224568999999999999999999999998888999999999


Q ss_pred             CCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          213 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       213 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +|+|.+++.....   .++|..+..++.|++.||+|||+.   +++|+||||+||+++.++.++++||
T Consensus        83 ~~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~  144 (256)
T cd05113          83 NGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDF  144 (256)
T ss_pred             CCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCC
Confidence            9999999976422   479999999999999999999998   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.93  E-value=5.8e-25  Score=189.71  Aligned_cols=143  Identities=28%  Similarity=0.348  Sum_probs=125.3

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ++|+..+.||+|+||.||++... ++..+|+|.++.........++.+|++++..++||||+++++++...+..+++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            35788899999999999999854 67889999886543333334688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++++|.++++..    ..+++.....++.|+++||.|||+.+  +++||||||+|||++.++.++++||
T Consensus        81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~df  144 (308)
T cd06615          81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDF  144 (308)
T ss_pred             cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccC
Confidence            9999999999764    24788899999999999999999732  8999999999999999999999998

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.93  E-value=5.6e-25  Score=191.53  Aligned_cols=136  Identities=27%  Similarity=0.374  Sum_probs=118.6

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEEeecccCc--ccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCCeeeEEEeCCCC
Q 023282          138 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  213 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~~lv~e~~~~  213 (284)
                      ++||+|+||.||+++.. +++.+|+|.++.....  .....+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999864 6789999999754322  2233577888888766 799999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          214 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       214 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+|..++....    .+++.....++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus        81 ~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~Df  140 (329)
T cd05618          81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDY  140 (329)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeC
Confidence            99998886532    488999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.93  E-value=4.2e-25  Score=191.67  Aligned_cols=136  Identities=29%  Similarity=0.418  Sum_probs=118.4

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCCeeeEEEeCCCC
Q 023282          138 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  213 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~~lv~e~~~~  213 (284)
                      ++||+|+||.||+|+.. +++.||+|.++....  ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999864 578999999875432  22234577888888765 799999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          214 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       214 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+|...+....    .+++.....++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus        81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Df  140 (321)
T cd05591          81 GDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADF  140 (321)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeec
Confidence            99999987543    478999999999999999999999   9999999999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.93  E-value=4.3e-25  Score=190.09  Aligned_cols=146  Identities=29%  Similarity=0.491  Sum_probs=124.6

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCc--EEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCCeeeEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGK--LVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~~lv  207 (284)
                      ++|+..+.||+|+||.||+|... ++.  .+|+|.++..........+.+|++++.++ +|+||+++++++...+..+++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            46777899999999999999864 444  46777775433333445788999999999 899999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCc
Q 023282          208 YPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  275 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~  275 (284)
                      +||+++|+|.++++....            ....+++.+++.++.|++.||+|||+.   +++||||||+|||++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence            999999999999975421            123578999999999999999999998   99999999999999999999


Q ss_pred             chhhh
Q 023282          276 SSKTI  280 (284)
Q Consensus       276 ~~~df  280 (284)
                      +++||
T Consensus       164 kl~df  168 (303)
T cd05088         164 KIADF  168 (303)
T ss_pred             EeCcc
Confidence            99998

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.93  E-value=8.4e-25  Score=184.52  Aligned_cols=146  Identities=18%  Similarity=0.289  Sum_probs=126.6

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|+..+.||+|+||.||+|+. .++..||+|.++....  ......+.+|+++++.++||||+++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            4688889999999999999985 4788999998754322  222346889999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++.........+++.....++.|++.||+|||+.   +++|+||||+||+++.++.++++||
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~  150 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDL  150 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECcc
Confidence            99999999999865333334578889999999999999999998   9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.92  E-value=4.8e-25  Score=188.98  Aligned_cols=146  Identities=28%  Similarity=0.437  Sum_probs=124.7

Q ss_pred             cCCCCCCeecccCceEEEEEEeCC---------------CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLAD---------------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG  196 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g  196 (284)
                      ++|...+.||+|+||.||+++..+               ...||+|.++..........+.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            467788999999999999987532               23589999875443333456899999999999999999999


Q ss_pred             EEeeCCeeeEEEeCCCCCChHHHHhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCee
Q 023282          197 FCTTVTEKLLVYPYMTNGSVASRLRERQS--------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL  268 (284)
Q Consensus       197 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiL  268 (284)
                      ++...+..+++|||+++++|.+++.....        ....++|..+..++.|++.||+|||+.   +++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence            99999999999999999999999965321        112468999999999999999999998   9999999999999


Q ss_pred             eCCCCCcchhhh
Q 023282          269 LDEDADQSSKTI  280 (284)
Q Consensus       269 ld~~~~~~~~df  280 (284)
                      ++.++.++++||
T Consensus       162 l~~~~~~kl~df  173 (295)
T cd05097         162 VGNHYTIKIADF  173 (295)
T ss_pred             EcCCCcEEeccc
Confidence            999999999998

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.92  E-value=8.9e-25  Score=182.59  Aligned_cols=137  Identities=34%  Similarity=0.537  Sum_probs=122.5

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCCChH
Q 023282          138 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVA  217 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g~L~  217 (284)
                      ++||+|+||.||+|...++..+|+|.++..........+.+|+++++.++||||+++++++...+..+++|||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999988888999999865443333446889999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          218 SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       218 ~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++....   ..++|..+..++.|++.||.|+|+.   +++||||||+||+++.++.++++||
T Consensus        81 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~  137 (250)
T cd05085          81 SFLRKKK---DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDF  137 (250)
T ss_pred             HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCC
Confidence            9987543   2478999999999999999999998   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=1.2e-25  Score=199.93  Aligned_cols=141  Identities=26%  Similarity=0.396  Sum_probs=126.7

Q ss_pred             CCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccCc--ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          133 GFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      -|+.++-||+|+.|.|..|+ ..+|+.+|||++......  .....+.+|+-+|+.+.|||++++++.+....++|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            46677889999999999998 468999999999654222  223358899999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++|.|.+++..++    ++...+..++..||..|+.|+|..   +|+||||||+|+|||.+++.||+||
T Consensus        93 yv~gGELFdylv~kG----~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADF  156 (786)
T KOG0588|consen   93 YVPGGELFDYLVRKG----PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADF  156 (786)
T ss_pred             ecCCchhHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeecc
Confidence            999999999998764    488899999999999999999999   9999999999999999999999999

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.92  E-value=3.9e-25  Score=189.17  Aligned_cols=150  Identities=30%  Similarity=0.472  Sum_probs=128.2

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEee
Q 023282          128 QVATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  200 (284)
Q Consensus       128 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~  200 (284)
                      ....++|+..+.||+|+||.||++...      ....+|+|.+..........++.+|++++.++ +|+||+++++++..
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            344456778899999999999999753      23579999987544333345688999999999 79999999999999


Q ss_pred             CCeeeEEEeCCCCCChHHHHhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCee
Q 023282          201 VTEKLLVYPYMTNGSVASRLRERQ------------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL  268 (284)
Q Consensus       201 ~~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiL  268 (284)
                      .+..+++|||+++|+|.++++...            .....++|..++.++.|++.||+|||+.   +|+||||||+||+
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil  164 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVL  164 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEE
Confidence            999999999999999999997532            2234689999999999999999999998   9999999999999


Q ss_pred             eCCCCCcchhhh
Q 023282          269 LDEDADQSSKTI  280 (284)
Q Consensus       269 ld~~~~~~~~df  280 (284)
                      ++.++.++++||
T Consensus       165 ~~~~~~~kL~Df  176 (293)
T cd05053         165 VTEDHVMKIADF  176 (293)
T ss_pred             EcCCCeEEeCcc
Confidence            999999999998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.92  E-value=6.6e-25  Score=190.45  Aligned_cols=136  Identities=27%  Similarity=0.386  Sum_probs=116.0

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHH-HHhcCCCCCceeeeeEEeeCCeeeEEEeCCCC
Q 023282          138 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVK-IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  213 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~  213 (284)
                      ++||+|+||.||+++.. +++.+|+|.+.....  ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999864 688999999864322  122234555554 57889999999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          214 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       214 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+|...+....    .+++.....++.|+++||.|||+.   +|+||||||+||+++.++.+||+||
T Consensus        81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Df  140 (321)
T cd05603          81 GELFFHLQRER----CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDF  140 (321)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccC
Confidence            99998886532    477888889999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.92  E-value=6e-25  Score=190.64  Aligned_cols=136  Identities=31%  Similarity=0.457  Sum_probs=118.4

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCCeeeEEEeCCCC
Q 023282          138 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  213 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~~lv~e~~~~  213 (284)
                      ++||+|+||.||+++.. +++.||+|.++....  ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999864 688999999865422  22234577888888766 699999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          214 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       214 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+|.+++....    .+++.....++.|++.||+|||+.   +++||||||+|||++.++.++|+||
T Consensus        81 g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~Df  140 (320)
T cd05590          81 GDLMFHIQKSR----RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADF  140 (320)
T ss_pred             chHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeC
Confidence            99999987643    478899999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.92  E-value=2.8e-25  Score=194.04  Aligned_cols=149  Identities=32%  Similarity=0.451  Sum_probs=124.2

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEeeC
Q 023282          129 VATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  201 (284)
Q Consensus       129 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~  201 (284)
                      .+.++|...+.||+|+||.||+|...      +++.||+|+++..........+..|+.++.++ +|+||++++++|...
T Consensus         4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            34457888899999999999999632      34689999987543333345678899999999 799999999988754


Q ss_pred             -CeeeEEEeCCCCCChHHHHhhcCCC------------------------------------------------------
Q 023282          202 -TEKLLVYPYMTNGSVASRLRERQSS------------------------------------------------------  226 (284)
Q Consensus       202 -~~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------------------------  226 (284)
                       ...++++||+++|+|.+++......                                                      
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence             4678999999999999998653210                                                      


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          227 ---LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       227 ---~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                         ...++|..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~Df  217 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDF  217 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEecc
Confidence               12589999999999999999999998   9999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.92  E-value=5.5e-25  Score=192.03  Aligned_cols=140  Identities=19%  Similarity=0.372  Sum_probs=119.7

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC-----eee
Q 023282          133 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-----EKL  205 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~-----~~~  205 (284)
                      +|+..+.||+|+||.||+|.. .++..||+|.++..... .....+.+|+++++.++||||+++++++....     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            366778999999999999985 46889999998643222 23346889999999999999999999886432     479


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +||||++ ++|.+++....    .+++.....++.|+++||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus        81 lv~e~~~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Df  147 (338)
T cd07859          81 VVFELME-SDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDF  147 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccC
Confidence            9999995 68999886532    488999999999999999999999   9999999999999999999999998

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.92  E-value=4.9e-25  Score=185.41  Aligned_cols=143  Identities=27%  Similarity=0.416  Sum_probs=126.8

Q ss_pred             hcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      .++|+..+.||+|+||.||+|...++..||+|.+....  .....+.+|+.+++.++|+||+++++++...+..+++|||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            35677889999999999999998788889999875432  2345789999999999999999999999998999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++|+|.++++...  ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        83 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df  147 (261)
T cd05072          83 MAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADF  147 (261)
T ss_pred             CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCC
Confidence            99999999997642  23578899999999999999999998   9999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.92  E-value=8e-25  Score=190.09  Aligned_cols=136  Identities=29%  Similarity=0.411  Sum_probs=116.6

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEEeecccCc--ccHHHHHHHHH-HHhcCCCCCceeeeeEEeeCCeeeEEEeCCCC
Q 023282          138 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVK-IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  213 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~-~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~  213 (284)
                      +.||+|+||+||+++.. +++.||+|.+......  .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999864 7889999998643221  22234555554 56889999999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          214 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       214 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+|.+++....    .+++.....++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus        81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Df  140 (323)
T cd05575          81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDF  140 (323)
T ss_pred             CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEecc
Confidence            99999997532    478889999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.92  E-value=8.1e-25  Score=189.51  Aligned_cols=136  Identities=26%  Similarity=0.409  Sum_probs=116.2

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhc-CCCCCceeeeeEEeeCCeeeEEEeCCCC
Q 023282          138 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISM-AVHRNLLRLYGFCTTVTEKLLVYPYMTN  213 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-~~h~niv~l~g~~~~~~~~~lv~e~~~~  213 (284)
                      ++||+|+||.||+|+.. +++.||+|.++....  ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999864 678999999975432  1223345566666654 5899999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          214 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       214 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus        81 g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Df  140 (316)
T cd05592          81 GDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADF  140 (316)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccC
Confidence            99999997542    478889999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.92  E-value=9.5e-25  Score=189.07  Aligned_cols=136  Identities=29%  Similarity=0.448  Sum_probs=117.9

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhc-CCCCCceeeeeEEeeCCeeeEEEeCCCC
Q 023282          138 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISM-AVHRNLLRLYGFCTTVTEKLLVYPYMTN  213 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-~~h~niv~l~g~~~~~~~~~lv~e~~~~  213 (284)
                      +.||+|+||.||+|+.. +++.||+|.++....  ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999865 578999999975432  2223356677777765 5899999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          214 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       214 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+|.+++....    .+++.+...++.|++.||.|||+.   +++||||||+|||++.++.++|+||
T Consensus        81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df  140 (316)
T cd05619          81 GDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADF  140 (316)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccC
Confidence            99999997532    478999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.92  E-value=1e-24  Score=183.01  Aligned_cols=140  Identities=31%  Similarity=0.450  Sum_probs=124.5

Q ss_pred             CCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCC
Q 023282          133 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  212 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~  212 (284)
                      +|+..+.||+|+||.||++...++..+|+|.+....  .....+.+|+++++.++||||+++++++...+..+++|||++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA--MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            466778899999999999998777789999885432  223468899999999999999999999999899999999999


Q ss_pred             CCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          213 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       213 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++|.+++.....   .++|.....++.|++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        83 ~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~df  144 (256)
T cd05059          83 NGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDF  144 (256)
T ss_pred             CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCc
Confidence            9999999976432   579999999999999999999998   9999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.92  E-value=8e-25  Score=187.69  Aligned_cols=146  Identities=27%  Similarity=0.425  Sum_probs=125.3

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-----------------CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-----------------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL  194 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l  194 (284)
                      ++|+..+.||+|+||.||++...                 ++..+|+|.++.........++.+|+++++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46888899999999999998532                 2346899998654333334578999999999999999999


Q ss_pred             eeEEeeCCeeeEEEeCCCCCChHHHHhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCe
Q 023282          195 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSS-------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANI  267 (284)
Q Consensus       195 ~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~Ni  267 (284)
                      ++++...+..+++|||+++|+|.+++......       ...+++.....++.|++.||+|||+.   +++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence            99999999999999999999999999764321       23478889999999999999999998   999999999999


Q ss_pred             eeCCCCCcchhhh
Q 023282          268 LLDEDADQSSKTI  280 (284)
Q Consensus       268 Lld~~~~~~~~df  280 (284)
                      |++.++.++++||
T Consensus       162 li~~~~~~~l~df  174 (296)
T cd05095         162 LVGKNYTIKIADF  174 (296)
T ss_pred             EEcCCCCEEeccC
Confidence            9999999999997

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.92  E-value=4.8e-25  Score=190.09  Aligned_cols=147  Identities=30%  Similarity=0.442  Sum_probs=126.0

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC--------CCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEeeC
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA--------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  201 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~  201 (284)
                      .++|...+.||+|+||.||++...        +...+|+|.++.........++..|++++..+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            356888899999999999999742        23469999987543333345688899999999 799999999999999


Q ss_pred             CeeeEEEeCCCCCChHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeee
Q 023282          202 TEKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  269 (284)
Q Consensus       202 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLl  269 (284)
                      +..+++|||+++|+|.+++.....            ....++|.+++.++.|++.||+|||+.   +++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence            999999999999999999976432            123588999999999999999999998   99999999999999


Q ss_pred             CCCCCcchhhh
Q 023282          270 DEDADQSSKTI  280 (284)
Q Consensus       270 d~~~~~~~~df  280 (284)
                      +.++.++++||
T Consensus       174 ~~~~~~kL~df  184 (307)
T cd05098         174 TEDNVMKIADF  184 (307)
T ss_pred             cCCCcEEECCC
Confidence            99999999998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.92  E-value=8.9e-25  Score=189.80  Aligned_cols=141  Identities=25%  Similarity=0.349  Sum_probs=121.1

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc--ccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCCeeeEEE
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      +|...+.||+|+||.||+|+.. ++..+|+|.++.....  .....+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4677889999999999999865 5789999998754322  2223466778887766 5899999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+.+....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus        81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~Df  145 (323)
T cd05616          81 EYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADF  145 (323)
T ss_pred             cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccC
Confidence            9999999999987542    478999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.92  E-value=1.7e-24  Score=182.54  Aligned_cols=146  Identities=20%  Similarity=0.313  Sum_probs=128.5

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|+..+.||+|+||.||+|... +++.+|+|.++....  ......+.+|++++++++|+|++++++++...+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            56888899999999999999865 789999998864222  222457889999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++.........+++.+...++.+++.||.|||+.   +++||||+|+||+++.++.++++||
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~  150 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDL  150 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEecc
Confidence            99999999999975433344688999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>PHA02988 hypothetical protein; Provisional

Probab=99.92  E-value=1.9e-24  Score=184.27  Aligned_cols=137  Identities=19%  Similarity=0.307  Sum_probs=118.4

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEeecccCccc--HHHHHHHHHHHhcCCCCCceeeeeEEee----CCeeeEEEeC
Q 023282          137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTT----VTEKLLVYPY  210 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~~h~niv~l~g~~~~----~~~~~lv~e~  210 (284)
                      ...||+|++|.||+|.. +|+.||||.++.......  .+.+.+|+.++++++||||++++|++..    ....+++|||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999998 688999999865432221  2468899999999999999999999876    3467899999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++|+|.+++....    .++|.....++.+++.||.|||+..  +++||||||+|||++.++.+|++||
T Consensus       104 ~~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~df  167 (283)
T PHA02988        104 CTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICH  167 (283)
T ss_pred             CCCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEccc
Confidence            99999999997642    4789999999999999999999732  6789999999999999999999998

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.92  E-value=6.7e-25  Score=186.37  Aligned_cols=146  Identities=32%  Similarity=0.534  Sum_probs=126.9

Q ss_pred             cCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  205 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~  205 (284)
                      ++|...+.||+|+||.||+|...      ++..+|+|.++.....+....+.+|+++++.++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            34667789999999999999753      246899999865443334567999999999999999999999999999999


Q ss_pred             EEEeCCCCCChHHHHhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCc
Q 023282          206 LVYPYMTNGSVASRLRERQS----------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  275 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~  275 (284)
                      ++|||+++++|.++++....          ....+++.....++.|++.|+.|||+.   +++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence            99999999999999976421          224578999999999999999999998   99999999999999999999


Q ss_pred             chhhh
Q 023282          276 SSKTI  280 (284)
Q Consensus       276 ~~~df  280 (284)
                      +++||
T Consensus       162 kl~d~  166 (280)
T cd05049         162 KIGDF  166 (280)
T ss_pred             EECCc
Confidence            99998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.92  E-value=6.1e-25  Score=189.10  Aligned_cols=148  Identities=28%  Similarity=0.450  Sum_probs=126.5

Q ss_pred             HhcCCCCCCeecccCceEEEEEEeC--------CCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEee
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRLA--------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  200 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~  200 (284)
                      ..++|...+.||+|+||.||+++..        ++..+|+|.++.........++.+|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3456778899999999999999631        24479999886543334445789999999999 79999999999999


Q ss_pred             CCeeeEEEeCCCCCChHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCee
Q 023282          201 VTEKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL  268 (284)
Q Consensus       201 ~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiL  268 (284)
                      ....+++|||+++|+|.+++.....            ....++|..+..++.|+++||.|||+.   +++||||||+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence            9999999999999999999976421            123578899999999999999999998   9999999999999


Q ss_pred             eCCCCCcchhhh
Q 023282          269 LDEDADQSSKTI  280 (284)
Q Consensus       269 ld~~~~~~~~df  280 (284)
                      ++.++.++++||
T Consensus       170 i~~~~~~kl~D~  181 (304)
T cd05101         170 VTENNVMKIADF  181 (304)
T ss_pred             EcCCCcEEECCC
Confidence            999999999998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.92  E-value=6.4e-25  Score=187.32  Aligned_cols=141  Identities=18%  Similarity=0.299  Sum_probs=121.8

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +|+..+.||+|+||.||+++.. +++.+|+|+++..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY   81 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence            5778899999999999999975 6789999998654322 2234688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++++.+..+....    ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+||
T Consensus        82 ~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Df  144 (287)
T cd07848          82 VEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDF  144 (287)
T ss_pred             CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeec
Confidence            9987666544321    2478899999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.92  E-value=1e-24  Score=189.53  Aligned_cols=136  Identities=27%  Similarity=0.387  Sum_probs=116.7

Q ss_pred             CeecccCceEEEEEEe-CCCcEEEEEEeecccCc--ccHHHHHHHHH-HHhcCCCCCceeeeeEEeeCCeeeEEEeCCCC
Q 023282          138 NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVK-IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  213 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~-~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~  213 (284)
                      ++||+|+||+||+++. .+|+.+|+|++......  .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999985 47889999998643221  22234555554 56789999999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          214 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       214 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+|..++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus        81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~Df  140 (325)
T cd05604          81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDF  140 (325)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeec
Confidence            99999886532    478999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.92  E-value=8.5e-25  Score=189.94  Aligned_cols=140  Identities=25%  Similarity=0.353  Sum_probs=120.8

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCC-CCCceeeeeEEeeCCeeeEEEe
Q 023282          134 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      |...+.||+|+||.||+++.. +++.||+|+++....  ......+..|..++..+. |++|+++.+++...+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            566789999999999999854 688999999875432  222345778888888776 5778889999988899999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++|+|.+++....    .+++.++..++.|++.||.|||+.   +++||||||+|||++.++.++|+||
T Consensus        82 y~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Df  145 (323)
T cd05615          82 YVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADF  145 (323)
T ss_pred             CCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEecc
Confidence            999999999987542    488999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.92  E-value=1.2e-24  Score=185.99  Aligned_cols=144  Identities=32%  Similarity=0.457  Sum_probs=123.4

Q ss_pred             CCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEE
Q 023282          134 FSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      |...+.||+|+||.||+|...      ....+++|.+...........+.+|+.+++.++||||+++++.+...+..+++
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI   81 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence            566789999999999999752      23468999886544333345788999999999999999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCe
Q 023282          208 YPYMTNGSVASRLRERQS--------------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANI  267 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~Ni  267 (284)
                      +||+++|+|.+++.....                    ....++|...+.++.|++.||.|||+.   +++||||||+||
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~ni  158 (290)
T cd05045          82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNV  158 (290)
T ss_pred             EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheE
Confidence            999999999999875321                    123578999999999999999999998   999999999999


Q ss_pred             eeCCCCCcchhhh
Q 023282          268 LLDEDADQSSKTI  280 (284)
Q Consensus       268 Lld~~~~~~~~df  280 (284)
                      |+++++.++++||
T Consensus       159 ll~~~~~~kl~df  171 (290)
T cd05045         159 LVAEGRKMKISDF  171 (290)
T ss_pred             EEcCCCcEEeccc
Confidence            9999999999997

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.92  E-value=1.3e-24  Score=184.81  Aligned_cols=143  Identities=28%  Similarity=0.465  Sum_probs=123.4

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCc----EEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeee
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  205 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~  205 (284)
                      .++|+..+.||+|+||+||+|++ .++.    .||+|.++.........++.+|+.+++.++|+||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            34677789999999999999984 3444    4899998655444445578899999999999999999999875 4578


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++||+++|+|.++++...   ..+++...+.++.|++.||+|||+.   +++||||||+|||++.++.++|+||
T Consensus        85 l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~df  153 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDF  153 (279)
T ss_pred             EEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCC
Confidence            9999999999999997642   2488999999999999999999998   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.92  E-value=1.5e-24  Score=184.84  Aligned_cols=142  Identities=27%  Similarity=0.455  Sum_probs=122.0

Q ss_pred             cCCCCCCeecccCceEEEEEEe-----CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeC--Cee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEK  204 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~--~~~  204 (284)
                      .+|...+.||+|+||.||++..     .++..||+|.++... ......+.+|+++++.++||||+++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            3567788999999999999974     257789999986432 23345789999999999999999999987543  467


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++++||+++|+|.+++....   ..++|..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~df  152 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDF  152 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCC
Confidence            89999999999999997542   2479999999999999999999998   9999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.7e-25  Score=198.65  Aligned_cols=145  Identities=28%  Similarity=0.429  Sum_probs=126.3

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc--ccHHHHHHHHHHHhcCC-CCCceeeeeEEeeCCe
Q 023282          128 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTE  203 (284)
Q Consensus       128 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~~~~  203 (284)
                      ....++|...++||+|+||+|+.+..+ +++.+|||+++++..-  ++.+..+.|-+++..+. ||.++.++.++.+.++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            445678899999999999999999865 6889999999876533  33456788888887665 9999999999999999


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .++||||+.+|++..+.+.     ..++..++..+|..|+.||.|||++   +||+||||.+|||||.+|.+||+||
T Consensus       444 l~fvmey~~Ggdm~~~~~~-----~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADF  512 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIHT-----DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADF  512 (694)
T ss_pred             EEEEEEecCCCcEEEEEec-----ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccc
Confidence            9999999999995544442     2489999999999999999999999   9999999999999999999999998

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.92  E-value=6.7e-25  Score=186.08  Aligned_cols=147  Identities=28%  Similarity=0.440  Sum_probs=126.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCee
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  204 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~  204 (284)
                      .++|...+.||+|+||.||+|...      .+..+|+|.+...........+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            456777899999999999999753      23689999986443333345688999999999999999999999999999


Q ss_pred             eEEEeCCCCCChHHHHhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchh
Q 023282          205 LLVYPYMTNGSVASRLRERQSS------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  278 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~  278 (284)
                      +++|||+++|+|.+++......      ...++|..+..++.|++.||.|||+.   +++||||||+||+++.++.++++
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence            9999999999999999754321      22478999999999999999999998   99999999999999999999999


Q ss_pred             hh
Q 023282          279 TI  280 (284)
Q Consensus       279 df  280 (284)
                      ||
T Consensus       162 df  163 (277)
T cd05032         162 DF  163 (277)
T ss_pred             Cc
Confidence            98

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.92  E-value=1.5e-24  Score=188.59  Aligned_cols=139  Identities=23%  Similarity=0.316  Sum_probs=121.1

Q ss_pred             CCeeccc--CceEEEEEEe-CCCcEEEEEEeecccCcc-cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCC
Q 023282          137 KNILGRG--GFGKVYKGRL-ADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  212 (284)
Q Consensus       137 ~~~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~  212 (284)
                      .++||+|  +|++||++.. .+++.||+|.++...... ....+.+|+++++.++||||+++++++...+..++|+||++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            5789999  7899999985 578999999986543322 23457789999999999999999999999999999999999


Q ss_pred             CCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          213 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       213 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +|+|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++++||
T Consensus        83 ~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~  145 (327)
T cd08227          83 YGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGL  145 (327)
T ss_pred             CCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEccc
Confidence            9999999975322  2488999999999999999999998   9999999999999999999999886

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.92  E-value=1.2e-24  Score=188.33  Aligned_cols=136  Identities=26%  Similarity=0.413  Sum_probs=117.7

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhc-CCCCCceeeeeEEeeCCeeeEEEeCCCC
Q 023282          138 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISM-AVHRNLLRLYGFCTTVTEKLLVYPYMTN  213 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~-~~h~niv~l~g~~~~~~~~~lv~e~~~~  213 (284)
                      ++||+|+||.||+++.. ++..||+|.++....  ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999865 688999999975432  2223356677777765 5899999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          214 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       214 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+|.+++....    .+++.+...++.|++.||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus        81 g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Df  140 (316)
T cd05620          81 GDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADF  140 (316)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCcc
Confidence            99999987642    478889999999999999999999   9999999999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.92  E-value=1.5e-24  Score=184.87  Aligned_cols=142  Identities=27%  Similarity=0.445  Sum_probs=123.1

Q ss_pred             CCCCCCeecccCceEEEEEEe-----CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeC--Ceee
Q 023282          133 GFSNKNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKL  205 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~--~~~~  205 (284)
                      .|+..+.||+|+||.||++..     .++..||+|.++..........+.+|+++++.++|||++++.+++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            356778999999999999974     246789999986544333445789999999999999999999998775  5688


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++|||+++++|.+++....   ..++|..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        85 lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~df  153 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDF  153 (284)
T ss_pred             EEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCC
Confidence            9999999999999996532   2479999999999999999999998   9999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.92  E-value=1.2e-24  Score=186.78  Aligned_cols=146  Identities=26%  Similarity=0.454  Sum_probs=124.2

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCc--EEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCCeeeEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGK--LVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~~lv  207 (284)
                      ++|+..++||+|+||.||+|... ++.  .+++|.++..........+.+|++++.++ +||||+++++++...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            46778899999999999999864 333  47888886433333345688999999998 799999999999998899999


Q ss_pred             EeCCCCCChHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCc
Q 023282          208 YPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  275 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~  275 (284)
                      +||+++|+|.++++....            ....+++.....++.|++.||+|||+.   +++||||||+|||++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence            999999999999975321            113578999999999999999999998   99999999999999999999


Q ss_pred             chhhh
Q 023282          276 SSKTI  280 (284)
Q Consensus       276 ~~~df  280 (284)
                      +++||
T Consensus       159 kl~df  163 (297)
T cd05089         159 KIADF  163 (297)
T ss_pred             EECCc
Confidence            99998

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.92  E-value=1.3e-24  Score=184.79  Aligned_cols=142  Identities=27%  Similarity=0.426  Sum_probs=119.2

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCc----EEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~l  206 (284)
                      ++|...+.||+|+||.||+|.+. +++    .+++|.+..........++..|+..++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            35677889999999999999853 444    4777877533222233467888889999999999999998754 55788


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++||+++|+|.+++....   ..++|.....++.|++.||+|||+.   +++||||||+|||++.++.++++||
T Consensus        86 i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Df  153 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADF  153 (279)
T ss_pred             EEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCC
Confidence            999999999999997643   2589999999999999999999998   8999999999999999999999998

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.92  E-value=1.3e-24  Score=189.11  Aligned_cols=136  Identities=28%  Similarity=0.375  Sum_probs=119.2

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEEeecccCc--ccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCCeeeEEEeCCCC
Q 023282          138 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  213 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~~lv~e~~~~  213 (284)
                      ++||+|+||.||+++.. +++.+|+|+++.....  .....+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999864 6789999999754322  2233578899988877 699999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          214 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       214 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+|..++....    .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.++|+||
T Consensus        81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Df  140 (327)
T cd05617          81 GDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDY  140 (327)
T ss_pred             CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEecc
Confidence            99999886532    489999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.92  E-value=7.8e-26  Score=198.08  Aligned_cols=131  Identities=32%  Similarity=0.510  Sum_probs=117.6

Q ss_pred             CCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCC
Q 023282          134 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  213 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~  213 (284)
                      ...++-||.|+-|.||+|++. ++.||||+++..        -..+|..|++++|+||+.+.|+|....-.++|||||+.
T Consensus       126 IsELeWlGSGaQGAVF~Grl~-netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~  196 (904)
T KOG4721|consen  126 ISELEWLGSGAQGAVFLGRLH-NETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ  196 (904)
T ss_pred             hhhhhhhccCcccceeeeecc-CceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence            344678999999999999984 678999988532        23578889999999999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          214 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       214 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |-|+..|+...    +++-.....+..+||.||.|||.+   .|||||||+-||||..+..+||+||
T Consensus       197 GqL~~VLka~~----~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDF  256 (904)
T KOG4721|consen  197 GQLYEVLKAGR----PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDF  256 (904)
T ss_pred             ccHHHHHhccC----ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccc
Confidence            99999998753    467778899999999999999999   9999999999999999999999999

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.92  E-value=5.4e-25  Score=185.06  Aligned_cols=144  Identities=30%  Similarity=0.445  Sum_probs=127.9

Q ss_pred             hcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ..+|+..+.||+|+||.||+|...++..+|+|.+.... ......+..|+.+++.++|+||+++++++......+++|||
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            34577789999999999999998778899999986443 22344688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++|+|.++++...  ...+++.++..++.|++.||.|||+.   +++||||||+||+++.++.++++||
T Consensus        84 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~  148 (261)
T cd05148          84 MEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADF  148 (261)
T ss_pred             cccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccc
Confidence            99999999998643  23589999999999999999999998   9999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.92  E-value=1.2e-24  Score=183.95  Aligned_cols=142  Identities=30%  Similarity=0.467  Sum_probs=124.2

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CC---cEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DG---KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      +|...+.||+|+||.||+|... ++   ..||+|.++.........+|..|+.+++.++||||+++.+++......+++|
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            3566789999999999999864 33   3699999865433334457999999999999999999999999989999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++....   ..+++.++..++.|++.||.|||+.   +++||||||+||+++.++.++++||
T Consensus        85 e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~df  150 (269)
T cd05065          85 EFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDF  150 (269)
T ss_pred             ecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCC
Confidence            9999999999997643   2478999999999999999999998   9999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.92  E-value=1.5e-24  Score=183.89  Aligned_cols=146  Identities=25%  Similarity=0.484  Sum_probs=125.0

Q ss_pred             cCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  205 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~  205 (284)
                      ++|...+.||+|+||.||+|+..      +...+++|.+...........+.+|++++++++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            46777889999999999999853      245799998754332223457899999999999999999999999888999


Q ss_pred             EEEeCCCCCChHHHHhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSS-----LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++|||+++|+|.+++......     ...++|..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999764321     12589999999999999999999998   9999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.92  E-value=1.4e-24  Score=205.71  Aligned_cols=146  Identities=22%  Similarity=0.352  Sum_probs=125.9

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcc--cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|...++||+|+||.||+|+.. +++.||+|+++......  ...++.+|+++++.++||||+++++++...+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            46778899999999999999864 68899999986543222  2346899999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQS-------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++.....       .....++...+.++.|+++||+|||+.   +|+||||||+|||++.++.++++||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDF  157 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDW  157 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEec
Confidence            99999999999864211       122457788899999999999999998   9999999999999999999999998

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.92  E-value=1.6e-24  Score=184.43  Aligned_cols=146  Identities=31%  Similarity=0.506  Sum_probs=125.3

Q ss_pred             cCCCCCCeecccCceEEEEEEeCC-C-----cEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLAD-G-----KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  205 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~  205 (284)
                      ++|+..+.||+|+||.||+|.... +     ..+|+|.++..........+.+|+.++..++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            357778899999999999998532 2     5799999865443333456899999999999999999999999888999


Q ss_pred             EEEeCCCCCChHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC
Q 023282          206 LVYPYMTNGSVASRLRERQSS------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  273 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~  273 (284)
                      ++|||+++|+|.+++......            ...+++.....++.|+++||.|||+.   +++||||||+||+++.++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence            999999999999999753211            13578899999999999999999998   999999999999999999


Q ss_pred             Ccchhhh
Q 023282          274 DQSSKTI  280 (284)
Q Consensus       274 ~~~~~df  280 (284)
                      .++|+||
T Consensus       162 ~~~L~df  168 (283)
T cd05048         162 TVKISDF  168 (283)
T ss_pred             cEEECCC
Confidence            9999997

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.92  E-value=1.2e-24  Score=184.93  Aligned_cols=148  Identities=26%  Similarity=0.418  Sum_probs=127.0

Q ss_pred             HhcCCCCCCeecccCceEEEEEEeCC-----CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEee-CCe
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRLAD-----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTE  203 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~-~~~  203 (284)
                      ..++|...++||+|+||.||+|...+     +..|++|.++..........+.+|+.++++++|+||+++++++.. ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            34567888999999999999998654     678999998654444445568899999999999999999998876 467


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhh
Q 023282          204 KLLVYPYMTNGSVASRLRERQSS----LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKT  279 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~----~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~d  279 (284)
                      .++++||+++|+|.+++......    ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence            89999999999999999764321    14689999999999999999999998   999999999999999999999998


Q ss_pred             h
Q 023282          280 I  280 (284)
Q Consensus       280 f  280 (284)
                      |
T Consensus       161 ~  161 (280)
T cd05043         161 N  161 (280)
T ss_pred             C
Confidence            6

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.92  E-value=2.2e-24  Score=181.30  Aligned_cols=134  Identities=25%  Similarity=0.382  Sum_probs=116.6

Q ss_pred             ecccCceEEEEEEeC---CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCCCh
Q 023282          140 LGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  216 (284)
Q Consensus       140 lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g~L  216 (284)
                      ||+|+||.||+|.+.   ++..||+|.+...........+.+|+.++++++||||+++++++. .+..++||||+++|+|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L   81 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL   81 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence            899999999999753   345799999865543333456899999999999999999999875 4578999999999999


Q ss_pred             HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          217 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       217 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .+++....   ..+++..+.+++.|+++||+|||+.   +++||||||+|||++.++.++++||
T Consensus        82 ~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df  139 (257)
T cd05115          82 NKFLSGKK---DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDF  139 (257)
T ss_pred             HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccC
Confidence            99997532   2589999999999999999999998   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.92  E-value=2e-24  Score=185.02  Aligned_cols=147  Identities=28%  Similarity=0.410  Sum_probs=126.9

Q ss_pred             hcCCCCCCeecccCceEEEEEEeCC-----------------CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCcee
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLAD-----------------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR  193 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~  193 (284)
                      ..+|...+.||+|+||.||++....                 +..||+|.+...........+.+|++++++++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3567888999999999999987532                 24689999875544444557899999999999999999


Q ss_pred             eeeEEeeCCeeeEEEeCCCCCChHHHHhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCC
Q 023282          194 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQS-------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN  266 (284)
Q Consensus       194 l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~N  266 (284)
                      +++++...+..++++||+++++|.+++.....       ....+++.....++.|++.||+|||+.   +++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence            99999998999999999999999999976431       122589999999999999999999998   99999999999


Q ss_pred             eeeCCCCCcchhhh
Q 023282          267 ILLDEDADQSSKTI  280 (284)
Q Consensus       267 iLld~~~~~~~~df  280 (284)
                      |+++.++.++++||
T Consensus       161 ili~~~~~~~l~df  174 (296)
T cd05051         161 CLVGKNYTIKIADF  174 (296)
T ss_pred             eeecCCCceEEccc
Confidence            99999999999998

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.92  E-value=1.9e-24  Score=182.59  Aligned_cols=143  Identities=29%  Similarity=0.510  Sum_probs=125.4

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CC---cEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DG---KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      ++|+..+.||+|+||.||+|... ++   ..+|+|.++..........+..|++++++++|||++++.+++...+..+++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            46777899999999999999864 33   379999886543333345789999999999999999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||+++++|.+++....   ..++|.++..++.|++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~df  151 (268)
T cd05063          85 TEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDF  151 (268)
T ss_pred             EEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCC
Confidence            99999999999997643   2589999999999999999999998   9999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=7.5e-25  Score=200.18  Aligned_cols=149  Identities=21%  Similarity=0.239  Sum_probs=126.7

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC----
Q 023282          129 VATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT----  202 (284)
Q Consensus       129 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~----  202 (284)
                      ...++|...+.||+|+||+||+++. .+++.||||.+...... .....+.+|+..+..++|+|++++.+.+...+    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            3446788899999999999999984 57899999998654332 23346889999999999999999988765432    


Q ss_pred             ----eeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchh
Q 023282          203 ----EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  278 (284)
Q Consensus       203 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~  278 (284)
                          ..++||||+++|+|.+++.........+++.....++.|++.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence                36799999999999999986544445689999999999999999999998   99999999999999999999999


Q ss_pred             hh
Q 023282          279 TI  280 (284)
Q Consensus       279 df  280 (284)
                      ||
T Consensus       186 DF  187 (496)
T PTZ00283        186 DF  187 (496)
T ss_pred             ec
Confidence            98

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.92  E-value=1.3e-24  Score=185.52  Aligned_cols=147  Identities=31%  Similarity=0.501  Sum_probs=127.0

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCee
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  204 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~  204 (284)
                      .++|+..+.||+|+||.||++...      ++..+|+|.+..........++.+|+.+++.++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            456888899999999999999853      45789999986544333345689999999999999999999999998899


Q ss_pred             eEEEeCCCCCChHHHHhhcCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCC
Q 023282          205 LLVYPYMTNGSVASRLRERQS------------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN  266 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~------------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~N  266 (284)
                      ++++||+++|+|.+++.....                  ....+++..++.++.|++.||+|||+.   +++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence            999999999999999975321                  113478889999999999999999998   99999999999


Q ss_pred             eeeCCCCCcchhhh
Q 023282          267 ILLDEDADQSSKTI  280 (284)
Q Consensus       267 iLld~~~~~~~~df  280 (284)
                      |+++.++.++++||
T Consensus       161 il~~~~~~~~l~df  174 (288)
T cd05050         161 CLVGENMVVKIADF  174 (288)
T ss_pred             eEecCCCceEECcc
Confidence            99999999999998

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.92  E-value=1.3e-24  Score=184.45  Aligned_cols=135  Identities=26%  Similarity=0.354  Sum_probs=112.7

Q ss_pred             eecccCceEEEEEEeCC-------------------------CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCcee
Q 023282          139 ILGRGGFGKVYKGRLAD-------------------------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR  193 (284)
Q Consensus       139 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~  193 (284)
                      .||+|+||.||+|....                         ...|++|.+.... ......+.+|+.+++.++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence            58999999999997421                         1358899885432 223346888999999999999999


Q ss_pred             eeeEEeeCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC
Q 023282          194 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  273 (284)
Q Consensus       194 l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~  273 (284)
                      +++++......++||||+++|+|..+++...   ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~  154 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG  154 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence            9999999999999999999999999987532   2478899999999999999999998   999999999999998654


Q ss_pred             C-------cchhhh
Q 023282          274 D-------QSSKTI  280 (284)
Q Consensus       274 ~-------~~~~df  280 (284)
                      .       .+++||
T Consensus       155 ~~~~~~~~~kl~d~  168 (274)
T cd05076         155 LAEGTSPFIKLSDP  168 (274)
T ss_pred             cccCccceeeecCC
Confidence            3       577776

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.92  E-value=1.3e-24  Score=193.31  Aligned_cols=135  Identities=24%  Similarity=0.304  Sum_probs=120.6

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      ..+|+..+.||+|+||.||++.. .+++.||+|....       ..+.+|+++++.++||||+++++++......++++|
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e  163 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP  163 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence            35799999999999999999985 4688999996532       246789999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++. ++|.+++....    .+++...+.++.|++.||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus       164 ~~~-~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DF  226 (391)
T PHA03212        164 RYK-TDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDF  226 (391)
T ss_pred             cCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeC
Confidence            995 78988886542    478999999999999999999998   9999999999999999999999998

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.92  E-value=1.8e-24  Score=187.41  Aligned_cols=136  Identities=30%  Similarity=0.439  Sum_probs=119.0

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCCeeeEEEeCCCC
Q 023282          138 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  213 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~~lv~e~~~~  213 (284)
                      ++||+|+||.||+++.. +++.+|+|.++....  ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 578999999975432  22234577888888877 699999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          214 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       214 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+|..++....    .+++.....++.|++.||+|||+.   +++||||||+|||++.++.++|+||
T Consensus        81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Df  140 (318)
T cd05570          81 GDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADF  140 (318)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEeccc
Confidence            99999987542    489999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.92  E-value=3.2e-24  Score=181.06  Aligned_cols=141  Identities=28%  Similarity=0.424  Sum_probs=125.3

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ++|+..+.||+|+||.||+|+. .+++.+|+|++.... ......+.+|+.+++.++||||+++++++...+..++|+||
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            4678889999999999999985 578899999986432 22334678899999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++++|.++++...    .+++.....++.|++.||.|||+.   +|+||||||+||+++.++.++++||
T Consensus        88 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~df  150 (267)
T cd06646          88 CGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADF  150 (267)
T ss_pred             CCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcC
Confidence            99999999987532    478999999999999999999998   9999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.92  E-value=1.5e-24  Score=187.67  Aligned_cols=150  Identities=28%  Similarity=0.441  Sum_probs=126.6

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEeC--------CCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEe
Q 023282          129 VATDGFSNKNILGRGGFGKVYKGRLA--------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCT  199 (284)
Q Consensus       129 ~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~  199 (284)
                      ...++|...+.||+|+||.||+++..        ....+|+|.++..........+..|+.+++.+ +||||+++++++.
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            34456778899999999999999742        24579999886543333345688999999999 5999999999999


Q ss_pred             eCCeeeEEEeCCCCCChHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCe
Q 023282          200 TVTEKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANI  267 (284)
Q Consensus       200 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~Ni  267 (284)
                      .....++++||+++|+|.+++.....            ....++|.+...++.|++.||.|||+.   +++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni  165 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNV  165 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeE
Confidence            88889999999999999999976421            123588999999999999999999998   999999999999


Q ss_pred             eeCCCCCcchhhhh
Q 023282          268 LLDEDADQSSKTIL  281 (284)
Q Consensus       268 Lld~~~~~~~~df~  281 (284)
                      |++.++.++++||=
T Consensus       166 ll~~~~~~kL~Dfg  179 (314)
T cd05099         166 LVTEDNVMKIADFG  179 (314)
T ss_pred             EEcCCCcEEEcccc
Confidence            99999999999973

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.92  E-value=1.9e-24  Score=187.85  Aligned_cols=136  Identities=28%  Similarity=0.387  Sum_probs=115.1

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHH-HHhcCCCCCceeeeeEEeeCCeeeEEEeCCCC
Q 023282          138 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVK-IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  213 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~  213 (284)
                      +.||+|+||+||+++.. +++.+|+|.+.....  ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999865 678899999864322  122234444544 56889999999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          214 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       214 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+|.+++....    .+.+.....++.|+++||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus        81 ~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~Df  140 (325)
T cd05602          81 GELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDF  140 (325)
T ss_pred             CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccC
Confidence            99999997632    367788888999999999999999   9999999999999999999999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.92  E-value=3.1e-24  Score=181.64  Aligned_cols=140  Identities=30%  Similarity=0.507  Sum_probs=119.8

Q ss_pred             CeecccCceEEEEEEeC-CCc--EEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCCeeeEEEeCCCC
Q 023282          138 NILGRGGFGKVYKGRLA-DGK--LVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  213 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~~lv~e~~~~  213 (284)
                      ++||+|+||.||+|... ++.  .+++|.++..........+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            46899999999999865 343  46888886443334445788999999999 799999999999998999999999999


Q ss_pred             CChHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          214 GSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       214 g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+|.++++....            ....+++.++..++.|++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCC
Confidence            999999975421            123478999999999999999999998   9999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.92  E-value=2.4e-24  Score=185.16  Aligned_cols=142  Identities=27%  Similarity=0.463  Sum_probs=124.6

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ++|...+.||+|+||.||+|+.. ++..||+|.++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            45777899999999999999864 67899999986544333344678899999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++ ++|.+++.....   .+++.....++.|+++||+|||+.   +++||||||+||+++.++.++++||
T Consensus        86 ~~-~~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  148 (301)
T cd07873          86 LD-KDLKQYLDDCGN---SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADF  148 (301)
T ss_pred             cc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcC
Confidence            97 589988875422   478899999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.92  E-value=2.1e-24  Score=180.99  Aligned_cols=142  Identities=30%  Similarity=0.500  Sum_probs=126.7

Q ss_pred             hcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      .++|+..+.||+|+||.||++... ++.||+|.++....  ...++.+|+.+++.++|+||+++++++...+..+++|||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            346778899999999999999874 78899999865432  345789999999999999999999999988899999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++++|.+++.....  ..++|.....++.|++.||.|||+.   +++||||||+||+++.++.++++||
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~  146 (256)
T cd05039          82 MAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDF  146 (256)
T ss_pred             cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccc
Confidence            999999999976432  2489999999999999999999998   9999999999999999999999997

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.92  E-value=2.6e-24  Score=183.79  Aligned_cols=145  Identities=28%  Similarity=0.476  Sum_probs=124.6

Q ss_pred             cCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  205 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~  205 (284)
                      ++|...+.||+|+||.||++...      ++..+|+|.+.... ......+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            45777899999999999999742      34568999885432 223446899999999999999999999999999999


Q ss_pred             EEEeCCCCCChHHHHhhcC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcc
Q 023282          206 LVYPYMTNGSVASRLRERQ---------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  276 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~  276 (284)
                      ++|||+++++|.+++....         .....++|..+..++.|++.||+|||+.   +++||||||+||+++.++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence            9999999999999997542         1223589999999999999999999998   999999999999999999999


Q ss_pred             hhhh
Q 023282          277 SKTI  280 (284)
Q Consensus       277 ~~df  280 (284)
                      ++||
T Consensus       161 l~df  164 (288)
T cd05093         161 IGDF  164 (288)
T ss_pred             eccC
Confidence            9998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.92  E-value=1.6e-24  Score=189.04  Aligned_cols=147  Identities=29%  Similarity=0.445  Sum_probs=125.2

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC--------CCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEeeC
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA--------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  201 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~  201 (284)
                      ..+|...+.||+|+||.||+++..        ....+|+|.++.........++.+|++++.++ +||||+++++++...
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            345778899999999999999742        12368999886543333445789999999999 799999999999998


Q ss_pred             CeeeEEEeCCCCCChHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeee
Q 023282          202 TEKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  269 (284)
Q Consensus       202 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLl  269 (284)
                      +..++++||+++|+|.+++.....            ....++|..+..++.|+++||+|||+.   +++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEE
Confidence            999999999999999999975321            123578999999999999999999998   99999999999999


Q ss_pred             CCCCCcchhhh
Q 023282          270 DEDADQSSKTI  280 (284)
Q Consensus       270 d~~~~~~~~df  280 (284)
                      +.++.++|+||
T Consensus       168 ~~~~~~kL~Df  178 (334)
T cd05100         168 TEDNVMKIADF  178 (334)
T ss_pred             cCCCcEEECCc
Confidence            99999999998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.92  E-value=5.7e-25  Score=194.48  Aligned_cols=146  Identities=26%  Similarity=0.424  Sum_probs=128.3

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEeC---CC--cEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC
Q 023282          128 QVATDGFSNKNILGRGGFGKVYKGRLA---DG--KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT  202 (284)
Q Consensus       128 ~~~~~~~~~~~~lg~G~~g~V~~~~~~---~~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~  202 (284)
                      +...+..+..++||+|-||.||+|..-   .|  ..||||..+.+...+..+.|..|..+|++++|||||+|+|.|.. .
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~  463 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q  463 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence            333444556688999999999999742   23  36999999988777777789999999999999999999999976 5


Q ss_pred             eeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          203 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       203 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ..|+|||.++.|.|..+|+....   .++......++.|++.||+|||+.   ++|||||.++|||+.+...+|++||
T Consensus       464 P~WivmEL~~~GELr~yLq~nk~---sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDF  535 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNKD---SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADF  535 (974)
T ss_pred             ceeEEEecccchhHHHHHHhccc---cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeeccc
Confidence            78999999999999999987654   377888999999999999999999   9999999999999999999999998

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.92  E-value=3.6e-24  Score=181.96  Aligned_cols=136  Identities=26%  Similarity=0.356  Sum_probs=118.0

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEeecccCc--ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCCCh
Q 023282          140 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  216 (284)
Q Consensus       140 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g~L  216 (284)
                      ||+|+||.||+++.. +|+.+|+|.+......  .....+..|++++++++||||+++.+++......+++|||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999854 6899999998643222  1233466799999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          217 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       217 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .+++....  ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+||
T Consensus        81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Df  139 (277)
T cd05607          81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDL  139 (277)
T ss_pred             HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeec
Confidence            99886532  22478999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.92  E-value=2.5e-24  Score=183.12  Aligned_cols=146  Identities=24%  Similarity=0.343  Sum_probs=123.1

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHH-HhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~-l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      ++|+..+.||+|+||.||++... +|..||+|.++.........++..|+.. ++..+|||++++++++...+..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            35777899999999999999864 6899999998754433334456666665 667789999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |++ |+|.+++.........+++.....++.|++.||+|||+++  +++||||||+||+++.++.++++||
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~df  148 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDF  148 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeec
Confidence            997 6898888764333356899999999999999999999753  7999999999999999999999998

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.92  E-value=4.2e-24  Score=182.54  Aligned_cols=142  Identities=29%  Similarity=0.506  Sum_probs=117.0

Q ss_pred             CCCCCCeecccCceEEEEEEe-C-CCcEEEEEEeecccCcc-cHHHHHHHHHHHhcC---CCCCceeeeeEEee-----C
Q 023282          133 GFSNKNILGRGGFGKVYKGRL-A-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMA---VHRNLLRLYGFCTT-----V  201 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~-~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~---~h~niv~l~g~~~~-----~  201 (284)
                      +|...+.||+|+||.||+|+. . ++..||+|.++...... ....+.+|+.+++.+   +||||++++++|..     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            577789999999999999985 3 46789999986543222 233566777776654   69999999999853     3


Q ss_pred             CeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          202 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       202 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ...+++|||++ ++|.+++.....  ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.++++||
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence            46889999996 699999975432  2478999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.92  E-value=3.7e-24  Score=182.06  Aligned_cols=137  Identities=26%  Similarity=0.369  Sum_probs=121.1

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCC
Q 023282          133 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      +|+..++||+|+||.||+|.. .+++.+|+|.+...........+.+|+.++++++||||+++++++...+..+++|||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            466778999999999999985 5788999999865433333456889999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++++|..+.        .+++.....++.|++.||.|||+.   +++|+||||+|||++.++.++++||
T Consensus        82 ~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~df  139 (279)
T cd06619          82 DGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDF  139 (279)
T ss_pred             CCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeC
Confidence            999996543        267888899999999999999998   9999999999999999999999998

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.92  E-value=3e-24  Score=182.82  Aligned_cols=138  Identities=30%  Similarity=0.473  Sum_probs=119.9

Q ss_pred             CCCCeecccCceEEEEEEe-----CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeC--CeeeEE
Q 023282          135 SNKNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLLV  207 (284)
Q Consensus       135 ~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~--~~~~lv  207 (284)
                      ...+.||+|+||+||.+..     .++..||+|.++..........+.+|++++++++||||+++++++...  ...+++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            6678999999999987642     357789999987543333445688999999999999999999988754  357899


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||+++|+|.+++...     .++|.++..++.|++.||.|||+.   +++||||||+|||++.++.++++||
T Consensus        87 ~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~df  151 (283)
T cd05080          87 MEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDF  151 (283)
T ss_pred             ecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeec
Confidence            9999999999999753     389999999999999999999998   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.92  E-value=1.6e-24  Score=186.46  Aligned_cols=145  Identities=29%  Similarity=0.395  Sum_probs=125.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEe------CCCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCCe
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTE  203 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~  203 (284)
                      .++|...+.||+|+||.||++..      ..+..+|+|.++..........+.+|+.+++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            35688889999999999999974      134579999886543333345689999999999 79999999999999999


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .+++|||+++|+|.++++....  ..+++.+...++.|++.||.|||+.   +++|+||||+|||++.++.++++||
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~df  185 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDF  185 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCC
Confidence            9999999999999999975332  2379999999999999999999998   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.92  E-value=2e-24  Score=191.14  Aligned_cols=140  Identities=25%  Similarity=0.337  Sum_probs=121.0

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccC-cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC-----eee
Q 023282          133 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-----EKL  205 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~-----~~~  205 (284)
                      +|+..+.||+|+||.||++.. .+++.||+|.+..... ......+.+|+++++.++|+||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            467789999999999999985 4789999999854322 122346889999999999999999999998766     789


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +|+||+. ++|.+.+...    ..+++..+..++.|++.||.|||+.   +++||||||+|||++.++.++|+||
T Consensus        81 lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Df  147 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDF  147 (372)
T ss_pred             EEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccc
Confidence            9999997 5888887543    2488999999999999999999999   9999999999999999999999998

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.92  E-value=2e-24  Score=182.22  Aligned_cols=146  Identities=20%  Similarity=0.316  Sum_probs=126.9

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc--ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|+..+.||+|+||.||++.. .++..+|||.+......  ....++.+|+.+++.++|+||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            3577788999999999999985 57889999987543221  22346889999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++++|.+++.........++|.....++.|+++||.|||+.   +++|+||||+||+++.++.++++||
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df  150 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDL  150 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcc
Confidence            99999999999875333334689999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.92  E-value=3.5e-24  Score=182.08  Aligned_cols=142  Identities=27%  Similarity=0.498  Sum_probs=123.2

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCc----EEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~l  206 (284)
                      .+|...+.||+|+||.||+|... ++.    .+|+|.+..........++.+|+.+++.++|||++++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            45677789999999999999853 333    6899988655443334578899999999999999999999987 78899


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++||+++|+|.+++.....   .+++.....++.|++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        86 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~df  153 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDF  153 (279)
T ss_pred             EEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCC
Confidence            9999999999999976432   489999999999999999999998   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.92  E-value=2.8e-24  Score=180.75  Aligned_cols=143  Identities=28%  Similarity=0.407  Sum_probs=125.3

Q ss_pred             HhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      ..++|...+.||+|+||.||+|...+++.+|+|.+....  .....+.+|+.+++.++|+|++++++++. .+..+++||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS--MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE   80 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC--CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence            345678889999999999999998888999999986433  23447889999999999999999999864 467899999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++++|.+++....  ...+++.+...++.|++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~df  146 (260)
T cd05067          81 YMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADF  146 (260)
T ss_pred             cCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccC
Confidence            999999999987643  23588999999999999999999998   9999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.92  E-value=3e-24  Score=183.22  Aligned_cols=142  Identities=28%  Similarity=0.370  Sum_probs=123.2

Q ss_pred             CCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcc--cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          134 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      |...+.||+|+||+||++.. .+++.+|+|.+.......  ....+.+|+++++.++|+|++++.+++...+..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            45568899999999999986 468899999986443222  223577899999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++++|.+++....  ...+++.....++.|++.||.|||+.   +|+||||||+||+++.++.++++||
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Df  146 (285)
T cd05632          82 MNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDL  146 (285)
T ss_pred             ccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecC
Confidence            99999999887532  22589999999999999999999998   9999999999999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.92  E-value=2.1e-24  Score=181.92  Aligned_cols=141  Identities=29%  Similarity=0.422  Sum_probs=124.5

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCC
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      +|...+.||+|+||.||+|... .+..+|+|.+...  .....++.+|+++++.++|+||+++++++...+..+++|||+
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            4667788999999999999854 5889999988643  223446889999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++++|.+++....  ...+++..+..++.|+++||+|||+.   +++||||||+||++++++.++++||
T Consensus        85 ~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df  148 (263)
T cd05052          85 TYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADF  148 (263)
T ss_pred             CCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCC
Confidence            9999999997543  23578999999999999999999998   9999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.92  E-value=3.7e-24  Score=179.96  Aligned_cols=144  Identities=30%  Similarity=0.452  Sum_probs=128.4

Q ss_pred             HhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      ..++|...+.||+|+||.||++...++..+|+|.+....  ....++.+|+.+++.++|+|++++++++......+++||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            456788889999999999999998778889999986432  234568999999999999999999999998889999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++++|.+++....  ...+++.+...++.+++.||.|||+.   +++|+||||+||+++.++.++++||
T Consensus        82 ~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~  147 (261)
T cd05034          82 YMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADF  147 (261)
T ss_pred             ccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECcc
Confidence            999999999997643  23589999999999999999999999   9999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.92  E-value=4.3e-24  Score=180.68  Aligned_cols=143  Identities=28%  Similarity=0.426  Sum_probs=118.3

Q ss_pred             CCCCeecccCceEEEEEEeCC-Cc--EEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeC------Cee
Q 023282          135 SNKNILGRGGFGKVYKGRLAD-GK--LVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV------TEK  204 (284)
Q Consensus       135 ~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~------~~~  204 (284)
                      ...+.||+|+||.||+|...+ +.  .+|+|.++..... .....+..|+++++.++|+||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456889999999999998653 33  5899988654322 2234688999999999999999999987532      246


Q ss_pred             eEEEeCCCCCChHHHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQ--SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++++||+++|+|.+++....  .....++|.....++.|++.||+|||+.   +|+||||||+|||++.++.++++||
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df  156 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADF  156 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCC
Confidence            89999999999999885322  1223588999999999999999999998   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.2e-25  Score=198.69  Aligned_cols=150  Identities=27%  Similarity=0.401  Sum_probs=134.0

Q ss_pred             HHHHHHHhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC
Q 023282          124 LRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT  202 (284)
Q Consensus       124 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~  202 (284)
                      .++|+....+......||-|.||.||.|.|+ ....||||.++++..  ...+|..|+.+|+.++|||+|+|+|+|....
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM--eveEFLkEAAvMKeikHpNLVqLLGVCT~Ep  336 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP  336 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch--hHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence            4777777778888899999999999999986 466899999987543  3457999999999999999999999999999


Q ss_pred             eeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          203 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       203 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ..|+|+|||.+|+|.++|++....  .++-...+.+|.||+.||+||...   ++|||||.++|+|+.++.-+||+||
T Consensus       337 PFYIiTEfM~yGNLLdYLRecnr~--ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADF  409 (1157)
T KOG4278|consen  337 PFYIITEFMCYGNLLDYLRECNRS--EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADF  409 (1157)
T ss_pred             CeEEEEecccCccHHHHHHHhchh--hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeecc
Confidence            999999999999999999975332  355667889999999999999998   9999999999999999999999999

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.92  E-value=2.6e-24  Score=182.74  Aligned_cols=147  Identities=31%  Similarity=0.415  Sum_probs=125.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCee
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  204 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~  204 (284)
                      .++|...+.||+|+||.||+|...      .+..||+|.+...........+..|+.+++.++|+||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            456788899999999999999864      35678999886544333445689999999999999999999999988899


Q ss_pred             eEEEeCCCCCChHHHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC---Ccchh
Q 023282          205 LLVYPYMTNGSVASRLRERQS---SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSK  278 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~---~~~~~  278 (284)
                      +++|||+++++|.+++.....   ....++|..+..++.|++.||+|||+.   +++||||||+||+++.++   .++++
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence            999999999999999976432   123589999999999999999999998   999999999999998765   48899


Q ss_pred             hh
Q 023282          279 TI  280 (284)
Q Consensus       279 df  280 (284)
                      ||
T Consensus       162 df  163 (277)
T cd05036         162 DF  163 (277)
T ss_pred             cC
Confidence            87

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.92  E-value=3e-24  Score=180.13  Aligned_cols=134  Identities=27%  Similarity=0.445  Sum_probs=115.3

Q ss_pred             CeecccCceEEEEEEeCC-C----------cEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeE
Q 023282          138 NILGRGGFGKVYKGRLAD-G----------KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~l  206 (284)
                      +.||+|+||.||+|...+ +          ..+++|.+......  ...+.+|+.+++.++||||+++++++.. ...++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence            468999999999998653 3          25778876543221  5578999999999999999999999988 78899


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC-------Ccchhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-------DQSSKT  279 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~-------~~~~~d  279 (284)
                      ++||+++|+|.+++.....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++       .++++|
T Consensus        78 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          78 VEEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             EEEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence            9999999999999986432   478999999999999999999998   999999999999999888       689988


Q ss_pred             h
Q 023282          280 I  280 (284)
Q Consensus       280 f  280 (284)
                      |
T Consensus       152 f  152 (259)
T cd05037         152 P  152 (259)
T ss_pred             C
Confidence            7

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.92  E-value=4.1e-24  Score=182.67  Aligned_cols=142  Identities=25%  Similarity=0.476  Sum_probs=124.7

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ++|+..+.||+|++|.||+|... +++.||+|.+...........+.+|+++++.++|+||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            56778899999999999999865 68899999986543333334577899999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++ ++|.+++.....   .+++.....++.|+++||.|||+.   +++||||||+||+++.++.++++||
T Consensus        85 ~~-~~L~~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df  147 (291)
T cd07844          85 LD-TDLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADF  147 (291)
T ss_pred             CC-CCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECcc
Confidence            98 499998875432   578999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.92  E-value=5.2e-24  Score=180.07  Aligned_cols=144  Identities=30%  Similarity=0.454  Sum_probs=121.5

Q ss_pred             CCCCCeecccCceEEEEEEeC-C---CcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCe-----
Q 023282          134 FSNKNILGRGGFGKVYKGRLA-D---GKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE-----  203 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~-----  203 (284)
                      |+..+.||+|+||.||+|... +   +..||+|.++..... .....+.+|++.++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            456788999999999999853 2   367999998754332 223468999999999999999999999876554     


Q ss_pred             -eeEEEeCCCCCChHHHHhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          204 -KLLVYPYMTNGSVASRLRERQS--SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       204 -~~lv~e~~~~g~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                       .++++||+++|+|..++.....  ....+++.....++.|++.||+|||+.   +++||||||+||++++++.++++||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             7899999999999999865321  223588999999999999999999998   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.91  E-value=5e-24  Score=179.67  Aligned_cols=141  Identities=26%  Similarity=0.466  Sum_probs=124.5

Q ss_pred             CCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcc-----cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEE
Q 023282          133 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG-----GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      +|+..+.||+|+||.||+|...+++.+|+|.++......     ....+.+|+++++.++|+||+++.+++...+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            366788999999999999998888999999886433211     123588999999999999999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +||+++++|.+++....    .+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++++||
T Consensus        81 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  146 (265)
T cd06631          81 MEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDF  146 (265)
T ss_pred             EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccc
Confidence            99999999999997542    478889999999999999999998   8999999999999999999999998

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.91  E-value=2.6e-24  Score=181.36  Aligned_cols=141  Identities=28%  Similarity=0.428  Sum_probs=122.7

Q ss_pred             cCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      ++|...+.||+|+||.||+|...+...||+|.++....  ....+.+|+++++.++||||+++++++. ....+++|||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            45778899999999999999877667899999864322  2346899999999999999999999874 45689999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++|+|.+++....  ...++|..+..++.|+++||+|||+.   +++||||||+||+++.++.++++||
T Consensus        83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~df  146 (262)
T cd05071          83 SKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF  146 (262)
T ss_pred             CCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccC
Confidence            9999999997632  22478999999999999999999998   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.91  E-value=7.9e-24  Score=177.45  Aligned_cols=143  Identities=17%  Similarity=0.297  Sum_probs=125.4

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCC
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      +|+..+.||+|+||.||++... ++..+|+|.++..........+..|+.+++.++|+|++++.+.+...+..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            3667789999999999999854 688999999864433334456889999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++|+|.+++....  ...+++.....++.|++.||.|||+.   +++|+||||+||+++.++.++++||
T Consensus        81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~df  144 (255)
T cd08219          81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDF  144 (255)
T ss_pred             CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEccc
Confidence            9999999987532  23478889999999999999999998   9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.91  E-value=4.1e-24  Score=180.53  Aligned_cols=147  Identities=25%  Similarity=0.373  Sum_probs=125.7

Q ss_pred             HHHHhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeee
Q 023282          127 LQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  205 (284)
Q Consensus       127 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~  205 (284)
                      ++.+++++.....||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++|+||+++++++...+..+
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            3455667777789999999999999854 67789999885432 223447899999999999999999999999999999


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC-CCCcchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPL--DWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l--~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~-~~~~~~~df  280 (284)
                      +++||+++++|.++++....   .+  ++..+..++.|++.||+|||+.   +++||||||+||+++. ++.++++||
T Consensus        82 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~df  153 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWG---PLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDF  153 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcc---cCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecc
Confidence            99999999999999986422   24  7788889999999999999998   9999999999999987 668999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.91  E-value=3.6e-24  Score=180.07  Aligned_cols=142  Identities=28%  Similarity=0.445  Sum_probs=124.1

Q ss_pred             hcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      .++|...+.||+|+||.||++...++..+|+|.+.....  ....+.+|+.++++++|+|++++++++. ....+++|||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY   81 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence            346777899999999999999988888899999865332  2346899999999999999999999875 4568899999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++++|.++++...  ...+++..+..++.|++.||.|||+.   +++||||||+||++++++.++++||
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~df  146 (260)
T cd05070          82 MSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADF  146 (260)
T ss_pred             cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCc
Confidence            99999999997632  23578999999999999999999998   9999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.91  E-value=5.7e-24  Score=181.52  Aligned_cols=142  Identities=27%  Similarity=0.366  Sum_probs=123.1

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCccc--HHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          134 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      |+..+.||+|+||.||++... +++.+|+|.+........  ...+..|+.++++++|++++++++.+...+..+++|||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            556788999999999999854 688999999864332222  23577899999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++++|.+++.....  ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++++||
T Consensus        82 ~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Df  146 (285)
T cd05630          82 MNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDL  146 (285)
T ss_pred             cCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeec
Confidence            999999999865322  2488899999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.91  E-value=5.2e-24  Score=182.10  Aligned_cols=143  Identities=25%  Similarity=0.393  Sum_probs=123.6

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      +++|...+.||+|+||.||+|.. .++..+|+|.+...........+.+|+.+++.++|+||+++.+++...+..++++|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            46788889999999999999985 46889999998654433333467889999999999999999999999889999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+. +++.+++....   ..+.+.....++.|++.||.|||+.   +++||||||+||+++.+++++++||
T Consensus        84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Df  147 (291)
T cd07870          84 YMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADF  147 (291)
T ss_pred             ccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecc
Confidence            996 78887775432   2467888899999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.8e-25  Score=196.57  Aligned_cols=140  Identities=31%  Similarity=0.456  Sum_probs=122.1

Q ss_pred             CCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc--ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          134 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      |..++.||.|+||.||-++. .+.+.||||++.-....  ....++..|+..|.+++|||+|.+.|+|......||||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            55567899999999999984 57889999998643322  2334799999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |- |+-.+++.-...   ++....+-.|+.+.+.||+|||++   +.||||||+.|||+.+.+-+|++||
T Consensus       108 Cl-GSAsDlleVhkK---plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDF  170 (948)
T KOG0577|consen  108 CL-GSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADF  170 (948)
T ss_pred             Hh-ccHHHHHHHHhc---cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccc
Confidence            95 688888865433   577888999999999999999999   9999999999999999999999998

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.91  E-value=2.7e-24  Score=190.10  Aligned_cols=143  Identities=25%  Similarity=0.381  Sum_probs=125.8

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCccc-HHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ...|.+...||+|.|+.|..++. .++..||||.+.+...... ...+.+|+++|+.++|||||+++.+......+++||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            34577788999999999999985 4788999999976543332 235889999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+.+|.+.+++.....    ........+..|+..|++|||++   .|+|||||++|+|||.+++.||+||
T Consensus       135 eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDf  199 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADF  199 (596)
T ss_pred             EeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeecc
Confidence            99999999999987543    44467788899999999999999   9999999999999999999999998

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.91  E-value=2.4e-24  Score=183.41  Aligned_cols=144  Identities=25%  Similarity=0.387  Sum_probs=122.3

Q ss_pred             CCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEE
Q 023282          134 FSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      |...+.||+|+||.||+|...      .+..||+|.++..........+..|+.++..++||||+++++++......+++
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~   86 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI   86 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence            445678999999999999853      24689999987543322334688999999999999999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCc
Q 023282          208 YPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  275 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~  275 (284)
                      +||+++++|.+++.....            ....+++..+..++.|++.||.|||+.   +++||||||+||++++++.+
T Consensus        87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~  163 (283)
T cd05091          87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNV  163 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCce
Confidence            999999999999864211            123478889999999999999999998   99999999999999999999


Q ss_pred             chhhh
Q 023282          276 SSKTI  280 (284)
Q Consensus       276 ~~~df  280 (284)
                      |++||
T Consensus       164 kl~Df  168 (283)
T cd05091         164 KISDL  168 (283)
T ss_pred             Eeccc
Confidence            99998

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.91  E-value=4.7e-24  Score=201.31  Aligned_cols=142  Identities=31%  Similarity=0.412  Sum_probs=125.7

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcc--cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|...+.||+|+||.||+|... ++..||+|+++......  ....+..|+.++..++||||+++++++......++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            56778899999999999999865 68899999986433222  2246888999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++++|.+++....    .+++...+.++.|++.||.|||..   +|+||||||+|||++.++.++|+||
T Consensus        84 Ey~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DF  148 (669)
T cd05610          84 EYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDF  148 (669)
T ss_pred             eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeC
Confidence            9999999999997532    478889999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.91  E-value=7.4e-26  Score=184.76  Aligned_cols=138  Identities=28%  Similarity=0.477  Sum_probs=125.1

Q ss_pred             CCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCC
Q 023282          134 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  212 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~  212 (284)
                      |+..+.||+|+||.||++.+ ..|+.+|+|.+..   ..+.+++..|+.+|++++.|++|++||.+.....+|+|||||.
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV---~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV---DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc---cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            55567899999999999985 4799999998853   3345678999999999999999999999999999999999999


Q ss_pred             CCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          213 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       213 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .|+..+.++.+..   ++++.++-.+....++||+|||..   .-+|||||+.|||++.+|.+|++||
T Consensus       112 AGSiSDI~R~R~K---~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADF  173 (502)
T KOG0574|consen  112 AGSISDIMRARRK---PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADF  173 (502)
T ss_pred             CCcHHHHHHHhcC---CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhc
Confidence            9999999987543   689999999999999999999998   8899999999999999999999998

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.91  E-value=3.1e-24  Score=182.95  Aligned_cols=145  Identities=25%  Similarity=0.368  Sum_probs=125.9

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCC
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      +|+..+.||+|+||.||++... ++..+|+|.++..........+.+|+.+++.++|+||+++++.+...+..+++|||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            5677889999999999999865 788999998865433333457889999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++++|..++.... ....+++.....++.+++.||.|||+.+  +++||||||+||+++.++.++++||
T Consensus        82 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~df  147 (286)
T cd06622          82 DAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDF  147 (286)
T ss_pred             CCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeec
Confidence            9999999887532 1235899999999999999999999632  8999999999999999999999997

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.91  E-value=8.4e-24  Score=177.15  Aligned_cols=143  Identities=24%  Similarity=0.359  Sum_probs=125.8

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-CcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +|+..+.||+|++|.||++... ++..+++|.+.... .......+.+|+++++.++|||++++++++...+..+++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            3666789999999999999864 68899999886432 223345788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++++|.++++...  ...+++.....++.|++.||.|||+.   +++|+||||+||+++.++.++++||
T Consensus        81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df  145 (256)
T cd08529          81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDL  145 (256)
T ss_pred             CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEccc
Confidence            99999999998642  23588999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.91  E-value=3.1e-24  Score=182.94  Aligned_cols=154  Identities=26%  Similarity=0.350  Sum_probs=129.1

Q ss_pred             ccHHHHHHHhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEe
Q 023282          122 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCT  199 (284)
Q Consensus       122 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~  199 (284)
                      +.++.+....++|+..+.||+|+||.||++... +++.+|+|.+...  .....++..|+.+++.+ +||||+++++++.
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   85 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI--HDIDEEIEAEYNILKALSDHPNVVKFYGMYY   85 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc--cchHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence            344566677888999999999999999999864 6789999987532  22234678899999998 6999999999884


Q ss_pred             e-----CCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCC
Q 023282          200 T-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  274 (284)
Q Consensus       200 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~  274 (284)
                      .     .+..+++|||+++++|.++++........+++..+..++.|+++||.|||+.   +++||||||+||+++.++.
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~  162 (286)
T cd06638          86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGG  162 (286)
T ss_pred             ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCC
Confidence            3     3568999999999999998875333334578899999999999999999998   9999999999999999999


Q ss_pred             cchhhh
Q 023282          275 QSSKTI  280 (284)
Q Consensus       275 ~~~~df  280 (284)
                      ++++||
T Consensus       163 ~kl~df  168 (286)
T cd06638         163 VKLVDF  168 (286)
T ss_pred             EEEccC
Confidence            999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.91  E-value=7.4e-25  Score=196.38  Aligned_cols=142  Identities=28%  Similarity=0.421  Sum_probs=121.3

Q ss_pred             CCCCeecccCceEEEEEE-eCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEee------CCeeeEE
Q 023282          135 SNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT------VTEKLLV  207 (284)
Q Consensus       135 ~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~------~~~~~lv  207 (284)
                      ...+.||+|+||.||+|+ ..+|+.||||.++........+...+|+++|++++|+|||++.+.-..      .....++
T Consensus        16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv   95 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV   95 (732)
T ss_pred             eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence            445789999999999999 558999999999877666667789999999999999999999987543      3467899


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC----Ccchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA----DQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~----~~~~~df  280 (284)
                      ||||.+|||...|.+..+ ...++..+.+.+..+++.||.|||.+   +|+||||||.||++-...    --|++||
T Consensus        96 mEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   96 MEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             EeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecc
Confidence            999999999999987543 45699999999999999999999998   999999999999985433    2566666

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.91  E-value=1e-23  Score=176.86  Aligned_cols=143  Identities=22%  Similarity=0.328  Sum_probs=125.7

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc-CcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          133 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +|+..++||+|+||.||.++. .++..+++|.+.... ......++.+|++++++++|+||+++++++...+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            367789999999999999884 468899999886433 233345688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++|+|.+++....  ...+++.....++.|++.||+|||+.   +++|+||+|+||+++.++.++++||
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~  145 (256)
T cd08221          81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDF  145 (256)
T ss_pred             cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcC
Confidence            99999999997642  23578999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.91  E-value=4.4e-24  Score=192.69  Aligned_cols=141  Identities=23%  Similarity=0.337  Sum_probs=116.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeC--------
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--------  201 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~--------  201 (284)
                      ..+|...+.||+|+||.||+|.. .+++.||||.+....     ....+|+.+++.++||||+++++++...        
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            45688899999999999999986 468899999885321     1345799999999999999999886432        


Q ss_pred             CeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC-Ccchhhh
Q 023282          202 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTI  280 (284)
Q Consensus       202 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~-~~~~~df  280 (284)
                      ...++||||+++ +|.+++.........+++.....++.|++.||+|||+.   +|+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence            136689999984 78777764333334688999999999999999999999   999999999999999765 6999998

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=5e-24  Score=185.61  Aligned_cols=134  Identities=25%  Similarity=0.284  Sum_probs=114.0

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEeecccCc--ccHHHHHHHHHHHhcC---CCCCceeeeeEEeeCCeeeEEEeCCCC
Q 023282          140 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMA---VHRNLLRLYGFCTTVTEKLLVYPYMTN  213 (284)
Q Consensus       140 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~---~h~niv~l~g~~~~~~~~~lv~e~~~~  213 (284)
                      ||+|+||+||+|+.. +++.||+|++......  .....+..|..++...   +||||+++++++...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999854 6889999998643211  1222355666666554   699999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          214 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       214 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+|.+++....    .+++.....++.|+++||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus        81 g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Df  140 (330)
T cd05586          81 GELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDF  140 (330)
T ss_pred             ChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecC
Confidence            99999987532    478899999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.91  E-value=1e-23  Score=176.83  Aligned_cols=140  Identities=34%  Similarity=0.545  Sum_probs=123.8

Q ss_pred             CeecccCceEEEEEEeCC----CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCC
Q 023282          138 NILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  213 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~  213 (284)
                      +.||+|+||.||++....    +..+++|.++..........+.+|++.+..++|+|++++++++......+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999998653    7789999997654433356789999999999999999999999998999999999999


Q ss_pred             CChHHHHhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          214 GSVASRLRERQSS-----LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       214 g~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++|.+++......     ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~df  149 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDF  149 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccc
Confidence            9999999875211     24689999999999999999999998   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.91  E-value=8.3e-25  Score=166.49  Aligned_cols=140  Identities=23%  Similarity=0.436  Sum_probs=120.7

Q ss_pred             CCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccCccc-HHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCC
Q 023282          134 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      |+..+.||+|.||+||+|+ ..+++.||+|..+.+...+. -....+|+.+++.++|.|||++++...+....-+|+|||
T Consensus         4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c   83 (292)
T KOG0662|consen    4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC   83 (292)
T ss_pred             hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence            4445789999999999998 55789999999875443332 235789999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .. +|.++...-   .+.++......++.|+.+||.|+|++   ++.||||||.|.|++.+|+.|++||
T Consensus        84 dq-dlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladf  145 (292)
T KOG0662|consen   84 DQ-DLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADF  145 (292)
T ss_pred             hH-HHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEeccc
Confidence            64 787777543   23578888899999999999999999   9999999999999999999999998

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.91  E-value=8.8e-24  Score=178.18  Aligned_cols=136  Identities=26%  Similarity=0.393  Sum_probs=113.9

Q ss_pred             CeecccCceEEEEEEeCC-------------CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCee
Q 023282          138 NILGRGGFGKVYKGRLAD-------------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  204 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~  204 (284)
                      +.||+|+||.||+|....             ...+++|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            358999999999997532             2258888875432 22334688899999999999999999999998899


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCC-------cch
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD-------QSS  277 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~-------~~~  277 (284)
                      +++|||+++|+|..+++...   ..+++..+..++.|+++||+|||+.   +++||||||+|||++.++.       .++
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l  153 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL  153 (262)
T ss_pred             EEEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence            99999999999999887532   2488999999999999999999998   9999999999999987664       677


Q ss_pred             hhh
Q 023282          278 KTI  280 (284)
Q Consensus       278 ~df  280 (284)
                      +||
T Consensus       154 ~d~  156 (262)
T cd05077         154 SDP  156 (262)
T ss_pred             CCC
Confidence            776

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.2e-23  Score=177.08  Aligned_cols=142  Identities=27%  Similarity=0.445  Sum_probs=125.0

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcc----cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG----GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~l  206 (284)
                      ++|...+.||+|++|.||++.. .++..+|+|.+.......    ....+.+|++++++++||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4688889999999999999985 468899999886432211    22368889999999999999999999999999999


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++||+++++|.+++....    .+++.....++.|++.||.|||+.   +++||||+|+||+++.++.++++||
T Consensus        82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~df  148 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDF  148 (263)
T ss_pred             EEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence            999999999999997542    478888999999999999999998   9999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.91  E-value=1e-23  Score=179.56  Aligned_cols=143  Identities=22%  Similarity=0.391  Sum_probs=123.8

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +|+..+.||+|++|.||+|+.. ++..||+|.++..... .....+.+|+.++..++|||++++++++...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            3667789999999999999864 6889999998643322 2234688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++ ++|.+++..... ...+++.....++.|+++||+|||+.   +++||||||+||+++.++.++|+||
T Consensus        81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  145 (285)
T cd07861          81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADF  145 (285)
T ss_pred             CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcc
Confidence            97 689888865322 23588999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.91  E-value=8.2e-24  Score=177.98  Aligned_cols=141  Identities=28%  Similarity=0.407  Sum_probs=122.1

Q ss_pred             cCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      ++|...+.||+|++|.||++...++..+|+|.+....  .....+.+|+.+++.++|+|++++++++. .+..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            4567778999999999999998777789999875432  23346889999999999999999999875 45688999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++|+|.++++...  ...++|..+..++.|++.||+|||+.   +++||||||+||++++++.++++||
T Consensus        83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~df  146 (260)
T cd05069          83 GKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADF  146 (260)
T ss_pred             CCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCC
Confidence            9999999997642  23478999999999999999999998   9999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.91  E-value=1.4e-23  Score=178.78  Aligned_cols=142  Identities=23%  Similarity=0.372  Sum_probs=124.0

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      ++|+..+.||+|+||.||+++.. +++.||+|.+...... ...+.+.+|+.+++.++|+|++++++++......+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            35777889999999999999865 6889999988643322 223457899999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |++++.|..++....    .++|..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~df  144 (286)
T cd07847          81 YCDHTVLNELEKNPR----GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDF  144 (286)
T ss_pred             ccCccHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECcc
Confidence            999988887765422    489999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.91  E-value=9.9e-24  Score=181.09  Aligned_cols=140  Identities=23%  Similarity=0.366  Sum_probs=125.4

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      .+|...+.||+|+||.||++.. .+++.||+|.+..... .....+.+|+.+++.++|+|++++++++...+..++||||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            5678889999999999999985 5789999999864332 2344688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++++|.+++.+.     .+++.++..++.|++.||.|||+.   +++||||||+||+++.++.++++||
T Consensus        98 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Df  159 (297)
T cd06656          98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDF  159 (297)
T ss_pred             cCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcC
Confidence            9999999998653     378889999999999999999998   9999999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.91  E-value=8.4e-24  Score=180.84  Aligned_cols=141  Identities=30%  Similarity=0.407  Sum_probs=125.2

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc--ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      +|+..+.||+|+||.||++... +++.+|+|.+......  .....+.+|++++++++||||+++++++......+++||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME   81 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence            5777899999999999999864 6889999998643321  223468899999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++++|.+++....    .+++..+..++.|+++||.|||+.   +++|+||+|+||+++.++.++++||
T Consensus        82 ~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~df  145 (290)
T cd05580          82 YVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDF  145 (290)
T ss_pred             cCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeC
Confidence            999999999997642    478899999999999999999998   9999999999999999999999997

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.91  E-value=1.1e-23  Score=180.75  Aligned_cols=140  Identities=22%  Similarity=0.365  Sum_probs=124.7

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      .+|+..+.||+|+||.||+|.. .++..+|+|.+..... .....+.+|+.+++.++|+|++++++.+......++||||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            4677788999999999999985 4688999998865432 2345688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++++|.+++...     .+++.+...++.|++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        99 ~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~df  160 (296)
T cd06654          99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDF  160 (296)
T ss_pred             cCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECcc
Confidence            9999999998643     378899999999999999999998   9999999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.91  E-value=7.4e-24  Score=178.26  Aligned_cols=143  Identities=24%  Similarity=0.375  Sum_probs=125.1

Q ss_pred             HhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      ..++|...+.||+|+||.||++...++..+|+|.+...  ......+.+|+++++.++|+|++++.+++.. ...+++||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE   80 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence            34567888999999999999999777778999988643  2223468899999999999999999999877 77899999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++|+|.+++....  ...++|..+..++.|++.||.|||+.   +++||||||+||+++.++.++++||
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~  146 (260)
T cd05073          81 FMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADF  146 (260)
T ss_pred             eCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCC
Confidence            999999999997643  23578999999999999999999998   9999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.91  E-value=1e-23  Score=179.32  Aligned_cols=142  Identities=26%  Similarity=0.433  Sum_probs=123.5

Q ss_pred             CCCCCCeecccCceEEEEEEeC-----CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEee--CCeee
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEKL  205 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~--~~~~~  205 (284)
                      .|+..+.||+|+||.||++...     ++..+|+|.++..........|.+|+++++.++|+||+++++++..  ....+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            4566788999999999999853     3678999998654332234579999999999999999999999877  55789


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++|||+++++|.+++.....   .++|..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  153 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDF  153 (284)
T ss_pred             EEEecCCCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccc
Confidence            99999999999999976432   489999999999999999999998   9999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.91  E-value=6.6e-24  Score=180.90  Aligned_cols=143  Identities=24%  Similarity=0.346  Sum_probs=125.2

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ++|+..+.||+|+||+||++.. ++++.+|+|.+...........+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            4566678899999999999985 468899999886544333445789999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++++|.+++....    .+++.....++.+++.||.|||+..  +++||||||+||+++.++.++++||
T Consensus        85 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~  148 (284)
T cd06620          85 MDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDF  148 (284)
T ss_pred             CCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccC
Confidence            99999999987632    4789999999999999999999732  7999999999999999999999998

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=6.5e-24  Score=180.46  Aligned_cols=143  Identities=31%  Similarity=0.446  Sum_probs=126.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      .++|+..+.||+|+||.||++... ++..+|+|.+... .......+..|++++++++|||++++++.+......++|||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            356777888999999999999864 6889999998643 22233468899999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++++|.+++....   ..+++.....++.|++.||.|||+.   +++|+||||+||+++.++..+++||
T Consensus        83 ~~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~  147 (280)
T cd06611          83 FCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADF  147 (280)
T ss_pred             ccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccC
Confidence            999999999987643   2488999999999999999999999   9999999999999999999999998

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.91  E-value=9.6e-24  Score=178.49  Aligned_cols=142  Identities=24%  Similarity=0.347  Sum_probs=121.8

Q ss_pred             cCCCCCCeecccCceEEEEEEeCC----CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      ++|...+.||+|+||.||+|...+    ...+|+|...........+.+.+|+.+++.++||||+++++++.. ...+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            456778899999999999998532    246899988654333344578999999999999999999998865 567899


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||+++|+|.+++....   ..+++..+..++.+++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        85 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~  151 (270)
T cd05056          85 MELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDF  151 (270)
T ss_pred             EEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccC
Confidence            99999999999997642   2479999999999999999999998   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.91  E-value=1.2e-23  Score=176.90  Aligned_cols=137  Identities=31%  Similarity=0.472  Sum_probs=115.6

Q ss_pred             CeecccCceEEEEEEeC----CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEee-CCeeeEEEeCCC
Q 023282          138 NILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTEKLLVYPYMT  212 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~-~~~~~lv~e~~~  212 (284)
                      +.||+|+||.||+|...    +...+|+|.+...........+.+|+.+++.++|||++++++++.. .+..++++||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    2357999988543333334578899999999999999999998764 456789999999


Q ss_pred             CCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          213 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       213 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +|+|.+++.....   ..++.....++.|++.||+|||+.   +++||||||+|||++.++.++++||
T Consensus        81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~df  142 (262)
T cd05058          81 HGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADF  142 (262)
T ss_pred             CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCc
Confidence            9999999975432   357888899999999999999998   9999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.91  E-value=8.3e-24  Score=190.97  Aligned_cols=135  Identities=24%  Similarity=0.282  Sum_probs=119.6

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      .+|...+.||+|+||.||++... .++.||+|....       ..+.+|++++++++|+|||++++++...+..+++||+
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            36888899999999999999865 578899995321       2357899999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +. ++|.+++....   ..++|.++..++.|+++||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus       242 ~~-~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DF  304 (461)
T PHA03211        242 YR-SDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDF  304 (461)
T ss_pred             cC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEccc
Confidence            95 79999886532   2589999999999999999999998   9999999999999999999999998

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.91  E-value=9.3e-24  Score=177.14  Aligned_cols=137  Identities=35%  Similarity=0.464  Sum_probs=120.3

Q ss_pred             CeecccCceEEEEEEeCC--C--cEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCC
Q 023282          138 NILGRGGFGKVYKGRLAD--G--KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  213 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~  213 (284)
                      ++||+|++|.||+|.+.+  +  ..+|+|.+...........+..|+.++++++||||+++++.+.. ...++++||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  3  36999998755443345579999999999999999999999988 889999999999


Q ss_pred             CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          214 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       214 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+|.+++.....  ..++|.....++.|+++||+|||+.   +++||||||+||+++.++.++++||
T Consensus        80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~df  141 (257)
T cd05040          80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDF  141 (257)
T ss_pred             CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccc
Confidence            999999986532  3589999999999999999999998   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.91  E-value=1.4e-23  Score=175.40  Aligned_cols=137  Identities=29%  Similarity=0.480  Sum_probs=122.4

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCCChH
Q 023282          138 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVA  217 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g~L~  217 (284)
                      +.||+|+||.||++...+++.||+|.+...........+..|++++++++|+||+++++++......++++||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46899999999999976689999998865443334457899999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          218 SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       218 ~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++.....   .+++.....++.+++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        81 ~~l~~~~~---~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~  137 (251)
T cd05041          81 TFLRKKKN---RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDF  137 (251)
T ss_pred             HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeec
Confidence            99976422   478899999999999999999999   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.91  E-value=1.9e-23  Score=175.05  Aligned_cols=140  Identities=27%  Similarity=0.449  Sum_probs=124.0

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC----cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          134 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT----SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      |...+.||+|+||.||+|... ++..|++|.+.....    .+..+.+.+|+.+++.++|+||+++++++......++++
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            566789999999999999865 788999998854321    122346889999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++++|.+++....    .+++.....++.|+++||+|||+.   +++|+||+|+||+++.++.++++||
T Consensus        82 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~  146 (258)
T cd06632          82 ELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADF  146 (258)
T ss_pred             EecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccC
Confidence            9999999999997542    478999999999999999999998   9999999999999999999999998

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.91  E-value=3e-24  Score=180.16  Aligned_cols=139  Identities=32%  Similarity=0.486  Sum_probs=121.6

Q ss_pred             CCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHH-HHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCC
Q 023282          135 SNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  212 (284)
Q Consensus       135 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~-~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~  212 (284)
                      +..+.||+|+||+||++... +++.+|+|.+.......... ...+|+..++.++||||+++++++......+++|||++
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~   81 (260)
T PF00069_consen    2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP   81 (260)
T ss_dssp             EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred             EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence            45678999999999999965 56789999997554332222 34569999999999999999999999999999999999


Q ss_pred             CCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          213 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       213 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++|.+++....    .+++..+..++.|+++||+|||+.   +++|+||||+||+++.+++++++||
T Consensus        82 ~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Df  142 (260)
T PF00069_consen   82 GGSLQDYLQKNK----PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDF  142 (260)
T ss_dssp             TEBHHHHHHHHS----SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSG
T ss_pred             cccccccccccc----cccccccccccccccccccccccc---ccccccccccccccccccccccccc
Confidence            999999998332    479999999999999999999999   9999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.91  E-value=1.6e-23  Score=176.71  Aligned_cols=142  Identities=26%  Similarity=0.426  Sum_probs=121.6

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc----ccHHHHHHHHHHHhcCCCCCceeeeeEEeeC--Cee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS----GGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEK  204 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~--~~~  204 (284)
                      .+|+..+.||+|+||.||++.. .++..||+|.+......    .....+.+|+.++++++||||+++++++...  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4677889999999999999986 46889999988533221    1123688899999999999999999988763  457


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++|||+++++|.+++....    .+++.....++.|++.||.|||+.   +++|+||||+||+++.++.++++||
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Df  150 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDF  150 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcC
Confidence            89999999999999987542    378888999999999999999998   9999999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.91  E-value=1.3e-23  Score=179.84  Aligned_cols=144  Identities=28%  Similarity=0.467  Sum_probs=123.2

Q ss_pred             CCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeE
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~l  206 (284)
                      +|...+.||+|+||.||++...      ++..+++|.+.... ......+.+|++++++++|+||+++++++...+..++
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            4666789999999999999742      34568899875432 2233468899999999999999999999999999999


Q ss_pred             EEeCCCCCChHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCC
Q 023282          207 VYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  274 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~  274 (284)
                      ||||+++++|.+++.....            ....++|..+..++.|++.||+|||+.   +++||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence            9999999999999976421            123488999999999999999999999   9999999999999999999


Q ss_pred             cchhhh
Q 023282          275 QSSKTI  280 (284)
Q Consensus       275 ~~~~df  280 (284)
                      ++++||
T Consensus       162 ~~l~df  167 (291)
T cd05094         162 VKIGDF  167 (291)
T ss_pred             EEECCC
Confidence            999997

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.91  E-value=1.6e-23  Score=178.22  Aligned_cols=143  Identities=26%  Similarity=0.469  Sum_probs=125.2

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCC
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      +|+..+.||+|++|.||+|+.. ++..||+|.++..........+.+|+++++.++|+||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4677889999999999999964 688999999875544334456788999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      + ++|.+++..... ...+++..+..++.|++.||.|||+.   +++||||||+||+++++++++++||
T Consensus        81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~  144 (284)
T cd07836          81 D-KDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADF  144 (284)
T ss_pred             C-ccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeec
Confidence            8 489988875432 23589999999999999999999998   9999999999999999999999997

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.91  E-value=1.5e-23  Score=179.79  Aligned_cols=140  Identities=26%  Similarity=0.439  Sum_probs=123.3

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc---c-cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          134 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS---G-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~-~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      |+..+.||+|+||.||+|... +++.||+|.++.....   . ....+..|+++++.++|+||+++++++...+..++||
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF   81 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence            666788999999999999864 6889999999654332   1 2335778999999999999999999999989999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+ +|+|.+++....   ..+++..+..++.|+++||.|||+.   +++|+||||+||+++.++.++|+||
T Consensus        82 e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~df  146 (298)
T cd07841          82 EFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADF  146 (298)
T ss_pred             ccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccc
Confidence            999 899999997543   2589999999999999999999999   9999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.91  E-value=1.1e-23  Score=181.35  Aligned_cols=142  Identities=28%  Similarity=0.494  Sum_probs=120.6

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCc----EEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~l  206 (284)
                      ++|+..+.||+|+||.||+|... ++.    .+|+|.+..........++.+|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            45677889999999999999853 444    47888886543333344688999999999999999999998754 5678


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++||+++|+|.+++.....   .+++.....++.|++.||.|||+.   +++||||||+||+++.++.+|++||
T Consensus        86 v~e~~~~g~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Df  153 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKD---NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDF  153 (303)
T ss_pred             eehhcCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccc
Confidence            9999999999999976432   478999999999999999999998   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.91  E-value=1.5e-23  Score=179.44  Aligned_cols=143  Identities=29%  Similarity=0.424  Sum_probs=125.6

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      .+.|+..+.||+|+||.||+|+.. ++..+++|.+... .......+.+|+.+++.++|+|++++++.+......++|||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   89 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE   89 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence            355777889999999999999864 5889999998543 22234568899999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++++|..++.+...   .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+||
T Consensus        90 ~~~~~~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~df  154 (292)
T cd06644          90 FCPGGAVDAIMLELDR---GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADF  154 (292)
T ss_pred             cCCCCcHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccC
Confidence            9999999988865322   489999999999999999999998   9999999999999999999999998

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.91  E-value=1.4e-23  Score=180.70  Aligned_cols=142  Identities=21%  Similarity=0.333  Sum_probs=124.9

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc--ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|+..+.||+|+||.||++... .++.|++|.+......  .....+.+|+++++.++||||+++++.+...+..+++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            35778899999999999999864 5789999998654321  22346889999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++++|.+++....    .+++.....++.|++.||.|||+.   +++||||||+||+++.++.++++||
T Consensus        81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~df  145 (305)
T cd05609          81 EYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDF  145 (305)
T ss_pred             ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeC
Confidence            9999999999997542    478999999999999999999998   9999999999999999999999997

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.91  E-value=2.1e-23  Score=175.19  Aligned_cols=135  Identities=30%  Similarity=0.482  Sum_probs=117.8

Q ss_pred             CeecccCceEEEEEEeC-C---CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCC
Q 023282          138 NILGRGGFGKVYKGRLA-D---GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  213 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~  213 (284)
                      +.||+|+||.||+|... .   +..+|+|.+..........++..|+.+++.+.|+|++++++++. .+..+++|||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999742 2   26899999875544334557899999999999999999999876 4568999999999


Q ss_pred             CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          214 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       214 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+|.+++....    .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.++++||
T Consensus        80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df  139 (257)
T cd05060          80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDF  139 (257)
T ss_pred             CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccc
Confidence            99999997643    478999999999999999999998   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.91  E-value=2.2e-23  Score=174.94  Aligned_cols=140  Identities=29%  Similarity=0.458  Sum_probs=121.8

Q ss_pred             cCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEee-CCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~-~~~~~lv~e~  210 (284)
                      ++|...+.||+|+||.||++... +..+|+|.++..   ...+.+.+|+.++++++|+|++++++++.. .+..++++||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC---chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            46777899999999999999764 778999988543   224468899999999999999999998654 4568999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++++|.++++....  ..++|.....++.|++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df  146 (256)
T cd05082          82 MAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDF  146 (256)
T ss_pred             CCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCC
Confidence            999999999976432  2478999999999999999999998   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.91  E-value=1.4e-23  Score=184.68  Aligned_cols=138  Identities=24%  Similarity=0.340  Sum_probs=120.9

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEE
Q 023282          129 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       129 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      ....+|...+.||+|+||.||+|+.. ++..||+|.....       ....|+.++++++||||+++++++......++|
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence            34557999999999999999999865 5678999975322       234689999999999999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +||+. ++|.+++....   ..++|..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus       136 ~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~Df  201 (357)
T PHA03209        136 LPHYS-SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDL  201 (357)
T ss_pred             EEccC-CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecC
Confidence            99995 68999887532   3589999999999999999999998   9999999999999999999999998

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.91  E-value=1.1e-23  Score=184.54  Aligned_cols=142  Identities=25%  Similarity=0.352  Sum_probs=125.4

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcc--cHHHHHHHHHHHhcCC-CCCceeeeeEEeeCCeeeEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~-h~niv~l~g~~~~~~~~~lv  207 (284)
                      +.|+..+.||+|.||.||+++.+ +|+.+|+|.+.......  ....+.+|+.+|+.+. |||||.+.+.+......++|
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv  114 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV  114 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence            45677789999999999999865 59999999997554332  2357899999999998 99999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC----Ccchhhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA----DQSSKTIL  281 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~----~~~~~df~  281 (284)
                      ||++.+|.|.+.+...     .+++.....++.|++.|+.|||+.   +++||||||+|+|+....    ..+++||-
T Consensus       115 mEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  115 MELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            9999999999999875     288999999999999999999998   999999999999997663    58999983

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.91  E-value=8.9e-24  Score=180.67  Aligned_cols=153  Identities=31%  Similarity=0.426  Sum_probs=129.1

Q ss_pred             cHHHHHHHhcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEee
Q 023282          123 SLRELQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  200 (284)
Q Consensus       123 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~  200 (284)
                      ++.++..++++|+..+.||+|+||.||++.. .+++.+|+|.+....  .....+.+|+.++.++ +|||++++++++..
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            3445556678899999999999999999986 468899999885421  2234677899999888 79999999999875


Q ss_pred             C-----CeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCc
Q 023282          201 V-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  275 (284)
Q Consensus       201 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~  275 (284)
                      .     ...++|+||+++|+|.++++........++|.....++.|++.||.|||+.   +++||||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence            4     357999999999999999875333334689999999999999999999998   99999999999999999999


Q ss_pred             chhhh
Q 023282          276 SSKTI  280 (284)
Q Consensus       276 ~~~df  280 (284)
                      +++||
T Consensus       168 kl~df  172 (291)
T cd06639         168 KLVDF  172 (291)
T ss_pred             EEeec
Confidence            99997

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.91  E-value=9.3e-24  Score=178.22  Aligned_cols=141  Identities=26%  Similarity=0.420  Sum_probs=123.9

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ++|...+.||+|+||.||+++. .++..+|+|.++... ......+.+|+.+++.++||||+++++.+...+..++++||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            3456667899999999999985 468899999986442 22234578899999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++++|.+++....    .+++.+...++.|++.||.|||+.   +++|+||||+||+++.++.++++||
T Consensus        88 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~df  150 (267)
T cd06645          88 CGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADF  150 (267)
T ss_pred             cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcc
Confidence            99999999987542    478999999999999999999999   9999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.91  E-value=1.2e-24  Score=172.94  Aligned_cols=149  Identities=28%  Similarity=0.350  Sum_probs=130.0

Q ss_pred             HhcCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeC-----Ce
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TE  203 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~-----~~  203 (284)
                      ..++|.+.+.||+|+|+.||.++ ..++..+|+|++.... .++....++|++..++++|||++++++++...     ..
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            34567788999999999999998 6788899999996543 34455789999999999999999999887543     35


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .|+++.|...|+|.+.+.........+++.+.+.|+.++++||.+||.. .|+.+||||||.|||+.+++++.+.||
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEec
Confidence            8999999999999999987665555789999999999999999999998 567999999999999999999999997

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.8e-23  Score=180.84  Aligned_cols=143  Identities=30%  Similarity=0.348  Sum_probs=125.9

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcc--cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      +|+..+.||+|+||.||++... ++..+|+|.+.......  ....+..|+++++.++|+||+++++.+......+++||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            5777889999999999999865 58899999986543332  33468899999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++++|.+++....  ...+++.....++.|+++||+|||+.   +++|+||||+||+++.++.++++||
T Consensus        82 ~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~df  147 (316)
T cd05574          82 YCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDF  147 (316)
T ss_pred             ecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeec
Confidence            999999999987532  23588999999999999999999998   9999999999999999999999997

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=3.3e-25  Score=188.81  Aligned_cols=142  Identities=33%  Similarity=0.447  Sum_probs=128.2

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCC
Q 023282          133 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      .|...+.||+|+||.||+|.. ..++.||+|++..+...++..++++|+.++.+++++||.+++|.+.....+|++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            466678999999999999985 4788999999988777777778999999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  281 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df~  281 (284)
                      .+|++.+.|....    .+.+....-+..++..||.|||++   +.+|||||+.|||+..++.+|++||.
T Consensus        94 ~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~Dfg  156 (467)
T KOG0201|consen   94 GGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFG  156 (467)
T ss_pred             cCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecc
Confidence            9999999997542    246666777889999999999999   99999999999999999999999994

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.91  E-value=1e-23  Score=178.32  Aligned_cols=144  Identities=31%  Similarity=0.484  Sum_probs=123.3

Q ss_pred             HhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEeeC------
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV------  201 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~------  201 (284)
                      +.+.|+..+.||+|+||.||+|... +++.+|+|.+....  .....+..|+.++.++ +|+|++++++++...      
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            4456777788999999999999864 67899999986432  3345688999999888 699999999998753      


Q ss_pred             CeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          202 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       202 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ...+++|||+++|+|.+++....  ...++|..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df  155 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF  155 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence            35789999999999999997632  23578999999999999999999998   9999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.91  E-value=1.3e-23  Score=179.39  Aligned_cols=145  Identities=28%  Similarity=0.358  Sum_probs=124.6

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeC--CeeeEEEe
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLLVYP  209 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~--~~~~lv~e  209 (284)
                      +|...+.||.|++|.||++... +++.+|+|.+...........+.+|+++++.++||||+++++++...  +..+++||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            5677889999999999999964 67899999986543333445789999999999999999999998653  36899999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++++|.+++.........+++.....++.|++.||+|||+.   +++|+||+|+||+++.++.++++||
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~df  149 (287)
T cd06621          82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDF  149 (287)
T ss_pred             ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeec
Confidence            9999999998765333334578889999999999999999998   9999999999999999999999998

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.91  E-value=1.8e-23  Score=176.99  Aligned_cols=140  Identities=27%  Similarity=0.435  Sum_probs=121.9

Q ss_pred             CCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcc---------cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCe
Q 023282          134 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG---------GELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  203 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~---------~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~  203 (284)
                      |...+.||+|+||.||+|.. .+++.+|+|.++......         ..+.+..|+.+++.++|||++++++++...+.
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   82 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY   82 (272)
T ss_pred             eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence            55678999999999999985 468899999875321110         11357889999999999999999999999999


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .++|+||+++++|.++++..    ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++++||
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~  152 (272)
T cd06629          83 LSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDF  152 (272)
T ss_pred             eEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeec
Confidence            99999999999999999764    2588899999999999999999998   9999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.91  E-value=1.9e-23  Score=177.81  Aligned_cols=140  Identities=30%  Similarity=0.468  Sum_probs=122.2

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCC
Q 023282          134 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  212 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~  212 (284)
                      |+..+.||+|+||.||++... ++..+++|.+.... ......+.+|+++++.++|||++++++++...+..++++||++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            345678999999999999865 57788999885332 2234468899999999999999999999999999999999999


Q ss_pred             CCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          213 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       213 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++|..++....   .+++|..+..++.|+++||.|||+.   +++||||||+||+++.++.++++||
T Consensus        86 ~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~df  147 (282)
T cd06643          86 GGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADF  147 (282)
T ss_pred             CCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccc
Confidence            999999886532   2589999999999999999999998   9999999999999999999999998

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=3.1e-23  Score=174.31  Aligned_cols=143  Identities=31%  Similarity=0.464  Sum_probs=126.8

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      .++|+..+.||+|+||.||++... ++..+++|.+...... ....+.+|+++++.++||||+++++++......+++||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e   80 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME   80 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence            356788899999999999999864 5788999998654322 44578999999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++++|.+++....   ..+++.....++.|++.||+|||+.   +++|+||||+||+++.++.++++||
T Consensus        81 ~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~  145 (262)
T cd06613          81 YCGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADF  145 (262)
T ss_pred             CCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECcc
Confidence            999999999987642   2478999999999999999999998   9999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.90  E-value=2.3e-23  Score=174.98  Aligned_cols=134  Identities=25%  Similarity=0.393  Sum_probs=116.0

Q ss_pred             eecccCceEEEEEEe---CCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCC
Q 023282          139 ILGRGGFGKVYKGRL---ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  214 (284)
Q Consensus       139 ~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g  214 (284)
                      .||+|+||.||+|.+   .++..+|+|.++..... ....++..|+.+++.++||||+++++++. .+..+++|||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999964   35678999998644322 22346899999999999999999999885 45678999999999


Q ss_pred             ChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          215 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       215 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +|.+++....    .+++.....++.|++.||.|||+.   +++||||||+||+++.++.++++||
T Consensus        81 ~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Df  139 (257)
T cd05116          81 PLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDF  139 (257)
T ss_pred             cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCC
Confidence            9999997532    478999999999999999999998   9999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.90  E-value=6.1e-24  Score=180.41  Aligned_cols=139  Identities=32%  Similarity=0.495  Sum_probs=122.3

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCC
Q 023282          134 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  212 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~  212 (284)
                      |+..+.||+|+||.||+|... ++..||+|.+...........+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            344567999999999999854 5788999988644333334568899999999999999999999999999999999999


Q ss_pred             CCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          213 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       213 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++|.+++...     .+++.....++.|+++||.|||+.   +++|+||+|+||+++.++.++++||
T Consensus        86 ~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~df  145 (277)
T cd06642          86 GGSALDLLKPG-----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADF  145 (277)
T ss_pred             CCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccc
Confidence            99999998642     478999999999999999999998   9999999999999999999999998

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.90  E-value=3.2e-24  Score=186.38  Aligned_cols=144  Identities=25%  Similarity=0.377  Sum_probs=127.4

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccH-HHHHHHHHHHhcCCCCCceeeeeEEeeCCe-eeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGE-LQFQTEVKIISMAVHRNLLRLYGFCTTVTE-KLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~e~~~l~~~~h~niv~l~g~~~~~~~-~~lv~  208 (284)
                      ++|...+++|+|+||.++..+.+ ++..+++|.+......+.. +...+|+.++++++|||||.+++.+...+. .+++|
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            56777899999999999988754 6778999999765544443 367899999999999999999999998887 99999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +|++||++.+.+....+  .-++..+...+..|++.|+.|||+.   +|+|||||+.||++..+..++++||
T Consensus        84 ~Y~eGg~l~~~i~~~k~--~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDf  150 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKG--VLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDF  150 (426)
T ss_pred             eecCCCCHHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecch
Confidence            99999999999987652  3578899999999999999999988   9999999999999999999999998

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=3.3e-24  Score=178.98  Aligned_cols=140  Identities=24%  Similarity=0.403  Sum_probs=119.7

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecc-cCcccHHHHHHHHHHHhcCCCCCceeeeeEEee-----CCeee
Q 023282          133 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEE-RTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-----VTEKL  205 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~-----~~~~~  205 (284)
                      .|...+.||+|+||.|+.+.. .+|..||||++... ......++-.+|+.+++.++|+||+.+++.+..     -...+
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY  102 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY  102 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence            344468899999999999985 47899999998632 222334567899999999999999999998865     34689


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +|+|+|+ -+|...++...    .++......+..|+++||.|+|+.   +++||||||+|+|++.+.+.||+||
T Consensus       103 iV~elMe-tDL~~iik~~~----~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DF  169 (359)
T KOG0660|consen  103 LVFELME-TDLHQIIKSQQ----DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDF  169 (359)
T ss_pred             EehhHHh-hHHHHHHHcCc----cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccc
Confidence            9999994 59999997643    388889999999999999999999   9999999999999999999999999

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.90  E-value=2.6e-23  Score=176.60  Aligned_cols=139  Identities=32%  Similarity=0.486  Sum_probs=123.5

Q ss_pred             CCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCC
Q 023282          134 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  212 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~  212 (284)
                      |+..+.||+|+||.||+|.. .++..+|+|.+...........+.+|+..++.++||||+++++++...+..++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            56678899999999999985 46789999987543333334568899999999999999999999999999999999999


Q ss_pred             CCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          213 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       213 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++|.+++...     .+++.....++.|++.|+.|||+.   +++|+||||+||+++.++.++++||
T Consensus        86 ~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~df  145 (277)
T cd06641          86 GGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADF  145 (277)
T ss_pred             CCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeec
Confidence            99999998642     478999999999999999999998   9999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.90  E-value=2.6e-23  Score=174.16  Aligned_cols=141  Identities=34%  Similarity=0.526  Sum_probs=124.0

Q ss_pred             CCCCeecccCceEEEEEEeCC-----CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          135 SNKNILGRGGFGKVYKGRLAD-----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       135 ~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      +..+.||.|+||.||++...+     +..+|+|.++..........+..|++.+..++|+||+++++++...+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            456889999999999998653     378999999655433345679999999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++++|.+++......  .+++.....++.|++.||+|||+.   +++|+||||+||+++.++.++++||
T Consensus        82 ~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~df  147 (258)
T smart00219       82 YMEGGDLLDYLRKNRPK--ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDF  147 (258)
T ss_pred             ccCCCCHHHHHHhhhhc--cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEccc
Confidence            99999999999764321  279999999999999999999999   9999999999999999999999997

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.90  E-value=2.8e-23  Score=174.00  Aligned_cols=141  Identities=30%  Similarity=0.461  Sum_probs=126.7

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      .++|+..+.||+|+||.||+|... ++..+++|.+.....   ..++.+|+++++.++|+|++++++++......++++|
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e   78 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME   78 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence            356888899999999999999975 478999999864322   4579999999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++++|.+++....   ..++|.....++.|++.||.|||+.   +++|+||+|+||+++.++.++++||
T Consensus        79 ~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~df  143 (256)
T cd06612          79 YCGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADF  143 (256)
T ss_pred             cCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEccc
Confidence            999999999997533   2589999999999999999999998   9999999999999999999999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.90  E-value=2e-23  Score=177.56  Aligned_cols=144  Identities=31%  Similarity=0.487  Sum_probs=123.4

Q ss_pred             CCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeE
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~l  206 (284)
                      ++...+.||+|+||.||++...      ++..+|+|.+... .......+.+|+++++.++|+||+++++++......++
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            4666789999999999999632      3557899987543 22334579999999999999999999999999899999


Q ss_pred             EEeCCCCCChHHHHhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCc
Q 023282          207 VYPYMTNGSVASRLRERQS-----------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  275 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~  275 (284)
                      ++||+++|+|.++++....           ....++|..+..++.|++.||+|||+.   +++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence            9999999999999976421           113578999999999999999999998   99999999999999999999


Q ss_pred             chhhh
Q 023282          276 SSKTI  280 (284)
Q Consensus       276 ~~~df  280 (284)
                      +++||
T Consensus       162 kL~df  166 (280)
T cd05092         162 KIGDF  166 (280)
T ss_pred             EECCC
Confidence            99997

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.90  E-value=2.7e-23  Score=176.52  Aligned_cols=140  Identities=31%  Similarity=0.467  Sum_probs=124.3

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCC
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      .|+..+.||+|+||.||+|... ++..+|+|.+...........+.+|+.+++.++||||+++++++......++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            3556688999999999999864 688999999865433334457889999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++|+|.+++...     ++++.+...++.|++.||+|||+.   +++|+||+|+||+++.++.++++||
T Consensus        85 ~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~df  145 (277)
T cd06640          85 GGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADF  145 (277)
T ss_pred             CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEccc
Confidence            999999998642     478889999999999999999998   9999999999999999999999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.90  E-value=1.5e-23  Score=184.79  Aligned_cols=140  Identities=23%  Similarity=0.292  Sum_probs=118.8

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC------
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT------  202 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~------  202 (284)
                      .++|...+.||+|+||.||++.. .++..||+|.+...... .....+.+|+.+++.++||||+++++++....      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            46788889999999999999985 46889999998643322 23446889999999999999999999986543      


Q ss_pred             eeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          203 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       203 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ..+++|||+++ +|.+.++.      .+++.....++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Df  167 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  167 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecC
Confidence            46899999975 67666643      267888899999999999999999   9999999999999999999999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.90  E-value=4e-23  Score=174.25  Aligned_cols=140  Identities=28%  Similarity=0.468  Sum_probs=122.4

Q ss_pred             CCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCccc--------HHHHHHHHHHHhcCCCCCceeeeeEEeeCCee
Q 023282          134 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGG--------ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  204 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~--------~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~  204 (284)
                      |.....||+|+||.||+|.. .++..+|+|.+........        ...+.+|+.++++++||||+++++++......
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            56678999999999999985 4678999998864332211        13578899999999999999999999999999


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++++||+++++|.+++....    .+++.....++.|++.||+|||+.   +++||||+|+||+++.++.++++||
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~df  150 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDF  150 (267)
T ss_pred             EEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEeccc
Confidence            99999999999999997642    478889999999999999999998   9999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.90  E-value=2.6e-23  Score=175.45  Aligned_cols=141  Identities=29%  Similarity=0.440  Sum_probs=123.0

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcc-----cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeE
Q 023282          133 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-----GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~l  206 (284)
                      +|+..+.||+|++|.||++.. .+++.+|+|.+.......     ....+..|+.++++++|+||+++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            467788999999999999985 578899999986433211     23468899999999999999999999999999999


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC-Ccchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~-~~~~~df  280 (284)
                      ++||+++++|.+++....    ++++.....++.|++.||.|||+.   +++|+||||+||+++.++ .++++||
T Consensus        81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~df  148 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADF  148 (268)
T ss_pred             EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccc
Confidence            999999999999997532    478999999999999999999999   999999999999998876 5899997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.90  E-value=9.8e-24  Score=179.77  Aligned_cols=141  Identities=24%  Similarity=0.407  Sum_probs=123.9

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcc-cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +|+..+.||+|+||.||+|... +++.+|+|.+....... ....+.+|+++++.++||||+++++++...+..++++||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF   81 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence            5777899999999999999975 58899999885433222 234688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++++|.++.....    .++|.++..++.|+++||+|||+.   +++|+||+|+||++++++.++++||
T Consensus        82 ~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~df  144 (286)
T cd07846          82 VDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDF  144 (286)
T ss_pred             CCccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEee
Confidence            99998888775432    379999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.90  E-value=5.6e-23  Score=173.10  Aligned_cols=145  Identities=29%  Similarity=0.434  Sum_probs=127.9

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ++|+..+.||+|+||+||+|... ++..+|+|.+...........+.+|++.++.++|+|++++++.+...+..++++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            36788899999999999999854 67899999986544334456789999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++++|.++++.... ...+++.....++.|++.||+|||+.   +++||||+|+||++++++..+++||
T Consensus        81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df  146 (267)
T cd06610          81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADF  146 (267)
T ss_pred             cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccc
Confidence            999999999976422 13578999999999999999999998   9999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.90  E-value=3.6e-23  Score=173.47  Aligned_cols=140  Identities=28%  Similarity=0.495  Sum_probs=124.2

Q ss_pred             CCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCC
Q 023282          133 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  212 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~  212 (284)
                      +|+..+.||+|+||.||++...++..+|+|.+....  ....++..|+++++.++|||++++++++......++++||++
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA--MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC--CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            566678999999999999987777889999886432  223468899999999999999999999998889999999999


Q ss_pred             CCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          213 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       213 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++|.+++.....   .++|.....++.+++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        83 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~  144 (256)
T cd05112          83 HGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDF  144 (256)
T ss_pred             CCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCC
Confidence            9999999975432   478999999999999999999998   9999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=2.6e-23  Score=176.16  Aligned_cols=140  Identities=31%  Similarity=0.421  Sum_probs=125.8

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCC
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      +|+..+.||.|++|.||+|... +++.+|+|.+...........+.+|+.+++.++|+|++++.+++......++++||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            4667788999999999999864 688999999865443344456889999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++++|.+++...     .+++.....++.|++.||.|||+.   +++||||+|+||+++.++.++++||
T Consensus        82 ~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~  142 (274)
T cd06609          82 GGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADF  142 (274)
T ss_pred             CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccc
Confidence            999999999753     588999999999999999999998   9999999999999999999999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.90  E-value=1.3e-23  Score=177.42  Aligned_cols=140  Identities=32%  Similarity=0.506  Sum_probs=119.6

Q ss_pred             CeecccCceEEEEEEeCC-------CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          138 NILGRGGFGKVYKGRLAD-------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +.||+|+||.||+|+..+       +..+|+|.+...........+.+|+.+++.++||||+++++++...+..+++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998532       2579999886543333455788999999999999999999999988899999999


Q ss_pred             CCCCChHHHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC-----Ccchhhh
Q 023282          211 MTNGSVASRLRERQS---SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-----DQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~-----~~~~~df  280 (284)
                      +++++|.++++....   ....++|.+++.++.|++.||.|||+.   +++|+||||+||+++.++     .++++||
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~df  155 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDF  155 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCc
Confidence            999999999975322   123478999999999999999999998   899999999999999888     8999987

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.90  E-value=1.2e-23  Score=200.33  Aligned_cols=153  Identities=16%  Similarity=0.278  Sum_probs=124.9

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeC--Ce
Q 023282          128 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TE  203 (284)
Q Consensus       128 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~--~~  203 (284)
                      ....++|.+.+.||+|+||+||++... ++..+|+|.+...... .....+..|+.+++.++|||||++++++...  ..
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            344567888999999999999999864 5778999988644322 2334688999999999999999999988653  46


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC----CCeeeeCCCCCCeeeCCC-------
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD----PKIIHRDVKAANILLDED-------  272 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~----~~ivHrdlk~~NiLld~~-------  272 (284)
                      .++||||+++|+|.++|.........+++..++.|+.||+.||+|||+.+.    .+|+||||||+|||++.+       
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            899999999999999997643333468999999999999999999998531    259999999999999653       


Q ss_pred             ----------CCcchhhh
Q 023282          273 ----------ADQSSKTI  280 (284)
Q Consensus       273 ----------~~~~~~df  280 (284)
                                ..+||+||
T Consensus       169 ~~~~~n~ng~~iVKLsDF  186 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDF  186 (1021)
T ss_pred             cccccccCCCCceEEccC
Confidence                      34788988

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.90  E-value=1.7e-24  Score=193.55  Aligned_cols=140  Identities=29%  Similarity=0.423  Sum_probs=123.8

Q ss_pred             CCCCeecccCceEEEEEEeC--CCc--EEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          135 SNKNILGRGGFGKVYKGRLA--DGK--LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       135 ~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ...++||+|+||.|++|.|.  +|+  .||||.++.+.......+|.+|+.+|.+++|+|+++|||...+ ....+|+|.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            34578999999999999875  344  6899999877655556689999999999999999999999987 678899999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++.|+|.+.|+..  ....+-......++.|||+||.||.++   ++|||||.++|+|+-....+||+||
T Consensus       192 aplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DF  256 (1039)
T KOG0199|consen  192 APLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDF  256 (1039)
T ss_pred             cccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecc
Confidence            9999999999982  223577788899999999999999999   9999999999999999999999999

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.90  E-value=6.6e-23  Score=173.04  Aligned_cols=142  Identities=27%  Similarity=0.449  Sum_probs=122.1

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc----ccHHHHHHHHHHHhcCCCCCceeeeeEEee--CCee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS----GGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEK  204 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~~~h~niv~l~g~~~~--~~~~  204 (284)
                      .+|+..+.||+|+||.||++.. .++..+|+|.+......    .....+.+|+.+++.++||||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            3678889999999999999985 46889999988643221    122358889999999999999999998865  3567


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++++||+++++|.+++....    .+++.....++.|++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~df  150 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDF  150 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccC
Confidence            89999999999999997532    478889999999999999999998   9999999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.90  E-value=4.6e-23  Score=172.82  Aligned_cols=143  Identities=20%  Similarity=0.314  Sum_probs=125.0

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccC-cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          133 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +|+..+.||+|+||.+|++.. .+++.+|+|.+..... .....++.+|+.++++++||||+++.+++...+..++++||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            366788999999999999985 4688999999864322 22344789999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++++|.+++.....  ..+++.+...++.|++.||.|||+.   +++|+||+|+||+++.+++++++||
T Consensus        81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~  145 (256)
T cd08218          81 CEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDF  145 (256)
T ss_pred             CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeec
Confidence            999999999976322  2478899999999999999999998   9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.90  E-value=2.1e-23  Score=182.62  Aligned_cols=141  Identities=25%  Similarity=0.348  Sum_probs=119.7

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeC------C
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV------T  202 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~------~  202 (284)
                      .++|...+.||+|+||.||++.. .++..||||.+...... .....+.+|+.+++.++||||+++++++...      .
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            46788889999999999999985 46789999998643222 2234577899999999999999999987532      3


Q ss_pred             eeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          203 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       203 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ..++++|++ +++|.+++...     .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        94 ~~~~~~~~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          94 EVYLVTNLM-GADLNNIVKCQ-----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             cEEEEeecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence            468999988 78998887532     488999999999999999999999   9999999999999999999999998

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.90  E-value=4.1e-23  Score=173.51  Aligned_cols=148  Identities=24%  Similarity=0.348  Sum_probs=124.0

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEee--CCeeeEEE
Q 023282          133 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEKLLVY  208 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~--~~~~~lv~  208 (284)
                      +|+..+.||.|+||.||++.. .++..+|+|.+...... .....+..|+++++.++|+|++++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            366778999999999999985 46789999998643322 233468899999999999999999998764  34578999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC--DPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~--~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++++|.+++.........+++.....++.|++.||+|||..+  ..+++|+||||+||+++.++.++++||
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~  154 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDF  154 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecc
Confidence            999999999999765333456899999999999999999999332  339999999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.90  E-value=2.3e-23  Score=175.41  Aligned_cols=142  Identities=32%  Similarity=0.417  Sum_probs=126.5

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCC
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      +|+..+.||+|+||.||++... +++.+|+|.+..........++.+|+++++.++||||+++++.+......++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            4666788999999999999865 688999999876544444557899999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++++|.+++....   ..+++.....++.|++.||+|||+ .   +++|+||||+||+++.++.++++||
T Consensus        82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~  145 (265)
T cd06605          82 DGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDF  145 (265)
T ss_pred             CCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeec
Confidence            9999999997643   357888999999999999999999 7   9999999999999999999999998

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.90  E-value=4.4e-23  Score=173.55  Aligned_cols=141  Identities=30%  Similarity=0.493  Sum_probs=125.3

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +|...+.||+|+||.||+|... ++..+++|.++..... .....+..|+++++.++|+||+++++++...+..++++||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            3667789999999999999854 6889999998754432 2345789999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++++|.+++....    .+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.++++||
T Consensus        81 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~  143 (264)
T cd06626          81 CSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDF  143 (264)
T ss_pred             CCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccc
Confidence            99999999997642    368889999999999999999998   9999999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=4.4e-23  Score=175.02  Aligned_cols=140  Identities=26%  Similarity=0.452  Sum_probs=124.1

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCC---CCCceeeeeEEeeCCeeeEEE
Q 023282          133 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV---HRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~---h~niv~l~g~~~~~~~~~lv~  208 (284)
                      .|+..+.||+|+||.||+|.. .++..+|+|.++.........++.+|+.+++.++   |||++++++++......+++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            356678899999999999985 5788999999865444444456889999998886   999999999999989999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++++|.++++..     .+++.....++.|+++||.|||+.   +++|+||+|+||+++.++.++++||
T Consensus        82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~df  145 (277)
T cd06917          82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDF  145 (277)
T ss_pred             ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccC
Confidence            999999999998653     488999999999999999999998   9999999999999999999999998

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.90  E-value=6e-23  Score=172.66  Aligned_cols=141  Identities=29%  Similarity=0.451  Sum_probs=127.0

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCC
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      +|+..+.||+|++|.||++... +++.+++|.+...........+..|+..+..++|+|++++++++......++++||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            5777899999999999999865 589999999865443334557999999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++++|.+++...    ..+++.....++.|+++||+|||+ .   +++||||+|+||+++.++.++++||
T Consensus        82 ~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df  144 (264)
T cd06623          82 DGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADF  144 (264)
T ss_pred             CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccC
Confidence            999999999764    358899999999999999999999 8   9999999999999999999999997

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.90  E-value=1.1e-23  Score=177.07  Aligned_cols=136  Identities=25%  Similarity=0.409  Sum_probs=114.6

Q ss_pred             CeecccCceEEEEEEeCC--------CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          138 NILGRGGFGKVYKGRLAD--------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      +.||+|+||.||+|....        ...+|+|.+.... ......+.+|+.+++.++|||++++++++......++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence            468999999999997532        2348888774322 2233468889999999999999999999999899999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCc--------chhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ--------SSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~--------~~~df  280 (284)
                      |+++|+|.++++....   .++|..+..++.|++.||+|||+.   +|+||||||+||+++.+++.        +++||
T Consensus        80 ~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          80 YVKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             cCCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence            9999999999976432   478999999999999999999998   99999999999999988875        66665

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.90  E-value=4.1e-23  Score=173.07  Aligned_cols=139  Identities=30%  Similarity=0.494  Sum_probs=121.0

Q ss_pred             cCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      ++|+..+.||+|+||.||++.. ++..+|+|.++...   ....+.+|+.+++.++|||++++++++.. +..+++|||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECC
Confidence            4577789999999999999875 57789999885432   23468899999999999999999999865 4579999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++++|.+++.....  ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++++||
T Consensus        81 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Df  144 (254)
T cd05083          81 SKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDF  144 (254)
T ss_pred             CCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCC
Confidence            99999999976432  2478999999999999999999998   9999999999999999999999997

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.90  E-value=4.7e-23  Score=175.51  Aligned_cols=141  Identities=26%  Similarity=0.405  Sum_probs=124.8

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC-cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +|+..+.||+|+||.||+|... ++..+|+|.+..... ......+.+|+.+++.++|||++++++++......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            3667789999999999999864 688999999865432 22345689999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      + +++|.+++....   ..+++..+..++.|+++||+|||+.   +++|+||||+||+++.++.++++||
T Consensus        81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~df  143 (286)
T cd07832          81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADF  143 (286)
T ss_pred             c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeee
Confidence            9 999999997543   3589999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.90  E-value=1.7e-23  Score=175.73  Aligned_cols=141  Identities=26%  Similarity=0.360  Sum_probs=125.4

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc--ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      +|...+.||+|+||.||++... ++..+|+|.+......  .....+.+|++++++++||||+++++++......++++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            3667789999999999999865 6889999998654322  234578999999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++++|.+++...    .++++.....++.|+++||.|||+.   +++|+||+|+||+++.++.++++||
T Consensus        81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~  144 (258)
T cd05578          81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDF  144 (258)
T ss_pred             CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeec
Confidence            99999999999764    2578999999999999999999998   9999999999999999999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.90  E-value=4.6e-23  Score=176.90  Aligned_cols=140  Identities=21%  Similarity=0.376  Sum_probs=125.1

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      .+|+..+.||.|++|.||+|.. .+++.|++|.+.... ......+.+|+.+++.++|||++++++++...+..++|+||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            3577788999999999999985 578899999886433 23345688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++++|.+++...     .++|.++..++.|++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~df  159 (296)
T cd06655          98 LAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDF  159 (296)
T ss_pred             cCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccC
Confidence            9999999998643     378999999999999999999999   9999999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.90  E-value=1.4e-23  Score=187.03  Aligned_cols=140  Identities=27%  Similarity=0.418  Sum_probs=121.0

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCC-C-----CCceeeeeEEeeCCeee
Q 023282          133 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-H-----RNLLRLYGFCTTVTEKL  205 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h-----~niv~l~g~~~~~~~~~  205 (284)
                      +|++.++||+|+||+|.+|.. .+++.||||+++...  ....+-..|+.+|..++ |     -|+|++++++...++.|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            577889999999999999984 579999999997543  23345678899998887 4     49999999999999999


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC--Ccchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA--DQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~--~~~~~df  280 (284)
                      ||+|.+. -+|+++|+....  ..++......++.||+.||.+||..   +|||+||||+||||.+-.  ++||.||
T Consensus       265 iVfELL~-~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDF  335 (586)
T KOG0667|consen  265 IVFELLS-TNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDF  335 (586)
T ss_pred             eeehhhh-hhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEec
Confidence            9999996 499999997543  3588899999999999999999999   999999999999997654  7899998

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.90  E-value=3.6e-23  Score=176.14  Aligned_cols=142  Identities=23%  Similarity=0.451  Sum_probs=123.8

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcc-cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +|+..+.||+|++|.||+|+.. +++.+|+|.++...... ....+.+|++++++++||||+++++++...+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4677889999999999999864 68899999886443222 234688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +. ++|.+++....  ...+++.....++.|+++||+|||+.   +++||||+|+||+++.++.++++||
T Consensus        81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~df  144 (284)
T cd07860          81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADF  144 (284)
T ss_pred             cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeec
Confidence            96 68999887543  23588999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.90  E-value=6.2e-23  Score=175.08  Aligned_cols=142  Identities=29%  Similarity=0.451  Sum_probs=116.1

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcc-cHHHHHHHHHHHhcC---CCCCceeeeeEEee-----CC
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMA---VHRNLLRLYGFCTT-----VT  202 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~---~h~niv~l~g~~~~-----~~  202 (284)
                      +|...+.||+|+||.||+|+.. +++.||+|.++...... ....+.+|+++++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            3667789999999999999864 68899999986533222 223456677766554   79999999998864     23


Q ss_pred             eeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          203 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       203 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ..++++||++ ++|.+++.....  ..+++..+..++.|++.||.|||+.   +++||||||+|||++.++.++++||
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~df  152 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADF  152 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcc
Confidence            5789999998 589888875322  3488999999999999999999999   9999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.90  E-value=2.9e-23  Score=176.79  Aligned_cols=140  Identities=22%  Similarity=0.447  Sum_probs=121.7

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCC
Q 023282          134 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      |+..+.||+|+||.||+++.. +|..+|+|.++..... .....+.+|+++++.++||||+++++++......++++||+
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC   81 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence            666788999999999999864 6889999998643222 22345788999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      + ++|.+++....   ..+++.....++.|+++||.|||+.   +++||||||+||+++.+++++++||
T Consensus        82 ~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~df  143 (284)
T cd07839          82 D-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADF  143 (284)
T ss_pred             C-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECcc
Confidence            7 58888876532   2489999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.90  E-value=2.7e-23  Score=182.82  Aligned_cols=141  Identities=23%  Similarity=0.303  Sum_probs=119.1

Q ss_pred             HhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeC------
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV------  201 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~------  201 (284)
                      ..++|...+.||+|+||.||++... .++.+|+|.+...... .....+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            3467888899999999999999854 6889999998644322 2234678899999999999999999988643      


Q ss_pred             CeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          202 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       202 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ...+++|||+++ ++.+.+..      .+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Df  163 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeC
Confidence            346899999975 67777653      378888999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.90  E-value=5e-23  Score=176.21  Aligned_cols=142  Identities=25%  Similarity=0.386  Sum_probs=123.0

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcc-cHHHHHHHHHHHhcCCCCCceeeeeEEeeC--CeeeEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLLV  207 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~g~~~~~--~~~~lv  207 (284)
                      ++|+..+.||+|+||.||+|... +++.+|+|.++...... ....+.+|+.++.+++||||+++++++...  ...+++
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            45777889999999999999965 68899999986443222 223567899999999999999999998877  889999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||++ ++|.+++.....   .+++.....++.|++.||+|||+.   +++|+||||+||+++.++.++++||
T Consensus        85 ~e~~~-~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~  150 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQ---PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDF  150 (293)
T ss_pred             ehhcC-cCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeec
Confidence            99997 599998875432   589999999999999999999998   9999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.90  E-value=6.5e-23  Score=175.54  Aligned_cols=145  Identities=26%  Similarity=0.417  Sum_probs=122.0

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCC-CCCceeeeeEEeeCCe-----
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTE-----  203 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~~~~-----  203 (284)
                      ++|+..+.||+|+||.||+|... +++.||+|.++..... .....+.+|+.+++.+. ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            35778899999999999999864 6889999988644322 22346888999999995 6999999999877655     


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC-CCCcchhhh
Q 023282          204 KLLVYPYMTNGSVASRLRERQSS-LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTI  280 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~-~~~~~~~df  280 (284)
                      .+++|||+++ +|.+++...... ...+++.....++.|+++||.|||+.   +++||||||+||+++. ++.++++||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~df  155 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADL  155 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeec
Confidence            7999999985 898888754322 34689999999999999999999998   9999999999999999 889999997

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.90  E-value=1.2e-22  Score=173.24  Aligned_cols=143  Identities=27%  Similarity=0.447  Sum_probs=128.0

Q ss_pred             HhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ..+.|+..+.||+|++|.||++... ++..+++|.+.....  ....+..|+++++.++|+|++++++++...+..++++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            4556777789999999999999875 688999999864432  3456889999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++++|.+++....   ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++++||
T Consensus        95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~  160 (286)
T cd06614          95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADF  160 (286)
T ss_pred             eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECcc
Confidence            9999999999998753   2589999999999999999999998   9999999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.90  E-value=6.8e-23  Score=175.12  Aligned_cols=141  Identities=28%  Similarity=0.344  Sum_probs=122.2

Q ss_pred             CCCCCCeecccCceEEEEEEe----CCCcEEEEEEeecccC---cccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCCee
Q 023282          133 GFSNKNILGRGGFGKVYKGRL----ADGKLVAVKRLKEERT---SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEK  204 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~  204 (284)
                      +|+..+.||+|+||.||+++.    .+|..+|+|.++....   ....+.+..|+.++..+ +|+||+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            366778999999999999975    3688999999865322   12234678899999999 599999999999888889


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++|+||+++++|.+++....    .+++.....++.|+++||.|||+.   +++||||+|+|||++.++.++++||
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df  149 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDF  149 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeC
Confidence            99999999999999997642    478888999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=5.5e-23  Score=173.80  Aligned_cols=146  Identities=32%  Similarity=0.453  Sum_probs=126.1

Q ss_pred             HhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCC-----
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVT-----  202 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~-----  202 (284)
                      ++++|+..+.||+|++|.||+|... +++.+++|.+.....  ....+.+|+.+++++ +|+||+++++++....     
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            4578899999999999999999964 678999998864322  335689999999998 6999999999997644     


Q ss_pred             -eeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          203 -EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       203 -~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                       ..+++|||+++++|.+++.........+++..+..++.|+++||.|||+.   +++|+||+|+||+++.++.++++||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~  157 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF  157 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCC
Confidence             48999999999999999876432234688999999999999999999998   9999999999999999999999998

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.89  E-value=8.7e-23  Score=173.38  Aligned_cols=136  Identities=29%  Similarity=0.409  Sum_probs=119.0

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCCCh
Q 023282          140 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  216 (284)
Q Consensus       140 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g~L  216 (284)
                      ||+|+||+||++... ++..+|+|.+.....  ......+..|+++++.++|||++++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999854 688999999864322  22233567899999999999999999999998999999999999999


Q ss_pred             HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          217 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       217 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .+++.....  ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++++||
T Consensus        81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~df  139 (277)
T cd05577          81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDL  139 (277)
T ss_pred             HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccC
Confidence            999976432  3588999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=9.5e-23  Score=171.89  Aligned_cols=142  Identities=27%  Similarity=0.440  Sum_probs=121.7

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccC----cccHHHHHHHHHHHhcCCCCCceeeeeEEeeC--Cee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT----SGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEK  204 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~--~~~  204 (284)
                      .+|...+.||+|+||.||++.. .++..+|+|.+.....    ......+.+|++++++++|+||+++++++...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            3677889999999999999985 4688999998753211    12234688999999999999999999998764  457


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++++||+++++|.+++....    .+++.....++.|++.||.|||+.   +++|+||||+||+++.++.++++||
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~df  150 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDF  150 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcc
Confidence            89999999999999997532    478888999999999999999998   9999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.89  E-value=2.8e-23  Score=177.90  Aligned_cols=135  Identities=26%  Similarity=0.375  Sum_probs=119.5

Q ss_pred             CCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCCC
Q 023282          137 KNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS  215 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g~  215 (284)
                      ...||+|+||.||++.. .++..||+|.+.... ......+.+|+..++.++|+|++++++.+...+..+++|||+++++
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~  105 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA  105 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence            46699999999999985 468899999885432 2334468899999999999999999999999999999999999999


Q ss_pred             hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          216 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       216 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |.+++...     .+++.....++.|++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus       106 L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~df  162 (292)
T cd06658         106 LTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDF  162 (292)
T ss_pred             HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccC
Confidence            99988542     378899999999999999999998   9999999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.89  E-value=1.3e-22  Score=170.11  Aligned_cols=143  Identities=23%  Similarity=0.338  Sum_probs=122.4

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEee-CCeeeEEEe
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTEKLLVYP  209 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~-~~~~~lv~e  209 (284)
                      +|+..+.||+|++|.||++... +++.+|+|.+...... .....+.+|+++++.++|+|++++.+.+.. ....+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4677899999999999999854 5789999998654322 233468899999999999999999998764 345789999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++++|.+++.....  ..+++.++..++.+++.|++|||+.   +++||||||+||+++.++..+++||
T Consensus        81 ~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df  146 (257)
T cd08223          81 FCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDL  146 (257)
T ss_pred             ccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecc
Confidence            9999999999976322  3578999999999999999999998   9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.89  E-value=1.3e-22  Score=174.85  Aligned_cols=142  Identities=30%  Similarity=0.442  Sum_probs=122.7

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc--ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ..|...+.||+|+||.||+|... +++.||+|.+......  ....++.+|+++++.++|||++++.+++...+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45777889999999999999864 6889999988643222  22346889999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||++ |++.+++....   ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++++||
T Consensus        95 e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~df  159 (307)
T cd06607          95 EYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADF  159 (307)
T ss_pred             HhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeec
Confidence            9997 67877776432   2489999999999999999999998   9999999999999999999999997

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.89  E-value=1.4e-22  Score=171.53  Aligned_cols=144  Identities=27%  Similarity=0.412  Sum_probs=118.9

Q ss_pred             CCCCCeecccCceEEEEEEeC----CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC------
Q 023282          134 FSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT------  202 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~------  202 (284)
                      |...+.||+|+||.||+|...    +++.+|||.+...... ....++.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            455688999999999999753    3678999998654322 23446889999999999999999999886532      


Q ss_pred             eeeEEEeCCCCCChHHHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          203 EKLLVYPYMTNGSVASRLRERQ--SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       203 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ..++++||+++|+|.+++....  .....+++.....++.|++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            2478899999999998885422  1223478889999999999999999998   9999999999999999999999998

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.89  E-value=9.9e-23  Score=172.13  Aligned_cols=146  Identities=24%  Similarity=0.351  Sum_probs=121.2

Q ss_pred             CCCCCCeecccCceEEEEEEeCC--CcEEEEEEeecccC---------cccHHHHHHHHHHHhc-CCCCCceeeeeEEee
Q 023282          133 GFSNKNILGRGGFGKVYKGRLAD--GKLVAVKRLKEERT---------SGGELQFQTEVKIISM-AVHRNLLRLYGFCTT  200 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~---------~~~~~~~~~e~~~l~~-~~h~niv~l~g~~~~  200 (284)
                      +|+..+.||+|+||.||++....  +..+|+|.+.....         .....++..|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            36777899999999999999654  67899998853221         1112346778887764 799999999999999


Q ss_pred             CCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          201 VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       201 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .+..+++|||+++++|.+++.........+++..+..++.|++.||.|||+..  +++|+||+|+||+++.++.++++||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999998653333345889999999999999999999631  7999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.89  E-value=5.9e-23  Score=181.25  Aligned_cols=140  Identities=22%  Similarity=0.298  Sum_probs=118.8

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeC------C
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV------T  202 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~------~  202 (284)
                      .++|...+.||+|+||.||++... .++.||||.+...... .....+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            467888899999999999999854 6789999998643322 2334678999999999999999999987543      3


Q ss_pred             eeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          203 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       203 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ..++||||+++ +|.+.+..      .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  170 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  170 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeC
Confidence            57999999975 77777753      368889999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.89  E-value=9.2e-23  Score=174.75  Aligned_cols=140  Identities=24%  Similarity=0.377  Sum_probs=124.2

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ++|...+.||+|+||.||++.. .++..+|+|.+.... ......+.+|+.+++.++|||++++++++...+..++|+||
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            5677789999999999999985 467899999885332 22344688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++++|.+++...     .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++++||
T Consensus        98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~df  159 (293)
T cd06647          98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDF  159 (293)
T ss_pred             CCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccC
Confidence            9999999999753     368899999999999999999999   9999999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.89  E-value=1.2e-22  Score=172.93  Aligned_cols=135  Identities=27%  Similarity=0.349  Sum_probs=113.0

Q ss_pred             eecccCceEEEEEEe-CCCcEEEEEEeecccCccc--HHHHHHHHHHH---hcCCCCCceeeeeEEeeCCeeeEEEeCCC
Q 023282          139 ILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGG--ELQFQTEVKII---SMAVHRNLLRLYGFCTTVTEKLLVYPYMT  212 (284)
Q Consensus       139 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l---~~~~h~niv~l~g~~~~~~~~~lv~e~~~  212 (284)
                      +||+|+||.||++.. .+++.+|+|.+........  ...+.+|..++   ...+|||++.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999986 4688999998865432211  22344444433   34579999999999999899999999999


Q ss_pred             CCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          213 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       213 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +|+|.+++....    .++|.....++.|++.||.|||+.   +++||||||+|||+++++.++++||
T Consensus        81 ~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~df  141 (279)
T cd05633          81 GGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDL  141 (279)
T ss_pred             CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccC
Confidence            999999987542    489999999999999999999998   9999999999999999999999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.89  E-value=9.3e-23  Score=177.50  Aligned_cols=138  Identities=30%  Similarity=0.415  Sum_probs=119.0

Q ss_pred             Ceeccc--CceEEEEEEe-CCCcEEEEEEeecccCcc-cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCC
Q 023282          138 NILGRG--GFGKVYKGRL-ADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  213 (284)
Q Consensus       138 ~~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~  213 (284)
                      ..||+|  +||+||+++. .+++.||+|.+....... ..+.+.+|+.+++.++||||+++++++...+..++++||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  8999999986 478999999986443222 234688999999999999999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          214 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       214 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++|.+++.....  ..+++.....++.|++.||+|||+.   +++||||||+|||++.++..+++||
T Consensus        84 ~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~  145 (328)
T cd08226          84 GSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGL  145 (328)
T ss_pred             CCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEech
Confidence            999999986432  2478889999999999999999998   9999999999999999999999887

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.89  E-value=1e-22  Score=174.91  Aligned_cols=145  Identities=29%  Similarity=0.462  Sum_probs=123.5

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC----
Q 023282          129 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT----  202 (284)
Q Consensus       129 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~----  202 (284)
                      ...++|+..+.||+|+||.||+|... +++.||+|.++..... .....+.+|+++++.++|||++++++++....    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34567888999999999999999965 6889999998654322 22346778999999999999999999987654    


Q ss_pred             ------eeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcc
Q 023282          203 ------EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  276 (284)
Q Consensus       203 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~  276 (284)
                            ..++++||+++ ++.+.+...   ...+++.....++.|++.||+|||+.   +|+||||||+||+++.++.++
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence                  78999999986 777777643   22589999999999999999999998   999999999999999999999


Q ss_pred             hhhh
Q 023282          277 SKTI  280 (284)
Q Consensus       277 ~~df  280 (284)
                      ++||
T Consensus       157 l~df  160 (302)
T cd07864         157 LADF  160 (302)
T ss_pred             eCcc
Confidence            9997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.89  E-value=6.5e-23  Score=182.73  Aligned_cols=136  Identities=25%  Similarity=0.296  Sum_probs=118.9

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC---CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      ..+|...+.||+|+||.||++...   .+..||+|.+...      ....+|+++++.++||||+++++++......+++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            346888899999999999999743   3567999987532      2356899999999999999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||++. ++|.+++...    ..++|..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus       165 ~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~Df  229 (392)
T PHA03207        165 MPKYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDF  229 (392)
T ss_pred             ehhcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccC
Confidence            99996 6898888432    2589999999999999999999998   9999999999999999999999998

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.89  E-value=6.6e-23  Score=176.01  Aligned_cols=135  Identities=24%  Similarity=0.346  Sum_probs=119.9

Q ss_pred             CCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCCC
Q 023282          137 KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS  215 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g~  215 (284)
                      ...||+|+||.||++... +++.+|+|.+.... ......+.+|+.++..++|||++++++++...+..++++||+++++
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            356999999999999854 68899999986432 2334568899999999999999999999999999999999999999


Q ss_pred             hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          216 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       216 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |.+++...     .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+||
T Consensus       105 L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~df  161 (297)
T cd06659         105 LTDIVSQT-----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDF  161 (297)
T ss_pred             HHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeec
Confidence            99987542     378999999999999999999998   9999999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.89  E-value=1.4e-22  Score=175.45  Aligned_cols=137  Identities=23%  Similarity=0.352  Sum_probs=112.6

Q ss_pred             CCeecccCceEEEEEEeC---CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEee--CCeeeEEEeCC
Q 023282          137 KNILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEKLLVYPYM  211 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~--~~~~~lv~e~~  211 (284)
                      ...||+|+||.||+|+..   ++..+|+|.+....   ....+.+|+.+++.++||||+++++++..  ....++++||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            467999999999999854   45789999885432   23357889999999999999999998864  34678999998


Q ss_pred             CCCChHHHHhhcCC-----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeee----CCCCCcchhhh
Q 023282          212 TNGSVASRLRERQS-----SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL----DEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~-----~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLl----d~~~~~~~~df  280 (284)
                      . ++|.+++.....     ....+++.....++.|++.||.|||+.   +|+||||||+|||+    +.++.+||+||
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            6 588888764221     123578889999999999999999999   99999999999999    55678999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.89  E-value=7.9e-24  Score=170.77  Aligned_cols=143  Identities=27%  Similarity=0.368  Sum_probs=122.8

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcc---cH----HHHHHHHHHHhcC-CCCCceeeeeEEeeC
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG---GE----LQFQTEVKIISMA-VHRNLLRLYGFCTTV  201 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~---~~----~~~~~e~~~l~~~-~h~niv~l~g~~~~~  201 (284)
                      -..|...+.||.|..+.|.++.. .+|...|+|++.......   ..    +.-.+|+.+++++ .||+|+++.+++.++
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            34677788999999999988874 478889999986433211   11    2356789999887 599999999999999


Q ss_pred             CeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          202 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       202 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ...++|+|.|+.|.|.++|.+.-    .+++.+..+|+.|+.+|++|||..   +||||||||+|||+|++++.+|+||
T Consensus        96 sF~FlVFdl~prGELFDyLts~V----tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSKV----TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhhe----eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence            99999999999999999997643    488899999999999999999999   9999999999999999999999998

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=8.7e-23  Score=177.53  Aligned_cols=135  Identities=20%  Similarity=0.204  Sum_probs=106.9

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEeC--CCcEEEEEEeecccC----cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC
Q 023282          129 VATDGFSNKNILGRGGFGKVYKGRLA--DGKLVAVKRLKEERT----SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT  202 (284)
Q Consensus       129 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~  202 (284)
                      ...++|...+.||+|+||+||+|+..  +++.+|||++.....    ......|.+|+++++.++|+|++..+..   .+
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence            34567889999999999999999864  577889998753211    1123468999999999999999853322   24


Q ss_pred             eeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCC-CCCCeeeCCCCCcchhhh
Q 023282          203 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV-KAANILLDEDADQSSKTI  280 (284)
Q Consensus       203 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdl-k~~NiLld~~~~~~~~df  280 (284)
                      ..++||||+++++|.. +..       ..   ...++.++++||.|||+.   +|+|||| ||+|||++.++.++|+||
T Consensus        92 ~~~LVmE~~~G~~L~~-~~~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF  156 (365)
T PRK09188         92 KDGLVRGWTEGVPLHL-ARP-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF  156 (365)
T ss_pred             CcEEEEEccCCCCHHH-hCc-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence            6799999999999962 211       11   145778999999999998   9999999 999999999999999998

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=3.9e-24  Score=199.84  Aligned_cols=150  Identities=24%  Similarity=0.308  Sum_probs=132.1

Q ss_pred             HHHHHHHhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc--ccHHHHHHHHHHHhcCCCCCceeeeeEEee
Q 023282          124 LRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTT  200 (284)
Q Consensus       124 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~g~~~~  200 (284)
                      ..+++...++|.+.++||+|+||.|..++.+ +++.+|+|++++....  .....|..|-.+|...+.+.|+.+.-.|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            4677778889999999999999999999864 6889999999653222  122358888899999999999999999999


Q ss_pred             CCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          201 VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       201 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ..++|+|||||+||+|..++....    .++......+...+..||.-||+.   ++|||||||+|||||..|.+|++||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF  219 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF  219 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence            999999999999999999998753    477777888999999999999999   9999999999999999999999999

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.89  E-value=1.6e-22  Score=169.33  Aligned_cols=143  Identities=28%  Similarity=0.401  Sum_probs=123.1

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccC-cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          133 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +|...+.||+|+||.||++.. .+++.+|+|.+..... ......+.+|+++++.++|||++++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            366778999999999999985 4688999999864432 22345788999999999999999999999888999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC-Ccchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~-~~~~~df  280 (284)
                      +++++|.+++....  ...+++..+..++.++++||+|||+.   +++|+||||+||+++.++ .++++||
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~  146 (256)
T cd08220          81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDF  146 (256)
T ss_pred             CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccC
Confidence            99999999997643  23478999999999999999999998   999999999999998654 5789887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.89  E-value=2.5e-22  Score=167.94  Aligned_cols=145  Identities=26%  Similarity=0.406  Sum_probs=127.4

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +|...+.||.|+||.||++... ++..+++|.+...... .....+.+|+++++.++|+|++++.+.+...+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            3667789999999999999864 6889999998654332 3345688999999999999999999999988999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++++|.+++.........+++.....++.+++.||.|||+.   +++|+||+|+||+++.++.++++||
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~  147 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDF  147 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCc
Confidence            999999999987532334689999999999999999999998   9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.89  E-value=1.7e-22  Score=171.95  Aligned_cols=151  Identities=30%  Similarity=0.476  Sum_probs=126.9

Q ss_pred             cHHHHHHHhcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEee
Q 023282          123 SLRELQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  200 (284)
Q Consensus       123 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~  200 (284)
                      ++.++..+.+.|+..+.||+|+||.||+|.. .+++.+|+|.+....  ....++..|+.++.++ +|+|++++++++..
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            4455555667888899999999999999986 468899999875432  2334678899998888 69999999999853


Q ss_pred             ------CCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCC
Q 023282          201 ------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  274 (284)
Q Consensus       201 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~  274 (284)
                            ....+++|||+++|+|.+++.....  ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~  159 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE  159 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence                  3567999999999999999976432  2477888899999999999999998   9999999999999999999


Q ss_pred             cchhhh
Q 023282          275 QSSKTI  280 (284)
Q Consensus       275 ~~~~df  280 (284)
                      ++++||
T Consensus       160 ~~l~df  165 (282)
T cd06636         160 VKLVDF  165 (282)
T ss_pred             EEEeeC
Confidence            999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.89  E-value=3.9e-22  Score=172.75  Aligned_cols=140  Identities=31%  Similarity=0.469  Sum_probs=121.1

Q ss_pred             CCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc--ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          134 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      |+..+.||+|+||.||+++. .++..+|+|.+......  +....+..|+++++.++|||++++++++......++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            55678899999999999985 46889999998643222  2234688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++ |++.+.+....   ..++|.++..++.|++.||.|||+.   +++||||+|+||+++.++.++++||
T Consensus       107 ~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~df  169 (317)
T cd06635         107 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADF  169 (317)
T ss_pred             CC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecC
Confidence            97 58888776432   2489999999999999999999998   9999999999999999999999998

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.89  E-value=9.4e-23  Score=171.34  Aligned_cols=134  Identities=28%  Similarity=0.415  Sum_probs=119.5

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEeecccCc--ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCCCh
Q 023282          140 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  216 (284)
Q Consensus       140 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g~L  216 (284)
                      ||+|+||.||+++.. +++.+++|.+......  .....+.+|++++++++|||++++++.+......++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999976 5899999998644321  2334688999999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          217 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       217 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .+++....    .+++..+..++.|+++||+|||+.   +++|+||+|+||+++.++.++++||
T Consensus        81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~df  137 (265)
T cd05579          81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDF  137 (265)
T ss_pred             HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEec
Confidence            99997643    478999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.89  E-value=2e-22  Score=169.61  Aligned_cols=134  Identities=26%  Similarity=0.374  Sum_probs=119.2

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEeecccCc--ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCCCh
Q 023282          140 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  216 (284)
Q Consensus       140 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g~L  216 (284)
                      ||.|++|.||+++.. +++.+|+|.+......  .....+.+|+.+++.++||||+++++.+......++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999965 5889999998654322  2345689999999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          217 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       217 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .+++....    .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++++||
T Consensus        81 ~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df  137 (262)
T cd05572          81 WTILRDRG----LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDF  137 (262)
T ss_pred             HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeC
Confidence            99997642    378889999999999999999998   9999999999999999999999996

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.89  E-value=1e-22  Score=177.82  Aligned_cols=141  Identities=21%  Similarity=0.351  Sum_probs=120.6

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC-----ee
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-----EK  204 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~-----~~  204 (284)
                      .++|+..+.||+|+||.||+|.. .+++.||+|.+...........+.+|+.+++.++|+||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            35788889999999999999985 4788999999864333333446888999999999999999999876543     47


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++++||++ ++|.+.+...     .+++.....++.|+++||.|||+.   +++||||||+||+++.++.++++||
T Consensus        84 ~lv~e~~~-~~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~df  150 (336)
T cd07849          84 YIVQELME-TDLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDF  150 (336)
T ss_pred             EEEehhcc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcc
Confidence            99999997 4888877542     488999999999999999999999   9999999999999999999999997

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.89  E-value=1.4e-22  Score=169.82  Aligned_cols=143  Identities=20%  Similarity=0.362  Sum_probs=123.3

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +|+..+.||+|+||.||++... ++..+|+|.+...... .....+.+|+++++.++|+|++++++.+......++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            3667789999999999999864 6788999998653222 2344688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCC-cchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD-QSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~-~~~~df  280 (284)
                      +++++|.+++.....  ..++|..+..++.|+++||.|||+.   +++|+||||+||++++++. ++++||
T Consensus        81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~  146 (257)
T cd08225          81 CDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDF  146 (257)
T ss_pred             CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEeccc
Confidence            999999999976432  2478999999999999999999998   9999999999999998864 588887

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.89  E-value=2.9e-23  Score=183.97  Aligned_cols=140  Identities=26%  Similarity=0.431  Sum_probs=117.8

Q ss_pred             CCCeecccCceEEEEEEeC-CCcEEEEEEeeccc---CcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCe--eeEEEe
Q 023282          136 NKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER---TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE--KLLVYP  209 (284)
Q Consensus       136 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~--~~lv~e  209 (284)
                      ...+||+|+|-+||||... +|..||.-.++...   .......|..|+++|+.++||||++++.+|.+...  .-+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            3478999999999999864 57777755443222   22233579999999999999999999999988665  678999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCC-CCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~-~~~~~~df  280 (284)
                      .+..|+|..++++.+    .++......++.||++||.|||++ +|+|+|||||.+||+++.+ |++||+|.
T Consensus       124 L~TSGtLr~Y~kk~~----~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDL  190 (632)
T KOG0584|consen  124 LFTSGTLREYRKKHR----RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDL  190 (632)
T ss_pred             cccCCcHHHHHHHhc----cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecch
Confidence            999999999998765    367788999999999999999997 8899999999999999865 69999985

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.89  E-value=2.5e-22  Score=173.46  Aligned_cols=143  Identities=23%  Similarity=0.394  Sum_probs=120.2

Q ss_pred             CCCCCeecccCceEEEEEEeC---CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeC--CeeeE
Q 023282          134 FSNKNILGRGGFGKVYKGRLA---DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLL  206 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~--~~~~l  206 (284)
                      |...+.||+|+||.||+|...   ++..+|+|.+.....  ......+.+|+.+++.++||||+++++++...  ...++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            566788999999999999864   478999999875321  22234678899999999999999999999887  78999


Q ss_pred             EEeCCCCCChHHHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC----CCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSS-LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE----DADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~----~~~~~~~df  280 (284)
                      ||||+++ ++.+++...... ...+++.....++.|++.||.|||+.   +++||||||+||+++.    ++.++++||
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            9999975 777777543222 23678889999999999999999998   9999999999999999    999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.89  E-value=2.9e-23  Score=170.76  Aligned_cols=144  Identities=25%  Similarity=0.391  Sum_probs=123.3

Q ss_pred             HHHHHHHhcCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCC-CCCceeeeeEEeeC
Q 023282          124 LRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTV  201 (284)
Q Consensus       124 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~~  201 (284)
                      +.+...-++     ++||+|+++.|-.+. +.+|..+|||++.+. ......+..+|++++...+ |+||+.|++++.+.
T Consensus        75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            344444443     779999999999887 778999999999655 3344456789999998775 99999999999999


Q ss_pred             CeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC---Ccchh
Q 023282          202 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSK  278 (284)
Q Consensus       202 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~---~~~~~  278 (284)
                      ...|||||-|.+|+|..+++++.    .+++.+..++..+|+.||.|||.+   +|.||||||+|||-..-.   -+||+
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~~----~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiC  221 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKRK----HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKIC  221 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHhh----hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeee
Confidence            99999999999999999998764    488999999999999999999999   999999999999975433   47888


Q ss_pred             hh
Q 023282          279 TI  280 (284)
Q Consensus       279 df  280 (284)
                      ||
T Consensus       222 Df  223 (463)
T KOG0607|consen  222 DF  223 (463)
T ss_pred             cc
Confidence            87

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.89  E-value=1.1e-22  Score=173.34  Aligned_cols=141  Identities=25%  Similarity=0.353  Sum_probs=122.5

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +|+..+.||+|+||.||+|... +++.||+|.++..... .....+.+|+++++.++|+||+++++++...+..+++|||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            5777889999999999999865 6889999988643322 2335689999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++++.+..+....    ..+++.....++.|++.||.|||+.   +++|+||+|+||+++.++.++++||
T Consensus        82 ~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~  144 (288)
T cd07833          82 VERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDF  144 (288)
T ss_pred             CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEee
Confidence            9987776655432    2478999999999999999999998   9999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.89  E-value=1.4e-22  Score=176.40  Aligned_cols=138  Identities=27%  Similarity=0.365  Sum_probs=118.5

Q ss_pred             CCeecccCceEEEEEEe-CCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCC
Q 023282          137 KNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG  214 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g  214 (284)
                      .++||+|.||+||-|.. ++|+.||||++.+.... ..+.+++.|+.+|.+++||.||.+.-.|.+++..++|||-+. |
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence            37899999999999985 47999999999765543 445679999999999999999999999999999999999995 5


Q ss_pred             ChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC---Ccchhhh
Q 023282          215 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSKTI  280 (284)
Q Consensus       215 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~---~~~~~df  280 (284)
                      +..+.+-...  .+.++......+..||+.||.|||.+   +|+|+||||+|||+.+..   .+|+|||
T Consensus       648 DMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDF  711 (888)
T KOG4236|consen  648 DMLEMILSSE--KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDF  711 (888)
T ss_pred             hHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccc
Confidence            7766665432  23588888889999999999999999   999999999999997653   6899998

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.89  E-value=2.6e-22  Score=173.15  Aligned_cols=143  Identities=29%  Similarity=0.472  Sum_probs=122.2

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCccc-HHHHHHHHHHHhcCCCCCceeeeeEEeeC--CeeeE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLL  206 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~~~h~niv~l~g~~~~~--~~~~l  206 (284)
                      .++|+..+.||+|+||.||+|... +++.||+|.++....... ...+.+|+.++++++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            457888899999999999999864 689999999864432222 23467899999999999999999998754  46899


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||||++ ++|.+++....   ..+++.++..++.|+++||+|||+.   +++||||||+||+++.++.++++||
T Consensus        86 v~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~df  152 (309)
T cd07845          86 VMEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADF  152 (309)
T ss_pred             EEecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcc
Confidence            999997 58988887532   3589999999999999999999999   9999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.88  E-value=2.6e-22  Score=170.58  Aligned_cols=139  Identities=24%  Similarity=0.335  Sum_probs=118.1

Q ss_pred             CCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCC-CCCceeeeeEEeeC--CeeeEEEe
Q 023282          134 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTV--TEKLLVYP  209 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~~--~~~~lv~e  209 (284)
                      |+..+.||+|+||.||++.. .++..+|+|.++.............|+.++.++. |+|++++++++...  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            45567899999999999985 4688999999865433333334567888888885 99999999999887  78999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |++ |++.+.+....   ..++|.++..++.|++.||.|||+.   +++||||||+||+++. +.++++||
T Consensus        81 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~df  143 (282)
T cd07831          81 LMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADF  143 (282)
T ss_pred             cCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEec
Confidence            997 58888887542   2589999999999999999999998   9999999999999999 99999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.88  E-value=2.5e-22  Score=172.91  Aligned_cols=143  Identities=29%  Similarity=0.467  Sum_probs=120.8

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcc-cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCe-----
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTE-----  203 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~-----  203 (284)
                      .++|+..+.||+|+||.||++... +++.||+|.+....... ....+.+|+.++++++||||+++++++.....     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            346888899999999999999864 68899999886443222 23356789999999999999999999876543     


Q ss_pred             ---eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          204 ---KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       204 ---~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                         .+++|||+. ++|.+.+....   ..+++.+...++.|++.||.|||+.   +++|+||||+||+++.++.++++||
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence               499999997 48888886532   2478999999999999999999998   9999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.88  E-value=9.3e-25  Score=173.57  Aligned_cols=143  Identities=23%  Similarity=0.323  Sum_probs=122.6

Q ss_pred             hcCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccC-cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++.|+..++||+|.|+.||++. .++|+.+|+|.++.... ..+.+++.+|+++.++++|||||+|...+.+....++|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            4566777899999999999986 45788899998864332 334567999999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC---Ccchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~---~~~~~df  280 (284)
                      |+|.+++|..-+-.+    ..+++...-....|+++||.|+|.+   +|||||+||.|+|+.+..   -+|++||
T Consensus        90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~F  157 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADF  157 (355)
T ss_pred             ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeeccc
Confidence            999999998888664    2467788889999999999999999   999999999999997643   5788887

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.88  E-value=3e-22  Score=170.45  Aligned_cols=141  Identities=24%  Similarity=0.447  Sum_probs=122.8

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcc-cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCC
Q 023282          134 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      |+..+.||+|++|.||+|... +|..||+|++....... ....+.+|+++++.++|||++++++++...+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            456788999999999999864 78999999986443222 2346888999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      + ++|.+++.....  ..+++..+..++.|+++||+|||+.   +++||||+|+||+++.++.++++||
T Consensus        81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df  143 (283)
T cd07835          81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADF  143 (283)
T ss_pred             C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeec
Confidence            5 689999876432  3589999999999999999999998   9999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.88  E-value=4.1e-22  Score=172.40  Aligned_cols=137  Identities=23%  Similarity=0.354  Sum_probs=112.3

Q ss_pred             CCeecccCceEEEEEEeC---CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEee--CCeeeEEEeCC
Q 023282          137 KNILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEKLLVYPYM  211 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~--~~~~~lv~e~~  211 (284)
                      ...||+|+||.||+|+..   ++..+|+|.+....   ....+.+|+++++.++||||+++++++..  ....++++||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence            357999999999999864   34689999885432   23357889999999999999999998854  45678999998


Q ss_pred             CCCChHHHHhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeee----CCCCCcchhhh
Q 023282          212 TNGSVASRLRERQ-----SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL----DEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLl----d~~~~~~~~df  280 (284)
                      + ++|.+++....     .....+++.....++.|++.||.|||+.   +++||||||+|||+    +.++.++|+||
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          83 E-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             C-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            7 47888775321     1123578899999999999999999998   99999999999999    56678999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.88  E-value=3.3e-22  Score=170.18  Aligned_cols=140  Identities=29%  Similarity=0.481  Sum_probs=121.8

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc-CcccHHHHHHHHHHHhcCCCCCceeeeeEEeeC--CeeeEEEe
Q 023282          134 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLLVYP  209 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~--~~~~lv~e  209 (284)
                      |+..+.||+|+||.||+|... +++.+|+|.+.... .......+.+|+++++.++|+|++++++++...  +..++++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            456688999999999999865 58899999997553 222334688999999999999999999999887  78999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++ +|.+++....   ..+++..+..++.|+++||+|||+.   +++|+||||+||++++++.++++||
T Consensus        81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~  144 (287)
T cd07840          81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADF  144 (287)
T ss_pred             cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccc
Confidence            9974 8988886542   3589999999999999999999998   9999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=6.5e-22  Score=165.30  Aligned_cols=141  Identities=29%  Similarity=0.484  Sum_probs=125.0

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +|+..+.||+|++|.||++... +++.+++|.+...... .....+.+|++++++++|+|++++.+++......++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            3667789999999999999864 6789999998654332 2334689999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++++|.+++...    ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++++||
T Consensus        81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~  143 (254)
T cd06627          81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADF  143 (254)
T ss_pred             CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEecc
Confidence            9999999999754    2589999999999999999999998   9999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.88  E-value=5.4e-22  Score=169.29  Aligned_cols=138  Identities=24%  Similarity=0.374  Sum_probs=121.9

Q ss_pred             CCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCC
Q 023282          134 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  212 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~  212 (284)
                      |...+.||+|++|.||++.. .+++.+++|.+.... ......+.+|+.+++.++|||++++++++...+..++++||++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            44457899999999999985 468899999885432 2234468899999999999999999999999999999999999


Q ss_pred             CCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          213 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       213 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++|.+++...     .+++.....++.|++.||+|||+.   +++||||+|+||+++.++.++++||
T Consensus       100 ~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~  159 (285)
T cd06648         100 GGALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDF  159 (285)
T ss_pred             CCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEccc
Confidence            99999998752     478899999999999999999998   9999999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.88  E-value=1.9e-22  Score=168.84  Aligned_cols=145  Identities=26%  Similarity=0.371  Sum_probs=126.1

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          133 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +|+..+.||+|+||.||++.. .+++.+++|.+...... .....+.+|+++++.++|+||+++.+++......++++||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            366778999999999999975 46789999998653322 2334678999999999999999999999998999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++++|.+++.........+++.....++.|++.||+|||+.   +++|+||+|+||+++.++..+++||
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~  147 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDL  147 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeec
Confidence            999999999976433334689999999999999999999998   9999999999999999999999997

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.88  E-value=2e-22  Score=171.49  Aligned_cols=141  Identities=28%  Similarity=0.434  Sum_probs=122.4

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCC-CCCceeeeeEEeeCCeeeEEEeCC
Q 023282          134 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      |+..+.||+|++|.||+|... +++.+++|.+.............+|+..+++++ |+|++++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            456788999999999999975 578899999865433333334567999999999 999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                       +|+|.+.+....  ...++|..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++++||
T Consensus        81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~  143 (283)
T cd07830          81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADF  143 (283)
T ss_pred             -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeec
Confidence             889999987643  23579999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.88  E-value=5.7e-22  Score=168.55  Aligned_cols=135  Identities=27%  Similarity=0.356  Sum_probs=112.8

Q ss_pred             eecccCceEEEEEEe-CCCcEEEEEEeecccCccc--HHHHHHHH---HHHhcCCCCCceeeeeEEeeCCeeeEEEeCCC
Q 023282          139 ILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGG--ELQFQTEV---KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  212 (284)
Q Consensus       139 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~e~---~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~  212 (284)
                      +||+|+||.||++.. .+++.||+|.+........  ...+..|.   ..++...||+|+++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999985 4688999998864432211  12233443   34455689999999999999999999999999


Q ss_pred             CCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          213 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       213 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +|+|.+++...    ..++|..+..++.|+++||.|||+.   +++||||||+||+++.++.++++||
T Consensus        81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~df  141 (278)
T cd05606          81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDL  141 (278)
T ss_pred             CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccC
Confidence            99999988653    2589999999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=1.3e-22  Score=162.46  Aligned_cols=134  Identities=16%  Similarity=0.230  Sum_probs=102.7

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEeecccCcccH--------HH-----------------HHHHHHHHhcCCCCCc
Q 023282          137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGE--------LQ-----------------FQTEVKIISMAVHRNL  191 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~--------~~-----------------~~~e~~~l~~~~h~ni  191 (284)
                      ...||+|+||.||+|...+|+.||||+++........        ..                 ...|++.+..+.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3679999999999999878999999999754321111        11                 2348899999988776


Q ss_pred             eeeeeEEeeCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeeeeCCCCCCeeeC
Q 023282          192 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL-HEHCDPKIIHRDVKAANILLD  270 (284)
Q Consensus       192 v~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yL-H~~~~~~ivHrdlk~~NiLld  270 (284)
                      .....+..  ...++||||++++++.......    .++++.....++.|++.+|.|+ |+.   +|+||||||+|||++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence            44333322  2348999999988776553221    2478889999999999999999 577   899999999999998


Q ss_pred             CCCCcchhhh
Q 023282          271 EDADQSSKTI  280 (284)
Q Consensus       271 ~~~~~~~~df  280 (284)
                       ++.+++.||
T Consensus       153 -~~~v~LiDF  161 (190)
T cd05147         153 -DGKLYIIDV  161 (190)
T ss_pred             -CCcEEEEEc
Confidence             478999998

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.88  E-value=7.7e-22  Score=164.29  Aligned_cols=140  Identities=34%  Similarity=0.532  Sum_probs=125.4

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCC
Q 023282          134 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  212 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~  212 (284)
                      |+..+.||+|++|.||++... ++..+++|++..... .....+.+|++.++.++|+|++++++++......++++||++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            666789999999999999975 688999999865433 344578999999999999999999999999999999999999


Q ss_pred             CCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          213 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       213 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++|.+++....   ..+++..+..++.|+++||.|||+.   +++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~  142 (253)
T cd05122          81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDF  142 (253)
T ss_pred             CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeec
Confidence            999999997642   3589999999999999999999998   9999999999999999999999987

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.88  E-value=6.4e-22  Score=169.44  Aligned_cols=143  Identities=23%  Similarity=0.415  Sum_probs=120.4

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      ++|+..+.||+|++|.||+|... +++.+|+|.+...... .....+.+|+++++.++||||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46778899999999999999864 6889999988643322 223468899999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC-CCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~-~~~~~~~df  280 (284)
                      |++ ++|.+++.....  ..+++.....++.|++.||+|||+.   +++||||+|+||+++. ++.+|++||
T Consensus        82 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~df  147 (294)
T PLN00009         82 YLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADF  147 (294)
T ss_pred             ccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEccc
Confidence            996 588888765322  2357788889999999999999998   9999999999999985 456899997

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.88  E-value=3.8e-22  Score=174.89  Aligned_cols=149  Identities=23%  Similarity=0.327  Sum_probs=124.7

Q ss_pred             cHHHHHHHhcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccC-cccHHHHHHHHHHHhcCCCCCceeeeeEEee
Q 023282          123 SLRELQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTT  200 (284)
Q Consensus       123 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~  200 (284)
                      ...++....++|+..+.||+|+||.||++.. .+++.||+|+++.... ......+.+|++++..++||||+++++++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            3455666778999999999999999999985 5788999999864322 2223467889999999999999999998754


Q ss_pred             C------CeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCC
Q 023282          201 V------TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  274 (284)
Q Consensus       201 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~  274 (284)
                      .      ...+++++++ +++|.+++...     .+++..+..++.|+++||+|||+.   +++||||||+||+++.++.
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~  158 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE  158 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence            3      3467788876 78998887642     378999999999999999999998   9999999999999999999


Q ss_pred             cchhhh
Q 023282          275 QSSKTI  280 (284)
Q Consensus       275 ~~~~df  280 (284)
                      ++++||
T Consensus       159 ~kl~df  164 (345)
T cd07877         159 LKILDF  164 (345)
T ss_pred             EEEecc
Confidence            999997

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.88  E-value=3.4e-22  Score=175.00  Aligned_cols=142  Identities=24%  Similarity=0.385  Sum_probs=120.7

Q ss_pred             HhcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcc-cHHHHHHHHHHHhcCCCCCceeeeeEEeeCC-----
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVT-----  202 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~-----  202 (284)
                      ..++|+..+.||+|+||.||++.. .++..||||.+....... ....+.+|+.+++.++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            356788889999999999999984 478899999985432222 2345789999999999999999999886543     


Q ss_pred             -eeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          203 -EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       203 -~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                       ..++||||+ +++|.+++...     .+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.++++||
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df  162 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF  162 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence             358999999 67898888642     478999999999999999999998   9999999999999999999999997

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=5.9e-24  Score=188.48  Aligned_cols=140  Identities=26%  Similarity=0.365  Sum_probs=121.6

Q ss_pred             CCCCCeecccCceEEEEEEeCC-CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCC
Q 023282          134 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  212 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~  212 (284)
                      |.+...||.|+||.||++..++ +...|.|++.. .......+|.-||++|..++||+||+|++.|...+.+|++.|||.
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet-kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET-KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcc-cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            4445679999999999998654 44567777742 233445579999999999999999999999999999999999999


Q ss_pred             CCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          213 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       213 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||-....+-+-+   .+++..++..++.|++.||.|||++   +|||||||+.|||+.-+|.++++||
T Consensus       113 GGAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADF  174 (1187)
T KOG0579|consen  113 GGAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADF  174 (1187)
T ss_pred             CchHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecc
Confidence            999988887643   3689999999999999999999999   9999999999999999999999998

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.88  E-value=2.2e-22  Score=170.71  Aligned_cols=142  Identities=27%  Similarity=0.384  Sum_probs=125.5

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCC-CCCceeeeeEEeeCCeeeEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~~~~~~lv  207 (284)
                      ++|...+.||+|+||.||++... +++.+|+|++.....  ......+..|.+++++++ ||||+++++++...+..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            35777889999999999999864 789999999864322  122346888999999998 99999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||+++++|.+++....    .+++.....++.|++.||.|||+.   +++|+||+|+||+++.++.++++||
T Consensus        81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df  146 (280)
T cd05581          81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDF  146 (280)
T ss_pred             EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCC
Confidence            99999999999997643    589999999999999999999998   9999999999999999999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.1e-22  Score=182.15  Aligned_cols=136  Identities=29%  Similarity=0.439  Sum_probs=118.6

Q ss_pred             CeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCCCh
Q 023282          138 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  216 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g~L  216 (284)
                      -+||+|.||+||-|+.. +...+|||.+.+. .....+.+.+|+.+.+.++|.|||+++|.+...+..-+.||-+|+|+|
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek-dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK-DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccc-cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            47999999999999965 4557999998543 333445689999999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC-CCCcchhhh
Q 023282          217 ASRLRERQSSLPPL--DWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTI  280 (284)
Q Consensus       217 ~~~l~~~~~~~~~l--~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~-~~~~~~~df  280 (284)
                      .++|+..   .+++  .+...-.+..||++||.|||.+   .|||||||-+|+|++. .|..||+||
T Consensus       660 SsLLrsk---WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDF  720 (1226)
T KOG4279|consen  660 SSLLRSK---WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDF  720 (1226)
T ss_pred             HHHHHhc---cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEeccc
Confidence            9999864   3345  6777888999999999999999   9999999999999985 689999998

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.88  E-value=8.7e-22  Score=164.65  Aligned_cols=141  Identities=33%  Similarity=0.503  Sum_probs=125.2

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeC--CeeeEEE
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLLVY  208 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~--~~~~lv~  208 (284)
                      +|+..+.||+|++|.||+|... ++..+++|.+...... .....+.+|+..+++++|+||+++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            3666789999999999999865 6889999998654322 2345789999999999999999999999888  8899999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++++|.+++....    .++|..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++++||
T Consensus        81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~  145 (260)
T cd06606          81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADF  145 (260)
T ss_pred             EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccc
Confidence            9999999999997643    589999999999999999999998   9999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.88  E-value=2.7e-22  Score=181.52  Aligned_cols=148  Identities=22%  Similarity=0.345  Sum_probs=115.0

Q ss_pred             HhcCCCCCCeecccCceEEEEEEe-----------------CCCcEEEEEEeecccCcc-------------cHHHHHHH
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRL-----------------ADGKLVAVKRLKEERTSG-------------GELQFQTE  179 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~-------------~~~~~~~e  179 (284)
                      ..++|+..++||+|+||.||+|..                 ..++.||||.++......             .......|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999963                 234679999986432110             11123456


Q ss_pred             HHHHhcCCCCCc-----eeeeeEEee--------CCeeeEEEeCCCCCChHHHHhhcCCC--------------------
Q 023282          180 VKIISMAVHRNL-----LRLYGFCTT--------VTEKLLVYPYMTNGSVASRLRERQSS--------------------  226 (284)
Q Consensus       180 ~~~l~~~~h~ni-----v~l~g~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------  226 (284)
                      +.++.+++|.++     ++++++|..        .+..++||||+++|+|.++++.....                    
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766554     677887753        35689999999999999999753211                    


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          227 LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       227 ~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ...++|..+..++.|+++||.|||+.   +|+||||||+|||++.++.++++||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DF  353 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDF  353 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeC
Confidence            12356788999999999999999998   9999999999999999999999998

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.88  E-value=5.6e-22  Score=170.03  Aligned_cols=144  Identities=24%  Similarity=0.438  Sum_probs=120.2

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCC-CCCceeeeeEEeeCCeeeEEE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~~~~~~lv~  208 (284)
                      .++|+..+.||+|+||.||+|... +++.+|||.++..........+..|+.++.+.. |+||+++++++......+++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            356777899999999999999976 488999999875433333445677777666665 999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||++ +++.+++.....   .+++..+..++.|++.||+|||+.+  +++||||+|+||+++.++.++|+||
T Consensus        94 e~~~-~~l~~l~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~df  159 (296)
T cd06618          94 ELMS-TCLDKLLKRIQG---PIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDF  159 (296)
T ss_pred             eccC-cCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECcc
Confidence            9985 477777655322   5899999999999999999999732  8999999999999999999999998

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.88  E-value=4.7e-22  Score=171.84  Aligned_cols=137  Identities=24%  Similarity=0.237  Sum_probs=114.9

Q ss_pred             eecccCceEEEEEEeCCCcEEEEEEeeccc-CcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCCChH
Q 023282          139 ILGRGGFGKVYKGRLADGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVA  217 (284)
Q Consensus       139 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g~L~  217 (284)
                      .+|.|+++.||++.. ++..+|+|+++... .......+..|+++++.++|+||+++++++...+..+++|||+++|+|.
T Consensus         9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   87 (314)
T cd08216           9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE   87 (314)
T ss_pred             hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence            344455555555544 68899999987542 2334457999999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhhh
Q 023282          218 SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  281 (284)
Q Consensus       218 ~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df~  281 (284)
                      +++.....  ..+++.....++.|+++||+|||+.   +|+||||||+||+++.++.++++||-
T Consensus        88 ~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~  146 (314)
T cd08216          88 DLLKTHFP--EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLR  146 (314)
T ss_pred             HHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCc
Confidence            99986422  2478888999999999999999999   99999999999999999999999973

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.88  E-value=4.7e-22  Score=170.34  Aligned_cols=134  Identities=25%  Similarity=0.385  Sum_probs=119.0

Q ss_pred             CeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCCCh
Q 023282          138 NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  216 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g~L  216 (284)
                      ..||+|+||.||++.. .+++.+|+|.+... .......+.+|+.+++.++|+|++++++++...+..+++|||+++++|
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            5699999999999986 47889999987532 223344688999999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          217 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       217 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .+++...     .+++.....++.|++.||+|||+.   +++|+||+|+||+++.++.++++||
T Consensus       105 ~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~df  160 (292)
T cd06657         105 TDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDF  160 (292)
T ss_pred             HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEccc
Confidence            9987542     378999999999999999999998   9999999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PTZ00284 protein kinase; Provisional

Probab=99.88  E-value=3.1e-22  Score=182.24  Aligned_cols=146  Identities=19%  Similarity=0.328  Sum_probs=114.8

Q ss_pred             HHHHHhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCC------CCCceeeeeEE
Q 023282          126 ELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV------HRNLLRLYGFC  198 (284)
Q Consensus       126 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~------h~niv~l~g~~  198 (284)
                      ++....++|...+.||+|+||+||+|... .++.||||+++...  ....++..|+.++..++      |.+++++++++
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            34455678999999999999999999854 67899999986421  12223455666665554      45688999988


Q ss_pred             eeC-CeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC----
Q 023282          199 TTV-TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA----  273 (284)
Q Consensus       199 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~----  273 (284)
                      ... ...++|||++ +++|.+++....    .+++..+..++.|++.||+|||+.+  +|+||||||+|||++.++    
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccc
Confidence            764 4678999988 678999887542    4899999999999999999999732  899999999999998776    


Q ss_pred             ------------Ccchhhh
Q 023282          274 ------------DQSSKTI  280 (284)
Q Consensus       274 ------------~~~~~df  280 (284)
                                  .+||+||
T Consensus       274 ~~~~~~~~~~~~~vkl~Df  292 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDL  292 (467)
T ss_pred             cccccccCCCCceEEECCC
Confidence                        3899998

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.88  E-value=3e-22  Score=174.75  Aligned_cols=141  Identities=23%  Similarity=0.374  Sum_probs=120.8

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEee----CCeee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT----VTEKL  205 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~----~~~~~  205 (284)
                      ++|+..+.||+|+||.||++.. .++..||+|.+...... .....+.+|+.+++.++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            5788889999999999999985 46889999998654322 233467789999999999999999998753    34679


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +|+||+. |+|.+++....    .+++.....++.|++.||.|||+.   +++||||||+||+++.++.++++||
T Consensus        85 lv~e~~~-~~l~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~df  151 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQ----PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDF  151 (334)
T ss_pred             EEEehhh-hhHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccc
Confidence            9999996 68998886432    489999999999999999999998   9999999999999999999999997

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.87  E-value=4.5e-22  Score=169.87  Aligned_cols=140  Identities=28%  Similarity=0.342  Sum_probs=120.9

Q ss_pred             CCCCCeecccCceEEEEEEe----CCCcEEEEEEeecccCc---ccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCCeee
Q 023282          134 FSNKNILGRGGFGKVYKGRL----ADGKLVAVKRLKEERTS---GGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKL  205 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~~  205 (284)
                      |+..+.||+|++|.||+++.    .++..+|||.++.....   .....+..|+.++..+ +||||+++.+.+......+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            56678899999999999874    25678999998643221   2234588999999999 5999999999999888999


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +||||+++|+|.+++....    .+++.....++.|+++||.|||+.   +++||||||+||+++.++.++++||
T Consensus        82 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df  149 (288)
T cd05583          82 LILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDF  149 (288)
T ss_pred             EEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEEC
Confidence            9999999999999987532    478889999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.87  E-value=6.6e-22  Score=172.19  Aligned_cols=144  Identities=24%  Similarity=0.382  Sum_probs=122.6

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEee-CCee
Q 023282          128 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTEK  204 (284)
Q Consensus       128 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~-~~~~  204 (284)
                      ...+++|+..+.||+|+||.||++... ++..+|+|.+...... .....+..|++++..++|||++++.+++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            345678999999999999999999854 7889999988543322 234568899999999999999999998865 4578


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++++||+ +++|.++++..     .+++.....++.|+++||.|||+.   +++||||+|+||+++.++.++++||
T Consensus        86 ~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~df  152 (328)
T cd07856          86 YFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDF  152 (328)
T ss_pred             EEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcc
Confidence            8999998 56898888642     367888889999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.87  E-value=4.9e-22  Score=173.56  Aligned_cols=141  Identities=23%  Similarity=0.391  Sum_probs=119.9

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC-cccHHHHHHHHHHHhcC-CCCCceeeeeEEeeC--Ceee
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV--TEKL  205 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~--~~~~  205 (284)
                      .++|+..+.||+|+||.||+|... ++..+|+|.+..... ......+.+|+.+++++ +||||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            356777889999999999999865 678999998854321 22234577899999999 999999999998654  3579


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +||||++ ++|.+++...     .++|.....++.|++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        86 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~  151 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADF  151 (337)
T ss_pred             EEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeec
Confidence            9999997 5999888653     478999999999999999999998   9999999999999999999999997

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=1.1e-21  Score=165.01  Aligned_cols=136  Identities=25%  Similarity=0.355  Sum_probs=114.1

Q ss_pred             CeecccCceEEEEEEe-CCCcEEEEEEeecccCc--ccHHHHHHHHHH-HhcCCCCCceeeeeEEeeCCeeeEEEeCCCC
Q 023282          138 NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKI-ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  213 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~-l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~  213 (284)
                      +.||+|+||.||+|.. .+++.||+|.+......  .....+..|..+ ....+|+|++++++++...+..++++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4689999999999986 46889999998543211  112234455444 4556899999999999999999999999999


Q ss_pred             CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          214 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       214 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++|.+++....    .+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++++||
T Consensus        82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  141 (260)
T cd05611          82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDF  141 (260)
T ss_pred             CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeec
Confidence            99999997542    478889999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.87  E-value=2.3e-21  Score=163.88  Aligned_cols=142  Identities=27%  Similarity=0.326  Sum_probs=115.8

Q ss_pred             HHHHHhcCCCCCCee--cccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHh-cCCCCCceeeeeEEeeC
Q 023282          126 ELQVATDGFSNKNIL--GRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLLRLYGFCTTV  201 (284)
Q Consensus       126 ~~~~~~~~~~~~~~l--g~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~-~~~h~niv~l~g~~~~~  201 (284)
                      +.....++|+..+.+  |+|+||.||++.. .++..+|+|.+.......    .  |+.... ..+|||++++++++...
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~--e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----I--EPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----h--hHHHHHHhhcCCCEEEEEEEEecC
Confidence            334445566666665  9999999999985 467889999886432211    1  222222 12699999999999999


Q ss_pred             CeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC-Ccchhhh
Q 023282          202 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTI  280 (284)
Q Consensus       202 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~-~~~~~df  280 (284)
                      +..++||||+++|+|.+++....    .++|.....++.|+++||.|||+.   +++||||||+||+++.++ .++++||
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~df  154 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDY  154 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecC
Confidence            99999999999999999997642    589999999999999999999998   899999999999999998 9999997

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.87  E-value=2.8e-21  Score=167.08  Aligned_cols=140  Identities=31%  Similarity=0.460  Sum_probs=120.5

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc--ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          134 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      |...+.||+|+||+||+|+.. ++..+++|.+......  .....+..|+++++.++|||++++++++......+++|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            455678999999999999854 6889999998643222  2224688899999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +. |++.+++....   .+++|.++..++.|++.||.|||+.   +++|+||+|+||+++.++.++++||
T Consensus       103 ~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~df  165 (313)
T cd06633         103 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADF  165 (313)
T ss_pred             CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeec
Confidence            96 68888876532   2589999999999999999999998   9999999999999999999999997

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.87  E-value=4.3e-22  Score=167.35  Aligned_cols=144  Identities=22%  Similarity=0.284  Sum_probs=119.0

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc----CcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEE
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER----TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      +|...+.||+|+||.||++... .+..+++|.++...    ......++..|+.+++.++||||+++++++......+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            3667789999999999999864 34456666654322    122334577899999999999999999999988899999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +||+++++|.+++.........+++..+..++.|+++||.|||+.   +++|+||||+||+++. +.++++||
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~  149 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDF  149 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeeccc
Confidence            999999999999976433345689999999999999999999998   9999999999999985 45899987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.87  E-value=6.6e-22  Score=168.78  Aligned_cols=145  Identities=25%  Similarity=0.370  Sum_probs=118.0

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCC-CCCceeeeeEEeeCCeeeEEEeC
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +|...+.||+|+||.||++... +++.+|+|.+...........+..|+.++.++. |+||+++++++......+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4455678999999999999854 688999999865433334456889999999986 99999999999988899999999


Q ss_pred             CCCCChHHHHhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRER-QSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~-~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++. ++.++.... ......+++.....++.+++.||+|||+.+  +++||||||+||+++.++.++++||
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~df  152 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDF  152 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeec
Confidence            864 555543210 111235889999999999999999999732  8999999999999999999999998

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.87  E-value=1.2e-21  Score=172.25  Aligned_cols=140  Identities=23%  Similarity=0.326  Sum_probs=118.9

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccC-cccHHHHHHHHHHHhcCCCCCceeeeeEEeeC------C
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTV------T  202 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~------~  202 (284)
                      .++|+..+.||+|+||.||++.. .++..||+|.+..... ......+.+|+.+++.++||||+++++++...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            46788889999999999999985 4788999999854322 22234677899999999999999999988643      3


Q ss_pred             eeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          203 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       203 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ..++||||+. ++|.+.+...      +++.....++.|++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        95 ~~~lv~e~~~-~~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Df  162 (353)
T cd07850          95 DVYLVMELMD-ANLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  162 (353)
T ss_pred             cEEEEEeccC-CCHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccC
Confidence            4699999996 5888887542      67888999999999999999998   9999999999999999999999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.87  E-value=1.4e-22  Score=157.45  Aligned_cols=154  Identities=26%  Similarity=0.355  Sum_probs=128.7

Q ss_pred             HHHHHHHhcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHH-hcCCCCCceeeeeEEeeC
Q 023282          124 LRELQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLRLYGFCTTV  201 (284)
Q Consensus       124 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l-~~~~h~niv~l~g~~~~~  201 (284)
                      .+.+++..++......||+|++|.|-+-++ .+|+..|+|.++.....+...+..+|+.+. +....|.+|.++|.....
T Consensus        38 ~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re  117 (282)
T KOG0984|consen   38 DRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE  117 (282)
T ss_pred             cCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc
Confidence            334555566666678899999999988774 589999999998666656666788888865 556799999999999999


Q ss_pred             CeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          202 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       202 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ...|+.||.|. -+|..+-++--......++...-+||..+.+||.|||++-  .++|||+||+|||++.+|.+|+|||
T Consensus       118 gdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDF  193 (282)
T KOG0984|consen  118 GDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDF  193 (282)
T ss_pred             ccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccc
Confidence            99999999996 4888777654444456788889999999999999999964  8999999999999999999999998

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.87  E-value=1.5e-21  Score=170.38  Aligned_cols=136  Identities=27%  Similarity=0.325  Sum_probs=118.0

Q ss_pred             CCeecccCceEEEEEEeC-CCcEEEEEEeecccCcc-------------cHHHHHHHHHHHhcCCCCCceeeeeEEeeCC
Q 023282          137 KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-------------GELQFQTEVKIISMAVHRNLLRLYGFCTTVT  202 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-------------~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~  202 (284)
                      .+.||+|+||+||+|... +++.||+|.++......             ....+.+|+++++.++|+||+++++++...+
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   93 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD   93 (335)
T ss_pred             hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence            477999999999999854 68899999886432221             0124778999999999999999999999999


Q ss_pred             eeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          203 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       203 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ..+++|||++ |+|.+++....    .+++.....++.|++.||.|||+.   +++|+||+|+||+++.++.++++||
T Consensus        94 ~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~df  163 (335)
T PTZ00024         94 FINLVMDIMA-SDLKKVVDRKI----RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADF  163 (335)
T ss_pred             cEEEEEeccc-cCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCc
Confidence            9999999997 69999986532    478899999999999999999998   9999999999999999999999998

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.87  E-value=1.6e-21  Score=168.22  Aligned_cols=140  Identities=31%  Similarity=0.469  Sum_probs=120.0

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          134 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      |+..+.||+|+||.||+|+.. ++..+|+|.+.....  .....++.+|+++++.++|+|++++.+++......++|+||
T Consensus        17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   96 (308)
T cd06634          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (308)
T ss_pred             HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence            555678999999999999864 678999998864322  22234688899999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +. |++.+.+....   ..+++.++..++.|++.||.|||+.   +++||||||+||+++.++.++++||
T Consensus        97 ~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~df  159 (308)
T cd06634          97 CL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDF  159 (308)
T ss_pred             cC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCc
Confidence            96 68888776432   2478899999999999999999998   9999999999999999999999998

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.87  E-value=4e-22  Score=182.70  Aligned_cols=147  Identities=19%  Similarity=0.254  Sum_probs=112.8

Q ss_pred             HhcCCCCCCeecccCceEEEEEEeCC--CcEEEEEE--------------eecc--cCcccHHHHHHHHHHHhcCCCCCc
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRLAD--GKLVAVKR--------------LKEE--RTSGGELQFQTEVKIISMAVHRNL  191 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~--------------~~~~--~~~~~~~~~~~e~~~l~~~~h~ni  191 (284)
                      ..++|...+.||+|+||+||++..+.  +...+.|.              +...  ........+.+|+.+++.++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            45689999999999999999986532  22222221              1000  011123358899999999999999


Q ss_pred             eeeeeEEeeCCeeeEEEeCCCCCChHHHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeC
Q 023282          192 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSS-LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD  270 (284)
Q Consensus       192 v~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld  270 (284)
                      +++++++...+..++++|++. ++|.+++...... ...........++.|++.||.|||+.   +|+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence            999999999999999999985 5788877543211 11223556778999999999999998   999999999999999


Q ss_pred             CCCCcchhhh
Q 023282          271 EDADQSSKTI  280 (284)
Q Consensus       271 ~~~~~~~~df  280 (284)
                      .++.+||+||
T Consensus       302 ~~~~vkL~DF  311 (501)
T PHA03210        302 CDGKIVLGDF  311 (501)
T ss_pred             CCCCEEEEeC
Confidence            9999999998

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.87  E-value=1.5e-22  Score=190.56  Aligned_cols=146  Identities=25%  Similarity=0.383  Sum_probs=115.1

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeC------
Q 023282          129 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV------  201 (284)
Q Consensus       129 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~------  201 (284)
                      ....+|++.++||+|+||.||+++-+ +|..+|||+|...........+.+|+.++++++|||||+++..+...      
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            44567888999999999999999854 89999999997654333345688999999999999999993222000      


Q ss_pred             --------------------------------------------------------------------------------
Q 023282          202 --------------------------------------------------------------------------------  201 (284)
Q Consensus       202 --------------------------------------------------------------------------------  201 (284)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------------CeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 023282          202 ---------------------------------TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY  248 (284)
Q Consensus       202 ---------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~y  248 (284)
                                                       ..+|+-||||+.-.+.+.++......   .-....++..+|++||+|
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHH
Confidence                                             12467788888777777766432110   234567889999999999


Q ss_pred             HHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          249 LHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       249 LH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +|+.   +||||||||.||++|++..+||+||
T Consensus       713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDF  741 (1351)
T KOG1035|consen  713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDF  741 (1351)
T ss_pred             HHhC---ceeeccCCcceeEEcCCCCeeeccc
Confidence            9999   9999999999999999999999998

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.87  E-value=1.1e-21  Score=171.35  Aligned_cols=141  Identities=21%  Similarity=0.369  Sum_probs=120.0

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccC-cccHHHHHHHHHHHhcCCCCCceeeeeEEeeC-----Cee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TEK  204 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~-----~~~  204 (284)
                      +.|...+.||+|+||+||+++. .++..||||.++.... ......+.+|+.+++.++|+||+++++++...     ...
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            4577788999999999999985 4688999999864322 22234677899999999999999999987653     347


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++++||+. ++|.+++...    ..+++.....++.|++.||.|||+.   +++||||||+||+++.++.++|+||
T Consensus        85 ~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Df  152 (337)
T cd07858          85 YIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDF  152 (337)
T ss_pred             EEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcC
Confidence            99999996 6898888653    2488999999999999999999998   9999999999999999999999997

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=2.1e-21  Score=155.80  Aligned_cols=133  Identities=18%  Similarity=0.221  Sum_probs=104.5

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEeecccCccc-------------------------HHHHHHHHHHHhcCCCCCc
Q 023282          137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG-------------------------ELQFQTEVKIISMAVHRNL  191 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-------------------------~~~~~~e~~~l~~~~h~ni  191 (284)
                      ...||+|+||.||+|...+|+.||||+++.......                         ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            467999999999999977899999999875421100                         1124578899999999988


Q ss_pred             eeeeeEEeeCCeeeEEEeCCCCCChHHH-HhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeeeCCCCCCeee
Q 023282          192 LRLYGFCTTVTEKLLVYPYMTNGSVASR-LRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILL  269 (284)
Q Consensus       192 v~l~g~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~ivHrdlk~~NiLl  269 (284)
                      .....+...  ..++||||++++++... +..     ..++......++.+++.++.++|+ .   +|+||||||+|||+
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll  151 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY  151 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence            655544333  34899999998855433 332     136777889999999999999999 8   99999999999999


Q ss_pred             CCCCCcchhhh
Q 023282          270 DEDADQSSKTI  280 (284)
Q Consensus       270 d~~~~~~~~df  280 (284)
                      + +++++++||
T Consensus       152 ~-~~~~~liDF  161 (190)
T cd05145         152 H-DGKPYIIDV  161 (190)
T ss_pred             E-CCCEEEEEc
Confidence            9 889999997

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.87  E-value=1.5e-22  Score=166.00  Aligned_cols=145  Identities=25%  Similarity=0.373  Sum_probs=119.8

Q ss_pred             cCCCCCCeecccCceEEEEEEeC---C--CcEEEEEEeecccCcc-cHHHHHHHHHHHhcCCCCCceeeeeEEee-CCee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA---D--GKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTT-VTEK  204 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~---~--~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~g~~~~-~~~~  204 (284)
                      ..|+....||+|.||.||++.-.   +  ...+|+|+++.+.... -.....+|+.+++.++|||+++|..++.. ....
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            45777888999999999999532   2  2368999997553322 23467899999999999999999998877 7789


Q ss_pred             eEEEeCCCCCChHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCC----CCcchhh
Q 023282          205 LLVYPYMTNGSVASRLRERQS-SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED----ADQSSKT  279 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~----~~~~~~d  279 (284)
                      ++++||.+. +|...++-++. ....++-.....|..|++.|+.|||++   -|+||||||.|||+-.+    |.+||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence            999999986 89998875432 234577778889999999999999999   89999999999999888    8899999


Q ss_pred             h
Q 023282          280 I  280 (284)
Q Consensus       280 f  280 (284)
                      +
T Consensus       180 l  180 (438)
T KOG0666|consen  180 L  180 (438)
T ss_pred             c
Confidence            7

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=4.6e-22  Score=172.91  Aligned_cols=141  Identities=25%  Similarity=0.340  Sum_probs=122.2

Q ss_pred             CCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCccc-HHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCC
Q 023282          134 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      |+..+-||+|.|..|-.+++ =+|..||||++.+.....- ...+.+|++.|+.++|||||+||++.......|||+|.=
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG   99 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG   99 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence            56667899999999999874 4799999999965433222 235889999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC-CCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~-~~~~~~~df  280 (284)
                      .+|+|++++-++..   .+.+....+++.||..|+.|+|+.   .+|||||||+|+.+-+ -|-+|+.||
T Consensus       100 D~GDl~DyImKHe~---Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDF  163 (864)
T KOG4717|consen  100 DGGDLFDYIMKHEE---GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDF  163 (864)
T ss_pred             CCchHHHHHHhhhc---cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeec
Confidence            99999999987654   378889999999999999999999   9999999999998755 467899988

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.86  E-value=1.7e-21  Score=165.57  Aligned_cols=140  Identities=26%  Similarity=0.449  Sum_probs=122.0

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCC
Q 023282          134 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      |+..+.||+|++|.||++... +++.+++|.++..... .....+..|+++++.++|+||+++++++...+..++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            455678999999999999864 6889999998654332 23446888999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++ ++.+++....   ..+++..+..++.|+++||.|||+.   +++|+||||+||+++.++.++++||
T Consensus        81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df  142 (283)
T cd05118          81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADF  142 (283)
T ss_pred             CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeee
Confidence            75 8888887642   3589999999999999999999998   9999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.86  E-value=1.5e-21  Score=178.64  Aligned_cols=151  Identities=30%  Similarity=0.455  Sum_probs=130.6

Q ss_pred             cHHHHHHHhcCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEee
Q 023282          123 SLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  200 (284)
Q Consensus       123 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~  200 (284)
                      .++.+...++-|++.++||.|.+|.||+++ .++++.+|+|++....  +.+.++..|.++++.. +|||++.++|++..
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~--d~deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE--DEEEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc--cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            344556677788899999999999999998 5678999999886543  3344677888888766 59999999999864


Q ss_pred             -----CCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCc
Q 023282          201 -----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  275 (284)
Q Consensus       201 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~  275 (284)
                           ++++|||||||.+|+..++++...  ...+.|..+..|+..++.|+.+||..   .++|||+|-.|||+..++++
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~V  162 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEV  162 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcE
Confidence                 568999999999999999998755  44689999999999999999999999   99999999999999999999


Q ss_pred             chhhh
Q 023282          276 SSKTI  280 (284)
Q Consensus       276 ~~~df  280 (284)
                      |+.||
T Consensus       163 KLvDF  167 (953)
T KOG0587|consen  163 KLVDF  167 (953)
T ss_pred             EEeee
Confidence            99998

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.86  E-value=1.8e-21  Score=170.42  Aligned_cols=139  Identities=25%  Similarity=0.407  Sum_probs=117.5

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC------e
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT------E  203 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~------~  203 (284)
                      ++|...+.||+|+||.||+|.. .+++.||+|.+...... .....+.+|+.+++.++||||+++++++....      .
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            5788889999999999999985 46899999998643222 22346889999999999999999999986542      4


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .++++||+.. +|..++..      .+++..+..++.|+++||+|||+.   +++||||||+||+++.++.++++||
T Consensus        95 ~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~df  161 (342)
T cd07879          95 FYLVMPYMQT-DLQKIMGH------PLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDF  161 (342)
T ss_pred             EEEEeccccc-CHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeC
Confidence            5899999964 77666521      378899999999999999999998   9999999999999999999999997

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.86  E-value=1.2e-21  Score=170.52  Aligned_cols=140  Identities=24%  Similarity=0.373  Sum_probs=121.7

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC-cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC-----eee
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-----EKL  205 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~-----~~~  205 (284)
                      +|...+.||+|+||.||+++.. +++.+|+|.+..... ......+.+|+.+++.++|+||+++.+++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            3667789999999999999865 588999999865432 233456889999999999999999999987765     789


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++|||++ ++|.+++....    .+++.....++.|++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        81 lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~df  147 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDF  147 (330)
T ss_pred             EEecchh-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccc
Confidence            9999998 58988886532    589999999999999999999999   9999999999999999999999997

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.86  E-value=8.8e-22  Score=183.56  Aligned_cols=152  Identities=26%  Similarity=0.389  Sum_probs=131.8

Q ss_pred             HHHHHhcCCCCCCeecccCceEEEEEEeC----C----CcEEEEEEeecccCcccHHHHHHHHHHHhcCC-CCCceeeee
Q 023282          126 ELQVATDGFSNKNILGRGGFGKVYKGRLA----D----GKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYG  196 (284)
Q Consensus       126 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~g  196 (284)
                      .++...+++...+.||+|.||.|++|...    .    ...||||+++......+.+.+..|+++|+.+. |+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            45555666667779999999999999742    1    34799999987776666678999999999885 999999999


Q ss_pred             EEeeCCeeeEEEeCCCCCChHHHHhhcC---CC-------C--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCC
Q 023282          197 FCTTVTEKLLVYPYMTNGSVASRLRERQ---SS-------L--PPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKA  264 (284)
Q Consensus       197 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~-------~--~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~  264 (284)
                      +|......++|.||+..|+|.++|+..+   .-       .  ..++....+.++.|||.||+||++.   +++||||.+
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence            9999999999999999999999999765   00       1  1388899999999999999999999   999999999


Q ss_pred             CCeeeCCCCCcchhhh
Q 023282          265 ANILLDEDADQSSKTI  280 (284)
Q Consensus       265 ~NiLld~~~~~~~~df  280 (284)
                      +|||+..+..+||+||
T Consensus       447 RNVLi~~~~~~kIaDF  462 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADF  462 (609)
T ss_pred             hhEEecCCCEEEEccc
Confidence            9999999999999998

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.86  E-value=1.5e-21  Score=168.18  Aligned_cols=143  Identities=30%  Similarity=0.459  Sum_probs=120.0

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcc-cHHHHHHHHHHHhcCCCCCceeeeeEEeeCC------
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVT------  202 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~------  202 (284)
                      .++|+..+.||+|+||.||+|... +++.+|+|.+......+ ....+.+|+++++.++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            467888899999999999999864 68899999986443322 2335778999999999999999999875433      


Q ss_pred             --eeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          203 --EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       203 --~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                        ..++++||+.. ++...+....   ..+++..+..++.|+++||+|||+.   +++||||||+||++++++.++++||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence              46899999974 6777776432   2589999999999999999999999   9999999999999999999999997

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.86  E-value=1.6e-21  Score=165.66  Aligned_cols=140  Identities=30%  Similarity=0.490  Sum_probs=122.4

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC-cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCC
Q 023282          134 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      |+..+.||+|.+|.||+|... +++.+|+|.+..... ......+..|+.+++.++|+|++++++++...+..++++||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            345678999999999999865 589999999875432 222346788999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      + ++|.+++....   ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++++||
T Consensus        81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~  142 (282)
T cd07829          81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADF  142 (282)
T ss_pred             C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecC
Confidence            8 59999997642   2589999999999999999999999   9999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.86  E-value=4.6e-21  Score=163.21  Aligned_cols=141  Identities=29%  Similarity=0.505  Sum_probs=117.4

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCccc-HHHHHHHHHHHhc---CCCCCceeeeeEEeeCCe-----
Q 023282          134 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG-ELQFQTEVKIISM---AVHRNLLRLYGFCTTVTE-----  203 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~---~~h~niv~l~g~~~~~~~-----  203 (284)
                      |+..+.||+|+||.||+|+.. ++..+|+|.++....... ...+..|+.++.+   ++|+|++++.+++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            456788999999999999976 588999999964333221 2346677776654   469999999999988776     


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .+++|||+. ++|.+++.....  ..++|..+..++.|+++||.|||+.   +++|+||+|+||+++.++.++++||
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~df  151 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADF  151 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEecc
Confidence            899999997 489998875432  2489999999999999999999998   9999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.86  E-value=3.6e-21  Score=167.78  Aligned_cols=140  Identities=24%  Similarity=0.364  Sum_probs=116.1

Q ss_pred             CCCCCCeecccCceEEEEEEeC-C--CcEEEEEEeecccCcc-cHHHHHHHHHHHhcC-CCCCceeeeeEEeeC----Ce
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-D--GKLVAVKRLKEERTSG-GELQFQTEVKIISMA-VHRNLLRLYGFCTTV----TE  203 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~----~~  203 (284)
                      +|+..+.||+|+||.||+++.. +  +..+|+|.+....... ....+.+|+++++++ +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            3666788999999999999864 4  7789999986432222 234678899999998 599999999875432    35


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .++++||+. ++|.+++....    .+++.....++.|++.||.|||+.   +++||||||+||+++.++.++|+||
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Df  149 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDF  149 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcC
Confidence            678889886 68999886432    488999999999999999999998   9999999999999999999999997

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.86  E-value=3.8e-21  Score=160.45  Aligned_cols=134  Identities=33%  Similarity=0.378  Sum_probs=119.2

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEeecccCcc--cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCCCh
Q 023282          140 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  216 (284)
Q Consensus       140 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g~L  216 (284)
                      ||+|+||.||++... +++.+|+|.+.......  ....+..|+.+++.++|||++++++.+...+..+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999865 58899999986543322  334688999999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          217 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       217 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .+++....    .+++.....++.|+++||.|||+.   +++|+||+|+||+++.++.++++||
T Consensus        81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~  137 (250)
T cd05123          81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDF  137 (250)
T ss_pred             HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeec
Confidence            99997642    478999999999999999999998   9999999999999999999999987

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.86  E-value=2e-22  Score=190.78  Aligned_cols=141  Identities=34%  Similarity=0.480  Sum_probs=123.0

Q ss_pred             CCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccC-cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          133 GFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ++.....||.|.||.||.+. .++|...|||.++-... ........+|..++..++|||+|+++|+-.+.+..++.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            56667889999999999998 67899999998864332 22234688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |++|+|.+.+...+    ..++.....+..|++.|++|||++   +|||||+||.||+||.+|-.|.+||
T Consensus      1316 C~~GsLa~ll~~gr----i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DF 1378 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGR----IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDF 1378 (1509)
T ss_pred             hccCcHHHHHHhcc----hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecc
Confidence            99999999997643    245666677889999999999999   9999999999999999999999998

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=8.8e-22  Score=174.72  Aligned_cols=141  Identities=23%  Similarity=0.301  Sum_probs=122.1

Q ss_pred             CCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccCccc--HHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          133 GFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      -|...+-||-|+||.|..++ .++...+|+|.+++......  ......|-.+|...+++.||+|+-.|.+.+.+|+|||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            46667889999999999997 45667899999864432211  2246778889999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++|++.++|...+    .+.+.....++..+..|+++.|..   ++|||||||+|||||.||..||.||
T Consensus       710 YIPGGDmMSLLIrmg----IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDF  773 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMG----IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDF  773 (1034)
T ss_pred             ccCCccHHHHHHHhc----cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeec
Confidence            999999999997643    477888888899999999999998   9999999999999999999999998

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=7e-21  Score=154.03  Aligned_cols=136  Identities=18%  Similarity=0.227  Sum_probs=104.1

Q ss_pred             CCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcC-----CCCCceeeeeEEeeCC---ee-
Q 023282          134 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-----VHRNLLRLYGFCTTVT---EK-  204 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-----~h~niv~l~g~~~~~~---~~-  204 (284)
                      ++..++||+|+||.||. .-.++.. +||++.... ....+.+.+|+.+++.+     .||||++++|++.+..   .. 
T Consensus         4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            34568899999999996 2223444 689886432 22345789999999998     6799999999998864   33 


Q ss_pred             eEEEeC--CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHH-HHHHcCCCCCeeeeCCCCCCeeeCC----CCCcch
Q 023282          205 LLVYPY--MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL-SYLHEHCDPKIIHRDVKAANILLDE----DADQSS  277 (284)
Q Consensus       205 ~lv~e~--~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl-~yLH~~~~~~ivHrdlk~~NiLld~----~~~~~~  277 (284)
                      .+|+||  +++|+|.+++.+.     .+++.  ..++.+++.++ +|||++   +|+||||||+|||++.    +..++|
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~L  150 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVV  150 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEE
Confidence            378999  6689999999652     14444  35577778777 999999   9999999999999974    347999


Q ss_pred             hhhhh
Q 023282          278 KTILR  282 (284)
Q Consensus       278 ~df~~  282 (284)
                      +|+.+
T Consensus       151 iDg~G  155 (210)
T PRK10345        151 CDNIG  155 (210)
T ss_pred             EECCC
Confidence            99754

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.85  E-value=6e-22  Score=169.68  Aligned_cols=147  Identities=29%  Similarity=0.414  Sum_probs=128.0

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc--ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeee
Q 023282          129 VATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  205 (284)
Q Consensus       129 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~  205 (284)
                      ...+.|..-++||+|+||.||-++. .+|+.+|+|.+.+....  ..+.-...|-.++.+++.+.||.+--.+.+.+.++
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC  261 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence            4445677889999999999999985 47999999988543322  22334678889999999999999999999999999


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +|+..|.+|+|.-+|.+.+.  ..+++.+...+|.+|+-||++||+.   +||.|||||+|||||++|.++|+|.
T Consensus       262 lVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDL  331 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDL  331 (591)
T ss_pred             EEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeecc
Confidence            99999999999999987654  3589999999999999999999999   9999999999999999999999995

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.85  E-value=5.3e-21  Score=167.43  Aligned_cols=139  Identities=26%  Similarity=0.375  Sum_probs=116.7

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeC---------
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV---------  201 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~---------  201 (284)
                      .+|...+.||.|+||.||+|.. .++..||+|.+..... ...+.+.+|++++++++||||+++++++...         
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            5677889999999999999985 4688999999864432 3345688999999999999999999776543         


Q ss_pred             -----CeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC-CCCc
Q 023282          202 -----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQ  275 (284)
Q Consensus       202 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~-~~~~  275 (284)
                           ...++++||++ ++|.+++...     .+++.....++.|+++||.|||+.   +++||||||+||+++. +..+
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence                 35789999997 5898888542     478899999999999999999998   9999999999999985 4567


Q ss_pred             chhhh
Q 023282          276 SSKTI  280 (284)
Q Consensus       276 ~~~df  280 (284)
                      +++||
T Consensus       155 kl~df  159 (342)
T cd07854         155 KIGDF  159 (342)
T ss_pred             EECCc
Confidence            88887

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=4e-22  Score=164.55  Aligned_cols=144  Identities=28%  Similarity=0.366  Sum_probs=126.0

Q ss_pred             HhcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccH--HHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeE
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGE--LQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~--~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~l  206 (284)
                      ..++|+.+++||+|.||.|-.++- .+++.+|+|+++++......  ..-..|-++++..+||.+..|.-.+...+..++
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            456788899999999999999984 57899999999876543222  235678899999999999999988999999999


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||||..+|.|.-+|...+    .+++.+...+...|..||.|||++   +||.||||.+|.|+|.||..||+||
T Consensus       246 VMeyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDF  312 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDF  312 (516)
T ss_pred             EEEEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeec
Confidence            999999999998887533    478888889999999999999999   9999999999999999999999998

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.85  E-value=9.3e-21  Score=157.36  Aligned_cols=125  Identities=21%  Similarity=0.211  Sum_probs=108.7

Q ss_pred             cCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCCChHHHHh
Q 023282          143 GGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR  221 (284)
Q Consensus       143 G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~  221 (284)
                      |.+|.||+++. .+++.+|+|.++...      .+..|...+....|||++++++++...+..+++|||+++|+|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            88999999985 478899999986432      23344555556679999999999999999999999999999999997


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          222 ERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       222 ~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ...    .+++.....++.|+++||.|||+.   +++||||||+||+++.++.++++||
T Consensus        78 ~~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df  129 (237)
T cd05576          78 KFL----NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYF  129 (237)
T ss_pred             Hhc----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecc
Confidence            642    388999999999999999999998   9999999999999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.84  E-value=4.9e-21  Score=167.72  Aligned_cols=141  Identities=25%  Similarity=0.379  Sum_probs=120.7

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC-cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCe-----
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE-----  203 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~-----  203 (284)
                      .++|...+.||+|++|.||+|+.. ++..+|+|.+..... ......+.+|+.+++.++|+|++++++++...+.     
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            457888899999999999999865 678999998864322 2223457789999999999999999998766554     


Q ss_pred             -eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          204 -KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       204 -~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                       .++|+||+ +++|.+++...     .+++..+..++.|+++||.|||+.   +++||||||+||+++.++.++++||
T Consensus        94 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~df  162 (343)
T cd07851          94 DVYLVTHLM-GADLNNIVKCQ-----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDF  162 (343)
T ss_pred             cEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccc
Confidence             89999998 56999988642     489999999999999999999998   9999999999999999999999997

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.84  E-value=1.1e-22  Score=163.50  Aligned_cols=142  Identities=27%  Similarity=0.388  Sum_probs=115.8

Q ss_pred             CCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHH-hcCCCCCceeeeeEEeeCCeeeEEEeCC
Q 023282          134 FSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l-~~~~h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      .+.+..||.|+||+|+|-.+ +.|+..|||+++......+++++..|.++. +.-+.||||+++|.+...+..|+-||.|
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM  145 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM  145 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence            33456799999999999875 479999999998776656667899999865 4556899999999999999999999999


Q ss_pred             CCCChHHHHh---hcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLR---ERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~---~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      . -++..+..   ...  ...+++...-.|......||.||-...  .|||||+||+|||+|..|.+|+|||
T Consensus       146 d-~SlDklYk~vy~vq--~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDF  212 (361)
T KOG1006|consen  146 D-ISLDKLYKRVYSVQ--KSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDF  212 (361)
T ss_pred             h-hhHHHHHHHHHHHH--hccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecc
Confidence            5 46654432   211  123667777788888899999998764  8999999999999999999999998

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.84  E-value=3e-21  Score=155.91  Aligned_cols=138  Identities=25%  Similarity=0.427  Sum_probs=117.5

Q ss_pred             CCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCC-CCCceeeeeEEeeCCeeeEEEeCCCCC
Q 023282          137 KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPYMTNG  214 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~~~~~~lv~e~~~~g  214 (284)
                      ...||.|+.|+|++.+.+ +|..+|||.+......++.+++...+.++.+.+ .|.||+.+|||......++-||.|. -
T Consensus        97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~  175 (391)
T KOG0983|consen   97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-T  175 (391)
T ss_pred             HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-H
Confidence            456999999999999864 688999999987666666667888888876665 8999999999999999999999985 3


Q ss_pred             ChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          215 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       215 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .+..+++.-..   ++++...-++...+..||.||-.++  +|+|||+||+|||+|+.|++|+|||
T Consensus       176 C~ekLlkrik~---piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDF  236 (391)
T KOG0983|consen  176 CAEKLLKRIKG---PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDF  236 (391)
T ss_pred             HHHHHHHHhcC---CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecc
Confidence            56666654332   4777778889999999999999865  8999999999999999999999998

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.83  E-value=7e-20  Score=157.01  Aligned_cols=141  Identities=21%  Similarity=0.268  Sum_probs=104.3

Q ss_pred             cCCCCCCeecccCceEEEEEEeCC----CcEEEEEEeecccCccc-H---------HHHHHHHHHHhcCCCCCceeeeeE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGG-E---------LQFQTEVKIISMAVHRNLLRLYGF  197 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~-~---------~~~~~e~~~l~~~~h~niv~l~g~  197 (284)
                      +.|...++||+|+||+||+|...+    +..+|+|.......... +         .....+...+..+.|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            568888999999999999998643    34566665432211110 0         112233445667889999999997


Q ss_pred             EeeCC----eeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC
Q 023282          198 CTTVT----EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  273 (284)
Q Consensus       198 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~  273 (284)
                      +....    ..++++|++. .++.+.+....    ..++.....++.|+++||+|||+.   +++||||||+|||++.++
T Consensus        92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeEecCCceEEEEEEehhc-cCHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence            76543    3467778764 36666665421    256788899999999999999998   999999999999999999


Q ss_pred             Ccchhhh
Q 023282          274 DQSSKTI  280 (284)
Q Consensus       274 ~~~~~df  280 (284)
                      .++++||
T Consensus       164 ~~~l~DF  170 (294)
T PHA02882        164 RGYIIDY  170 (294)
T ss_pred             cEEEEEc
Confidence            9999998

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.83  E-value=1.3e-19  Score=148.47  Aligned_cols=141  Identities=34%  Similarity=0.495  Sum_probs=123.7

Q ss_pred             CCCCCeecccCceEEEEEEeCC-CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCC
Q 023282          134 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT  212 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~  212 (284)
                      |...+.||+|++|.||++...+ ++.+++|.+...........+.+|++.+..++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4456789999999999999764 889999998654333234578899999999999999999999998899999999999


Q ss_pred             CCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          213 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       213 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++|.+++.....   .+++.....++.+++.++.|||..   +++|+|++|+||+++.++.++++||
T Consensus        81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~  142 (225)
T smart00221       81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADF  142 (225)
T ss_pred             CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeC
Confidence            9999999976432   178899999999999999999998   9999999999999999999999997

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=4.5e-21  Score=164.20  Aligned_cols=143  Identities=27%  Similarity=0.393  Sum_probs=119.6

Q ss_pred             CCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccCcccH------HHHHHHHHHHhcCCCCCceeeeeEEee-CCee
Q 023282          133 GFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE------LQFQTEVKIISMAVHRNLLRLYGFCTT-VTEK  204 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~------~~~~~e~~~l~~~~h~niv~l~g~~~~-~~~~  204 (284)
                      +|-.+.+||+|+|+.||++. +...+.||||+-.....+.++      +...+|..+.+.++||-||++|+|+.- .+..
T Consensus       464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF  543 (775)
T KOG1151|consen  464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF  543 (775)
T ss_pred             HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence            34556789999999999998 556778999976443333322      246789999999999999999999865 5567


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC---CCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~---~~~~~~~df  280 (284)
                      +-|+|||++.+|.-+|....    .+++.+...|+.||..||.||... .|+|||-||||.||||-.   -|+.||.||
T Consensus       544 CTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  544 CTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             eeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence            89999999999999998754    378889999999999999999986 889999999999999954   468899998

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.82  E-value=1.6e-20  Score=165.22  Aligned_cols=142  Identities=23%  Similarity=0.320  Sum_probs=121.3

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCccc----HH---HHHHHHHHHhcCC---CCCceeeeeEEee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG----EL---QFQTEVKIISMAV---HRNLLRLYGFCTT  200 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~----~~---~~~~e~~~l~~~~---h~niv~l~g~~~~  200 (284)
                      .+|+....+|+|+||.|+.+..+ +...|.+|.+.++..-.+    .+   ..-.|+++|..++   |+||++++++|..
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            35777899999999999999865 456899999865432111    11   3567999999998   9999999999999


Q ss_pred             CCeeeEEEeCC-CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhh
Q 023282          201 VTEKLLVYPYM-TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKT  279 (284)
Q Consensus       201 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~d  279 (284)
                      .+..+|+||-- ++-+|.+++..+.    .+++.+...|..||+.|+++||++   +|||||||-+|+.+|.+|-+|+.|
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp----~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKP----RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccC----ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence            99999999964 5679999997543    478899999999999999999999   999999999999999999999999


Q ss_pred             h
Q 023282          280 I  280 (284)
Q Consensus       280 f  280 (284)
                      |
T Consensus       714 f  714 (772)
T KOG1152|consen  714 F  714 (772)
T ss_pred             c
Confidence            8

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.82  E-value=3.7e-19  Score=143.56  Aligned_cols=135  Identities=37%  Similarity=0.554  Sum_probs=119.5

Q ss_pred             ecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCCChHH
Q 023282          140 LGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVAS  218 (284)
Q Consensus       140 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g~L~~  218 (284)
                      ||+|.+|.||++... +++.+++|.............+.+|++.++.+.|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999975 4889999998654332234578999999999999999999999999899999999999999999


Q ss_pred             HHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC-CCCcchhhh
Q 023282          219 RLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTI  280 (284)
Q Consensus       219 ~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~-~~~~~~~df  280 (284)
                      ++....   ..+++..+..++.++++++.|||+.   +++|+||+|.||+++. ++.++++||
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~  137 (215)
T cd00180          81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADF  137 (215)
T ss_pred             HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecC
Confidence            997642   2478999999999999999999999   9999999999999999 899999987

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.81  E-value=3.9e-21  Score=171.41  Aligned_cols=143  Identities=29%  Similarity=0.428  Sum_probs=127.3

Q ss_pred             HhcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      +.++|+....+|.|.+|.|||++. ..++..|+|+++.+.. ++..-.++|+-+++..+|||||.++|.+...+..|+.|
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~-dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG-DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCC-ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            446788889999999999999984 5789999999976543 33446788999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||.+|+|++.-+..+    ++++.++-..+....+||+|||+.   +-+|||||-.|||+.+.+++|++||
T Consensus        92 EycgggslQdiy~~Tg----plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDf  156 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADF  156 (829)
T ss_pred             EecCCCcccceeeecc----cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeeccc
Confidence            9999999999887543    588888999999999999999999   8899999999999999999999998

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=5.7e-19  Score=144.04  Aligned_cols=130  Identities=17%  Similarity=0.233  Sum_probs=109.1

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEEeecccCccc-------HHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          138 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG-------ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +.||+|++|.||+|.. .+..+++|..........       ...+.+|++++..++|+++.....++......+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 667889998654322111       12477899999999999998888887777888999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++++|.+++...       .+ .+..++.+++.+|.++|+.   +++|+|++|+|||++ ++.++++||
T Consensus        81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf  138 (211)
T PRK14879         81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDF  138 (211)
T ss_pred             eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEEC
Confidence            9999999998642       22 7889999999999999998   999999999999999 788899998

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.80  E-value=6.6e-19  Score=145.54  Aligned_cols=130  Identities=35%  Similarity=0.507  Sum_probs=115.9

Q ss_pred             CceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCCChHHHHhh
Q 023282          144 GFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE  222 (284)
Q Consensus       144 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~  222 (284)
                      +||.||+|... +++.+++|++...........+.+|++.+++++|+|++++.+++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999975 58899999986544333256799999999999999999999999999999999999999999999976


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          223 RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       223 ~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ..    .+++.....++.++++++.|||..   +++|+||+|+||+++.+++++++||
T Consensus        81 ~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~  131 (244)
T smart00220       81 RG----RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADF  131 (244)
T ss_pred             cc----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccc
Confidence            43    278999999999999999999998   9999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=8.3e-22  Score=157.49  Aligned_cols=140  Identities=32%  Similarity=0.542  Sum_probs=115.6

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeC--------Ce
Q 023282          134 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV--------TE  203 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~--------~~  203 (284)
                      |+....||+|.||.||+++.+ +|+.||+|+.--+... ..-....+|+.++..++|+|++.+++.|...        ..
T Consensus        19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t   98 (376)
T KOG0669|consen   19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT   98 (376)
T ss_pred             HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence            444577999999999999854 5778898865322222 2223567999999999999999999988642        24


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .++|+++|+. +|.-+|....   ..++..++.+++.++..||.|+|+.   .|+|||+||.|+|++.++..|++||
T Consensus        99 ~ylVf~~ceh-DLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADF  168 (376)
T KOG0669|consen   99 FYLVFDFCEH-DLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADF  168 (376)
T ss_pred             eeeeHHHhhh-hHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecc
Confidence            7899999975 8998887542   2478889999999999999999999   9999999999999999999999998

>smart00090 RIO RIO-like kinase

Probab=99.79  E-value=4.6e-19  Score=146.66  Aligned_cols=136  Identities=14%  Similarity=0.121  Sum_probs=103.6

Q ss_pred             CCCCCCeecccCceEEEEEE--eCCCcEEEEEEeecccCcc-----------------------cHHHHHHHHHHHhcCC
Q 023282          133 GFSNKNILGRGGFGKVYKGR--LADGKLVAVKRLKEERTSG-----------------------GELQFQTEVKIISMAV  187 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~e~~~l~~~~  187 (284)
                      .|...+.||+|+||.||+|.  ..+|+.||+|.++......                       ....+..|++.+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            36677899999999999998  5689999999987432110                       0113568999999887


Q ss_pred             CCC--ceeeeeEEeeCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-eeeeCCCC
Q 023282          188 HRN--LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK-IIHRDVKA  264 (284)
Q Consensus       188 h~n--iv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~-ivHrdlk~  264 (284)
                      +..  +.+++++    ...++||||+++++|........    .+.......++.|++.++.+||+.   + ++||||||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp  177 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV----EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE  177 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC----CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence            533  3333432    24589999999988876543211    245556778999999999999999   8 99999999


Q ss_pred             CCeeeCCCCCcchhhh
Q 023282          265 ANILLDEDADQSSKTI  280 (284)
Q Consensus       265 ~NiLld~~~~~~~~df  280 (284)
                      +||+++ ++++++.||
T Consensus       178 ~NIli~-~~~i~LiDF  192 (237)
T smart00090      178 YNILVH-DGKVVIIDV  192 (237)
T ss_pred             hhEEEE-CCCEEEEEC
Confidence            999999 888999987

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.79  E-value=7.2e-20  Score=149.63  Aligned_cols=139  Identities=25%  Similarity=0.326  Sum_probs=114.1

Q ss_pred             hcCCCC-CCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEee----CCe
Q 023282          131 TDGFSN-KNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT----VTE  203 (284)
Q Consensus       131 ~~~~~~-~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~----~~~  203 (284)
                      +++|.+ .++||-|-.|.|..+.. .+++.+|+|++...      ...++|++..-+. .|||||++++.|..    ...
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            344543 36899999999999975 47889999988432      2356888876554 59999999998754    345


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC---CCCcchhhh
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTI  280 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~---~~~~~~~df  280 (284)
                      +.+|||.|++|.|.+.+++++.  .++++.+.-.|+.||+.|+.|||+.   +|.||||||+|+|...   |...|++||
T Consensus       134 LLiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             eEeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccc
Confidence            7899999999999999988643  4689999999999999999999999   9999999999999865   456788887

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.79  E-value=3.4e-19  Score=164.86  Aligned_cols=143  Identities=23%  Similarity=0.264  Sum_probs=99.9

Q ss_pred             HhcCCCCCCeecccCceEEEEEEeC-C----CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeE------E
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRLA-D----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF------C  198 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~------~  198 (284)
                      ..++|...+.||+|+||.||+|+.. +    +..||+|++.....   ...+..|  .+....+.++..+...      +
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence            4578889999999999999999864 4    68999998753221   1111111  1222222222222211      2


Q ss_pred             eeCCeeeEEEeCCCCCChHHHHhhcCCCC----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCC
Q 023282          199 TTVTEKLLVYPYMTNGSVASRLRERQSSL----------------PPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV  262 (284)
Q Consensus       199 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~----------------~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdl  262 (284)
                      ......++||||+++++|.+++.......                ....+..+..++.|++.||.|||+.   +|+||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL  281 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV  281 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence            34567899999999999999997532110                0111234557899999999999998   9999999


Q ss_pred             CCCCeeeCC-CCCcchhhh
Q 023282          263 KAANILLDE-DADQSSKTI  280 (284)
Q Consensus       263 k~~NiLld~-~~~~~~~df  280 (284)
                      ||+|||++. ++.+||+||
T Consensus       282 KP~NILl~~~~~~~KL~DF  300 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDL  300 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeC
Confidence            999999996 578999998

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.78  E-value=4.3e-20  Score=156.96  Aligned_cols=145  Identities=24%  Similarity=0.359  Sum_probs=122.0

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccH--HHHHHHHHHHhcC-CCCCceeeeeEEeeCCee
Q 023282          129 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGE--LQFQTEVKIISMA-VHRNLLRLYGFCTTVTEK  204 (284)
Q Consensus       129 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~--~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~  204 (284)
                      +...+|....+||+|+||.|..+..+ +.+.+|||+++.+...++.  +--+.|-++|..- +-|.++++..++.+.+.+
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL  425 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL  425 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence            33446888899999999999999754 5678999999876543322  2234566666655 468899999999999999


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++||||+.+|+|.-.+++.+    .+.++.+..+|..||-||-|||++   +|+.||||..|||||.+|.+||+||
T Consensus       426 yFVMEyvnGGDLMyhiQQ~G----kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DF  494 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQQVG----KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADF  494 (683)
T ss_pred             eeEEEEecCchhhhHHHHhc----ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeec
Confidence            99999999999999998643    477788999999999999999999   9999999999999999999999998

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.78  E-value=7.2e-19  Score=152.08  Aligned_cols=134  Identities=22%  Similarity=0.344  Sum_probs=111.3

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCC-----C---CCceeeeeEEee--
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-----H---RNLLRLYGFCTT--  200 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-----h---~niv~l~g~~~~--  200 (284)
                      .+|...+.||-|.|++||.+.. .+.+.||+|+.+..  ....+....||.+|++++     |   ..||+|++.|..  
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            5677889999999999999984 56778999998743  233345778999998774     2   479999999865  


Q ss_pred             --CCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCC
Q 023282          201 --VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED  272 (284)
Q Consensus       201 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~  272 (284)
                        ..+.++|+|++ +-+|..+|....  .+.++.....+|+.||+.||.|||..|  +|||-||||+|||+-..
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST  224 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence              34789999999 568999998643  335788899999999999999999998  99999999999999765

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.78  E-value=1.5e-19  Score=152.61  Aligned_cols=153  Identities=25%  Similarity=0.325  Sum_probs=128.5

Q ss_pred             HHHHHHHhcCCCCCCeecccCceEEEEEEeCC------CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeE
Q 023282          124 LRELQVATDGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF  197 (284)
Q Consensus       124 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~  197 (284)
                      .+++....+++....++-+|.||.||+|.+.+      .+.|-+|.++...+.-....+..|...+..+.|||+..+.+.
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            45667777788888899999999999997643      345778888766655555578999999999999999999999


Q ss_pred             EeeC-CeeeEEEeCCCCCChHHHHhhcC----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCC
Q 023282          198 CTTV-TEKLLVYPYMTNGSVASRLRERQ----SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED  272 (284)
Q Consensus       198 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~----~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~  272 (284)
                      +... ...+.+|.++.-|+|..+|...+    ...+.++-.+...++.|++.|++|||++   ++||.||.++|+++|+.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence            8764 56789999999999999998322    2234567788999999999999999999   99999999999999999


Q ss_pred             CCcchhh
Q 023282          273 ADQSSKT  279 (284)
Q Consensus       273 ~~~~~~d  279 (284)
                      ..+|++|
T Consensus       433 LqVkltD  439 (563)
T KOG1024|consen  433 LQVKLTD  439 (563)
T ss_pred             eeEEecc
Confidence            9999987

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=1.3e-18  Score=140.61  Aligned_cols=126  Identities=17%  Similarity=0.246  Sum_probs=102.6

Q ss_pred             eecccCceEEEEEEeCCCcEEEEEEeecccCccc-------HHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCC
Q 023282          139 ILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG-------ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       139 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      +||+|+||.||+|.+ ++..+++|..........       ...+.+|++++..++|+++.....++...+..+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999986 567899998643321111       135778999999999888766666666777789999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++++|.+++....           ..++.+++.+|.+||+.   +++|+|++|+||+++ ++.+++.||
T Consensus        80 ~g~~l~~~~~~~~-----------~~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDf  133 (199)
T TIGR03724        80 EGKPLKDVIEEGN-----------DELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDF  133 (199)
T ss_pred             CCccHHHHHhhcH-----------HHHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEEC
Confidence            9999999875421           07899999999999998   999999999999999 888999997

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=1.9e-18  Score=159.57  Aligned_cols=131  Identities=15%  Similarity=0.213  Sum_probs=105.4

Q ss_pred             CCCCCCeecccCceEEEEEEeCCCcEEEEEEe-ecccCcc------cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeee
Q 023282          133 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRL-KEERTSG------GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  205 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~-~~~~~~~------~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~  205 (284)
                      .|...+.||+|+||.||+|.+.+.. +++|+. .......      ....+.+|++++..++|++++....++......+
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~  412 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT  412 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence            3456789999999999999875443 333432 2111111      1235889999999999999998888888777889


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +||||+++++|.+++.            ....++.+++++|.|||+.   +++||||||+|||+ .++.++++||
T Consensus       413 lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDF  471 (535)
T PRK09605        413 IVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDF  471 (535)
T ss_pred             EEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeC
Confidence            9999999999998885            2467899999999999998   99999999999999 5778999997

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.77  E-value=2.4e-20  Score=150.80  Aligned_cols=137  Identities=25%  Similarity=0.342  Sum_probs=112.8

Q ss_pred             CCCeecccCceEEEEEEeC-CCcEEEEEEeecccC-cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC-----eeeEEE
Q 023282          136 NKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-----EKLLVY  208 (284)
Q Consensus       136 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~-----~~~lv~  208 (284)
                      ..+.||-|+||.||....+ +|+.||.|++..-.. -...+.+.+|+.++..++|.|++..++...-+.     +.|+++
T Consensus        57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T  136 (449)
T KOG0664|consen   57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT  136 (449)
T ss_pred             CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence            3477999999999999864 799999998843211 122346889999999999999999998775432     467888


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |.|. .+|.+.+-..    .+++-....-+..||++||.|||+.   +|.||||||.|.|++++...||+||
T Consensus       137 ELmQ-SDLHKIIVSP----Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDF  200 (449)
T KOG0664|consen  137 ELMQ-SDLHKIIVSP----QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDF  200 (449)
T ss_pred             HHHH-hhhhheeccC----CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccc
Confidence            8885 4788777643    2577778888999999999999999   9999999999999999999999999

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.77  E-value=1.5e-18  Score=140.25  Aligned_cols=132  Identities=22%  Similarity=0.170  Sum_probs=102.8

Q ss_pred             CCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCc-----c----------------cHHHHHHHHHHHhcCCCCC-
Q 023282          133 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-----G----------------GELQFQTEVKIISMAVHRN-  190 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----~----------------~~~~~~~e~~~l~~~~h~n-  190 (284)
                      -|...+.||+|+||.||++..++|+.||||++......     .                ....+..|+..+..+.|++ 
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            36677899999999999999888999999987543210     0                0113567888888887774 


Q ss_pred             -ceeeeeEEeeCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeee
Q 023282          191 -LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  269 (284)
Q Consensus       191 -iv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLl  269 (284)
                       +...++    ....+++|||+++++|.+....          .....++.+++.++.++|+.   +++||||||+||++
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill  158 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILV  158 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEE
Confidence             444443    2456899999999998765421          23457889999999999998   99999999999999


Q ss_pred             CCCCCcchhhhh
Q 023282          270 DEDADQSSKTIL  281 (284)
Q Consensus       270 d~~~~~~~~df~  281 (284)
                      +++++++++||=
T Consensus       159 ~~~~~~~liDfg  170 (198)
T cd05144         159 DDDEKIYIIDWP  170 (198)
T ss_pred             cCCCcEEEEECC
Confidence            999999999983

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.77  E-value=4.4e-19  Score=147.31  Aligned_cols=144  Identities=26%  Similarity=0.356  Sum_probs=124.5

Q ss_pred             HhcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccH--HHHHHHHHHHhcC-CCCCceeeeeEEeeCCeee
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGE--LQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKL  205 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~--~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~~  205 (284)
                      ...+|..+++||+|+|++|..+++ ++.+.+|+|+++++...+++  .-.+.|-.+.... +||.+|-+..++.+...++
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            445788999999999999999985 46889999999876554443  2356677776554 6999999999999999999


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +|.||+++|+|.-+++..+    .+++.....+...|+.||.|||+.   +|+.||||..|+|+|.++..|+.|+
T Consensus       328 fvieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdy  395 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDY  395 (593)
T ss_pred             EEEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeeccc
Confidence            9999999999998887643    488899999999999999999999   9999999999999999999999986

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.75  E-value=4e-18  Score=138.64  Aligned_cols=134  Identities=10%  Similarity=0.098  Sum_probs=108.3

Q ss_pred             HhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccH--HH------HHHHHHHHhcCCCCCceeeeeEEeeC
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGE--LQ------FQTEVKIISMAVHRNLLRLYGFCTTV  201 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~--~~------~~~e~~~l~~~~h~niv~l~g~~~~~  201 (284)
                      -..+|...+++|.|+||.||.... ++..+|+|.+++.......  ..      +.+|+..+.++.|++|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            356788899999999999999655 5668999999755433221  11      67899999999999999998885532


Q ss_pred             --------CeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC
Q 023282          202 --------TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  273 (284)
Q Consensus       202 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~  273 (284)
                              ...+++|||+++.+|.++..        ++.    ....+++.+|..+|+.   +++|||+||+|++++.++
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence                    35789999999999987742        222    2456899999999999   999999999999999988


Q ss_pred             Ccchhhh
Q 023282          274 DQSSKTI  280 (284)
Q Consensus       274 ~~~~~df  280 (284)
                       +++.||
T Consensus       173 -i~liDf  178 (232)
T PRK10359        173 -LRIIDL  178 (232)
T ss_pred             -EEEEEC
Confidence             999997

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.75  E-value=3.8e-19  Score=140.48  Aligned_cols=135  Identities=21%  Similarity=0.381  Sum_probs=112.1

Q ss_pred             hcCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCC-CCCceeeeeEEeeCC--eeeE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVT--EKLL  206 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~~~--~~~l  206 (284)
                      .++|++.+.+|+|.++.||.|. ..+.+.+.||++++-.    .+.+.+|+.++..+. ||||++|++...++.  ...|
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            3466777889999999999997 5678899999997532    346889999999998 999999999987654  4679


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC-Ccchhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKT  279 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~-~~~~~d  279 (284)
                      ++||+.+.+...+..       .++...+..+..+++.||.|+|+.   +|+|||+||.|+++|... ..++.|
T Consensus       113 iFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlID  176 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLID  176 (338)
T ss_pred             HhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeee
Confidence            999999987766553       266677889999999999999999   999999999999999764 445444

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.75  E-value=1.2e-17  Score=133.35  Aligned_cols=126  Identities=18%  Similarity=0.146  Sum_probs=99.2

Q ss_pred             CCCeecccCceEEEEEEeCCCcEEEEEEeecccCccc---HHHHHHHHHHHhcCC-CCCceeeeeEEeeCCeeeEEEeCC
Q 023282          136 NKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG---ELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       136 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~e~~~l~~~~-h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      ....|++|.||+||.+.. .+..++.+.+........   ...+.+|+++|+++. |+++.+++++    +..+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            457899999999997655 567777776654332211   124789999999996 5789999886    4579999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCC-CCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV-KAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdl-k~~NiLld~~~~~~~~df  280 (284)
                      ++.+|...+..           ....+..|++++|.++|+.   +|+|||| ||+|||++.++.++|+||
T Consensus        81 ~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDF  136 (218)
T PRK12274         81 AGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDF  136 (218)
T ss_pred             cCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEEC
Confidence            99888754421           1134678899999999999   9999999 799999999999999998

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.75  E-value=1.5e-18  Score=158.53  Aligned_cols=138  Identities=30%  Similarity=0.353  Sum_probs=108.5

Q ss_pred             CCCCCeecccCce-EEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCC-CCCceeeeeEEeeCCeeeEEEeCC
Q 023282          134 FSNKNILGRGGFG-KVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       134 ~~~~~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      |...+++|.|+-| .||+|.. +++.||||++-.+.    ..-..+|+..++.-+ |||||++++.-.+....|+..|.|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            4556789999987 4799988 57899999884332    224578999988774 999999999888888999999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC---C--CCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---D--ADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~---~--~~~~~~df  280 (284)
                      . .+|.+++...........-.....+..|++.||++||+.   +||||||||.||||+.   +  ..++|+||
T Consensus       586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDf  655 (903)
T KOG1027|consen  586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDF  655 (903)
T ss_pred             h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccc
Confidence            6 599999987411111111134567788999999999997   9999999999999987   3  47899998

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=3.6e-18  Score=149.84  Aligned_cols=140  Identities=21%  Similarity=0.299  Sum_probs=118.8

Q ss_pred             CCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcc-cHHHHHHHHHHHhcCC-CCCceeeeeEEeeCCeeeEEEeC
Q 023282          133 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~-h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      .|+..+.||.|+.+.||++...+.+.+|+|++....... ....|..|+..|.+++ |.+||+|++|-..++..|+||||
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~  441 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC  441 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence            477789999999999999998888899999876443322 2346999999999996 99999999999999999999997


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      = ..+|..+|+.....  ...| .+..+..|++.++.++|.+   +|||.||||.|+|+- .|..||.||
T Consensus       442 G-d~DL~kiL~k~~~~--~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDF  503 (677)
T KOG0596|consen  442 G-DIDLNKILKKKKSI--DPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDF  503 (677)
T ss_pred             c-cccHHHHHHhccCC--CchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeee
Confidence            6 46999999876433  2345 6788899999999999999   999999999999985 677899988

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.74  E-value=1.5e-18  Score=140.27  Aligned_cols=139  Identities=22%  Similarity=0.372  Sum_probs=113.1

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeE-EeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGF-CTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~-~~~~~~~~lv~  208 (284)
                      +.|.+.+.||+|.||.+-.++++ +.+.+++|-+.....  ..++|.+|..---.+ .|.||+.-|+. +.+.+...+++
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t--t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT--TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh--hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            45777889999999999999875 567899998754432  345789998765445 48999987764 56667788999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeee-CCC-CCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL-DED-ADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLl-d~~-~~~~~~df  280 (284)
                      ||+|.|+|.+-+...     .+.+....+++.|++.|+.|+|+.   ++||||||.+|||+ +.| ..+|++||
T Consensus       102 E~aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDF  167 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDF  167 (378)
T ss_pred             ccCccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeec
Confidence            999999999887543     367778899999999999999999   99999999999998 333 48999998

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.73  E-value=3.2e-19  Score=155.02  Aligned_cols=142  Identities=25%  Similarity=0.306  Sum_probs=121.3

Q ss_pred             cCCCCCCeecccCceEEEEEEeCCCc-EEEEEEeecccCc--ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLADGK-LVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      .+++...-||-|+||.|=........ .+|+|.+++....  ..+.....|-.+|..++.|.||++|..|.+....|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            34555566999999999888764333 4899988754332  23345778999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |-|-+|.|...|+.++    .++......++..+.+|++|||++   +||.|||||+|.++|.+|=+|+.||
T Consensus       500 EaClGGElWTiLrdRg----~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDF  564 (732)
T KOG0614|consen  500 EACLGGELWTILRDRG----SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDF  564 (732)
T ss_pred             HhhcCchhhhhhhhcC----CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeeh
Confidence            9999999999998864    377778889999999999999999   9999999999999999999999998

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.72  E-value=6.4e-18  Score=150.71  Aligned_cols=138  Identities=24%  Similarity=0.332  Sum_probs=114.5

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhc-CCCCCceeeeeEEeeCCeeeEEE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++.|.....+|.|+|+.|-++.. .+++..++|++....     .+-.+|+.++.. -+||||+++.+.+....+.|+||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            55677778899999999999874 578889999985441     123456655544 46999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeee-CCCCCcchhhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL-DEDADQSSKTIL  281 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLl-d~~~~~~~~df~  281 (284)
                      |.+.++-+.+.+.....    .. .++..|+.+++.|+.|||.+   +++||||||+|||+ +..+..+++||=
T Consensus       396 e~l~g~ell~ri~~~~~----~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG  461 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKPE----FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFG  461 (612)
T ss_pred             hhccccHHHHHHHhcch----hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEec
Confidence            99999999888876432    22 67778999999999999998   99999999999999 588899999983

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.69  E-value=4.3e-17  Score=138.92  Aligned_cols=141  Identities=21%  Similarity=0.362  Sum_probs=118.1

Q ss_pred             HHHHhcCCCCCCeecccCceEEEEEEeC----CCcEEEEEEeecccCcccHHHHHHHHHHHhcCC-CCCceeeeeEEeeC
Q 023282          127 LQVATDGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTV  201 (284)
Q Consensus       127 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~~  201 (284)
                      +....+.|...+.||+|.|++||++...    ....||+|.+......   ..+..|+++|..+. +.||+++.+++...
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccC
Confidence            3445566888899999999999999743    3568999998644322   25789999998886 89999999999999


Q ss_pred             CeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC-Ccchhhh
Q 023282          202 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTI  280 (284)
Q Consensus       202 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~-~~~~~df  280 (284)
                      ++..+|+||++.-...++...       ++......+...+..||+++|.+   +|||||+||+|+|.+... .-.|.||
T Consensus       108 d~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDF  177 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDF  177 (418)
T ss_pred             CeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEec
Confidence            999999999999999888875       56778899999999999999999   999999999999998664 3445554

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.69  E-value=5.5e-17  Score=129.75  Aligned_cols=130  Identities=21%  Similarity=0.265  Sum_probs=91.2

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEeecccCcccH-HH----------------------HHHHHHHHhcCCCCC--c
Q 023282          137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGE-LQ----------------------FQTEVKIISMAVHRN--L  191 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~-~~----------------------~~~e~~~l~~~~h~n--i  191 (284)
                      .+.||+|+||+||+|...+++.||||+++........ ..                      ...|...+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999999878999999998653221111 11                      134555555554332  3


Q ss_pred             eeeeeEEeeCCeeeEEEeCCCCCChHH-HHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeeeCCCCCCeee
Q 023282          192 LRLYGFCTTVTEKLLVYPYMTNGSVAS-RLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILL  269 (284)
Q Consensus       192 v~l~g~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~ivHrdlk~~NiLl  269 (284)
                      .+.+++    ...+++|||++++.+.. .+....     .. .....++.+++.++.++|. .   +++||||||+||++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili  148 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV  148 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence            333332    34689999999855432 121110     01 4567899999999999999 7   99999999999999


Q ss_pred             CCCCCcchhhh
Q 023282          270 DEDADQSSKTI  280 (284)
Q Consensus       270 d~~~~~~~~df  280 (284)
                      + ++.++++||
T Consensus       149 ~-~~~~~liDf  158 (187)
T cd05119         149 D-DGKVYIIDV  158 (187)
T ss_pred             E-CCcEEEEEC
Confidence            9 889999997

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.69  E-value=1.6e-16  Score=121.91  Aligned_cols=129  Identities=17%  Similarity=0.131  Sum_probs=107.4

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCC--CCceeeeeEEeeCCeeeEEEeCCCCC
Q 023282          137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH--RNLLRLYGFCTTVTEKLLVYPYMTNG  214 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h--~niv~l~g~~~~~~~~~lv~e~~~~g  214 (284)
                      .+.||+|.++.||++...+ ..+++|.......   ...+..|+..+..++|  .++.+++++....+..++++||++++
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            4679999999999999754 6789998754332   3468899999999876  58889988888778899999999987


Q ss_pred             ChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          215 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       215 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .+..+           ++.....++.+++++++++|.....+++|+|++|+||+++..+.+++.||
T Consensus        79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df  133 (155)
T cd05120          79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDW  133 (155)
T ss_pred             ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEec
Confidence            76543           44567788999999999999864457999999999999999889999998

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.67  E-value=3.7e-16  Score=135.61  Aligned_cols=141  Identities=21%  Similarity=0.277  Sum_probs=112.7

Q ss_pred             CCCCCCeecccCceEEEEEEeCCC--cEEEEEEeecccCcccHHHHHHHHHHHhcCCC----CCceeeeeEE-eeCCeee
Q 023282          133 GFSNKNILGRGGFGKVYKGRLADG--KLVAVKRLKEERTSGGELQFQTEVKIISMAVH----RNLLRLYGFC-TTVTEKL  205 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h----~niv~l~g~~-~~~~~~~  205 (284)
                      .|...+.||+|+||.||.+.....  ..+|+|........... .+..|..++..+..    +++..+++.. ......+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            688889999999999999986543  47888877544333322 57778888877762    5888888888 4677889


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC-----Ccchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-----DQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~-----~~~~~df  280 (284)
                      +||+.+ +.+|.++.....  ...++..+.+.++.|+..+|.+||+.   +++||||||.|++++...     ...+.||
T Consensus        98 iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             EEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            999977 779999886543  34688999999999999999999999   999999999999998763     3566665

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.66  E-value=9.3e-17  Score=132.57  Aligned_cols=138  Identities=25%  Similarity=0.308  Sum_probs=110.3

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC-cccHHHHHHHHHHHhcCCCCCceeeeeEEeeC------Cee
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTV------TEK  204 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~------~~~  204 (284)
                      +|.....+|.|.- .|..+... .+++||+|++..... ....++..+|...+..++|+|+++++.++.-.      .+.
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~   96 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV   96 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence            3555567788776 55555432 578999998753322 22344678999999999999999999998643      357


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  281 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df~  281 (284)
                      ++|||||. ++|...++..      ++-.+...+..|++.|+.|||+.   +|+||||||+||++..+...||.||.
T Consensus        97 y~v~e~m~-~nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg  163 (369)
T KOG0665|consen   97 YLVMELMD-ANLCQVILME------LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFG  163 (369)
T ss_pred             HHHHHhhh-hHHHHHHHHh------cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccch
Confidence            89999995 5899888743      56677889999999999999999   99999999999999999999999984

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.66  E-value=4e-16  Score=124.40  Aligned_cols=140  Identities=20%  Similarity=0.261  Sum_probs=111.9

Q ss_pred             hcCCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCC-CCceeeeeEEeeCCeeeEEE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH-RNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h-~niv~l~g~~~~~~~~~lv~  208 (284)
                      ...|...+.||.|+||.+|.|. ..+|+.||+|.-....   ...++.-|..+...++| ..|..+..|..+...-.+||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a---~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA---KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC---CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            3467888999999999999997 6789999999764322   23357788888888875 56666777777888889999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC---Ccchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~---~~~~~df  280 (284)
                      |.+ +.+|.++..-..   ..++..+.+.+|-|+..-++|+|.+   +++||||||+|+|.+-+-   ...+.||
T Consensus        91 dLL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDF  158 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDF  158 (341)
T ss_pred             ecc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEec
Confidence            988 779999886432   2478889999999999999999999   899999999999987553   3445554

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.65  E-value=2.2e-16  Score=133.14  Aligned_cols=134  Identities=20%  Similarity=0.296  Sum_probs=110.9

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCC--C----CceeeeeEEeeCCe
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH--R----NLLRLYGFCTTVTE  203 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h--~----niv~l~g~~~~~~~  203 (284)
                      +.+|.+...+|+|.||.|-.+... .+..||+|+++.-  ....+.-+-|++++.++.+  |    -.|.+.+|+...++
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            677888999999999999999853 5789999999643  2333456789999998843  2    25778888988999


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCC
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED  272 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~  272 (284)
                      .++|+|.+ +-++.++|.+..  ..+++..+...++.|++++++|||+.   .++|-||||+|||+-+.
T Consensus       166 iCivfell-G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss  228 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSS  228 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEecc
Confidence            99999988 559999998743  34677889999999999999999999   99999999999998654

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.63  E-value=3e-15  Score=124.17  Aligned_cols=131  Identities=16%  Similarity=0.182  Sum_probs=99.1

Q ss_pred             CCeec-ccCceEEEEEEeCCCcEEEEEEeeccc----------C--cccHHHHHHHHHHHhcCCCCCc--eeeeeEEeeC
Q 023282          137 KNILG-RGGFGKVYKGRLADGKLVAVKRLKEER----------T--SGGELQFQTEVKIISMAVHRNL--LRLYGFCTTV  201 (284)
Q Consensus       137 ~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~----------~--~~~~~~~~~e~~~l~~~~h~ni--v~l~g~~~~~  201 (284)
                      ...|| .|+.|+||..... +..+++|......          .  ......+.+|++++..++|+++  .+.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            36687 7889999998874 6678888774311          0  1122357889999999998775  6677664432


Q ss_pred             C----eeeEEEeCCCC-CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcc
Q 023282          202 T----EKLLVYPYMTN-GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  276 (284)
Q Consensus       202 ~----~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~  276 (284)
                      .    ..++|+||+++ .+|.+++...     .++..    ...+++++|.+||+.   +|+||||||.|||++.+++++
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence            2    23599999997 6898888642     23432    356899999999999   999999999999999999999


Q ss_pred             hhhh
Q 023282          277 SKTI  280 (284)
Q Consensus       277 ~~df  280 (284)
                      ++||
T Consensus       183 LIDf  186 (239)
T PRK01723        183 LIDF  186 (239)
T ss_pred             EEEC
Confidence            9998

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.63  E-value=6.5e-15  Score=126.39  Aligned_cols=142  Identities=34%  Similarity=0.467  Sum_probs=120.8

Q ss_pred             CCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCccc--HHHHHHHHHHHhcCCCC-CceeeeeEEeeCCeeeEEEeC
Q 023282          134 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHR-NLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~~h~-niv~l~g~~~~~~~~~lv~e~  210 (284)
                      |.....||.|+||.||++...  ..+++|.+........  ...+.+|+.++..+.|+ +++++.+.+......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            455678999999999999876  7889999876554443  55799999999999988 799999999777778999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC-Ccchhhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTIL  281 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~-~~~~~df~  281 (284)
                      +.++++.+++...... ..+.......+..|++.++.|+|..   +++|||+||+||+++... ..+++||-
T Consensus        80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg  147 (384)
T COG0515          80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFG  147 (384)
T ss_pred             CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccC
Confidence            9999999777654211 2477888999999999999999999   899999999999999998 69999984

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.59  E-value=6.6e-15  Score=122.45  Aligned_cols=131  Identities=21%  Similarity=0.319  Sum_probs=107.6

Q ss_pred             CCCCCCeecccCceEEEEEE-eCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCC-CCCceeeeeEEeeCCeeeEEEeC
Q 023282          133 GFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      .|...+.||+|+||..+.|. +-++++||||.-..   ..+.-++..|.+..+.+. .+.|..++-+.....+-.||+|.
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr---kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR---KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccc---cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            47778999999999999997 66899999996532   222336788888888775 57888877777777788899998


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  273 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~  273 (284)
                      + +.+|.++..-.+   ..++..+...+|.|+..-++|+|++   .+|.|||||+|+||..-+
T Consensus       106 L-GPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~  161 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPG  161 (449)
T ss_pred             h-CcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCC
Confidence            8 678988886432   3588889999999999999999999   999999999999998644

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.54  E-value=5.1e-15  Score=140.61  Aligned_cols=144  Identities=22%  Similarity=0.256  Sum_probs=109.7

Q ss_pred             HHHHHhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCC---CCCceeeeeEEeeCC
Q 023282          126 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV---HRNLLRLYGFCTTVT  202 (284)
Q Consensus       126 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~---h~niv~l~g~~~~~~  202 (284)
                      +.+...+.|.+.+.||+|+||.||+|...+|+.||+|+-+....++-.    --.+++.+++   -+-|..+...+...+
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfY----I~~q~~~RLk~~~~~~~~~~~~a~~~~~  767 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFY----ICLQVMERLKPQMLPSIMHISSAHVFQN  767 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeee----ehHHHHHhhchhhhcchHHHHHHHccCC
Confidence            344455567778899999999999999888999999998776655432    1122333333   133444445555667


Q ss_pred             eeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCC-------CCc
Q 023282          203 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-------ADQ  275 (284)
Q Consensus       203 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~-------~~~  275 (284)
                      .-++|+||.+.|+|.+++..    ....+|.....++.|+++-++.||..   +|||+||||+|+||...       ...
T Consensus       768 ~S~lv~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l  840 (974)
T KOG1166|consen  768 ASVLVSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGL  840 (974)
T ss_pred             cceeeeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccce
Confidence            88999999999999999973    33589999999999999999999998   99999999999998432       235


Q ss_pred             chhhh
Q 023282          276 SSKTI  280 (284)
Q Consensus       276 ~~~df  280 (284)
                      +|.||
T Consensus       841 ~lIDf  845 (974)
T KOG1166|consen  841 YLIDF  845 (974)
T ss_pred             EEEec
Confidence            56665

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.54  E-value=2.3e-14  Score=128.74  Aligned_cols=135  Identities=22%  Similarity=0.239  Sum_probs=95.7

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEeecccCccc---------------------------------------HHHHH
Q 023282          137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG---------------------------------------ELQFQ  177 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---------------------------------------~~~~~  177 (284)
                      .+.||.|++|+||+|++.+|+.||||+.+......-                                       +.+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            367999999999999999999999999865321100                                       01244


Q ss_pred             HHHHHHhcC----CCCCceeeeeEEe-eCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHH-HHHHHHc
Q 023282          178 TEVKIISMA----VHRNLLRLYGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR-GLSYLHE  251 (284)
Q Consensus       178 ~e~~~l~~~----~h~niv~l~g~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~-gl~yLH~  251 (284)
                      .|.+.+.++    +|.+-+.+...+. .....+++|||+++++|.+........   .   .+..++..+++ .+..+|.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~---~---~~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG---L---DRKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC---C---CHHHHHHHHHHHHHHHHHh
Confidence            555555443    3433444444443 245679999999999998887542111   2   24556666666 4677888


Q ss_pred             CCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          252 HCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       252 ~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .   +++|+|++|.||+++.++.+++.||
T Consensus       276 ~---g~~H~D~hPgNilv~~~g~i~liDf  301 (437)
T TIGR01982       276 D---GFFHADLHPGNIFVLKDGKIIALDF  301 (437)
T ss_pred             C---CceeCCCCcccEEECCCCcEEEEeC
Confidence            7   9999999999999999999999997

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.53  E-value=1.2e-14  Score=127.23  Aligned_cols=144  Identities=19%  Similarity=0.240  Sum_probs=117.7

Q ss_pred             HhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCC------CCceeeeeEEeeCC
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH------RNLLRLYGFCTTVT  202 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h------~niv~l~g~~~~~~  202 (284)
                      -...|....-.|+|-|++|.+|... .|+.||||+|.....  ..+.=+.|+++|++++.      -+.++|+..|...+
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~--M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn  507 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV--MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN  507 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH--HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence            3455666677899999999999854 578999999975432  23345689999998862      37889999999999


Q ss_pred             eeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC-Ccchhhh
Q 023282          203 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTI  280 (284)
Q Consensus       203 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~-~~~~~df  280 (284)
                      ++|||+|-+. .+|.+.|...+.. -.|.......++.|+..||..|-..   +|+|.||||.|||+++.- ..|||||
T Consensus       508 HLClVFE~Ls-lNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDf  581 (752)
T KOG0670|consen  508 HLCLVFEPLS-LNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDF  581 (752)
T ss_pred             eeEEEehhhh-chHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccC
Confidence            9999999885 5899999876433 3467778889999999999999987   999999999999999865 6899998

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.53  E-value=1.5e-15  Score=123.19  Aligned_cols=137  Identities=26%  Similarity=0.432  Sum_probs=114.4

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEEeec-ccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCCCh
Q 023282          138 NILGRGGFGKVYKGRLADGKLVAVKRLKE-ERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSV  216 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g~L  216 (284)
                      ..|.+...|..|+|+++.+.. .+|+++. +......++|..|.-.++-+.||||+.++|.|.++....++..||+.|+|
T Consensus       196 tkl~e~hsgelwrgrwqgndi-vakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl  274 (448)
T KOG0195|consen  196 TKLAESHSGELWRGRWQGNDI-VAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL  274 (448)
T ss_pred             hhhccCCCcccccccccCcch-hhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence            457788899999999976554 4577653 33344456899999999999999999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchh
Q 023282          217 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  278 (284)
Q Consensus       217 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~  278 (284)
                      +..|++..+  ...+-.+..+++.++|+|++|||+. .|-|..--|.+..+++|++.+++|+
T Consensus       275 ynvlhe~t~--vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris  333 (448)
T KOG0195|consen  275 YNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS  333 (448)
T ss_pred             HHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee
Confidence            999997533  3467778999999999999999997 4556666799999999999988875

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.37  E-value=1.2e-12  Score=119.43  Aligned_cols=138  Identities=21%  Similarity=0.227  Sum_probs=87.7

Q ss_pred             CCCCCCeecccCceEEEEEEeCC-CcEEEEEEeecccCc---------------------------------c------c
Q 023282          133 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTS---------------------------------G------G  172 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---------------------------------~------~  172 (284)
                      .|+. +.||.|++|+||+|++.+ |+.||||++++....                                 +      .
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4665 789999999999999876 999999999743210                                 0      0


Q ss_pred             HHHHHHHHHHHhcC----CCCCceeeeeEEee-CCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHH-H
Q 023282          173 ELQFQTEVKIISMA----VHRNLLRLYGFCTT-VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG-L  246 (284)
Q Consensus       173 ~~~~~~e~~~l~~~----~h~niv~l~g~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~g-l  246 (284)
                      +.+|.+|+..+.++    .+.+.+.+...+.+ ....+|||||++++++.+.-.....   ..+   +..++...++. +
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~---g~d---~~~la~~~v~~~~  273 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAA---GTD---MKLLAERGVEVFF  273 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhc---CCC---HHHHHHHHHHHHH
Confidence            11245555544433    34555555454433 4567899999999999875321111   111   11222222211 1


Q ss_pred             HHHHcCCCCCeeeeCCCCCCeeeCCCC----Ccchhhh
Q 023282          247 SYLHEHCDPKIIHRDVKAANILLDEDA----DQSSKTI  280 (284)
Q Consensus       247 ~yLH~~~~~~ivHrdlk~~NiLld~~~----~~~~~df  280 (284)
                      .-+...   +++|+|+||.||+++.++    ..++.||
T Consensus       274 ~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDF  308 (537)
T PRK04750        274 TQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDF  308 (537)
T ss_pred             HHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEec
Confidence            122344   899999999999999988    8888887

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.37  E-value=1.8e-12  Score=101.77  Aligned_cols=125  Identities=20%  Similarity=0.170  Sum_probs=89.8

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCce-eeeeEEeeCCeeeEEEeCCCCCCh
Q 023282          138 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL-RLYGFCTTVTEKLLVYPYMTNGSV  216 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv-~l~g~~~~~~~~~lv~e~~~~g~L  216 (284)
                      +.++.|.++.||+++.. +..+++|.......  ....+..|+..+..+.+.+++ +++.+.  ....++||||+++.++
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            56889999999999875 67899998754321  122467888888887655544 444433  3346899999999877


Q ss_pred             HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          217 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC--DPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       217 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~--~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .+.-         .   ....+..+++++|+.||...  ...++|+|++|.||+++ ++.+++.||
T Consensus        79 ~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf  131 (170)
T cd05151          79 LTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDW  131 (170)
T ss_pred             cccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEec
Confidence            5430         0   11345678999999999972  22369999999999999 667888887

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.35  E-value=3.9e-13  Score=130.06  Aligned_cols=89  Identities=11%  Similarity=0.014  Sum_probs=68.5

Q ss_pred             cCCC-CCceeeeeEE-------eeCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 023282          185 MAVH-RNLLRLYGFC-------TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK  256 (284)
Q Consensus       185 ~~~h-~niv~l~g~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~  256 (284)
                      .++| +||+++++++       ......+.++||+ .++|.++|....   ..+++.+++.++.||++||+|||++   +
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---g  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQ---G  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            3345 5888888877       2223567788887 569999997532   3589999999999999999999998   9


Q ss_pred             eeeeCCCCCCeeeCCCCCcchhhh
Q 023282          257 IIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       257 ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+||||||+|||++..++.|++||
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~  124 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIES  124 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeec
Confidence            999999999999965444444433

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.28  E-value=2.7e-11  Score=99.15  Aligned_cols=138  Identities=17%  Similarity=0.227  Sum_probs=102.3

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCC--CCceeeeeEEeeCC---eeeEEEeCCC
Q 023282          138 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH--RNLLRLYGFCTTVT---EKLLVYPYMT  212 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h--~niv~l~g~~~~~~---~~~lv~e~~~  212 (284)
                      +.|+.|..+.+|++...+|..+++|.............+..|.+++..+.+  .++.+++.+.....   ..+++|||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            568999999999998876688999987543322223468899999988875  34566777765532   5689999999


Q ss_pred             CCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------------
Q 023282          213 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC---------------------------------------  253 (284)
Q Consensus       213 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~---------------------------------------  253 (284)
                      +.++.+.+..     ..++..+...++.+++++|.+||+..                                       
T Consensus        84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9888765531     13566777788888888888888521                                       


Q ss_pred             --------------CCCeeeeCCCCCCeeeCC--CCCcchhhh
Q 023282          254 --------------DPKIIHRDVKAANILLDE--DADQSSKTI  280 (284)
Q Consensus       254 --------------~~~ivHrdlk~~NiLld~--~~~~~~~df  280 (284)
                                    ...++|+|+.+.||+++.  +..+.+.||
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~  201 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDW  201 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEec
Confidence                          245799999999999998  455677776

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.26  E-value=2.2e-12  Score=119.71  Aligned_cols=138  Identities=21%  Similarity=0.238  Sum_probs=103.0

Q ss_pred             CCCeecccCceEEEEEEeC-CCcEEEEEEee----cc-cCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          136 NKNILGRGGFGKVYKGRLA-DGKLVAVKRLK----EE-RTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       136 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~----~~-~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      ..+++|.|++|.|+..... .....+.|..+    .. ........+..|+.+-..+.|+|++..+..+.......-.||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            4578999999977766532 33333434322    11 111111125667777889999999887777766665555699


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  281 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df~  281 (284)
                      |+++ +|..++....    .++-.++..+..|+..|+.|+|+.   ++.|||+|++|+++..++..|++||-
T Consensus       402 ~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg  465 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFG  465 (601)
T ss_pred             cccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecC
Confidence            9999 9999997641    356677888999999999999999   99999999999999999999999984

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.22  E-value=1.2e-10  Score=92.85  Aligned_cols=132  Identities=14%  Similarity=0.160  Sum_probs=91.3

Q ss_pred             CeecccCceEEEEEEeCC-------CcEEEEEEeecccC-----------c---------cc-HHHH----HHHHHHHhc
Q 023282          138 NILGRGGFGKVYKGRLAD-------GKLVAVKRLKEERT-----------S---------GG-ELQF----QTEVKIISM  185 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~-----------~---------~~-~~~~----~~e~~~l~~  185 (284)
                      ..||.|.-+.||.|...+       +..+|||+.+....           .         .. ...+    .+|++.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999997543       47899998753210           0         00 1122    378888887


Q ss_pred             CCC--CCceeeeeEEeeCCeeeEEEeCCCCCChHH-HHhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeeeeC
Q 023282          186 AVH--RNLLRLYGFCTTVTEKLLVYPYMTNGSVAS-RLRERQSSLPPLDWPTRKKIALGSARGLSYL-HEHCDPKIIHRD  261 (284)
Q Consensus       186 ~~h--~niv~l~g~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yL-H~~~~~~ivHrd  261 (284)
                      +..  -++.+++++    ...++||||+.+..+.. .+++.     .++..+...+..++..+|.++ |..   +++|+|
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD  150 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD  150 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            753  345555543    56789999997654422 23221     234445667788999999999 666   999999


Q ss_pred             CCCCCeeeCCCCCcchhhhhh
Q 023282          262 VKAANILLDEDADQSSKTILR  282 (284)
Q Consensus       262 lk~~NiLld~~~~~~~~df~~  282 (284)
                      |++.|||++ ++.+.+.||=+
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~q  170 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQ  170 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCC
Confidence            999999997 46788998843

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.19  E-value=3.7e-12  Score=120.50  Aligned_cols=139  Identities=23%  Similarity=0.223  Sum_probs=111.4

Q ss_pred             CCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHH--HhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          133 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKI--ISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~--l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ++...+.||++.|=+|.+++.++|. |.||++......-..+.|.++++-  ....+|||.+.+..+.......+||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            4666788999999999999998887 888988544433333334433332  5667899999988887777788889899


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ..+ +|+|.|..+.    -+...+..-|+.|+..||.-+|..   +|+|+|||.+|||+..-.=+.++||
T Consensus       103 vkh-nLyDRlSTRP----FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDF  164 (1431)
T KOG1240|consen  103 VKH-NLYDRLSTRP----FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDF  164 (1431)
T ss_pred             Hhh-hhhhhhccch----HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcc
Confidence            854 8999997643    366677788999999999999999   9999999999999999888888887

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.16  E-value=2.6e-10  Score=95.88  Aligned_cols=142  Identities=23%  Similarity=0.340  Sum_probs=89.6

Q ss_pred             CCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--CcccHHHHHHHHHHHhcCCC----------CCceeeeeEE----
Q 023282          136 NKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVH----------RNLLRLYGFC----  198 (284)
Q Consensus       136 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h----------~niv~l~g~~----  198 (284)
                      ..+.||.|+++.||.++.. +++.+|+|......  .....+++.+|.-....+.+          -.++...+..    
T Consensus        16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~   95 (288)
T PF14531_consen   16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG   95 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred             EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence            3578999999999999975 68999999875322  22234456666655544332          1121112211    


Q ss_pred             -----eeCC--------eeeEEEeCCCCCChHHHHhh---cCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCC
Q 023282          199 -----TTVT--------EKLLVYPYMTNGSVASRLRE---RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV  262 (284)
Q Consensus       199 -----~~~~--------~~~lv~e~~~~g~L~~~l~~---~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdl  262 (284)
                           ....        ..+++|+-+ .++|.+++..   .......+....++.+..|+.+.+++||+.   +++|+||
T Consensus        96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi  171 (288)
T PF14531_consen   96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDI  171 (288)
T ss_dssp             S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-
T ss_pred             CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEeccc
Confidence                 1111        235677777 4688887642   222112244556777889999999999999   9999999


Q ss_pred             CCCCeeeCCCCCcchhhhh
Q 023282          263 KAANILLDEDADQSSKTIL  281 (284)
Q Consensus       263 k~~NiLld~~~~~~~~df~  281 (284)
                      ||+|++++.+|.+.++||-
T Consensus       172 ~~~nfll~~~G~v~Lg~F~  190 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFS  190 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GG
T ss_pred             ceeeEEEcCCCCEEEcChH
Confidence            9999999999999999984

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.13  E-value=3.2e-11  Score=103.06  Aligned_cols=78  Identities=28%  Similarity=0.382  Sum_probs=60.2

Q ss_pred             CCCCCceeeeeEEee---------------------------CCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHH
Q 023282          186 AVHRNLLRLYGFCTT---------------------------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI  238 (284)
Q Consensus       186 ~~h~niv~l~g~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i  238 (284)
                      .+|||||++.++|.+                           +...|+||.-.+. +|..++-.+.     .+.....-+
T Consensus       273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-----~s~r~~~~~  346 (598)
T KOG4158|consen  273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-----RSYRTGRVI  346 (598)
T ss_pred             CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-----CchHHHHHH
Confidence            469999999887642                           1235778776653 7888886542     344566778


Q ss_pred             HHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCC
Q 023282          239 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED  272 (284)
Q Consensus       239 ~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~  272 (284)
                      ..|+++|+.|||.+   +|.|||+|++|||+.-+
T Consensus       347 laQlLEav~hL~~h---gvAhRDlKSDNiL~Eld  377 (598)
T KOG4158|consen  347 LAQLLEAVTHLHKH---GVAHRDLKSDNILLELD  377 (598)
T ss_pred             HHHHHHHHHHHHHc---cchhhcccccceEEEec
Confidence            89999999999999   99999999999998544

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.08  E-value=2.7e-11  Score=108.80  Aligned_cols=136  Identities=25%  Similarity=0.271  Sum_probs=110.0

Q ss_pred             eecccCceEEEEEE----eCCCcEEEEEEeecccCcccHH-HHHHHHHHHhcCC-CCCceeeeeEEeeCCeeeEEEeCCC
Q 023282          139 ILGRGGFGKVYKGR----LADGKLVAVKRLKEERTSGGEL-QFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPYMT  212 (284)
Q Consensus       139 ~lg~G~~g~V~~~~----~~~~~~vavK~~~~~~~~~~~~-~~~~e~~~l~~~~-h~niv~l~g~~~~~~~~~lv~e~~~  212 (284)
                      ++|+|+||.|+.++    .+.+..+|+|.++........+ ....|-.++..++ ||.+|++.-.+..+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999998764    2356789999886544322221 3456677788887 9999999999999999999999999


Q ss_pred             CCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhhh
Q 023282          213 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  281 (284)
Q Consensus       213 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df~  281 (284)
                      +|+|...+....    .++......+...++-|++++|..   +++|||+|++||++|.+|.+++.||=
T Consensus        81 gg~lft~l~~~~----~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfg  142 (612)
T KOG0603|consen   81 GGDLFTRLSKEV----MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFG  142 (612)
T ss_pred             cchhhhccccCC----chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCch
Confidence            999998887643    255556666778889999999999   99999999999999999999999984

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.05  E-value=2.6e-10  Score=101.95  Aligned_cols=92  Identities=24%  Similarity=0.335  Sum_probs=84.1

Q ss_pred             HhcCCCCCceeeeeEEeeCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe-eeeC
Q 023282          183 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI-IHRD  261 (284)
Q Consensus       183 l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~i-vHrd  261 (284)
                      |+.+.|.|+.+++|.+..++..+.|.+||+.|+|.+.+...   ...++|.-...+..++++||+|||+-   +| .|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence            45688999999999999999999999999999999999863   23589999999999999999999986   44 9999


Q ss_pred             CCCCCeeeCCCCCcchhhh
Q 023282          262 VKAANILLDEDADQSSKTI  280 (284)
Q Consensus       262 lk~~NiLld~~~~~~~~df  280 (284)
                      |+++|+++|..+..|++||
T Consensus        75 l~s~nClvd~~w~lklt~~   93 (484)
T KOG1023|consen   75 LKSSNCLVDSRWVLKLTDF   93 (484)
T ss_pred             eccccceeeeeEEEEechh
Confidence            9999999999999999997

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.03  E-value=4.6e-09  Score=81.39  Aligned_cols=139  Identities=14%  Similarity=0.190  Sum_probs=99.2

Q ss_pred             CCCeecccCceEEEEEEeCCCcEEEEEEee-cccCcc------cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          136 NKNILGRGGFGKVYKGRLADGKLVAVKRLK-EERTSG------GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       136 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~-~~~~~~------~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ...++-+|+-+.|+++.++ |+...||.-. +.+...      ....-.+|++.+.+++--.|....=++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4578899999999999884 6666666432 211111      1224678999998877555555555666777788999


Q ss_pred             eCCCC-CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcc---hhhh
Q 023282          209 PYMTN-GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS---SKTI  280 (284)
Q Consensus       209 e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~---~~df  280 (284)
                      ||+++ .++.+++......  .........++..+-+.+.-||..   .++|+||..+||++..+++..   +.||
T Consensus        90 E~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             EeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEee
Confidence            99976 4788888765432  122223367889999999999999   999999999999998887644   5555

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.96  E-value=7.3e-09  Score=80.52  Aligned_cols=127  Identities=18%  Similarity=0.232  Sum_probs=92.9

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEEee-cccCccc------HHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          138 NILGRGGFGKVYKGRLADGKLVAVKRLK-EERTSGG------ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~~~~vavK~~~-~~~~~~~------~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ..+++|+-+.+|.+.+- |..+.+|.-. +..-...      ...-.+|+.++.+++--.|....=+..+++...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999998763 3346666432 2221111      11356789999888765665555566778888999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++-.|.+.+...           +..++..+-+-+.-||..   +|+|+||.++||++..+. +.+.||
T Consensus        81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDf  135 (204)
T COG3642          81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDF  135 (204)
T ss_pred             eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEEC
Confidence            9998888888653           246677888888999999   999999999999998765 666666

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.94  E-value=1.8e-08  Score=84.73  Aligned_cols=137  Identities=15%  Similarity=0.102  Sum_probs=92.0

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEEeecccCc----------ccHHHHHHHHHHHhcCCCC--CceeeeeEEee-----
Q 023282          138 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTS----------GGELQFQTEVKIISMAVHR--NLLRLYGFCTT-----  200 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~e~~~l~~~~h~--niv~l~g~~~~-----  200 (284)
                      +++-+.....|++..+ +|+.+.||........          .....+.+|...+..+...  ....++++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4444444445667666 5678999966332210          1111367888888766432  33344455432     


Q ss_pred             CCeeeEEEeCCCCC-ChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC-------C
Q 023282          201 VTEKLLVYPYMTNG-SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-------D  272 (284)
Q Consensus       201 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~-------~  272 (284)
                      ....++|+|++++- +|.+++.....  .+.+......++.++++.+.-||..   +|+|+|++++|||++.       +
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~  181 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED  181 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence            23578999999976 78888853211  1234556778999999999999999   9999999999999985       4


Q ss_pred             CCcchhhh
Q 023282          273 ADQSSKTI  280 (284)
Q Consensus       273 ~~~~~~df  280 (284)
                      ..+.+.||
T Consensus       182 ~~~~LIDl  189 (268)
T PRK15123        182 LKLSVIDL  189 (268)
T ss_pred             ceEEEEEC
Confidence            56777776

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.84  E-value=2e-08  Score=79.87  Aligned_cols=122  Identities=20%  Similarity=0.222  Sum_probs=77.0

Q ss_pred             EEEEEEeCCCcEEEEEEeecccC------------cc---------c----HHHHHHHHHHHhcCCCC--CceeeeeEEe
Q 023282          147 KVYKGRLADGKLVAVKRLKEERT------------SG---------G----ELQFQTEVKIISMAVHR--NLLRLYGFCT  199 (284)
Q Consensus       147 ~V~~~~~~~~~~vavK~~~~~~~------------~~---------~----~~~~~~e~~~l~~~~h~--niv~l~g~~~  199 (284)
                      .||.|...+|..+|+|..+....            ..         .    .....+|.+.|.++..-  ++.+++.+  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            38999988899999998753210            00         0    11356799999998765  44555543  


Q ss_pred             eCCeeeEEEeCCC--CCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeeeeCCCCCCeeeCCCCCcc
Q 023282          200 TVTEKLLVYPYMT--NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL-HEHCDPKIIHRDVKAANILLDEDADQS  276 (284)
Q Consensus       200 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yL-H~~~~~~ivHrdlk~~NiLld~~~~~~  276 (284)
                        ....+||||++  +..+..+....      ++......+..++...+..+ |..   +++|+||.+.|||++++ .+.
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred             --eCCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence              24579999998  54554433321      11223566777777766664 666   99999999999999988 899


Q ss_pred             hhhhhh
Q 023282          277 SKTILR  282 (284)
Q Consensus       277 ~~df~~  282 (284)
                      +.||=+
T Consensus       147 iIDf~q  152 (188)
T PF01163_consen  147 IIDFGQ  152 (188)
T ss_dssp             E--GTT
T ss_pred             EEecCc
Confidence            999843

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.83  E-value=1.6e-08  Score=92.06  Aligned_cols=116  Identities=19%  Similarity=0.196  Sum_probs=93.8

Q ss_pred             eCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCH
Q 023282          153 LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDW  232 (284)
Q Consensus       153 ~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~  232 (284)
                      ..++.+|.|...+.... .......+.+..++.++||||++++..+...+..|+|+|-+.  .|..++.+..       .
T Consensus        34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-------~  103 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-------K  103 (690)
T ss_pred             eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-------H
Confidence            45788888888865443 223346778889999999999999999999999999999885  5777776532       2


Q ss_pred             HHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          233 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       233 ~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ....-.+.||+.||.|||+.|  +++|++|.-..|.+++.|+-+|+.|
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggl  149 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGL  149 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeee
Confidence            334455789999999999876  8999999999999999999998875

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.76  E-value=4.3e-09  Score=88.24  Aligned_cols=96  Identities=26%  Similarity=0.414  Sum_probs=79.7

Q ss_pred             HHhcCCCCCceeeeeEEeeC-----CeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 023282          182 IISMAVHRNLLRLYGFCTTV-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK  256 (284)
Q Consensus       182 ~l~~~~h~niv~l~g~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~  256 (284)
                      -+-.+.|.|||++..|+.+.     ....++.|||+.|++..+|++.......+......+++.||..||.|||+ |+|+
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCc
Confidence            34456699999999998654     35688999999999999998755444456666778899999999999999 6999


Q ss_pred             eeeeCCCCCCeeeCCCCCcchh
Q 023282          257 IIHRDVKAANILLDEDADQSSK  278 (284)
Q Consensus       257 ivHrdlk~~NiLld~~~~~~~~  278 (284)
                      |+|+++..+-|.+..++-+|+.
T Consensus       199 iihgnlTc~tifiq~ngLIkig  220 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIG  220 (458)
T ss_pred             cccCCcchhheeecCCceEEec
Confidence            9999999999999988877664

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.65  E-value=9.8e-08  Score=78.65  Aligned_cols=132  Identities=20%  Similarity=0.170  Sum_probs=90.3

Q ss_pred             CCCCeecccCceEEEEEEeCCCcEEEEEEeecccC-------------------cc--cHHHHHHHHHHHhcCCCC--Cc
Q 023282          135 SNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERT-------------------SG--GELQFQTEVKIISMAVHR--NL  191 (284)
Q Consensus       135 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-------------------~~--~~~~~~~e~~~l~~~~h~--ni  191 (284)
                      ...+.||.|.=+.||.|..+.|..+|||.=+....                   +.  ......+|.+.|.++...  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            34588999999999999999999999995432110                   00  012356788888888644  45


Q ss_pred             eeeeeEEeeCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC
Q 023282          192 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE  271 (284)
Q Consensus       192 v~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~  271 (284)
                      .+.+++    +...+||||+++-.|...--         +-...-.+...|.+-+.-+-..   ++||+|+.+=||++++
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r~---------~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~  237 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLRL---------DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCcccc----ccceeeeehcccceeecccC---------cccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence            554443    56789999999866654331         1112233344444444444455   8999999999999999


Q ss_pred             CCCcchhhhhh
Q 023282          272 DADQSSKTILR  282 (284)
Q Consensus       272 ~~~~~~~df~~  282 (284)
                      |+++.+.||=|
T Consensus       238 dg~~~vIDwPQ  248 (304)
T COG0478         238 DGDIVVIDWPQ  248 (304)
T ss_pred             CCCEEEEeCcc
Confidence            99999999854

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.63  E-value=3e-07  Score=74.59  Aligned_cols=99  Identities=18%  Similarity=0.213  Sum_probs=74.9

Q ss_pred             HHHHHHHHHhcCC--CCCceeeeeEEeeCC----eeeEEEeCCCCC-ChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 023282          175 QFQTEVKIISMAV--HRNLLRLYGFCTTVT----EKLLVYPYMTNG-SVASRLRERQSSLPPLDWPTRKKIALGSARGLS  247 (284)
Q Consensus       175 ~~~~e~~~l~~~~--h~niv~l~g~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~  247 (284)
                      ...+|...+..+.  .-...+.+++.....    ..++|+|++++. +|.+++.....    .+......++.++++.++
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARLIA  132 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHHHH
Confidence            4677777766654  333455566655422    358999999874 79998875321    344567889999999999


Q ss_pred             HHHcCCCCCeeeeCCCCCCeeeCCCC---Ccchhhh
Q 023282          248 YLHEHCDPKIIHRDVKAANILLDEDA---DQSSKTI  280 (284)
Q Consensus       248 yLH~~~~~~ivHrdlk~~NiLld~~~---~~~~~df  280 (284)
                      -||..   +|+|+|++++|||++.+.   +..+.||
T Consensus       133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDl  165 (206)
T PF06293_consen  133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDL  165 (206)
T ss_pred             HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcc
Confidence            99999   999999999999999987   7777776

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=98.62  E-value=9e-09  Score=95.90  Aligned_cols=143  Identities=22%  Similarity=0.300  Sum_probs=109.8

Q ss_pred             CCCCCCeecccCceEEEEEEeC--CCcEEEEEEeeccc-CcccHHHHHHHHHHHhcCC-CCCceeeeeEEeeCCeeeEEE
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA--DGKLVAVKRLKEER-TSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~~~~~~lv~  208 (284)
                      .|...+.||+|+|+.|-.....  ....+|+|.+.... ..........|..+-..+. |+|++.+++........++.+
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            4555677999999998877643  33456777664332 1222233455777767776 999999999999999999999


Q ss_pred             eCCCCCChHHHH-hhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeeeeCCCCCCeeeCCCC-Ccchhhhh
Q 023282          209 PYMTNGSVASRL-RERQSSLPPLDWPTRKKIALGSARGLSYLH-EHCDPKIIHRDVKAANILLDEDA-DQSSKTIL  281 (284)
Q Consensus       209 e~~~~g~L~~~l-~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH-~~~~~~ivHrdlk~~NiLld~~~-~~~~~df~  281 (284)
                      ||..+|++.+.+ .....   ..+....-.+..|+..++.|+| ..   ++.|||+||+|.+++..+ ..+++||.
T Consensus       101 ~~s~g~~~f~~i~~~~~~---~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~  170 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHPDST---GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFG  170 (601)
T ss_pred             CcccccccccccccCCcc---CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCch
Confidence            999999999888 33211   2334456678899999999999 76   899999999999999999 99999985

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.61  E-value=2.6e-08  Score=89.53  Aligned_cols=144  Identities=19%  Similarity=0.193  Sum_probs=109.0

Q ss_pred             HhcCCCCCCeecccCceEEEEEEe--CCCcEEEEEEeecccCcccHH-HHHHHHHHHhcC-CCCCceeeeeEEeeCCeee
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRL--ADGKLVAVKRLKEERTSGGEL-QFQTEVKIISMA-VHRNLLRLYGFCTTVTEKL  205 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~-~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~~  205 (284)
                      .+.+|.....||.|.|+.|++...  .++..+++|.+.........+ .-..|+.+...+ .|.+++++...+....+.+
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            445688888999999999998764  367789999886544332222 223455555544 4888898888887778888


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCC-CCcchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~-~~~~~~df  280 (284)
                      +-.||+.++++...+.-..    .++...++++..|++.++.++|+.   .++|+|+||+||++..+ +.-+++||
T Consensus       343 ip~e~~~~~s~~l~~~~~~----~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~  411 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVTSQ----MLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDF  411 (524)
T ss_pred             CchhhhcCcchhhhhHHHH----hcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccc
Confidence            9999999998877663221    356667889999999999999988   99999999999999886 56666665

>PRK09902 hypothetical protein; Provisional

Probab=98.55  E-value=1.9e-06  Score=69.22  Aligned_cols=134  Identities=19%  Similarity=0.181  Sum_probs=94.2

Q ss_pred             ecccCceEEEEEEeCCCcEEEEEEeeccc--C---cccHHHHHHHHHHHhcCCCC--CceeeeeEEe-e----CCeeeEE
Q 023282          140 LGRGGFGKVYKGRLADGKLVAVKRLKEER--T---SGGELQFQTEVKIISMAVHR--NLLRLYGFCT-T----VTEKLLV  207 (284)
Q Consensus       140 lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~---~~~~~~~~~e~~~l~~~~h~--niv~l~g~~~-~----~~~~~lv  207 (284)
                      -|.|+-+.|++-... |..+-+|.-....  +   ......|.+|...+..+..-  .+.++. ++. .    .-..+||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            356788888887664 4467788663111  1   22455799999999877632  233443 332 1    1246799


Q ss_pred             EeCCCC-CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCC--cchhhh
Q 023282          208 YPYMTN-GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD--QSSKTI  280 (284)
Q Consensus       208 ~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~--~~~~df  280 (284)
                      +|-+++ -+|.+++.+..  ..+.+...+..+..++++.+.-||+.   ++.|+|+-+.||+++.+++  +++.||
T Consensus       104 Te~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDl  174 (216)
T PRK09902        104 TEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDL  174 (216)
T ss_pred             EEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEh
Confidence            997753 58888886532  22356667789999999999999999   9999999999999986666  777776

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.51  E-value=8.8e-07  Score=78.90  Aligned_cols=129  Identities=16%  Similarity=0.138  Sum_probs=97.2

Q ss_pred             eEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEee----CCeeeEEEeCCCC-CChHHH
Q 023282          146 GKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT----VTEKLLVYPYMTN-GSVASR  219 (284)
Q Consensus       146 g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~----~~~~~lv~e~~~~-g~L~~~  219 (284)
                      .+.||+.. .+|..+..|+++.+...... ....-++.++++.|+|+|++...+..    ....++||+|.|+ ++|.++
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n-k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTN-KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcc-cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            56789874 47889999999543322111 12345788999999999999998763    3467899999985 677776


Q ss_pred             HhhcC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchh
Q 023282          220 LRERQ-----------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  278 (284)
Q Consensus       220 l~~~~-----------~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~  278 (284)
                      -....           ......++.....++.|+..||.++|+.   ++.-+-|-+++||++.+...+++
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS  435 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRIS  435 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEe
Confidence            54321           1122456778889999999999999999   99999999999999998766654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.48  E-value=5.1e-07  Score=82.35  Aligned_cols=134  Identities=18%  Similarity=0.182  Sum_probs=86.7

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEEeecccCccc---------------------------------------HHHHHH
Q 023282          138 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG---------------------------------------ELQFQT  178 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---------------------------------------~~~~~~  178 (284)
                      +.|+.++-|+||+|++.+|+.||||+.++.-...-                                       +.++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            67999999999999999999999999865311000                                       112344


Q ss_pred             HHHHHhc----CCCCCceeeeeEEe-eCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHH-HHHHcC
Q 023282          179 EVKIISM----AVHRNLLRLYGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL-SYLHEH  252 (284)
Q Consensus       179 e~~~l~~----~~h~niv~l~g~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl-~yLH~~  252 (284)
                      |..-+.+    +++..-+++-..+. ......|+|||++|-.+.+.......   ..+   +..++..++++. .-+-..
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~---g~d---~k~ia~~~~~~f~~q~~~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA---GID---RKELAELLVRAFLRQLLRD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc---CCC---HHHHHHHHHHHHHHHHHhc
Confidence            5544433    23333344444443 45678999999999988887533221   133   334444443331 112223


Q ss_pred             CCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          253 CDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       253 ~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                         +++|.|..|.||+++.++..-+-||
T Consensus       285 ---gffHaDpHpGNi~v~~~g~i~~lDf  309 (517)
T COG0661         285 ---GFFHADPHPGNILVRSDGRIVLLDF  309 (517)
T ss_pred             ---CccccCCCccceEEecCCcEEEEcC
Confidence               8999999999999999988777776

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.36  E-value=3.4e-07  Score=87.40  Aligned_cols=104  Identities=24%  Similarity=0.441  Sum_probs=72.9

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ++|...+.|..|++|.||..+++ ..+++|+| +++...      +.+-  ++.....|.+|                  
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l------ilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL------ILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccch------hhhc--cccccCCccee------------------
Confidence            57888899999999999999865 46788884 332211      1110  23333344333                  


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                         |+-...+...+    ++.        .+.+.+++|||+.   +|+|||+||+|.|+..-|..|+.||
T Consensus       136 ---gDc~tllk~~g----~lP--------vdmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDf  187 (1205)
T KOG0606|consen  136 ---GDCATLLKNIG----PLP--------VDMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDF  187 (1205)
T ss_pred             ---chhhhhcccCC----CCc--------chhhHHhHhhccC---CeecCCCCCCcceeeecccccccch
Confidence               55555665422    121        1227889999998   9999999999999999999999998

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.35  E-value=1.5e-06  Score=69.24  Aligned_cols=99  Identities=22%  Similarity=0.264  Sum_probs=76.4

Q ss_pred             HHHHHHHhcCCC-CCceeeeeEEeeCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 023282          177 QTEVKIISMAVH-RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP  255 (284)
Q Consensus       177 ~~e~~~l~~~~h-~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~  255 (284)
                      ..|.-+++.+.+ +++.+++|+|-    .+.+.||...+++...-.. ......-+|..|.+||.++++.+.++++....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            357778888876 69999999993    4678899987766432100 01111358999999999999999999996444


Q ss_pred             CeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          256 KIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       256 ~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .+.-.|++++|+-+++++++|+.|.
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDl  106 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDL  106 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEec
Confidence            6788999999999999999999884

Proteins in this uncharacterised family are described as transmembrane proteins.

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=98.31  E-value=1.3e-06  Score=68.70  Aligned_cols=52  Identities=33%  Similarity=0.297  Sum_probs=45.1

Q ss_pred             CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcch
Q 023282          214 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS  277 (284)
Q Consensus       214 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~  277 (284)
                      |+|.++++...   ..++|.++..++.|++.||.|||+.   +      ||+|||++.++.+++
T Consensus         1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~   52 (176)
T smart00750        1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL   52 (176)
T ss_pred             CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee
Confidence            78999997643   2589999999999999999999998   4      999999999887664

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.29  E-value=1.3e-05  Score=66.05  Aligned_cols=72  Identities=13%  Similarity=0.123  Sum_probs=50.3

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCC--ceeeeeEEeeCCeeeEEEeCCCCCC
Q 023282          138 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN--LLRLYGFCTTVTEKLLVYPYMTNGS  215 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n--iv~l~g~~~~~~~~~lv~e~~~~g~  215 (284)
                      ..||+|..+.||+.   .+..+++|......   ......+|.+++..+..-.  +.+.+++....+...++||+++|.+
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            56899999999984   24456678764322   2335678888887775333  4566777766677789999998863

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.13  E-value=1.4e-05  Score=72.94  Aligned_cols=134  Identities=17%  Similarity=0.144  Sum_probs=78.8

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEEeecccCcc------------------------------------cHHHHHHHHH
Q 023282          138 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG------------------------------------GELQFQTEVK  181 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------------------------------------~~~~~~~e~~  181 (284)
                      +.||.-+.|+||+|++++|+.||||+-++.-...                                    .+.+|..|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            5799999999999999999999999886532111                                    0112334443


Q ss_pred             HH----hcCCCCC---ceeeeeEEee-CCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC
Q 023282          182 II----SMAVHRN---LLRLYGFCTT-VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC  253 (284)
Q Consensus       182 ~l----~~~~h~n---iv~l~g~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~  253 (284)
                      -.    ..+.|-+   -|.+-..+.+ .....|+||||+|..+.+.-.-...+   ++-.   .++..+.++..  +.--
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g---i~~~---~i~~~l~~~~~--~qIf  318 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG---ISPH---DILNKLVEAYL--EQIF  318 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC---CCHH---HHHHHHHHHHH--HHHH
Confidence            22    2334555   2223333322 35688999999998776654322111   3322   33333333221  1111


Q ss_pred             CCCeeeeCCCCCCeeeCC----CCCcchhh
Q 023282          254 DPKIIHRDVKAANILLDE----DADQSSKT  279 (284)
Q Consensus       254 ~~~ivHrdlk~~NiLld~----~~~~~~~d  279 (284)
                      ..+++|+|-.|.||++..    +++..+-|
T Consensus       319 ~~GffHaDPHPGNilv~~~~~~~~~ivllD  348 (538)
T KOG1235|consen  319 KTGFFHADPHPGNILVRPNPEGDEEIVLLD  348 (538)
T ss_pred             hcCCccCCCCCCcEEEecCCCCCccEEEEc
Confidence            128999999999999995    34444444

>PLN02876 acyl-CoA dehydrogenase

Probab=98.12  E-value=2.9e-05  Score=75.81  Aligned_cols=79  Identities=13%  Similarity=0.296  Sum_probs=55.3

Q ss_pred             CCeecccCceEEEEEEeCCC---cEEEEEEeecccCcccHHHHHHHHHHHhcCC-CCCc--eeeeeEEeeC---CeeeEE
Q 023282          137 KNILGRGGFGKVYKGRLADG---KLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNL--LRLYGFCTTV---TEKLLV  207 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~ni--v~l~g~~~~~---~~~~lv  207 (284)
                      .+.++.|.++.+|+....++   ..+++|+............+.+|+++++.+. |+++  .+++++|...   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46688999999999876543   3567776543222223346889999999885 6654  6777777654   467899


Q ss_pred             EeCCCCCC
Q 023282          208 YPYMTNGS  215 (284)
Q Consensus       208 ~e~~~~g~  215 (284)
                      |||+++..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99998754

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.11  E-value=8.8e-05  Score=59.53  Aligned_cols=125  Identities=22%  Similarity=0.344  Sum_probs=85.3

Q ss_pred             CCCCeecccCceEEEEEEeCCCcEEEEEEeeccc---------------CcccHHHHHHHHHHHhcCC------CCCcee
Q 023282          135 SNKNILGRGGFGKVYKGRLADGKLVAVKRLKEER---------------TSGGELQFQTEVKIISMAV------HRNLLR  193 (284)
Q Consensus       135 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~e~~~l~~~~------h~niv~  193 (284)
                      +....||+|+.=.||.  +++.....||+.....               .....++..+|+.-...+.      +.+|.+
T Consensus         4 ~~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    4 SESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            3457799999988886  4555567889886554               1112345566665544443      889999


Q ss_pred             eeeEEeeCCeeeEEEeCCCC------CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCe
Q 023282          194 LYGFCTTVTEKLLVYPYMTN------GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANI  267 (284)
Q Consensus       194 l~g~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~Ni  267 (284)
                      ++|+..+....-+|+|.+.+      -+|.+++....     ++.    .+...+-+=..||-..   .|+.+|++|.||
T Consensus        82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-----~~~----~~~~~L~~f~~~l~~~---~Iv~~dl~~~NI  149 (199)
T PF10707_consen   82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-----LTE----ELRQALDEFKRYLLDH---HIVIRDLNPHNI  149 (199)
T ss_pred             EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-----ccH----HHHHHHHHHHHHHHHc---CCeecCCCcccE
Confidence            99999999999999987642      36777775432     333    2233333445667666   899999999999


Q ss_pred             eeCCCC
Q 023282          268 LLDEDA  273 (284)
Q Consensus       268 Lld~~~  273 (284)
                      ++....
T Consensus       150 v~~~~~  155 (199)
T PF10707_consen  150 VVQRRD  155 (199)
T ss_pred             EEEecC
Confidence            997654

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.10  E-value=2.8e-06  Score=76.67  Aligned_cols=140  Identities=21%  Similarity=0.115  Sum_probs=102.8

Q ss_pred             CCCCCeecc--cCceEEEEEEe---CCCcEEEEEEeecccC-cccHHHHHHHHHHHhcCC-CCCceeeeeEEeeCCeeeE
Q 023282          134 FSNKNILGR--GGFGKVYKGRL---ADGKLVAVKRLKEERT-SGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       134 ~~~~~~lg~--G~~g~V~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~~~~~~l  206 (284)
                      |....-+|.  |.+|.||.+..   .++..+|+|.-+.... ......-.+|+....+++ |+|.++....+...+..++
T Consensus       116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi  195 (524)
T KOG0601|consen  116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI  195 (524)
T ss_pred             cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence            444567899  99999999976   3577899987432211 122223346677777775 9999998888888999999


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHH----HHHHHHcCCCCCeeeeCCCCCCeeeCCC-CCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR----GLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~----gl~yLH~~~~~~ivHrdlk~~NiLld~~-~~~~~~df  280 (284)
                      -+|++. .+|.++.+....   .++.........+...    ||.++|+.   +++|-|+||.||.+..+ ..-++.||
T Consensus       196 qtE~~~-~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  196 QTELCG-ESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eecccc-chhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence            999885 688888775432   1333344455555555    99999998   99999999999999999 67777776

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.03  E-value=6.7e-05  Score=62.43  Aligned_cols=75  Identities=9%  Similarity=0.058  Sum_probs=49.9

Q ss_pred             ecccCc-eEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCC-CCCceeeeeEEeeCCeeeEEEeCCCCCChH
Q 023282          140 LGRGGF-GKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPYMTNGSVA  217 (284)
Q Consensus       140 lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~~~~~~lv~e~~~~g~L~  217 (284)
                      |-.|.. ..||+...+ +..+.+|......    ...+.+|+++++.+. +--+.+++++....+..++|||++++.++.
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            444554 688998764 3677788764322    224667888877664 334556777776666789999999987766


Q ss_pred             HH
Q 023282          218 SR  219 (284)
Q Consensus       218 ~~  219 (284)
                      ..
T Consensus        81 ~~   82 (244)
T cd05150          81 AL   82 (244)
T ss_pred             Hh
Confidence            43

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PRK10593 hypothetical protein; Provisional

Probab=98.01  E-value=9.7e-05  Score=63.41  Aligned_cols=77  Identities=14%  Similarity=0.089  Sum_probs=54.1

Q ss_pred             CCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCC---CCceeeeeEEee---CCeeeEEEe
Q 023282          136 NKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH---RNLLRLYGFCTT---VTEKLLVYP  209 (284)
Q Consensus       136 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h---~niv~l~g~~~~---~~~~~lv~e  209 (284)
                      ..+.||.|..+.||+....++ .+.+|..+. .  .....+..|.+.++.+.-   ..+.+++++|..   .+..++|||
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~-~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQG-NPMPLMARS-F--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             eeeecCCccceeEEEEEcCCC-CEEEEEecc-c--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            346799999999999876555 356676432 1  122368889988887753   356778877754   356899999


Q ss_pred             CCCCCCh
Q 023282          210 YMTNGSV  216 (284)
Q Consensus       210 ~~~~g~L  216 (284)
                      +++++++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.94  E-value=0.00013  Score=59.12  Aligned_cols=133  Identities=16%  Similarity=0.172  Sum_probs=80.2

Q ss_pred             HhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHH---------HHHHHHHhcCCCC---CceeeeeE
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQF---------QTEVKIISMAVHR---NLLRLYGF  197 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~---------~~e~~~l~~~~h~---niv~l~g~  197 (284)
                      ...+|...+++-......|.+-.. +|..+.+|..++... ..++.|         .+++..+..++..   ....++-.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~-r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENR-RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhh-hHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            344566666666666555555555 567788887754331 112211         2233333333221   22222222


Q ss_pred             E-----eeCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCC
Q 023282          198 C-----TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED  272 (284)
Q Consensus       198 ~-----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~  272 (284)
                      .     .-....+++|||++|..|.+...        ++.    .++..+.+++.-+|..   ++.|+|..|.|+++..+
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~  171 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN  171 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC
Confidence            1     12245679999999988766542        221    3456677889999999   99999999999999855


Q ss_pred             CCcchhhh
Q 023282          273 ADQSSKTI  280 (284)
Q Consensus       273 ~~~~~~df  280 (284)
                      + .++.|+
T Consensus       172 ~-i~iID~  178 (229)
T PF06176_consen  172 G-IRIIDT  178 (229)
T ss_pred             c-EEEEEC
Confidence            4 778776

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=97.92  E-value=3.2e-06  Score=75.27  Aligned_cols=73  Identities=19%  Similarity=0.223  Sum_probs=63.9

Q ss_pred             eeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhhhh
Q 023282          203 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR  282 (284)
Q Consensus       203 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df~~  282 (284)
                      ..++.|++|...+|.+||..+.. ....+|...+.++.|++.|+.|   +   +.+|||+||.||....+...||.||+=
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence            57899999999999999975432 2346788999999999999999   5   899999999999999999999999973

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.91  E-value=5.9e-05  Score=61.87  Aligned_cols=77  Identities=16%  Similarity=0.213  Sum_probs=53.1

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCC--CceeeeeEEee---CCeeeEEEeCCC
Q 023282          138 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR--NLLRLYGFCTT---VTEKLLVYPYMT  212 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~--niv~l~g~~~~---~~~~~lv~e~~~  212 (284)
                      +.++.|..+.||+....+ ..+++|.....   .....+..|..++..+...  .+.+++.+...   ....+++|++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            568999999999999877 58899986433   2334577888887766532  34566664433   234689999999


Q ss_pred             CCChHH
Q 023282          213 NGSVAS  218 (284)
Q Consensus       213 ~g~L~~  218 (284)
                      +..+..
T Consensus        79 g~~~~~   84 (239)
T PF01636_consen   79 GRPLDD   84 (239)
T ss_dssp             SEEHHH
T ss_pred             cccccc
Confidence            887776

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.85  E-value=0.0001  Score=60.52  Aligned_cols=149  Identities=19%  Similarity=0.252  Sum_probs=90.1

Q ss_pred             ccHHHHHHHhcCCCCCCe---ecccCceEEEEEEeCCCcEEEEEEeecccCcccH------------------H-----H
Q 023282          122 FSLRELQVATDGFSNKNI---LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGE------------------L-----Q  175 (284)
Q Consensus       122 ~~~~~~~~~~~~~~~~~~---lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~------------------~-----~  175 (284)
                      .++..+....+...+.++   |.+|.-+.||+|...++..+|||+.+........                  +     -
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            444555555555555444   4567777899998878899999998643321110                  0     0


Q ss_pred             HHHHHHHHhcCCC--CCceeeeeEEeeCCeeeEEEeCCCCC-ChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC
Q 023282          176 FQTEVKIISMAVH--RNLLRLYGFCTTVTEKLLVYPYMTNG-SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH  252 (284)
Q Consensus       176 ~~~e~~~l~~~~h--~niv~l~g~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~  252 (284)
                      ...|..-|.++..  -.+.+.+++    ..-.|||||+... .-.-.|..-     ++...+...+..++.+.+.-|-..
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkDv-----~~e~~e~~~~~~~~v~~~~~l~~~  185 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKDV-----PLELEEAEGLYEDVVEYMRRLYKE  185 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCcccC-----CcCchhHHHHHHHHHHHHHHHHHh
Confidence            2234444444331  122222222    2346999999653 222222221     122235667777888888888773


Q ss_pred             CCCCeeeeCCCCCCeeeCCCCCcchhhhhh
Q 023282          253 CDPKIIHRDVKAANILLDEDADQSSKTILR  282 (284)
Q Consensus       253 ~~~~ivHrdlk~~NiLld~~~~~~~~df~~  282 (284)
                      +  ++||+||..=|||++ ++++-+.|+=|
T Consensus       186 a--~LVHgDLSEyNiL~~-~~~p~iID~~Q  212 (268)
T COG1718         186 A--GLVHGDLSEYNILVH-DGEPYIIDVSQ  212 (268)
T ss_pred             c--CcccccchhhheEEE-CCeEEEEECcc
Confidence            2  899999999999999 88888888744

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.80  E-value=0.00023  Score=56.88  Aligned_cols=123  Identities=23%  Similarity=0.328  Sum_probs=84.8

Q ss_pred             cCCCCCCeecccCc-eEEEEEEeCCCcEEEEEEeec---c--------cCc---------ccHHHHHHHHHHHhcCC---
Q 023282          132 DGFSNKNILGRGGF-GKVYKGRLADGKLVAVKRLKE---E--------RTS---------GGELQFQTEVKIISMAV---  187 (284)
Q Consensus       132 ~~~~~~~~lg~G~~-g~V~~~~~~~~~~vavK~~~~---~--------~~~---------~~~~~~~~e~~~l~~~~---  187 (284)
                      .+++..+.||.|.- |.||+++. +|..+|+|..+.   .        ...         .....|..|.+..++++   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            56777899999999 99999998 567999999321   0        000         11124888998887765   


Q ss_pred             CCCc--eeeeeEEeeC------------------CeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 023282          188 HRNL--LRLYGFCTTV------------------TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS  247 (284)
Q Consensus       188 h~ni--v~l~g~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~  247 (284)
                      +.++  |+.+||..-.                  ....+|.||++...             .+    ..+-+.++.+-|.
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~----~~~~~~~~~~dl~  178 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PL----QIRDIPQMLRDLK  178 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------cc----chhHHHHHHHHHH
Confidence            4566  8999987322                  12357778776543             01    2233566777788


Q ss_pred             HHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          248 YLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       248 yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .+|..   +|+-+|+|+.|..     +-+++||
T Consensus       179 ~~~k~---gI~~~Dv~~~ny~-----~G~lvDf  203 (207)
T PF13095_consen  179 ILHKL---GIVPRDVKPRNYR-----GGKLVDF  203 (207)
T ss_pred             HHHHC---CeeeccCcccccc-----CCEEEec
Confidence            89998   9999999999975     3355555

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.75  E-value=0.00024  Score=55.26  Aligned_cols=122  Identities=20%  Similarity=0.247  Sum_probs=79.2

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCcee-eeeEEeeCCeeeEEEeCCCCCC
Q 023282          137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR-LYGFCTTVTEKLLVYPYMTNGS  215 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~-l~g~~~~~~~~~lv~e~~~~g~  215 (284)
                      .+.|++|.+|.||.|.+. |..+|+|+-+.+.   ....+..|++++..+.-.++.. ++.|    +.-++.|||+.+-+
T Consensus        27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds---~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~G~~   98 (201)
T COG2112          27 EKELAKGTTSVVYLGEWR-GGEVALKVRRRDS---PRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYIDGRP   98 (201)
T ss_pred             hhhhhcccccEEEEeecc-CceEEEEEecCCc---chhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhcCcc
Confidence            467999999999999985 4478888775432   3446889999998887666543 3333    23345599999888


Q ss_pred             hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCC-CCCCeeeCCCCCcchhhh
Q 023282          216 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV-KAANILLDEDADQSSKTI  280 (284)
Q Consensus       216 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdl-k~~NiLld~~~~~~~~df  280 (284)
                      |.++-...       +    .+-...+++.---|-..   +|-|..| .|...++-.+.++-|.||
T Consensus        99 L~~~~~~~-------~----rk~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDF  150 (201)
T COG2112          99 LGKLEIGG-------D----RKHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDF  150 (201)
T ss_pred             hhhhhhcc-------c----HHHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEc
Confidence            87766431       1    11223334442223333   7777777 455555555658888887

>PLN03150 hypothetical protein; Provisional

Probab=97.72  E-value=3.6e-05  Score=72.78  Aligned_cols=44  Identities=30%  Similarity=0.538  Sum_probs=22.7

Q ss_pred             ccEEEccCCCCcccCCCCCC--CCccCcccccCCcCCCCCCCCCCC
Q 023282            2 TALRDLSNNRLSGPVPDNGS--FSQFTPISFENNLNLCGPNTKKPC   45 (284)
Q Consensus         2 ~~~~dlS~N~lsG~iP~~~~--~~~~~~~s~~gN~~lcg~~~~~~c   45 (284)
                      |+.||||+|+|+|.+|....  +.+.....+.+|.++|+.+....|
T Consensus       492 L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C  537 (623)
T PLN03150        492 LRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC  537 (623)
T ss_pred             CCEEECcCCcccccCChHHhhccccCceEEecCCccccCCCCCCCC
Confidence            45555555555555554311  122234456677778875433344

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.57  E-value=0.00099  Score=54.98  Aligned_cols=73  Identities=16%  Similarity=0.235  Sum_probs=45.0

Q ss_pred             CeecccCceEEEEEEeCC--CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCc-eeeeeEEeeCCeeeEEEeCCCCC
Q 023282          138 NILGRGGFGKVYKGRLAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL-LRLYGFCTTVTEKLLVYPYMTNG  214 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni-v~l~g~~~~~~~~~lv~e~~~~g  214 (284)
                      +.|..|-...+|+....+  +..+.+|........  ..+..+|+.++..+....+ .++++...    ..++|||+++.
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~--~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~   77 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL--IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR   77 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc--eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence            457778888999988654  567888876432211  1123467777777643333 34443322    24899999886


Q ss_pred             Ch
Q 023282          215 SV  216 (284)
Q Consensus       215 ~L  216 (284)
                      ++
T Consensus        78 ~l   79 (235)
T cd05157          78 TL   79 (235)
T ss_pred             cC
Confidence            65

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.49  E-value=0.0031  Score=56.20  Aligned_cols=76  Identities=14%  Similarity=0.177  Sum_probs=51.2

Q ss_pred             CeecccCceEEEEEEeCCC-cEEEEEEeeccc----C--cccHHHHHHHHHHHhcCC---CCCceeeeeEEeeCCeeeEE
Q 023282          138 NILGRGGFGKVYKGRLADG-KLVAVKRLKEER----T--SGGELQFQTEVKIISMAV---HRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~----~--~~~~~~~~~e~~~l~~~~---h~niv~l~g~~~~~~~~~lv  207 (284)
                      +.||.|.+..||+....+| +.+.||.-.+..    .  ......+..|.+.|..+.   ...+.+++.+  .....++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5789999999999998776 489999753211    1  112335667777776642   2455666665  34567899


Q ss_pred             EeCCCCCC
Q 023282          208 YPYMTNGS  215 (284)
Q Consensus       208 ~e~~~~g~  215 (284)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.34  E-value=0.0014  Score=54.18  Aligned_cols=73  Identities=14%  Similarity=0.153  Sum_probs=41.1

Q ss_pred             CeecccCce-EEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCC---CceeeeeEEeeC---CeeeEEEeC
Q 023282          138 NILGRGGFG-KVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR---NLLRLYGFCTTV---TEKLLVYPY  210 (284)
Q Consensus       138 ~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~---niv~l~g~~~~~---~~~~lv~e~  210 (284)
                      +.++.|+.. .||+.    +..+.+|..+..   .....+.+|.+.+..+...   .+.++++.....   ...+++|++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~---~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA---GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc---chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            456666555 58874    234566754321   1233688899888766521   223333333221   234889999


Q ss_pred             CCCCChH
Q 023282          211 MTNGSVA  217 (284)
Q Consensus       211 ~~~g~L~  217 (284)
                      +++.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9886653

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.18  E-value=0.002  Score=55.23  Aligned_cols=139  Identities=14%  Similarity=0.108  Sum_probs=78.0

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCC--CceeeeeE------EeeCCeeeEEE
Q 023282          137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR--NLLRLYGF------CTTVTEKLLVY  208 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~--niv~l~g~------~~~~~~~~lv~  208 (284)
                      .+.+..|....+|+....++ .+++|....    ........|++++..+.+.  .+.+++..      ....+..+.++
T Consensus        19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSG-RYVLTLFEK----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeCCC-cEEEEEcCC----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            45577787788999876544 678887643    1223455677766665432  23343331      12234568999


Q ss_pred             eCCCCCChHH--------------HHhhcCCC-------CCCCCHHHHHH----------HHHHHHHHHHHHHc----CC
Q 023282          209 PYMTNGSVAS--------------RLRERQSS-------LPPLDWPTRKK----------IALGSARGLSYLHE----HC  253 (284)
Q Consensus       209 e~~~~g~L~~--------------~l~~~~~~-------~~~l~~~~~~~----------i~~~i~~gl~yLH~----~~  253 (284)
                      +|+++..+..              .+|.....       .....|.....          ....+..++.++..    ..
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9998766421              11111100       01123432211          11123344555543    12


Q ss_pred             CCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          254 DPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       254 ~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ...++|+|+.|.|+|++.+....|.||
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDf  200 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDF  200 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeeh
Confidence            346999999999999998776678887

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.11  E-value=0.0081  Score=50.31  Aligned_cols=134  Identities=15%  Similarity=0.094  Sum_probs=70.4

Q ss_pred             ecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCc-eeeeeEEeeCCeeeEEEeCCCCCChHH
Q 023282          140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL-LRLYGFCTTVTEKLLVYPYMTNGSVAS  218 (284)
Q Consensus       140 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni-v~l~g~~~~~~~~~lv~e~~~~g~L~~  218 (284)
                      +..|-.+.+|+... ++..+.+|........- .....+|.++++.+....+ .++++..    ..++||||+++..+..
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKAL-GVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL   77 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccc-cCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence            45677788898874 46677888654322111 1134678888877754333 2333332    2468999998765431


Q ss_pred             -----------------HHhhcCCCCCCCCHHHH-HHHHHHH---------HHHHHHHHcC-----CCCCeeeeCCCCCC
Q 023282          219 -----------------RLRERQSSLPPLDWPTR-KKIALGS---------ARGLSYLHEH-----CDPKIIHRDVKAAN  266 (284)
Q Consensus       219 -----------------~l~~~~~~~~~l~~~~~-~~i~~~i---------~~gl~yLH~~-----~~~~ivHrdlk~~N  266 (284)
                                       .+|.......+++.... ..+..++         ..-+..+-..     ..+.++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence                             11221111112222111 1111111         1111212111     13368999999999


Q ss_pred             eeeCCCCCcchhhh
Q 023282          267 ILLDEDADQSSKTI  280 (284)
Q Consensus       267 iLld~~~~~~~~df  280 (284)
                      |+++.++ ..+.||
T Consensus       158 il~~~~~-~~lIDw  170 (256)
T TIGR02721       158 LVVTPQG-LKLIDW  170 (256)
T ss_pred             EEEeCCC-CEEEec
Confidence            9999876 677776

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.99  E-value=0.018  Score=49.59  Aligned_cols=140  Identities=13%  Similarity=0.119  Sum_probs=74.9

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCC--CceeeeeEE------eeCCeeeEEE
Q 023282          137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR--NLLRLYGFC------TTVTEKLLVY  208 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~--niv~l~g~~------~~~~~~~lv~  208 (284)
                      .+.++.|....+|+....++ .+.+|......   .......|.+++..+...  .+.+++...      ...+..++++
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~---~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV---KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC---CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            45677777788998876555 56678664321   122344555555544321  233333211      1234578999


Q ss_pred             eCCCCCChH----H----------HHhhcCCCC--------CCCCHHHHHH------------HHHHHHHHHHHHHc---
Q 023282          209 PYMTNGSVA----S----------RLRERQSSL--------PPLDWPTRKK------------IALGSARGLSYLHE---  251 (284)
Q Consensus       209 e~~~~g~L~----~----------~l~~~~~~~--------~~l~~~~~~~------------i~~~i~~gl~yLH~---  251 (284)
                      ||++|..+.    +          .+|......        ..-.|.....            ....+.+.++++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            999875431    1          112111100        0112322111            01123345555543   


Q ss_pred             -CCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          252 -HCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       252 -~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                       .....++|+|+.+.|++++.++...|.||
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDf  212 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDF  212 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeec
Confidence             22458999999999999998876678776

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.88  E-value=0.0061  Score=52.38  Aligned_cols=74  Identities=19%  Similarity=0.275  Sum_probs=44.1

Q ss_pred             CeecccCceEEEEEEeCC-------CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCc-eeeeeEEeeCCeeeEEEe
Q 023282          138 NILGRGGFGKVYKGRLAD-------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL-LRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni-v~l~g~~~~~~~~~lv~e  209 (284)
                      +.+..|-...+|+....+       +..+.+|.......  ...+...|.+++..+....+ .++++++.    -.+|+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e   77 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE--LLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEE   77 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc--ceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhh
Confidence            345566677899887654       46888888644321  11234567777766543223 34455443    246899


Q ss_pred             CCCCCChH
Q 023282          210 YMTNGSVA  217 (284)
Q Consensus       210 ~~~~g~L~  217 (284)
                      |+++..+.
T Consensus        78 ~i~G~~l~   85 (302)
T cd05156          78 FIPSRTLT   85 (302)
T ss_pred             eeCCCcCC
Confidence            98876653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=96.86  E-value=0.037  Score=47.93  Aligned_cols=27  Identities=22%  Similarity=0.294  Sum_probs=22.1

Q ss_pred             CCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          254 DPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       254 ~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ..+++|+|+.+.|||++.+....+.||
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf  212 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDF  212 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEec
Confidence            347999999999999996655567776

>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=96.72  E-value=0.00047  Score=34.25  Aligned_cols=18  Identities=33%  Similarity=0.514  Sum_probs=16.4

Q ss_pred             CccEEEccCCCCcccCCCC
Q 023282            1 MTALRDLSNNRLSGPVPDN   19 (284)
Q Consensus         1 ~~~~~dlS~N~lsG~iP~~   19 (284)
                      +|+.||||+|+|+ .||..
T Consensus         1 ~L~~Ldls~n~l~-~ip~~   18 (22)
T PF00560_consen    1 NLEYLDLSGNNLT-SIPSS   18 (22)
T ss_dssp             TESEEEETSSEES-EEGTT
T ss_pred             CccEEECCCCcCE-eCChh
Confidence            5899999999999 99975

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A ....

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.72  E-value=0.012  Score=50.16  Aligned_cols=139  Identities=19%  Similarity=0.249  Sum_probs=71.1

Q ss_pred             CCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCC---CCCceeeeeEEeeCCeeeEEEeCCC
Q 023282          136 NKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV---HRNLLRLYGFCTTVTEKLLVYPYMT  212 (284)
Q Consensus       136 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~---h~niv~l~g~~~~~~~~~lv~e~~~  212 (284)
                      ..+.++.|....+|+.. .++..+.||.-...    ....|..|.+-|+.+.   --.+.+++++....+..+|++||++
T Consensus        21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSES----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGG----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeEecCCCChhheEEEE-CCCccEEEEecChh----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            34668889999999877 56778999976521    1224778887776663   4456788888877778899999998


Q ss_pred             CCCh-----------HHHHhh-cCCCCC-----------------CCCHHHH-----HHHHHHHH--------------H
Q 023282          213 NGSV-----------ASRLRE-RQSSLP-----------------PLDWPTR-----KKIALGSA--------------R  244 (284)
Q Consensus       213 ~g~L-----------~~~l~~-~~~~~~-----------------~l~~~~~-----~~i~~~i~--------------~  244 (284)
                      .+..           ...||. ......                 .-+|...     +....+.+              +
T Consensus        96 ~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~  175 (288)
T PF03881_consen   96 MGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVE  175 (288)
T ss_dssp             -----CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHH
Confidence            7611           112333 111110                 1134322     22222111              1


Q ss_pred             HH-HHHHc-CCCCCeeeeCCCCCCeeeCCCCCcchhh
Q 023282          245 GL-SYLHE-HCDPKIIHRDVKAANILLDEDADQSSKT  279 (284)
Q Consensus       245 gl-~yLH~-~~~~~ivHrdlk~~NiLld~~~~~~~~d  279 (284)
                      .+ ..|+. ...|..+|+||-+.|++.+.++++.|.|
T Consensus       176 ~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~D  212 (288)
T PF03881_consen  176 RLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFD  212 (288)
T ss_dssp             HHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S
T ss_pred             HHHHHhcCCCCCceeeEcCccccceeecCCCCceeec
Confidence            11 12222 2367899999999999999998887766

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=96.50  E-value=0.00039  Score=67.20  Aligned_cols=144  Identities=18%  Similarity=0.221  Sum_probs=90.9

Q ss_pred             HhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc--ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeE
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~l  206 (284)
                      ..+++.+.+-+-+|+++.++-+.-. .|...+.|........  .+.+....+-.+.-.-+||-+++..--+.......|
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            3455666666777888888776522 3433344433211110  001111222222222334555544444445567899


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++|..+++|...|+....    .+..-.......+.++++|||..   .+.|||++|.|.|...++.-+++||
T Consensus       882 ~~~~~~~~~~~Skl~~~~~----~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~  948 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSGC----LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDF  948 (1205)
T ss_pred             hhHHhccCCchhhhhcCCC----cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcc
Confidence            9999999999999987542    23222344556677899999997   7999999999999999999999887

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.29  E-value=0.019  Score=50.14  Aligned_cols=126  Identities=17%  Similarity=0.281  Sum_probs=81.1

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEeecccC--------------------ccc-HH----HHHHHHHHHhcCCCCCc
Q 023282          137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERT--------------------SGG-EL----QFQTEVKIISMAVHRNL  191 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------------------~~~-~~----~~~~e~~~l~~~~h~ni  191 (284)
                      ..+|..|.-+.||.+.-.+|..+|||+.+..-.                    ... .+    ....|++-|.+++...|
T Consensus       149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI  228 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI  228 (520)
T ss_pred             ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            356888888999999988999999998763210                    000 00    12346666666654443


Q ss_pred             eeeeeEEeeCCeeeEEEeCCCC-CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeC
Q 023282          192 LRLYGFCTTVTEKLLVYPYMTN-GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD  270 (284)
Q Consensus       192 v~l~g~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld  270 (284)
                      ...--...  ....|||+|+.. |=..-.|+.     -.++...+..+-.+++.-|.-|.+.|  +.||.||.-=|+|+.
T Consensus       229 P~PePIlL--k~hVLVM~FlGrdgw~aPkLKd-----~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh  299 (520)
T KOG2270|consen  229 PCPEPILL--KNHVLVMEFLGRDGWAAPKLKD-----ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH  299 (520)
T ss_pred             CCCCceee--ecceEeeeeccCCCCcCccccc-----ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence            22111111  245789999852 111222222     13565667778888888899998888  899999999999985


Q ss_pred             C
Q 023282          271 E  271 (284)
Q Consensus       271 ~  271 (284)
                      +
T Consensus       300 d  300 (520)
T KOG2270|consen  300 D  300 (520)
T ss_pred             C
Confidence            4

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.20  E-value=0.038  Score=47.72  Aligned_cols=124  Identities=15%  Similarity=0.245  Sum_probs=66.9

Q ss_pred             CcEEEEEEeec-ccCcccHHHHHHHHHHHhcCCC--CCceeeeeEEeeCC--eeeEEEeCCCCCChH-------------
Q 023282          156 GKLVAVKRLKE-ERTSGGELQFQTEVKIISMAVH--RNLLRLYGFCTTVT--EKLLVYPYMTNGSVA-------------  217 (284)
Q Consensus       156 ~~~vavK~~~~-~~~~~~~~~~~~e~~~l~~~~h--~niv~l~g~~~~~~--~~~lv~e~~~~g~L~-------------  217 (284)
                      ++.+.+. ... ...........+|.++++.+.-  .-+-+.+++|....  ..+.||+|+++..+.             
T Consensus        48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~  126 (321)
T COG3173          48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA  126 (321)
T ss_pred             CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence            6677777 321 2222333356677777776643  23345566776655  679999999873221             


Q ss_pred             -----HHHhh---cCC----C-C--------CCCCHHHHHHHHH--------HHHHHHHHHHcC-----CCCCeeeeCCC
Q 023282          218 -----SRLRE---RQS----S-L--------PPLDWPTRKKIAL--------GSARGLSYLHEH-----CDPKIIHRDVK  263 (284)
Q Consensus       218 -----~~l~~---~~~----~-~--------~~l~~~~~~~i~~--------~i~~gl~yLH~~-----~~~~ivHrdlk  263 (284)
                           +.|..   -..    . .        +--.|....+.+.        ....-..||+.+     ..+.++|+|+.
T Consensus       127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~  206 (321)
T COG3173         127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR  206 (321)
T ss_pred             HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence                 11111   000    0 0        0011222221111        112234555543     23579999999


Q ss_pred             CCCeeeCCCCCcchhhh
Q 023282          264 AANILLDEDADQSSKTI  280 (284)
Q Consensus       264 ~~NiLld~~~~~~~~df  280 (284)
                      +.|++++.+...-|.||
T Consensus       207 ~gNlii~~~~~~gVlDw  223 (321)
T COG3173         207 PGNLIIDPGRPTGVLDW  223 (321)
T ss_pred             cCCEEEeCCCeeEEEec
Confidence            99999999888777776

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.02  E-value=0.094  Score=45.11  Aligned_cols=25  Identities=24%  Similarity=0.288  Sum_probs=20.9

Q ss_pred             CCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          255 PKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       255 ~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .+++|+|+.+.||+++. +.+.+.||
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDf  211 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDF  211 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEEC
Confidence            47899999999999987 55667776

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=96.01  E-value=0.0015  Score=60.29  Aligned_cols=126  Identities=19%  Similarity=0.159  Sum_probs=81.3

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCC-ceeeeeEEeeCCeeeEEEeCCCCC-C
Q 023282          138 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN-LLRLYGFCTTVTEKLLVYPYMTNG-S  215 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n-iv~l~g~~~~~~~~~lv~e~~~~g-~  215 (284)
                      .-+++++++.++|.+-...+....+.+...      ....-++++|.+++||| .+..++-+...+..++.++++..| +
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs  321 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS  321 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence            457889999999987432223335544221      34667889999999999 777777777788899999999877 2


Q ss_pred             hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          216 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       216 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      -........   -.+...+...+...-.++++|+|+.   .-+|||    ||+..+ .+.+..||
T Consensus       322 ~~~~~~~se---~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~  375 (829)
T KOG0576|consen  322 SALEMTVSE---IALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDF  375 (829)
T ss_pred             ccccCChhh---Hhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccc
Confidence            221111100   0122334445556667899999986   568998    776654 44444443

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.87  E-value=0.3  Score=43.75  Aligned_cols=74  Identities=15%  Similarity=0.099  Sum_probs=46.6

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEeecccC---c---ccHHHHHHHHHHHhcCC---CCCceeeeeEEeeCCeeeEE
Q 023282          137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERT---S---GGELQFQTEVKIISMAV---HRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~---~~~~~~~~e~~~l~~~~---h~niv~l~g~~~~~~~~~lv  207 (284)
                      .+.||.|....||+...+ +..+.||.-.....   .   ....+-..|.+.|+.+.   ...+.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            467899999999998764 45688887541111   0   11122334455555443   346777887776  556788


Q ss_pred             EeCCCC
Q 023282          208 YPYMTN  213 (284)
Q Consensus       208 ~e~~~~  213 (284)
                      |||+++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=95.78  E-value=0.09  Score=44.66  Aligned_cols=45  Identities=11%  Similarity=0.017  Sum_probs=26.9

Q ss_pred             ecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCC
Q 023282          140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV  187 (284)
Q Consensus       140 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~  187 (284)
                      .++|-...|+.....+|..+++|.-+...   ....+.+|.+++..+.
T Consensus        19 ~~~g~~~~v~~i~~~~g~~~VlR~p~~~~---~~~~l~rE~~vL~~L~   63 (276)
T cd05152          19 NESGLDFQVVFAKDTDGVPWVLRIPRRPD---VSERAAAEKRVLALVR   63 (276)
T ss_pred             cCCcceeEEEEEEcCCCCeEEEEecCCHH---HHHHHHHHHHHHHHHH
Confidence            34444445665544567788888663211   1235778888887775

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=95.55  E-value=0.17  Score=44.51  Aligned_cols=136  Identities=15%  Similarity=0.187  Sum_probs=71.9

Q ss_pred             eecccCceEEEEEEeCC-----CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCc-eeeeeEEeeCCeeeEEEeCCC
Q 023282          139 ILGRGGFGKVYKGRLAD-----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL-LRLYGFCTTVTEKLLVYPYMT  212 (284)
Q Consensus       139 ~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni-v~l~g~~~~~~~~~lv~e~~~  212 (284)
                      .+-.|-...+|+....+     +..+.+|.......  ...+-..|..++..+..-++ .++++.+..  .  .|+||++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~--~~idR~~E~~~~~~l~~~gl~P~~~~~~~~--g--~v~efi~  116 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE--LFFDRDDEIRTFECMSRHGQGPRLLGRFPN--G--RVEEFIH  116 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC--eeechHHHHHHHHHHHHcCCCCceEEEECC--c--eEEEeeC
Confidence            34456777889887532     35788887654321  11123567777766654333 245555422  2  5789997


Q ss_pred             CCChHHH-----------------HhhcCCCCC--CCCHHHHHHHHHH-----------------HHHHHHHH----Hc-
Q 023282          213 NGSVASR-----------------LRERQSSLP--PLDWPTRKKIALG-----------------SARGLSYL----HE-  251 (284)
Q Consensus       213 ~g~L~~~-----------------l~~~~~~~~--~l~~~~~~~i~~~-----------------i~~gl~yL----H~-  251 (284)
                      +.++...                 +|.......  ...|.+..++..+                 +...+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            7665311                 121111110  1223333232211                 11122222    21 


Q ss_pred             CCCCCeeeeCCCCCCeeeCCC-CCcchhhh
Q 023282          252 HCDPKIIHRDVKAANILLDED-ADQSSKTI  280 (284)
Q Consensus       252 ~~~~~ivHrdlk~~NiLld~~-~~~~~~df  280 (284)
                      .....++|+|+++.|||++++ ....+.||
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~  226 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDY  226 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEee
Confidence            223468999999999999864 56788776

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=95.40  E-value=0.012  Score=50.60  Aligned_cols=132  Identities=17%  Similarity=0.151  Sum_probs=85.4

Q ss_pred             CCCCCeecccCceEEEEEEeCCCcEEEEEEeeccc-------------------Cccc--HHHHHHHHHHHhcCCC-C-C
Q 023282          134 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEER-------------------TSGG--ELQFQTEVKIISMAVH-R-N  190 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------~~~~--~~~~~~e~~~l~~~~h-~-n  190 (284)
                      +...+.||-|.-+-||.+-..+|.+.++|.-+...                   ++..  .....+|...|+.+.. . .
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            45678999999999999998889888888432110                   1111  1134567777777652 1 2


Q ss_pred             ceeeeeEEeeCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeC
Q 023282          191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD  270 (284)
Q Consensus       191 iv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld  270 (284)
                      +.+.+++    +..++|||++.+-.|...-+-.       +.+....-+.+   -+.-|-.+   ++||+|..-=||+++
T Consensus       174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~-------d~~~ly~~lm~---~Iv~la~~---GlIHgDFNEFNimv~  236 (465)
T KOG2268|consen  174 VPKPIDH----NRHCVVMELVDGYPLRQVRHVE-------DPPTLYDDLMG---LIVRLANH---GLIHGDFNEFNIMVK  236 (465)
T ss_pred             CCCcccc----cceeeHHHhhcccceeeeeecC-------ChHHHHHHHHH---HHHHHHHc---CceecccchheeEEe
Confidence            2223332    4568999999887776544321       22222222222   23345555   999999999999999


Q ss_pred             CCCCcchhhhhh
Q 023282          271 EDADQSSKTILR  282 (284)
Q Consensus       271 ~~~~~~~~df~~  282 (284)
                      +++.+.+.||=|
T Consensus       237 dd~~i~vIDFPQ  248 (465)
T KOG2268|consen  237 DDDKIVVIDFPQ  248 (465)
T ss_pred             cCCCEEEeechH
Confidence            999999999954

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.25  E-value=0.042  Score=48.74  Aligned_cols=63  Identities=21%  Similarity=0.172  Sum_probs=42.2

Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  273 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~  273 (284)
                      ..++-+|+++-++..++....     .++....+++.--+.|+.-+---  -+++|.|+.|.||++--+.
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~-----~pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlirf~~  382 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKS-----QPEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIRFNK  382 (565)
T ss_pred             ceeeeeccccccHHhhhhccc-----ChHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEEecC
Confidence            456667888888888887543     23344556666555665543321  1799999999999986543

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.21  E-value=0.32  Score=42.77  Aligned_cols=73  Identities=12%  Similarity=0.093  Sum_probs=43.7

Q ss_pred             eecccCceEEEEEEeCCC-cEEEEEEeeccc-----C-cccHHHHHHHHHHHhcCC--CCC-ceeeeeEEeeCCeeeEEE
Q 023282          139 ILGRGGFGKVYKGRLADG-KLVAVKRLKEER-----T-SGGELQFQTEVKIISMAV--HRN-LLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       139 ~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~-----~-~~~~~~~~~e~~~l~~~~--h~n-iv~l~g~~~~~~~~~lv~  208 (284)
                      .||.|....||++..+++ ..+.||.-.+-.     . .-...+..-|.+.|....  -|. +.+++.  .++....++|
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            479999999999997654 578999653111     1 111223445666665443  233 333333  3445567999


Q ss_pred             eCCCC
Q 023282          209 PYMTN  213 (284)
Q Consensus       209 e~~~~  213 (284)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99965

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG4258 consensus Insulin/growth factor receptor (contains protein kinase domain) [Signal transduction mechanisms]

Probab=95.10  E-value=0.04  Score=52.42  Aligned_cols=32  Identities=31%  Similarity=0.607  Sum_probs=26.3

Q ss_pred             ccHHHHHHHhcCCCCCCeecccCceEEEEEEeC
Q 023282          122 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLA  154 (284)
Q Consensus       122 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~  154 (284)
                      +-.++|+...+ ....+.||+|+||.||.|.-.
T Consensus       985 yv~deWe~~r~-it~~relg~gsfg~Vy~g~~n 1016 (1025)
T KOG4258|consen  985 YVPDEWEVSRE-ITLGRELGQGSFGMVYEGNAN 1016 (1025)
T ss_pred             CChhHHHHHHH-HhhhhhhccCccceEEEecCC
Confidence            55677887777 778899999999999998643

>PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ]

Probab=94.53  E-value=0.012  Score=33.53  Aligned_cols=29  Identities=28%  Similarity=0.472  Sum_probs=12.8

Q ss_pred             CCcchhhhhHHHHHHHHHHhheeEEEEec
Q 023282           68 SNAAIPVGVALGAALLFAVPVIGFAYWRR   96 (284)
Q Consensus        68 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~   96 (284)
                      ....+.+++++..+++++++.+.+++|+|
T Consensus         9 ~~vaIa~~VvVPV~vI~~vl~~~l~~~~r   37 (40)
T PF08693_consen    9 NTVAIAVGVVVPVGVIIIVLGAFLFFWYR   37 (40)
T ss_pred             ceEEEEEEEEechHHHHHHHHHHhheEEe
Confidence            34455555554444444444333333333

This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis [].

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=94.51  E-value=0.015  Score=42.60  Aligned_cols=44  Identities=27%  Similarity=0.403  Sum_probs=33.1

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHh
Q 023282          137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIIS  184 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~  184 (284)
                      .+.||.|+.|+||+|++.+|+.||||+.++...    ..+...+.+++
T Consensus        16 ~~PlasASiaQVh~a~l~~g~~VaVKV~rP~i~----~~i~~Dl~~l~   59 (119)
T PF03109_consen   16 PEPLASASIAQVHRARLKDGEEVAVKVQRPGIE----EQIEADLRILR   59 (119)
T ss_pred             cchhhheehhhheeeeecccchhhhhhcchHHH----HHHHHHHHHHH
Confidence            367999999999999999999999999865432    23444444443

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=94.50  E-value=0.48  Score=41.27  Aligned_cols=133  Identities=18%  Similarity=0.271  Sum_probs=70.8

Q ss_pred             CceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCC---CCC---ceeeeeEE----eeCCeeeEEEeCCCC
Q 023282          144 GFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV---HRN---LLRLYGFC----TTVTEKLLVYPYMTN  213 (284)
Q Consensus       144 ~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~---h~n---iv~l~g~~----~~~~~~~lv~e~~~~  213 (284)
                      .-..+|+....+|.. ++|..... .  ...++..|...+..+.   .+-   +..+-|-.    ..+...+-+++|++|
T Consensus        37 ~eN~~f~~~~~~g~~-iLki~~~~-~--~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G  112 (331)
T COG2334          37 EENSNFRVQTEDGRY-ILKIYRPG-W--TRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPG  112 (331)
T ss_pred             ccCceEEEEecCCCe-EEEEecCC-C--CHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCC
Confidence            345688888777766 77877554 2  2234455555555442   111   22222211    111367889999998


Q ss_pred             CChHH---------------HHhhcC--------CCCCCCCHHH----H---------HHHHHHHHHHHHHHHcCC----
Q 023282          214 GSVAS---------------RLRERQ--------SSLPPLDWPT----R---------KKIALGSARGLSYLHEHC----  253 (284)
Q Consensus       214 g~L~~---------------~l~~~~--------~~~~~l~~~~----~---------~~i~~~i~~gl~yLH~~~----  253 (284)
                      ..+..               .|+...        .......|..    .         .....++...+..+....    
T Consensus       113 ~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~l  192 (331)
T COG2334         113 RPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHL  192 (331)
T ss_pred             cCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhC
Confidence            77762               111110        0011233431    0         012233444455554421    


Q ss_pred             CC-C--eeeeCCCCCCeeeCCCCC-cchhhh
Q 023282          254 DP-K--IIHRDVKAANILLDEDAD-QSSKTI  280 (284)
Q Consensus       254 ~~-~--ivHrdlk~~NiLld~~~~-~~~~df  280 (284)
                      .. +  +||+|+.|.||++|.+.. ..+.||
T Consensus       193 p~~~~~iIH~D~~~~NVl~d~~~~~~g~iDF  223 (331)
T COG2334         193 PALGDQIIHGDLHPDNVLFDDDTDVSGFIDF  223 (331)
T ss_pred             CcccceeeecCCCccceeEcCCCCeeeEEEc
Confidence            11 2  899999999999999986 667666

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=94.50  E-value=0.29  Score=40.20  Aligned_cols=75  Identities=13%  Similarity=0.186  Sum_probs=45.5

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCC---CCCceeeeeEEeeCCeeeEEEeCCCCC
Q 023282          138 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV---HRNLLRLYGFCTTVTEKLLVYPYMTNG  214 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~---h~niv~l~g~~~~~~~~~lv~e~~~~g  214 (284)
                      +.+.-|..-..|+... +..++.||+-..    ....-|..|+.-|..+.   --.+.+++..-......++|+||++-|
T Consensus        22 ~~v~gG~inea~~v~d-g~~~~FvK~n~~----~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~   96 (286)
T COG3001          22 EEVSGGDINEAWRLRD-GTDPFFVKCNQR----EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG   96 (286)
T ss_pred             cccCCccccceeEeec-CCcceEEEecch----hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence            3344444444444332 456788886422    12234777776555443   445666666767788999999999986


Q ss_pred             ChH
Q 023282          215 SVA  217 (284)
Q Consensus       215 ~L~  217 (284)
                      .+.
T Consensus        97 ~~d   99 (286)
T COG3001          97 PLD   99 (286)
T ss_pred             CCC
Confidence            654

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=94.48  E-value=0.52  Score=41.14  Aligned_cols=73  Identities=11%  Similarity=0.178  Sum_probs=41.7

Q ss_pred             CeecccCceEEEEEEeCC----CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCc-eeeeeEEeeCCeeeEEEeCCC
Q 023282          138 NILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL-LRLYGFCTTVTEKLLVYPYMT  212 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni-v~l~g~~~~~~~~~lv~e~~~  212 (284)
                      +.|..|-...+|+....+    +..+.+|.......  ...+-.+|..+++.+..-++ .++++++.  +.  +|.+|++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~~IdR~~E~~il~~l~~~gl~P~~l~~~~--~G--~i~~fi~   93 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--YVIDRERELQAIKYLSAAGFGAKLLGVFG--NG--MIQSFIN   93 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--eEechHHHHHHHHHHHhcCCCCceeEEeC--Cc--Eeehhhc
Confidence            345456667788886543    23788887644322  11133567777776654444 34555542  22  5889987


Q ss_pred             CCCh
Q 023282          213 NGSV  216 (284)
Q Consensus       213 ~g~L  216 (284)
                      +-.+
T Consensus        94 g~~l   97 (330)
T PLN02421         94 ARTL   97 (330)
T ss_pred             CCCC
Confidence            6554

>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D

Probab=94.41  E-value=0.024  Score=26.04  Aligned_cols=13  Identities=54%  Similarity=0.542  Sum_probs=9.1

Q ss_pred             CccEEEccCCCCc
Q 023282            1 MTALRDLSNNRLS   13 (284)
Q Consensus         1 ~~~~~dlS~N~ls   13 (284)
                      +|++||||+|+|+
T Consensus         2 ~L~~L~l~~n~L~   14 (17)
T PF13504_consen    2 NLRTLDLSNNRLT   14 (17)
T ss_dssp             T-SEEEETSS--S
T ss_pred             ccCEEECCCCCCC
Confidence            5899999999987

...

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=94.27  E-value=0.027  Score=33.22  Aligned_cols=33  Identities=24%  Similarity=0.389  Sum_probs=24.0

Q ss_pred             CccEEEccCCCCcccCCC-CCCCCccCcccccCCc
Q 023282            1 MTALRDLSNNRLSGPVPD-NGSFSQFTPISFENNL   34 (284)
Q Consensus         1 ~~~~~dlS~N~lsG~iP~-~~~~~~~~~~s~~gN~   34 (284)
                      +|+.|++++|+++ .||. ...+.++....+.+|.
T Consensus         2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~   35 (44)
T PF12799_consen    2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNP   35 (44)
T ss_dssp             T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSC
T ss_pred             cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCC
Confidence            5899999999999 5776 5666777777777774

...

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.09  E-value=0.25  Score=40.37  Aligned_cols=100  Identities=13%  Similarity=0.133  Sum_probs=62.0

Q ss_pred             EEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHH
Q 023282          158 LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKK  237 (284)
Q Consensus       158 ~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~  237 (284)
                      +..+|++......-...-|..+..++++++  .|+++..-  .....-++.|+|-....             .   ..-.
T Consensus        87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-------------~---~~N~  146 (308)
T PF07387_consen   87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-------------N---FSNF  146 (308)
T ss_pred             hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------------c---hhHH
Confidence            345666643322222335777888888775  56666632  22234578888743111             0   0111


Q ss_pred             HHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhh
Q 023282          238 IALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKT  279 (284)
Q Consensus       238 i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~d  279 (284)
                      |..+ ..+|.-.|+. .++.+|+|-.|+||+-|.+|..|+.|
T Consensus       147 i~ag-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVD  186 (308)
T PF07387_consen  147 ITAG-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVD  186 (308)
T ss_pred             HHHh-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecC
Confidence            2222 3567778865 45899999999999999999999877

The function of this family is unknown.

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=94.04  E-value=0.32  Score=40.64  Aligned_cols=78  Identities=19%  Similarity=0.079  Sum_probs=52.2

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCC-CCCCh
Q 023282          138 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM-TNGSV  216 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~-~~g~L  216 (284)
                      ..+..|..+.|+.++..+|.++++|..........+  . .....|+..+-...|++++.-  .....+++|.+ ++-+|
T Consensus         8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E--~-~g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~~L   82 (253)
T PF04655_consen    8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHE--A-RGEAALRWWNGRGAVRLLAAD--PERGALLLERLDPGRSL   82 (253)
T ss_pred             CCCCCCcceEEEEEEcCCCCeEEEEecCCcccchhh--h-hHHhHhheeCCCCceeeeccc--cccchhhhhhccCCCch
Confidence            345678899999999989999999987543221111  1 122457777777788888754  34567888888 44466


Q ss_pred             HHHH
Q 023282          217 ASRL  220 (284)
Q Consensus       217 ~~~l  220 (284)
                      .+..
T Consensus        83 ~~~~   86 (253)
T PF04655_consen   83 ASLP   86 (253)
T ss_pred             hhcc
Confidence            5544

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=93.62  E-value=0.015  Score=52.35  Aligned_cols=74  Identities=24%  Similarity=0.357  Sum_probs=57.8

Q ss_pred             HHHHhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEee
Q 023282          127 LQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT  200 (284)
Q Consensus       127 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~  200 (284)
                      .....++|....++|.|+||+|+.+... ++-.+|||.|.............+|+..+.++.|++++++...+..
T Consensus        44 ~sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~  118 (516)
T KOG1033|consen   44 TSREANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWYE  118 (516)
T ss_pred             hhhhhccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheeceec
Confidence            3445678899999999999999999755 4447999998654444444567888889999999999998876654

>PRK06148 hypothetical protein; Provisional

Probab=93.56  E-value=1.2  Score=44.97  Aligned_cols=76  Identities=12%  Similarity=0.119  Sum_probs=41.1

Q ss_pred             eecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcC-------CCCCceeee-eE----Eee-CC--e
Q 023282          139 ILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-------VHRNLLRLY-GF----CTT-VT--E  203 (284)
Q Consensus       139 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-------~h~niv~l~-g~----~~~-~~--~  203 (284)
                      .|+ |..-.+|+....+|..+.+|+.+....   ......|.+.+..+       .-|.+++-. |-    ... .+  .
T Consensus        32 ~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~---~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         32 PLD-GERDLNFRLTTDDGADYILKIVNPSEP---RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             ecC-CcCCceEEEEeCCCCeEEEEEcCCccc---hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            353 345678888877788899999865421   22233344444322       223333322 11    111 11  3


Q ss_pred             eeEEEeCCCCCChHH
Q 023282          204 KLLVYPYMTNGSVAS  218 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~  218 (284)
                      .+-+++|+++..+.+
T Consensus       108 ~vrLl~~l~G~~l~~  122 (1013)
T PRK06148        108 LLRLLSWLPGTPLAE  122 (1013)
T ss_pred             EEEEEeccCCCcHHh
Confidence            567899999877654

>PF12191 stn_TNFRSF12A: Tumour necrosis factor receptor stn_TNFRSF12A_TNFR domain; InterPro: IPR022316 The tumour necrosis factor (TNF) receptor (TNFR) superfamily comprises more than 20 type-I transmembrane proteins

Probab=93.15  E-value=0.044  Score=39.66  Aligned_cols=32  Identities=34%  Similarity=0.479  Sum_probs=0.4

Q ss_pred             cchhhhhHHHHHHHHHHhheeEEEEeccCCCcc
Q 023282           70 AAIPVGVALGAALLFAVPVIGFAYWRRTRPHEF  102 (284)
Q Consensus        70 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  102 (284)
                      .+.+.+.+.+++++ +.++.++++|+|.|+++.
T Consensus        78 ~~pi~~sal~v~lV-l~llsg~lv~rrcrrr~~  109 (129)
T PF12191_consen   78 LWPILGSALSVVLV-LALLSGFLVWRRCRRREK  109 (129)
T ss_dssp             S--------------------------------
T ss_pred             ehhhhhhHHHHHHH-HHHHHHHHHHhhhhcccc
Confidence            34433334343333 333445566665555443

Family members are defined based on similarity in their extracellular domain - a region that contains many cysteine residues arranged in a specific repetitive pattern []. The cysteines allow formation of an extended rod-like structure, responsible for ligand binding []. Upon receptor activation, different intracellular signalling complexes are assembled for different members of the TNFR superfamily, depending on their intracellular domains and sequences []. Activation of TNFRs can therefore induce a range of disparate effects, including cell proliferation, differentiation, survival, or apoptotic cell death, depending upon the receptor involved []. TNFRs are widely distributed and play important roles in many crucial biological processes, such as lymphoid and neuronal development, innate and adaptive immunity, and maintenance of cellular homeostasis []. Drugs that manipulate their signalling have potential roles in the prevention and treatment of many diseases, such as viral infections, coronary heart disease, transplant rejection, and immune disease []. TNF receptor 12 (also known as TWEAK receptor, and fibroblast growth factor-inducible-14 (Fn14)) has been implicated in endothelial cell growth and migration []. The receptor may also play a role in cell-matrix interactions [].; PDB: 2KN0_A 2RPJ_A 2KMZ_A 2EQP_A.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=93.07  E-value=2.3  Score=37.00  Aligned_cols=69  Identities=17%  Similarity=0.189  Sum_probs=39.5

Q ss_pred             ceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCC--CCcee---eee--EEeeCCeeeEEEeCCCCCC
Q 023282          145 FGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH--RNLLR---LYG--FCTTVTEKLLVYPYMTNGS  215 (284)
Q Consensus       145 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h--~niv~---l~g--~~~~~~~~~lv~e~~~~g~  215 (284)
                      -..||+....++..+++|..+...  ....++..|++.+..+..  -.++.   .-|  .....+..+.++++++|..
T Consensus        38 eN~vy~v~~~~~~~~vlKv~r~~~--~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         38 ENRVYQFGDEDGRRVVAKFYRPER--WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             cceEEEEecCCCCEEEEEEcCccc--CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            367899888778889999875332  123345566666554421  11222   112  1222456778999987654

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	284
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-84
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-82
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-25
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-25
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-25
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-25
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-25
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-23
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-13
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-13
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-12
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-12
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-11
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-11
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-11
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-11
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-11
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-11
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-11
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-11
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-11
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-11
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-11
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-11
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-11
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-11
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-11
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-11
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-11
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-11
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-11
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-11
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-11
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-11
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-11
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-11
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		7e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		8e-11
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-11
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-10
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-10
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-10
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-10
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-10
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-10
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-10
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-10
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-10
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-10
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-10
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-10
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-10
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-10
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-10
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-10
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-10
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-10
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-10
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-10
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-10
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-09
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-09
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-09
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-09
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-09
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-09
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-09
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-09
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-09
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-09
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-09
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-09
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-09
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		7e-09
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		7e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		7e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		8e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		8e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		8e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		8e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-09
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		8e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		8e-09
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		8e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		8e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		8e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		9e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		9e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		9e-09
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		9e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		9e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		9e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-08
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-08
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-08
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-08
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-08
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-08
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-08
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-08
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-08
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-08
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-08
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-08
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-08
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-08
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-08
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-08
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-08
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-08
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-08
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-08
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-08
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-08
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-08
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-08
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-08
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-08
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-08
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-08
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-08
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-08
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-08
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-08
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-08
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-08
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-08
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-08
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-08
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-08
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-08
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-08
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-08
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-08
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-08
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-08
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-08
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-08
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		7e-08
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		7e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		7e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		7e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		7e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		7e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		8e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		8e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		8e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		8e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		9e-08
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		9e-08
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-08
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		9e-08
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		9e-08
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		9e-08
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-08
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-07
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-07
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-07
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-07
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-07
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-07
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-07
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-07
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-07
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-07
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-07
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-07
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-07
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-07
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-07
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-07
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-07
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-07
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-07
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-07
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-07
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-07
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-07
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-07
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-07
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-07
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-07
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-07
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-07
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-07
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-07
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-07
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-07
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-07
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-07
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-07
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-07
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-07
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-07
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-07
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-07
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-07
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-07
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-07
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-07
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-07
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-07
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-07
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-07
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-07
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-07
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-07
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-07
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		5e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-07
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-07
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		5e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-07
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		6e-07
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		6e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-07
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-07
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		7e-07
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		7e-07
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		7e-07
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-07
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		8e-07
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		8e-07
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		8e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		8e-07
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-07
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-06
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-06
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-06
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-06
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-06
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-06
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-06
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-06
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-06
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-06
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-06
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-06
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-06
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-06
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-06
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-06
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-06
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-06
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-06
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-06
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-06
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-06
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-06
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-06
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-06
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-06
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-06
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-06
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-06
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-06
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-06
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-06
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-06
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-06
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-06
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-06
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-06
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-06
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-06
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-06
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-06
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		6e-06
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-06
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-06
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		7e-06
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		7e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		7e-06
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-06
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-06
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		8e-06
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-06
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-06
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-06
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-06
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		8e-06
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		8e-06
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		8e-06
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		8e-06
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-06
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		8e-06
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-06
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-06
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		8e-06
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-06
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		9e-06
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		9e-06
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		9e-06
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		9e-06
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-05
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-05
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-05
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-05
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-05
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-05
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-05
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-05
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-05
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-05
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-05
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-05
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-05
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-05
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-05
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-05
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-05
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-05
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-05
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-05
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-05
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-05
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-05
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-05
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-05
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-05
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-05
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-05
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-05
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-05
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-05
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-05
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-05
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-05
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-05
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-05
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-05
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-05
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-05
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-05
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-05
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-05
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		3e-05
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-05
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-05
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-05
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		3e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		3e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		3e-05
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-05
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-05
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-05
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-05
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-05
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-05
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-05
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		5e-05
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-05
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		5e-05
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		5e-05
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-05
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		5e-05
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		6e-05
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-05
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-05
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		6e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-05
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		6e-05
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		7e-05
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		7e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		7e-05
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		7e-05
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-05
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-05
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-05
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		8e-05
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-05
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-05
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		9e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-04
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-04
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-04
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-04
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-04
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-04
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-04
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-04
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-04
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-04
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-04
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-04
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-04
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-04
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-04
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-04
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-04
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-04
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-04
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-04
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-04
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-04
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-04
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-04
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-04
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-04
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		6e-04
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-04
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		6e-04
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-04
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-04
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		8e-04
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-04
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-04
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-04
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-04
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		9e-04
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		9e-04
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  309 bits (791), Expect = 1e-84,   Method: Compositional matrix adjust.
 Identities = 147/178 (82%), Positives = 160/178 (89%)
Query: 95  RRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLA 154
           RR +P + FFDVPAE+D E+ LGQLKRFSLRELQVA+D FSNKNILGRGGFGKVYKGRLA
Sbjct: 1   RRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA 60
Query: 155 DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNG 214
           DG LVAVKRLKEER  GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NG
Sbjct: 61  DGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 120
Query: 215 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           SVAS LRER  S PPLDWP R++IALGSARGL+YLH+HCDPKIIHRDVKAANILLDE+
Sbjct: 121 SVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE 178

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  301 bits (772), Expect = 2e-82,   Method: Compositional matrix adjust.
 Identities = 144/170 (84%), Positives = 155/170 (91%)
Query: 103 FFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVK 162
           FFDVPAE+D E+ LGQLKRFSLRELQVA+D F NKNILGRGGFGKVYKGRLADG LVAVK
Sbjct: 1   FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVK 60
Query: 163 RLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE 222
           RLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NGSVAS LRE
Sbjct: 61  RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 223 RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           R  S PPLDWP R++IALGSARGL+YLH+HCDPKIIHRDVKAANILLDE+
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE 170

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 68/152 (44%), Positives = 93/152 (61%), Gaps = 4/152 (2%)
Query: 121 RFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEV 180
           R  L +L+ AT+ F +K ++G G FGKVYKG L DG  VA+KR   E +S G  +F+TE+
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-SSQGIEEFETEI 86
Query: 181 KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL 240
           + +S   H +L+ L GFC    E +L+Y YM NG++   L         + W  R +I +
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 241 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           G+ARGL YLH      IIHRDVK+ NILLDE+
Sbjct: 147 GAARGLHYLHTRA---IIHRDVKSINILLDEN 175

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 68/152 (44%), Positives = 93/152 (61%), Gaps = 4/152 (2%)
Query: 121 RFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEV 180
           R  L +L+ AT+ F +K ++G G FGKVYKG L DG  VA+KR   E +S G  +F+TE+
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-SSQGIEEFETEI 86
Query: 181 KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL 240
           + +S   H +L+ L GFC    E +L+Y YM NG++   L         + W  R +I +
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 241 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           G+ARGL YLH      IIHRDVK+ NILLDE+
Sbjct: 147 GAARGLHYLHTRA---IIHRDVKSINILLDEN 175

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 68/159 (42%), Positives = 93/159 (58%), Gaps = 14/159 (8%)
Query: 122 FSLRELQVATDGFSNK------NILGRGGFGKVYKGRLADGKLVAVKRLK---EERTSGG 172
           FS  EL+  T+ F  +      N +G GGFG VYKG + +   VAVK+L    +  T   
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 173 ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDW 232
           + QF  E+K+++   H NL+ L GF +   +  LVY YM NGS+  RL     + PPL W
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT-PPLSW 132
Query: 233 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 271
             R KIA G+A G+++LHE+     IHRD+K+ANILLDE
Sbjct: 133 HMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 68/159 (42%), Positives = 93/159 (58%), Gaps = 14/159 (8%)
Query: 122 FSLRELQVATDGFSNK------NILGRGGFGKVYKGRLADGKLVAVKRLK---EERTSGG 172
           FS  EL+  T+ F  +      N +G GGFG VYKG + +   VAVK+L    +  T   
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 173 ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDW 232
           + QF  E+K+++   H NL+ L GF +   +  LVY YM NGS+  RL     + PPL W
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT-PPLSW 132
Query: 233 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 271
             R KIA G+A G+++LHE+     IHRD+K+ANILLDE
Sbjct: 133 HMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 68/159 (42%), Positives = 93/159 (58%), Gaps = 14/159 (8%)
Query: 122 FSLRELQVATDGFSNK------NILGRGGFGKVYKGRLADGKLVAVKRLK---EERTSGG 172
           FS  EL+  T+ F  +      N +G GGFG VYKG + +   VAVK+L    +  T   
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 67
Query: 173 ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDW 232
           + QF  E+K+++   H NL+ L GF +   +  LVY YM NGS+  RL     + PPL W
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT-PPLSW 126
Query: 233 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 271
             R KIA G+A G+++LHE+     IHRD+K+ANILLDE
Sbjct: 127 HMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 162

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/159 (42%), Positives = 90/159 (56%), Gaps = 14/159 (8%)
Query: 122 FSLRELQVATDGFSNK------NILGRGGFGKVYKGRLADGKLVAVKRLK---EERTSGG 172
           FS  EL+  T+ F  +      N  G GGFG VYKG + +   VAVK+L    +  T   
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 64
Query: 173 ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDW 232
           + QF  E+K+ +   H NL+ L GF +   +  LVY Y  NGS+  RL     + PPL W
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGT-PPLSW 123
Query: 233 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 271
             R KIA G+A G+++LHE+     IHRD+K+ANILLDE
Sbjct: 124 HXRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 159

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 80/150 (53%), Gaps = 16/150 (10%)
Query: 140 LGRGGFGKVYKGRLA-DGKLVAVKRL----KEERTSGGE--LQFQTEVKIISMAVHRNLL 192
           +G+GGFG V+KGRL  D  +VA+K L     E  T   E   +FQ EV I+S   H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
           +LYG         +V  ++  G +  RL ++     P+ W  + ++ L  A G+ Y+   
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 253 CDPKIIHRDVKAANIL---LDEDADQSSKT 279
            +P I+HRD+++ NI    LDE+A   +K 
Sbjct: 142 -NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 80/150 (53%), Gaps = 16/150 (10%)
Query: 140 LGRGGFGKVYKGRLA-DGKLVAVKRL----KEERTSGGE--LQFQTEVKIISMAVHRNLL 192
           +G+GGFG V+KGRL  D  +VA+K L     E  T   E   +FQ EV I+S   H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
           +LYG         +V  ++  G +  RL ++     P+ W  + ++ L  A G+ Y+   
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 253 CDPKIIHRDVKAANIL---LDEDADQSSKT 279
            +P I+HRD+++ NI    LDE+A   +K 
Sbjct: 142 -NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 80/150 (53%), Gaps = 16/150 (10%)
Query: 140 LGRGGFGKVYKGRLA-DGKLVAVKRL----KEERTSGGE--LQFQTEVKIISMAVHRNLL 192
           +G+GGFG V+KGRL  D  +VA+K L     E  T   E   +FQ EV I+S   H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
           +LYG         +V  ++  G +  RL ++     P+ W  + ++ L  A G+ Y+   
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 253 CDPKIIHRDVKAANIL---LDEDADQSSKT 279
            +P I+HRD+++ NI    LDE+A   +K 
Sbjct: 142 -NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/133 (34%), Positives = 66/133 (49%), Gaps = 7/133 (5%)
Query: 140 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 198
           +GRG FG+V+ GRL AD  LVAVK  +E      + +F  E +I+    H N++RL G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 258
           T      +V   +  G   + LR   +    L   T  ++   +A G+ YL   C    I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLESKC---CI 235
Query: 259 HRDVKAANILLDE 271
           HRD+ A N L+ E
Sbjct: 236 HRDLAARNCLVTE 248

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/133 (34%), Positives = 66/133 (49%), Gaps = 7/133 (5%)
Query: 140 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 198
           +GRG FG+V+ GRL AD  LVAVK  +E      + +F  E +I+    H N++RL G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 258
           T      +V   +  G   + LR   +    L   T  ++   +A G+ YL   C    I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLESKC---CI 235
Query: 259 HRDVKAANILLDE 271
           HRD+ A N L+ E
Sbjct: 236 HRDLAARNCLVTE 248

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 83/163 (50%), Gaps = 18/163 (11%)
Query: 127 LQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLK---EERTSGGELQFQTEVKII 183
           L++     + + I+G GGFGKVY+     G  VAVK  +   +E  S      + E K+ 
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 184 SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIAL 240
           +M  H N++ L G C       LV  +   G +   L  ++  +PP   ++W      A+
Sbjct: 61  AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNW------AV 112
Query: 241 GSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTI 280
             ARG++YLH+     IIHRD+K++NIL+    E+ D S+K +
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 139 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 195 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 250
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 167
Query: 251 EHCDPKIIHRDVKAANILLDE 271
                K +HRD+ A N +LDE
Sbjct: 168 --ASKKFVHRDLAARNCMLDE 186

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 139 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 195 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 250
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 148
Query: 251 EHCDPKIIHRDVKAANILLDE 271
                K +HRD+ A N +LDE
Sbjct: 149 --ASKKFVHRDLAARNCMLDE 167

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 139 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 195 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 250
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 149
Query: 251 EHCDPKIIHRDVKAANILLDE 271
                K +HRD+ A N +LDE
Sbjct: 150 --ASKKFVHRDLAARNCMLDE 168

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 139 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 195 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 250
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 149
Query: 251 EHCDPKIIHRDVKAANILLDE 271
                K +HRD+ A N +LDE
Sbjct: 150 --ASKKFVHRDLAARNCMLDE 168

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 139 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 195 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 250
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 146
Query: 251 EHCDPKIIHRDVKAANILLDE 271
                K +HRD+ A N +LDE
Sbjct: 147 --ASKKFVHRDLAARNCMLDE 165

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 139 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 195 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 250
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 168
Query: 251 EHCDPKIIHRDVKAANILLDE 271
                K +HRD+ A N +LDE
Sbjct: 169 --ASKKFVHRDLAARNCMLDE 187

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 139 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 195 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 250
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 144
Query: 251 EHCDPKIIHRDVKAANILLDE 271
                K +HRD+ A N +LDE
Sbjct: 145 --ASKKFVHRDLAARNCMLDE 163

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 139 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 195 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 250
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 147
Query: 251 EHCDPKIIHRDVKAANILLDE 271
                K +HRD+ A N +LDE
Sbjct: 148 --ASKKFVHRDLAARNCMLDE 166

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 139 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 195 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 250
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 148
Query: 251 EHCDPKIIHRDVKAANILLDE 271
                K +HRD+ A N +LDE
Sbjct: 149 --ASKKFVHRDLAARNCMLDE 167

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 139 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 195 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 250
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ YL 
Sbjct: 89  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKYL- 141
Query: 251 EHCDPKIIHRDVKAANILLDE 271
                K +HRD+ A N +LDE
Sbjct: 142 --ASKKFVHRDLAARNCMLDE 160

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 66/133 (49%), Gaps = 8/133 (6%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           +G G FG V+ G   +   VA+K +KE   S  E  F  E +++    H  L++LYG C 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMS--EDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 LV+ +M +G ++  LR ++         T   + L    G++YL E C   +IH
Sbjct: 93  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIH 146
Query: 260 RDVKAANILLDED 272
           RD+ A N L+ E+
Sbjct: 147 RDLAARNCLVGEN 159

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 67/145 (46%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G V   L++    L   D           A 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQK----LSKFDEQRTATYITELAN 124
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     ++IHRD+K  N+LL
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLL 146

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 67/145 (46%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G V   L++    L   D           A 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQK----LSKFDEQRTATYITELAN 124
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     ++IHRD+K  N+LL
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLL 146

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 71/143 (49%), Gaps = 11/143 (7%)
Query: 135 SNKNILGRGGFGKVYKGRL--ADGKL---VAVKRLKEERTSGGELQFQTEVKIISMAVHR 189
           + + ++G G FG+VYKG L  + GK    VA+K LK   T    + F  E  I+    H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           N++RL G  +     +++  YM NG++   LRE+      L      +   G A G+ YL
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR---GIAAGMKYL 163
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
               +   +HRD+ A NIL++ +
Sbjct: 164 ---ANMNYVHRDLAARNILVNSN 183

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 139 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 195 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 250
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ +L 
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL- 154
Query: 251 EHCDPKIIHRDVKAANILLDE 271
                K +HRD+ A N +LDE
Sbjct: 155 --ASKKFVHRDLAARNCMLDE 173

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 139 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 195 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 250
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ +L 
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL- 147
Query: 251 EHCDPKIIHRDVKAANILLDE 271
                K +HRD+ A N +LDE
Sbjct: 148 --ASKKFVHRDLAARNCMLDE 166

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 21  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 80
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 81  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 136
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     ++IHRD+K  N+LL
Sbjct: 137 ALSYCH---SKRVIHRDIKPENLLL 158

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 139 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 195 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 250
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ +L 
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL- 150
Query: 251 EHCDPKIIHRDVKAANILLDE 271
                K +HRD+ A N +LDE
Sbjct: 151 --ASKKFVHRDLAARNCMLDE 169

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 66/133 (49%), Gaps = 8/133 (6%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           +G G FG V+ G   +   VA+K ++E   S  E  F  E +++    H  L++LYG C 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 LV+ +M +G ++  LR ++         T   + L    G++YL E C   +IH
Sbjct: 73  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIH 126
Query: 260 RDVKAANILLDED 272
           RD+ A N L+ E+
Sbjct: 127 RDLAARNCLVGEN 139

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 139 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 195 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 250
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ +L 
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL- 149
Query: 251 EHCDPKIIHRDVKAANILLDE 271
                K +HRD+ A N +LDE
Sbjct: 150 --ASKKFVHRDLAARNCMLDE 168

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 139 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 195 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 250
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ +L 
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL- 150
Query: 251 EHCDPKIIHRDVKAANILLDE 271
                K +HRD+ A N +LDE
Sbjct: 151 --ASKKFVHRDLAARNCMLDE 169

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 69/145 (47%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R  + K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     K+IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKKVIHRDIKPENLLL 141

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 145
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     ++IHRD+K  N+LL
Sbjct: 146 ALSYCHSK---RVIHRDIKPENLLL 167

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 139 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 195 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 250
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ +L 
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL- 149
Query: 251 EHCDPKIIHRDVKAANILLDE 271
                K +HRD+ A N +LDE
Sbjct: 150 --ASKKFVHRDLAARNCMLDE 168

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 145
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     ++IHRD+K  N+LL
Sbjct: 146 ALSYCH---SKRVIHRDIKPENLLL 167

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 66/133 (49%), Gaps = 8/133 (6%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           +G G FG V+ G   +   VA+K ++E   S  E  F  E +++    H  L++LYG C 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 LV+ +M +G ++  LR ++         T   + L    G++YL E C   +IH
Sbjct: 76  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIH 129
Query: 260 RDVKAANILLDED 272
           RD+ A N L+ E+
Sbjct: 130 RDLAARNCLVGEN 142

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/141 (36%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 139 ILGRGGFGKVYKGRLAD--GKLV--AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           ++GRG FG VY G L D  GK +  AVK L      G   QF TE  I+    H N+L L
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 195 YGFCT-TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI---ALGSARGLSYLH 250
            G C  +    L+V PYM +G + + +R    +      PT K +    L  A+G+ +L 
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL- 208
Query: 251 EHCDPKIIHRDVKAANILLDE 271
                K +HRD+ A N +LDE
Sbjct: 209 --ASKKFVHRDLAARNCMLDE 227

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 66/133 (49%), Gaps = 8/133 (6%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           +G G FG V+ G   +   VA+K ++E   S  E  F  E +++    H  L++LYG C 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 LV+ +M +G ++  LR ++         T   + L    G++YL E C   +IH
Sbjct: 71  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIH 124
Query: 260 RDVKAANILLDED 272
           RD+ A N L+ E+
Sbjct: 125 RDLAARNCLVGEN 137

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 121
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     ++IHRD+K  N+LL
Sbjct: 122 ALSYCH---SKRVIHRDIKPENLLL 143

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 121
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     ++IHRD+K  N+LL
Sbjct: 122 ALSYCH---SKRVIHRDIKPENLLL 143

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 122
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     ++IHRD+K  N+LL
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLL 144

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 120
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     ++IHRD+K  N+LL
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLL 142

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 124
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     ++IHRD+K  N+LL
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLL 146

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 73/160 (45%), Gaps = 31/160 (19%)
Query: 140 LGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
           +G G FG+V++ R A G L       VAVK LKEE ++  +  FQ E  +++   + N++
Sbjct: 55  IGEGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 193 RLYGFCTTVTEKLLVYPYMTNG--------------------SVASRLRERQSSLPPLDW 232
           +L G C       L++ YM  G                     +++R R      PPL  
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 233 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
             +  IA   A G++YL E    K +HRD+   N L+ E+
Sbjct: 174 AEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGEN 210

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 124
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     ++IHRD+K  N+LL
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLL 146

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 120
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     ++IHRD+K  N+LL
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLL 142

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 120
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     ++IHRD+K  N+LL
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLL 142

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     ++IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLL 141

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 124
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     ++IHRD+K  N+LL
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLL 146

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     ++IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLL 141

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     ++IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLL 141

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     ++IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLL 141

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 122
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     ++IHRD+K  N+LL
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLL 144

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 122
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     ++IHRD+K  N+LL
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLL 144

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 122
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     ++IHRD+K  N+LL
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLL 144

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 3   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 62
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 63  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 118
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     ++IHRD+K  N+LL
Sbjct: 119 ALSYCH---SKRVIHRDIKPENLLL 140

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 83/164 (50%), Gaps = 15/164 (9%)
Query: 119 LKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQ 177
           L    L  L+     F    ++G G +G+VYKGR +  G+L A+K +  + T   E + +
Sbjct: 11  LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEEEIK 68
Query: 178 TEVKIIS-MAVHRNLLRLYGFCTT-----VTEKL-LVYPYMTNGSVASRLRERQSSLPPL 230
            E+ ++   + HRN+   YG         + ++L LV  +   GSV   ++  + +    
Sbjct: 69  QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 128
Query: 231 DWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 274
           +W     I     RGLS+LH+H   K+IHRD+K  N+LL E+A+
Sbjct: 129 EWIAY--ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAE 167

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 122
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     ++IHRD+K  N+LL
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLL 144

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 122
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     ++IHRD+K  N+LL
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLL 144

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     ++IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLL 141

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     ++IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLL 141

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 8   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 67
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 123
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     ++IHRD+K  N+LL
Sbjct: 124 ALSYCH---SKRVIHRDIKPENLLL 145

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 119
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     ++IHRD+K  N+LL
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLL 141

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 71/136 (52%), Gaps = 4/136 (2%)
Query: 137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVHRNLLRLY 195
           K  +G G FG V++     G  VAVK L E+      + +F  EV I+    H N++   
Sbjct: 42  KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G  T      +V  Y++ GS+  RL  +  +   LD   R  +A   A+G++YLH   +P
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSL-YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NP 158
Query: 256 KIIHRDVKAANILLDE 271
            I+HRD+K+ N+L+D+
Sbjct: 159 PIVHRDLKSPNLLVDK 174

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 82/193 (42%), Gaps = 41/193 (21%)
Query: 112 SELQLGQLKRFSLRELQVATDGFSN------------------KNI-----LGRGGFGKV 148
           SELQ  + K   LR   + TD   N                  KNI     LG G FG+V
Sbjct: 28  SELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEV 87
Query: 149 YKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT 202
           Y+G+++          VAVK L E  +   EL F  E  IIS   H+N++R  G      
Sbjct: 88  YEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147
Query: 203 EKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 256
            + ++   M  G + S LRE      + SSL  LD      +A   A G  YL E+    
Sbjct: 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQYLEEN---H 201
Query: 257 IIHRDVKAANILL 269
            IHRD+ A N LL
Sbjct: 202 FIHRDIAARNCLL 214

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q A + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 1   QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELAN 116
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            LSY H     ++IHRD+K  N+LL
Sbjct: 117 ALSYCH---SKRVIHRDIKPENLLL 138

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 82/193 (42%), Gaps = 41/193 (21%)
Query: 112 SELQLGQLKRFSLRELQVATDGFSN------------------KNI-----LGRGGFGKV 148
           SELQ  + K   LR   + TD   N                  KNI     LG G FG+V
Sbjct: 5   SELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEV 64
Query: 149 YKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT 202
           Y+G+++          VAVK L E  +   EL F  E  IIS   H+N++R  G      
Sbjct: 65  YEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 124
Query: 203 EKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 256
            + ++   M  G + S LRE      + SSL  LD      +A   A G  YL E+    
Sbjct: 125 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQYLEEN---H 178
Query: 257 IIHRDVKAANILL 269
            IHRD+ A N LL
Sbjct: 179 FIHRDIAARNCLL 191

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           +G G FG V+ G   +   VA+K ++E   S  E  F  E +++    H  L++LYG C 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 LV  +M +G ++  LR ++         T   + L    G++YL E C   +IH
Sbjct: 74  EQAPICLVTEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 260 RDVKAANILLDED 272
           RD+ A N L+ E+
Sbjct: 128 RDLAARNCLVGEN 140

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 140 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 247
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 169
Query: 248 YLHEHCDPKIIHRDVKAANILL 269
           YL E+     IHRD+ A N LL
Sbjct: 170 YLEEN---HFIHRDIAARNCLL 188

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 140 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 247
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 248 YLHEHCDPKIIHRDVKAANILL 269
           YL E+     IHRD+ A N LL
Sbjct: 156 YLEEN---HFIHRDIAARNCLL 174

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 140 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 247
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD---LLHVARDIACGCQ 169
Query: 248 YLHEHCDPKIIHRDVKAANILL 269
           YL E+     IHRD+ A N LL
Sbjct: 170 YLEEN---HFIHRDIAARNCLL 188

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 140 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 247
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 169
Query: 248 YLHEHCDPKIIHRDVKAANILL 269
           YL E+     IHRD+ A N LL
Sbjct: 170 YLEEN---HFIHRDIAARNCLL 188

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 140 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 247
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 248 YLHEHCDPKIIHRDVKAANILL 269
           YL E+     IHRD+ A N LL
Sbjct: 156 YLEEN---HFIHRDIAARNCLL 174

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 140 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 247
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD---LLHVARDIACGCQ 154
Query: 248 YLHEHCDPKIIHRDVKAANILL 269
           YL E+     IHRD+ A N LL
Sbjct: 155 YLEEN---HFIHRDIAARNCLL 173

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 140 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 247
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 154
Query: 248 YLHEHCDPKIIHRDVKAANILL 269
           YL E+     IHRD+ A N LL
Sbjct: 155 YLEEN---HFIHRDIAARNCLL 173

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 140 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 247
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 161
Query: 248 YLHEHCDPKIIHRDVKAANILL 269
           YL E+     IHRD+ A N LL
Sbjct: 162 YLEEN---HFIHRDIAARNCLL 180

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 140 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 247
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 171
Query: 248 YLHEHCDPKIIHRDVKAANILL 269
           YL E+     IHRD+ A N LL
Sbjct: 172 YLEEN---HFIHRDIAARNCLL 190

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 140 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 247
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 248 YLHEHCDPKIIHRDVKAANILL 269
           YL E+     IHRD+ A N LL
Sbjct: 156 YLEEN---HFIHRDIAARNCLL 174

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 140 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 247
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 181
Query: 248 YLHEHCDPKIIHRDVKAANILL 269
           YL E+     IHRD+ A N LL
Sbjct: 182 YLEEN---HFIHRDIAARNCLL 200

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 67/142 (47%), Gaps = 18/142 (12%)
Query: 140 LGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
           LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N++R
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRE------RQSSLPPLDWPTRKKIALGSARGLS 247
             G       + ++   M  G + S LRE      + SSL  LD      +A   A G  
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD---LLHVARDIACGCQ 146
Query: 248 YLHEHCDPKIIHRDVKAANILL 269
           YL E+     IHRD+ A N LL
Sbjct: 147 YLEEN---HFIHRDIAARNCLL 165

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/147 (34%), Positives = 69/147 (46%), Gaps = 23/147 (15%)
Query: 139 ILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKI--ISMAVHRNLLRLYG 196
           ++GRG +G VYKG L D + VAVK      +      F  E  I  + +  H N+ R   
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVF----SFANRQNFINEKNIYRVPLMEHDNIARFIV 74
Query: 197 FCTTVT-----EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH- 250
               VT     E LLV  Y  NGS+   L     SL   DW +  ++A    RGL+YLH 
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSSCRLAHSVTRGLAYLHT 129
Query: 251 -----EHCDPKIIHRDVKAANILLDED 272
                +H  P I HRD+ + N+L+  D
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKND 156

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 69/150 (46%), Gaps = 10/150 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q   + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQS 67
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSRFDEQRTATYITELAN 123
Query: 245 GLSYLHEHCDPKIIHRDVKAANILLDEDAD 274
            LSY H     ++IHRD+K  N+LL  + +
Sbjct: 124 ALSYCH---SKRVIHRDIKPENLLLGSNGE 150

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 69/150 (46%), Gaps = 10/150 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           Q   + F     LG+G FG VY  R    K + A+K L   +   +G E Q + EV+I S
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQS 67
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LRLYG+    T   L+  Y   G+V   L++    L   D           A 
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSRFDEQRTATYITELAN 123
Query: 245 GLSYLHEHCDPKIIHRDVKAANILLDEDAD 274
            LSY H     ++IHRD+K  N+LL  + +
Sbjct: 124 ALSYCH---SKRVIHRDIKPENLLLGSNGE 150

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 74/142 (52%), Gaps = 14/142 (9%)
Query: 137 KNILGRGGFGKVYKGRL-ADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
           + ++G G FG+V +GRL A GK    VA+K LK   T     +F +E  I+    H N++
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVAS--RLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
           RL G  T     +++  +M NG++ S  RL + Q ++  L    R     G A G+ YL 
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR-----GIASGMRYLA 135
Query: 251 EHCDPKIIHRDVKAANILLDED 272
           E      +HRD+ A NIL++ +
Sbjct: 136 EM---SYVHRDLAARNILVNSN 154

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 74/142 (52%), Gaps = 14/142 (9%)
Query: 137 KNILGRGGFGKVYKGRL-ADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
           + ++G G FG+V +GRL A GK    VA+K LK   T     +F +E  I+    H N++
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVAS--RLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
           RL G  T     +++  +M NG++ S  RL + Q ++  L    R     G A G+ YL 
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR-----GIASGMRYLA 133
Query: 251 EHCDPKIIHRDVKAANILLDED 272
           E      +HRD+ A NIL++ +
Sbjct: 134 EM---SYVHRDLAARNILVNSN 152

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           +G G FG V+ G   +   VA+K ++E   S  E  F  E +++    H  L++LYG C 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 LV+ +M +G ++  LR ++         T   + L    G++YL E     +IH
Sbjct: 73  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEE---ASVIH 126
Query: 260 RDVKAANILLDED 272
           RD+ A N L+ E+
Sbjct: 127 RDLAARNCLVGEN 139

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 71/136 (52%), Gaps = 4/136 (2%)
Query: 137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVHRNLLRLY 195
           K  +G G FG V++     G  VAVK L E+      + +F  EV I+    H N++   
Sbjct: 42  KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G  T      +V  Y++ GS+  RL  +  +   LD   R  +A   A+G++YLH   +P
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSL-YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NP 158
Query: 256 KIIHRDVKAANILLDE 271
            I+HR++K+ N+L+D+
Sbjct: 159 PIVHRNLKSPNLLVDK 174

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 63/133 (47%), Gaps = 8/133 (6%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG V  G+      VAVK +KE   S  E +F  E + +    H  L++ YG C+
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 +V  Y++NG + + LR     L P       ++      G+++L  H   + IH
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHGKGLEP---SQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 260 RDVKAANILLDED 272
           RD+ A N L+D D
Sbjct: 128 RDLAARNCLVDRD 140

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 74/153 (48%), Gaps = 14/153 (9%)
Query: 117 GQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQF 176
           G L     +E++V       + ++GRG FG V K +    K VA+K+++ E        F
Sbjct: 1   GSLHMIDYKEIEV-------EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKA---F 49
Query: 177 QTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK 236
             E++ +S   H N+++LYG C  +    LV  Y   GS+ + L   +  LP        
Sbjct: 50  IVELRQLSRVNHPNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAM 106
Query: 237 KIALGSARGLSYLHEHCDPKIIHRDVKAANILL 269
              L  ++G++YLH      +IHRD+K  N+LL
Sbjct: 107 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL 139

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 67/140 (47%), Gaps = 10/140 (7%)
Query: 137 KNILGRGGFGKVYKGRLA-DGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
           + ++G G FG+V  G L   GK    VA+K LK   T      F +E  I+    H N++
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
            L G  T  T  +++  +M NGS+ S LR+       +       +  G A G+ YL   
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQ---LVGMLRGIAAGMKYL--- 151
Query: 253 CDPKIIHRDVKAANILLDED 272
            D   +HRD+ A NIL++ +
Sbjct: 152 ADMNYVHRDLAARNILVNSN 171

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FGKVYK +  +  ++A  ++ + ++      +  E+ I++   H N+++L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 ++  +   G+V + + E +    PL     + +   +   L+YLH   D KIIH
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLH---DNKIIH 158
Query: 260 RDVKAANILLDEDAD----------QSSKTILRR 283
           RD+KA NIL   D D          ++++TI RR
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 192

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 134 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 186
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 187 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +       +  G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGM 160
Query: 247 SYLHEHCDPKIIHRDVKAANILLDED 272
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGFVHRDLAARNILINSN 183

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 66/135 (48%), Gaps = 6/135 (4%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FGKVYK +  +  ++A  ++ + ++      +  E+ I++   H N+++L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 ++  +   G+V + + E +    PL     + +   +   L+YLH   D KIIH
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLH---DNKIIH 158
Query: 260 RDVKAANILLDEDAD 274
           RD+KA NIL   D D
Sbjct: 159 RDLKAGNILFTLDGD 173

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 66/135 (48%), Gaps = 6/135 (4%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FGKVYK +  +  ++A  ++ + ++      +  E+ I++   H N+++L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 ++  +   G+V + + E +    PL     + +   +   L+YLH   D KIIH
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLH---DNKIIH 158
Query: 260 RDVKAANILLDEDAD 274
           RD+KA NIL   D D
Sbjct: 159 RDLKAGNILFTLDGD 173

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 76/170 (44%), Gaps = 36/170 (21%)
Query: 134 FSNKNI-----LGRGGFGKVYK-------GRLADGKLVAVKRLKEERTSGGELQFQTEVK 181
           F  KN+     LG G FGKV K       GR A    VAVK LKE  +        +E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGR-AGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 182 IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP------------P 229
           ++    H ++++LYG C+     LL+  Y   GS+   LRE +   P             
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 230 LDWPTRKKIALGS--------ARGLSYLHEHCDPKIIHRDVKAANILLDE 271
           LD P  + + +G         ++G+ YL E    K++HRD+ A NIL+ E
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAE 185

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 76/170 (44%), Gaps = 36/170 (21%)
Query: 134 FSNKNI-----LGRGGFGKVYK-------GRLADGKLVAVKRLKEERTSGGELQFQTEVK 181
           F  KN+     LG G FGKV K       GR A    VAVK LKE  +        +E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGR-AGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 182 IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP------------P 229
           ++    H ++++LYG C+     LL+  Y   GS+   LRE +   P             
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 230 LDWPTRKKIALGS--------ARGLSYLHEHCDPKIIHRDVKAANILLDE 271
           LD P  + + +G         ++G+ YL E    K++HRD+ A NIL+ E
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAE 185

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/134 (35%), Positives = 64/134 (47%), Gaps = 10/134 (7%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 198
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 258
           T    +L +      GS  S      +S    +      IA  +ARG+ YLH      II
Sbjct: 90  TA--PQLAIVTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---II 142
Query: 259 HRDVKAANILLDED 272
           HRD+K+ NI L ED
Sbjct: 143 HRDLKSNNIFLHED 156

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 134 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 186
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 187 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +       +  G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGM 160
Query: 247 SYLHEHCDPKIIHRDVKAANILLDED 272
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSN 183

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 134 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 186
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 187 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +       +  G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGM 160
Query: 247 SYLHEHCDPKIIHRDVKAANILLDED 272
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSN 183

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 72/139 (51%), Gaps = 18/139 (12%)
Query: 139 ILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
           +LG G FG VYKG  + +G+ V    A+K L E       ++F  E  I++   H +L+R
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYLH 250
           L G C + T + LV   M +G +   + E + ++     L+W       +  A+G+ YL 
Sbjct: 82  LLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 134
Query: 251 EHCDPKIIHRDVKAANILL 269
           E    +++HRD+ A N+L+
Sbjct: 135 ER---RLVHRDLAARNVLV 150

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 134 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 186
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 187 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +       +  G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGM 160
Query: 247 SYLHEHCDPKIIHRDVKAANILLDED 272
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSN 183

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 134 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 186
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 187 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +       +  G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGM 160
Query: 247 SYLHEHCDPKIIHRDVKAANILLDED 272
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSN 183

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 134 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 186
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 187 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +       +  G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGM 160
Query: 247 SYLHEHCDPKIIHRDVKAANILLDED 272
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSN 183

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 134 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 186
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 18  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 74
Query: 187 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +      +   G A G+
Sbjct: 75  DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 131
Query: 247 SYLHEHCDPKIIHRDVKAANILLDED 272
            YL    D   +HRD+ A NIL++ +
Sbjct: 132 KYLS---DMGYVHRDLAARNILINSN 154

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 134 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 186
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 35  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 91
Query: 187 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +      +   G A G+
Sbjct: 92  DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 148
Query: 247 SYLHEHCDPKIIHRDVKAANILLDED 272
            YL    D   +HRD+ A NIL++ +
Sbjct: 149 KYLS---DMGYVHRDLAARNILINSN 171

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 134 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 186
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 187 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +       +  G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGM 160
Query: 247 SYLHEHCDPKIIHRDVKAANILLDED 272
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSN 183

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/134 (35%), Positives = 64/134 (47%), Gaps = 10/134 (7%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 198
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 20  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 258
           T    +L +      GS  S      +S    +      IA  +ARG+ YLH      II
Sbjct: 78  TK--PQLAIVTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---II 130
Query: 259 HRDVKAANILLDED 272
           HRD+K+ NI L ED
Sbjct: 131 HRDLKSNNIFLHED 144

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/134 (35%), Positives = 64/134 (47%), Gaps = 10/134 (7%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 198
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 258
           T    +L +      GS  S      +S    +      IA  +ARG+ YLH      II
Sbjct: 90  TK--PQLAIVTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---II 142
Query: 259 HRDVKAANILLDED 272
           HRD+K+ NI L ED
Sbjct: 143 HRDLKSNNIFLHED 156

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 68/146 (46%), Gaps = 16/146 (10%)
Query: 134 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 186
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 45  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 101
Query: 187 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
            H N++RL G  T     ++V  YM NGS+ S LR+  +    +       +  G A G+
Sbjct: 102 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGM 158
Query: 247 SYLHEHCDPKIIHRDVKAANILLDED 272
            YL    D   +HRD+ A NIL++ +
Sbjct: 159 KYL---SDMGYVHRDLAARNILINSN 181

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 72/139 (51%), Gaps = 18/139 (12%)
Query: 139 ILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
           +LG G FG VYKG  + +G+ V    A+K L E       ++F  E  I++   H +L+R
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 104
Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYLH 250
           L G C + T + LV   M +G +   + E + ++     L+W       +  A+G+ YL 
Sbjct: 105 LLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 157
Query: 251 EHCDPKIIHRDVKAANILL 269
           E    +++HRD+ A N+L+
Sbjct: 158 ER---RLVHRDLAARNVLV 173

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 67/133 (50%), Gaps = 7/133 (5%)
Query: 137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 196
           + ++GRG FG V K +    K VA+K+++ E        F  E++ +S   H N+++LYG
Sbjct: 13  EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKA---FIVELRQLSRVNHPNIVKLYG 68
Query: 197 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 256
            C  +    LV  Y   GS+ + L   +  LP           L  ++G++YLH      
Sbjct: 69  AC--LNPVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 257 IIHRDVKAANILL 269
           +IHRD+K  N+LL
Sbjct: 126 LIHRDLKPPNLLL 138

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 68/149 (45%), Gaps = 21/149 (14%)
Query: 140 LGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
           LG G FGKV+           D  LVAVK LKE   S  +  FQ E ++++M  H++++R
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ-DFQREAELLTMLQHQHIVR 84
Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRER----------QSSLP-PLDWPTRKKIALGS 242
            +G CT     L+V+ YM +G +   LR            +   P PL       +A   
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDE 271
           A G+ YL        +HRD+   N L+ +
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQ 170

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 68/149 (45%), Gaps = 21/149 (14%)
Query: 140 LGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
           LG G FGKV+           D  LVAVK LKE   S  +  FQ E ++++M  H++++R
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ-DFQREAELLTMLQHQHIVR 78
Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRER----------QSSLP-PLDWPTRKKIALGS 242
            +G CT     L+V+ YM +G +   LR            +   P PL       +A   
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDE 271
           A G+ YL        +HRD+   N L+ +
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQ 164

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 68/149 (45%), Gaps = 21/149 (14%)
Query: 140 LGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
           LG G FGKV+           D  LVAVK LKE   S  +  FQ E ++++M  H++++R
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ-DFQREAELLTMLQHQHIVR 107
Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRER----------QSSLP-PLDWPTRKKIALGS 242
            +G CT     L+V+ YM +G +   LR            +   P PL       +A   
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDE 271
           A G+ YL        +HRD+   N L+ +
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQ 193

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 14/155 (9%)
Query: 122 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEV 180
            SL + ++     + K+ LG G FG+VY+G      L VAVK LKE+     E  F  E 
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEA 58
Query: 181 KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKI 238
            ++    H NL++L G CT      ++  +MT G++   LRE  RQ             +
Sbjct: 59  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VSAVV 110
Query: 239 ALGSARGLSYLHEHCDPK-IIHRDVKAANILLDED 272
            L  A  +S   E+ + K  IHRD+ A N L+ E+
Sbjct: 111 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN 145

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 67/142 (47%), Gaps = 9/142 (6%)
Query: 134 FSNKNILGRGGFGKVYKGRLADGK-LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
           F+  + +G+G FG+VYKG     K +VA+K +  E         Q E+ ++S      + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
           R +G     T+  ++  Y+  GS    L+       PL+      I     +GL YLH  
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPG-----PLEETYIATILREILKGLDYLHSE 135
Query: 253 CDPKIIHRDVKAANILLDEDAD 274
              + IHRD+KAAN+LL E  D
Sbjct: 136 ---RKIHRDIKAANVLLSEQGD 154

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 71/156 (45%), Gaps = 12/156 (7%)
Query: 123 SLRELQVATDGFSNK--NILGRGGFGKVYKGRL-ADGK---LVAVKRLKEERTSGGELQF 176
           ++RE     D    K   ++G G FG+V  GRL   GK    VA+K LK   T      F
Sbjct: 18  AVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDF 77
Query: 177 QTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK 236
            +E  I+    H N++ L G  T     +++  YM NGS+ + LR+       +      
Sbjct: 78  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGML 137
Query: 237 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           +   G   G+ YL    D   +HRD+ A NIL++ +
Sbjct: 138 R---GIGSGMKYLS---DMSAVHRDLAARNILVNSN 167

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 71/156 (45%), Gaps = 12/156 (7%)
Query: 123 SLRELQVATDGFSNK--NILGRGGFGKVYKGRL-ADGK---LVAVKRLKEERTSGGELQF 176
           ++RE     D    K   ++G G FG+V  GRL   GK    VA+K LK   T      F
Sbjct: 3   AVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDF 62
Query: 177 QTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK 236
            +E  I+    H N++ L G  T     +++  YM NGS+ + LR+       +      
Sbjct: 63  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGML 122
Query: 237 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           +   G   G+ YL    D   +HRD+ A NIL++ +
Sbjct: 123 R---GIGSGMKYLS---DMSYVHRDLAARNILVNSN 152

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 75/170 (44%), Gaps = 36/170 (21%)
Query: 134 FSNKNI-----LGRGGFGKVYK-------GRLADGKLVAVKRLKEERTSGGELQFQTEVK 181
           F  KN+     LG G FGKV K       GR A    VAVK LKE  +        +E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGR-AGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 182 IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP------------P 229
           ++    H ++++LYG C+     LL+  Y   GS+   LRE +   P             
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 230 LDWPTRKKIALGS--------ARGLSYLHEHCDPKIIHRDVKAANILLDE 271
           LD P  + + +G         ++G+ YL E     ++HRD+ A NIL+ E
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAE 185

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 80/160 (50%), Gaps = 17/160 (10%)
Query: 126 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 178
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 179 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 235
           E  ++      +++RL G  +     L++   MT G + S LR  + ++   P L  P+ 
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 236 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 138 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 74/148 (50%), Gaps = 19/148 (12%)
Query: 140 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 192
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 193 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL-----DWPTRKKIALGS---A 243
            L G CT     L+V   +   G++++ LR +++   P      D+ T + +   S   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 244 RGLSYLHEHCDPKIIHRDVKAANILLDE 271
           +G+ +L      K IHRD+ A NILL E
Sbjct: 155 KGMEFLASR---KXIHRDLAARNILLSE 179

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 80/160 (50%), Gaps = 17/160 (10%)
Query: 126 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 178
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 9   EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 67
Query: 179 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 235
           E  ++      +++RL G  +     L++   MT G + S LR  + ++   P L  P+ 
Sbjct: 68  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 127
Query: 236 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 128 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 164

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 66/140 (47%), Gaps = 10/140 (7%)
Query: 137 KNILGRGGFGKVYKGRL-ADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
           + ++G G FG+V  GRL   GK    VA+K LK   T      F +E  I+    H N++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
            L G  T     +++  YM NGS+ + LR+       +      +   G   G+ YL   
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR---GIGSGMKYLS-- 127
Query: 253 CDPKIIHRDVKAANILLDED 272
            D   +HRD+ A NIL++ +
Sbjct: 128 -DMSYVHRDLAARNILVNSN 146

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 123 SLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVK 181
           SL + ++     + K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 59
Query: 182 IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIA 239
           ++    H NL++L G CT      ++  +MT G++   LRE  RQ             + 
Sbjct: 60  VMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE--------VSAVVL 111
Query: 240 LGSARGLSYLHEHCDPK-IIHRDVKAANILLDED 272
           L  A  +S   E+ + K  IHRD+ A N L+ E+
Sbjct: 112 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN 145

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 76/160 (47%), Gaps = 17/160 (10%)
Query: 126 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 178
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 62
Query: 179 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDW 232
           E  ++      +++RL G  +     L++   MT G + S LR      E    L P   
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 122
Query: 233 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
               ++A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 123 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 159

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 76/160 (47%), Gaps = 17/160 (10%)
Query: 126 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 178
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 71
Query: 179 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDW 232
           E  ++      +++RL G  +     L++   MT G + S LR      E    L P   
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 233 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
               ++A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 132 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 168

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 126 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 178
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 179 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWPTR 235
           E  ++      +++RL G  +     L++   MT G + S LR  +  +   P L  P+ 
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 137
Query: 236 KK---IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
            K   +A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 138 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 17/164 (10%)
Query: 122 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGEL 174
           F   E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    +
Sbjct: 6   FVPDEWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERI 64
Query: 175 QFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLP 228
           +F  E  ++      +++RL G  +     L++   MT G + S LR      E    L 
Sbjct: 65  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 124
Query: 229 PLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           P       ++A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 125 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 165

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 66/140 (47%), Gaps = 10/140 (7%)
Query: 137 KNILGRGGFGKVYKGRLA-DGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
           + ++G G FG+V  G L   GK    VA+K LK   T      F +E  I+    H N++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
            L G  T  T  +++  +M NGS+ S LR+       +      +   G A G+ YL   
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYL--- 125
Query: 253 CDPKIIHRDVKAANILLDED 272
            D   +HR + A NIL++ +
Sbjct: 126 ADMNYVHRALAARNILVNSN 145

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 74/148 (50%), Gaps = 19/148 (12%)
Query: 140 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 192
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 193 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL-----DWPTRKKIALGS---A 243
            L G CT     L+V   +   G++++ LR +++   P      D+ T + +   S   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 244 RGLSYLHEHCDPKIIHRDVKAANILLDE 271
           +G+ +L      K IHRD+ A NILL E
Sbjct: 155 KGMEFLASR---KXIHRDLAARNILLSE 179

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 76/160 (47%), Gaps = 17/160 (10%)
Query: 126 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 178
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 179 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDW 232
           E  ++      +++RL G  +     L++   MT G + S LR      E    L P   
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 233 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
               ++A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 125 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 161

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 76/160 (47%), Gaps = 17/160 (10%)
Query: 126 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 178
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 179 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDW 232
           E  ++      +++RL G  +     L++   MT G + S LR      E    L P   
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 233 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
               ++A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 131 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 167

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 133 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 190
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 74
Query: 191 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 242
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 131
Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPD 158

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 14/155 (9%)
Query: 122 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEV 180
            SL + ++     + K+ LG G +G+VY+G      L VAVK LKE+     E  F  E 
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEA 58
Query: 181 KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKI 238
            ++    H NL++L G CT      ++  +MT G++   LRE  RQ             +
Sbjct: 59  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VSAVV 110
Query: 239 ALGSARGLSYLHEHCDPK-IIHRDVKAANILLDED 272
            L  A  +S   E+ + K  IHRD+ A N L+ E+
Sbjct: 111 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN 145

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 73/151 (48%), Gaps = 22/151 (14%)
Query: 133 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 190
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 74
Query: 191 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 242
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 131
Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDEDA 273
            R L+Y+H      I HRD+K  N+LLD D 
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDT 159

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 22/151 (14%)
Query: 140 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 192
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 193 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL--------DWPTRKKIALGS- 242
            L G CT     L+V   +   G++++ LR +++   P         D+ T + +   S 
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 243 --ARGLSYLHEHCDPKIIHRDVKAANILLDE 271
             A+G+ +L      K IHRD+ A NILL E
Sbjct: 156 QVAKGMEFLASR---KCIHRDLAARNILLSE 183

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 87/175 (49%), Gaps = 20/175 (11%)
Query: 104 FDVPAEDDSELQ-LGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKG-RLADGKLV-- 159
           +D+P  ++   Q  G+    +L  +   T+ F    +LG G FG VYKG  + +G+ V  
Sbjct: 12  YDIPTTENLYFQGSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKI 70
Query: 160 --AVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVA 217
             A+K L+E  +     +   E  +++   + ++ RL G C T T +L+    M  G + 
Sbjct: 71  PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQ-LMPFGCLL 129
Query: 218 SRLRERQSSLPP---LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 269
             +RE + ++     L+W       +  A+G++YL    D +++HRD+ A N+L+
Sbjct: 130 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLV 175

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 76/160 (47%), Gaps = 17/160 (10%)
Query: 126 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 178
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 41  EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 99
Query: 179 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDW 232
           E  ++      +++RL G  +     L++   MT G + S LR      E    L P   
Sbjct: 100 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 159
Query: 233 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
               ++A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 160 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 196

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 76/160 (47%), Gaps = 17/160 (10%)
Query: 126 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 178
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 71
Query: 179 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDW 232
           E  ++      +++RL G  +     L++   MT G + S LR      E    L P   
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 233 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
               ++A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 132 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 168

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 133 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 190
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 74
Query: 191 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 242
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 131
Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPD 158

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 133 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 190
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 74
Query: 191 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 242
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 75  IVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 131
Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPD 158

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 133 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 190
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 87
Query: 191 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 242
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 88  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 144
Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 145 FRSLAYIHSF---GICHRDIKPQNLLLDPD 171

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 66/134 (49%), Gaps = 10/134 (7%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 198
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 72
Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 258
           +T  +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 73  STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAK---SII 126
Query: 259 HRDVKAANILLDED 272
           HRD+K+ NI L ED
Sbjct: 127 HRDLKSNNIFLHED 140

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 76/160 (47%), Gaps = 17/160 (10%)
Query: 126 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 178
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 179 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDW 232
           E  ++      +++RL G  +     L++   MT G + S LR      E    L P   
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 233 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
               ++A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 131 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 167

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 133 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 190
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 93
Query: 191 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 242
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 94  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 150
Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 151 FRSLAYIHSF---GICHRDIKPQNLLLDPD 177

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 133 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 190
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 86
Query: 191 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 242
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 143
Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 144 FRSLAYIHSF---GICHRDIKPQNLLLDPD 170

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 133 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 190
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 75
Query: 191 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 242
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 76  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 132
Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 133 FRSLAYIHSF---GICHRDIKPQNLLLDPD 159

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 133 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 190
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 82
Query: 191 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 242
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 83  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 139
Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 140 FRSLAYIHSF---GICHRDIKPQNLLLDPD 166

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 133 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 190
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 78
Query: 191 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 242
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 79  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 135
Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 136 FRSLAYIHSF---GICHRDIKPQNLLLDPD 162

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 133 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 190
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 79
Query: 191 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 242
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 80  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 136
Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 137 FRSLAYIHSF---GICHRDIKPQNLLLDPD 163

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 66/144 (45%), Gaps = 13/144 (9%)
Query: 134 FSNKNILGRGGFGKVYKGRLADG---KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
           F+    +G+G FG+V+KG   D    K+VA+K +  E         Q E+ ++S      
Sbjct: 29  FTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 86
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
           + + YG     T+  ++  Y+  GS    L        PLD      I     +GL YLH
Sbjct: 87  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLH 141
Query: 251 EHCDPKIIHRDVKAANILLDEDAD 274
                K IHRD+KAAN+LL E  +
Sbjct: 142 SE---KKIHRDIKAANVLLSEHGE 162

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 133 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 190
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 102
Query: 191 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 242
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 103 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 159
Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 160 FRSLAYIHSF---GICHRDIKPQNLLLDPD 186

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 133 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 190
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 108
Query: 191 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 242
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 165
Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 166 FRSLAYIHSF---GICHRDIKPQNLLLDPD 192

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 133 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 190
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 108
Query: 191 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 242
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 165
Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 166 FRSLAYIHSF---GICHRDIKPQNLLLDPD 192

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 133 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRN 190
            +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCN 86
Query: 191 LLRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 242
           ++RL  F  +  EK        +L Y   T   VA      + +LP +     K      
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQL 143
Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
            R L+Y+H      I HRD+K  N+LLD D
Sbjct: 144 FRSLAYIHSF---GICHRDIKPQNLLLDPD 170

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 188
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 245
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 81  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 133
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           ++YL    D +++HRD+ A N+L+
Sbjct: 134 MNYLE---DRRLVHRDLAARNVLV 154

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 73/149 (48%), Gaps = 22/149 (14%)
Query: 134 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNL 191
           +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N+
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNI 111
Query: 192 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 243
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQLF 168
Query: 244 RGLSYLHEHCDPKIIHRDVKAANILLDED 272
           R L+Y+H      I HRD+K  N+LLD D
Sbjct: 169 RSLAYIHSF---GICHRDIKPQNLLLDPD 194

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 66/144 (45%), Gaps = 13/144 (9%)
Query: 134 FSNKNILGRGGFGKVYKGRLADG---KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
           F+    +G+G FG+V+KG   D    K+VA+K +  E         Q E+ ++S      
Sbjct: 24  FTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
           + + YG     T+  ++  Y+  GS    L        PLD      I     +GL YLH
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLH 136
Query: 251 EHCDPKIIHRDVKAANILLDEDAD 274
                K IHRD+KAAN+LL E  +
Sbjct: 137 SE---KKIHRDIKAANVLLSEHGE 157

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 140 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 192
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 193 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 242
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 243 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 271
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSE 183

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 188
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 245
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 78  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 130
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           ++YL    D +++HRD+ A N+L+
Sbjct: 131 MNYLE---DRRLVHRDLAARNVLV 151

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 140 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 192
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 193 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 242
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 243 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 271
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSE 183

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 140 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 192
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 193 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 242
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 243 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 271
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSE 183

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 140 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 192
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 193 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 242
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 243 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 271
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 157 FQVAKGMEFLASR---KCIHRDLAARNILLSE 185

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 74/150 (49%), Gaps = 21/150 (14%)
Query: 140 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 192
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 193 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL-------DWPTRKKIALGS-- 242
            L G CT     L+V   +   G++++ LR +++   P        D+ T + +   S  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 243 -ARGLSYLHEHCDPKIIHRDVKAANILLDE 271
            A+G+ +L      K IHRD+ A NILL E
Sbjct: 157 VAKGMEFLASR---KXIHRDLAARNILLSE 183

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 188
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 245
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           ++YL    D +++HRD+ A N+L+
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLV 152

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 188
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 245
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           ++YL    D +++HRD+ A N+L+
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLV 150

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 140 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 192
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 193 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 242
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 243 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 271
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSE 174

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 137 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 80
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 81  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 132
Query: 254 DPK-IIHRDVKAANILLDED 272
           + K  IHRD+ A N L+ E+
Sbjct: 133 EKKNFIHRDLAARNCLVGEN 152

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 73/149 (48%), Gaps = 22/149 (14%)
Query: 134 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNL 191
           +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N+
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNI 154
Query: 192 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 243
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQLF 211
Query: 244 RGLSYLHEHCDPKIIHRDVKAANILLDED 272
           R L+Y+H      I HRD+K  N+LLD D
Sbjct: 212 RSLAYIHSF---GICHRDIKPQNLLLDPD 237

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 140 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 192
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 193 RLYGFCTTVTEKLLVYP-YMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 242
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 243 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 271
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSE 174

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 67/146 (45%), Gaps = 16/146 (10%)
Query: 134 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 186
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 187 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
            H N++RL G  T     ++V   M NGS+ S LR+  +    +       +  G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGM 160
Query: 247 SYLHEHCDPKIIHRDVKAANILLDED 272
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGAVHRDLAARNILINSN 183

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 73/149 (48%), Gaps = 22/149 (14%)
Query: 134 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNL 191
           +++  ++G G FG VY+ +L D G+LVA+K+ L+++R    ELQ   ++       H N+
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD------HCNI 113
Query: 192 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 243
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQLF 170
Query: 244 RGLSYLHEHCDPKIIHRDVKAANILLDED 272
           R L+Y+H      I HRD+K  N+LLD D
Sbjct: 171 RSLAYIHSF---GICHRDIKPQNLLLDPD 196

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 140 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 192
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 193 RLYGFCTTVTEKLLVYP-YMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 242
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 243 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 271
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSE 174

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 188
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 245
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           ++YL    D +++HRD+ A N+L+
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLV 152

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 66/144 (45%), Gaps = 13/144 (9%)
Query: 134 FSNKNILGRGGFGKVYKGRLADG---KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
           F+    +G+G FG+V+KG   D    K+VA+K +  E         Q E+ ++S      
Sbjct: 9   FTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
           + + YG     T+  ++  Y+  GS    L        PLD      I     +GL YLH
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLH 121
Query: 251 EHCDPKIIHRDVKAANILLDEDAD 274
                K IHRD+KAAN+LL E  +
Sbjct: 122 SE---KKIHRDIKAANVLLSEHGE 142

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 67/146 (45%), Gaps = 16/146 (10%)
Query: 134 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 186
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 47  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 187 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
            H N++RL G  T     ++V   M NGS+ S LR+  +    +       +  G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ---LVGMLRGIASGM 160
Query: 247 SYLHEHCDPKIIHRDVKAANILLDED 272
            YL    D   +HRD+ A NIL++ +
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSN 183

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 188
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 245
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 80  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           ++YL    D +++HRD+ A N+L+
Sbjct: 133 MNYLE---DRRLVHRDLAARNVLV 153

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 134 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 188
           F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++   +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 245
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 81  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 133
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           ++YL    D +++HRD+ A N+L+
Sbjct: 134 MNYLE---DRRLVHRDLAARNVLV 154

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 188
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 245
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           ++YL    D +++HRD+ A N+L+
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLV 152

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 75/162 (46%), Gaps = 15/162 (9%)
Query: 117 GQLKRFSLRELQVATDG---FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGG 172
           G LK   + EL    D    FS+   +G G FG VY  R + + ++VA+K++        
Sbjct: 36  GSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN 95
Query: 173 ELQFQ---TEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP 229
           E ++Q    EV+ +    H N ++  G         LV  Y   GS +  L   +    P
Sbjct: 96  E-KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK---P 150
Query: 230 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 271
           L       +  G+ +GL+YLH H    +IHRDVKA NILL E
Sbjct: 151 LQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSE 189

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 69/139 (49%), Gaps = 18/139 (12%)
Query: 139 ILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
           +LG G FG VYKG  + DG+     VA+K L+E  +     +   E  +++      + R
Sbjct: 24  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSR 83
Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRE---RQSSLPPLDWPTRKKIALGSARGLSYLH 250
           L G C T T + LV   M  G +   +RE   R  S   L+W       +  A+G+SYL 
Sbjct: 84  LLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNW------CMQIAKGMSYLE 136
Query: 251 EHCDPKIIHRDVKAANILL 269
              D +++HRD+ A N+L+
Sbjct: 137 ---DVRLVHRDLAARNVLV 152

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 66/144 (45%), Gaps = 13/144 (9%)
Query: 134 FSNKNILGRGGFGKVYKGRLADG---KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
           F+    +G+G FG+V+KG   D    K+VA+K +  E         Q E+ ++S      
Sbjct: 9   FTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
           + + YG     T+  ++  Y+  GS    L        PLD      I     +GL YLH
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLH 121
Query: 251 EHCDPKIIHRDVKAANILLDEDAD 274
                K IHRD+KAAN+LL E  +
Sbjct: 122 SE---KKIHRDIKAANVLLSEHGE 142

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 67/146 (45%), Gaps = 16/146 (10%)
Query: 134 FSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQTEVKIISMA 186
            S   ++G G FG+V  GRL   KL       VA+K LK   T      F  E  I+   
Sbjct: 18  ISIDKVVGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 74
Query: 187 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
            H N++RL G  T     ++V   M NGS+ S LR+  +    +      +   G A G+
Sbjct: 75  DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 131
Query: 247 SYLHEHCDPKIIHRDVKAANILLDED 272
            YL    D   +HRD+ A NIL++ +
Sbjct: 132 KYLS---DMGYVHRDLAARNILINSN 154

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 140 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 192
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 193 RLYGFCTTVTEKLLVYP-YMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 242
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 243 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 271
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSE 174

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 140 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 192
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 193 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL---------DWPTRKKIALGS 242
            L G CT     L+V   +   G++++ LR +++   P          D+ T + +   S
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 243 ---ARGLSYLHEHCDPKIIHRDVKAANILLDE 271
              A+G+ +L      K IHRD+ A NILL E
Sbjct: 192 FQVAKGMEFLASR---KCIHRDLAARNILLSE 220

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 18/144 (12%)
Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 188
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 245
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 78  PHVCRLLGICLTSTVQLIMQ-LMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKG 130
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           ++YL    D +++HRD+ A N+L+
Sbjct: 131 MNYLE---DRRLVHRDLAARNVLV 151

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 137 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 80
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 132
Query: 254 DPK-IIHRDVKAANILLDED 272
           + K  IHRD+ A N L+ E+
Sbjct: 133 EKKNFIHRDLAARNCLVGEN 152

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 137 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 19  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 76
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 77  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 128
Query: 254 DPK-IIHRDVKAANILLDED 272
           + K  IHRD+ A N L+ E+
Sbjct: 129 EKKNFIHRDLAARNCLVGEN 148

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 137 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 80
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 132
Query: 254 DPK-IIHRDVKAANILLDED 272
           + K  IHRD+ A N L+ E+
Sbjct: 133 EKKNFIHRDLAARNCLVGEN 152

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 188
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 245
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 87  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 139
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           ++YL    D +++HRD+ A N+L+
Sbjct: 140 MNYLE---DRRLVHRDLAARNVLV 160

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 188
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 245
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           ++YL    D +++HRD+ A N+L+
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLV 152

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 137 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 19  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 76
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 77  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 128
Query: 254 DPK-IIHRDVKAANILLDED 272
           + K  IHRD+ A N L+ E+
Sbjct: 129 EKKNFIHRDLAARNCLVGEN 148

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 198
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 18  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 258
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 76  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHA---KSII 128
Query: 259 HRDVKAANILLDED 272
           HRD+K+ NI L ED
Sbjct: 129 HRDLKSNNIFLHED 142

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 70/136 (51%), Gaps = 12/136 (8%)
Query: 140 LGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 197
           LG G +G VYK    + G++VA+K++  E     +LQ    E+ I+      ++++ YG 
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 198 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
               T+  +V  Y   GSV+  +R R  +L   +  T   I   + +GL YLH     + 
Sbjct: 93  YFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT---ILQSTLKGLEYLHFM---RK 146
Query: 258 IHRDVKAANILLDEDA 273
           IHRD+KA NILL+ + 
Sbjct: 147 IHRDIKAGNILLNTEG 162

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 137 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 79
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 80  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 131
Query: 254 DPK-IIHRDVKAANILLDED 272
           + K  IHRD+ A N L+ E+
Sbjct: 132 EKKNFIHRDLAARNCLVGEN 151

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 198
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 258
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 74  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAKS---II 126
Query: 259 HRDVKAANILLDED 272
           HRD+K+ NI L ED
Sbjct: 127 HRDLKSNNIFLHED 140

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 198
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 258
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 79  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAKS---II 131
Query: 259 HRDVKAANILLDED 272
           HRD+K+ NI L ED
Sbjct: 132 HRDLKSNNIFLHED 145

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 64/134 (47%), Gaps = 12/134 (8%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--ARGLSYLHEHCDPKI 257
                 ++  YM NG + + LRE +         T++ + +       + YL      + 
Sbjct: 70  KQRPIFIITEYMANGCLLNYLREMRHRF-----QTQQLLEMCKDVCEAMEYLE---SKQF 121
Query: 258 IHRDVKAANILLDE 271
           +HRD+ A N L+++
Sbjct: 122 LHRDLAARNCLVND 135

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 198
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 258
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 79  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHA---KSII 131
Query: 259 HRDVKAANILLDED 272
           HRD+K+ NI L ED
Sbjct: 132 HRDLKSNNIFLHED 145

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 137 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 80
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 132
Query: 254 DPK-IIHRDVKAANILLDED 272
           + K  IHRD+ A N L+ E+
Sbjct: 133 EKKNFIHRDLAARNCLVGEN 152

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 188
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 245
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           ++YL    D +++HRD+ A N+L+
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLV 150

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 137 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 75
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 127
Query: 254 DPK-IIHRDVKAANILLDED 272
           + K  IHRD+ A N L+ E+
Sbjct: 128 EKKNFIHRDLAARNCLVGEN 147

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 137 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 77
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 129
Query: 254 DPK-IIHRDVKAANILLDED 272
           + K  IHRD+ A N L+ E+
Sbjct: 130 EKKNFIHRDLAARNCLVGEN 149

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 188
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 245
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           ++YL    D +++HRD+ A N+L+
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLV 150

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 198
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 258
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 74  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAK---SII 126
Query: 259 HRDVKAANILLDED 272
           HRD+K+ NI L ED
Sbjct: 127 HRDLKSNNIFLHED 140

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 137 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 75
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYL 127
Query: 254 DPK-IIHRDVKAANILLDED 272
           + K  IHRD+ A N L+ E+
Sbjct: 128 EKKNFIHRDLAARNCLVGEN 147

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 137 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 75
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 127
Query: 254 DPK-IIHRDVKAANILLDED 272
           + K  IHRD+ A N L+ E+
Sbjct: 128 EKKNFIHRDLAARNCLVGEN 147

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 137 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 31  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 88
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 89  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 140
Query: 254 DPK-IIHRDVKAANILLDED 272
           + K  IHRD+ A N L+ E+
Sbjct: 141 EKKNFIHRDLAARNCLVGEN 160

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 188
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 245
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 83  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 135
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           ++YL    D +++HRD+ A N+L+
Sbjct: 136 MNYLE---DRRLVHRDLAARNVLV 156

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 64/134 (47%), Gaps = 12/134 (8%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--ARGLSYLHEHCDPKI 257
                 ++  YM NG + + LRE +         T++ + +       + YL      + 
Sbjct: 74  KQRPIFIITEYMANGCLLNYLREMRHRF-----QTQQLLEMCKDVCEAMEYLE---SKQF 125
Query: 258 IHRDVKAANILLDE 271
           +HRD+ A N L+++
Sbjct: 126 LHRDLAARNCLVND 139

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 198
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 43  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 258
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 101 TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 153
Query: 259 HRDVKAANILLDED 272
           HRD+K+ NI L ED
Sbjct: 154 HRDLKSNNIFLHED 167

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 188
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 245
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 80  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           ++YL    D +++HRD+ A N+L+
Sbjct: 133 MNYLE---DRRLVHRDLAARNVLV 153

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 64/134 (47%), Gaps = 12/134 (8%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--ARGLSYLHEHCDPKI 257
                 ++  YM NG + + LRE +         T++ + +       + YL      + 
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRF-----QTQQLLEMCKDVCEAMEYLE---SKQF 126
Query: 258 IHRDVKAANILLDE 271
           +HRD+ A N L+++
Sbjct: 127 LHRDLAARNCLVND 140

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 188
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 245
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 71  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 123
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           ++YL    D +++HRD+ A N+L+
Sbjct: 124 MNYLE---DRRLVHRDLAARNVLV 144

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 188
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 245
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 80  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           ++YL    D +++HRD+ A N+L+
Sbjct: 133 MNYLE---DRRLVHRDLAARNVLV 153

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 188
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 245
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 79  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           ++YL    D +++HRD+ A N+L+
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLV 152

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 188
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 245
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 80  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           ++YL    D +++HRD+ A N+L+
Sbjct: 133 MNYLE---DRRLVHRDLAARNVLV 153

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 64/134 (47%), Gaps = 12/134 (8%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--ARGLSYLHEHCDPKI 257
                 ++  YM NG + + LRE +         T++ + +       + YL      + 
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRF-----QTQQLLEMCKDVCEAMEYLE---SKQF 126
Query: 258 IHRDVKAANILLDE 271
           +HRD+ A N L+++
Sbjct: 127 LHRDLAARNCLVND 140

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 198
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 36  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 258
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 94  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 146
Query: 259 HRDVKAANILLDED 272
           HRD+K+ NI L ED
Sbjct: 147 HRDLKSNNIFLHED 160

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 188
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 245
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 84  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           ++YL    D +++HRD+ A N+L+
Sbjct: 137 MNYLE---DRRLVHRDLAARNVLV 157

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 137 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 75
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYL 127
Query: 254 DPK-IIHRDVKAANILLDED 272
           + K  IHRD+ A N L+ E+
Sbjct: 128 EKKNFIHRDLAARNCLVGEN 147

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 137 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 77
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 129
Query: 254 DPK-IIHRDVKAANILLDED 272
           + K  IHRD+ A N L+ E+
Sbjct: 130 EKKNFIHRDLAARNCLVGEN 149

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 64/133 (48%), Gaps = 10/133 (7%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK-II 258
                 ++  YM NG + + LRE +          + +  L   + +    E+ + K  +
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRF-------QTQQLLEMCKDVCEAMEYLESKQFL 142
Query: 259 HRDVKAANILLDE 271
           HRD+ A N L+++
Sbjct: 143 HRDLAARNCLVND 155

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 137 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 77
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 129
Query: 254 DPK-IIHRDVKAANILLDED 272
           + K  IHRD+ A N L+ E+
Sbjct: 130 EKKNFIHRDLAARNCLVGEN 149

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 68/142 (47%), Gaps = 12/142 (8%)
Query: 134 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQ---TEVKIISMAVHR 189
           FS+   +G G FG VY  R + + ++VA+K++        E ++Q    EV+ +    H 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQKLRHP 75
Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           N ++  G         LV  Y   GS +  L   +    PL       +  G+ +GL+YL
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYL 131
Query: 250 HEHCDPKIIHRDVKAANILLDE 271
           H H    +IHRDVKA NILL E
Sbjct: 132 HSH---NMIHRDVKAGNILLSE 150

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 64/133 (48%), Gaps = 10/133 (7%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK-II 258
                 ++  YM NG + + LRE +          + +  L   + +    E+ + K  +
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRF-------QTQQLLEMCKDVCEAMEYLESKQFL 142
Query: 259 HRDVKAANILLDE 271
           HRD+ A N L+++
Sbjct: 143 HRDLAARNCLVND 155

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 188
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 245
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           ++YL    D +++HRD+ A N+L+
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLV 150

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 198
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 258
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 102 TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 154
Query: 259 HRDVKAANILLDED 272
           HRD+K+ NI L ED
Sbjct: 155 HRDLKSNNIFLHED 168

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 188
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 245
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 84  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           ++YL    D +++HRD+ A N+L+
Sbjct: 137 MNYLE---DRRLVHRDLAARNVLV 157

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 188
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 245
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLITQ-LMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           ++YL    D +++HRD+ A N+L+
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLV 150

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 67/148 (45%), Gaps = 12/148 (8%)
Query: 132 DGFSNKNILGRGGFGKVYKGRLADGK-LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
           D +  + ++G G    V     A  K  VA+KR+  E+      +   E++ +S   H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWPTRKKIALGSAR 244
           ++  Y       E  LV   ++ GSV   ++      E +S +  LD  T   I      
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV--LDESTIATILREVLE 132
Query: 245 GLSYLHEHCDPKIIHRDVKAANILLDED 272
           GL YLH++     IHRDVKA NILL ED
Sbjct: 133 GLEYLHKNGQ---IHRDVKAGNILLGED 157

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 137 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 80
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYL 132
Query: 254 DPK-IIHRDVKAANILLDED 272
           + K  IHRD+ A N L+ E+
Sbjct: 133 EKKNFIHRDLAARNCLVGEN 152

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 198
           +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 258
           T   +  +V  +    S+   L   ++    +       IA  +A+G+ YLH      II
Sbjct: 102 TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS---II 154
Query: 259 HRDVKAANILLDED 272
           HRD+K+ NI L ED
Sbjct: 155 HRDLKSNNIFLHED 168

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 64/134 (47%), Gaps = 12/134 (8%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG CT
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS--ARGLSYLHEHCDPKI 257
                 ++  YM NG + + LRE +         T++ + +       + YL      + 
Sbjct: 81  KQRPIFIITEYMANGCLLNYLREMRHRF-----QTQQLLEMCKDVCEAMEYLE---SKQF 132
Query: 258 IHRDVKAANILLDE 271
           +HRD+ A N L+++
Sbjct: 133 LHRDLAARNCLVND 146

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 17/160 (10%)
Query: 126 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-------VAVKRLKEERTSGGELQFQT 178
           E +VA +  +    LG+G FG VY+G +A G +       VA+K + E  +    ++F  
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 179 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDW 232
           E  ++      +++RL G  +     L++   MT G + S LR      E    L P   
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 233 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
               ++A   A G++YL+ +   K +HRD+ A N  + ED
Sbjct: 125 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAED 161

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 137 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 75
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYL 127
Query: 254 DPK-IIHRDVKAANILLDED 272
           + K  IHRD+ A N L+ E+
Sbjct: 128 EKKNFIHRDLAARNCLVGEN 147

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 67/148 (45%), Gaps = 12/148 (8%)
Query: 132 DGFSNKNILGRGGFGKVYKGRLADGK-LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
           D +  + ++G G    V     A  K  VA+KR+  E+      +   E++ +S   H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWPTRKKIALGSAR 244
           ++  Y       E  LV   ++ GSV   ++      E +S +  LD  T   I      
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV--LDESTIATILREVLE 127
Query: 245 GLSYLHEHCDPKIIHRDVKAANILLDED 272
           GL YLH++     IHRDVKA NILL ED
Sbjct: 128 GLEYLHKNGQ---IHRDVKAGNILLGED 152

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 137 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 75
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYL 127
Query: 254 DPK-IIHRDVKAANILLDED 272
           + K  IHRD+ A N L+ E+
Sbjct: 128 EKKNFIHRDLAARNCLVGEN 147

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 68/138 (49%), Gaps = 11/138 (7%)
Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 197
           +G+G F KV   R +  GK VAVK + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 198 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 256
             T     LV  Y + G V   L           W  ++K A    R +    ++C  K 
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAH-------GW-MKEKEARAKFRQIVSAVQYCHQKF 126
Query: 257 IIHRDVKAANILLDEDAD 274
           I+HRD+KA N+LLD D +
Sbjct: 127 IVHRDLKAENLLLDADMN 144

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 72/149 (48%), Gaps = 20/149 (13%)
Query: 133 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 191
            +++  ++G G FG VY+ +L D G+LVA+K++ +     G+     E++I+    H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----GKAFKNRELQIMRKLDHCNI 75
Query: 192 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 243
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVI---YVKLYMYQLF 132
Query: 244 RGLSYLHEHCDPKIIHRDVKAANILLDED 272
           R L+Y+H      I HRD+K  N+LLD D
Sbjct: 133 RSLAYIHSF---GICHRDIKPQNLLLDPD 158

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 66/144 (45%), Gaps = 13/144 (9%)
Query: 134 FSNKNILGRGGFGKVYKGRLADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
           F+    +G+G FG+V+KG   D +   +VA+K +  E         Q E+ ++S      
Sbjct: 25  FTKLERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSY 82
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
           + + YG     ++  ++  Y+  GS    LR       P D      +     +GL YLH
Sbjct: 83  VTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLH 137
Query: 251 EHCDPKIIHRDVKAANILLDEDAD 274
                K IHRD+KAAN+LL E  D
Sbjct: 138 SE---KKIHRDIKAANVLLSEQGD 158

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 60/132 (45%), Gaps = 7/132 (5%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG+V+ G   +   VAVK LK    S     F  E  ++    H  L+RLY   T
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ--AFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 ++  YM  GS+   L+  +     L  P     +   A G++Y+        IH
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERK---NYIH 133
Query: 260 RDVKAANILLDE 271
           RD++AAN+L+ E
Sbjct: 134 RDLRAANVLVSE 145

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 83/184 (45%), Gaps = 15/184 (8%)
Query: 93  YWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR 152
           Y++   P   F+   AE  +  + G+  R   RE++ +      + I+G G  G+V  GR
Sbjct: 15  YFQGKLPEPQFY---AEPHTYEEPGRAGRSFTREIEASR--IHIEKIIGSGDSGEVCYGR 69
Query: 153 L-ADGKL---VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY 208
           L   G+    VA+K LK   T      F +E  I+    H N++RL G  T     ++V 
Sbjct: 70  LRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVT 129
Query: 209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL 268
            YM NGS+ + LR        +      +   G   G+ YL    D   +HRD+ A N+L
Sbjct: 130 EYMENGSLDTFLRTHDGQFTIMQLVGMLR---GVGAGMRYL---SDLGYVHRDLAARNVL 183
Query: 269 LDED 272
           +D +
Sbjct: 184 VDSN 187

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 72/144 (50%), Gaps = 18/144 (12%)
Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 188
           F    +LG G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 245
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A G
Sbjct: 74  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAEG 126
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           ++YL    D +++HRD+ A N+L+
Sbjct: 127 MNYLE---DRRLVHRDLAARNVLV 147

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 83/184 (45%), Gaps = 15/184 (8%)
Query: 93  YWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR 152
           Y++   P   F+   AE  +  + G+  R   RE++ +      + I+G G  G+V  GR
Sbjct: 15  YFQGKLPEPQFY---AEPHTYEEPGRAGRSFTREIEASR--IHIEKIIGSGDSGEVCYGR 69
Query: 153 L-ADGKL---VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY 208
           L   G+    VA+K LK   T      F +E  I+    H N++RL G  T     ++V 
Sbjct: 70  LRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVT 129
Query: 209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL 268
            YM NGS+ + LR        +      +   G   G+ YL    D   +HRD+ A N+L
Sbjct: 130 EYMENGSLDTFLRTHDGQFTIMQLVGMLR---GVGAGMRYL---SDLGYVHRDLAARNVL 183
Query: 269 LDED 272
           +D +
Sbjct: 184 VDSN 187

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 72/149 (48%), Gaps = 20/149 (13%)
Query: 133 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 191
            +++  ++G G FG VY+ +L D G+LVA+K++ +     G+     E++I+    H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----GKAFKNRELQIMRKLDHCNI 75
Query: 192 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 243
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQLF 132
Query: 244 RGLSYLHEHCDPKIIHRDVKAANILLDED 272
           R L+Y+H      I HRD+K  N+LLD D
Sbjct: 133 RSLAYIHSF---GICHRDIKPQNLLLDPD 158

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 72/149 (48%), Gaps = 20/149 (13%)
Query: 133 GFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 191
            +++  ++G G FG VY+ +L D G+LVA+K++ +     G+     E++I+    H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----GKAFKNRELQIMRKLDHCNI 75
Query: 192 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 243
           +RL  F  +  EK        +L Y   T   VA      + +LP +     K       
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQLF 132
Query: 244 RGLSYLHEHCDPKIIHRDVKAANILLDED 272
           R L+Y+H      I HRD+K  N+LLD D
Sbjct: 133 RSLAYIHSF---GICHRDIKPQNLLLDPD 158

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 71/146 (48%), Gaps = 15/146 (10%)
Query: 139 ILGRGGFGKVYKGRL--ADGKL--VAVKRLKEERTSGGEL-QFQTEVKIISMAVHRNLLR 193
           ILG G FG V +G L   DG    VAVK +K + +S  E+ +F +E   +    H N++R
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 194 LYGFCTTVTEK-----LLVYPYMTNGSVASRLRERQSSLPPLDWP--TRKKIALGSARGL 246
           L G C  ++ +     +++ P+M  G + + L   +    P   P  T  K  +  A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 247 SYLHEHCDPKIIHRDVKAANILLDED 272
            YL        +HRD+ A N +L +D
Sbjct: 161 EYLSNR---NFLHRDLAARNCMLRDD 183

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 123 SLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVK 181
           S+ + ++     + K+ LG G +G+VY G      L VAVK LKE+     E  F  E  
Sbjct: 23  SMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 80
Query: 182 IISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALG 241
           ++    H NL++L G CT      +V  YM  G++   LRE               + L 
Sbjct: 81  VMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNRE------EVTAVVLLY 134
Query: 242 SARGLSYLHEHCDPK-IIHRDVKAANILLDED 272
            A  +S   E+ + K  IHRD+ A N L+ E+
Sbjct: 135 MATQISSAMEYLEKKNFIHRDLAARNCLVGEN 166

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 74/163 (45%), Gaps = 15/163 (9%)
Query: 122 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD---GKL---VAVKRLKEERTSGGELQ 175
           F   E +V+ +  +    LG+G FG VY+G   D   G+    VAVK + E  +    ++
Sbjct: 7   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 176 FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPP 229
           F  E  ++      +++RL G  +     L+V   M +G + S LR      E     PP
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 230 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
                  ++A   A G++YL+     K +HRD+ A N ++  D
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 166

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 74/163 (45%), Gaps = 15/163 (9%)
Query: 122 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD---GKL---VAVKRLKEERTSGGELQ 175
           F   E +V+ +  +    LG+G FG VY+G   D   G+    VAVK + E  +    ++
Sbjct: 4   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 63
Query: 176 FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPP 229
           F  E  ++      +++RL G  +     L+V   M +G + S LR      E     PP
Sbjct: 64  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 123
Query: 230 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
                  ++A   A G++YL+     K +HRD+ A N ++  D
Sbjct: 124 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 163

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 197
           +G+G F KV   R +  GK VAVK + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 198 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 256
             T     LV  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR--------MKEKEARAKFRQIVSAVQYCHQKF 133
Query: 257 IIHRDVKAANILLDEDAD 274
           I+HRD+KA N+LLD D +
Sbjct: 134 IVHRDLKAENLLLDADMN 151

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 197
           +G+G F KV   R +  GK VAVK + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 198 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 256
             T     LV  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR--------MKEKEARAKFRQIVSAVQYCHQKF 133
Query: 257 IIHRDVKAANILLDEDAD 274
           I+HRD+KA N+LLD D +
Sbjct: 134 IVHRDLKAENLLLDADMN 151

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 74/163 (45%), Gaps = 15/163 (9%)
Query: 122 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD---GKL---VAVKRLKEERTSGGELQ 175
           F   E +V+ +  +    LG+G FG VY+G   D   G+    VAVK + E  +    ++
Sbjct: 7   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 176 FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPP 229
           F  E  ++      +++RL G  +     L+V   M +G + S LR      E     PP
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 230 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
                  ++A   A G++YL+     K +HRD+ A N ++  D
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 166

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 197
           +G+G F KV   R +  GK VAVK + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 198 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 256
             T     LV  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR--------MKEKEARAKFRQIVSAVQYCHQKF 133
Query: 257 IIHRDVKAANILLDEDAD 274
           I+HRD+KA N+LLD D +
Sbjct: 134 IVHRDLKAENLLLDADMN 151

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 74/163 (45%), Gaps = 15/163 (9%)
Query: 122 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD---GKL---VAVKRLKEERTSGGELQ 175
           F   E +V+ +  +    LG+G FG VY+G   D   G+    VAVK + E  +    ++
Sbjct: 7   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 176 FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPP 229
           F  E  ++      +++RL G  +     L+V   M +G + S LR      E     PP
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 230 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
                  ++A   A G++YL+     K +HRD+ A N ++  D
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 166

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 69/149 (46%), Gaps = 10/149 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKL---VAVKRLKEERTSGGELQFQTEVKII 183
           ++     + + ++G G FG+V  GRL   GK    VA+K LK   T      F  E  I+
Sbjct: 18  EIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIM 77
Query: 184 SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 243
               H N++ L G  T     ++V  YM NGS+ + L++       +      +   G +
Sbjct: 78  GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLR---GIS 134
Query: 244 RGLSYLHEHCDPKIIHRDVKAANILLDED 272
            G+ YL    D   +HRD+ A NIL++ +
Sbjct: 135 AGMKYLS---DMGYVHRDLAARNILINSN 160

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 140 LGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLR 193
           LG G FG V +G      GK V  AVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           LYG   T   K +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYLESK- 134
Query: 254 DPKIIHRDVKAANILL 269
             + IHRD+ A N+LL
Sbjct: 135 --RFIHRDLAARNLLL 148

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 15/159 (9%)
Query: 126 ELQVATDGFSNKNILGRGGFGKVYKGRLAD---GKL---VAVKRLKEERTSGGELQFQTE 179
           E +V+ +  +    LG+G FG VY+G   D   G+    VAVK + E  +    ++F  E
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 70
Query: 180 VKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWP 233
             ++      +++RL G  +     L+V   M +G + S LR      E     PP    
Sbjct: 71  ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 130
Query: 234 TRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
              ++A   A G++YL+     K +HRD+ A N ++  D
Sbjct: 131 EMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 166

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 19/152 (12%)
Query: 137 KNILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 192
           ++++G G FG+V K R+    L    A+KR+KE  +      F  E++++  +  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ------------SSLPPLDWPTRKKIAL 240
            L G C       L   Y  +G++   LR+ +            S+   L        A 
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 241 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
             ARG+ YL +    + IHRD+ A NIL+ E+
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGEN 178

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 140 LGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLR 193
           LG G FG V +G      GK V  AVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           LYG   T   K +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYLESK- 140
Query: 254 DPKIIHRDVKAANILL 269
             + IHRD+ A N+LL
Sbjct: 141 --RFIHRDLAARNLLL 154

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 140 LGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLR 193
           LG G FG V +G      GK V  AVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           LYG   T   K +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYLESK- 130
Query: 254 DPKIIHRDVKAANILL 269
             + IHRD+ A N+LL
Sbjct: 131 --RFIHRDLAARNLLL 144

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 73/167 (43%), Gaps = 6/167 (3%)
Query: 111 DSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAV--KRLKEE 167
           DS+  L  L+   L    +  D F +  +LGRGGFG+V+  ++ A GKL A      K  
Sbjct: 164 DSKYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL 223
Query: 168 RTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL 227
           +   G      E KI++    R ++ L     T T+  LV   M  G +   +       
Sbjct: 224 KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN 283
Query: 228 PPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 274
           P    P           GL +LH+     II+RD+K  N+LLD+D +
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGN 327

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 19/152 (12%)
Query: 137 KNILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 192
           ++++G G FG+V K R+    L    A+KR+KE  +      F  E++++  +  H N++
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ------------SSLPPLDWPTRKKIAL 240
            L G C       L   Y  +G++   LR+ +            S+   L        A 
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 241 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
             ARG+ YL +    + IHRD+ A NIL+ E+
Sbjct: 140 DVARGMDYLSQK---QFIHRDLAARNILVGEN 168

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 73/144 (50%), Gaps = 18/144 (12%)
Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 188
           F    +L  G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 245
            ++ RL G C T T +L++   M  G +   +RE + ++     L+W       +  A+G
Sbjct: 84  PHVCRLLGICLTSTVQLIMQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           ++YL    D +++HRD+ A N+L+
Sbjct: 137 MNYLE---DRRLVHRDLAARNVLV 157

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 140 LGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLR 193
           LG G FG V +G      GK V  AVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           LYG   T   K +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYLESK- 130
Query: 254 DPKIIHRDVKAANILL 269
             + IHRD+ A N+LL
Sbjct: 131 --RFIHRDLAARNLLL 144

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 140 LGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLR 193
           LG G FG V +G      GK V  AVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           LYG   T   K +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYLESK- 140
Query: 254 DPKIIHRDVKAANILL 269
             + IHRD+ A N+LL
Sbjct: 141 --RFIHRDLAARNLLL 154

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 129 VATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISM 185
           +  D F +  +LGRGGFG+V+  ++ A GKL A K+L ++R     G      E KI++ 
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 186 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 245
              R ++ L     T T+  LV   M  G +   +       P    P           G
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 246 LSYLHEHCDPKIIHRDVKAANILLDEDAD 274
           L +LH+     II+RD+K  N+LLD+D +
Sbjct: 302 LEHLHQR---NIIYRDLKPENVLLDDDGN 327

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 129 VATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISM 185
           +  D F +  +LGRGGFG+V+  ++ A GKL A K+L ++R     G      E KI++ 
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 186 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 245
              R ++ L     T T+  LV   M  G +   +       P    P           G
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 246 LSYLHEHCDPKIIHRDVKAANILLDEDAD 274
           L +LH+     II+RD+K  N+LLD+D +
Sbjct: 302 LEHLHQR---NIIYRDLKPENVLLDDDGN 327

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 140 LGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLR 193
           LG G FG V +G      GK V  AVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           LYG   T   K +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYLESK- 134
Query: 254 DPKIIHRDVKAANILL 269
             + IHRD+ A N+LL
Sbjct: 135 --RFIHRDLAARNLLL 148

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 129 VATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISM 185
           +  D F +  +LGRGGFG+V+  ++ A GKL A K+L ++R     G      E KI++ 
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 186 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 245
              R ++ L     T T+  LV   M  G +   +       P    P           G
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 246 LSYLHEHCDPKIIHRDVKAANILLDEDAD 274
           L +LH+     II+RD+K  N+LLD+D +
Sbjct: 302 LEHLHQR---NIIYRDLKPENVLLDDDGN 327

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 140 LGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLR 193
           LG G FG V +G      GK V  AVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           LYG   T   K +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL---LGTLSRYAVQVAEGMGYLESK- 130
Query: 254 DPKIIHRDVKAANILL 269
             + IHRD+ A N+LL
Sbjct: 131 --RFIHRDLAARNLLL 144

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 72/144 (50%), Gaps = 18/144 (12%)
Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 188
           F    +L  G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 245
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 77  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           ++YL    D +++HRD+ A N+L+
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLV 150

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 137 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 282
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQISSAMEYL 334
Query: 254 DPK-IIHRDVKAANILLDED 272
           + K  IHR++ A N L+ E+
Sbjct: 335 EKKNFIHRNLAARNCLVGEN 354

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 72/144 (50%), Gaps = 18/144 (12%)
Query: 134 FSNKNILGRGGFGKVYKG-RLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVH 188
           F    +LG G FG VYKG  + +G+     VA+  L+E  +     +   E  +++   +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 245
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 111 PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 163
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           ++YL    D +++HRD+ A N+L+
Sbjct: 164 MNYLE---DRRLVHRDLAARNVLV 184

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 9/146 (6%)
Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRL-KEERTSGGELQ-FQTEVKIISMAVH 188
           + F   N+LG+G F  VY+   +  G  VA+K + K+     G +Q  Q EVKI     H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 248
            ++L LY +        LV     NG +   L+ R   + P      +        G+ Y
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLY 127
Query: 249 LHEHCDPKIIHRDVKAANILLDEDAD 274
           LH H    I+HRD+  +N+LL  + +
Sbjct: 128 LHSH---GILHRDLTLSNLLLTRNMN 150

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 60/132 (45%), Gaps = 7/132 (5%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG+V+ G   +   VAVK LK    S     F  E  ++    H  L+RLY   T
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ--AFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 ++  +M  GS+   L+  +     L  P     +   A G++Y+        IH
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERK---NYIH 132
Query: 260 RDVKAANILLDE 271
           RD++AAN+L+ E
Sbjct: 133 RDLRAANVLVSE 144

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 68/140 (48%), Gaps = 14/140 (10%)
Query: 137 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 264 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 321
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           G CT      ++  +MT G++   LRE  RQ             + L  A  +S   E+ 
Sbjct: 322 GVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQISSAMEYL 373
Query: 254 DPK-IIHRDVKAANILLDED 272
           + K  IHR++ A N L+ E+
Sbjct: 374 EKKNFIHRNLAARNCLVGEN 393

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 75/156 (48%), Gaps = 17/156 (10%)
Query: 121 RFSLRELQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQT- 178
           ++SL++ Q+          LG G FG+V+  R   +G+  A+K LK+E     +    T 
Sbjct: 2   KYSLQDFQIL-------RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN 54
Query: 179 -EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKK 237
            E  ++S+  H  ++R++G      +  ++  Y+  G + S LR+ Q   P    P  K 
Sbjct: 55  DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR-FPN---PVAKF 110
Query: 238 IALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA 273
            A      L YLH      II+RD+K  NILLD++ 
Sbjct: 111 YAAEVCLALEYLHSK---DIIYRDLKPENILLDKNG 143

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 66/140 (47%), Gaps = 10/140 (7%)
Query: 137 KNILGRGGFGKVYKGRLA-DGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
           + ++G G FG+V  GRL   GK    VA+K LK   T      F  E  I+    H N++
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
            L G  T     ++V  +M NG++ + LR+       +      +   G A G+ YL   
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLR---GIAAGMRYL--- 161
Query: 253 CDPKIIHRDVKAANILLDED 272
            D   +HRD+ A NIL++ +
Sbjct: 162 ADMGYVHRDLAARNILVNSN 181

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 79
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 80  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 133
Query: 260 RDVKAANILLDE 271
           RD++AANIL+ +
Sbjct: 134 RDLRAANILVSD 145

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 72/144 (50%), Gaps = 18/144 (12%)
Query: 134 FSNKNILGRGGFGKVYKG-RLADGKLV----AVKRLKEERTSGGELQFQTEVKIISMAVH 188
           F    +L  G FG VYKG  + +G+ V    A+K L+E  +     +   E  +++   +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARG 245
            ++ RL G C T T +L+    M  G +   +RE + ++     L+W       +  A+G
Sbjct: 84  PHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           ++YL    D +++HRD+ A N+L+
Sbjct: 137 MNYLE---DRRLVHRDLAARNVLV 157

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 79  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 132
Query: 260 RDVKAANILLDE 271
           RD++AANIL+ +
Sbjct: 133 RDLRAANILVSD 144

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 87
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 88  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 141
Query: 260 RDVKAANILLDE 271
           RD++AANIL+ +
Sbjct: 142 RDLRAANILVSD 153

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 65/136 (47%), Gaps = 14/136 (10%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           +G+G FG V  G    G  VAVK +K + T+     F  E  +++   H NL++L G   
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLG--V 254
Query: 200 TVTEK---LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 256
            V EK    +V  YM  GS+   LR R  S+  L      K +L     + YL  +    
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGN---N 309
Query: 257 IIHRDVKAANILLDED 272
            +HRD+ A N+L+ ED
Sbjct: 310 FVHRDLAARNVLVSED 325

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 85  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 138
Query: 260 RDVKAANILLDE 271
           RD++AANIL+ +
Sbjct: 139 RDLRAANILVSD 150

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 80
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 81  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 134
Query: 260 RDVKAANILLDE 271
           RD++AANIL+ +
Sbjct: 135 RDLRAANILVSD 146

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 86
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 87  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 140
Query: 260 RDVKAANILLDE 271
           RD++AANIL+ +
Sbjct: 141 RDLRAANILVSD 152

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 63/133 (47%), Gaps = 10/133 (7%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 198
           +G G FG VYKG+      VAVK LK    +  + Q F+ EV ++    H N+L   G+ 
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101
Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 258
           T      +V  +    S+   L  +++            IA  +A+G+ YLH      II
Sbjct: 102 TK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQ---LIDIARQTAQGMDYLHA---KNII 154
Query: 259 HRDVKAANILLDE 271
           HRD+K+ NI L E
Sbjct: 155 HRDMKSNNIFLHE 167

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 83
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 84  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 137
Query: 260 RDVKAANILLDE 271
           RD++AANIL+ +
Sbjct: 138 RDLRAANILVSD 149

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 15/145 (10%)
Query: 140 LGRGGFGKVYKGRLAD---GKL---VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
           LG+G FG VY+G   D   G+    VAVK + E  +    ++F  E  ++      +++R
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWPTRKKIALGSARGLS 247
           L G  +     L+V   M +G + S LR      E     PP       ++A   A G++
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           YL+     K +HRD+ A N ++  D
Sbjct: 144 YLNAK---KFVHRDLAARNCMVAHD 165

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 79  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 132
Query: 260 RDVKAANILLDE 271
           RD++AANIL+ +
Sbjct: 133 RDLRAANILVSD 144

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 85  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 138
Query: 260 RDVKAANILLDE 271
           RD++AANIL+ +
Sbjct: 139 RDLRAANILVSD 150

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 73
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 74  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 127
Query: 260 RDVKAANILLDE 271
           RD++AANIL+ +
Sbjct: 128 RDLRAANILVSD 139

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 65/136 (47%), Gaps = 14/136 (10%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           +G+G FG V  G     K VAVK +K + T+     F  E  +++   H NL++L G   
Sbjct: 14  IGKGEFGDVMLGDYRGNK-VAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLG--V 67
Query: 200 TVTEK---LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 256
            V EK    +V  YM  GS+   LR R  S+  L      K +L     + YL  +    
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGN---N 122
Query: 257 IIHRDVKAANILLDED 272
            +HRD+ A N+L+ ED
Sbjct: 123 FVHRDLAARNVLVSED 138

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 79  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 132
Query: 260 RDVKAANILLDE 271
           RD++AANIL+ +
Sbjct: 133 RDLRAANILVSD 144

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 88
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 89  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 142
Query: 260 RDVKAANILLDE 271
           RD++AANIL+ +
Sbjct: 143 RDLRAANILVSD 154

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 65/136 (47%), Gaps = 14/136 (10%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           +G+G FG V  G     K VAVK +K + T+     F  E  +++   H NL++L G   
Sbjct: 20  IGKGEFGDVMLGDYRGNK-VAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLG--V 73
Query: 200 TVTEK---LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 256
            V EK    +V  YM  GS+   LR R  S+  L      K +L     + YL  +    
Sbjct: 74  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGN---N 128
Query: 257 IIHRDVKAANILLDED 272
            +HRD+ A N+L+ ED
Sbjct: 129 FVHRDLAARNVLVSED 144

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 65/136 (47%), Gaps = 14/136 (10%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           +G+G FG V  G     K VAVK +K + T+     F  E  +++   H NL++L G   
Sbjct: 29  IGKGEFGDVMLGDYRGNK-VAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLG--V 82
Query: 200 TVTEK---LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 256
            V EK    +V  YM  GS+   LR R  S+  L      K +L     + YL  +    
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGN---N 137
Query: 257 IIHRDVKAANILLDED 272
            +HRD+ A N+L+ ED
Sbjct: 138 FVHRDLAARNVLVSED 153

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 197
           +G+G F KV   R +  GK VAV+ + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 198 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 256
             T     LV  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR--------MKEKEARAKFRQIVSAVQYCHQKF 133
Query: 257 IIHRDVKAANILLDEDAD 274
           I+HRD+KA N+LLD D +
Sbjct: 134 IVHRDLKAENLLLDADMN 151

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 197
           +G+G F KV   R +  GK VAV+ + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 198 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 256
             T     LV  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR--------MKEKEARAKFRQIVSAVQYCHQKF 133
Query: 257 IIHRDVKAANILLDEDAD 274
           I+HRD+KA N+LLD D +
Sbjct: 134 IVHRDLKAENLLLDADMN 151

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 67/144 (46%), Gaps = 9/144 (6%)
Query: 130 ATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT-EVKIISMAV 187
           + + + N  ++G G +G V K R  D G++VA+K+  E        +    E+K++    
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           H NL+ L   C       LV+ ++ +    + L + +     LD+   +K       G+ 
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDH----TILDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 248 YLHEHCDPKIIHRDVKAANILLDE 271
           + H H    IIHRD+K  NIL+ +
Sbjct: 139 FCHSH---NIIHRDIKPENILVSQ 159

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 66/138 (47%), Gaps = 11/138 (7%)
Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 197
           +G+G F KV   R +  GK VAVK + + + +   LQ    EV+I  +  H N+++L+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 198 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 256
             T     LV  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRX--------KEKEARAKFRQIVSAVQYCHQKF 133
Query: 257 IIHRDVKAANILLDEDAD 274
           I+HRD+KA N+LLD D +
Sbjct: 134 IVHRDLKAENLLLDADXN 151

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 68/145 (46%), Gaps = 7/145 (4%)
Query: 130 ATDGFSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH 188
           ++  F     LG G +  VYKG     G  VA+K +K +   G       E+ ++    H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP--LDWPTRKKIALGSARGL 246
            N++RLY    T  +  LV+ +M N  +   +  R     P  L+    K       +GL
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 247 SYLHEHCDPKIIHRDVKAANILLDE 271
           ++ HE+   KI+HRD+K  N+L+++
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINK 143

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 64/148 (43%), Gaps = 19/148 (12%)
Query: 140 LGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
           LG G FGKV+           D  LVAVK LK+  +      F  E ++++   H ++++
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVK 79
Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL-------PPLDWPTRK--KIALGSAR 244
            YG C      ++V+ YM +G +   LR             PP +    +   IA   A 
Sbjct: 80  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAA 139
Query: 245 GLSYLHEHCDPKIIHRDVKAANILLDED 272
           G+ YL        +HRD+   N L+ E+
Sbjct: 140 GMVYL---ASQHFVHRDLATRNCLVGEN 164

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 247
Query: 200 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 248 VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 302
Query: 258 IHRDVKAANILLDED 272
           +HRD++AANIL+ E+
Sbjct: 303 VHRDLRAANILVGEN 317

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 67/145 (46%), Gaps = 19/145 (13%)
Query: 140 LGRGGFGKVYKGRL-ADGKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 197
           +G+G FG+V+K R    G+ VA+K+ L E    G  +    E+KI+ +  H N++ L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 198 CTTVTEKLLVYPY-MTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR--------GLSY 248
           C T        PY    GS+       +  L  L      K  L   +        GL Y
Sbjct: 86  CRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 249 LHEHCDPKIIHRDVKAANILLDEDA 273
           +H +   KI+HRD+KAAN+L+  D 
Sbjct: 141 IHRN---KILHRDMKAANVLITRDG 162

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYA--- 329
Query: 200 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 330 VVSEEPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERM---NY 384
Query: 258 IHRDVKAANILLDED 272
           +HRD++AANIL+ E+
Sbjct: 385 VHRDLRAANILVGEN 399

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 62/145 (42%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           +   D F     LG+G FG VY  R    K + A+K L   +    G E Q + E++I S
Sbjct: 11  KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 70
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LR+Y +        L+  +   G +   L++        D           A 
Sbjct: 71  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR----FDEQRSATFMEELAD 126
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            L Y HE    K+IHRD+K  N+L+
Sbjct: 127 ALHYCHER---KVIHRDIKPENLLM 148

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 80
Query: 200 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVIEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 258 IHRDVKAANILLDED 272
           +HRD++AANIL+ E+
Sbjct: 136 VHRDLRAANILVGEN 150

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKIRHEKLVQLYA--- 80
Query: 200 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 258 IHRDVKAANILLDED 272
           +HRD++AANIL+ E+
Sbjct: 136 VHRDLRAANILVGEN 150

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 80
Query: 200 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVIEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 258 IHRDVKAANILLDED 272
           +HRD++AANIL+ E+
Sbjct: 136 VHRDLRAANILVGEN 150

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 80
Query: 200 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVCEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 258 IHRDVKAANILLDED 272
           +HRD++AANIL+ E+
Sbjct: 136 VHRDLRAANILVGEN 150

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 62/145 (42%), Gaps = 10/145 (6%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLV-AVKRL--KEERTSGGELQFQTEVKIIS 184
           +   D F     LG+G FG VY  R    K + A+K L   +    G E Q + E++I S
Sbjct: 10  KFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              H N+LR+Y +        L+  +   G +   L++        D           A 
Sbjct: 70  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR----FDEQRSATFMEELAD 125
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            L Y HE    K+IHRD+K  N+L+
Sbjct: 126 ALHYCHER---KVIHRDIKPENLLM 147

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 71
Query: 200 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 72  VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 126
Query: 258 IHRDVKAANILLDED 272
           +HRD++AANIL+ E+
Sbjct: 127 VHRDLRAANILVGEN 141

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 140 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 190
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 241
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 242 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 67/145 (46%), Gaps = 19/145 (13%)
Query: 140 LGRGGFGKVYKGRL-ADGKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 197
           +G+G FG+V+K R    G+ VA+K+ L E    G  +    E+KI+ +  H N++ L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 198 CTTVTEKLLVYPY-MTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR--------GLSY 248
           C T        PY    GS+       +  L  L      K  L   +        GL Y
Sbjct: 85  CRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 139
Query: 249 LHEHCDPKIIHRDVKAANILLDEDA 273
           +H +   KI+HRD+KAAN+L+  D 
Sbjct: 140 IHRN---KILHRDMKAANVLITRDG 161

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 71/148 (47%), Gaps = 9/148 (6%)
Query: 124 LRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKI 182
           L+E  +  +      ++G+G FG+VY GR      VA++ +  ER +  +L+ F+ EV  
Sbjct: 25  LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMA 82
Query: 183 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 242
                H N++   G C +     ++       ++ S +R+ +     LD    ++IA   
Sbjct: 83  YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV---LDVNKTRQIAQEI 139
Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLD 270
            +G+ YLH      I+H+D+K+ N+  D
Sbjct: 140 VKGMGYLHAK---GILHKDLKSKNVFYD 164

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 68/141 (48%), Gaps = 17/141 (12%)
Query: 140 LGRGGFGKVYKGRLAD--GKLVAVKRLKEER-TSGGELQFQTEVKII---SMAVHRNLLR 193
           +G G +GKV+K R     G+ VA+KR++ +    G  L    EV ++       H N++R
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 194 LYGFCTTV-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 248
           L+  CT       T+  LV+ ++         +  +  +P     T K +     RGL +
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT---ETIKDMMFQLLRGLDF 135
Query: 249 LHEHCDPKIIHRDVKAANILL 269
           LH H   +++HRD+K  NIL+
Sbjct: 136 LHSH---RVVHRDLKPQNILV 153

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 246
Query: 200 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 247 VVSEEPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 258 IHRDVKAANILLDED 272
           +HRD++AANIL+ E+
Sbjct: 302 VHRDLRAANILVGEN 316

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 80
Query: 200 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 258 IHRDVKAANILLDED 272
           +HRD++AANIL+ E+
Sbjct: 136 VHRDLRAANILVGEN 150

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 69
Query: 200 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 70  VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 124
Query: 258 IHRDVKAANILLDED 272
           +HRD++AANIL+ E+
Sbjct: 125 VHRDLRAANILVGEN 139

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 67/145 (46%), Gaps = 19/145 (13%)
Query: 140 LGRGGFGKVYKGRL-ADGKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 197
           +G+G FG+V+K R    G+ VA+K+ L E    G  +    E+KI+ +  H N++ L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 198 CTTVTEKLLVYPY-MTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR--------GLSY 248
           C T        PY    GS+       +  L  L      K  L   +        GL Y
Sbjct: 86  CRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 249 LHEHCDPKIIHRDVKAANILLDEDA 273
           +H +   KI+HRD+KAAN+L+  D 
Sbjct: 141 IHRN---KILHRDMKAANVLITRDG 162

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 246
Query: 200 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 247 VVSEEPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 258 IHRDVKAANILLDED 272
           +HRD++AANIL+ E+
Sbjct: 302 VHRDLRAANILVGEN 316

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 140 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 190
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 241
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 242 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 69/145 (47%), Gaps = 12/145 (8%)
Query: 134 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLK----EERTSGGELQFQTEVKIISMAVH 188
           +   + LG G F  VYK R  +  ++VA+K++K     E   G       E+K++    H
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 248
            N++ L       +   LV+ +M    +   +++    L P      K   L + +GL Y
Sbjct: 72  PNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTP---SHIKAYMLMTLQGLEY 127
Query: 249 LHEHCDPKIIHRDVKAANILLDEDA 273
           LH+H    I+HRD+K  N+LLDE+ 
Sbjct: 128 LHQHW---ILHRDLKPNNLLLDENG 149

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 140 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 190
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 241
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 242 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 70/152 (46%), Gaps = 19/152 (12%)
Query: 137 KNILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 192
           ++++G G FG+V K R+    L    A+KR+KE  +      F  E++++  +  H N++
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ------------SSLPPLDWPTRKKIAL 240
            L G C       L   Y  +G++   LR+ +            S+   L        A 
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 241 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
             ARG+ YL +    + IHR++ A NIL+ E+
Sbjct: 147 DVARGMDYLSQK---QFIHRNLAARNILVGEN 175

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 140 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 190
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 241
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 242 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 15/159 (9%)
Query: 126 ELQVATDGFSNKNILGRGGFGKVYKGRLAD---GKL---VAVKRLKEERTSGGELQFQTE 179
           E +V+ +  +    LG+G FG VY+G   D   G+    VAVK + E  +    ++F  E
Sbjct: 12  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 71
Query: 180 VKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWP 233
             ++      +++RL G  +     L+V   M +G + S LR      E     PP    
Sbjct: 72  ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 131
Query: 234 TRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
              ++A   A G++YL+     K +HR++ A N ++  D
Sbjct: 132 EMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHD 167

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 70
Query: 200 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 71  VVSEEPIXIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERM---NY 125
Query: 258 IHRDVKAANILLDED 272
           +HRD++AANIL+ E+
Sbjct: 126 VHRDLRAANILVGEN 140

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 15/159 (9%)
Query: 126 ELQVATDGFSNKNILGRGGFGKVYKGRLAD---GKL---VAVKRLKEERTSGGELQFQTE 179
           E +V+ +  +    LG+G FG VY+G   D   G+    VAVK + E  +    ++F  E
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 70
Query: 180 VKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWP 233
             ++      +++RL G  +     L+V   M +G + S LR      E     PP    
Sbjct: 71  ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 130
Query: 234 TRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
              ++A   A G++YL+     K +HR++ A N ++  D
Sbjct: 131 EMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHD 166

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 140 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 190
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 241
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 242 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 73
Query: 200 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 74  VVSEEPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERM---NY 128
Query: 258 IHRDVKAANILLDED 272
           +HRD++AANIL+ E+
Sbjct: 129 VHRDLRAANILVGEN 143

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 140 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 190
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 241
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 242 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 140 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 190
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 241
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 242 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 68/141 (48%), Gaps = 17/141 (12%)
Query: 140 LGRGGFGKVYKGRLAD--GKLVAVKRLKEER-TSGGELQFQTEVKII---SMAVHRNLLR 193
           +G G +GKV+K R     G+ VA+KR++ +    G  L    EV ++       H N++R
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 194 LYGFCTTV-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 248
           L+  CT       T+  LV+ ++         +  +  +P     T K +     RGL +
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT---ETIKDMMFQLLRGLDF 135
Query: 249 LHEHCDPKIIHRDVKAANILL 269
           LH H   +++HRD+K  NIL+
Sbjct: 136 LHSH---RVVHRDLKPQNILV 153

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 140 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 190
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 241
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 242 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 68/141 (48%), Gaps = 17/141 (12%)
Query: 140 LGRGGFGKVYKGRLAD--GKLVAVKRLKEER-TSGGELQFQTEVKII---SMAVHRNLLR 193
           +G G +GKV+K R     G+ VA+KR++ +    G  L    EV ++       H N++R
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 194 LYGFCTTV-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 248
           L+  CT       T+  LV+ ++         +  +  +P     T K +     RGL +
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT---ETIKDMMFQLLRGLDF 135
Query: 249 LHEHCDPKIIHRDVKAANILL 269
           LH H   +++HRD+K  NIL+
Sbjct: 136 LHSH---RVVHRDLKPQNILV 153

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 12/135 (8%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 246
Query: 200 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 247 VVSEEPIYIVGEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 258 IHRDVKAANILLDED 272
           +HRD++AANIL+ E+
Sbjct: 302 VHRDLRAANILVGEN 316

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 63/132 (47%), Gaps = 8/132 (6%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 74
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 ++  YM NGS+   L  +  S   L       +A   A G++++ E      IH
Sbjct: 75  Q-EPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 128
Query: 260 RDVKAANILLDE 271
           R+++AANIL+ +
Sbjct: 129 RNLRAANILVSD 140

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 65/135 (48%), Gaps = 12/135 (8%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 80
Query: 200 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
            V+E+   +V  YM+ GS+   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVTEYMSKGSLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 258 IHRDVKAANILLDED 272
           +HRD+ AANIL+ E+
Sbjct: 136 VHRDLAAANILVGEN 150

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 140 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 190
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 241
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 242 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 197
           +G+G F KV   R +  G+ VAVK + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 198 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 256
             T     LV  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVAHGR--------MKEKEARAKFRQIVSAVQYCHQKY 134
Query: 257 IIHRDVKAANILLDEDAD 274
           I+HRD+KA N+LLD D +
Sbjct: 135 IVHRDLKAENLLLDGDMN 152

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 73/147 (49%), Gaps = 27/147 (18%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 197
           +G+G FG+V++G+   G+ VAVK    +EER+   E +    V    M  H N+L   GF
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTV----MLRHENIL---GF 63
Query: 198 CT-------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
                    T T+  LV  Y  +GS+   L     ++  +      K+AL +A GL++LH
Sbjct: 64  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLH 118
Query: 251 EHC-----DPKIIHRDVKAANILLDED 272
                    P I HRD+K+ NIL+ ++
Sbjct: 119 MEIVGTQGKPAIAHRDLKSKNILVKKN 145

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 140 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 190
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 241
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 242 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 209 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 239

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 74/140 (52%), Gaps = 18/140 (12%)
Query: 138 NILGRGGFGKVYKG-RLADGKLVAVK---RLKEERTSGGELQFQTEVKI-ISMAVHRNLL 192
            +LG G FG V+KG  + +G+ + +    ++ E+++     Q  T+  + I    H +++
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYL 249
           RL G C   + + LV  Y+  GS+   +R+ + +L P   L+W       +  A+G+ YL
Sbjct: 97  RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGMYYL 149
Query: 250 HEHCDPKIIHRDVKAANILL 269
            EH    ++HR++ A N+LL
Sbjct: 150 EEH---GMVHRNLAARNVLL 166

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 140 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 190
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 241
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 242 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 152 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 182

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 65/135 (48%), Gaps = 12/135 (8%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 80
Query: 200 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
            V+E+   +V  YM+ G +   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVMEYMSKGCLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 258 IHRDVKAANILLDED 272
           +HRD++AANIL+ E+
Sbjct: 136 VHRDLRAANILVGEN 150

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 64/132 (48%), Gaps = 12/132 (9%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG+V+ G       VA+K LK    S     F  E +I+    H  L++LY    
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPE--SFLEEAQIMKKLKHDKLVQLYA--- 71
Query: 200 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
            V+E+   +V  YM  GS+   L++ +     L  P    +A   A G++Y+        
Sbjct: 72  VVSEEPIYIVTEYMNKGSLLDFLKDGEGR--ALKLPNLVDMAAQVAAGMAYIERM---NY 126
Query: 258 IHRDVKAANILL 269
           IHRD+++ANIL+
Sbjct: 127 IHRDLRSANILV 138

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 140 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 190
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 241
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 242 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 155 TYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 185

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 73/147 (49%), Gaps = 27/147 (18%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 197
           +G+G FG+V++G+   G+ VAVK    +EER+   E +    V    M  H N+L   GF
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTV----MLRHENIL---GF 62
Query: 198 CT-------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
                    T T+  LV  Y  +GS+   L     ++  +      K+AL +A GL++LH
Sbjct: 63  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLH 117
Query: 251 EHC-----DPKIIHRDVKAANILLDED 272
                    P I HRD+K+ NIL+ ++
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKN 144

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 27/148 (18%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 197
           +G+G FG+V++G+   G+ VAVK    +EER+   E +    V    M  H N+L   GF
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTV----MLRHENIL---GF 101
Query: 198 CT-------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
                    T T+  LV  Y  +GS+   L     ++  +      K+AL +A GL++LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLH 156
Query: 251 EHC-----DPKIIHRDVKAANILLDEDA 273
                    P I HRD+K+ NIL+ ++ 
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNG 184

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 38/142 (26%), Positives = 71/142 (50%), Gaps = 22/142 (15%)
Query: 138 NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRL 194
           + LG G FGKV  G+    G  VAVK L  ++    ++  + + E++ + +  H ++++L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 195 YGFCTTVTEKLLVYPYMTNGSVAS------RLRERQSSLPPLDWPTRKKIALGSARGLSY 248
           Y   +T ++  +V  Y++ G +        RL E++S          +++      G+ Y
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES----------RRLFQQILSGVDY 131
Query: 249 LHEHCDPKIIHRDVKAANILLD 270
            H H    ++HRD+K  N+LLD
Sbjct: 132 CHRHM---VVHRDLKPENVLLD 150

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 140 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 190
           LG G FG+V         K +  +   VAVK LK++ T        +E++++ M   H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS---------SLPPLDWPTRKKIALG 241
           ++ L G CT      ++  Y + G++   LR R+          +  P +  T K +   
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 242 S---ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           +   ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 150 TYQLARGMEYLASQ---KCIHRDLTARNVLVTEN 180

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FGKVYK +  +   +A  ++ E ++      +  E++I++   H  +++L G   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
              +  ++  +   G+V + + E    L     P  + +       L++LH     +IIH
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTE---PQIQVVCRQMLEALNFLHSK---RIIH 132
Query: 260 RDVKAANILLDEDAD 274
           RD+KA N+L+  + D
Sbjct: 133 RDLKAGNVLMTLEGD 147

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 73/147 (49%), Gaps = 27/147 (18%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 197
           +G+G FG+V++G+   G+ VAVK    +EER+   E +    V    M  H N+L   GF
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTV----MLRHENIL---GF 68
Query: 198 CT-------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
                    T T+  LV  Y  +GS+   L     ++  +      K+AL +A GL++LH
Sbjct: 69  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLH 123
Query: 251 EHC-----DPKIIHRDVKAANILLDED 272
                    P I HRD+K+ NIL+ ++
Sbjct: 124 MEIVGTQGKPAIAHRDLKSKNILVKKN 150

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 27/148 (18%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 197
           +G+G FG+V++G+   G+ VAVK    +EER+   E +    V    M  H N+L   GF
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTV----MLRHENIL---GF 65
Query: 198 CT-------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
                    T T+  LV  Y  +GS+   L     ++  +      K+AL +A GL++LH
Sbjct: 66  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLH 120
Query: 251 EHC-----DPKIIHRDVKAANILLDEDA 273
                    P I HRD+K+ NIL+ ++ 
Sbjct: 121 MEIVGTQGKPAIAHRDLKSKNILVKKNG 148

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 27/148 (18%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 197
           +G+G FG+V++G+   G+ VAVK    +EER+   E +    V    M  H N+L   GF
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTV----MLRHENIL---GF 88
Query: 198 CT-------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
                    T T+  LV  Y  +GS+   L     ++  +      K+AL +A GL++LH
Sbjct: 89  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLH 143
Query: 251 EHC-----DPKIIHRDVKAANILLDEDA 273
                    P I HRD+K+ NIL+ ++ 
Sbjct: 144 MEIVGTQGKPAIAHRDLKSKNILVKKNG 171

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 65/139 (46%), Gaps = 12/139 (8%)
Query: 139 ILGRGGFGKVYK-GRLADGKLVAVKRLK--EERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           +LG+G FG+  K      G+++ +K L   +E T   +  F  EVK++    H N+L+  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEET---QRTFLKEVKVMRCLEHPNVLKFI 73
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G          +  Y+  G++   ++   S  P   W  R   A   A G++YLH     
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYP---WSQRVSFAKDIASGMAYLHSM--- 127
Query: 256 KIIHRDVKAANILLDEDAD 274
            IIHRD+ + N L+ E+ +
Sbjct: 128 NIIHRDLNSHNCLVRENKN 146

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FGKVYK +  +   +A  ++ E ++      +  E++I++   H  +++L G   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
              +  ++  +   G+V + + E    L     P  + +       L++LH     +IIH
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTE---PQIQVVCRQMLEALNFLHSK---RIIH 140
Query: 260 RDVKAANILLDEDAD 274
           RD+KA N+L+  + D
Sbjct: 141 RDLKAGNVLMTLEGD 155

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 65/135 (48%), Gaps = 12/135 (8%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 80
Query: 200 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
            V+E+   +V  YM+ G +   L+        L  P    +A   A G++Y+        
Sbjct: 81  VVSEEPIYIVTEYMSKGCLLDFLKGEMGKY--LRLPQLVDMAAQIASGMAYVERM---NY 135
Query: 258 IHRDVKAANILLDED 272
           +HRD++AANIL+ E+
Sbjct: 136 VHRDLRAANILVGEN 150

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 65/151 (43%), Gaps = 16/151 (10%)
Query: 129 VATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE--LQFQT--EVKII 183
           +AT  +     +G G +G VYK R    G  VA   LK  R   GE  L   T  EV ++
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVA---LKSVRVPNGEEGLPISTVREVALL 57
Query: 184 ---SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWP--TRKKI 238
                  H N++RL   C T      +   +    V   LR      PP   P  T K +
Sbjct: 58  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 117
Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 269
                RGL +LH +C   I+HRD+K  NIL+
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILV 145

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 74/140 (52%), Gaps = 18/140 (12%)
Query: 138 NILGRGGFGKVYKG-RLADGKLVAVK---RLKEERTSGGELQFQTEVKI-ISMAVHRNLL 192
            +LG G FG V+KG  + +G+ + +    ++ E+++     Q  T+  + I    H +++
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYL 249
           RL G C   + + LV  Y+  GS+   +R+ + +L P   L+W       +  A+G+ YL
Sbjct: 79  RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGMYYL 131
Query: 250 HEHCDPKIIHRDVKAANILL 269
            EH    ++HR++ A N+LL
Sbjct: 132 EEH---GMVHRNLAARNVLL 148

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 65/151 (43%), Gaps = 16/151 (10%)
Query: 129 VATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE--LQFQT--EVKII 183
           +AT  +     +G G +G VYK R    G  VA   LK  R   GE  L   T  EV ++
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVA---LKSVRVPNGEEGLPISTVREVALL 57
Query: 184 ---SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWP--TRKKI 238
                  H N++RL   C T      +   +    V   LR      PP   P  T K +
Sbjct: 58  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 117
Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 269
                RGL +LH +C   I+HRD+K  NIL+
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILV 145

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 65/151 (43%), Gaps = 16/151 (10%)
Query: 129 VATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE--LQFQT--EVKII 183
           +AT  +     +G G +G VYK R    G  VA   LK  R   GE  L   T  EV ++
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVA---LKSVRVPNGEEGLPISTVREVALL 57
Query: 184 ---SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWP--TRKKI 238
                  H N++RL   C T      +   +    V   LR      PP   P  T K +
Sbjct: 58  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 117
Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 269
                RGL +LH +C   I+HRD+K  NIL+
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILV 145

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 69/144 (47%), Gaps = 17/144 (11%)
Query: 140 LGRGGFGKVYKGRL-ADGKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 197
           +G+G FG+V+K R    G+ VA+K+ L E    G  +    E+KI+ +  H N++ L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 198 CTTVTEKL--------LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           C T             LV+ +  +  +A  L    + L        K++      GL Y+
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEH-DLAGLL---SNVLVKFTLSEIKRVMQMLLNGLYYI 141
Query: 250 HEHCDPKIIHRDVKAANILLDEDA 273
           H +   KI+HRD+KAAN+L+  D 
Sbjct: 142 HRN---KILHRDMKAANVLITRDG 162

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 197
           +G+G F KV   R +  G+ VA+K + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 198 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 256
             T     L+  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGR--------MKEKEARSKFRQIVSAVQYCHQKR 131
Query: 257 IIHRDVKAANILLDEDAD 274
           I+HRD+KA N+LLD D +
Sbjct: 132 IVHRDLKAENLLLDADMN 149

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 67/138 (48%), Gaps = 11/138 (7%)
Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 197
           +G+G F KV   R +  G+ VA+K + + + +   LQ    EV+I+ +  H N+++L+  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 198 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK- 256
             T     L+  Y + G V   L              ++K A    R +    ++C  K 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGR--------MKEKEARSKFRQIVSAVQYCHQKR 134
Query: 257 IIHRDVKAANILLDEDAD 274
           I+HRD+KA N+LLD D +
Sbjct: 135 IVHRDLKAENLLLDADMN 152

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 140 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 190
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS-----SLPPLDWPTRK-------KI 238
           ++ L G CT      ++  Y + G++   L+ R+      S  P   P  +         
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 186

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 140 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 190
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS-----SLPPLDWPTRK-------KI 238
           ++ L G CT      ++  Y + G++   L+ R+      S  P   P  +         
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 186

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 140 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 190
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-----QSSLPPLDWPTRK-------KI 238
           ++ L G CT      ++  Y + G++   L+ R     + S  P   P  +         
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 175

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 140 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 190
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-----QSSLPPLDWPTRK-------KI 238
           ++ L G CT      ++  Y + G++   L+ R     + S  P   P  +         
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 179

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 140 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 190
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-----QSSLPPLDWPTRK-------KI 238
           ++ L G CT      ++  Y + G++   L+ R     + S  P   P  +         
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 227

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 65/135 (48%), Gaps = 12/135 (8%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 77
Query: 200 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
            V+E+   +V  YM  GS+   L+        L  P    ++   A G++Y+        
Sbjct: 78  VVSEEPIYIVTEYMNKGSLLDFLKGETGKY--LRLPQLVDMSAQIASGMAYVERM---NY 132
Query: 258 IHRDVKAANILLDED 272
           +HRD++AANIL+ E+
Sbjct: 133 VHRDLRAANILVGEN 147

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 140 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 190
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-----QSSLPPLDWPTRK-------KI 238
           ++ L G CT      ++  Y + G++   L+ R     + S  P   P  +         
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 178

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 65/135 (48%), Gaps = 12/135 (8%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY    
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA--- 77
Query: 200 TVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
            V+E+   +V  YM  GS+   L+        L  P    ++   A G++Y+        
Sbjct: 78  VVSEEPIYIVTEYMNKGSLLDFLKGETGKY--LRLPQLVDMSAQIASGMAYVERM---NY 132
Query: 258 IHRDVKAANILLDED 272
           +HRD++AANIL+ E+
Sbjct: 133 VHRDLRAANILVGEN 147

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 66/151 (43%), Gaps = 22/151 (14%)
Query: 137 KNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
           K  LG G FGKV+           D  LVAVK LK+  T      FQ E ++++   H +
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEH 78
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-QSSLPPLDWPTRK-----------KI 238
           +++ YG C      ++V+ YM +G +   LR     ++  +D   R+            I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 269
           A   A G+ YL        +HRD+   N L+
Sbjct: 139 ASQIASGMVYL---ASQHFVHRDLATRNCLV 166

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 24/154 (15%)
Query: 140 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 190
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-----QSSLPPLDWPTRK-------KI 238
           ++ L G CT      ++  Y + G++   L+ R     + S  P   P  +         
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTED 186

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 62/132 (46%), Gaps = 8/132 (6%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G  G+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY   T
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPD--AFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 ++  YM NGS+   L+    S   L       +A   A G++++ E      IH
Sbjct: 79  Q-EPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 132
Query: 260 RDVKAANILLDE 271
           RD++AANIL+ +
Sbjct: 133 RDLRAANILVSD 144

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 12/153 (7%)
Query: 128 QVATDGF---SNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKII 183
           Q A + F   S   ILG G FG+V+K    A G  +A K +K       E + + E+ ++
Sbjct: 82  QGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE-EVKNEISVM 140
Query: 184 SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 243
           +   H NL++LY    +  + +LV  Y+  G +  R+ +   +L  LD     K      
Sbjct: 141 NQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK---QIC 197
Query: 244 RGLSYLHEHCDPKIIHRDVKAANIL-LDEDADQ 275
            G+ ++H+     I+H D+K  NIL ++ DA Q
Sbjct: 198 EGIRHMHQMY---ILHLDLKPENILCVNRDAKQ 227

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 79/175 (45%), Gaps = 29/175 (16%)
Query: 116 LGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRL---ADG---KLVAVKRLKEERT 169
           + Q K+  L+E+ ++   F  +  LG   FGKVYKG L   A G   + VA+K LK++  
Sbjct: 12  INQHKQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE 69
Query: 170 SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL--------- 220
                +F+ E  + +   H N++ L G  T      +++ Y ++G +   L         
Sbjct: 70  GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDV 129
Query: 221 ------RERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 269
                 R  +S+L P   P    +    A G+ YL  H    ++H+D+   N+L+
Sbjct: 130 GSTDDDRTVKSALEP---PDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV 178

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 68/143 (47%), Gaps = 16/143 (11%)
Query: 140 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 192
           LG G FGKV +         D  L VAVK LK    +  +    +E+KI+S +  H N++
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRER-QSSLP-----PLDWPTRKKIALGSARGL 246
            L G CT     L++  Y   G + + LR + ++ L      PL+       +   A+G+
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 165
Query: 247 SYLHEHCDPKIIHRDVKAANILL 269
           ++L        IHRDV A N+LL
Sbjct: 166 AFL---ASKNCIHRDVAARNVLL 185

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 65/142 (45%), Gaps = 19/142 (13%)
Query: 140 LGRGGFGKVY-----KGRLADGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLL 192
           LG G FGKV            G++VAVK LKE    G +L+  +Q E++I+    H +++
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKE--GCGPQLRSGWQREIEILRTLYHEHIV 73
Query: 193 RLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
           +  G C    EK   LV  Y+  GS+   L      L  L        A     G++YLH
Sbjct: 74  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICEGMAYLH 128
Query: 251 EHCDPKIIHRDVKAANILLDED 272
                  IHR + A N+LLD D
Sbjct: 129 AQ---HYIHRALAARNVLLDND 147

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 71/158 (44%), Gaps = 31/158 (19%)
Query: 139 ILGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNL 191
           +LG G FGKV         +      VAVK LKE+  S       +E+K+++ +  H N+
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 192 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP--PLDWPTRKKI----------- 238
           + L G CT      L++ Y   G + + LR ++       +++  +K++           
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 239 ------ALGSARGLSYLH-EHCDPKIIHRDVKAANILL 269
                 A   A+G+ +L  + C    +HRD+ A N+L+
Sbjct: 172 EDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLV 205

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 68/143 (47%), Gaps = 16/143 (11%)
Query: 140 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 192
           LG G FGKV +         D  L VAVK LK    +  +    +E+KI+S +  H N++
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRER-QSSLP-----PLDWPTRKKIALGSARGL 246
            L G CT     L++  Y   G + + LR + ++ L      PL+       +   A+G+
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 173
Query: 247 SYLHEHCDPKIIHRDVKAANILL 269
           ++L        IHRDV A N+LL
Sbjct: 174 AFL---ASKNCIHRDVAARNVLL 193

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 65/142 (45%), Gaps = 19/142 (13%)
Query: 140 LGRGGFGKVY-----KGRLADGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLL 192
           LG G FGKV            G++VAVK LKE    G +L+  +Q E++I+    H +++
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKE--GCGPQLRSGWQREIEILRTLYHEHIV 74
Query: 193 RLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
           +  G C    EK   LV  Y+  GS+   L      L  L        A     G++YLH
Sbjct: 75  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICEGMAYLH 129
Query: 251 EHCDPKIIHRDVKAANILLDED 272
                  IHR + A N+LLD D
Sbjct: 130 AQ---HYIHRALAARNVLLDND 148

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 78/170 (45%), Gaps = 23/170 (13%)
Query: 111 DSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS 170
           DS L L ++K   +   +V T    +  ++G+G FG VY G   D     ++   +  + 
Sbjct: 4   DSAL-LAEVKDVLIPHERVVT---HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR 59
Query: 171 GGELQ----FQTEVKIISMAVHRNLLRLYGFCTTVTEKL--LVYPYMTNGSVASRLRERQ 224
             E+Q    F  E  ++    H N+L L G      E L  ++ PYM +G +   +R  Q
Sbjct: 60  ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP-PEGLPHVLLPYMCHGDLLQFIRSPQ 118
Query: 225 SSLPPLDWPTRKKI---ALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 271
            +      PT K +    L  ARG+ YL E    K +HRD+ A N +LDE
Sbjct: 119 RN------PTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDE 159

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 70/156 (44%), Gaps = 28/156 (17%)
Query: 140 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 190
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDW---PTRK----------- 236
           ++ L G CT      ++  Y + G++   L+ R+   P L++   P+             
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRP--PGLEYCYNPSHNPEEQLSSKDLV 138
Query: 237 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
             A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 139 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTED 171

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/145 (24%), Positives = 72/145 (49%), Gaps = 8/145 (5%)
Query: 130 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 187
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           H N+++L     T  +  LV+ ++   S+  +     S+L  +  P  K       +GL+
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           + H H   +++HRD+K  N+L++ +
Sbjct: 121 FCHSH---RVLHRDLKPENLLINTE 142

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/145 (24%), Positives = 72/145 (49%), Gaps = 8/145 (5%)
Query: 130 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 187
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           H N+++L     T  +  LV+ ++   S+  +     S+L  +  P  K       +GL+
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           + H H   +++HRD+K  N+L++ +
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTE 140

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 70/156 (44%), Gaps = 28/156 (17%)
Query: 140 LGRGGFGKVY--------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRN 190
           LG G FG+V         K +      VAVK LK + T        +E++++ M   H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDW---PTRK----------- 236
           ++ L G CT      ++  Y + G++   L+ R+   P L++   P+             
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRP--PGLEYCYNPSHNPEEQLSSKDLV 153
Query: 237 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
             A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTED 186

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 70/136 (51%), Gaps = 10/136 (7%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 198
           +G G +G VYK + + G++VA+KR++ +    G       E+ ++    H N++ L    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS-ARGLSYLHEHCDPKI 257
            +     LV+ +M    +   L E ++ L      ++ KI L    RG+++ H+H   +I
Sbjct: 89  HSERCLTLVFEFMEK-DLKKVLDENKTGLQ----DSQIKIYLYQLLRGVAHCHQH---RI 140
Query: 258 IHRDVKAANILLDEDA 273
           +HRD+K  N+L++ D 
Sbjct: 141 LHRDLKPQNLLINSDG 156

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 77/155 (49%), Gaps = 20/155 (12%)
Query: 124 LRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKI 182
           L E     D   ++ +LG+G +G VY GR L++   +A+K +  ER S        E+ +
Sbjct: 14  LLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP-ERDSRYSQPLHEEIAL 72
Query: 183 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN---GSVASRLRERQSSLP----PLDWPTR 235
                H+N+++  G   + +E   +  +M     GS+++ LR +   L      + + T+
Sbjct: 73  HKHLKHKNIVQYLG---SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK 129
Query: 236 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 270
           + +      GL YLH   D +I+HRD+K  N+L++
Sbjct: 130 QIL-----EGLKYLH---DNQIVHRDIKGDNVLIN 156

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 67/140 (47%), Gaps = 13/140 (9%)
Query: 140 LGRGGFGKVYKGRLA-----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           LG G FGKV   R        G+ VAVK LK E         + E++I+    H N+++ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 195 YGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
            G CT        L+  ++ +GS+   L + ++    ++   + K A+   +G+ YL   
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYLGSR 145
Query: 253 CDPKIIHRDVKAANILLDED 272
              + +HRD+ A N+L++ +
Sbjct: 146 ---QYVHRDLAARNVLVESE 162

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 67/140 (47%), Gaps = 13/140 (9%)
Query: 140 LGRGGFGKVYKGRLA-----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           LG G FGKV   R        G+ VAVK LK E         + E++I+    H N+++ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 195 YGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
            G CT        L+  ++ +GS+   L + ++    ++   + K A+   +G+ YL   
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYLGSR 133
Query: 253 CDPKIIHRDVKAANILLDED 272
              + +HRD+ A N+L++ +
Sbjct: 134 ---QYVHRDLAARNVLVESE 150

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 70/136 (51%), Gaps = 10/136 (7%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 198
           +G G +G VYK + + G++VA+KR++ +    G       E+ ++    H N++ L    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS-ARGLSYLHEHCDPKI 257
            +     LV+ +M    +   L E ++ L      ++ KI L    RG+++ H+H   +I
Sbjct: 89  HSERCLTLVFEFMEK-DLKKVLDENKTGLQ----DSQIKIYLYQLLRGVAHCHQH---RI 140
Query: 258 IHRDVKAANILLDEDA 273
           +HRD+K  N+L++ D 
Sbjct: 141 LHRDLKPQNLLINSDG 156

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 66/151 (43%), Gaps = 13/151 (8%)
Query: 129 VATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVK--RLKEERTSGGELQFQT--EVKII 183
           +AT  +     +G G +G VYK R    G  VA+K  R+      GG L   T  EV ++
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 184 ---SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWP--TRKKI 238
                  H N++RL   C T      +   +    V   LR      PP   P  T K +
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 269
                RGL +LH +C   I+HRD+K  NIL+
Sbjct: 126 MRQFLRGLDFLHANC---IVHRDLKPENILV 153

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 68/149 (45%), Gaps = 22/149 (14%)
Query: 140 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 192
           LG G FGKV +         D  L VAVK LK    +  +    +E+KI+S +  H N++
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ----------SSLPPLDWPTRKKIALGS 242
            L G CT     L++  Y   G + + LR ++          S  P     +R  +   S
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSS 173
Query: 243 --ARGLSYLHEHCDPKIIHRDVKAANILL 269
             A+G+++L        IHRDV A N+LL
Sbjct: 174 QVAQGMAFL---ASKNCIHRDVAARNVLL 199

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/145 (24%), Positives = 72/145 (49%), Gaps = 8/145 (5%)
Query: 130 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 187
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           H N+++L     T  +  LV+ ++   S+  +     S+L  +  P  K       +GL+
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           + H H   +++HRD+K  N+L++ +
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTE 141

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/145 (24%), Positives = 72/145 (49%), Gaps = 8/145 (5%)
Query: 130 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 187
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           H N+++L     T  +  LV+ ++   S+  +     S+L  +  P  K       +GL+
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           + H H   +++HRD+K  N+L++ +
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTE 142

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 71/145 (48%), Gaps = 25/145 (17%)
Query: 139 ILGRGGFGKVYKGRLADGKLVAVKRLK-EERTSGGELQFQTEVKIISM--AVHRNLLRLY 195
           +  RG FG V+K +L + + VAVK    +++ S     +Q E ++ S+    H N+L+  
Sbjct: 31  VKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQS-----WQNEYEVYSLPGMKHENILQFI 84
Query: 196 GF---CTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 251
           G     T+V   L L+  +   GS++  L+    S     W     IA   ARGL+YLHE
Sbjct: 85  GAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVS-----WNELCHIAETMARGLAYLHE 139
Query: 252 HC-------DPKIIHRDVKAANILL 269
                     P I HRD+K+ N+LL
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLL 164

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 61/140 (43%), Gaps = 15/140 (10%)
Query: 140 LGRGGFGKVY-----KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           LG G FGKV            G++VAVK LK +        ++ E+ I+    H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 195 YGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
            G C    EK   LV  Y+  GS+   L      L  L        A     G++YLH  
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHSQ 136
Query: 253 CDPKIIHRDVKAANILLDED 272
                IHR++ A N+LLD D
Sbjct: 137 ---HYIHRNLAARNVLLDND 153

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 10/134 (7%)
Query: 140 LGRGGFGKVYKGR--LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 197
           LG G +  VYKG+  L D  LVA+K ++ E   G       EV ++    H N++ L+  
Sbjct: 10  LGEGTYATVYKGKSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 198 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
             T     LV+ Y+ +  +   L +  +    ++    K       RGL+Y H     K+
Sbjct: 69  IHTEKSLTLVFEYL-DKDLKQYLDDCGNI---INMHNVKLFLFQLLRGLAYCHRQ---KV 121
Query: 258 IHRDVKAANILLDE 271
           +HRD+K  N+L++E
Sbjct: 122 LHRDLKPQNLLINE 135

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 67/147 (45%), Gaps = 20/147 (13%)
Query: 140 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 192
           LG G FGKV +         D  L VAVK LK    +  +    +E+KI+S +  H N++
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPL-----DWPTRKKIALGS-- 242
            L G CT     L++  Y   G + + LR +   L   P          TR  +   S  
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQV 173
Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILL 269
           A+G+++L        IHRDV A N+LL
Sbjct: 174 AQGMAFL---ASKNCIHRDVAARNVLL 197

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 60/138 (43%), Gaps = 10/138 (7%)
Query: 132 DGFSNKNILGRGGFGKVYKGRLADGK-LVAVKRLKEERTS--GGELQFQTEVKIISMAVH 188
           D F     LG+G FG VY  R      +VA+K L + +    G E Q + E++I +   H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 248
            N+LRLY +        L+  Y   G +   L++  +     D      I    A  L Y
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCT----FDEQRTATIMEELADALMY 138
Query: 249 LHEHCDPKIIHRDVKAAN 266
            H     K+IHRD+K  N
Sbjct: 139 CH---GKKVIHRDIKPEN 153

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 77/146 (52%), Gaps = 15/146 (10%)
Query: 140 LGRGGFGKVYKG---RLAD-GKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 191
           LG+G F K++KG    + D G+L    V +K L +   +  E  F+    ++S   H++L
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEA-ASMMSKLSHKHL 74
Query: 192 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 251
           +  YG C    E +LV  ++  GS+ + L++ ++ +  L W  + ++A   A  + +L E
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINIL-W--KLEVAKQLAAAMHFLEE 131
Query: 252 HCDPKIIHRDVKAANILLDEDADQSS 277
           +    +IH +V A NILL  + D+ +
Sbjct: 132 N---TLIHGNVCAKNILLIREEDRKT 154

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 67/147 (45%), Gaps = 20/147 (13%)
Query: 140 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 192
           LG G FGKV +         D  L VAVK LK    +  +    +E+KI+S +  H N++
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL---PPLDWP-----TRKKIALGS-- 242
            L G CT     L++  Y   G + + LR +   L   P          TR  +   S  
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILL 269
           A+G+++L        IHRDV A N+LL
Sbjct: 174 AQGMAFL---ASKNCIHRDVAARNVLL 197

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 60/130 (46%), Gaps = 8/130 (6%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG+V+         VAVK +K    S     F  E  ++    H  L++L+   T
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE--AFLAEANVMKTLQHDKLVKLHAVVT 247
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 ++  +M  GS+   L+  + S  PL  P     +   A G++++ +      IH
Sbjct: 248 K-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NYIH 301
Query: 260 RDVKAANILL 269
           RD++AANIL+
Sbjct: 302 RDLRAANILV 311

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/136 (25%), Positives = 68/136 (50%), Gaps = 8/136 (5%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQT-EVKIISMAVHRNLLRLYGFC 198
           +G G +G VYK +   G+  A+K+++ E+   G       E+ I+    H N+++LY   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 258
            T    +LV+ ++ +  +   L   +  L  +   T K   L    G++Y H   D +++
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLDVCEGGLESV---TAKSFLLQLLNGIAYCH---DRRVL 122
Query: 259 HRDVKAANILLDEDAD 274
           HRD+K  N+L++ + +
Sbjct: 123 HRDLKPQNLLINREGE 138

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 61/140 (43%), Gaps = 15/140 (10%)
Query: 140 LGRGGFGKVY-----KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           LG G FGKV            G++VAVK LK +        ++ E+ I+    H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 195 YGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
            G C    EK   LV  Y+  GS+   L      L  L        A     G++YLH  
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHAQ 136
Query: 253 CDPKIIHRDVKAANILLDED 272
                IHR++ A N+LLD D
Sbjct: 137 ---HYIHRNLAARNVLLDND 153

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 60/130 (46%), Gaps = 8/130 (6%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG+V+         VAVK +K    S     F  E  ++    H  L++L+   T
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE--AFLAEANVMKTLQHDKLVKLHAVVT 80
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 ++  +M  GS+   L+  + S  PL  P     +   A G++++ +      IH
Sbjct: 81  K-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NYIH 134
Query: 260 RDVKAANILL 269
           RD++AANIL+
Sbjct: 135 RDLRAANILV 144

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/136 (25%), Positives = 68/136 (50%), Gaps = 8/136 (5%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQT-EVKIISMAVHRNLLRLYGFC 198
           +G G +G VYK +   G+  A+K+++ E+   G       E+ I+    H N+++LY   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 258
            T    +LV+ ++ +  +   L   +  L  +   T K   L    G++Y H   D +++
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLDVCEGGLESV---TAKSFLLQLLNGIAYCH---DRRVL 122
Query: 259 HRDVKAANILLDEDAD 274
           HRD+K  N+L++ + +
Sbjct: 123 HRDLKPQNLLINREGE 138

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/136 (25%), Positives = 68/136 (50%), Gaps = 8/136 (5%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQT-EVKIISMAVHRNLLRLYGFC 198
           +G G +G VYK +   G+  A+K+++ E+   G       E+ I+    H N+++LY   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 258
            T    +LV+ ++ +  +   L   +  L  +   T K   L    G++Y H   D +++
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLLDVCEGGLESV---TAKSFLLQLLNGIAYCH---DRRVL 122
Query: 259 HRDVKAANILLDEDAD 274
           HRD+K  N+L++ + +
Sbjct: 123 HRDLKPQNLLINREGE 138

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 22/165 (13%)
Query: 124 LRELQVATDGFSNKNILGRGGFGKVYKGRL--ADGKLV--AVKRLKEERTSGGELQ-FQT 178
           L ++ +    F+   +LG+G FG V + +L   DG  V  AVK LK +  +  +++ F  
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 179 EVKIISMAVHRNLLRLYGFCTTVTEK------LLVYPYMTNGSV-----ASRLRERQSSL 227
           E   +    H ++ +L G       K      +++ P+M +G +     ASR+ E   +L
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 228 PPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           P     T  +  +  A G+ YL        IHRD+ A N +L ED
Sbjct: 135 P---LQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED 173

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 76/153 (49%), Gaps = 20/153 (13%)
Query: 126 ELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS 184
           E     D   ++ +LG+G +G VY GR L++   +A+K +  ER S        E+ +  
Sbjct: 2   EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP-ERDSRYSQPLHEEIALHK 60
Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTN---GSVASRLRERQSSLP----PLDWPTRKK 237
              H+N+++  G   + +E   +  +M     GS+++ LR +   L      + + T++ 
Sbjct: 61  HLKHKNIVQYLG---SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI 117
Query: 238 IALGSARGLSYLHEHCDPKIIHRDVKAANILLD 270
           +      GL YLH   D +I+HRD+K  N+L++
Sbjct: 118 L-----EGLKYLH---DNQIVHRDIKGDNVLIN 142

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 60/130 (46%), Gaps = 8/130 (6%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG+V+         VAVK +K    S     F  E  ++    H  L++L+   T
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE--AFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
                 ++  +M  GS+   L+  + S  PL  P     +   A G++++ +      IH
Sbjct: 254 K-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NYIH 307
Query: 260 RDVKAANILL 269
           RD++AANIL+
Sbjct: 308 RDLRAANILV 317

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 71/148 (47%), Gaps = 17/148 (11%)
Query: 129 VATDGFSNKNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIIS 184
           +A +      ILG G FG+VY+G   + K     VAVK  K++ T   + +F +E  I+ 
Sbjct: 5   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 64
Query: 185 MAVHRNLLRLYGFCTTVTEKLLV--YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 242
              H ++++L G        +++  YPY   G +   L   ++SL  L   T    +L  
Sbjct: 65  NLDHPHIVKLIGIIEEEPTWIIMELYPY---GELGHYLERNKNSLKVL---TLVLYSLQI 118
Query: 243 ARGLSYLHE-HCDPKIIHRDVKAANILL 269
            + ++YL   +C    +HRD+   NIL+
Sbjct: 119 CKAMAYLESINC----VHRDIAVRNILV 142

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 76/174 (43%), Gaps = 34/174 (19%)
Query: 117 GQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRL---ADG---KLVAVKRLKEERTS 170
           G+LK  SL  ++   +       LG   FGKVYKG L   A G   + VA+K LK++   
Sbjct: 1   GKLKEISLSAVRFMEE-------LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG 53
Query: 171 GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL---------- 220
               +F+ E  + +   H N++ L G  T      +++ Y ++G +   L          
Sbjct: 54  PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVG 113
Query: 221 -----RERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 269
                R  +S+L P   P    +    A G+ YL  H    ++H+D+   N+L+
Sbjct: 114 STDDDRTVKSALEP---PDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV 161

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/143 (25%), Positives = 69/143 (48%), Gaps = 8/143 (5%)
Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 189
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GLS+ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLSFC 119
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
           H H   +++HRD+K  N+L++ +
Sbjct: 120 HSH---RVLHRDLKPQNLLINTE 139

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 129 VATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMA 186
           V  + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++   
Sbjct: 4   VDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 187 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
            H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGL 120
Query: 247 SYLHEHCDPKIIHRDVKAANILLDED 272
           ++ H H   +++HRD+K  N+L++ +
Sbjct: 121 AFCHSH---RVLHRDLKPQNLLINTE 143

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 71/148 (47%), Gaps = 17/148 (11%)
Query: 129 VATDGFSNKNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIIS 184
           +A +      ILG G FG+VY+G   + K     VAVK  K++ T   + +F +E  I+ 
Sbjct: 9   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 68
Query: 185 MAVHRNLLRLYGFCTTVTEKLLV--YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 242
              H ++++L G        +++  YPY   G +   L   ++SL  L   T    +L  
Sbjct: 69  NLDHPHIVKLIGIIEEEPTWIIMELYPY---GELGHYLERNKNSLKVL---TLVLYSLQI 122
Query: 243 ARGLSYLHE-HCDPKIIHRDVKAANILL 269
            + ++YL   +C    +HRD+   NIL+
Sbjct: 123 CKAMAYLESINC----VHRDIAVRNILV 146

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 72/150 (48%), Gaps = 11/150 (7%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERT-SGGELQF-QTEVKIIS 184
           ++  D F    +LG+G FGKV   R+ + G L AVK LK++      +++   TE +I+S
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 185 MAVHRNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 243
           +A +   L     C    ++L  V  ++  G +   +++ +      D    +  A    
Sbjct: 79  LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR----FDEARARFYAAEII 134
Query: 244 RGLSYLHEHCDPKIIHRDVKAANILLDEDA 273
             L +LH   D  II+RD+K  N+LLD + 
Sbjct: 135 SALMFLH---DKGIIYRDLKLDNVLLDHEG 161

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 59/140 (42%), Gaps = 15/140 (10%)
Query: 140 LGRGGFGKVY-----KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           LG G FGKV            G++VAVK LK +        ++ E+ I+    H ++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 195 YGFC--TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
            G C         LV  Y+  GS+   L      L  L        A     G++YLH  
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHAQ 153
Query: 253 CDPKIIHRDVKAANILLDED 272
                IHRD+ A N+LLD D
Sbjct: 154 ---HYIHRDLAARNVLLDND 170

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 71/148 (47%), Gaps = 17/148 (11%)
Query: 129 VATDGFSNKNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIIS 184
           +A +      ILG G FG+VY+G   + K     VAVK  K++ T   + +F +E  I+ 
Sbjct: 21  IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 80
Query: 185 MAVHRNLLRLYGFCTTVTEKLLV--YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 242
              H ++++L G        +++  YPY   G +   L   ++SL  L   T    +L  
Sbjct: 81  NLDHPHIVKLIGIIEEEPTWIIMELYPY---GELGHYLERNKNSLKVL---TLVLYSLQI 134
Query: 243 ARGLSYLHE-HCDPKIIHRDVKAANILL 269
            + ++YL   +C    +HRD+   NIL+
Sbjct: 135 CKAMAYLESINC----VHRDIAVRNILV 158

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 130 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 187
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KTFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 248 YLHEHCDPKIIHRDVKAANILLDEDA 273
           + H H   +++HRD+K  N+L++ + 
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEG 143

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 77/146 (52%), Gaps = 15/146 (10%)
Query: 140 LGRGGFGKVYKG---RLAD-GKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 191
           LG+G F K++KG    + D G+L    V +K L +   +  E  F+    ++S   H++L
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEA-ASMMSKLSHKHL 74
Query: 192 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 251
           +  YG C    E +LV  ++  GS+ + L++ ++ +  L W  + ++A   A  + +L E
Sbjct: 75  VLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINIL-W--KLEVAKQLAWAMHFLEE 131
Query: 252 HCDPKIIHRDVKAANILLDEDADQSS 277
           +    +IH +V A NILL  + D+ +
Sbjct: 132 N---TLIHGNVCAKNILLIREEDRKT 154

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 64/139 (46%), Gaps = 20/139 (14%)
Query: 140 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 198
           +G G  G V    + + GKLVAVK++   +    EL F  EV I+    H N++ +Y   
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 95
Query: 199 TTVTEKLLVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
               E  +V  ++  G++      +R+ E Q +           + L   + LS LH   
Sbjct: 96  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----------AVCLAVLQALSVLHAQ- 144
Query: 254 DPKIIHRDVKAANILLDED 272
              +IHRD+K+ +ILL  D
Sbjct: 145 --GVIHRDIKSDSILLTHD 161

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 64/140 (45%), Gaps = 20/140 (14%)
Query: 140 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 198
           +G G  G V    + + GKLVAVK++   +    EL F  EV I+    H N++ +Y   
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 217
Query: 199 TTVTEKLLVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
               E  +V  ++  G++      +R+ E Q +           + L   + LS LH   
Sbjct: 218 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----------AVCLAVLQALSVLHAQ- 266
Query: 254 DPKIIHRDVKAANILLDEDA 273
              +IHRD+K+ +ILL  D 
Sbjct: 267 --GVIHRDIKSDSILLTHDG 284

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 64/139 (46%), Gaps = 20/139 (14%)
Query: 140 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 198
           +G G  G V    + + GKLVAVK++   +    EL F  EV I+    H N++ +Y   
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 86
Query: 199 TTVTEKLLVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
               E  +V  ++  G++      +R+ E Q +           + L   + LS LH   
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----------AVCLAVLQALSVLHAQ- 135
Query: 254 DPKIIHRDVKAANILLDED 272
              +IHRD+K+ +ILL  D
Sbjct: 136 --GVIHRDIKSDSILLTHD 152

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 64/139 (46%), Gaps = 20/139 (14%)
Query: 140 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 198
           +G G  G V    + + GKLVAVK++   +    EL F  EV I+    H N++ +Y   
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 97
Query: 199 TTVTEKLLVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
               E  +V  ++  G++      +R+ E Q +           + L   + LS LH   
Sbjct: 98  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----------AVCLAVLQALSVLHAQ- 146
Query: 254 DPKIIHRDVKAANILLDED 272
              +IHRD+K+ +ILL  D
Sbjct: 147 --GVIHRDIKSDSILLTHD 163

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 73/149 (48%), Gaps = 14/149 (9%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA 186
           Q   +   N   +G G  G+V+K R    G ++AVK++   R SG + + +  +  + + 
Sbjct: 21  QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM---RRSGNKEENKRILMDLDVV 77
Query: 187 VHRN----LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 242
           +  +    +++ +G   T T+  +    M  G+ A +L++R     P+      K+ +  
Sbjct: 78  LKSHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQG--PIPERILGKMTVAI 133
Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDE 271
            + L YL E     +IHRDVK +NILLDE
Sbjct: 134 VKALYYLKEK--HGVIHRDVKPSNILLDE 160

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 65/144 (45%), Gaps = 16/144 (11%)
Query: 137 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           + +L  GGF  VY+ + +  G+  A+KRL            Q    +  ++ H N+++  
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ-- 90
Query: 196 GFCTTVT----------EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 245
            FC+  +           + L+   +  G +   L++ +S   PL   T  KI   + R 
Sbjct: 91  -FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR-GPLSCDTVLKIFYQTCRA 148
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           + ++H    P IIHRD+K  N+LL
Sbjct: 149 VQHMHRQ-KPPIIHRDLKVENLLL 171

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 72/147 (48%), Gaps = 12/147 (8%)
Query: 130 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 187
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARG 245
           H N+++L     T  +  LV+ ++        L++    S+L  +  P  K       +G
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-----LKDFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 246 LSYLHEHCDPKIIHRDVKAANILLDED 272
           L++ H H   +++HRD+K  N+L++ +
Sbjct: 116 LAFCHSH---RVLHRDLKPENLLINTE 139

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 70/145 (48%), Gaps = 8/145 (5%)
Query: 130 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 187
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           + H H   +++HRD+K  N+L++ +
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTE 139

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 70/145 (48%), Gaps = 8/145 (5%)
Query: 130 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 187
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           + H H   +++HRD+K  N+L++ +
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTE 139

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 70/145 (48%), Gaps = 8/145 (5%)
Query: 130 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 187
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           + H H   +++HRD+K  N+L++ +
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTE 142

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 70/145 (48%), Gaps = 8/145 (5%)
Query: 130 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 187
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           + H H   +++HRD+K  N+L++ +
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTE 141

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 70/145 (48%), Gaps = 8/145 (5%)
Query: 130 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 187
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           + H H   +++HRD+K  N+L++ +
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTE 139

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 13/153 (8%)
Query: 126 ELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEV--KI 182
           ++++  + F    +LG+G FGKV+        +  A+K LK++     +    T V  ++
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 183 ISMAVHRNLLRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL 240
           +S+A     L  + FCT  T++    V  Y+  G +   ++    S    D       A 
Sbjct: 72  LSLAWEHPFLT-HMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAA 126
Query: 241 GSARGLSYLHEHCDPKIIHRDVKAANILLDEDA 273
               GL +LH      I++RD+K  NILLD+D 
Sbjct: 127 EIILGLQFLHSK---GIVYRDLKLDNILLDKDG 156

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 64/139 (46%), Gaps = 20/139 (14%)
Query: 140 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 198
           +G G  G V    + + GKLVAVK++   +    EL F  EV I+    H N++ +Y   
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 90
Query: 199 TTVTEKLLVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
               E  +V  ++  G++      +R+ E Q +           + L   + LS LH   
Sbjct: 91  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----------AVCLAVLQALSVLHAQ- 139
Query: 254 DPKIIHRDVKAANILLDED 272
              +IHRD+K+ +ILL  D
Sbjct: 140 --GVIHRDIKSDSILLTHD 156

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 70/145 (48%), Gaps = 8/145 (5%)
Query: 130 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 187
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           + H H   +++HRD+K  N+L++ +
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTE 140

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 70/145 (48%), Gaps = 8/145 (5%)
Query: 130 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 187
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           + H H   +++HRD+K  N+L++ +
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTE 140

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 68/147 (46%), Gaps = 21/147 (14%)
Query: 133 GFSNKNILGRGGFGKVYKGRLADGKLVAVKR-LKEERTSGGELQFQTEVKIISMAVHRNL 191
            ++N  ++G G FG V++ +L +   VA+K+ L+++R    ELQ    VK      H N+
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVK------HPNV 94
Query: 192 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 243
           + L  F  +  +K        +L Y   T    +    + + ++P L     K       
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML---LIKLYMYQLL 151
Query: 244 RGLSYLHEHCDPKIIHRDVKAANILLD 270
           R L+Y+H      I HRD+K  N+LLD
Sbjct: 152 RSLAYIHSI---GICHRDIKPQNLLLD 175

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 77/162 (47%), Gaps = 29/162 (17%)
Query: 127 LQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLK--EERTSGGELQFQTEVKII 183
           L+ A+D F    +LG+G FG+V K R A D +  A+K+++  EE+ S       +EV ++
Sbjct: 2   LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS----TILSEVMLL 56
Query: 184 SMAVHRNLLRLYGF----------CTTVTEKLLVY---PYMTNGSVASRLR-ERQSSLPP 229
           +   H+ ++R Y             T V +K  ++    Y  NG++   +  E  +    
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116
Query: 230 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 271
             W   ++I       LSY+H      IIHRD+K  NI +DE
Sbjct: 117 EYWRLFRQIL----EALSYIHSQG---IIHRDLKPMNIFIDE 151

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 70/145 (48%), Gaps = 8/145 (5%)
Query: 130 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 187
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           + H H   +++HRD+K  N+L++ +
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTE 139

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 70/145 (48%), Gaps = 8/145 (5%)
Query: 130 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 187
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           + H H   +++HRD+K  N+L++ +
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTE 141

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 70/145 (48%), Gaps = 8/145 (5%)
Query: 130 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 187
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           + H H   +++HRD+K  N+L++ +
Sbjct: 120 FCHSH---RVLHRDLKPENLLINTE 141

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 70/160 (43%), Gaps = 30/160 (18%)
Query: 140 LGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 198
           +G G  G V    + + GKLVAVK++   +    EL F  EV I+    H N++ +Y   
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNSY 140
Query: 199 TTVTEKLLVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
               E  +V  ++  G++      +R+ E Q +           + L   + LS LH   
Sbjct: 141 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----------AVCLAVLQALSVLHAQ- 189
Query: 254 DPKIIHRDVKAANILLDED----------ADQSSKTILRR 283
              +IHRD+K+ +ILL  D            Q SK + RR
Sbjct: 190 --GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 227

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 70/145 (48%), Gaps = 8/145 (5%)
Query: 130 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 187
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           + H H   +++HRD+K  N+L++ +
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTE 140

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 130 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 187
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 248 YLHEHCDPKIIHRDVKAANILLDEDA 273
           + H H   +++HRD+K  N+L++ + 
Sbjct: 122 FCHSH---RVLHRDLKPQNLLINTEG 144

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 130 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 187
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           H N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL+
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 248 YLHEHCDPKIIHRDVKAANILLDEDA 273
           + H H   +++HRD+K  N+L++ + 
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEG 143

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 67/146 (45%), Gaps = 23/146 (15%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           +G+G +G+V+ G+   G+ VAVK      T       +TE+    +  H N+L   GF  
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFT--TEEASWFRETEIYQTVLMRHENIL---GFIA 98
Query: 200 -------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
                  + T+  L+  Y  NGS+   L+        LD  +  K+A  S  GL +LH  
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-----LDAKSMLKLAYSSVSGLCHLHTE 153
Query: 253 C-----DPKIIHRDVKAANILLDEDA 273
                  P I HRD+K+ NIL+ ++ 
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNG 179

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 8/143 (5%)
Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 189
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
           H H   +++HRD+K  N+L++ +
Sbjct: 119 HSH---RVLHRDLKPQNLLINTE 138

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 189
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 250 HEHCDPKIIHRDVKAANILLDEDA 273
           H H   +++HRD+K  N+L++ + 
Sbjct: 127 HSH---RVLHRDLKPQNLLINTEG 147

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 8/143 (5%)
Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 189
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
           H H   +++HRD+K  N+L++ +
Sbjct: 119 HSH---RVLHRDLKPQNLLINTE 138

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 80/161 (49%), Gaps = 20/161 (12%)
Query: 129 VATDGFSNKNILGRGGFGKVY------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKI 182
           + +D +  + +LG+G FG+V        G+    K+++ +++K++      L+   EV++
Sbjct: 29  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR---EVQL 85
Query: 183 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL--RERQSSLPPLDWPTRKKIAL 240
           +    H N+++LY F        LV    T G +   +  R+R S +         +I  
Sbjct: 86  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA------ARIIR 139
Query: 241 GSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL 281
               G++Y+H++   KI+HRD+K  N+LL+  +  ++  I+
Sbjct: 140 QVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRII 177

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 8/143 (5%)
Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 189
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
           H H   +++HRD+K  N+L++ +
Sbjct: 119 HSH---RVLHRDLKPQNLLINTE 138

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 8/143 (5%)
Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 189
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
           H H   +++HRD+K  N+L++ +
Sbjct: 120 HSH---RVLHRDLKPQNLLINTE 139

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 80/161 (49%), Gaps = 20/161 (12%)
Query: 129 VATDGFSNKNILGRGGFGKVY------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKI 182
           + +D +  + +LG+G FG+V        G+    K+++ +++K++      L+   EV++
Sbjct: 23  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR---EVQL 79
Query: 183 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL--RERQSSLPPLDWPTRKKIAL 240
           +    H N+++LY F        LV    T G +   +  R+R S +         +I  
Sbjct: 80  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA------ARIIR 133
Query: 241 GSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL 281
               G++Y+H++   KI+HRD+K  N+LL+  +  ++  I+
Sbjct: 134 QVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRII 171

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 8/143 (5%)
Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 189
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
           H H   +++HRD+K  N+L++ +
Sbjct: 119 HSH---RVLHRDLKPQNLLINTE 138

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 8/143 (5%)
Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 189
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
           H H   +++HRD+K  N+L++ +
Sbjct: 121 HSH---RVLHRDLKPQNLLINTE 140

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 8/143 (5%)
Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 189
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
           H H   +++HRD+K  N+L++ +
Sbjct: 120 HSH---RVLHRDLKPQNLLINTE 139

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 8/143 (5%)
Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 189
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
           H H   +++HRD+K  N+L++ +
Sbjct: 120 HSH---RVLHRDLKPQNLLINTE 139

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 63/136 (46%), Gaps = 14/136 (10%)
Query: 140 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I +M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFY 71
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 256 KIIHRDVKAANILLDE 271
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 189
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 250 HEHCDPKIIHRDVKAANILLDEDA 273
           H H   +++HRD+K  N+L++ + 
Sbjct: 127 HSH---RVLHRDLKPQNLLINTEG 147

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 75/169 (44%), Gaps = 14/169 (8%)
Query: 109 EDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEE 167
           E D   +  Q K   L  + +  + FS   I+GRGGFG+VY  R AD GK+ A+K L ++
Sbjct: 166 ESDKFTRFCQWKNVELN-IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK 224
Query: 168 RTS--GGELQFQTEVKIISMAVHRN--LLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRE 222
           R     GE     E  ++S+    +   +    +     +KL  +   M  G +   L +
Sbjct: 225 RIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ 284
Query: 223 RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 271
                        +  A     GL ++H      +++RD+K ANILLDE
Sbjct: 285 HGV----FSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDE 326

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 75/169 (44%), Gaps = 14/169 (8%)
Query: 109 EDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEE 167
           E D   +  Q K   L  + +  + FS   I+GRGGFG+VY  R AD GK+ A+K L ++
Sbjct: 167 ESDKFTRFCQWKNVELN-IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK 225
Query: 168 RTS--GGELQFQTEVKIISMAVHRN--LLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRE 222
           R     GE     E  ++S+    +   +    +     +KL  +   M  G +   L +
Sbjct: 226 RIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ 285
Query: 223 RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 271
                        +  A     GL ++H      +++RD+K ANILLDE
Sbjct: 286 HGV----FSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDE 327

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 75/169 (44%), Gaps = 14/169 (8%)
Query: 109 EDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEE 167
           E D   +  Q K   L  + +  + FS   I+GRGGFG+VY  R AD GK+ A+K L ++
Sbjct: 167 ESDKFTRFCQWKNVELN-IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK 225
Query: 168 RTS--GGELQFQTEVKIISMAVHRN--LLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRE 222
           R     GE     E  ++S+    +   +    +     +KL  +   M  G +   L +
Sbjct: 226 RIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ 285
Query: 223 RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 271
                        +  A     GL ++H      +++RD+K ANILLDE
Sbjct: 286 HGV----FSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDE 327

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 75/169 (44%), Gaps = 14/169 (8%)
Query: 109 EDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEE 167
           E D   +  Q K   L  + +  + FS   I+GRGGFG+VY  R AD GK+ A+K L ++
Sbjct: 167 ESDKFTRFCQWKNVELN-IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK 225
Query: 168 RTS--GGELQFQTEVKIISMAVHRN--LLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRE 222
           R     GE     E  ++S+    +   +    +     +KL  +   M  G +   L +
Sbjct: 226 RIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ 285
Query: 223 RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 271
                        +  A     GL ++H      +++RD+K ANILLDE
Sbjct: 286 HGV----FSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDE 327

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 67/156 (42%), Gaps = 29/156 (18%)
Query: 140 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 192
           LG G FGKV +         D  L VAVK LK    +  +    +E+KI+S +  H N++
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP-------------------PLDWP 233
            L G CT     L++  Y   G + + LR +  ++                    PL+  
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELR 158
Query: 234 TRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 269
                +   A+G+++L        IHRDV A N+LL
Sbjct: 159 DLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLL 191

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 140 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 70
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 256 KIIHRDVKAANILLDE 271
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 13/153 (8%)
Query: 126 ELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEV--KI 182
           ++++  + F    +LG+G FGKV+        +  A+K LK++     +    T V  ++
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 183 ISMAVHRNLLRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL 240
           +S+A     L  + FCT  T++    V  Y+  G +   ++    S    D       A 
Sbjct: 71  LSLAWEHPFLT-HMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAA 125
Query: 241 GSARGLSYLHEHCDPKIIHRDVKAANILLDEDA 273
               GL +LH      I++RD+K  NILLD+D 
Sbjct: 126 EIILGLQFLHSK---GIVYRDLKLDNILLDKDG 155

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 8/143 (5%)
Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 189
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQDL---KTFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
           H H   +++HRD+K  N+L++ +
Sbjct: 119 HSH---RVLHRDLKPQNLLINTE 138

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/148 (25%), Positives = 72/148 (48%), Gaps = 12/148 (8%)
Query: 130 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV 187
           + + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARG 245
           H N+++L     T  +  LV+ +     V   L++    S+L  +  P  K       +G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEH-----VDQDLKKFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 246 LSYLHEHCDPKIIHRDVKAANILLDEDA 273
           L++ H H   +++HRD+K  N+L++ + 
Sbjct: 119 LAFCHSH---RVLHRDLKPQNLLINTEG 143

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 140 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 70
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 256 KIIHRDVKAANILLDE 271
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 140 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 71
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 256 KIIHRDVKAANILLDE 271
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 80/161 (49%), Gaps = 20/161 (12%)
Query: 129 VATDGFSNKNILGRGGFGKVY------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKI 182
           + +D +  + +LG+G FG+V        G+    K+++ +++K++      L+   EV++
Sbjct: 46  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR---EVQL 102
Query: 183 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL--RERQSSLPPLDWPTRKKIAL 240
           +    H N+++LY F        LV    T G +   +  R+R S +         +I  
Sbjct: 103 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA------ARIIR 156
Query: 241 GSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL 281
               G++Y+H++   KI+HRD+K  N+LL+  +  ++  I+
Sbjct: 157 QVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRII 194

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 140 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           LG+G FG V   R   L D  G++VAVK+L +  T      F+ E++I+    H N+++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 195 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 249
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 130
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
                 + IHRD+   NIL++ +
Sbjct: 131 ---GTKRYIHRDLATRNILVENE 150

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 80/161 (49%), Gaps = 20/161 (12%)
Query: 129 VATDGFSNKNILGRGGFGKVY------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKI 182
           + +D +  + +LG+G FG+V        G+    K+++ +++K++      L+   EV++
Sbjct: 47  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR---EVQL 103
Query: 183 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL--RERQSSLPPLDWPTRKKIAL 240
           +    H N+++LY F        LV    T G +   +  R+R S +         +I  
Sbjct: 104 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA------ARIIR 157
Query: 241 GSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL 281
               G++Y+H++   KI+HRD+K  N+LL+  +  ++  I+
Sbjct: 158 QVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRII 195

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 140 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           LG+G FG V   R   L D  G++VAVK+L +  T      F+ E++I+    H N+++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 195 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 249
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 133
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
                 + IHRD+   NIL++ +
Sbjct: 134 ---GTKRYIHRDLATRNILVENE 153

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 140 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           LG+G FG V   R   L D  G++VAVK+L +  T      F+ E++I+    H N+++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 195 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 249
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 130
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
                 + IHRD+   NIL++ +
Sbjct: 131 ---GTKRYIHRDLATRNILVENE 150

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 20/160 (12%)
Query: 124 LRELQVATDGFSNKN-------ILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQ 175
           + EL+    G SN          +GRG F  VYKG   +  + VA   L++ + +  E Q
Sbjct: 11  IEELETKAVGXSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ 70
Query: 176 -FQTEVKIISMAVHRNLLRLY-GFCTTVTEK---LLVYPYMTNGSVASRL-RERQSSLPP 229
            F+ E + +    H N++R Y  + +TV  K   +LV    T+G++ + L R +   +  
Sbjct: 71  RFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKV 130
Query: 230 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 269
           L    R+ +     +GL +LH    P IIHRD+K  NI +
Sbjct: 131 LRSWCRQIL-----KGLQFLHTR-TPPIIHRDLKCDNIFI 164

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 140 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           LG+G FG V   R   L D  G++VAVK+L +  T      F+ E++I+    H N+++ 
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 195 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 249
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 135
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
                 + IHRD+   NIL++ +
Sbjct: 136 ---GTKRYIHRDLATRNILVENE 155

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 140 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           LG+G FG V   R   L D  G++VAVK+L +  T      F+ E++I+    H N+++ 
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 195 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 249
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 136
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
                 + IHRD+   NIL++ +
Sbjct: 137 ---GTKRYIHRDLATRNILVENE 156

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 140 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           LG+G FG V   R   L D  G++VAVK+L +  T      F+ E++I+    H N+++ 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 195 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 249
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 148
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
                 + IHRD+   NIL++ +
Sbjct: 149 ---GTKRYIHRDLATRNILVENE 168

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 140 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 195 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 249
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 137
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
                 + IHRD+   NIL++ +
Sbjct: 138 ---GTKRYIHRDLATRNILVENE 157

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 140 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           LG+G FG V   R   L D  G++VAVK+L +  T      F+ E++I+    H N+++ 
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 195 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 249
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 161
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
                 + IHRD+   NIL++ +
Sbjct: 162 ---GTKRYIHRDLATRNILVENE 181

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 140 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           LG+G FG V   R   L D  G++VAVK+L +  T      F+ E++I+    H N+++ 
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 195 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 249
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 129
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
                 + IHRD+   NIL++ +
Sbjct: 130 ---GTKRYIHRDLATRNILVENE 149

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 140 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 256 KIIHRDVKAANILLDE 271
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 140 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           LG+G FG V   R   L D  G++VAVK+L +  T      F+ E++I+    H N+++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 195 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 249
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 130
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
                 + IHRD+   NIL++ +
Sbjct: 131 ---GTKRYIHRDLATRNILVENE 150

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 140 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 195 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 249
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 148
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
                 + IHRD+   NIL++ +
Sbjct: 149 ---GTKRYIHRDLATRNILVENE 168

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 140 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           LG+G FG V   R   L D  G++VAVK+L +  T      F+ E++I+    H N+++ 
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEILKSLQHDNIVKY 74
Query: 195 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 249
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 75  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 128
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
                 + IHRD+   NIL++ +
Sbjct: 129 ---GTKRYIHRDLATRNILVENE 148

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 140 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 195 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 249
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 81  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 134
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
                 + IHRD+   NIL++ +
Sbjct: 135 GTK---RYIHRDLATRNILVENE 154

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 140 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 256 KIIHRDVKAANILLDE 271
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 140 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 256 KIIHRDVKAANILLDE 271
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 140 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 256 KIIHRDVKAANILLDE 271
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 140 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 256 KIIHRDVKAANILLDE 271
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 140 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 256 KIIHRDVKAANILLDE 271
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 140 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 256 KIIHRDVKAANILLDE 271
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 140 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 13  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 69
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 70  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 122
Query: 256 KIIHRDVKAANILLDE 271
            I HRD+K  N+LLDE
Sbjct: 123 GITHRDIKPENLLLDE 138

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 140 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 256 KIIHRDVKAANILLDE 271
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 140 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 195 YGFCTTVTEK--LLVYPYMTNGSVASRLR---ERQSSLPPLDWPTRKKIALGSARGLSYL 249
            G C +   +   L+  Y+  GS+   L+   ER   +  L + ++        +G+ YL
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQ------ICKGMEYL 133
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
                 + IHRD+   NIL++ +
Sbjct: 134 ---GTKRYIHRDLATRNILVENE 153

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 140 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 256 KIIHRDVKAANILLDE 271
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 140 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 256 KIIHRDVKAANILLDE 271
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 140 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 256 KIIHRDVKAANILLDE 271
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 67/140 (47%), Gaps = 17/140 (12%)
Query: 134 FSNKNILGRGGFGKVY--KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 191
           F    +LG G F +V+  K RL  GKL A+K +K+   +  +   + E+ ++    H N+
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLT-GKLFALKCIKK-SPAFRDSSLENEIAVLKKIKHENI 68
Query: 192 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS---Y 248
           + L     + T   LV   ++ G +  R+ ER          T K  +L   + LS   Y
Sbjct: 69  VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVY-------TEKDASLVIQQVLSAVKY 121
Query: 249 LHEHCDPKIIHRDVKAANIL 268
           LHE+    I+HRD+K  N+L
Sbjct: 122 LHEN---GIVHRDLKPENLL 138

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 67/151 (44%), Gaps = 28/151 (18%)
Query: 138 NILGRGGFGKVYKGRLADGKLVAVK--RLKEERTSGGELQFQTEVKIISM--AVHRNLLR 193
            I  RG FG V+K +L +   VAVK   L+++++      +Q+E +I S     H NLL+
Sbjct: 21  EIKARGRFGCVWKAQLMN-DFVAVKIFPLQDKQS------WQSEREIFSTPGMKHENLLQ 73
Query: 194 LYGF----CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
                        E  L+  +   GS+   L+        + W     +A   +RGLSYL
Sbjct: 74  FIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGNI-----ITWNELCHVAETMSRGLSYL 128
Query: 250 HEHC--------DPKIIHRDVKAANILLDED 272
           HE           P I HRD K+ N+LL  D
Sbjct: 129 HEDVPWCRGEGHKPSIAHRDFKSKNVLLKSD 159

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 140 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 256 KIIHRDVKAANILLDE 271
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 140 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 256 KIIHRDVKAANILLDE 271
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 140 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 15  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 124
Query: 256 KIIHRDVKAANILLDE 271
            I HRD+K  N+LLDE
Sbjct: 125 GITHRDIKPENLLLDE 140

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 140 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           LG G +G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 256 KIIHRDVKAANILLDE 271
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 75/165 (45%), Gaps = 17/165 (10%)
Query: 116 LGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSG 171
           LG ++    ++ +   D +  +++LG G F +V    LA+ K    LVA+K + +E   G
Sbjct: 2   LGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVI---LAEDKRTQKLVAIKCIAKEALEG 58
Query: 172 GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLD 231
            E   + E+ ++    H N++ L     +     L+   ++ G +  R+ E+        
Sbjct: 59  KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE--- 115
Query: 232 WPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL---LDEDA 273
                ++       + YLH   D  I+HRD+K  N+L   LDED+
Sbjct: 116 -RDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDS 156

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 70/143 (48%), Gaps = 19/143 (13%)
Query: 137 KNILGRGGFGKV-----YKGRLADGKLVAVKRLKEE--RTSGGELQFQTEVKIISMAVHR 189
           +  LG G FGKV     YK +    + VA+K +  +  + S   ++ + E+  + +  H 
Sbjct: 14  RETLGEGSFGKVKLATHYKTQ----QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           ++++LY   TT T+ ++V  Y   G +   + E++     +     ++        + Y 
Sbjct: 70  HIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKR----MTEDEGRRFFQQIICAIEYC 124
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
           H H   KI+HRD+K  N+LLD++
Sbjct: 125 HRH---KIVHRDLKPENLLLDDN 144

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 131 TDGFSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVK-IISMAV- 187
           T  F     +G G FG V+K  +  DG + A+KR K  +   G +  Q  ++ + + AV 
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSK--KPLAGSVDEQNALREVYAHAVL 65
Query: 188 --HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 245
             H +++R +         L+   Y   GS+A  + E    +        K + L   RG
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 125
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           L Y+H      ++H D+K +NI +
Sbjct: 126 LRYIHSM---SLVHMDIKPSNIFI 146

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 69/143 (48%), Gaps = 11/143 (7%)
Query: 134 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
           +  K  LG GGFG V +    D G+ VA+K+ ++E +     ++  E++I+    H N++
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 193 RLYGFCTTVTE------KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
                   + +       LL   Y   G +   L + ++     + P R  ++  S+  L
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS-AL 134
Query: 247 SYLHEHCDPKIIHRDVKAANILL 269
            YLHE+   +IIHRD+K  NI+L
Sbjct: 135 RYLHEN---RIIHRDLKPENIVL 154

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 75/165 (45%), Gaps = 17/165 (10%)
Query: 116 LGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSG 171
           LG ++    ++ +   D +  +++LG G F +V    LA+ K    LVA+K + +E   G
Sbjct: 2   LGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVI---LAEDKRTQKLVAIKCIAKEALEG 58
Query: 172 GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLD 231
            E   + E+ ++    H N++ L     +     L+   ++ G +  R+ E+        
Sbjct: 59  KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE--- 115
Query: 232 WPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL---LDEDA 273
                ++       + YLH   D  I+HRD+K  N+L   LDED+
Sbjct: 116 -RDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDS 156

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 75/165 (45%), Gaps = 17/165 (10%)
Query: 116 LGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSG 171
           LG ++    ++ +   D +  +++LG G F +V    LA+ K    LVA+K + +E   G
Sbjct: 2   LGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVI---LAEDKRTQKLVAIKCIAKEALEG 58
Query: 172 GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLD 231
            E   + E+ ++    H N++ L     +     L+   ++ G +  R+ E+        
Sbjct: 59  KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE--- 115
Query: 232 WPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL---LDEDA 273
                ++       + YLH   D  I+HRD+K  N+L   LDED+
Sbjct: 116 -RDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDS 156

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 69/143 (48%), Gaps = 11/143 (7%)
Query: 134 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
           +  K  LG GGFG V +    D G+ VA+K+ ++E +     ++  E++I+    H N++
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 193 RLYGFCTTVTE------KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
                   + +       LL   Y   G +   L + ++     + P R  ++  S+  L
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS-AL 135
Query: 247 SYLHEHCDPKIIHRDVKAANILL 269
            YLHE+   +IIHRD+K  NI+L
Sbjct: 136 RYLHEN---RIIHRDLKPENIVL 155

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 131 TDGFSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVK-IISMAV- 187
           T  F     +G G FG V+K  +  DG + A+KR K  +   G +  Q  ++ + + AV 
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSK--KPLAGSVDEQNALREVYAHAVL 63
Query: 188 --HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 245
             H +++R +         L+   Y   GS+A  + E    +        K + L   RG
Sbjct: 64  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 123
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           L Y+H      ++H D+K +NI +
Sbjct: 124 LRYIHSM---SLVHMDIKPSNIFI 144

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 131 TDGFSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVK-IISMAV- 187
           T  F     +G G FG V+K  +  DG + A+KR K  +   G +  Q  ++ + + AV 
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSK--KPLAGSVDEQNALREVYAHAVL 67
Query: 188 --HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 245
             H +++R +         L+   Y   GS+A  + E    +        K + L   RG
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           L Y+H      ++H D+K +NI +
Sbjct: 128 LRYIHSM---SLVHMDIKPSNIFI 148

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 131 TDGFSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVK-IISMAV- 187
           T  F     +G G FG V+K  +  DG + A+KR K  +   G +  Q  ++ + + AV 
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSK--KPLAGSVDEQNALREVYAHAVL 65
Query: 188 --HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 245
             H +++R +         L+   Y   GS+A  + E    +        K + L   RG
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 125
Query: 246 LSYLHEHCDPKIIHRDVKAANILL 269
           L Y+H      ++H D+K +NI +
Sbjct: 126 LRYIHSM---SLVHMDIKPSNIFI 146

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 57/123 (46%), Gaps = 19/123 (15%)
Query: 156 GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS 215
           GK VAVK++   +    EL F  EV I+    H N++ +Y       E  +V  ++  G+
Sbjct: 70  GKQVAVKKMDLRKQQRRELLF-NEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGA 128
Query: 216 VA-----SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 270
           +      +R+ E Q +           + L   R LSYLH      +IHRD+K+ +ILL 
Sbjct: 129 LTDIVTHTRMNEEQIA----------TVCLSVLRALSYLHNQ---GVIHRDIKSDSILLT 175
Query: 271 EDA 273
            D 
Sbjct: 176 SDG 178

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 140 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 195 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 249
            G C +   +   L+  ++  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 133
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
                 + IHRD+   NIL++ +
Sbjct: 134 ---GTKRYIHRDLATRNILVENE 153

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/143 (23%), Positives = 68/143 (47%), Gaps = 8/143 (5%)
Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 189
           + F     +G G +G VYK R    G++VA+ +++ +  T G       E+ ++    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
           H H   +++HRD+K  N+L++ +
Sbjct: 120 HSH---RVLHRDLKPQNLLINTE 139

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/143 (23%), Positives = 68/143 (47%), Gaps = 8/143 (5%)
Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 189
           + F     +G G +G VYK R    G++VA+ +++ +  T G       E+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
           H H   +++HRD+K  N+L++ +
Sbjct: 119 HSH---RVLHRDLKPQNLLINTE 138

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 66/146 (45%), Gaps = 23/146 (15%)
Query: 140 LGRGGFGKV--YKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 197
           LG GGF  V   +G L DG   A+KR+        E + Q E  +  +  H N+LRL  +
Sbjct: 37  LGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDRE-EAQREADMHRLFNHPNILRLVAY 94
Query: 198 CT----TVTEKLLVYPYMTNGSV---ASRLRERQSSLPPLDWPTRKKIA---LGSARGLS 247
           C        E  L+ P+   G++     RL+++ + L      T  +I    LG  RGL 
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFL------TEDQILWLLLGICRGLE 148
Query: 248 YLHEHCDPKIIHRDVKAANILLDEDA 273
            +H        HRD+K  NILL ++ 
Sbjct: 149 AIHA---KGYAHRDLKPTNILLGDEG 171

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 64/135 (47%), Gaps = 11/135 (8%)
Query: 140 LGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRLYG 196
           LG G FGKV        G+ VA+K + ++  +  ++Q   + E+  + +  H ++++LY 
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 197 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 256
              +  E ++V  Y  N  +   + +R      +     ++        + Y H H   K
Sbjct: 82  VIKSKDEIIMVIEYAGN-ELFDYIVQRDK----MSEQEARRFFQQIISAVEYCHRH---K 133
Query: 257 IIHRDVKAANILLDE 271
           I+HRD+K  N+LLDE
Sbjct: 134 IVHRDLKPENLLLDE 148

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 64/135 (47%), Gaps = 11/135 (8%)
Query: 140 LGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRLYG 196
           LG G FGKV        G+ VA+K + ++  +  ++Q   + E+  + +  H ++++LY 
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 197 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 256
              +  E ++V  Y  N  +   + +R      +     ++        + Y H H   K
Sbjct: 76  VIKSKDEIIMVIEYAGN-ELFDYIVQRDK----MSEQEARRFFQQIISAVEYCHRH---K 127
Query: 257 IIHRDVKAANILLDE 271
           I+HRD+K  N+LLDE
Sbjct: 128 IVHRDLKPENLLLDE 142

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 64/135 (47%), Gaps = 11/135 (8%)
Query: 140 LGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRLYG 196
           LG G FGKV        G+ VA+K + ++  +  ++Q   + E+  + +  H ++++LY 
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 197 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 256
              +  E ++V  Y  N  +   + +R      +     ++        + Y H H   K
Sbjct: 72  VIKSKDEIIMVIEYAGN-ELFDYIVQRDK----MSEQEARRFFQQIISAVEYCHRH---K 123
Query: 257 IIHRDVKAANILLDE 271
           I+HRD+K  N+LLDE
Sbjct: 124 IVHRDLKPENLLLDE 138

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 27/148 (18%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 197
           +G+G +G+V++G    G+ VAVK    ++E++   E    TE+    M  H N+L   GF
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE----TELYNTVMLRHENIL---GF 67
Query: 198 CTT-------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
             +        T+  L+  Y   GS+   L+     L  LD  +  +I L  A GL++LH
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLH 122
Query: 251 -----EHCDPKIIHRDVKAANILLDEDA 273
                    P I HRD+K+ NIL+ ++ 
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNG 150

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 64/135 (47%), Gaps = 11/135 (8%)
Query: 140 LGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRLYG 196
           LG G FGKV        G+ VA+K + ++  +  ++Q   + E+  + +  H ++++LY 
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 197 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 256
              +  E ++V  Y  N  +   + +R      +     ++        + Y H H   K
Sbjct: 81  VIKSKDEIIMVIEYAGN-ELFDYIVQRDK----MSEQEARRFFQQIISAVEYCHRH---K 132
Query: 257 IIHRDVKAANILLDE 271
           I+HRD+K  N+LLDE
Sbjct: 133 IVHRDLKPENLLLDE 147

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 20/33 (60%), Positives = 22/33 (66%)
Query: 6   DLSNNRLSGPVPDNGSFSQFTPISFENNLNLCG 38
           DLSNN LSGP+P+ G F  F P  F NN  LCG
Sbjct: 707 DLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 739

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 27/148 (18%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 197
           +G+G +G+V++G    G+ VAVK    ++E++   E    TE+    M  H N+L   GF
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE----TELYNTVMLRHENIL---GF 67
Query: 198 CTT-------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
             +        T+  L+  Y   GS+   L+     L  LD  +  +I L  A GL++LH
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLH 122
Query: 251 -----EHCDPKIIHRDVKAANILLDEDA 273
                    P I HRD+K+ NIL+ ++ 
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNG 150

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 20/143 (13%)
Query: 140 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           LG+G FG V   R   L D  G++VAVK+L+   T      F+ E++I+    H N+++ 
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 195 YGFCTTVTEK--LLVYPYMTNGSVASRL---RERQSSLPPLDWPTRKKIALGSARGLSYL 249
            G C +   +   L+  Y+  GS+   L   +ER   +  L + ++        +G+ YL
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ------ICKGMEYL 131
Query: 250 HEHCDPKIIHRDVKAANILLDED 272
                 + IHR++   NIL++ +
Sbjct: 132 ---GTKRYIHRNLATRNILVENE 151

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 71/148 (47%), Gaps = 27/148 (18%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 197
           +G+G +G+V++G    G+ VAVK    ++E++   E +    V    M  H N+L   GF
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTV----MLRHENIL---GF 96
Query: 198 CTT-------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
             +        T+  L+  Y   GS+   L+     L  LD  +  +I L  A GL++LH
Sbjct: 97  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLH 151
Query: 251 -----EHCDPKIIHRDVKAANILLDEDA 273
                    P I HRD+K+ NIL+ ++ 
Sbjct: 152 IEIFGTQGKPAIAHRDLKSKNILVKKNG 179

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 20/33 (60%), Positives = 22/33 (66%)
Query: 6   DLSNNRLSGPVPDNGSFSQFTPISFENNLNLCG 38
           DLSNN LSGP+P+ G F  F P  F NN  LCG
Sbjct: 710 DLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 742

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRL-KEERTSGGELQFQT-EVKIISMAVH 188
           + F    ILG G F  V   R LA  +  A+K L K       ++ + T E  ++S   H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 189 RNLLRLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
              ++LY FC    EKL     Y  NG +   +R+  S     D    +         L 
Sbjct: 97  PFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALE 151
Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           YLH      IIHRD+K  NILL+ED
Sbjct: 152 YLH---GKGIIHRDLKPENILLNED 173

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 65/130 (50%), Gaps = 7/130 (5%)
Query: 146 GKVYKGRLADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT--VT 202
           G+++KGR   G  + VK LK  + ++     F  E   + +  H N+L + G C +    
Sbjct: 24  GELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 203 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV 262
              L+  +M  GS+ + L E  + +  +D     K AL  ARG+++LH   +P I    +
Sbjct: 83  HPTLITHWMPYGSLYNVLHEGTNFV--VDQSQAVKFALDMARGMAFLHT-LEPLIPRHAL 139
Query: 263 KAANILLDED 272
            + ++++DED
Sbjct: 140 NSRSVMIDED 149

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/142 (25%), Positives = 68/142 (47%), Gaps = 22/142 (15%)
Query: 138 NILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRL 194
           + LG G FGKV  G     G  VAVK L  ++    ++  + + E++ + +  H ++++L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 195 YGFCTTVTEKLLVYPYMTNGSV------ASRLRERQSSLPPLDWPTRKKIALGSARGLSY 248
           Y   +T T+  +V  Y++ G +        R+ E ++          +++       + Y
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA----------RRLFQQILSAVDY 126
Query: 249 LHEHCDPKIIHRDVKAANILLD 270
            H H    ++HRD+K  N+LLD
Sbjct: 127 CHRH---MVVHRDLKPENVLLD 145

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 140 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 192
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 193 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPP 229
            L G CT     L+V   +   G++++ LR +++   P
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 140 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 192
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 193 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPP 229
            L G CT     L+V   +   G++++ LR +++   P
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 127

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/142 (25%), Positives = 68/142 (47%), Gaps = 22/142 (15%)
Query: 138 NILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRL 194
           + LG G FGKV  G     G  VAVK L  ++    ++  + + E++ + +  H ++++L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 195 YGFCTTVTEKLLVYPYMTNGSV------ASRLRERQSSLPPLDWPTRKKIALGSARGLSY 248
           Y   +T T+  +V  Y++ G +        R+ E ++          +++       + Y
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA----------RRLFQQILSAVDY 126
Query: 249 LHEHCDPKIIHRDVKAANILLD 270
            H H    ++HRD+K  N+LLD
Sbjct: 127 CHRH---MVVHRDLKPENVLLD 145

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 140 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 192
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 193 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPP 229
            L G CT     L+V   +   G++++ LR +++   P
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 134

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 140 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 192
           LGRG FG+V +       + A  + VAVK LKE  T        +E+KI I +  H N++
Sbjct: 28  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 87
Query: 193 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPP 229
            L G CT     L+V   +   G++++ LR +++   P
Sbjct: 88  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 125

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 11/139 (7%)
Query: 139 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV-HRNLLRL 194
           ++GRG + KV   RL    ++ A+K +K+E  +  E     QTE  +   A  H  L+ L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 195 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 254
           +    T +    V  Y+  G +   + +RQ  LP       +  +   +  L+YLHE   
Sbjct: 76  HSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPE---EHARFYSAEISLALNYLHER-- 129
Query: 255 PKIIHRDVKAANILLDEDA 273
             II+RD+K  N+LLD + 
Sbjct: 130 -GIIYRDLKLDNVLLDSEG 147

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 69/152 (45%), Gaps = 26/152 (17%)
Query: 140 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 192
           LG G FGKV +        +D  + VAVK LK            +E+K++S +  H N++
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL------PPL--------DWPTRKKI 238
            L G CT     L++  Y   G + + LR ++ S       P +        D       
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 239 ALGSARGLSYL-HEHCDPKIIHRDVKAANILL 269
           +   A+G+++L  ++C    IHRD+ A NILL
Sbjct: 151 SYQVAKGMAFLASKNC----IHRDLAARNILL 178

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 11/139 (7%)
Query: 139 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV-HRNLLRL 194
           ++GRG + KV   RL    ++ A+K +K+E  +  E     QTE  +   A  H  L+ L
Sbjct: 27  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 86
Query: 195 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 254
           +    T +    V  Y+  G +   + +RQ  LP       +  +   +  L+YLHE   
Sbjct: 87  HSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPE---EHARFYSAEISLALNYLHER-- 140
Query: 255 PKIIHRDVKAANILLDEDA 273
             II+RD+K  N+LLD + 
Sbjct: 141 -GIIYRDLKLDNVLLDSEG 158

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 11/139 (7%)
Query: 139 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV-HRNLLRL 194
           ++GRG + KV   RL    ++ A+K +K+E  +  E     QTE  +   A  H  L+ L
Sbjct: 12  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 71
Query: 195 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 254
           +    T +    V  Y+  G +   + +RQ  LP       +  +   +  L+YLHE   
Sbjct: 72  HSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPE---EHARFYSAEISLALNYLHER-- 125
Query: 255 PKIIHRDVKAANILLDEDA 273
             II+RD+K  N+LLD + 
Sbjct: 126 -GIIYRDLKLDNVLLDSEG 143

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 47/104 (45%), Gaps = 10/104 (9%)
Query: 176 FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVAS------RLRERQSSLPP 229
           F+ E++II+   +   L   G  T   E  ++Y YM N S+         L +  +   P
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 230 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA 273
           +     K I        SY+H   +  I HRDVK +NIL+D++ 
Sbjct: 150 I--QVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNG 189

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 69/152 (45%), Gaps = 26/152 (17%)
Query: 140 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 192
           LG G FGKV +        +D  + VAVK LK            +E+K++S +  H N++
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL------PPL--------DWPTRKKI 238
            L G CT     L++  Y   G + + LR ++ S       P +        D       
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 239 ALGSARGLSYL-HEHCDPKIIHRDVKAANILL 269
           +   A+G+++L  ++C    IHRD+ A NILL
Sbjct: 167 SYQVAKGMAFLASKNC----IHRDLAARNILL 194

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 73/150 (48%), Gaps = 20/150 (13%)
Query: 129 VATDGFSNKNILGRGGFGKVY------KGRLADGKLVAVKRLKEERTSGGELQFQTEVKI 182
           + +D +  + +LG+G FG+V        G+    K+++ +++K++      L+   EV++
Sbjct: 23  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR---EVQL 79
Query: 183 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRL--RERQSSLPPLDWPTRKKIAL 240
           +    H N+ +LY F        LV    T G +   +  R+R S +         +I  
Sbjct: 80  LKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA------ARIIR 133
Query: 241 GSARGLSYLHEHCDPKIIHRDVKAANILLD 270
               G++Y H++   KI+HRD+K  N+LL+
Sbjct: 134 QVLSGITYXHKN---KIVHRDLKPENLLLE 160

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 69/152 (45%), Gaps = 26/152 (17%)
Query: 140 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 192
           LG G FGKV +        +D  + VAVK LK            +E+K++S +  H N++
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL------PPL--------DWPTRKKI 238
            L G CT     L++  Y   G + + LR ++ S       P +        D       
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 239 ALGSARGLSYL-HEHCDPKIIHRDVKAANILL 269
           +   A+G+++L  ++C    IHRD+ A NILL
Sbjct: 169 SYQVAKGMAFLASKNC----IHRDLAARNILL 196

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 66/149 (44%), Gaps = 9/149 (6%)
Query: 134 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
           F  K  LG G F +V      A GKL AVK + ++   G E   + E+ ++    H N++
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
            L     +     LV   ++ G +  R+ E+       D  T  +  L +   + YLH  
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEK-GFYTEKDASTLIRQVLDA---VYYLHRM 139
Query: 253 CDPKIIHRDVKAANILLDEDADQSSKTIL 281
               I+HRD+K  N LL    D+ SK ++
Sbjct: 140 ---GIVHRDLKPEN-LLYYSQDEESKIMI 164

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 69/152 (45%), Gaps = 26/152 (17%)
Query: 140 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 192
           LG G FGKV +        +D  + VAVK LK            +E+K++S +  H N++
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL------PPL--------DWPTRKKI 238
            L G CT     L++  Y   G + + LR ++ S       P +        D       
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 239 ALGSARGLSYL-HEHCDPKIIHRDVKAANILL 269
           +   A+G+++L  ++C    IHRD+ A NILL
Sbjct: 174 SYQVAKGMAFLASKNC----IHRDLAARNILL 201

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 29/162 (17%)
Query: 127 LQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLK--EERTSGGELQFQTEVKII 183
           L+ A+D F    +LG+G FG+V K R A D +  A+K+++  EE+ S       +EV ++
Sbjct: 2   LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS----TILSEVMLL 56
Query: 184 SMAVHRNLLRLYGF----------CTTVTEKLLVY---PYMTNGSVASRLR-ERQSSLPP 229
           +   H+ ++R Y             T V +K  ++    Y  N ++   +  E  +    
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRD 116
Query: 230 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 271
             W   ++I       LSY+H      IIHRD+K  NI +DE
Sbjct: 117 EYWRLFRQIL----EALSYIHSQG---IIHRDLKPMNIFIDE 151

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 61/136 (44%), Gaps = 14/136 (10%)
Query: 140 LGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           LG G  G+V   +LA  ++    VAVK +  +R        + E+ I  M  H N+++ Y
Sbjct: 14  LGEGAAGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G       + L   Y + G +  R+ E    +P    P  ++       G+ YLH     
Sbjct: 71  GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE---PDAQRFFHQLMAGVVYLH---GI 123
Query: 256 KIIHRDVKAANILLDE 271
            I HRD+K  N+LLDE
Sbjct: 124 GITHRDIKPENLLLDE 139

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 66/151 (43%), Gaps = 24/151 (15%)
Query: 140 LGRGGFGKVYKGRL-----ADGKL-VAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 192
           LG G FGKV +        +D  + VAVK LK            +E+K++S +  H N++
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL------PPL--------DWPTRKKI 238
            L G CT     L++  Y   G + + LR ++ S       P +        D       
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILL 269
           +   A+G+++L        IHRD+ A NILL
Sbjct: 174 SYQVAKGMAFL---ASKNCIHRDLAARNILL 201

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 74/144 (51%), Gaps = 27/144 (18%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRL--KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 197
           +G+G +G+V++G L  G+ VAVK    ++E++   E    TE+    +  H N+L   GF
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRE----TEIYNTVLLRHDNIL---GF 67
Query: 198 CTT-------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
             +        T+  L+  Y  +GS+   L +RQ+  P L      ++A+ +A GL++LH
Sbjct: 68  IASDMTSRNSSTQLWLITHYHEHGSLYDFL-QRQTLEPHL----ALRLAVSAACGLAHLH 122
Query: 251 EHC-----DPKIIHRDVKAANILL 269
                    P I HRD K+ N+L+
Sbjct: 123 VEIFGTQGKPAIAHRDFKSRNVLV 146

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 74/147 (50%), Gaps = 26/147 (17%)
Query: 140 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLL 192
           LG+G FG V   R   L D  G LVAVK+L+    SG + Q  FQ E++I+  A+H + +
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDFQREIQILK-ALHSDFI 70
Query: 193 RLY---GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA---RGL 246
             Y    +     E  LV  Y+ +G +   L+  ++ L         ++ L S+   +G+
Sbjct: 71  VKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARL------DASRLLLYSSQICKGM 124
Query: 247 SYLHEHCDPKIIHRDVKAANILLDEDA 273
            YL      + +HRD+ A NIL++ +A
Sbjct: 125 EYLGSR---RCVHRDLAARNILVESEA 148

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 61/132 (46%), Gaps = 9/132 (6%)
Query: 140 LGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT-EVKIISMAVHRNLLRLYGF 197
           +G G +G V+K R  D G++VA+K+  E        +    E++++    H NL+ L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 198 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
                   LV+ Y  + +V   L   Q  +P       K I   + + +++ H+H     
Sbjct: 71  FRRKRRLHLVFEY-CDHTVLHELDRYQRGVPE---HLVKSITWQTLQAVNFCHKH---NC 123
Query: 258 IHRDVKAANILL 269
           IHRDVK  NIL+
Sbjct: 124 IHRDVKPENILI 135

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 60/136 (44%), Gaps = 15/136 (11%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRL-----KEERTSGGELQFQTEVKIISMAVHRNLLRL 194
           LG G +G+V    L   K+  V+R      K   ++    +   EV ++ +  H N+++L
Sbjct: 45  LGSGAYGEVL---LCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 195 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 254
           Y F        LV      G +   +  R      +D     K  L    G++YLH+H  
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMK-FNEVDAAVIIKQVLS---GVTYLHKH-- 155
Query: 255 PKIIHRDVKAANILLD 270
             I+HRD+K  N+LL+
Sbjct: 156 -NIVHRDLKPENLLLE 170

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 68/149 (45%), Gaps = 17/149 (11%)
Query: 132 DGFSNKNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAV 187
           D +  +++LG G F +V    LA+ K    LVA+K + ++   G E   + E+ ++    
Sbjct: 18  DIYDFRDVLGTGAFSEVI---LAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 74
Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           H N++ L     +     L+   ++ G +  R+ E+             ++       + 
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE----RDASRLIFQVLDAVK 130
Query: 248 YLHEHCDPKIIHRDVKAANIL---LDEDA 273
           YLH   D  I+HRD+K  N+L   LDED+
Sbjct: 131 YLH---DLGIVHRDLKPENLLYYSLDEDS 156

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 64/144 (44%), Gaps = 12/144 (8%)
Query: 131 TDGFSNKNILGRGGFGKVY--KGRLADGKLVAVKRLKEER--TSGGELQFQTEVKIISMA 186
           +D +     LG G +G+V   K +L  G   A+K +K+    T+        EV ++   
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 187 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
            H N+++LY F        LV      G +   +  RQ     +D     K  L    G 
Sbjct: 62  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQK-FSEVDAAVIMKQVLS---GT 117
Query: 247 SYLHEHCDPKIIHRDVKAANILLD 270
           +YLH+H    I+HRD+K  N+LL+
Sbjct: 118 TYLHKH---NIVHRDLKPENLLLE 138

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 62/140 (44%), Gaps = 15/140 (10%)
Query: 140 LGRGGFGK-VYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 197
           +G G FGK +      DG+   +K +   R S  E +  + EV +++   H N+++    
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 198 CTTVTEKLLVYPYMTNGSVASRLRERQSSL----PPLDWPTRKKIALGSARGLSYLHEHC 253
                   +V  Y   G +  R+  ++  L      LDW  +  +AL         H H 
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK--------HVH- 142
Query: 254 DPKIIHRDVKAANILLDEDA 273
           D KI+HRD+K+ NI L +D 
Sbjct: 143 DRKILHRDIKSQNIFLTKDG 162

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 60/137 (43%), Gaps = 6/137 (4%)
Query: 140 LGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 197
           +G G +G+  K  R +DGK++  K L     +  E Q   +EV ++    H N++R Y  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 198 CT--TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD- 254
               T T   +V  Y   G +AS + +       LD     ++       L   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 255 -PKIIHRDVKAANILLD 270
              ++HRD+K AN+ LD
Sbjct: 134 GHTVLHRDLKPANVFLD 150

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 66/139 (47%), Gaps = 11/139 (7%)
Query: 139 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV-HRNLLRL 194
           ++GRG + KV   RL    ++ A++ +K+E  +  E     QTE  +   A  H  L+ L
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 195 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 254
           +    T +    V  Y+  G +   + +RQ  LP       +  +   +  L+YLHE   
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPE---EHARFYSAEISLALNYLHER-- 172
Query: 255 PKIIHRDVKAANILLDEDA 273
             II+RD+K  N+LLD + 
Sbjct: 173 -GIIYRDLKLDNVLLDSEG 190

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 60/137 (43%), Gaps = 6/137 (4%)
Query: 140 LGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 197
           +G G +G+  K  R +DGK++  K L     +  E Q   +EV ++    H N++R Y  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 198 CT--TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD- 254
               T T   +V  Y   G +AS + +       LD     ++       L   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 255 -PKIIHRDVKAANILLD 270
              ++HRD+K AN+ LD
Sbjct: 134 GHTVLHRDLKPANVFLD 150

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 60/137 (43%), Gaps = 6/137 (4%)
Query: 140 LGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGF 197
           +G G +G+  K  R +DGK++  K L     +  E Q   +EV ++    H N++R Y  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 198 CT--TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD- 254
               T T   +V  Y   G +AS + +       LD     ++       L   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 255 -PKIIHRDVKAANILLD 270
              ++HRD+K AN+ LD
Sbjct: 134 GHTVLHRDLKPANVFLD 150

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 65/148 (43%), Gaps = 12/148 (8%)
Query: 127 LQVATDGFSNKNILGRGGFGKVY--KGRLADGKLVAVKRLKEER--TSGGELQFQTEVKI 182
            Q  +D +     LG G +G+V   K +L  G   A+K +K+    T+        EV +
Sbjct: 16  FQGLSDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAV 74
Query: 183 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 242
           +    H N+++LY F        LV      G +   +  RQ     +D     K  L  
Sbjct: 75  LKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQK-FSEVDAAVIMKQVLS- 132
Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLD 270
             G +YLH+H    I+HRD+K  N+LL+
Sbjct: 133 --GTTYLHKH---NIVHRDLKPENLLLE 155

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 8/93 (8%)
Query: 140 LGRGGFGKVYKG------RLADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLL 192
           LGRG FGKV +       +    + VAVK LKE  T+       TE+KI++ +  H N++
Sbjct: 35  LGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKEGATASEYKALMTELKILTHIGHHLNVV 94
Query: 193 RLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQ 224
            L G CT     L+V   Y   G++++ L+ ++
Sbjct: 95  NLLGACTKQGGPLMVIVEYCKYGNLSNYLKSKR 127

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/151 (21%), Positives = 63/151 (41%), Gaps = 4/151 (2%)
Query: 132 DGFSNKNILGRGGFGKVY-KGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
           D F  K  LG G FG V+     + G    +K + ++R+     Q + E++++    H N
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
           +++++          +V      G +  R+   Q+    L      ++       L+Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 251 EHCDPKIIHRDVKAANILLDEDADQSSKTIL 281
                 ++H+D+K  NIL  + +  S   I+
Sbjct: 142 SQ---HVVHKDLKPENILFQDTSPHSPIKII 169

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 64/144 (44%), Gaps = 24/144 (16%)
Query: 140 LGRGGFGKVYKGRLAD---GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 196
           LGRG FG+V+  R+ D   G   AVK+++ E     EL         +      ++ LYG
Sbjct: 82  LGRGSFGEVH--RMEDKQTGFQCAVKKVRLEVFRAEELM------ACAGLTSPRIVPLYG 133
Query: 197 FCTTVTEKLLVYPYMT--NGSVASRLRERQSSLPPLDWPTRKKIALGSA-RGLSYLHEHC 253
               V E   V  +M    G    +L + Q  LP      R    LG A  GL YLH   
Sbjct: 134 ---AVREGPWVNIFMELLEGGSLGQLVKEQGCLPE----DRALYYLGQALEGLEYLHSR- 185
Query: 254 DPKIIHRDVKAANILLDEDADQSS 277
             +I+H DVKA N+LL  D   ++
Sbjct: 186 --RILHGDVKADNVLLSSDGSHAA 207

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 7/145 (4%)
Query: 127 LQVATDGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 185
           +++  D F   + LG G  G V+K      G ++A K +  E       Q   E++++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 186 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 245
                ++  YG   +  E  +   +M  GS+   L+ +   +P        K+++   +G
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE---QILGKVSIAVIKG 116
Query: 246 LSYLHEHCDPKIIHRDVKAANILLD 270
           L+YL E    KI+HRDVK +NIL++
Sbjct: 117 LTYLREK--HKIMHRDVKPSNILVN 139

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 7/145 (4%)
Query: 127 LQVATDGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 185
           +++  D F   + LG G  G V+K      G ++A K +  E       Q   E++++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 186 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 245
                ++  YG   +  E  +   +M  GS+   L+ +   +P        K+++   +G
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE---QILGKVSIAVIKG 116
Query: 246 LSYLHEHCDPKIIHRDVKAANILLD 270
           L+YL E    KI+HRDVK +NIL++
Sbjct: 117 LTYLREK--HKIMHRDVKPSNILVN 139

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 29/162 (17%)
Query: 127 LQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLK--EERTSGGELQFQTEVKII 183
           L+ A+D F    +LG+G FG+V K R A D +  A+K+++  EE+ S       +EV ++
Sbjct: 2   LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS----TILSEVXLL 56
Query: 184 SMAVHRNLLRLYGFC----------TTVTEKLLVY---PYMTNGSVASRLR-ERQSSLPP 229
           +   H+ ++R Y             T V +K  ++    Y  N ++   +  E  +    
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRD 116
Query: 230 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE 271
             W   ++I       LSY+H      IIHR++K  NI +DE
Sbjct: 117 EYWRLFRQIL----EALSYIHSQG---IIHRNLKPXNIFIDE 151

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 64/144 (44%), Gaps = 24/144 (16%)
Query: 140 LGRGGFGKVYKGRLAD---GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 196
           LGRG FG+V+  R+ D   G   AVK+++ E     EL         +      ++ LYG
Sbjct: 101 LGRGSFGEVH--RMEDKQTGFQCAVKKVRLEVFRAEELM------ACAGLTSPRIVPLYG 152
Query: 197 FCTTVTEKLLVYPYMT--NGSVASRLRERQSSLPPLDWPTRKKIALGSA-RGLSYLHEHC 253
               V E   V  +M    G    +L + Q  LP      R    LG A  GL YLH   
Sbjct: 153 ---AVREGPWVNIFMELLEGGSLGQLVKEQGCLPE----DRALYYLGQALEGLEYLHSR- 204
Query: 254 DPKIIHRDVKAANILLDEDADQSS 277
             +I+H DVKA N+LL  D   ++
Sbjct: 205 --RILHGDVKADNVLLSSDGSHAA 226

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 7/145 (4%)
Query: 127 LQVATDGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 185
           +++  D F   + LG G  G V+K      G ++A K +  E       Q   E++++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 186 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 245
                ++  YG   +  E  +   +M  GS+   L+ +   +P        K+++   +G
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE---QILGKVSIAVIKG 116
Query: 246 LSYLHEHCDPKIIHRDVKAANILLD 270
           L+YL E    KI+HRDVK +NIL++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVN 139

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 7/145 (4%)
Query: 127 LQVATDGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 185
           +++  D F   + LG G  G V+K      G ++A K +  E       Q   E++++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 186 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 245
                ++  YG   +  E  +   +M  GS+   L+ +   +P        K+++   +G
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE---QILGKVSIAVIKG 116
Query: 246 LSYLHEHCDPKIIHRDVKAANILLD 270
           L+YL E    KI+HRDVK +NIL++
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVN 139

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 7/145 (4%)
Query: 127 LQVATDGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM 185
           +++  D F   + LG G  G V+K      G ++A K +  E       Q   E++++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 186 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 245
                ++  YG   +  E  +   +M  GS+   L+ +   +P        K+++   +G
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE---QILGKVSIAVIKG 116
Query: 246 LSYLHEHCDPKIIHRDVKAANILLD 270
           L+YL E    KI+HRDVK +NIL++
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVN 139

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 70/145 (48%), Gaps = 12/145 (8%)
Query: 131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEE--RTSGGELQFQTEVKIISMAV 187
           +D +    ILG GG  +V+  R L D + VAVK L+ +  R     L+F+ E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 188 HRNLLRLY--GFCTTVTEKLLVYPYMTNGSV-ASRLRERQSSLPPLDWPTRKKIALGSAR 244
           H  ++ +Y  G   T    L   PY+    V    LR+   +  P+      ++   + +
Sbjct: 71  HPAIVAVYDTGEAETPAGPL---PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            L++ H++    IIHRDVK ANIL+
Sbjct: 128 ALNFSHQN---GIIHRDVKPANILI 149

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/141 (22%), Positives = 58/141 (41%), Gaps = 6/141 (4%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           LG G FG V++        V V +         +   + E+ I++   H  L+ L+    
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH 259
              E +L+  +++ G +  R+      +   +     + A     GL ++HEH    I+H
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQA---CEGLKHMHEHS---IVH 172
Query: 260 RDVKAANILLDEDADQSSKTI 280
            D+K  NI+ +     S K I
Sbjct: 173 LDIKPENIMCETKKASSVKII 193

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 73/147 (49%), Gaps = 26/147 (17%)
Query: 140 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLL 192
           LG+G FG V   R   L D  G LVAVK+L+    SG + Q  FQ E++I+  A+H + +
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDFQREIQILK-ALHSDFI 73
Query: 193 RLY---GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA---RGL 246
             Y    +        LV  Y+ +G +   L+  ++ L         ++ L S+   +G+
Sbjct: 74  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL------DASRLLLYSSQICKGM 127
Query: 247 SYLHEHCDPKIIHRDVKAANILLDEDA 273
            YL      + +HRD+ A NIL++ +A
Sbjct: 128 EYLGSR---RCVHRDLAARNILVESEA 151

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 73/147 (49%), Gaps = 26/147 (17%)
Query: 140 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLL 192
           LG+G FG V   R   L D  G LVAVK+L+    SG + Q  FQ E++I+  A+H + +
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDFQREIQILK-ALHSDFI 74
Query: 193 RLY---GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA---RGL 246
             Y    +        LV  Y+ +G +   L+  ++ L         ++ L S+   +G+
Sbjct: 75  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL------DASRLLLYSSQICKGM 128
Query: 247 SYLHEHCDPKIIHRDVKAANILLDEDA 273
            YL      + +HRD+ A NIL++ +A
Sbjct: 129 EYLGSR---RCVHRDLAARNILVESEA 152

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 73/147 (49%), Gaps = 26/147 (17%)
Query: 140 LGRGGFGKVYKGR---LAD--GKLVAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLL 192
           LG+G FG V   R   L D  G LVAVK+L+    SG + Q  FQ E++I+  A+H + +
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDFQREIQILK-ALHSDFI 86
Query: 193 RLY---GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA---RGL 246
             Y    +        LV  Y+ +G +   L+  ++ L         ++ L S+   +G+
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL------DASRLLLYSSQICKGM 140
Query: 247 SYLHEHCDPKIIHRDVKAANILLDEDA 273
            YL      + +HRD+ A NIL++ +A
Sbjct: 141 EYLGSR---RCVHRDLAARNILVESEA 164

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 67/144 (46%), Gaps = 7/144 (4%)
Query: 128 QVATDGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMA 186
           ++  D F   + LG G  G V+K      G ++A K +  E       Q   E++++   
Sbjct: 29  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 88
Query: 187 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
               ++  YG   +  E  +   +M  GS+   L+ +   +P        K+++   +GL
Sbjct: 89  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE---QILGKVSIAVIKGL 144
Query: 247 SYLHEHCDPKIIHRDVKAANILLD 270
           +YL E    KI+HRDVK +NIL++
Sbjct: 145 TYLREK--HKIMHRDVKPSNILVN 166

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 59/136 (43%), Gaps = 11/136 (8%)
Query: 139 ILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLY 195
           ++G+G FGKV   R  A+    AVK L+++       E    +E  ++   V    L   
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 196 GFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 254
            F     +KL  V  Y+  G +   L+  +  L P      +  A   A  L YLH    
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP----RARFYAAEIASALGYLHSL-- 158
Query: 255 PKIIHRDVKAANILLD 270
             I++RD+K  NILLD
Sbjct: 159 -NIVYRDLKPENILLD 173

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 67/144 (46%), Gaps = 7/144 (4%)
Query: 128 QVATDGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMA 186
           ++  D F   + LG G  G V+K      G ++A K +  E       Q   E++++   
Sbjct: 64  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 123
Query: 187 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
               ++  YG   +  E  +   +M  GS+   L+ +   +P        K+++   +GL
Sbjct: 124 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIP---EQILGKVSIAVIKGL 179
Query: 247 SYLHEHCDPKIIHRDVKAANILLD 270
           +YL E    KI+HRDVK +NIL++
Sbjct: 180 TYLREKH--KIMHRDVKPSNILVN 201

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 66/154 (42%), Gaps = 44/154 (28%)
Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR---------- 189
           LGRG FG+V+             R+K+++T      FQ  VK + + V R          
Sbjct: 80  LGRGSFGEVH-------------RMKDKQTG-----FQCAVKKVRLEVFRVEELVACAGL 121
Query: 190 ---NLLRLYGFCTTVTEKLLVYPYMT--NGSVASRLRERQSSLPPLDWPTRKKIALGSA- 243
               ++ LYG    V E   V  +M    G    +L ++   LP      R    LG A 
Sbjct: 122 SSPRIVPLYG---AVREGPWVNIFMELLEGGSLGQLIKQMGCLPE----DRALYYLGQAL 174
Query: 244 RGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 277
            GL YLH     +I+H DVKA N+LL  D  +++
Sbjct: 175 EGLEYLHTR---RILHGDVKADNVLLSSDGSRAA 205

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 70/145 (48%), Gaps = 12/145 (8%)
Query: 131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEE--RTSGGELQFQTEVKIISMAV 187
           +D +    ILG GG  +V+  R L D + VAVK L+ +  R     L+F+ E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 188 HRNLLRLY--GFCTTVTEKLLVYPYMTNGSV-ASRLRERQSSLPPLDWPTRKKIALGSAR 244
           H  ++ +Y  G   T    L   PY+    V    LR+   +  P+      ++   + +
Sbjct: 71  HPAIVAVYDTGEAETPAGPL---PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            L++ H++    IIHRDVK ANI++
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMI 149

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 72/147 (48%), Gaps = 22/147 (14%)
Query: 129 VATDGFSNKNILGRGGFGK-VYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMA- 186
           V    F  K++LG G  G  VY+G + D + VAVKR+  E  S  +     EV+++  + 
Sbjct: 21  VGKISFCPKDVLGHGAEGTIVYRG-MFDNRDVAVKRILPECFSFAD----REVQLLRESD 75
Query: 187 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIAL--GS 242
            H N++R   FC   TEK   + Y+     A+ L+E   Q     L     + I L   +
Sbjct: 76  EHPNVIRY--FC---TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGL---EPITLLQQT 127
Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILL 269
             GL++LH      I+HRD+K  NIL+
Sbjct: 128 TSGLAHLH---SLNIVHRDLKPHNILI 151

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 67/144 (46%), Gaps = 7/144 (4%)
Query: 128 QVATDGFSNKNILGRGGFGKVYK-GRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMA 186
           ++  D F   + LG G  G V+K      G ++A K +  E       Q   E++++   
Sbjct: 5   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 64
Query: 187 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
               ++  YG   +  E  +   +M  GS+   L+ +   +P        K+++   +GL
Sbjct: 65  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE---QILGKVSIAVIKGL 120
Query: 247 SYLHEHCDPKIIHRDVKAANILLD 270
           +YL E    KI+HRDVK +NIL++
Sbjct: 121 TYLRE--KHKIMHRDVKPSNILVN 142

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 67/144 (46%), Gaps = 7/144 (4%)
Query: 128 QVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA 186
           ++  D F   + LG G  G V K +    G ++A K +  E       Q   E++++   
Sbjct: 12  ELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 71
Query: 187 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
               ++  YG   +  E  +   +M  GS+   L+E +     +      K+++   RGL
Sbjct: 72  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR----IPEEILGKVSIAVLRGL 127
Query: 247 SYLHEHCDPKIIHRDVKAANILLD 270
           +YL E    +I+HRDVK +NIL++
Sbjct: 128 AYLREKH--QIMHRDVKPSNILVN 149

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 70/145 (48%), Gaps = 12/145 (8%)
Query: 131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEE--RTSGGELQFQTEVKIISMAV 187
           +D +    ILG GG  +V+  R L D + VAVK L+ +  R     L+F+ E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 188 HRNLLRLY--GFCTTVTEKLLVYPYMTNGSV-ASRLRERQSSLPPLDWPTRKKIALGSAR 244
           H  ++ +Y  G   T    L   PY+    V    LR+   +  P+      ++   + +
Sbjct: 71  HPAIVAVYDTGEAETPAGPL---PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 245 GLSYLHEHCDPKIIHRDVKAANILL 269
            L++ H++    IIHRDVK ANI++
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMI 149

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR 189
           +D F  ++ LGRG    VY+ +     K  A+K LK  +T   ++  +TE+ ++    H 
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKI-VRTEIGVLLRLSHP 108
Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           N+++L     T TE  LV   +T G +  R+ E+            K+I       ++YL
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI----LEAVAYL 164
Query: 250 HEHCDPKIIHRDVKAANIL 268
           HE+    I+HRD+K  N+L
Sbjct: 165 HEN---GIVHRDLKPENLL 180

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 62/160 (38%), Gaps = 33/160 (20%)
Query: 134 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
           F     LGRGGFG V++ +   D    A+KR++         +   EVK ++   H  ++
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 193 RLYG--FCTTVTEKLL-----VYPYM-------------TNGSVASRLRERQSSLPPLDW 232
           R +        TEKL      VY Y+              NG      RER   L     
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL----- 121
Query: 233 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
                I L  A  + +LH      ++HRD+K +NI    D
Sbjct: 122 ----HIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMD 154

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 70/169 (41%), Gaps = 30/169 (17%)
Query: 117 GQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQ 175
           G+LK    +      +   +   +GRG +G V K      G+++AVKR++       + Q
Sbjct: 7   GKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQ 66
Query: 176 FQTEVKIISMAVH-RNLLRLYG---------FC----TTVTEKLLVYPYMTNGSVASRLR 221
              ++ ++  +     +++ YG          C    +T  +K   Y Y     V     
Sbjct: 67  LLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPE-- 124
Query: 222 ERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 270
                          KI L + + L++L E+   KIIHRD+K +NILLD
Sbjct: 125 -----------EILGKITLATVKALNHLKENL--KIIHRDIKPSNILLD 160

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 40.8 bits (94), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 38/162 (23%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 117 GQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKG-RLADGKLVAVKRLKE--ERTSGGE 173
           G++ R  LR+ ++          LG+G +G V+K      G++VAVK++ +  + ++  +
Sbjct: 1   GRVDRHVLRKYELVKK-------LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ 53
Query: 174 LQFQTEVKIISMAVHRNLLRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLD 231
             F+  + +  ++ H N++ L        ++   LV+ YM     A     R + L P+ 
Sbjct: 54  RTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVI---RANILEPVH 110
Query: 232 WPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA 273
              ++ +     + + YLH      ++HRD+K +NILL+ + 
Sbjct: 111 ---KQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAEC 146

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	284
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-115
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-82
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-77
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-49
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	9e-43
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-42
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	8e-41
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-40
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-39
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-39
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	6e-36
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	9e-36
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-35
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-35
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-34
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-34
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-34
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-32
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-30
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-29
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-29
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-28
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-28
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-28
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-28
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-28
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-28
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-27
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-27
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-27
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-27
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-27
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-27
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	6e-27
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-27
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-27
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-27
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-27
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	7e-27
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-27
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	9e-27
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-26
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-26
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-26
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-26
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-26
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-26
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-26
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-26
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	7e-26
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-26
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	9e-26
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-25
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-25
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-25
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-25
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-25
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-25
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-25
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-25
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-25
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-25
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-25
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-25
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	9e-25
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-24
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-24
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-24
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-24
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-24
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-24
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-24
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-24
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-24
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-24
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-24
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	9e-24
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-23
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-23
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-23
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-23
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-23
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-23
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-23
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-23
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	8e-23
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-22
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-22
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-22
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-22
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-22
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-22
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	8e-22
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	9e-22
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-21
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-21
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-21
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-21
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-21
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-21
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-20
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-20
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-20
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-20
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	9e-20
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-19
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-19
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-19
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-18
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-18
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-18
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-18
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-17
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	9e-17
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-16
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-16
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-16
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-16
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-16
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-16
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	9e-16
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-15
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-15
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-15
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-15
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-15
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-15
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-15
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-15
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-15
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-15
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-15
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-15
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-15
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-15
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-15
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-15
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-15
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-14
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-14
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-14
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-14
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-14
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-14
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-14
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-14
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-14
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-14
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-14
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-14
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-14
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	7e-14
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-14
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-14
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-14
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-13
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-13
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-13
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-13
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-13
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-13
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-13
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-13
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-13
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-13
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-13
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-13
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-13
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-13
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-13
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	7e-13
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	7e-13
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	9e-13
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-12
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-12
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-12
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-12
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-12
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-12
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	7e-12
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-12
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-11
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-11
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-11
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	8e-11
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	8e-11
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-10
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-10
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-10
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-10
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-10
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	9e-10
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-09
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-09
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-09
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-09
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-09
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-09
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-09
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	7e-09
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	8e-09
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-08
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-08
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-08
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-08
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-08
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-08
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-08
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	8e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	9e-08
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-07
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-07
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-07
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-06
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-05
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	7e-05
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	9e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-04
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-04
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-04
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-04
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-04
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-04
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-04
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  333 bits (857), Expect = e-115
 Identities = 145/170 (85%), Positives = 156/170 (91%)

Query: 103 FFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVK 162
           FFDVPAE+D E+ LGQLKRFSLRELQVA+D FSNKNILGRGGFGKVYKGRLADG LVAVK
Sbjct: 1   FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60

Query: 163 RLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE 222
           RLKEERT GGELQFQTEV++ISMAVHRNLLRL GFC T TE+LLVYPYM NGSVAS LRE
Sbjct: 61  RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120

Query: 223 RQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           R  S PPLDWP R++IALGSARGL+YLH+HCDPKIIHRDVKAANILLDE+
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE 170

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  249 bits (637), Expect = 3e-82
 Identities = 68/173 (39%), Positives = 94/173 (54%), Gaps = 14/173 (8%)

Query: 109 EDDSELQLGQLKRFSLRELQVATDGFSNK------NILGRGGFGKVYKGRLADGKLVAVK 162
               E+   +   FS  EL+  T+ F  +      N +G GGFG VYKG + +   VAVK
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60

Query: 163 RLKEERTSG---GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASR 219
           +L           + QF  E+K+++   H NL+ L GF +   +  LVY YM NGS+  R
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120

Query: 220 LRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           L     + PPL W  R KIA G+A G+++LHE+     IHRD+K+ANILLDE 
Sbjct: 121 LSCLDGT-PPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEA 169

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  236 bits (604), Expect = 4e-77
 Identities = 71/167 (42%), Positives = 96/167 (57%), Gaps = 6/167 (3%)

Query: 107 PAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKE 166
            A   S L   +  R  L +L+ AT+ F +K ++G G FGKVYKG L DG  VA+KR   
Sbjct: 14  DALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP 73

Query: 167 ERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQS 225
           E  S  G  +F+TE++ +S   H +L+ L GFC    E +L+Y YM NG++   L     
Sbjct: 74  E--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL 131

Query: 226 SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
               + W  R +I +G+ARGL YLH      IIHRDVK+ NILLDE+
Sbjct: 132 PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDEN 175

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  165 bits (419), Expect = 2e-49
 Identities = 43/162 (26%), Positives = 65/162 (40%), Gaps = 19/162 (11%)

Query: 122 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVK 181
                L   +       +  RG FG V+K +L   + VAVK    +       Q + EV 
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ--DKQSWQNEYEVY 70

Query: 182 IISMAVHRNLLRLYGFCT----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKK 237
            +    H N+L+  G          +  L+  +   GS++  L+        + W     
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-----VVSWNELCH 125

Query: 238 IALGSARGLSYLHEH-------CDPKIIHRDVKAANILLDED 272
           IA   ARGL+YLHE          P I HRD+K+ N+LL  +
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN 167

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  147 bits (372), Expect = 9e-43
 Identities = 50/184 (27%), Positives = 86/184 (46%), Gaps = 28/184 (15%)

Query: 108 AEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKE 166
           A   SE    +L   +  E++        +  +G+GGFG V+KGR + D  +VA+K L  
Sbjct: 2   AMGGSEFPKSRLPTLADNEIEY-------EKQIGKGGFGLVHKGRLVKDKSVVAIKSLIL 54

Query: 167 ERTSGGEL------QFQTEVKIISMAVHRNLLRLYGFCTT----VTEKLLVYPYMTNGSV 216
             + G         +FQ EV I+S   H N+++LYG        V E      ++  G +
Sbjct: 55  GDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVME------FVPCGDL 108

Query: 217 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS 276
             RL ++     P+ W  + ++ L  A G+ Y+  + +P I+HRD+++ NI L    + +
Sbjct: 109 YHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENA 164

Query: 277 SKTI 280
               
Sbjct: 165 PVCA 168

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  147 bits (373), Expect = 1e-42
 Identities = 50/164 (30%), Positives = 68/164 (41%), Gaps = 23/164 (14%)

Query: 122 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVK 181
            +  E  +  D      ++GRG +G VYKG L D + VAVK             F  E  
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFS----FANRQNFINEKN 57

Query: 182 IISMAV--HRNLLRLYGFCTTV-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPT 234
           I  + +  H N+ R       V      E LLV  Y  NGS+   L          DW +
Sbjct: 58  IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-----TSDWVS 112

Query: 235 RKKIALGSARGLSYLHE------HCDPKIIHRDVKAANILLDED 272
             ++A    RGL+YLH       H  P I HRD+ + N+L+  D
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND 156

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  142 bits (360), Expect = 8e-41
 Identities = 42/140 (30%), Positives = 66/140 (47%), Gaps = 15/140 (10%)

Query: 137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 196
           + ++GRG FG V K +    K VA+K+++ E        F  E++ +S   H N+++LYG
Sbjct: 13  EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE---RKAFIVELRQLSRVNHPNIVKLYG 68

Query: 197 FCTT----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
            C      V E      Y   GS+ + L   +  LP           L  ++G++YLH  
Sbjct: 69  ACLNPVCLVME------YAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 253 CDPKIIHRDVKAANILLDED 272
               +IHRD+K  N+LL   
Sbjct: 122 QPKALIHRDLKPPNLLLVAG 141

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  142 bits (359), Expect = 1e-40
 Identities = 45/143 (31%), Positives = 71/143 (49%), Gaps = 16/143 (11%)

Query: 137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLY 195
           K  +G G FG V++     G  VAVK L E+      +  F  EV I+    H N++   
Sbjct: 42  KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100

Query: 196 GFCTT------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           G  T       VTE      Y++ GS+   L  +  +   LD   R  +A   A+G++YL
Sbjct: 101 GAVTQPPNLSIVTE------YLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYL 153

Query: 250 HEHCDPKIIHRDVKAANILLDED 272
           H + +P I+HR++K+ N+L+D+ 
Sbjct: 154 H-NRNPPIVHRNLKSPNLLVDKK 175

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  138 bits (349), Expect = 1e-39
 Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 21/152 (13%)

Query: 137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEER---TSGGELQFQTEVKIISMAVHRNLLR 193
           + I+G GGFGKVY+     G  VAVK  + +     S      + E K+ +M  H N++ 
Sbjct: 12  EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70

Query: 194 LYGFCTT------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           L G C        V E      +   G +   L  ++     +        A+  ARG++
Sbjct: 71  LRGVCLKEPNLCLVME------FARGGPLNRVLSGKR-----IPPDILVNWAVQIARGMN 119

Query: 248 YLHEHCDPKIIHRDVKAANILLDEDADQSSKT 279
           YLH+     IIHRD+K++NIL+ +  +    +
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLS 151

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  137 bits (347), Expect = 2e-39
 Identities = 38/145 (26%), Positives = 65/145 (44%), Gaps = 19/145 (13%)

Query: 137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLY 195
              L     G+++KGR   G  + VK LK    S  + + F  E   + +  H N+L + 
Sbjct: 15  LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73

Query: 196 GFCTT--------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           G C +        +T       +M  GS+ + L E  +    +D     K AL  ARG++
Sbjct: 74  GACQSPPAPHPTLITH------WMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMA 125

Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           +LH   +P I    + + ++++DED
Sbjct: 126 FLH-TLEPLIPRHALNSRSVMIDED 149

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  129 bits (327), Expect = 6e-36
 Identities = 38/143 (26%), Positives = 62/143 (43%), Gaps = 20/143 (13%)

Query: 137 KNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
             +LG+G FG+  K      G+++ +K L        +  F  EVK++    H N+L+  
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE-TQRTFLKEVKVMRCLEHPNVLKFI 73

Query: 196 GFCTT------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           G          +TE      Y+  G++   ++   S      W  R   A   A G++YL
Sbjct: 74  GVLYKDKRLNFITE------YIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYL 124

Query: 250 HEHCDPKIIHRDVKAANILLDED 272
           H      IIHRD+ + N L+ E+
Sbjct: 125 HSM---NIIHRDLNSHNCLVREN 144

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  128 bits (323), Expect = 1e-35
 Identities = 47/139 (33%), Positives = 65/139 (46%), Gaps = 20/139 (14%)

Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFC 198
           +G G FG VYKG+   G  VAVK L     +  +LQ F+ EV ++    H N+L   G+ 
Sbjct: 32  IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 199 T-----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           T      VT+      +    S+   L   +      +      IA  +ARG+ YLH   
Sbjct: 90  TAPQLAIVTQ------WCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK- 139

Query: 254 DPKIIHRDVKAANILLDED 272
              IIHRD+K+ NI L ED
Sbjct: 140 --SIIHRDLKSNNIFLHED 156

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  129 bits (325), Expect = 2e-35
 Identities = 38/143 (26%), Positives = 68/143 (47%), Gaps = 21/143 (14%)

Query: 137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLY 195
             ++G+G FG+VY GR   G+ VA++ +  ER +  +L+ F+ EV       H N++   
Sbjct: 38  GELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95

Query: 196 GFCTT------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           G C +      +T            ++ S +R+ +     LD    ++IA    +G+ YL
Sbjct: 96  GACMSPPHLAIITS------LCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYL 146

Query: 250 HEHCDPKIIHRDVKAANILLDED 272
           H      I+H+D+K+ N+  D  
Sbjct: 147 HAK---GILHKDLKSKNVFYDNG 166

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  125 bits (316), Expect = 2e-34
 Identities = 41/165 (24%), Positives = 71/165 (43%), Gaps = 28/165 (16%)

Query: 119 LKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQT 178
           ++R   R++ +          +G+G +G+V++G    G+ VAVK          E  +  
Sbjct: 2   MQRTVARDITL-------LECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFR 49

Query: 179 EVKIISMAV--HRNLLRLYGFCTTVTEK----LLVYPYMTNGSVASRLRERQSSLPPLDW 232
           E ++ +  +  H N+L       T         L+  Y   GS+   L+        LD 
Sbjct: 50  ETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-----TLDT 104

Query: 233 PTRKKIALGSARGLSYLHE-----HCDPKIIHRDVKAANILLDED 272
            +  +I L  A GL++LH         P I HRD+K+ NIL+ ++
Sbjct: 105 VSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN 149

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  126 bits (318), Expect = 2e-34
 Identities = 41/146 (28%), Positives = 65/146 (44%), Gaps = 21/146 (14%)

Query: 138 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV--HRNLLRLY 195
             +G+G +G+V+ G+   G+ VAVK          E  +  E +I    +  H N+L   
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFI 97

Query: 196 GFCT----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 251
                   + T+  L+  Y  NGS+   L+        LD  +  K+A  S  GL +LH 
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHT 152

Query: 252 -----HCDPKIIHRDVKAANILLDED 272
                   P I HRD+K+ NIL+ ++
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKN 178

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  120 bits (303), Expect = 3e-32
 Identities = 42/146 (28%), Positives = 66/146 (45%), Gaps = 21/146 (14%)

Query: 138 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV--HRNLLRLY 195
             +G+G FG+V++G+   G+ VAVK          E  +  E +I    +  H N+L   
Sbjct: 48  ESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFI 102

Query: 196 GFCT----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 251
                   T T+  LV  Y  +GS+   L         +      K+AL +A GL++LH 
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHM 157

Query: 252 -----HCDPKIIHRDVKAANILLDED 272
                   P I HRD+K+ NIL+ ++
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKN 183

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  116 bits (293), Expect = 2e-30
 Identities = 45/137 (32%), Positives = 65/137 (47%), Gaps = 7/137 (5%)

Query: 137 KNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
              +GRG FG+V+ GRL AD  LVAVK  +E      + +F  E +I+    H N++RL 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178

Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G CT      +V   +  G   + LR   + L      T  ++   +A G+ YL      
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV---KTLLQMVGDAAAGMEYLESK--- 232

Query: 256 KIIHRDVKAANILLDED 272
             IHRD+ A N L+ E 
Sbjct: 233 CCIHRDLAARNCLVTEK 249

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  111 bits (280), Expect = 4e-29
 Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 15/148 (10%)

Query: 137 KNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNL 191
             ILG G FG V +G L         VAVK +K + +S  E++ F +E   +    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 192 LRLYGFCT-----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK--KIALGSAR 244
           +RL G C       + + +++ P+M  G + + L   +    P   P +   K  +  A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 245 GLSYLHEHCDPKIIHRDVKAANILLDED 272
           G+ YL        +HRD+ A N +L +D
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDD 183

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  110 bits (278), Expect = 6e-29
 Identities = 48/140 (34%), Positives = 62/140 (44%), Gaps = 11/140 (7%)

Query: 138 NILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
            ++GRG FG VY G L D        AVK L      G   QF TE  I+    H N+L 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 194 LYGFCTTVTEKLL-VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
           L G C       L V PYM +G + + +R    +    D        L  A+G+ YL   
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKYLASK 147

Query: 253 CDPKIIHRDVKAANILLDED 272
              K +HRD+ A N +LDE 
Sbjct: 148 ---KFVHRDLAARNCMLDEK 164

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  110 bits (276), Expect = 1e-28
 Identities = 38/143 (26%), Positives = 66/143 (46%), Gaps = 13/143 (9%)

Query: 137 KNILGRGGFGKVYKGRLA-----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 191
              LG G FGKV   R        G+ VAVK LK E         + E++I+    H N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 192 LRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           ++  G CT        L+  ++ +GS+   L + ++ +       + K A+   +G+ YL
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL---KQQLKYAVQICKGMDYL 142

Query: 250 HEHCDPKIIHRDVKAANILLDED 272
                 + +HRD+ A N+L++ +
Sbjct: 143 GSR---QYVHRDLAARNVLVESE 162

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  109 bits (274), Expect = 3e-28
 Identities = 42/143 (29%), Positives = 59/143 (41%), Gaps = 15/143 (10%)

Query: 137 KNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 191
              LG G FGKV            G++VAVK LK +        ++ E+ I+    H ++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 192 LRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           ++  G C         LV  Y+  GS+   L      L  L        A     G++YL
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYL 150

Query: 250 HEHCDPKIIHRDVKAANILLDED 272
           H       IHRD+ A N+LLD D
Sbjct: 151 HAQ---HYIHRDLAARNVLLDND 170

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  109 bits (274), Expect = 4e-28
 Identities = 35/145 (24%), Positives = 64/145 (44%), Gaps = 22/145 (15%)

Query: 138 NILGRGGFGKVYKGRLADGKL-----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
            +LG G FG VYKG            VA+K L+E  +     +   E  +++   + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 193 RLYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           RL G C T     +T+       M  G +   +RE + ++            +  A+G++
Sbjct: 81  RLLGICLTSTVQLITQ------LMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 131

Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           YL +    +++HRD+ A N+L+   
Sbjct: 132 YLEDR---RLVHRDLAARNVLVKTP 153

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  108 bits (272), Expect = 5e-28
 Identities = 40/141 (28%), Positives = 57/141 (40%), Gaps = 11/141 (7%)

Query: 137 KNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
             ++G+G FG VY G   D        A+K L           F  E  ++    H N+L
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 193 RLYGFCTTVTE-KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 251
            L G          ++ PYM +G +   +R  Q +             L  ARG+ YL E
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV---KDLISFGLQVARGMEYLAE 142

Query: 252 HCDPKIIHRDVKAANILLDED 272
               K +HRD+ A N +LDE 
Sbjct: 143 Q---KFVHRDLAARNCMLDES 160

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  108 bits (272), Expect = 6e-28
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 15/148 (10%)

Query: 137 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
              LG+G FG VY+G             VA+K + E  +    ++F  E  ++      +
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER---QSSLPPLDWPTRK---KIALGSAR 244
           ++RL G  +     L++   MT G + S LR      ++ P L  P+     ++A   A 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 245 GLSYLHEHCDPKIIHRDVKAANILLDED 272
           G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 150 GMAYLNAN---KFVHRDLAARNCMVAED 174

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  108 bits (272), Expect = 7e-28
 Identities = 38/149 (25%), Positives = 65/149 (43%), Gaps = 16/149 (10%)

Query: 137 KNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNL 191
             +LG+G FG V + +L         VAVK LK +  +  +++ F  E   +    H ++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 192 LRLYGFCT------TVTEKLLVYPYMTNGSVASRLRERQSSLPP--LDWPTRKKIALGSA 243
            +L G          +   +++ P+M +G + + L   +    P  L   T  +  +  A
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 244 RGLSYLHEHCDPKIIHRDVKAANILLDED 272
            G+ YL        IHRD+ A N +L ED
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAED 173

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  108 bits (272), Expect = 1e-27
 Identities = 47/140 (33%), Positives = 62/140 (44%), Gaps = 11/140 (7%)

Query: 138 NILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
            ++GRG FG VY G L D        AVK L      G   QF TE  I+    H N+L 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 194 LYGFCTTVTEKLL-VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
           L G C       L V PYM +G + + +R    +    D        L  A+G+ +L   
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKFLASK 211

Query: 253 CDPKIIHRDVKAANILLDED 272
              K +HRD+ A N +LDE 
Sbjct: 212 ---KFVHRDLAARNCMLDEK 228

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  106 bits (267), Expect = 1e-27
 Identities = 40/136 (29%), Positives = 64/136 (47%), Gaps = 8/136 (5%)

Query: 137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 196
              +G G FG V+ G   +   VA+K ++E   S  E  F  E +++    H  L++LYG
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYG 70

Query: 197 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 256
            C       LV  +M +G ++  LR ++         T   + L    G++YL E     
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEA---C 124

Query: 257 IIHRDVKAANILLDED 272
           +IHRD+ A N L+ E+
Sbjct: 125 VIHRDLAARNCLVGEN 140

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  106 bits (267), Expect = 2e-27
 Identities = 37/145 (25%), Positives = 61/145 (42%), Gaps = 21/145 (14%)

Query: 137 KNILGRGGFGKVYKGRLADGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
             ILG G FG+VY+G   + K     VAVK  K++ T   + +F +E  I+    H +++
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 193 RLYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           +L G         + E          G +   L   ++SL      T    +L   + ++
Sbjct: 77  KLIGIIEEEPTWIIME------LYPYGELGHYLERNKNSLKV---LTLVLYSLQICKAMA 127

Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           YL        +HRD+   NIL+   
Sbjct: 128 YLESI---NCVHRDIAVRNILVASP 149

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  106 bits (266), Expect = 3e-27
 Identities = 34/143 (23%), Positives = 59/143 (41%), Gaps = 21/143 (14%)

Query: 139 ILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
            +G G FG V++G     +     VA+K  K   +     +F  E   +    H ++++L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 195 YGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
            G  T      + E        T G + S L+ R+ SL      +    A   +  L+YL
Sbjct: 82  IGVITENPVWIIME------LCTLGELRSFLQVRKYSLDL---ASLILYAYQLSTALAYL 132

Query: 250 HEHCDPKIIHRDVKAANILLDED 272
                 + +HRD+ A N+L+  +
Sbjct: 133 ESK---RFVHRDIAARNVLVSSN 152

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  105 bits (264), Expect = 5e-27
 Identities = 38/138 (27%), Positives = 64/138 (46%), Gaps = 11/138 (7%)

Query: 139 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVHRNLLRLYG 196
            +GRG F  VYKG        VA   L++ + +  E  +F+ E +++    H N++R Y 
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 197 -FCTTVTEKLLVY---PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
            + +TV  K  +      MT+G++ + L+        +     +       +GL +LH  
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR 148

Query: 253 CDPKIIHRDVKAANILLD 270
             P IIHRD+K  NI + 
Sbjct: 149 -TPPIIHRDLKCDNIFIT 165

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  105 bits (265), Expect = 6e-27
 Identities = 36/146 (24%), Positives = 62/146 (42%), Gaps = 22/146 (15%)

Query: 137 KNILGRGGFGKVYKGRLADGKL-----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 191
             +LG G FG V+KG            V +K ++++            +  I    H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 192 LRLYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
           +RL G C       VT+      Y+  GS+   +R+ + +L P          +  A+G+
Sbjct: 78  VRLLGLCPGSSLQLVTQ------YLPLGSLLDHVRQHRGALGP---QLLLNWGVQIAKGM 128

Query: 247 SYLHEHCDPKIIHRDVKAANILLDED 272
            YL EH    ++HR++ A N+LL   
Sbjct: 129 YYLEEH---GMVHRNLAARNVLLKSP 151

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  105 bits (264), Expect = 6e-27
 Identities = 36/143 (25%), Positives = 65/143 (45%), Gaps = 14/143 (9%)

Query: 137 KNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 191
              LG+G FG V   R        G++VAVK+L+   T      F+ E++I+    H N+
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNI 73

Query: 192 LRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           ++  G C +   +   L+  Y+  GS+   L++ +  +         +      +G+ YL
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH---IKLLQYTSQICKGMEYL 130

Query: 250 HEHCDPKIIHRDVKAANILLDED 272
                 + IHRD+   NIL++ +
Sbjct: 131 GTK---RYIHRDLATRNILVENE 150

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  105 bits (265), Expect = 6e-27
 Identities = 47/147 (31%), Positives = 63/147 (42%), Gaps = 12/147 (8%)

Query: 137 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
              LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER---QSSLPPLDWPTRKKIALGSARGLS 247
           ++R  G       + ++   M  G + S LRE     S    L       +A   A G  
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 248 YLHEHCDPKIIHRDVKAANILLDEDAD 274
           YL E+     IHRD+ A N LL     
Sbjct: 155 YLEEN---HFIHRDIAARNCLLTCPGP 178

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  105 bits (263), Expect = 6e-27
 Identities = 35/144 (24%), Positives = 55/144 (38%), Gaps = 20/144 (13%)

Query: 137 KNILGRGGFGKVYKGRLADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
              LG G FG V +G     K    VA+K LK+        +   E +I+    +  ++R
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 194 LYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 248
           L G C       V E          G +   L  ++  +P        ++    + G+ Y
Sbjct: 75  LIGVCQAEALMLVME------MAGGGPLHKFLVGKREEIPV---SNVAELLHQVSMGMKY 125

Query: 249 LHEHCDPKIIHRDVKAANILLDED 272
           L E      +HRD+ A N+LL   
Sbjct: 126 LEEK---NFVHRDLAARNVLLVNR 146

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  105 bits (265), Expect = 7e-27
 Identities = 36/143 (25%), Positives = 65/143 (45%), Gaps = 14/143 (9%)

Query: 137 KNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 191
              LG+G FG V   R        G++VAVK+L+   T      F+ E++I+    H N+
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNI 104

Query: 192 LRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           ++  G C +   +   L+  Y+  GS+   L++ +  +         +      +G+ YL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH---IKLLQYTSQICKGMEYL 161

Query: 250 HEHCDPKIIHRDVKAANILLDED 272
                 + IHRD+   NIL++ +
Sbjct: 162 GTK---RYIHRDLATRNILVENE 181

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  104 bits (263), Expect = 7e-27
 Identities = 39/136 (28%), Positives = 61/136 (44%), Gaps = 8/136 (5%)

Query: 137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 196
              LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++LYG
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYG 86

Query: 197 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 256
            CT      ++  YM NG + + LRE +            ++       + YL      +
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---Q 140

Query: 257 IIHRDVKAANILLDED 272
            +HRD+ A N L+++ 
Sbjct: 141 FLHRDLAARNCLVNDQ 156

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  104 bits (262), Expect = 7e-27
 Identities = 42/136 (30%), Positives = 63/136 (46%), Gaps = 8/136 (5%)

Query: 137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 196
              LG G FG V  G+      VAVK +KE   S  E +F  E + +    H  L++ YG
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYG 70

Query: 197 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 256
            C+      +V  Y++NG + + LR     L P       ++      G+++L  H   +
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEP---SQLLEMCYDVCEGMAFLESH---Q 124

Query: 257 IIHRDVKAANILLDED 272
            IHRD+ A N L+D D
Sbjct: 125 FIHRDLAARNCLVDRD 140

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  105 bits (263), Expect = 9e-27
 Identities = 34/134 (25%), Positives = 68/134 (50%), Gaps = 8/134 (5%)

Query: 139 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 197
           +LG+G +G VY GR L++   +A+K + E  +   +     E+ +     H+N+++  G 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHKHLKHKNIVQYLGS 87

Query: 198 CTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 256
            +     + ++   +  GS+++ LR +   L   +  T          GL YLH++   +
Sbjct: 88  FSE-NGFIKIFMEQVPGGSLSALLRSKWGPLKDNE-QTIGFYTKQILEGLKYLHDN---Q 142

Query: 257 IIHRDVKAANILLD 270
           I+HRD+K  N+L++
Sbjct: 143 IVHRDIKGDNVLIN 156

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  108 bits (271), Expect = 9e-27
 Identities = 52/269 (19%), Positives = 86/269 (31%), Gaps = 31/269 (11%)

Query: 16  VPDNGSFSQFTPISFENNLNLCGPNTK--KPCSGSPPFSPPPPFGPTSSPGRNKSNAAIP 73
           +P+   F     +     L   G      + C  S   +      PT     +       
Sbjct: 223 IPEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQR 282

Query: 74  VGVALGAALLFAVP--VIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVAT 131
               L +      P  +      R        F+ P  D  EL+    K+  L+   +  
Sbjct: 283 RIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKD---KKLFLKRDNLLI 339

Query: 132 DGFSNKNILGRGGFGKVYKGRLADGK---LVAVKRLKEERTSGGELQFQTEVKIISMAVH 188
                   LG G FG V +G     K    VA+K LK+        +   E +I+    +
Sbjct: 340 A----DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 395

Query: 189 RNLLRLYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 243
             ++RL G C       V E          G +   L  ++  +P        ++    +
Sbjct: 396 PYIVRLIGVCQAEALMLVME------MAGGGPLHKFLVGKREEIPV---SNVAELLHQVS 446

Query: 244 RGLSYLHEHCDPKIIHRDVKAANILLDED 272
            G+ YL E      +HR++ A N+LL   
Sbjct: 447 MGMKYLEEK---NFVHRNLAARNVLLVNR 472

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  105 bits (264), Expect = 2e-26
 Identities = 45/147 (30%), Positives = 62/147 (42%), Gaps = 12/147 (8%)

Query: 137 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
              LG G FG+VY+G+++          VAVK L E  +   EL F  E  IIS   H+N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK---KIALGSARGLS 247
           ++R  G       + ++   M  G + S LRE +                +A   A G  
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 248 YLHEHCDPKIIHRDVKAANILLDEDAD 274
           YL E+     IHRD+ A N LL     
Sbjct: 196 YLEEN---HFIHRDIAARNCLLTCPGP 219

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  103 bits (260), Expect = 2e-26
 Identities = 52/145 (35%), Positives = 64/145 (44%), Gaps = 23/145 (15%)

Query: 139 ILGRGGFGKVYKGRL--ADGKL--VAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLL 192
            LG G FG V +G      GK   VAVK LK +  S  E    F  EV  +    HRNL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 193 RLYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           RLYG   T     VTE          GS+  RLR+ Q         T  + A+  A G+ 
Sbjct: 85  RLYGVVLTPPMKMVTE------LAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEGMG 135

Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           YL      + IHRD+ A N+LL   
Sbjct: 136 YLESK---RFIHRDLAARNLLLATR 157

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  103 bits (259), Expect = 2e-26
 Identities = 44/141 (31%), Positives = 63/141 (44%), Gaps = 18/141 (12%)

Query: 137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 196
              LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L+RLY 
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRLVRLYA 75

Query: 197 FCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 251
             T      +TE      YM NGS+   L+        L       +A   A G++++ E
Sbjct: 76  VVTQEPIYIITE------YMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE 127

Query: 252 HCDPKIIHRDVKAANILLDED 272
                 IHRD++AANIL+ + 
Sbjct: 128 R---NYIHRDLRAANILVSDT 145

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  103 bits (259), Expect = 3e-26
 Identities = 37/143 (25%), Positives = 60/143 (41%), Gaps = 8/143 (5%)

Query: 134 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIIS-MAVHRN 190
           F     +G G FG V+K     DG + A+KR K     S  E     EV   + +  H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 191 LLRLYGFCTTVTEKLLVY-PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           ++R +       + +L+   Y   GS+A  + E    +        K + L   RGL Y+
Sbjct: 73  VVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131

Query: 250 HEHCDPKIIHRDVKAANILLDED 272
           H      ++H D+K +NI +   
Sbjct: 132 HSM---SLVHMDIKPSNIFISRT 151

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  104 bits (261), Expect = 3e-26
 Identities = 42/140 (30%), Positives = 62/140 (44%), Gaps = 10/140 (7%)

Query: 137 KNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
           + I+G G  G+V  GRL         VA+K LK   T      F +E  I+    H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
           RL G  T     ++V  YM NGS+ + LR                +  G   G+ YL + 
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI---MQLVGMLRGVGAGMRYLSDL 170

Query: 253 CDPKIIHRDVKAANILLDED 272
                +HRD+ A N+L+D +
Sbjct: 171 ---GYVHRDLAARNVLVDSN 187

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  103 bits (260), Expect = 3e-26
 Identities = 35/145 (24%), Positives = 64/145 (44%), Gaps = 22/145 (15%)

Query: 138 NILGRGGFGKVYKGRLADGK-----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
            +LG G FG VYKG            VA+K L+E  +     +   E  +++   + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 193 RLYGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           RL G C T     +T+       M  G +   +RE + ++            +  A+G++
Sbjct: 81  RLLGICLTSTVQLITQ------LMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 131

Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           YL +    +++HRD+ A N+L+   
Sbjct: 132 YLEDR---RLVHRDLAARNVLVKTP 153

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  103 bits (258), Expect = 4e-26
 Identities = 37/149 (24%), Positives = 69/149 (46%), Gaps = 15/149 (10%)

Query: 137 KNILGRGGFGKVYKGRL--------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH 188
              LG+G F K++KG               V +K L +   +  E  F     ++S   H
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE-SFFEAASMMSKLSH 71

Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 248
           ++L+  YG C    E +LV  ++  GS+ + L++ ++ +       + ++A   A  + +
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINI---LWKLEVAKQLAAAMHF 128

Query: 249 LHEHCDPKIIHRDVKAANILLDEDADQSS 277
           L E+    +IH +V A NILL  + D+ +
Sbjct: 129 LEEN---TLIHGNVCAKNILLIREEDRKT 154

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  102 bits (256), Expect = 6e-26
 Identities = 43/137 (31%), Positives = 65/137 (47%), Gaps = 8/137 (5%)

Query: 137 KNILGRGGFGKVYKGRLADGKL-VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           K+ LG G +G+VY+G      L VAVK LKE+     E  F  E  ++    H NL++L 
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLL 75

Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
           G CT      ++  +MT G++   LRE       +       +A   +  + YL +    
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQ--EVSAVVLLYMATQISSAMEYLEKK--- 130

Query: 256 KIIHRDVKAANILLDED 272
             IHRD+ A N L+ E+
Sbjct: 131 NFIHRDLAARNCLVGEN 147

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  106 bits (265), Expect = 7e-26
 Identities = 41/196 (20%), Positives = 74/196 (37%), Gaps = 36/196 (18%)

Query: 86  VPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGF 145
           V V     +      E  + +P+  D E+Q  +++                   +G G F
Sbjct: 359 VSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIEL---------------GRCIGEGQF 403

Query: 146 GKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT- 200
           G V++G     +     VA+K  K   +     +F  E   +    H ++++L G  T  
Sbjct: 404 GDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN 463

Query: 201 ----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 256
               + E        T G + S L+ R+ SL      +    A   +  L+YL      +
Sbjct: 464 PVWIIME------LCTLGELRSFLQVRKFSLDL---ASLILYAYQLSTALAYLESK---R 511

Query: 257 IIHRDVKAANILLDED 272
            +HRD+ A N+L+  +
Sbjct: 512 FVHRDIAARNVLVSSN 527

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  102 bits (256), Expect = 7e-26
 Identities = 44/143 (30%), Positives = 61/143 (42%), Gaps = 22/143 (15%)

Query: 137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 196
              +G+G FG V  G    G  VAVK +K + T      F  E  +++   H NL++L G
Sbjct: 26  LQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLG 81

Query: 197 FCTT-------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
                      VTE      YM  GS+   LR R  S   L      K +L     + YL
Sbjct: 82  VIVEEKGGLYIVTE------YMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYL 133

Query: 250 HEHCDPKIIHRDVKAANILLDED 272
             +     +HRD+ A N+L+ ED
Sbjct: 134 EGN---NFVHRDLAARNVLVSED 153

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  102 bits (257), Expect = 9e-26
 Identities = 35/143 (24%), Positives = 62/143 (43%), Gaps = 14/143 (9%)

Query: 137 KNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 191
            + LG+G FG V   R        G LVAVK+L+       +  FQ E++I+       +
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFI 86

Query: 192 LRLYGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           ++  G       +   LV  Y+ +G +   L+  ++ L           +    +G+ YL
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA---SRLLLYSSQICKGMEYL 143

Query: 250 HEHCDPKIIHRDVKAANILLDED 272
                 + +HRD+ A NIL++ +
Sbjct: 144 GSR---RCVHRDLAARNILVESE 163

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  101 bits (255), Expect = 1e-25
 Identities = 35/143 (24%), Positives = 54/143 (37%), Gaps = 22/143 (15%)

Query: 139 ILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRL 194
            LG G FG V KG     K+   VAVK LK E            E  ++    +  ++R+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 195 YGFCTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
            G C       V E          G +   L++ +     +      ++    + G+ YL
Sbjct: 84  IGICEAESWMLVME------MAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYL 133

Query: 250 HEHCDPKIIHRDVKAANILLDED 272
            E      +HRD+ A N+LL   
Sbjct: 134 EES---NFVHRDLAARNVLLVTQ 153

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  102 bits (256), Expect = 1e-25
 Identities = 42/141 (29%), Positives = 65/141 (46%), Gaps = 11/141 (7%)

Query: 137 KNILGRGGFGKVYKGRLADGK-----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 191
           + ++G G FG+VYKG L          VA+K LK   T    + F  E  I+    H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 192 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 251
           +RL G  +     +++  YM NG++   LRE+              +  G A G+ YL  
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSV---LQLVGMLRGIAAGMKYLAN 165

Query: 252 HCDPKIIHRDVKAANILLDED 272
                 +HRD+ A NIL++ +
Sbjct: 166 M---NYVHRDLAARNILVNSN 183

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  101 bits (254), Expect = 1e-25
 Identities = 37/154 (24%), Positives = 64/154 (41%), Gaps = 21/154 (13%)

Query: 137 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
              LG   FGKVYKG L           VA+K LK++       +F+ E  + +   H N
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER------------QSSLPPLDWPTRKKI 238
           ++ L G  T      +++ Y ++G +   L  R            ++    L+ P    +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
               A G+ YL  H    ++H+D+   N+L+ + 
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDK 164

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  104 bits (260), Expect = 1e-25
 Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 18/140 (12%)

Query: 138 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 197
             LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY  
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 198 CT-----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
            +      VTE      YM+ GS+   L+        L  P    +A   A G++Y+   
Sbjct: 248 VSEEPIYIVTE------YMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM 299

Query: 253 CDPKIIHRDVKAANILLDED 272
                +HRD++AANIL+ E+
Sbjct: 300 ---NYVHRDLRAANILVGEN 316

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  102 bits (256), Expect = 2e-25
 Identities = 44/140 (31%), Positives = 64/140 (45%), Gaps = 10/140 (7%)

Query: 137 KNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
             ++G G FG+V  GRL         VA+K LK   T      F  E  I+    H N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
           RL G  T     ++V  YM NGS+ S LR+  +            +  G A G+ YL + 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV---IQLVGMLRGIASGMKYLSDM 166

Query: 253 CDPKIIHRDVKAANILLDED 272
                +HRD+ A NIL++ +
Sbjct: 167 ---GYVHRDLAARNILINSN 183

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  101 bits (253), Expect = 2e-25
 Identities = 41/149 (27%), Positives = 64/149 (42%), Gaps = 10/149 (6%)

Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
           D +  + ++G G    V         + VA+KR+  E+      +   E++ +S   H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 191 LLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWP-TRKKIAL---GSARG 245
           ++  Y     V ++L LV   ++ GSV   ++   +             IA        G
Sbjct: 75  IVSYYT-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133

Query: 246 LSYLHEHCDPKIIHRDVKAANILLDEDAD 274
           L YLH++     IHRDVKA NILL ED  
Sbjct: 134 LEYLHKN---GQIHRDVKAGNILLGEDGS 159

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  101 bits (254), Expect = 3e-25
 Identities = 40/152 (26%), Positives = 67/152 (44%), Gaps = 19/152 (12%)

Query: 137 KNILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQFQTEVKIISM-AVHRNLL 192
           ++++G G FG+V K R+    L    A+KR+KE  +      F  E++++     H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK------------KIAL 240
            L G C       L   Y  +G++   LR+ +       +                  A 
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 241 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
             ARG+ YL +    + IHRD+ A NIL+ E+
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGEN 178

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  103 bits (258), Expect = 3e-25
 Identities = 44/143 (30%), Positives = 61/143 (42%), Gaps = 22/143 (15%)

Query: 137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 196
              +G+G FG V  G    G  VAVK +K + T      F  E  +++   H NL++L G
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLG 253

Query: 197 FCTT-------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
                      VTE      YM  GS+   LR R  S   L      K +L     + YL
Sbjct: 254 VIVEEKGGLYIVTE------YMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYL 305

Query: 250 HEHCDPKIIHRDVKAANILLDED 272
             +     +HRD+ A N+L+ ED
Sbjct: 306 EGN---NFVHRDLAARNVLVSED 325

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  100 bits (252), Expect = 3e-25
 Identities = 41/154 (26%), Positives = 64/154 (41%), Gaps = 22/154 (14%)

Query: 137 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
           K  LG G FGKV+     +        LVAVK LK+  T      FQ E ++++   H +
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEH 78

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER------------QSSLPPLDWPTRKKI 238
           +++ YG C      ++V+ YM +G +   LR              + +   L       I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           A   A G+ YL        +HRD+   N L+  +
Sbjct: 139 ASQIASGMVYLASQ---HFVHRDLATRNCLVGAN 169

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  100 bits (252), Expect = 4e-25
 Identities = 40/157 (25%), Positives = 65/157 (41%), Gaps = 17/157 (10%)

Query: 125 RELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRL----KEERTSGGELQFQTE 179
             + +    +     LG GGF  V     L DG   A+KR+    +++R      + Q E
Sbjct: 22  HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE-----EAQRE 76

Query: 180 VKIISMAVHRNLLRLYGFC----TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR 235
             +  +  H N+LRL  +C        E  L+ P+   G++ + +   +     L     
Sbjct: 77  ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI 136

Query: 236 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
             + LG  RGL  +H        HRD+K  NILL ++
Sbjct: 137 LWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDE 170

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  101 bits (253), Expect = 4e-25
 Identities = 41/153 (26%), Positives = 60/153 (39%), Gaps = 20/153 (13%)

Query: 137 KNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHR 189
              LG G FGKV +              VAVK LK    +  +    +E+KI+S    H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK----------KIA 239
           N++ L G CT     L++  Y   G + + LR +   L                     +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 240 LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
              A+G+++L        IHRDV A N+LL   
Sbjct: 171 SQVAQGMAFLASK---NCIHRDVAARNVLLTNG 200

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  100 bits (252), Expect = 4e-25
 Identities = 48/162 (29%), Positives = 71/162 (43%), Gaps = 21/162 (12%)

Query: 134 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
           F+    +G+G FG+V+KG      K+VA+K +  E         Q E+ ++S      + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 193 RLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 251
           + YG       KL ++  Y+  GS    L        PLD      I     +GL YLH 
Sbjct: 84  KYYG-SYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHS 137

Query: 252 HCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 283
               K IHRD+KAAN+LL E  +          Q + T ++R
Sbjct: 138 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  102 bits (256), Expect = 6e-25
 Identities = 39/140 (27%), Positives = 61/140 (43%), Gaps = 18/140 (12%)

Query: 138 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 197
             LG G FG+V+         VAVK +K    S     F  E  ++    H  L++L+  
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKLVKLHAV 251

Query: 198 CTT-----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
            T      +TE      +M  GS+   L+  + S  PL  P     +   A G++++ + 
Sbjct: 252 VTKEPIYIITE------FMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR 303

Query: 253 CDPKIIHRDVKAANILLDED 272
                IHRD++AANIL+   
Sbjct: 304 ---NYIHRDLRAANILVSAS 320

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  100 bits (250), Expect = 9e-25
 Identities = 44/156 (28%), Positives = 66/156 (42%), Gaps = 23/156 (14%)

Query: 137 KNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHR 189
              LGRG FG+V +            + VAVK LKE  T        +E+KI+     H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91

Query: 190 NLLRLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPLDWPTRK------------ 236
           N++ L G CT     L+V   +   G++++ LR +++   P                   
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 237 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
             +   A+G+ +L      K IHRD+ A NILL E 
Sbjct: 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK 184

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  100 bits (250), Expect = 1e-24
 Identities = 40/157 (25%), Positives = 64/157 (40%), Gaps = 24/157 (15%)

Query: 137 KNILGRGGFGKVYKGRLADGK--------LVAVKRLKEERTSGGELQFQTEVKIISM-AV 187
              LG G FG+V                  VAVK LK++ T        +E++++ M   
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER------------QSSLPPLDWPTR 235
           H+N++ L G CT      ++  Y + G++   LR R            +     + +   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 236 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
                  ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 193

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 99.3 bits (248), Expect = 1e-24
 Identities = 45/166 (27%), Positives = 78/166 (46%), Gaps = 28/166 (16%)

Query: 134 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNL 191
           +     LG G FGKVYK +    G L A K ++ +  S  EL+ +  E++I++   H  +
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYI 78

Query: 192 LRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL---GSARGLS 247
           ++L G       KL ++  +   G+V + + E    L      T  +I +        L+
Sbjct: 79  VKLLG-AYYHDGKLWIMIEFCPGGAVDAIMLELDRGL------TEPQIQVVCRQMLEALN 131

Query: 248 YLHEHCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 283
           +LH     +IIHRD+KA N+L+  + D          ++ KT+ +R
Sbjct: 132 FLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 174

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 99.3 bits (248), Expect = 2e-24
 Identities = 44/153 (28%), Positives = 67/153 (43%), Gaps = 21/153 (13%)

Query: 137 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
           K  LG G FGKV+     +        LVAVK LKE  +      FQ E ++++M  H++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQH 104

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-----------QSSLPPLDWPTRKKIA 239
           ++R +G CT     L+V+ YM +G +   LR               +  PL       +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 240 LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
              A G+ YL        +HRD+   N L+ + 
Sbjct: 165 SQVAAGMVYLAGL---HFVHRDLATRNCLVGQG 194

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  100 bits (250), Expect = 2e-24
 Identities = 33/149 (22%), Positives = 58/149 (38%), Gaps = 11/149 (7%)

Query: 131 TDGFSNKNILGRG--GFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QTEVKIISMA 186
              +    ++G+G      V   R    G+ V V+R+  E  S   + F Q E+ +  + 
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 187 VHRNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 245
            H N++           +L +V  +M  GS    +         ++      I  G  + 
Sbjct: 84  NHPNIVPYRA-TFIADNELWVVTSFMAYGSAKDLICTHFMD--GMNELAIAYILQGVLKA 140

Query: 246 LSYLHEHCDPKIIHRDVKAANILLDEDAD 274
           L Y+H       +HR VKA++IL+  D  
Sbjct: 141 LDYIHHM---GYVHRSVKASHILISVDGK 166

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  101 bits (253), Expect = 2e-24
 Identities = 42/140 (30%), Positives = 64/140 (45%), Gaps = 18/140 (12%)

Query: 138 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 197
             LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L++LY  
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 198 CT-----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
            +      VTE      YM+ GS+   L+        L  P    +A   A G++Y+   
Sbjct: 331 VSEEPIYIVTE------YMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERM 382

Query: 253 CDPKIIHRDVKAANILLDED 272
                +HRD++AANIL+ E+
Sbjct: 383 ---NYVHRDLRAANILVGEN 399

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 98.8 bits (247), Expect = 2e-24
 Identities = 46/162 (28%), Positives = 64/162 (39%), Gaps = 29/162 (17%)

Query: 137 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
              LG G FGKV K      K       VAVK LKE  +        +E  ++    H +
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER-----------------QSSLPPLDWP 233
           +++LYG C+     LL+  Y   GS+   LRE                      P     
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 234 TRK---KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           T       A   ++G+ YL E    K++HRD+ A NIL+ E 
Sbjct: 148 TMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEG 186

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 99.7 bits (249), Expect = 3e-24
 Identities = 40/157 (25%), Positives = 64/157 (40%), Gaps = 24/157 (15%)

Query: 137 KNILGRGGFGKVYKGRLADGK--------LVAVKRLKEERTSGGELQFQTEVKIISM-AV 187
              LG G FG+V                  VAVK LK++ T        +E++++ M   
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER------------QSSLPPLDWPTR 235
           H+N++ L G CT      ++  Y + G++   LR R            +     + +   
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 236 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
                  ARG+ YL      K IHRD+ A N+L+ E+
Sbjct: 206 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTEN 239

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  100 bits (250), Expect = 4e-24
 Identities = 39/136 (28%), Positives = 63/136 (46%), Gaps = 8/136 (5%)

Query: 138 NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 196
           + LG G +G+VY+G        VAVK LKE+       +F  E  ++    H NL++L G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 197 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 256
            CT      ++  +MT G++   LRE       +       +A   +  + YL +     
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQ--EVSAVVLLYMATQISSAMEYLEKK---N 338

Query: 257 IIHRDVKAANILLDED 272
            IHR++ A N L+ E+
Sbjct: 339 FIHRNLAARNCLVGEN 354

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 98.5 bits (246), Expect = 4e-24
 Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 29/162 (17%)

Query: 137 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
              +G G FG+V++ R           +VAVK LKEE ++  +  FQ E  +++   + N
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER--------------------QSSLPPL 230
           +++L G C       L++ YM  G +   LR                          PPL
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 231 DWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
               +  IA   A G++YL E    K +HRD+   N L+ E+
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGEN 210

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 97.9 bits (244), Expect = 6e-24
 Identities = 38/180 (21%), Positives = 68/180 (37%), Gaps = 14/180 (7%)

Query: 94  WRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR- 152
           W              ED+  + L +  +    E +      +++  +GRG FG+V++ + 
Sbjct: 20  WSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKD 79

Query: 153 LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMT 212
              G   AVK+++ E           E+   +      ++ LYG         +    + 
Sbjct: 80  KQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133

Query: 213 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
            GS+   +++       L           +  GL YLH     +I+H DVKA N+LL  D
Sbjct: 134 GGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSD 186

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 97.8 bits (244), Expect = 8e-24
 Identities = 38/162 (23%), Positives = 62/162 (38%), Gaps = 29/162 (17%)

Query: 137 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISM-AVHR 189
             +LG G FGKV                VAVK LKE+  S       +E+K+++    H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS------- 242
           N++ L G CT      L++ Y   G + + LR ++      +     +  L         
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 243 ------------ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
                       A+G+ +L        +HRD+ A N+L+   
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHG 208

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 98.2 bits (245), Expect = 9e-24
 Identities = 41/157 (26%), Positives = 63/157 (40%), Gaps = 24/157 (15%)

Query: 137 KNILGRGGFGKVYKGRLADGK--------LVAVKRLKEERTSGGELQFQTEVKIISM-AV 187
              LG G FG+V                  VAVK LK + T        +E++++ M   
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK----------- 236
           H+N++ L G CT      ++  Y + G++   L+ R+       +               
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 237 -KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
              A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 194 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTED 227

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 96.9 bits (242), Expect = 1e-23
 Identities = 42/157 (26%), Positives = 61/157 (38%), Gaps = 24/157 (15%)

Query: 137 KNILGRGGFGKVYKGRLADGK------LVAVKRLKEERTSGGELQFQTEVKIISM-AVHR 189
              LG G FGKV +              VAVK LK            +E+K++S    H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE-RQSSLPPLDWPTRKK----------- 237
           N++ L G CT     L++  Y   G + + LR  R S +     P   +           
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 238 --IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
              +   A+G+++L        IHRD+ A NILL   
Sbjct: 148 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHG 181

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 96.6 bits (241), Expect = 1e-23
 Identities = 38/156 (24%), Positives = 65/156 (41%), Gaps = 24/156 (15%)

Query: 134 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
           F    +LG+G FG+V K R   D +  A+K+++   T        +EV +++   H+ ++
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEKLSTILSEVMLLASLNHQYVV 65

Query: 193 RLYGF------------CTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLD-WPTRKKI 238
           R Y                     L +   Y  NG++   +     +    + W   ++I
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125

Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 274
                  LSY+H      IIHRD+K  NI +DE  +
Sbjct: 126 LEA----LSYIHSQ---GIIHRDLKPMNIFIDESRN 154

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 96.6 bits (241), Expect = 1e-23
 Identities = 34/158 (21%), Positives = 67/158 (42%), Gaps = 15/158 (9%)

Query: 120 KRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQT 178
           +    + + V    +S    +G GG  KV++      ++ A+K +  E      L  ++ 
Sbjct: 16  ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRN 75

Query: 179 EVKIISMAVHRNL--LRLYGFCTTVTEKLLVYPYM--TNGSVASRLRERQSSLPPLDWPT 234
           E+  ++     +   +RLY +  T      +Y  M   N  + S L++++S    +D   
Sbjct: 76  EIAYLNKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKS----IDPWE 128

Query: 235 RKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           RK         +  +H+H    I+H D+K AN L+ + 
Sbjct: 129 RKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG 163

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 97.1 bits (242), Expect = 2e-23
 Identities = 32/140 (22%), Positives = 61/140 (43%), Gaps = 15/140 (10%)

Query: 138 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNL--LRL 194
             +G GG  KV++      ++ A+K +  E      L  ++ E+  ++     +   +RL
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 195 YGFCTTVTEKLLVYPYM--TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
           Y +  T      +Y  M   N  + S L++++S    +D   RK         +  +H+H
Sbjct: 75  YDYEITDQY---IYMVMECGNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIHQH 127

Query: 253 CDPKIIHRDVKAANILLDED 272
               I+H D+K AN L+ + 
Sbjct: 128 ---GIVHSDLKPANFLIVDG 144

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 96.7 bits (241), Expect = 2e-23
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 43/199 (21%)

Query: 112 SELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTS 170
           S+     L    L  L+     F    ++G G +G+VYKGR +  G+L A+K +      
Sbjct: 4   SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--- 60

Query: 171 GGELQ-FQTEVKIIS-MAVHRNLLRLYG-----FCTTVTEKL-LVYPYMTNGSVA----- 217
           G E +  + E+ ++   + HRN+   YG         + ++L LV  +   GSV      
Sbjct: 61  GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN 120

Query: 218 ---SRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 274
              + L+E   +           I     RGLS+LH+H   K+IHRD+K  N+LL E+A+
Sbjct: 121 TKGNTLKEEWIAY----------ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAE 167

Query: 275 ----------QSSKTILRR 283
                     Q  +T+ RR
Sbjct: 168 VKLVDFGVSAQLDRTVGRR 186

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 95.3 bits (238), Expect = 2e-23
 Identities = 40/137 (29%), Positives = 62/137 (45%), Gaps = 11/137 (8%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRL-KEE-RTSGGELQFQTEVKIISMAVHRNLLRLYG 196
           LG+G F  VY+   +  G  VA+K + K+    +G   + Q EVKI     H ++L LY 
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 197 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-LGSARGLSYLHEHCDP 255
           +        LV     NG +   L+ R       +   R  +  +    G+ YLH H   
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS--ENEARHFMHQI--ITGMLYLHSH--- 131

Query: 256 KIIHRDVKAANILLDED 272
            I+HRD+  +N+LL  +
Sbjct: 132 GILHRDLTLSNLLLTRN 148

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 95.5 bits (238), Expect = 4e-23
 Identities = 30/144 (20%), Positives = 61/144 (42%), Gaps = 6/144 (4%)

Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQF-QTEVKIISMAVH 188
             F  +  +GRG F +VY+   L DG  VA+K+++  +            E+ ++    H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 248
            N+++ Y       E  +V      G ++  ++  +     +   T  K  +     L +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 249 LHEHCDPKIIHRDVKAANILLDED 272
           +H     +++HRD+K AN+ +   
Sbjct: 152 MHSR---RVMHRDIKPANVFITAT 172

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 95.2 bits (237), Expect = 5e-23
 Identities = 33/153 (21%), Positives = 64/153 (41%), Gaps = 7/153 (4%)

Query: 128 QVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMA 186
             +   +   +ILG+G    V++GR    G L A+K                E +++   
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 187 VHRNLLRLYGFCTTVTEKL--LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
            H+N+++L+      T +   L+  +   GS+ + L E  ++   L       +      
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVG 123

Query: 245 GLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 277
           G+++L E+    I+HR++K  NI+     D  S
Sbjct: 124 GMNHLREN---GIVHRNIKPGNIMRVIGEDGQS 153

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 94.3 bits (235), Expect = 8e-23
 Identities = 33/154 (21%), Positives = 59/154 (38%), Gaps = 17/154 (11%)

Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
             F     LGRGGFG V++ +   D    A+KR++         +   EVK ++   H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 191 LLRLYGF---------CTTVTEKLLVY---PYMTNGSVASRLRERQSSLPPLDWPTRKKI 238
           ++R +               + K+ +Y         ++   +  R +     +      I
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHI 123

Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
            L  A  + +LH      ++HRD+K +NI    D
Sbjct: 124 FLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMD 154

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 95.7 bits (238), Expect = 1e-22
 Identities = 30/137 (21%), Positives = 61/137 (44%), Gaps = 11/137 (8%)

Query: 138 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNL--LRL 194
             +G GG  KV++      ++ A+K +  E      L  ++ E+  ++     +   +RL
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 195 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 254
           Y +  T  + + +     N  + S L++++S    +D   RK         +  +H+H  
Sbjct: 122 YDYEIT-DQYIYMVMECGNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIHQH-- 174

Query: 255 PKIIHRDVKAANILLDE 271
             I+H D+K AN L+ +
Sbjct: 175 -GIVHSDLKPANFLIVD 190

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 93.9 bits (234), Expect = 1e-22
 Identities = 44/187 (23%), Positives = 65/187 (34%), Gaps = 18/187 (9%)

Query: 91  FAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYK 150
           F    + +P    F   A +  +       R      Q     F   + LG G +G+V+K
Sbjct: 20  FQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQS----FQRLSRLGHGSYGEVFK 75

Query: 151 GR-LADGKLVAVKRL-KEERTSGGELQFQTEVKII-SMAVHRNLLRLYGFCTTVTEKLLV 207
            R   DG+L AVKR     R      +   EV     +  H   +RL        E  ++
Sbjct: 76  VRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ---AWEEGGIL 132

Query: 208 YPYMT--NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAA 265
           Y        S+        +SLP             +   L++LH      ++H DVK A
Sbjct: 133 YLQTELCGPSLQQHCEAWGASLPE---AQVWGYLRDTLLALAHLHSQ---GLVHLDVKPA 186

Query: 266 NILLDED 272
           NI L   
Sbjct: 187 NIFLGPR 193

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 93.9 bits (234), Expect = 2e-22
 Identities = 40/166 (24%), Positives = 73/166 (43%), Gaps = 6/166 (3%)

Query: 112 SELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTS 170
           S    G+LK    +      +   +   +GRG +G V K      G+++AVKR++     
Sbjct: 2   SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 61

Query: 171 GGELQFQTEVKII-SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP- 228
             + Q   ++ ++   +    +++ YG      +  +    M + S     +   S L  
Sbjct: 62  KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDD 120

Query: 229 PLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 274
            +      KI L + + L++L E  + KIIHRD+K +NILLD   +
Sbjct: 121 VIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGN 164

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 94.1 bits (234), Expect = 3e-22
 Identities = 33/153 (21%), Positives = 64/153 (41%), Gaps = 7/153 (4%)

Query: 128 QVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMA 186
             +   +   +ILG+G    V++GR    G L A+K                E +++   
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 187 VHRNLLRLYGFCTTVTEKL--LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
            H+N+++L+      T +   L+  +   GS+ + L E  ++   L       +      
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVG 123

Query: 245 GLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 277
           G+++L E+    I+HR++K  NI+     D  S
Sbjct: 124 GMNHLREN---GIVHRNIKPGNIMRVIGEDGQS 153

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 93.3 bits (232), Expect = 4e-22
 Identities = 56/199 (28%), Positives = 84/199 (42%), Gaps = 32/199 (16%)

Query: 97  TRPHEFFFDVPAEDDSELQ-----------LGQLKRFSLRELQVATD---GFSNKNILGR 142
              H   +D+P  ++   Q            G LK   + EL    D    FS+   +G 
Sbjct: 5   HHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGH 64

Query: 143 GGFGKVYKGR-LADGKLVAVKR--LKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT 199
           G FG VY  R + + ++VA+K+     ++++        EV+ +    H N ++  G C 
Sbjct: 65  GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG-CY 123

Query: 200 TVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL---GSARGLSYLHEHCDP 255
                  LV  Y   GS +  L   +  L         +IA    G+ +GL+YLH H   
Sbjct: 124 LREHTAWLVMEYC-LGSASDLLEVHKKPL------QEVEIAAVTHGALQGLAYLHSH--- 173

Query: 256 KIIHRDVKAANILLDEDAD 274
            +IHRDVKA NILL E   
Sbjct: 174 NMIHRDVKAGNILLSEPGL 192

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 92.0 bits (229), Expect = 4e-22
 Identities = 36/156 (23%), Positives = 70/156 (44%), Gaps = 27/156 (17%)

Query: 134 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
           F    ++G GGFG+V+K +   DGK   +KR+K         + + EVK ++   H N++
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIV 67

Query: 193 RLYGF-------------CTTVTEKLLVYPYM---TNGSVASRLRERQSSLPPLDWPTRK 236
              G               ++ ++   ++  M     G++   + +R+     LD     
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE--KLDKVLAL 125

Query: 237 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           ++     +G+ Y+H     K+I+RD+K +NI L + 
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT 158

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 92.5 bits (230), Expect = 8e-22
 Identities = 37/147 (25%), Positives = 65/147 (44%), Gaps = 15/147 (10%)

Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QTEVKIISMAVHR 189
           + +     +G G FGK    +   DG+   +K +   R S  E +  + EV +++   H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPP----LDWPTRKKIALGSARG 245
           N+++            +V  Y   G +  R+  ++  L      LDW    +I L     
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV--QICLA---- 137

Query: 246 LSYLHEHCDPKIIHRDVKAANILLDED 272
           L ++H+    KI+HRD+K+ NI L +D
Sbjct: 138 LKHVHDR---KILHRDIKSQNIFLTKD 161

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 91.6 bits (228), Expect = 9e-22
 Identities = 36/162 (22%), Positives = 71/162 (43%), Gaps = 22/162 (13%)

Query: 134 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
           ++    +G+G  G VY    +A G+ VA++++  ++    EL    E+ ++    + N++
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIV 80

Query: 193 RLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 251
                   V ++L +V  Y+  GS+   + E       +D      +     + L +LH 
Sbjct: 81  NYLD-SYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS 134

Query: 252 HCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 283
           +   ++IHRD+K+ NILL  D            Q +    +R
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 90.7 bits (226), Expect = 1e-21
 Identities = 45/136 (33%), Positives = 64/136 (47%), Gaps = 10/136 (7%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYG 196
           LG+G FG VY  R      ++A+K L + +   +G E Q + EV+I S   H N+LRLYG
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76

Query: 197 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 256
           +    T   L+  Y   G+V   L++        D           A  LSY H     +
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---R 129

Query: 257 IIHRDVKAANILLDED 272
           +IHRD+K  N+LL   
Sbjct: 130 VIHRDIKPENLLLGSA 145

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 91.1 bits (227), Expect = 1e-21
 Identities = 31/136 (22%), Positives = 56/136 (41%), Gaps = 10/136 (7%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYG 196
           LG+GGF K ++       ++ A K + +          +   E+ I     H++++  +G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 197 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 256
           F        +V       S+    + R+     L  P  +        G  YLH +   +
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---R 135

Query: 257 IIHRDVKAANILLDED 272
           +IHRD+K  N+ L+ED
Sbjct: 136 VIHRDLKLGNLFLNED 151

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 90.9 bits (226), Expect = 2e-21
 Identities = 43/167 (25%), Positives = 69/167 (41%), Gaps = 32/167 (19%)

Query: 134 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
             +   +G G  G V   R    G+ VAVK +   +    EL    EV I+    H N++
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL-LFNEVVIMRDYQHFNVV 105

Query: 193 RLYGFCTTVTEKL-LVYPYMTNGSVA-----SRLRERQSSLPPLDWPTRKKIALGSARGL 246
            +Y     V E+L ++  ++  G++       RL E Q +           +     + L
Sbjct: 106 EMYK-SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT----------VCEAVLQAL 154

Query: 247 SYLHEHCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 283
           +YLH      +IHRD+K+ +ILL  D            Q SK + +R
Sbjct: 155 AYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 198

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 90.0 bits (224), Expect = 2e-21
 Identities = 37/147 (25%), Positives = 61/147 (41%), Gaps = 6/147 (4%)

Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QTEVKIISMAVHR 189
           + +     +G G +G+  K R  +DGK++  K L     +  E Q   +EV ++    H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 190 NLLRLYG-FCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           N++R Y          L +V  Y   G +AS + +       LD     ++       L 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 248 YLHEHCDP--KIIHRDVKAANILLDED 272
             H   D    ++HRD+K AN+ LD  
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGK 152

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 90.5 bits (225), Expect = 3e-21
 Identities = 47/166 (28%), Positives = 74/166 (44%), Gaps = 30/166 (18%)

Query: 134 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHRNL 191
           F     LG G +G VYK      G++VA+K++  E        +   E+ I+      ++
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ----EIIKEISIMQQCDSPHV 86

Query: 192 LRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL---GSARGLS 247
           ++ YG        L +V  Y   GSV+  +R R  +L      T  +IA     + +GL 
Sbjct: 87  VKYYG-SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTL------TEDEIATILQSTLKGLE 139

Query: 248 YLHEHCDPKIIHRDVKAANILLDEDAD----------QSSKTILRR 283
           YLH     + IHRD+KA NILL+ +            Q + T+ +R
Sbjct: 140 YLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR 182

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 90.4 bits (225), Expect = 4e-21
 Identities = 31/136 (22%), Positives = 56/136 (41%), Gaps = 10/136 (7%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYG 196
           LG+GGF K ++       ++ A K + +          +   E+ I     H++++  +G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 197 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 256
           F        +V       S+    + R+     L  P  +        G  YLH +   +
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---R 161

Query: 257 IIHRDVKAANILLDED 272
           +IHRD+K  N+ L+ED
Sbjct: 162 VIHRDLKLGNLFLNED 177

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 88.1 bits (219), Expect = 1e-20
 Identities = 35/150 (23%), Positives = 64/150 (42%), Gaps = 5/150 (3%)

Query: 127 LQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKII-S 184
           ++V  D       LGRG +G V K R +  G+++AVKR++    S  + +   ++ I   
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61

Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
                  +  YG      +  +    M + S+    ++       +      KIA+   +
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120

Query: 245 GLSYLHEHCDPKIIHRDVKAANILLDEDAD 274
            L +LH      +IHRDVK +N+L++    
Sbjct: 121 ALEHLHS--KLSVIHRDVKPSNVLINALGQ 148

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 89.1 bits (221), Expect = 2e-20
 Identities = 32/149 (21%), Positives = 60/149 (40%), Gaps = 12/149 (8%)

Query: 134 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 192
           F  K++LG G  G +    + D + VAVKR+  E  S        EV++      H N++
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVI 81

Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
           R +        + +        ++   + ++  +   L+      +   +  GL++LH  
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLHSL 137

Query: 253 CDPKIIHRDVKAANILLDEDADQSSKTIL 281
               I+HRD+K  NIL+           +
Sbjct: 138 ---NIVHRDLKPHNILISMPNAHGKIKAM 163

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 89.7 bits (222), Expect = 2e-20
 Identities = 41/150 (27%), Positives = 64/150 (42%), Gaps = 17/150 (11%)

Query: 137 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           K  LG GGFG V +      G+ VA+K+ ++E +     ++  E++I+    H N++   
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78

Query: 196 ------GFCTTVTEKLLVYPYMTNGSVASRL--RERQSSLPPLDWPTRKKIA-LGSARGL 246
                          LL   Y   G +   L   E    L       R  ++ + SA  L
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP--IRTLLSDISSA--L 134

Query: 247 SYLHEHCDPKIIHRDVKAANILLDEDADQS 276
            YLHE+   +IIHRD+K  NI+L     + 
Sbjct: 135 RYLHEN---RIIHRDLKPENIVLQPGPQRL 161

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 86.5 bits (215), Expect = 5e-20
 Identities = 39/137 (28%), Positives = 64/137 (46%), Gaps = 12/137 (8%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYG 196
           LG+G FG VY  R   +  ++A+K L + +    G E Q + E++I S   H N+LR+Y 
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 197 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-LGSARGLSYLHEHCDP 255
           +        L+  +   G +   L+ +       +  +   +  L  A  L Y HE    
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQ-KHGRFD--EQRSATFMEELADA--LHYCHER--- 133

Query: 256 KIIHRDVKAANILLDED 272
           K+IHRD+K  N+L+   
Sbjct: 134 KVIHRDIKPENLLMGYK 150

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 86.7 bits (215), Expect = 9e-20
 Identities = 36/153 (23%), Positives = 58/153 (37%), Gaps = 23/153 (15%)

Query: 140 LGRGGFGKVYKGRLADGKLVAVKRLK----------------EERTSGGELQFQTEVKII 183
           L +G F K+      D K  A+K+ +                +         F+ E++II
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 184 SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ----SSLPPLDWPTRKKIA 239
           +   +   L   G  T   E  ++Y YM N S+            +    +     K I 
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 240 LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
                  SY+H   +  I HRDVK +NIL+D++
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKN 188

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 86.4 bits (214), Expect = 1e-19
 Identities = 42/176 (23%), Positives = 76/176 (43%), Gaps = 15/176 (8%)

Query: 108 AEDDSELQLGQLKRFSLREL--------QVATDGFSNKNILGRGGFGKVYKGRL-ADGKL 158
            +   EL+L + +R  L           ++  D F   + LG G  G V+K      G +
Sbjct: 1   GKKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLV 60

Query: 159 VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVAS 218
           +A K +  E       Q   E++++       ++  YG   +  E  +   +M  GS+  
Sbjct: 61  MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120

Query: 219 RLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 274
            L++       +      K+++   +GL+YL E    KI+HRDVK +NIL++   +
Sbjct: 121 VLKKAG----RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGE 170

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 84.6 bits (209), Expect = 6e-19
 Identities = 24/160 (15%), Positives = 58/160 (36%), Gaps = 11/160 (6%)

Query: 125 RELQVATDGFSNKNILGRGGFGKVYKGR------LADGKLVAVKRLKEERTSGGELQFQT 178
            E Q+ +      ++LG G F +VY+          + +   +K  K        +  Q 
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ- 116

Query: 179 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE-RQSSLPPLDWPTRKK 237
            ++ +  ++    ++ Y         +LV    + G++ + +   + +    +       
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176

Query: 238 IALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 277
            A+     +  +H+    +IIH D+K  N +L     +  
Sbjct: 177 FAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQD 213

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 83.6 bits (206), Expect = 2e-18
 Identities = 18/165 (10%), Positives = 36/165 (21%), Gaps = 34/165 (20%)

Query: 139 ILGRGGFGKVYKGR-LADGKLVAVK--RLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
            L  G    V+  R +   +  A+K   +  E +     +        +  +  +     
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 196 GFC--------------------------TTVTEKLLVYPYM--TNGSVASRLRERQSSL 227
                                          V   LL+ P        + S L       
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 228 PPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
                     +     R  + L       ++H      N+ +  D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPD 230

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 83.3 bits (206), Expect = 3e-18
 Identities = 37/150 (24%), Positives = 60/150 (40%), Gaps = 12/150 (8%)

Query: 134 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKI-ISMAVHRNLL 192
             ++ ILG G  G V       G+ VAVKR+  +           E+K+      H N++
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD----IALMEIKLLTESDDHPNVI 72

Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR---KKIALGSARGLSYL 249
           R Y   TT     +      N ++   +  +  S   L          +    A G+++L
Sbjct: 73  RYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131

Query: 250 HEHCDPKIIHRDVKAANILLDEDADQSSKT 279
           H     KIIHRD+K  NIL+   +  ++  
Sbjct: 132 HSL---KIIHRDLKPQNILVSTSSRFTADQ 158

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 81.3 bits (201), Expect = 5e-18
 Identities = 35/154 (22%), Positives = 66/154 (42%), Gaps = 8/154 (5%)

Query: 123 SLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVK 181
             +  Q   +   N   +G G  G+V+K R    G ++AVK+++         +   ++ 
Sbjct: 16  GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD 75

Query: 182 IISMAV-HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL 240
           ++  +     +++ +G   T T+  +    M   +   + R +     P+      K+ +
Sbjct: 76  VVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG----PIPERILGKMTV 131

Query: 241 GSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 274
              + L YL E     +IHRDVK +NILLDE   
Sbjct: 132 AIVKALYYLKE--KHGVIHRDVKPSNILLDERGQ 163

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 81.3 bits (201), Expect = 6e-18
 Identities = 37/142 (26%), Positives = 62/142 (43%), Gaps = 12/142 (8%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLRLYGF 197
           L  GGF  VY+ + +  G+  A+KRL              EV  +  ++ H N+++    
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLS-NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 198 CTTVTEK-------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
            +   E+        L+   +  G +   L++ +S   PL   T  KI   + R + ++H
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR-GPLSCDTVLKIFYQTCRAVQHMH 153

Query: 251 EHCDPKIIHRDVKAANILLDED 272
               P IIHRD+K  N+LL   
Sbjct: 154 -RQKPPIIHRDLKVENLLLSNQ 174

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 78.8 bits (195), Expect = 4e-17
 Identities = 35/150 (23%), Positives = 55/150 (36%), Gaps = 34/150 (22%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVK---RLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           LG G +GKV +          AVK   + K  R   GE   + E++++    H+N+++L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 196 GFCTTVTEK--LLVYPYMTNGS-------VASRLRERQSSLPPLDWPTRKK----IALGS 242
                  ++   +V  Y   G           R    Q+                I    
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQA---------HGYFCQLID--- 120

Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
             GL YLH      I+H+D+K  N+LL   
Sbjct: 121 --GLEYLHSQ---GIVHKDIKPGNLLLTTG 145

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 78.5 bits (193), Expect = 9e-17
 Identities = 27/166 (16%), Positives = 55/166 (33%), Gaps = 35/166 (21%)

Query: 139 ILGRGGFGKVYKGR-LADGKLVAVK--------------RLKEERTSGGELQ-------- 175
           +LG+       +      G+   V               ++KEE      L+        
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 176 -----FQTEVKIISMAVHRNLLRLYGFCTT--VTEKLLVYPYM--TNGSVASRLRERQSS 226
                F     ++     + ++R+        V  +  +YP M     +    L    S+
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 227 LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
              L    R ++ L   R L+ LH +    ++H  ++  +I+LD+ 
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQR 242

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 77.2 bits (191), Expect = 1e-16
 Identities = 43/156 (27%), Positives = 66/156 (42%), Gaps = 19/156 (12%)

Query: 130 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QT---EVKI-- 182
           AT  +     +G G +G VYK R    G  VA+K ++     GG      +   EV +  
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 183 -ISMAVHRNLLRLYGFCTTVTEKL-----LVYPYMTNGSVASRLRERQSSLPPLDWPTRK 236
            +    H N++RL   C T          LV+ ++    + + L +     P L   T K
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP--PGLPAETIK 123

Query: 237 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
            +     RGL +LH +    I+HRD+K  NIL+   
Sbjct: 124 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSG 156

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 76.5 bits (189), Expect = 2e-16
 Identities = 36/144 (25%), Positives = 57/144 (39%), Gaps = 28/144 (19%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 198
           LG G +G+V         + VAVK +  +R        + E+ I  M  H N+++ YG  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 199 TTVTEKLLVYPYMTNGSV------ASRLRERQSSLPPLDWPTRKK----IALGSARGLSY 248
                + L   Y + G +         + E  +         ++     +A     G+ Y
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA---------QRFFHQLMA-----GVVY 120

Query: 249 LHEHCDPKIIHRDVKAANILLDED 272
           LH      I HRD+K  N+LLDE 
Sbjct: 121 LHGI---GITHRDIKPENLLLDER 141

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 76.6 bits (189), Expect = 2e-16
 Identities = 31/151 (20%), Positives = 55/151 (36%), Gaps = 34/151 (22%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVK-----RLKEERTSGGELQFQTEVKIISMAVHR--NL 191
           LG GGFG VY G  ++D   VA+K     R+ +        +   EV ++         +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 192 LRLYGFCTTVTEKLLVYPYMTNG-------SVASRLRERQSSLPPLDWPTRKK---IALG 241
           +RL  +       +L+              +    L+E  +         R     +   
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA---------RSFFWQVL-- 159

Query: 242 SARGLSYLHEHCDPKIIHRDVKAANILLDED 272
               + + H      ++HRD+K  NIL+D +
Sbjct: 160 --EAVRHCHNC---GVLHRDIKDENILIDLN 185

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 76.2 bits (188), Expect = 4e-16
 Identities = 36/144 (25%), Positives = 56/144 (38%), Gaps = 28/144 (19%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 198
           LG G +G+V         + VAVK +  +R        + E+ I  M  H N+++ YG  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 199 TTVTEKLLVYPYMTNG------SVASRLRERQSSLPPLDWPTRKK----IALGSARGLSY 248
                + L   Y + G           + E  +         ++     +A     G+ Y
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA---------QRFFHQLMA-----GVVY 120

Query: 249 LHEHCDPKIIHRDVKAANILLDED 272
           LH      I HRD+K  N+LLDE 
Sbjct: 121 LHGI---GITHRDIKPENLLLDER 141

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 75.7 bits (187), Expect = 4e-16
 Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 10/143 (6%)

Query: 132 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVHR 189
           + +     +G G +G VYK + + G++VA+KR++ +    G +      E+ ++    H 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEG-IPSTAIREISLLKELHHP 79

Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           N++ L     +     LV+ +M    +   L E ++ L        K       RG+++ 
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQD---SQIKIYLYQLLRGVAHC 135

Query: 250 HEHCDPKIIHRDVKAANILLDED 272
           H+H   +I+HRD+K  N+L++ D
Sbjct: 136 HQH---RILHRDLKPQNLLINSD 155

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 76.6 bits (188), Expect = 5e-16
 Identities = 27/166 (16%), Positives = 51/166 (30%), Gaps = 35/166 (21%)

Query: 139 ILGRGGFGKVYKGR-LADGKLVAVK--RLKEERTSGGELQFQTEVKII------------ 183
           +LG+       +      G+   V      E   S    Q + EV  +            
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 184 ----SMAVHRNLLRLYGFCT-----------TVTEKLLVYPYM--TNGSVASRLRERQSS 226
                     +L++                  V  +  +YP M     +    L    S+
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 227 LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
              L    R ++ L   R L+ LH +    ++H  ++  +I+LD+ 
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQR 247

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 75.0 bits (185), Expect = 9e-16
 Identities = 41/142 (28%), Positives = 69/142 (48%), Gaps = 23/142 (16%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRL-KEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 197
           +G+G F KV   R +  G+ VA+K + K +       +   EV+I+ +  H N+++L+  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 198 CTTVTEKLLVYPYMTNGSV------ASRLRERQSSLPPLDWPTRKKIA-LGSARGLSYLH 250
             T     L+  Y + G V        R++E+++         R K   + SA  + Y H
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEA---------RSKFRQIVSA--VQYCH 131

Query: 251 EHCDPKIIHRDVKAANILLDED 272
           +     I+HRD+KA N+LLD D
Sbjct: 132 QKR---IVHRDLKAENLLLDAD 150

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 74.7 bits (184), Expect = 1e-15
 Identities = 34/150 (22%), Positives = 53/150 (35%), Gaps = 30/150 (20%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVK-----RLKEERTSGGELQFQTEVKIISM----AVHR 189
           LG+GGFG V+ G  L D   VA+K     R+         +    EV ++        H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNG-------SVASRLRERQSSLPPLDWPTRKKIALGS 242
            ++RL  +  T    +LV              +    L E  S          +      
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS----------RCFFGQV 148

Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
              + + H      ++HRD+K  NIL+D  
Sbjct: 149 VAAIQHCHSR---GVVHRDIKDENILIDLR 175

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 74.6 bits (184), Expect = 1e-15
 Identities = 35/149 (23%), Positives = 59/149 (39%), Gaps = 16/149 (10%)

Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QT---EVKIISMA 186
           D +     LG G +G+VYK       + VA+KR++ E    G      T   EV ++   
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEG---VPGTAIREVSLLKEL 90

Query: 187 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
            HRN++ L           L++ Y       + L++     P +     K        G+
Sbjct: 91  QHRNIIELKSVIHHNHRLHLIFEYAE-----NDLKKYMDKNPDVSMRVIKSFLYQLINGV 145

Query: 247 SYLHEHCDPKIIHRDVKAANILLDEDADQ 275
           ++ H     + +HRD+K  N+LL      
Sbjct: 146 NFCHSR---RCLHRDLKPQNLLLSVSDAS 171

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 74.1 bits (183), Expect = 1e-15
 Identities = 35/146 (23%), Positives = 72/146 (49%), Gaps = 14/146 (9%)

Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVH 188
           + F     +G G +G VYK R    G++VA+K+++ +  + G +      E+ ++    H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNH 61

Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGL 246
            N+++L     T  +  LV+ ++        L++    S+L  +  P  K       +GL
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH-----QDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116

Query: 247 SYLHEHCDPKIIHRDVKAANILLDED 272
           ++ H H   +++HRD+K  N+L++ +
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTE 139

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 74.1 bits (183), Expect = 2e-15
 Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 10/143 (6%)

Query: 132 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVHR 189
           + +     +G G +G VYK +   G+  A+K+++ E+   G +   T  E+ I+    H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG-IPSTTIREISILKELKHS 60

Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           N+++LY    T    +LV+ ++    +   L   +  L      T K   L    G++Y 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLES---VTAKSFLLQLLNGIAYC 116

Query: 250 HEHCDPKIIHRDVKAANILLDED 272
           H+    +++HRD+K  N+L++ +
Sbjct: 117 HDR---RVLHRDLKPQNLLINRE 136

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 74.8 bits (184), Expect = 2e-15
 Identities = 48/267 (17%), Positives = 82/267 (30%), Gaps = 47/267 (17%)

Query: 23  SQFTPISFENNLNLCGPNTKKPCSGSPPFSPPPPFGPTSSPGRNKSNAAIPVGVALGAAL 82
                   +N  N      ++     P  +         S   + S +A           
Sbjct: 4   HHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANL--------- 54

Query: 83  LFAVPVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGR 142
                       +       +F     +D        K F           +  K+++GR
Sbjct: 55  --LAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEF--------YQKYDPKDVIGR 104

Query: 143 GGFGKVYKGR-LADGKLVAVK-------RLKEERTSGGELQFQTEVKII-SMAVHRNLLR 193
           G    V +    A G   AVK       RL  E+        + E  I+  +A H +++ 
Sbjct: 105 GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164

Query: 194 LYGFCTTVTEKLLVYPYMTNGS-----VAS-RLRERQSSLPPLDWPTRKKIALGSARGLS 247
           L     + +   LV+  M  G           L E+++            I       +S
Sbjct: 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR----------SIMRSLLEAVS 214

Query: 248 YLHEHCDPKIIHRDVKAANILLDEDAD 274
           +LH +    I+HRD+K  NILLD++  
Sbjct: 215 FLHAN---NIVHRDLKPENILLDDNMQ 238

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 75.1 bits (185), Expect = 2e-15
 Identities = 38/188 (20%), Positives = 71/188 (37%), Gaps = 27/188 (14%)

Query: 109 EDDSELQLGQLKRF-------SLRELQVATDGFSNK----NILGRGGFGKVYKGR-LADG 156
            ++SE+ L   +         ++ +  V      ++      LG G  G+V         
Sbjct: 101 NNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTC 160

Query: 157 KLVAVK-------RLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP 209
           K VA++        +   R +   L  +TE++I+    H  ++++  F     +  +V  
Sbjct: 161 KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLE 219

Query: 210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 269
            M  G +  ++   +     L   T K         + YLHE+    IIHRD+K  N+LL
Sbjct: 220 LMEGGELFDKVVGNKR----LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLL 272

Query: 270 DEDADQSS 277
               +   
Sbjct: 273 SSQEEDCL 280

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 74.1 bits (182), Expect = 2e-15
 Identities = 32/185 (17%), Positives = 50/185 (27%), Gaps = 44/185 (23%)

Query: 137 KNILGRGGFGKVYKGR-LADGKLVAVK----RLKEERTSGGELQFQTEVKIISMAVHRNL 191
           K  +G+G +G V          + A+K        +       + +TEV+++    H N+
Sbjct: 31  KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90

Query: 192 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR------- 244
            RLY          LV      G +  +L                K  +           
Sbjct: 91  ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150

Query: 245 -----------------------------GLSYLHEHCDPKIIHRDVKAANILLDEDADQ 275
                                         L YLH      I HRD+K  N L   +   
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSF 207

Query: 276 SSKTI 280
             K +
Sbjct: 208 EIKLV 212

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 74.2 bits (183), Expect = 2e-15
 Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 23/154 (14%)

Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QT---EVKIISMA 186
             +     +G+G FG+V+K R    G+ VA+K++  E    G   F  T   E+KI+ + 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLL 73

Query: 187 VHRNLLRLYGFCTTVTEKL--------LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI 238
            H N++ L   C T             LV+ +  +  +A  L               K++
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTL---SEIKRV 129

Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
                 GL Y+H +   KI+HRD+KAAN+L+  D
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRD 160

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 74.5 bits (183), Expect = 3e-15
 Identities = 36/183 (19%), Positives = 74/183 (40%), Gaps = 20/183 (10%)

Query: 107 PAEDDSELQLGQLKRFSLRELQVATDGFSNK----NILGRGGFGKVYKGR-LADGKLVAV 161
            + +         K++  + +++  D   +       LG G FG V++    A G   A 
Sbjct: 128 VSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAA 187

Query: 162 KRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR 221
           K +     S  E   + E++ +S+  H  L+ L+       E +++Y +M+ G +  ++ 
Sbjct: 188 KFVMTPHESDKE-TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA 246

Query: 222 ERQSSLPPLDWPTRKKIALGSAR----GLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 277
           +  + +   +       A+   R    GL ++HE+     +H D+K  NI+         
Sbjct: 247 DEHNKMSEDE-------AVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNEL 296

Query: 278 KTI 280
           K I
Sbjct: 297 KLI 299

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 73.4 bits (181), Expect = 3e-15
 Identities = 37/142 (26%), Positives = 63/142 (44%), Gaps = 8/142 (5%)

Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
           + +   + LG G +  VYKG+      LVA+K ++ E   G       EV ++    H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
           ++ L+    T     LV+ Y+    +   L +  + +        K       RGL+Y H
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINM---HNVKLFLFQLLRGLAYCH 117

Query: 251 EHCDPKIIHRDVKAANILLDED 272
                K++HRD+K  N+L++E 
Sbjct: 118 RQ---KVLHRDLKPQNLLINER 136

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 73.4 bits (181), Expect = 4e-15
 Identities = 42/146 (28%), Positives = 70/146 (47%), Gaps = 12/146 (8%)

Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQF-QT---EVKIISMA 186
             +   + LG G F  VYK R     ++VA+K++K    S  +    +T   E+K++   
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 187 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
            H N++ L       +   LV+ +M    +   +++    L P      K   L + +GL
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTP---SHIKAYMLMTLQGL 125

Query: 247 SYLHEHCDPKIIHRDVKAANILLDED 272
            YLH+H    I+HRD+K  N+LLDE+
Sbjct: 126 EYLHQH---WILHRDLKPNNLLLDEN 148

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 73.6 bits (181), Expect = 5e-15
 Identities = 35/155 (22%), Positives = 62/155 (40%), Gaps = 14/155 (9%)

Query: 131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVH 188
           ++ +     LG G +G+V   R        A+K +++   S         EV ++ +  H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK--KIALGSARGL 246
            N+++LY F        LV      G +   +  R        +       I      G+
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK------FNEVDAAVIIKQVLSGV 149

Query: 247 SYLHEHCDPKIIHRDVKAANILLDEDADQSS-KTI 280
           +YLH+H    I+HRD+K  N+LL+     +  K +
Sbjct: 150 TYLHKH---NIVHRDLKPENLLLESKEKDALIKIV 181

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 73.0 bits (180), Expect = 5e-15
 Identities = 36/144 (25%), Positives = 64/144 (44%), Gaps = 11/144 (7%)

Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVH 188
           + + N  ++G G +G V K R    G++VA+K+  E       ++     E+K++    H
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM-VKKIAMREIKLLKQLRH 83

Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 248
            NL+ L   C       LV+ ++ + ++   L    + L        +K       G+ +
Sbjct: 84  ENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDY---QVVQKYLFQIINGIGF 139

Query: 249 LHEHCDPKIIHRDVKAANILLDED 272
            H H    IIHRD+K  NIL+ + 
Sbjct: 140 CHSH---NIIHRDIKPENILVSQS 160

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 72.8 bits (179), Expect = 5e-15
 Identities = 35/151 (23%), Positives = 53/151 (35%), Gaps = 34/151 (22%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEER-------TSGGELQFQTEVKIISMAVHRNL 191
           LG G FG V+        K V VK +K+E+             +   E+ I+S   H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 192 LRLYGFCTTVTEKLLVYPYMTNG-------SVASRLRERQSSLPPLDWPTRKK---IALG 241
           +++           LV     +G           RL E  +               +   
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLA---------SYIFRQLV-- 140

Query: 242 SARGLSYLHEHCDPKIIHRDVKAANILLDED 272
               + YL       IIHRD+K  NI++ ED
Sbjct: 141 --SAVGYLRLK---DIIHRDIKDENIVIAED 166

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 72.2 bits (178), Expect = 6e-15
 Identities = 29/144 (20%), Positives = 62/144 (43%), Gaps = 11/144 (7%)

Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVH 188
             +     +G G +G V+K +     ++VA+KR++ +    G +      E+ ++    H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG-VPSSALREICLLKELKH 60

Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 248
           +N++RL+    +  +  LV+ +     +          L P      K       +GL +
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDP---EIVKSFLFQLLKGLGF 116

Query: 249 LHEHCDPKIIHRDVKAANILLDED 272
            H      ++HRD+K  N+L++ +
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRN 137

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 73.4 bits (180), Expect = 7e-15
 Identities = 27/140 (19%), Positives = 52/140 (37%), Gaps = 16/140 (11%)

Query: 140 LGRGGFGKVYKGR--LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF 197
           +  GG G +Y       +G+ V +K L     +  +     E + ++  VH ++++++ F
Sbjct: 88  IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147

Query: 198 CTTVTEKLLVYPYM-----TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
                       Y+        S+     +       L         L     LSYLH  
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI 201

Query: 253 CDPKIIHRDVKAANILLDED 272
               +++ D+K  NI+L E+
Sbjct: 202 ---GLVYNDLKPENIMLTEE 218

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 72.8 bits (179), Expect = 7e-15
 Identities = 38/144 (26%), Positives = 57/144 (39%), Gaps = 30/144 (20%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 198
           +G G FG     R     +LVAVK +  ER +  +   Q E+       H N++R     
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85

Query: 199 TTVTEKLLVYPYMTNGSV------ASRLRERQSSLPPLDWPTRKK----IALGSARGLSY 248
            T T   ++  Y + G +      A R  E ++         R      ++     G+SY
Sbjct: 86  LTPTHLAIIMEYASGGELYERICNAGRFSEDEA---------RFFFQQLLS-----GVSY 131

Query: 249 LHEHCDPKIIHRDVKAANILLDED 272
            H     +I HRD+K  N LLD  
Sbjct: 132 CHSM---QICHRDLKLENTLLDGS 152

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 72.1 bits (177), Expect = 1e-14
 Identities = 36/183 (19%), Positives = 70/183 (38%), Gaps = 20/183 (10%)

Query: 107 PAEDDSELQLGQLKRFSLRELQVATDGFSNK----NILGRGGFGKVYKGR-LADGKLVAV 161
              D  +      K++  + ++V      +       LG G FG V++    A G++   
Sbjct: 22  KINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVA 81

Query: 162 KRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR 221
           K +            + E+ I++   H  L+ L+       E +L+  +++ G +  R+ 
Sbjct: 82  KFINTPYPLDKY-TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA 140

Query: 222 ERQSSLPPLDWPTRKKIALGSAR----GLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 277
                +   +        +   R    GL ++HEH    I+H D+K  NI+ +     S 
Sbjct: 141 AEDYKMSEAE-------VINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSV 190

Query: 278 KTI 280
           K I
Sbjct: 191 KII 193

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 72.1 bits (177), Expect = 1e-14
 Identities = 33/144 (22%), Positives = 61/144 (42%), Gaps = 15/144 (10%)

Query: 140 LGRGGFGKVYKGR---LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 196
           +GRG +G VYK +     D K  A+K+++     G  +    E+ ++    H N++ L  
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELKHPNVISLQK 85

Query: 197 FCTTVTEKL--LVYPYM----TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
              +  ++   L++ Y      +     R  +       L     K +      G+ YLH
Sbjct: 86  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145

Query: 251 EHCDPKIIHRDVKAANILLDEDAD 274
            +    ++HRD+K ANIL+  +  
Sbjct: 146 AN---WVLHRDLKPANILVMGEGP 166

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 71.4 bits (176), Expect = 1e-14
 Identities = 36/145 (24%), Positives = 63/145 (43%), Gaps = 13/145 (8%)

Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---EVKIISMAV 187
           + +     +G G +G V+K R    G++VA+K+  E        +      E++++    
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKK--IALREIRMLKQLK 60

Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           H NL+ L           LV+ Y  + +V   L   Q  +P       K I   + + ++
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPE---HLVKSITWQTLQAVN 116

Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           + H+H     IHRDVK  NIL+ + 
Sbjct: 117 FCHKH---NCIHRDVKPENILITKH 138

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 71.1 bits (175), Expect = 2e-14
 Identities = 42/148 (28%), Positives = 60/148 (40%), Gaps = 17/148 (11%)

Query: 137 KNILGRGGFGKVYKGR-LADGKLVAVK--------RLKEERTSGGELQFQTEVKII-SMA 186
           K ILGRG    V +       K  AVK            E           EV I+  ++
Sbjct: 22  KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81

Query: 187 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
            H N+++L     T T   LV+  M  G +   L E+ +    L     +KI       +
Sbjct: 82  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRALLEVI 137

Query: 247 SYLHEHCDPKIIHRDVKAANILLDEDAD 274
             LH+     I+HRD+K  NILLD+D +
Sbjct: 138 CALHKL---NIVHRDLKPENILLDDDMN 162

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 72.0 bits (177), Expect = 2e-14
 Identities = 36/148 (24%), Positives = 66/148 (44%), Gaps = 15/148 (10%)

Query: 134 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
           ++N  ++G G FG V++ +L +   VA+K++ +++          E++I+ +  H N++ 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN-----RELQIMRIVKHPNVVD 96

Query: 194 LYGFCTTVTEKL------LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           L  F  +  +K       LV  Y+   +V    R        +     K       R L+
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155

Query: 248 YLHEHCDPKIIHRDVKAANILLDEDADQ 275
           Y+H      I HRD+K  N+LLD  +  
Sbjct: 156 YIHSI---GICHRDIKPQNLLLDPPSGV 180

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 71.1 bits (175), Expect = 2e-14
 Identities = 31/146 (21%), Positives = 61/146 (41%), Gaps = 5/146 (3%)

Query: 137 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           K  LG G FG V+     + G    +K + ++R+     Q + E++++    H N+++++
Sbjct: 27  KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86

Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
                     +V      G +  R+   Q+    L      ++       L+Y H     
Sbjct: 87  EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ--- 143

Query: 256 KIIHRDVKAANILLDEDADQSS-KTI 280
            ++H+D+K  NIL  + +  S  K I
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKII 169

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 70.7 bits (174), Expect = 2e-14
 Identities = 37/146 (25%), Positives = 68/146 (46%), Gaps = 30/146 (20%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLRLYG 196
           LG G FGKV  G     G  VAVK L  ++    ++  + + E++ + +  H ++++LY 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 197 FCTTVTEKLLVYPYMTNGSV------ASRLRERQSSLPPLDWPTRKK----IALGSARGL 246
             +T T+  +V  Y++ G +        R+ E ++         R+     ++      +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA---------RRLFQQILS-----AV 124

Query: 247 SYLHEHCDPKIIHRDVKAANILLDED 272
            Y H H    ++HRD+K  N+LLD  
Sbjct: 125 DYCHRH---MVVHRDLKPENVLLDAH 147

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 71.6 bits (176), Expect = 2e-14
 Identities = 35/159 (22%), Positives = 67/159 (42%), Gaps = 22/159 (13%)

Query: 131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVH 188
            + ++   +LG+G FG+V K +     +  AVK + +      +      EV+++    H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWPTRKKIALGS 242
            N+++L+      +   +V    T G +   +       E  ++          +I    
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA----------RIIKQV 130

Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS-KTI 280
             G++Y+H+H    I+HRD+K  NILL+        K I
Sbjct: 131 FSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKII 166

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 70.7 bits (174), Expect = 3e-14
 Identities = 39/146 (26%), Positives = 65/146 (44%), Gaps = 7/146 (4%)

Query: 130 ATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH 188
           ++  F     LG G +  VYKG     G  VA+K +K +   G       E+ ++    H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62

Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTN--GSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
            N++RLY    T  +  LV+ +M N             +    L+    K       +GL
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTP-RGLELNLVKYFQWQLLQGL 121

Query: 247 SYLHEHCDPKIIHRDVKAANILLDED 272
           ++ HE+   KI+HRD+K  N+L+++ 
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINKR 144

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 70.9 bits (174), Expect = 3e-14
 Identities = 41/148 (27%), Positives = 68/148 (45%), Gaps = 8/148 (5%)

Query: 134 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
            S   ILG G FG+V+K    A G  +A K +K       E + + E+ +++   H NL+
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE-EVKNEISVMNQLDHANLI 149

Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
           +LY    +  + +LV  Y+  G +  R+ +   +L  LD     K       G+ ++H+ 
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE---GIRHMHQM 206

Query: 253 CDPKIIHRDVKAANILLDEDADQSSKTI 280
               I+H D+K  NIL      +  K I
Sbjct: 207 ---YILHLDLKPENILCVNRDAKQIKII 231

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 71.4 bits (175), Expect = 4e-14
 Identities = 53/186 (28%), Positives = 79/186 (42%), Gaps = 24/186 (12%)

Query: 96  RTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD 155
              P + F D         +  Q K    +   +  D F +  +LGRGGFG+V+  ++  
Sbjct: 155 GQAPFQEFLDSLYFL----RFLQWKWLEAQ--PMGEDWFLDFRVLGRGGFGEVFACQMKA 208

Query: 156 -GKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRL-YGFCTTVTEKL-LVYPY 210
            GKL A K+L ++R     G      E KI++    R ++ L Y F T     L LV   
Sbjct: 209 TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK--TDLCLVMTI 266

Query: 211 MTNGSVASRLRERQSSLPPLDWPTRK----KIALGSARGLSYLHEHCDPKIIHRDVKAAN 266
           M  G +   +       P    P       +I  G    L +LH+     II+RD+K  N
Sbjct: 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEHLHQR---NIIYRDLKPEN 319

Query: 267 ILLDED 272
           +LLD+D
Sbjct: 320 VLLDDD 325

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 70.9 bits (174), Expect = 4e-14
 Identities = 37/156 (23%), Positives = 72/156 (46%), Gaps = 15/156 (9%)

Query: 131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE--LQFQTEVKIISMAV 187
           +D +  + +LG+G FG+V   +    G+  AVK + + +            EV+++    
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK--KIALGSARG 245
           H N+++LY F        LV    T G +   +  R+       +      +I      G
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR------FSEVDAARIIRQVLSG 138

Query: 246 LSYLHEHCDPKIIHRDVKAANILLDEDADQSS-KTI 280
           ++Y+H++   KI+HRD+K  N+LL+  +  ++ + I
Sbjct: 139 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRII 171

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 70.0 bits (172), Expect = 7e-14
 Identities = 29/146 (19%), Positives = 54/146 (36%), Gaps = 11/146 (7%)

Query: 137 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL----QFQTEVKIISMAVHRNL 191
             ++G+G F  V +      G+  AVK +   + +          + E  I  M  H ++
Sbjct: 29  CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88

Query: 192 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 251
           + L    ++     +V+ +M    +   + +R  +                   L Y H+
Sbjct: 89  VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148

Query: 252 HCDPKIIHRDVKAANILL---DEDAD 274
           +    IIHRDVK   +LL   +  A 
Sbjct: 149 N---NIIHRDVKPHCVLLASKENSAP 171

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 69.6 bits (171), Expect = 7e-14
 Identities = 37/155 (23%), Positives = 59/155 (38%), Gaps = 28/155 (18%)

Query: 137 KNILGRGGFGKVYKGR-LADGKLVAVK-------RLKEERTSGGELQFQTEVKIISMAVH 188
              LG G  G+V         K VA+K        +   R +   L  +TE++I+    H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74

Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNG------SVASRLRERQSSLPPLDWPTRKKIALGS 242
             ++++  F     +  +V   M  G          RL+E    L         ++ L  
Sbjct: 75  PCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKL------YFYQMLL-- 125

Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 277
              + YLHE+    IIHRD+K  N+LL    +   
Sbjct: 126 --AVQYLHEN---GIIHRDLKPENVLLSSQEEDCL 155

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 69.2 bits (170), Expect = 7e-14
 Identities = 39/169 (23%), Positives = 60/169 (35%), Gaps = 52/169 (30%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVK-------------------------RLKEERTSGGE 173
           +G+G +G V       D    A+K                              +  G  
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 174 LQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLD 231
            Q   E+ I+    H N+++L        E  L  V+  +  G V             ++
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-------------ME 127

Query: 232 WPTRKKIALGSAR--------GLSYLHEHCDPKIIHRDVKAANILLDED 272
            PT K ++   AR        G+ YLH     KIIHRD+K +N+L+ ED
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGED 173

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 70.2 bits (172), Expect = 8e-14
 Identities = 39/146 (26%), Positives = 70/146 (47%), Gaps = 30/146 (20%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYG 196
           LG G FGKV  G+    G  VAVK L  ++  +     + + E++ + +  H ++++LY 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 197 FCTTVTEKLLVYPYMTNGSV------ASRLRERQSSLPPLDWPTRKK----IALGSARGL 246
             +T ++  +V  Y++ G +        RL E++S         R+     ++     G+
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES---------RRLFQQILS-----GV 129

Query: 247 SYLHEHCDPKIIHRDVKAANILLDED 272
            Y H H    ++HRD+K  N+LLD  
Sbjct: 130 DYCHRH---MVVHRDLKPENVLLDAH 152

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 69.7 bits (171), Expect = 8e-14
 Identities = 43/149 (28%), Positives = 70/149 (46%), Gaps = 16/149 (10%)

Query: 134 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
           +++  ++G G FG VY+ +L D G+LVA+K++ +++          E++I+    H N++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIV 110

Query: 193 RLYGFCTTVTEKL------LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
           RL  F  +  EK       LV  Y+   +V    R    +   L     K       R L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169

Query: 247 SYLHEHCDPKIIHRDVKAANILLDEDADQ 275
           +Y+H      I HRD+K  N+LLD D   
Sbjct: 170 AYIHSF---GICHRDIKPQNLLLDPDTAV 195

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 69.2 bits (170), Expect = 1e-13
 Identities = 40/157 (25%), Positives = 67/157 (42%), Gaps = 27/157 (17%)

Query: 132 DGFSNKNILGRGGFGKVYKGR--LADGKLVAVKRLKEERTSGGELQF-QT---EVKI--- 182
             +     +G G +GKV+K R     G+ VA+KR++ +    G      +   EV +   
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG---MPLSTIREVAVLRH 67

Query: 183 ISMAVHRNLLRLYGFCTTVTEKL-----LVYPYMTNGSVASRLRE--RQSSLPPLDWPTR 235
           +    H N++RL+  CT           LV+ ++        L     +   P +   T 
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-----QDLTTYLDKVPEPGVPTETI 122

Query: 236 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           K +     RGL +LH H   +++HRD+K  NIL+   
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSS 156

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 68.8 bits (169), Expect = 1e-13
 Identities = 35/158 (22%), Positives = 64/158 (40%), Gaps = 21/158 (13%)

Query: 131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVK-----RLKEERTSGGELQFQTEVKIIS 184
            D +     LG G F  V K R  + G   A K     + +  R      + + EV I+ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
             +H N++ L+      T+ +L+   ++ G +   L +++S        + ++      +
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES-------LSEEEAT-SFIK 122

Query: 245 ----GLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK 278
               G++YLH     KI H D+K  NI+L +       
Sbjct: 123 QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPH 157

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 68.8 bits (169), Expect = 1e-13
 Identities = 36/149 (24%), Positives = 63/149 (42%), Gaps = 37/149 (24%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT--EVKIISMAVHRNLLRLYG 196
           LG G FGKV         + VA+K +  +     ++  +   E+  + +  H ++++LY 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 197 FCTTVTEKLLVYPY---------MTNGSVASRLRERQSSLPPLDWPTRKK----IALGSA 243
             TT T+ ++V  Y         +       R+ E +          R+     I     
Sbjct: 77  VITTPTDIVMVIEYAGGELFDYIVEKK----RMTEDEG---------RRFFQQIIC---- 119

Query: 244 RGLSYLHEHCDPKIIHRDVKAANILLDED 272
             + Y H H   KI+HRD+K  N+LLD++
Sbjct: 120 -AIEYCHRH---KIVHRDLKPENLLLDDN 144

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 68.4 bits (168), Expect = 1e-13
 Identities = 33/151 (21%), Positives = 60/151 (39%), Gaps = 25/151 (16%)

Query: 137 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRL 194
           K  LG+G F  V +      G   A K +  ++ S  + Q  + E +I     H N++RL
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 70

Query: 195 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR--------GL 246
           +      +   LV+  +T G +   +  R+         +        A          +
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFY-------SEAD-----ASHCIQQILESI 118

Query: 247 SYLHEHCDPKIIHRDVKAANILLDEDADQSS 277
           +Y H +    I+HR++K  N+LL   A  ++
Sbjct: 119 AYCHSN---GIVHRNLKPENLLLASKAKGAA 146

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 68.9 bits (169), Expect = 1e-13
 Identities = 35/158 (22%), Positives = 64/158 (40%), Gaps = 21/158 (13%)

Query: 131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVK-----RLKEERTSGGELQFQTEVKIIS 184
            D +     LG G F  V K R  + G   A K     + +  R      + + EV I+ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
             +H N++ L+      T+ +L+   ++ G +   L +++S        + ++      +
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES-------LSEEEAT-SFIK 122

Query: 245 ----GLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK 278
               G++YLH     KI H D+K  NI+L +       
Sbjct: 123 QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPH 157

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 68.0 bits (167), Expect = 2e-13
 Identities = 35/138 (25%), Positives = 55/138 (39%), Gaps = 14/138 (10%)

Query: 140 LGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRL 194
           LG GG   VY     D  L   VA+K +        E    F+ EV   S   H+N++ +
Sbjct: 19  LGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 195 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 254
                      LV  Y+   +++  +        PL   T          G+ + H+   
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDM-- 130

Query: 255 PKIIHRDVKAANILLDED 272
            +I+HRD+K  NIL+D +
Sbjct: 131 -RIVHRDIKPQNILIDSN 147

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 68.0 bits (167), Expect = 2e-13
 Identities = 40/160 (25%), Positives = 63/160 (39%), Gaps = 25/160 (15%)

Query: 131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVK-----RLKEERTSGGELQFQTEVKIIS 184
            D +     LG G F  V K R    GK  A K     RL   R      + + EV I+ 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA----- 239
              H N++ L+      T+ +L+   ++ G +   L E++S        T  +       
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES-------LTEDEATQFLKQ 116

Query: 240 -LGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK 278
            L    G+ YLH     +I H D+K  NI+L +    + +
Sbjct: 117 ILD---GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPR 150

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 68.5 bits (168), Expect = 2e-13
 Identities = 38/176 (21%), Positives = 70/176 (39%), Gaps = 17/176 (9%)

Query: 107 PAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK 165
            A      Q+G+   F +      +D +  K  LG+G F  V +      G   A K + 
Sbjct: 4   MASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN 63

Query: 166 EERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ 224
            ++ S  + Q  + E +I     H N++RL+      +   LV+  +T G +   +  R+
Sbjct: 64  TKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE 123

Query: 225 SSLPPLDWPTRKKIALGSAR----GLSYLHEHCDPKIIHRDVKAANILLDEDADQS 276
                    +    A    +     ++Y H +    I+HR++K  N+LL   A  +
Sbjct: 124 FY-------SEAD-ASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGA 168

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 67.7 bits (166), Expect = 3e-13
 Identities = 37/148 (25%), Positives = 62/148 (41%), Gaps = 20/148 (13%)

Query: 137 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRNLLRL 194
           +++LG G   +V     L   +  AVK ++++       +   EV+++     HRN+L L
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS-RVFREVEMLYQCQGHRNVLEL 76

Query: 195 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-----LGSARGLSYL 249
             F        LV+  M  GS+ S + +R+            + +     + SA  L +L
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHF-------NELEASVVVQDVASA--LDFL 127

Query: 250 HEHCDPKIIHRDVKAANILLDEDADQSS 277
           H      I HRD+K  NIL +     S 
Sbjct: 128 HNK---GIAHRDLKPENILCEHPNQVSP 152

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 68.0 bits (167), Expect = 3e-13
 Identities = 32/155 (20%), Positives = 65/155 (41%), Gaps = 17/155 (10%)

Query: 131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR 189
            + +     LGRG FG V++    +  K    K +K       ++  + E+ I+++A HR
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHR 61

Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR----G 245
           N+L L+    ++ E ++++ +++   +  R+      L   +        +         
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNERE-------IVSYVHQVCEA 114

Query: 246 LSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI 280
           L +LH H    I H D++  NI+       + K I
Sbjct: 115 LQFLHSH---NIGHFDIRPENIIYQTRRSSTIKII 146

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 67.3 bits (165), Expect = 3e-13
 Identities = 33/148 (22%), Positives = 63/148 (42%), Gaps = 19/148 (12%)

Query: 137 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRL 194
             +LG+G FG+V K +     +  AVK + +      +      EV+++    H N+++L
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86

Query: 195 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-----LGSARGLSYL 249
           +      +   +V    T G +   + +R+         +    A     + S   ++Y+
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRF-------SEHDAARIIKQVFSG--ITYM 137

Query: 250 HEHCDPKIIHRDVKAANILLDEDADQSS 277
           H+H    I+HRD+K  NILL+       
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCD 162

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 67.7 bits (166), Expect = 4e-13
 Identities = 27/146 (18%), Positives = 59/146 (40%), Gaps = 17/146 (11%)

Query: 137 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRL 194
              LG+G F  V +   +  G+  A   +  ++ S  + Q  + E +I  +  H N++RL
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL 75

Query: 195 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR----GLSYLH 250
           +   +      L++  +T G +   +  R+         +    A    +     + + H
Sbjct: 76  HDSISEEGHHYLIFDLVTGGELFEDIVAREYY-------SEAD-ASHCIQQILEAVLHCH 127

Query: 251 EHCDPKIIHRDVKAANILLDEDADQS 276
           +     ++HR++K  N+LL      +
Sbjct: 128 QM---GVVHRNLKPENLLLASKLKGA 150

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 67.9 bits (166), Expect = 5e-13
 Identities = 50/180 (27%), Positives = 76/180 (42%), Gaps = 14/180 (7%)

Query: 100 HEFFFDVPAED--DSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-G 156
           HE+    P  D  DS      L+   L    V  + F    +LG+GGFG+V   ++   G
Sbjct: 150 HEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATG 209

Query: 157 KLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRL-YGFCTTVTEKL-LVYPYMT 212
           K+ A K+L+++R     GE     E +I+     R ++ L Y + T   + L LV   M 
Sbjct: 210 KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDALCLVLTLMN 267

Query: 213 NGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
            G +   +                  A     GL  LH     +I++RD+K  NILLD+ 
Sbjct: 268 GGDLKFHI--YHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDH 322

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 66.9 bits (164), Expect = 5e-13
 Identities = 39/160 (24%), Positives = 61/160 (38%), Gaps = 25/160 (15%)

Query: 131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVK-----RLKEERTSGGELQFQTEVKIIS 184
            D +     LG G F  V K R  + G   A K     R K  R        + EV I+ 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA----- 239
              H N++ L+      T+ +L+   +  G +   L E++S        T ++       
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-------LTEEEATEFLKQ 122

Query: 240 -LGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK 278
            L    G+ YLH     +I H D+K  NI+L +      +
Sbjct: 123 ILN---GVYYLHSL---QIAHFDLKPENIMLLDRNVPKPR 156

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 66.9 bits (164), Expect = 7e-13
 Identities = 29/155 (18%), Positives = 60/155 (38%), Gaps = 24/155 (15%)

Query: 131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-H 188
           TDG+  K  +G G +    +    A     AVK + + +    E     E++I+     H
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-----EIEILLRYGQH 75

Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-----LGSA 243
            N++ L           +V   M  G +  ++  ++         + ++ +     +   
Sbjct: 76  PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFF-------SEREASAVLFTITKT 128

Query: 244 RGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK 278
             + YLH      ++HRD+K +NIL  +++     
Sbjct: 129 --VEYLHAQ---GVVHRDLKPSNILYVDESGNPES 158

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 67.6 bits (165), Expect = 7e-13
 Identities = 54/183 (29%), Positives = 79/183 (43%), Gaps = 30/183 (16%)

Query: 104 FDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVK 162
           F    E D   +  Q K   L    +  + FS   I+GRGGFG+VY  R AD GK+ A+K
Sbjct: 162 FQKFIESDKFTRFCQWKNVELNI-HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 220

Query: 163 RLKEER--TSGGELQFQTEVKI---ISMAVHRNLLRL-YGFCTTVTEKL-LVYPYMTNGS 215
            L ++R     GE     E  +   +S      ++ + Y F T   +KL  +   M  G 
Sbjct: 221 CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILDLMNGGD 278

Query: 216 VASRL-RERQSSLPPLDWPTRKK-----IALGSARGLSYLHEHCDPKIIHRDVKAANILL 269
           +   L +    S          +     I LG    L ++H      +++RD+K ANILL
Sbjct: 279 LHYHLSQHGVFSEA------DMRFYAAEIILG----LEHMHNR---FVVYRDLKPANILL 325

Query: 270 DED 272
           DE 
Sbjct: 326 DEH 328

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 66.5 bits (163), Expect = 9e-13
 Identities = 35/151 (23%), Positives = 65/151 (43%), Gaps = 14/151 (9%)

Query: 131 TDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKR-LKEERTSGGELQFQTEVKIISMAVH 188
            D F  + + G+G FG V  G+    G  VA+K+ +++ R    ELQ    ++ +++  H
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ---IMQDLAVLHH 78

Query: 189 RNLLRLYGFCTTVTEK-------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALG 241
            N+++L  +  T+ E+        +V  Y+   ++    R              K     
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137

Query: 242 SARGLSYLHEHCDPKIIHRDVKAANILLDED 272
             R +  LH      + HRD+K  N+L++E 
Sbjct: 138 LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEA 167

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 66.6 bits (163), Expect = 1e-12
 Identities = 32/170 (18%), Positives = 61/170 (35%), Gaps = 33/170 (19%)

Query: 131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK------------EERTSGGELQFQ 177
            + +     LG G +G+V   +        A+K +K             +       +  
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 178 TEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLD 231
            E+ ++    H N+++L+          LV  +   G +  ++       E  ++     
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA----- 149

Query: 232 WPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSS-KTI 280
                 I      G+ YLH+H    I+HRD+K  NILL+      + K +
Sbjct: 150 -----NIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIV 191

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 65.7 bits (161), Expect = 1e-12
 Identities = 34/142 (23%), Positives = 61/142 (42%), Gaps = 18/142 (12%)

Query: 140 LGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRL 194
           LG GG  +V+  R  D +    VAVK L+ +          F+ E +  +   H  ++ +
Sbjct: 20  LGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77

Query: 195 Y--GFCTTVTEKL--LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
           Y  G   T    L  +V  Y+   ++   +        P+      ++   + + L++ H
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSH 133

Query: 251 EHCDPKIIHRDVKAANILLDED 272
           ++    IIHRDVK ANI++   
Sbjct: 134 QN---GIIHRDVKPANIMISAT 152

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 65.4 bits (160), Expect = 2e-12
 Identities = 34/138 (24%), Positives = 53/138 (38%), Gaps = 14/138 (10%)

Query: 140 LGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRL 194
           +GRGG G VY+    D      VA+K + E  +S    +   Q E +        +++ +
Sbjct: 42  VGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99

Query: 195 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 254
           + F     +  +    +    +A+ LR +     PL  P    I       L   H    
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAA-- 153

Query: 255 PKIIHRDVKAANILLDED 272
               HRDVK  NIL+  D
Sbjct: 154 -GATHRDVKPENILVSAD 170

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 64.5 bits (158), Expect = 3e-12
 Identities = 34/148 (22%), Positives = 59/148 (39%), Gaps = 21/148 (14%)

Query: 137 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           +N +GRG +G+V            A K++ +      + +F+ E++I+    H N++RLY
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD-RFKQEIEIMKSLDHPNIIRLY 72

Query: 196 GFCTTVTEKLLVYPYMTNG------SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
                 T+  LV    T G            RE  ++         K +       ++Y 
Sbjct: 73  ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR------IMKDV----LSAVAYC 122

Query: 250 HEHCDPKIIHRDVKAANILLDEDADQSS 277
           H+     + HRD+K  N L   D+  S 
Sbjct: 123 HKL---NVAHRDLKPENFLFLTDSPDSP 147

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 65.0 bits (158), Expect = 3e-12
 Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 8/102 (7%)

Query: 137 KNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HR 189
              LGRG FG+V +         A  + VAVK LKE  T        +E+KI+     H 
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86

Query: 190 NLLRLYGFCTTVTEKLLV-YPYMTNGSVASRLRERQSSLPPL 230
           N++ L G CT     L+V   +   G++++ LR +++   P 
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 64.7 bits (158), Expect = 4e-12
 Identities = 40/156 (25%), Positives = 71/156 (45%), Gaps = 15/156 (9%)

Query: 123 SLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRL-KEERTSGGEL-QFQTE 179
            L+E+++  D F    ++GRG F +V   ++   G++ A+K + K +    GE+  F+ E
Sbjct: 52  RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREE 111

Query: 180 VKIISMAVHRNLLRL-YGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKK 237
             ++     R + +L + F       L LV  Y   G + + L  +     P +   R  
Sbjct: 112 RDVLVNGDRRWITQLHFAFQDE--NYLYLVMEYYVGGDLLTLLS-KFGERIPAEM-ARFY 167

Query: 238 IA-LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           +A +  A  +  +H       +HRD+K  NILLD  
Sbjct: 168 LAEIVMA--IDSVHRL---GYVHRDIKPDNILLDRC 198

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 64.1 bits (156), Expect = 5e-12
 Identities = 29/188 (15%), Positives = 60/188 (31%), Gaps = 54/188 (28%)

Query: 139 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG- 196
            +GRGGFG V++ +   D    A+KR++         +   EVK ++   H  ++R +  
Sbjct: 13  CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72

Query: 197 -------------FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 243
                            + ++   +P  +   + +   + +   P     T  ++   S 
Sbjct: 73  WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132

Query: 244 RGLSYLH-EHCDP--------------------------------------KIIHRDVKA 264
           +   Y+  + C                                         ++HRD+K 
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKP 192

Query: 265 ANILLDED 272
           +NI    D
Sbjct: 193 SNIFFTMD 200

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 64.0 bits (156), Expect = 7e-12
 Identities = 40/156 (25%), Positives = 73/156 (46%), Gaps = 15/156 (9%)

Query: 123 SLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRL-KEERTSGGELQ-FQTE 179
            ++++++  + F    ++GRG FG+V   +L +  K+ A+K L K E     E   F+ E
Sbjct: 65  KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124

Query: 180 VKIISMAVHRNLLRL-YGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKK 237
             ++     + +  L Y F       L LV  Y   G + + L + +  LP  +   R  
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDD--NNLYLVMDYYVGGDLLTLLSKFEDRLPE-EM-ARFY 180

Query: 238 IA-LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           +A +  A  +  +H+      +HRD+K  NIL+D +
Sbjct: 181 LAEMVIA--IDSVHQL---HYVHRDIKPDNILMDMN 211

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 64.2 bits (157), Expect = 9e-12
 Identities = 20/49 (40%), Positives = 24/49 (48%)

Query: 6   DLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSGSPPFSPP 54
           DLSNN LSGP+P+ G F  F P  F NN  LCG    +    +      
Sbjct: 710 DLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAH 758

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 63.0 bits (154), Expect = 1e-11
 Identities = 34/148 (22%), Positives = 63/148 (42%), Gaps = 21/148 (14%)

Query: 137 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
             +LG G F +V+  +    GKL A+K +K +  +  +   + E+ ++    H N++ L 
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIK-KSPAFRDSSLENEIAVLKKIKHENIVTLE 72

Query: 196 GFCTTVTEKLLVYPYMTNG------SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
               + T   LV   ++ G             E+ +SL        +++       + YL
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL------VIQQV----LSAVKYL 122

Query: 250 HEHCDPKIIHRDVKAANILLDEDADQSS 277
           HE+    I+HRD+K  N+L     + S 
Sbjct: 123 HEN---GIVHRDLKPENLLYLTPEENSK 147

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 63.0 bits (154), Expect = 1e-11
 Identities = 36/149 (24%), Positives = 58/149 (38%), Gaps = 27/149 (18%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHR-NLLRLYG 196
           LGRG F  V +    + G+  A K LK+ R           E+ ++ +A     ++ L+ 
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 197 FCTTVTEKLLVYPYMTNG--------SVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 248
                +E +L+  Y   G         +A  + E             K+I      G+ Y
Sbjct: 97  VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIR------LIKQI----LEGVYY 146

Query: 249 LHEHCDPKIIHRDVKAANILL---DEDAD 274
           LH++    I+H D+K  NILL       D
Sbjct: 147 LHQN---NIVHLDLKPQNILLSSIYPLGD 172

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 61.6 bits (150), Expect = 5e-11
 Identities = 41/163 (25%), Positives = 66/163 (40%), Gaps = 31/163 (19%)

Query: 123 SLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRL-KEERTSGGELQ-FQTE 179
            +R+L++  + +    ++GRG FG+V   R     K+ A+K L K E     +   F  E
Sbjct: 60  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 119

Query: 180 VKIISMAVHRNLLRL-YGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKK 237
             I++ A    +++L Y F       L +V  YM  G + + +                 
Sbjct: 120 RDIMAFANSPWVVQLFYAFQDD--RYLYMVMEYMPGGDLVNLMS-------------NYD 164

Query: 238 IALGSAR--------GLSYLHEHCDPKIIHRDVKAANILLDED 272
           +    AR         L  +H       IHRDVK  N+LLD+ 
Sbjct: 165 VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKS 204

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 61.2 bits (149), Expect = 5e-11
 Identities = 29/148 (19%), Positives = 60/148 (40%), Gaps = 26/148 (17%)

Query: 137 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLRL 194
              LG G F    K       +  AVK + +      E   Q E+  +     H N+++L
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKL 71

Query: 195 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-----LGSARGLSYL 249
           +          LV   +  G +  R+++++         +  + +     L SA  +S++
Sbjct: 72  HEVFHDQLHTFLVMELLNGGELFERIKKKKHF-------SETEASYIMRKLVSA--VSHM 122

Query: 250 HEHCDPKIIHRDVKAANILL---DEDAD 274
           H+     ++HRD+K  N+L    +++ +
Sbjct: 123 HDV---GVVHRDLKPENLLFTDENDNLE 147

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 60.7 bits (146), Expect = 8e-11
 Identities = 33/196 (16%), Positives = 53/196 (27%), Gaps = 45/196 (22%)

Query: 117 GQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVK--RLKEERTSGGEL 174
            Q          + T+       +G G FG+V++   AD   VA+K   ++      G  
Sbjct: 6   SQKGPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSH 63

Query: 175 Q-----FQTEVKI---------ISMAVHRNLLRLYGF--CTTVTEKLLVYPYM----TNG 214
           Q        E+ I                  + L            LL+  +     T G
Sbjct: 64  QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123

Query: 215 SVASRLRERQSSLPPL-------------------DWPTRKKIALGSARGLSYLHEHCDP 255
           S   R    +     +                      T K I       L+        
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL-- 181

Query: 256 KIIHRDVKAANILLDE 271
           +  HRD+   N+LL +
Sbjct: 182 RFEHRDLHWGNVLLKK 197

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 60.8 bits (148), Expect = 8e-11
 Identities = 36/153 (23%), Positives = 60/153 (39%), Gaps = 29/153 (18%)

Query: 137 KNILGRGGFGKVYKGR-LADGKLVAVKRL-KEERTSGGELQFQTEVKIISMAV-HRNLLR 193
           K +LG G  GKV +      G+  A+K L    +        + EV     A    +++ 
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVC 86

Query: 194 LYGFCTTVTEK----LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-----LGSAR 244
           +      +       L++   M  G + SR++ER          T ++ A     +G+A 
Sbjct: 87  ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQ-----AFTEREAAEIMRDIGTA- 140

Query: 245 GLSYLHEHCDPKIIHRDVKAANILLDEDADQSS 277
            + +LH H    I HRDVK  N+L       + 
Sbjct: 141 -IQFLHSH---NIAHRDVKPENLLYTSKEKDAV 169

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 59.5 bits (145), Expect = 2e-10
 Identities = 47/174 (27%), Positives = 67/174 (38%), Gaps = 20/174 (11%)

Query: 107 PAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRL- 164
            AE        Q  +   +  +   + F    ILG G F  V   R  A  +  A+K L 
Sbjct: 5   AAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE 64

Query: 165 KEERTSGGELQF-QTEVKIISMAVHRNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRE 222
           K       ++ +   E  ++S   H   ++LY       EKL     Y  NG +   +R+
Sbjct: 65  KRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLYFGLSYAKNGELLKYIRK 123

Query: 223 RQSSLPPLDWPTRK----KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
             S     D    +    +I       L YLH      IIHRD+K  NILL+ED
Sbjct: 124 IGS----FDETCTRFYTAEIVSA----LEYLHGK---GIIHRDLKPENILLNED 166

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 58.6 bits (142), Expect = 3e-10
 Identities = 16/138 (11%), Positives = 37/138 (26%), Gaps = 16/138 (11%)

Query: 140 LGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQ--FQTEVKIISMAVHRNLLRL 194
            G     + ++    D  L   VA+  +  +     ++     +    +S      + R+
Sbjct: 39  HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 195 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 254
                T    L+V  ++  GS+            P       +     A      H    
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSP---VGAIRAMQSLAAAADAAHRA-- 148

Query: 255 PKIIHRDVKAANILLDED 272
             +       + + +  D
Sbjct: 149 -GVALSIDHPSRVRVSID 165

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 58.5 bits (142), Expect = 4e-10
 Identities = 38/146 (26%), Positives = 67/146 (45%), Gaps = 19/146 (13%)

Query: 137 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY 195
           ++ LGRG    VY+ +     K  A+K LK    +  +   +TE+ ++    H N+++L 
Sbjct: 58  ESELGRGATSIVYRCKQKGTQKPYALKVLK---KTVDKKIVRTEIGVLLRLSHPNIIKLK 114

Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR----GLSYLHE 251
               T TE  LV   +T G +  R+ E+          + +  A  + +     ++YLHE
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYY-------SERD-AADAVKQILEAVAYLHE 166

Query: 252 HCDPKIIHRDVKAANILLDEDADQSS 277
           +    I+HRD+K  N+L    A  + 
Sbjct: 167 N---GIVHRDLKPENLLYATPAPDAP 189

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 58.6 bits (142), Expect = 5e-10
 Identities = 38/195 (19%), Positives = 68/195 (34%), Gaps = 29/195 (14%)

Query: 95  RRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGR-L 153
               PH      P       Q        +++  +  D      +LG G  GKV +    
Sbjct: 25  TPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNK 84

Query: 154 ADGKLVAVKRL-KEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEK----LLV 207
              +  A+K L    +        + EV++   A    +++R+      +       L+V
Sbjct: 85  RTQEKFALKMLQDCPK-------ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 137

Query: 208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-----LGSARGLSYLHEHCDPKIIHRDV 262
              +  G + SR+++R          T ++ +     +G A  + YLH      I HRDV
Sbjct: 138 MECLDGGELFSRIQDRGDQ-----AFTEREASEIMKSIGEA--IQYLHSI---NIAHRDV 187

Query: 263 KAANILLDEDADQSS 277
           K  N+L       + 
Sbjct: 188 KPENLLYTSKRPNAI 202

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 57.6 bits (140), Expect = 7e-10
 Identities = 43/146 (29%), Positives = 67/146 (45%), Gaps = 28/146 (19%)

Query: 140 LGRGGFGKVY----KGRLADGKLVAVKRLKEER-TSGGELQFQTEVKIISMAVHRNLLRL 194
           LG+G FGKV+           +L A+K LK+        ++ + E  I+    H  +++L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 195 -YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IALGSARGL 246
            Y F T    KL L+  ++  G + +RL +E   +          K     +AL     L
Sbjct: 92  HYAFQTE--GKLYLILDFLRGGDLFTRLSKEVMFTEE------DVKFYLAELALA----L 139

Query: 247 SYLHEHCDPKIIHRDVKAANILLDED 272
            +LH      II+RD+K  NILLDE+
Sbjct: 140 DHLHSL---GIIYRDLKPENILLDEE 162

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 57.3 bits (139), Expect = 9e-10
 Identities = 33/152 (21%), Positives = 61/152 (40%), Gaps = 27/152 (17%)

Query: 137 KNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRL 194
             +LG G  GKV +       +  A+K L++        + + EV++   A    +++R+
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRI 76

Query: 195 YGFCTTVTEK----LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA-----LGSARG 245
                 +       L+V   +  G + SR+++R          T ++ +     +G A  
Sbjct: 77  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-----AFTEREASEIMKSIGEA-- 129

Query: 246 LSYLHEHCDPKIIHRDVKAANILLDEDADQSS 277
           + YLH      I HRDVK  N+L       + 
Sbjct: 130 IQYLHSI---NIAHRDVKPENLLYTSKRPNAI 158

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 56.9 bits (138), Expect = 1e-09
 Identities = 41/140 (29%), Positives = 63/140 (45%), Gaps = 18/140 (12%)

Query: 140 LGRGGFGKVYKGRLAD-GKLVAVKRL-KEERTSGGELQF-QTEVKIISMAVHRNLLRL-Y 195
           +G+G FGKV   +  D  K+ A+K + K++     E++    E++I+    H  L+ L Y
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82

Query: 196 GFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKKIA-LGSARGLSYLHEH 252
            F     E + +V   +  G +   L +             +  I  L  A  L YL   
Sbjct: 83  SFQDE--EDMFMVVDLLLGGDLRYHLQQNVHFKEET----VKLFICELVMA--LDYLQNQ 134

Query: 253 CDPKIIHRDVKAANILLDED 272
              +IIHRD+K  NILLDE 
Sbjct: 135 ---RIIHRDMKPDNILLDEH 151

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 56.3 bits (136), Expect = 2e-09
 Identities = 29/188 (15%), Positives = 64/188 (34%), Gaps = 48/188 (25%)

Query: 127 LQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT-EVKIIS 184
           L+ ++  +S    LG G FG V +    + GK  A+K++ ++       +++  E+ I+ 
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMK 55

Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR--------- 235
           +  H N+++L  +  T  ++    P   +       +    +                  
Sbjct: 56  VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115

Query: 236 ---------KKIALGSA-------------------RGLSYLHEHCDPKIIHRDVKAANI 267
                     K+                        R + ++H      I HRD+K  N+
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNL 172

Query: 268 LLDEDADQ 275
           L++   + 
Sbjct: 173 LVNSKDNT 180

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 55.6 bits (135), Expect = 3e-09
 Identities = 13/41 (31%), Positives = 21/41 (51%), Gaps = 1/41 (2%)

Query: 6   DLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCS 46
           ++S N L G +P  G+  +F   ++ NN  LCG      C+
Sbjct: 274 NVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL-PACT 313

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 55.7 bits (135), Expect = 3e-09
 Identities = 45/151 (29%), Positives = 62/151 (41%), Gaps = 39/151 (25%)

Query: 140 LGRGGFGKVYKGRL-ADGKLVAVKRLK---------EERTSGGELQFQTEVKIISMAV-H 188
           +G+G FGKV   R  A+    AVK L+         E+          +E  ++   V H
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHI-------MSERNVLLKNVKH 98

Query: 189 RNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IALG 241
             L+ L+ F     +KL  V  Y+  G +   L RER    P      R +     IA  
Sbjct: 99  PFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP------RARFYAAEIASA 151

Query: 242 SARGLSYLHEHCDPKIIHRDVKAANILLDED 272
               L YLH      I++RD+K  NILLD  
Sbjct: 152 ----LGYLHSL---NIVYRDLKPENILLDSQ 175

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 55.4 bits (134), Expect = 5e-09
 Identities = 36/148 (24%), Positives = 61/148 (41%), Gaps = 18/148 (12%)

Query: 132 DGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRL-KEERTSGGELQ-FQTEVKIISMAVH 188
           D F     LG G FG+V   +  + G   A+K L K++     +++    E +I+     
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK----KIALGSAR 244
             L++L       +   +V  Y+  G + S LR           P  +    +I L    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLT--- 153

Query: 245 GLSYLHEHCDPKIIHRDVKAANILLDED 272
              YLH      +I+RD+K  N+L+D+ 
Sbjct: 154 -FEYLHSL---DLIYRDLKPENLLIDQQ 177

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 54.9 bits (133), Expect = 6e-09
 Identities = 42/155 (27%), Positives = 66/155 (42%), Gaps = 44/155 (28%)

Query: 140 LGRGGFGKVYKGRLA----DGKLVAVKRLKE----------ERTSGGELQFQTEVKIISM 185
           LG+GG+GKV++ R       GK+ A+K LK+            T       + E  I+  
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-------KAERNILEE 77

Query: 186 AVHRNLLRL-YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK----- 237
             H  ++ L Y F T    KL L+  Y++ G +  +L RE                    
Sbjct: 78  VKHPFIVDLIYAFQTG--GKLYLILEYLSGGELFMQLEREGIFMED------TACFYLAE 129

Query: 238 IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           I++     L +LH+     II+RD+K  NI+L+  
Sbjct: 130 ISMA----LGHLHQK---GIIYRDLKPENIMLNHQ 157

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 54.9 bits (133), Expect = 6e-09
 Identities = 45/163 (27%), Positives = 68/163 (41%), Gaps = 40/163 (24%)

Query: 128 QVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKE---------ERTSGGELQFQ 177
           +V  + F    +LG+G FGKV   R  A G+  A+K L++           T        
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-------V 53

Query: 178 TEVKIISMAVHRNLLRL-YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPT 234
           TE +++    H  L  L Y F T   ++L  V  Y   G +   L RER  +        
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTH--DRLCFVMEYANGGELFFHLSRERVFTEE------ 105

Query: 235 RKK-----IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           R +     I       L YLH      +++RD+K  N++LD+D
Sbjct: 106 RARFYGAEIVSA----LEYLHSR---DVVYRDIKLENLMLDKD 141

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 55.1 bits (133), Expect = 7e-09
 Identities = 49/226 (21%), Positives = 80/226 (35%), Gaps = 53/226 (23%)

Query: 87  PVIGFAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKN-------- 138
            +I    W       F  + P E +      Q     L++   A   F + +        
Sbjct: 73  FIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAE 132

Query: 139 ----------------------ILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQ 175
                                 +LG+G FGKV   +    G+  A+K LK+E     +  
Sbjct: 133 EMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEV 192

Query: 176 FQT--EVKIISMAVHRNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLD 231
             T  E +++  + H  L  L  +     ++L  V  Y   G +   L RER  S     
Sbjct: 193 AHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED--- 248

Query: 232 WPTRKK-----IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
              R +     I       L YLH   +  +++RD+K  N++LD+D
Sbjct: 249 ---RARFYGAEIVSA----LDYLHSEKN--VVYRDLKLENLMLDKD 285

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 54.5 bits (132), Expect = 8e-09
 Identities = 43/160 (26%), Positives = 70/160 (43%), Gaps = 34/160 (21%)

Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLK---------EERTSGGELQFQ 177
           + +   F     LG G FG+V+  R    G+  A+K LK          E T        
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT-------N 54

Query: 178 TEVKIISMAVHRNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRK 236
            E  ++S+  H  ++R++G      +++ ++  Y+  G + S LR+ Q        P  K
Sbjct: 55  DERLMLSIVTHPFIIRMWGTFQD-AQQIFMIMDYIEGGELFSLLRKSQR----FPNPVAK 109

Query: 237 ----KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
               ++ L     L YLH      II+RD+K  NILLD++
Sbjct: 110 FYAAEVCLA----LEYLHSK---DIIYRDLKPENILLDKN 142

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 54.1 bits (131), Expect = 1e-08
 Identities = 43/152 (28%), Positives = 61/152 (40%), Gaps = 41/152 (26%)

Query: 140 LGRGGFGKVYKGRL-ADGKLVAVKRLK---------EERTSGGELQFQTEVKIISMAV-H 188
           LG+G FGKV+        +  A+K LK          E T         E +++S+A  H
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT-------MVEKRVLSLAWEH 77

Query: 189 RNLLRL-YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IAL 240
             L  +   F T   E L  V  Y+  G +   +    +  L       R       I L
Sbjct: 78  PFLTHMFCTFQTK--ENLFFVMEYLNGGDLMYHIQSCHKFDLS------RATFYAAEIIL 129

Query: 241 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           G    L +LH      I++RD+K  NILLD+D
Sbjct: 130 G----LQFLHSK---GIVYRDLKLDNILLDKD 154

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 53.1 bits (128), Expect = 3e-08
 Identities = 45/197 (22%), Positives = 80/197 (40%), Gaps = 37/197 (18%)

Query: 99  PHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKN------------ILGRGGFG 146
            H   +D+P  ++   Q          +  + T      +            ++GRG + 
Sbjct: 7   HHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYA 66

Query: 147 KVYKGRLAD-GKLVAVKRLKEER-TSGGELQF-QTEVKIISMAV-HRNLLRLYGFCTTVT 202
           KV   RL    ++ A++ +K+E      ++ + QTE  +   A  H  L+ L+  C    
Sbjct: 67  KVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTE 125

Query: 203 EKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IALGSARGLSYLHEHCDP 255
            +L  V  Y+  G +   + R+R+            +     I+L     L+YLHE    
Sbjct: 126 SRLFFVIEYVNGGDLMFHMQRQRKLPEE------HARFYSAEISLA----LNYLHER--- 172

Query: 256 KIIHRDVKAANILLDED 272
            II+RD+K  N+LLD +
Sbjct: 173 GIIYRDLKLDNVLLDSE 189

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 52.7 bits (127), Expect = 4e-08
 Identities = 34/169 (20%), Positives = 64/169 (37%), Gaps = 42/169 (24%)

Query: 131 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQT---------EV 180
              ++ +  +  G +G V  G  ++G  VA+KR+    + G  +              E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 181 KIISMAVHRNLLRLYG-FCTTVTEKL----LVYPYMTNGSVASRLRERQSSLPP------ 229
           ++++   H N+L L   F       +    LV   M    +A  + +++  + P      
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYF 139

Query: 230 ----LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 274
               L              GL  LH   +  ++HRD+   NILL ++ D
Sbjct: 140 MYHIL-------------LGLHVLH---EAGVVHRDLHPGNILLADNND 172

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 52.2 bits (126), Expect = 5e-08
 Identities = 37/151 (24%), Positives = 61/151 (40%), Gaps = 39/151 (25%)

Query: 140 LGRGGFGKVYKGRLAD-GKLVAVKRLKE---------ERTSGGELQFQTEVKIISMAV-H 188
           LG+G FGKV         +L AVK LK+         E T         E +++++    
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT-------MVEKRVLALPGKP 80

Query: 189 RNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IALG 241
             L +L+  C    ++L  V  Y+  G +   + +  +   P              IA+G
Sbjct: 81  PFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP------HAVFYAAEIAIG 133

Query: 242 SARGLSYLHEHCDPKIIHRDVKAANILLDED 272
               L +L       II+RD+K  N++LD +
Sbjct: 134 ----LFFLQSK---GIIYRDLKLDNVMLDSE 157

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 51.9 bits (125), Expect = 6e-08
 Identities = 45/156 (28%), Positives = 66/156 (42%), Gaps = 45/156 (28%)

Query: 140 LGRGGFGKVY---KGRLAD-GKLVAVKRLK----------EERTSGGELQFQTEVKIISM 185
           LG G +GKV+   K    D GKL A+K LK           E T       +TE +++  
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT-------RTERQVLEH 114

Query: 186 AVHRN-LLRL-YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK---- 237
                 L+ L Y F T    KL L+  Y+  G + + L +  + +          +    
Sbjct: 115 IRQSPFLVTLHYAFQTE--TKLHLILDYINGGELFTHLSQRERFTEH------EVQIYVG 166

Query: 238 -IALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
            I L     L +LH+     II+RD+K  NILLD +
Sbjct: 167 EIVLA----LEHLHKL---GIIYRDIKLENILLDSN 195

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 52.3 bits (125), Expect = 6e-08
 Identities = 35/145 (24%), Positives = 64/145 (44%), Gaps = 25/145 (17%)

Query: 139 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEER-TSGGELQF-QTEVKIISMAV-HRNLLRL 194
           +LG+G FGKV         +L AVK LK++      +++    E +++++      L +L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407

Query: 195 YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IALGSARGLS 247
           +  C    ++L  V  Y+  G +   + +  +   P              IA+G    L 
Sbjct: 408 H-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP------HAVFYAAEIAIG----LF 456

Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           +L       II+RD+K  N++LD +
Sbjct: 457 FLQSK---GIIYRDLKLDNVMLDSE 478

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 51.9 bits (125), Expect = 7e-08
 Identities = 44/151 (29%), Positives = 68/151 (45%), Gaps = 39/151 (25%)

Query: 140 LGRGGFGKVYKGRLAD-GKLVAVKRLKE---------ERTSGGELQFQTEVKIISMAV-H 188
           LG+G FGKV   R+ + G L AVK LK+         E T        TE +I+S+A  H
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECT-------MTEKRILSLARNH 83

Query: 189 RNLLRLYGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IALG 241
             L +L+  C    ++L  V  ++  G +   + + R+          R +     I   
Sbjct: 84  PFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA------RARFYAAEIISA 136

Query: 242 SARGLSYLHEHCDPKIIHRDVKAANILLDED 272
               L +LH+     II+RD+K  N+LLD +
Sbjct: 137 ----LMFLHDK---GIIYRDLKLDNVLLDHE 160

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 51.8 bits (125), Expect = 8e-08
 Identities = 41/145 (28%), Positives = 68/145 (46%), Gaps = 25/145 (17%)

Query: 139 ILGRGGFGKVYKGRLAD-GKLVAVKRLKEER-TSGGELQF-QTEVKIISMAV-HRNLLRL 194
           ++GRG + KV   RL    ++ A+K +K+E      ++ + QTE  +   A  H  L+ L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75

Query: 195 YGFCTTVTEKL-LVYPYMTNGSVASRL-RERQSSLPPLDWPTRKK-----IALGSARGLS 247
           +  C     +L  V  Y+  G +   + R+R+            +     I+L     L+
Sbjct: 76  H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE------HARFYSAEISLA----LN 124

Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           YLHE     II+RD+K  N+LLD +
Sbjct: 125 YLHER---GIIYRDLKLDNVLLDSE 146

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 51.7 bits (124), Expect = 9e-08
 Identities = 36/158 (22%), Positives = 63/158 (39%), Gaps = 33/158 (20%)

Query: 139 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR------NL 191
           ++G+G FG+V K       + VA+K ++ E+      Q   E++I+     +      N+
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF--HRQAAEEIRILEHLRKQDKDNTMNV 161

Query: 192 LRLYGF-------CTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGS 242
           + +          C    E L           +  L E  +++       P  +K A   
Sbjct: 162 IHMLENFTFRNHICM-TFELL-----------SMNLYELIKKNKFQGFSLPLVRKFAHSI 209

Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI 280
            + L  LH++   +IIH D+K  NILL +      K I
Sbjct: 210 LQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVI 244

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 50.3 bits (121), Expect = 2e-07
 Identities = 33/142 (23%), Positives = 65/142 (45%), Gaps = 28/142 (19%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLK---EERTSGGELQFQTEVKII-SMAVHRNLLRL 194
           LGRG + +V++   + + + V VK LK   +++        + E+KI+ ++    N++ L
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI-------KREIKILENLRGGPNIITL 96

Query: 195 YGFCTTVTEK--LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI--ALGSARGLSYLH 250
                    +   LV+ ++ N    +  ++   +L   D   R  +   L   + L Y H
Sbjct: 97  ADIVKDPVSRTPALVFEHVNN----TDFKQLYQTLTDYD--IRFYMYEIL---KALDYCH 147

Query: 251 EHCDPKIIHRDVKAANILLDED 272
                 I+HRDVK  N+++D +
Sbjct: 148 SM---GIMHRDVKPHNVMIDHE 166

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 50.1 bits (120), Expect = 3e-07
 Identities = 31/168 (18%), Positives = 60/168 (35%), Gaps = 39/168 (23%)

Query: 139 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISM-----------A 186
            LG G F  V+  + + +   VA+K ++ ++        + E+K++              
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE--AAEDEIKLLQRVNDADNTKEDSM 83

Query: 187 VHRNLLRLY------GFCTT----VTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPT 234
              ++L+L       G        V E L              L    ++     +    
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVL-----------GENLLALIKKYEHRGIPLIY 132

Query: 235 RKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTILR 282
            K+I+     GL Y+H  C   IIH D+K  N+L++      +   ++
Sbjct: 133 VKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIK 178

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 49.3 bits (118), Expect = 6e-07
 Identities = 35/159 (22%), Positives = 64/159 (40%), Gaps = 31/159 (19%)

Query: 138 NILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISM------AVHRN 190
           +++G+G FG+V K     + + VA+K +K ++      Q Q EV+++ +       +   
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF--LNQAQIEVRLLELMNKHDTEMKYY 117

Query: 191 LLRLYGF-------CTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALG 241
           ++ L          C  V E L           +  L +  R ++   +     +K A  
Sbjct: 118 IVHLKRHFMFRNHLCL-VFEML-----------SYNLYDLLRNTNFRGVSLNLTRKFAQQ 165

Query: 242 SARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI 280
               L +L    +  IIH D+K  NILL      + K +
Sbjct: 166 MCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV 203

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 49.1 bits (117), Expect = 7e-07
 Identities = 29/169 (17%), Positives = 61/169 (36%), Gaps = 51/169 (30%)

Query: 131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EV 180
            D +  ++++G G +G V +     + ++VA+K++           F+          E+
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV--------FEDLIDCKRILREI 103

Query: 181 KIISMAVHRNLLRLYGFCTTVTEKL-----LVYPYMTNGSVASRLRERQSSLPPLDWPTR 235
            I++   H +++++         +      +V                 S    L    R
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA------------DSDFKKL---FR 148

Query: 236 KKIALGSA----------RGLSYLHEHCDPKIIHRDVKAANILLDEDAD 274
             + L              G+ Y+H      I+HRD+K AN L+++D  
Sbjct: 149 TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCS 194

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 47.4 bits (113), Expect = 2e-06
 Identities = 36/153 (23%), Positives = 52/153 (33%), Gaps = 34/153 (22%)

Query: 140 LGRGGFGKVYKG-RLADGKLVAVKRLKEERTSGGELQFQTEVKI---------ISMAVHR 189
           +G GGFG +Y        +  A   +K E    G L    E+K          I   + R
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS--ELKFYQRVAKKDCIKKWIER 102

Query: 190 NLLRLYGF-----CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK-------K 237
             L   G            K   Y +M    V  RL      L  +             +
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFM----VMERL---GIDLQKISGQNGTFKKSTVLQ 155

Query: 238 IALGSARGLSYLHEHCDPKIIHRDVKAANILLD 270
           + +     L Y+HE+     +H D+KAAN+LL 
Sbjct: 156 LGIRMLDVLEYIHENE---YVHGDIKAANLLLG 185

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.2 bits (111), Expect = 4e-06
 Identities = 34/201 (16%), Positives = 66/201 (32%), Gaps = 66/201 (32%)

Query: 91  FAYWRRTRPHEFFFDVPAEDDSELQLGQLKRFSLRELQVATDGFSNKNIL--GRGGFGK- 147
           FA +  +R   +           L+L    R +L EL+        KN+L  G  G GK 
Sbjct: 126 FAKYNVSRLQPY-----------LKL----RQALLELR------PAKNVLIDGVLGSGKT 164

Query: 148 VYKGRLADGKLVAVKRLKEERTSGGEL------QFQTEVKIISMAVHRNLLRLYGFCTTV 201
                +A   L      K +     ++         +   ++ M     L +L       
Sbjct: 165 W----VA---LDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEM-----LQKLL------ 206

Query: 202 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRD 261
               +   + +    +S ++ R  S+         +  L   R L     + +  ++  +
Sbjct: 207 --YQIDPNWTSRSDHSSNIKLRIHSI---------QAEL---RRLLKSKPYENCLLVLLN 252

Query: 262 VKAANILLDEDA-DQSSKTIL 281
           V+ A      +A + S K +L
Sbjct: 253 VQNAKAW---NAFNLSCKILL 270

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 45.8 bits (109), Expect = 5e-06
 Identities = 30/146 (20%), Positives = 57/146 (39%), Gaps = 18/146 (12%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH-RNLLRLYGF 197
           +G G FG +++G  L + + VA+K    E       Q + E +   +      +  +Y F
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 74

Query: 198 CTTVTEKLLVYPYMTNGSVASRLRE---RQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 254
                  +LV   +  G     L +   R+ S+      T    A      +  +HE   
Sbjct: 75  GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSV-----KTVAMAAKQMLARVQSIHEKS- 126

Query: 255 PKIIHRDVKAANILLDEDADQSSKTI 280
             +++RD+K  N L+     +++  I
Sbjct: 127 --LVYRDIKPDNFLIGRPNSKNANMI 150

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 44.2 bits (105), Expect = 2e-05
 Identities = 30/152 (19%), Positives = 57/152 (37%), Gaps = 32/152 (21%)

Query: 139 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISM-----AVHRNLL 192
            +G G FG+V   + + + K  AVK ++  +        + E  I+         + N++
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY--TRSAKIEADILKKIQNDDINNNNIV 99

Query: 193 RLYGF-------CTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSA 243
           + +G        C  + E L              L E   +++         K   +   
Sbjct: 100 KYHGKFMYYDHMCL-IFEPL-----------GPSLYEIITRNNYNGFHIEDIKLYCIEIL 147

Query: 244 RGLSYLHEHCDPKIIHRDVKAANILLDEDADQ 275
           + L+YL +     + H D+K  NILLD+   +
Sbjct: 148 KALNYLRKM---SLTHTDLKPENILLDDPYFE 176

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 43.2 bits (102), Expect = 5e-05
 Identities = 33/156 (21%), Positives = 59/156 (37%), Gaps = 37/156 (23%)

Query: 140 LGRGGFGKVYKGRLADGKLVAVKR---LKEERTSGGELQFQTEVKI---------ISMAV 187
           +G+GGFG +Y   +   + V       +K E +  G L    E+K          I   +
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFT--ELKFYQRAAKPEQIQKWI 100

Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR----ERQ-SSLPPL-DWPTRK----- 236
               L+  G           +    +       R    +R  S L  + +   ++     
Sbjct: 101 RTRKLKYLGVPK-------YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKT 153

Query: 237 --KIALGSARGLSYLHEHCDPKIIHRDVKAANILLD 270
             +++L     L Y+HEH     +H D+KA+N+LL+
Sbjct: 154 VLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 42.8 bits (101), Expect = 7e-05
 Identities = 38/169 (22%), Positives = 60/169 (35%), Gaps = 51/169 (30%)

Query: 131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EV 180
            D +  K+++GRG +G VY        K VA+K++           F+          E+
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM--------FEDLIDCKRILREI 76

Query: 181 KIISMAVHRNLLRLYGFCTTVTEKL-----LVYPYMTNGSVASRLRERQSSLPPLDWPTR 235
            I++      ++RLY               +V                 S L  L    +
Sbjct: 77  TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA------------DSDLKKL---FK 121

Query: 236 KKIALGSA----------RGLSYLHEHCDPKIIHRDVKAANILLDEDAD 274
             I L              G +++HE     IIHRD+K AN LL++D  
Sbjct: 122 TPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCS 167

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 42.0 bits (99), Expect = 9e-05
 Identities = 34/140 (24%), Positives = 49/140 (35%), Gaps = 12/140 (8%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLLRLYGF 197
           +G G FG +Y G  +A G+ VA+K    E       Q   E KI   M     +  +   
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 73

Query: 198 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
                  ++V   +  G     L    S    L   T   +A      + Y+H       
Sbjct: 74  GAEGDYNVMVMELL--GPSLEDLFNFCSRKFSL--KTVLLLADQMISRIEYIHSKN---F 126

Query: 258 IHRDVKAANILLDEDADQSS 277
           IHRDVK  N L+      + 
Sbjct: 127 IHRDVKPDNFLMGLGKKGNL 146

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 42.3 bits (100), Expect = 1e-04
 Identities = 29/157 (18%), Positives = 52/157 (33%), Gaps = 38/157 (24%)

Query: 139 ILGRGGFGKVYKG--RLADGKLVAVK--RLKEERTSGGELQFQTEVKIISM------AVH 188
            LG G FGKV +          VA+K  R   +         + E+ ++           
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKENK 81

Query: 189 RNLLRLYGF-------CTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIA 239
              + +  +       C    E L                E  ++++  P   P  + +A
Sbjct: 82  FLCVLMSDWFNFHGHMCI-AFELL-----------GKNTFEFLKENNFQPYPLPHVRHMA 129

Query: 240 LGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS 276
                 L +LHE+   ++ H D+K  NIL      ++
Sbjct: 130 YQLCHALRFLHEN---QLTHTDLKPENILFVNSEFET 163

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 41.9 bits (99), Expect = 1e-04
 Identities = 31/162 (19%), Positives = 60/162 (37%), Gaps = 38/162 (23%)

Query: 131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EV 180
              + +   +G G +G V        G+ VA+K+L           FQ+         E+
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--------PFQSEIFAKRAYREL 74

Query: 181 KIISMAVHRNLLRLY------GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDW 232
            ++    H N++ L              +  LV P+M      + L++            
Sbjct: 75  LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGL----KFSE 125

Query: 233 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 274
              + +     +GL Y+H      ++HRD+K  N+ ++ED +
Sbjct: 126 EKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCE 164

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 42.0 bits (99), Expect = 1e-04
 Identities = 34/146 (23%), Positives = 58/146 (39%), Gaps = 18/146 (12%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH-RNLLRLYGF 197
           +G G FG++  G+ L   + VA+K    E       Q   E +          + ++Y F
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 73

Query: 198 CTTVTEKLLVYPYMTNG-SVAS--RLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 254
                   +V   +  G S+     L +R  SL      T   IA+     + Y+H    
Sbjct: 74  GPCGKYNAMVLELL--GPSLEDLFDLCDRTFSL-----KTVLMIAIQLISRMEYVHSKN- 125

Query: 255 PKIIHRDVKAANILLDEDADQSSKTI 280
             +I+RDVK  N L+    +++ + I
Sbjct: 126 --LIYRDVKPENFLIGRPGNKTQQVI 149

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 32/159 (20%), Positives = 55/159 (34%), Gaps = 38/159 (23%)

Query: 134 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EVKII 183
           + N   +G G  G V         + VA+K+L           FQ          E+ ++
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR--------PFQNQTHAKRAYRELVLM 78

Query: 184 SMAVHRNLLRLY------GFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTR 235
               H+N++ L              +  +V   M      + L +  +      LD    
Sbjct: 79  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-----ANLCQVIQM----ELDHERM 129

Query: 236 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 274
             +      G+ +LH      IIHRD+K +NI++  D  
Sbjct: 130 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 165

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 41.1 bits (97), Expect = 2e-04
 Identities = 30/153 (19%), Positives = 58/153 (37%), Gaps = 38/153 (24%)

Query: 139 ILGRGGFGKVYKG--RLADGKLVAVK--RLKEERTSGGELQFQTEVKIISM------AVH 188
            LG G FGKV +     A G+ VAVK  +  +          ++E++++           
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCE----AARSEIQVLEHLNTTDPNST 76

Query: 189 RNLLRLYGF-------CTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIA 239
              +++  +       C  V E L                +  +++   P      +K+A
Sbjct: 77  FRCVQMLEWFEHHGHICI-VFELL-----------GLSTYDFIKENGFLPFRLDHIRKMA 124

Query: 240 LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
               + +++LH +   K+ H D+K  NIL  + 
Sbjct: 125 YQICKSVNFLHSN---KLTHTDLKPENILFVQS 154

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 41.0 bits (96), Expect = 3e-04
 Identities = 33/161 (20%), Positives = 54/161 (33%), Gaps = 36/161 (22%)

Query: 131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EV 180
              + N   +G G  G V         + VA+K+L           FQ          E+
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR--------PFQNQTHAKRAYREL 112

Query: 181 KIISMAVHRNLLRLY------GFCTTVTEKLLVYPYM-TNGSVASRLRERQSSLPPLDWP 233
            ++    H+N++ L              +  LV   M  N     ++         LD  
Sbjct: 113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--------ELDHE 164

Query: 234 TRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 274
               +      G+ +LH      IIHRD+K +NI++  D  
Sbjct: 165 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 202

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 40.8 bits (96), Expect = 3e-04
 Identities = 36/157 (22%), Positives = 64/157 (40%), Gaps = 33/157 (21%)

Query: 134 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EVKII 183
           + +   +G G +G V        G  VA+K+L           FQ+         E++++
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--------PFQSELFAKRAYRELRLL 78

Query: 184 SMAVHRNLLRLY------GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKK 237
               H N++ L             T+  LV P+M  G+   +L + +     L     + 
Sbjct: 79  KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE----KLGEDRIQF 132

Query: 238 IALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 274
           +     +GL Y+H      IIHRD+K  N+ ++ED +
Sbjct: 133 LVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCE 166

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 40.4 bits (94), Expect = 5e-04
 Identities = 30/139 (21%), Positives = 49/139 (35%), Gaps = 12/139 (8%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLLRLYGF 197
           +G G FG++Y G  +   + VA+K    E       Q   E KI   +     +  +  F
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKIYRILQGGTGIPNVRWF 71

Query: 198 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
                  +LV   +  G     L    S    L   T   +A      + ++H       
Sbjct: 72  GVEGDYNVLVMDLL--GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKS---F 124

Query: 258 IHRDVKAANILLDEDADQS 276
           +HRD+K  N L+      +
Sbjct: 125 LHRDIKPDNFLMGLGRRAN 143

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 40.0 bits (94), Expect = 5e-04
 Identities = 33/156 (21%), Positives = 60/156 (38%), Gaps = 33/156 (21%)

Query: 134 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQT---------EVKII 183
           ++N + +G G +G V       +   VA+K++           F+          E+KI+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS---------PFEHQTYCQRTLREIKIL 79

Query: 184 SMAVHRNLLRLYGFCTTVTEKL-----LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI 238
               H N++ +       T +      +V   M   +   +L + Q     L        
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKTQ----HLSNDHICYF 133

Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD 274
                RGL Y+H      ++HRD+K +N+LL+   D
Sbjct: 134 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCD 166

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 40.3 bits (94), Expect = 5e-04
 Identities = 20/41 (48%), Positives = 23/41 (56%), Gaps = 2/41 (4%)

Query: 229 PLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL 269
            L  P  KKI     +GL YLH  C  +IIH D+K  NILL
Sbjct: 142 GLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILL 180

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 40.1 bits (94), Expect = 5e-04
 Identities = 11/31 (35%), Positives = 19/31 (61%), Gaps = 3/31 (9%)

Query: 244 RGLSYLHEHCDPKIIHRDVKAANILLDEDAD 274
           + + YLH      ++HRD+K +NILL+ +  
Sbjct: 120 KVIKYLH---SGGLLHRDMKPSNILLNAECH 147

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 39.5 bits (93), Expect = 6e-04
 Identities = 11/31 (35%), Positives = 19/31 (61%), Gaps = 3/31 (9%)

Query: 244 RGLSYLHEHCDPKIIHRDVKAANILLDEDAD 274
           R +  LH      +IHRD+K +N+L++ + D
Sbjct: 123 RAVKVLH---GSNVIHRDLKPSNLLINSNCD 150

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	284
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.98
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.97
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.97
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.97
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.96
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.96
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.96
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.96
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.96
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.96
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.96
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.96
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.96
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.96
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.96
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.96
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.96
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.95
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.95
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.95
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.95
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.95
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.95
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.95
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.95
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.95
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.95
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.95
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.95
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.95
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.95
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.95
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.95
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.95
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.95
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.95
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.95
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.95
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.95
3niz_A	311	Rhodanese family protein; structural genomics, str	99.95
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.95
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.95
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.95
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.95
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.95
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.95
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.95
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.95
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.95
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.95
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.95
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.95
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.95
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.95
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.95
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.95
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.95
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.95
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.95
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.95
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.95
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.95
3uqc_A	286	Probable conserved transmembrane protein; structur	99.95
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.95
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.94
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.94
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.94
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.94
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.94
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.94
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.94
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.94
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.94
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.94
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.94
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.94
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.94
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.94
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.94
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.94
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.94
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.94
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.94
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.94
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.94
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.94
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.94
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.94
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.94
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.94
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.94
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.94
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.94
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.94
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.94
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.94
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.94
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.94
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.94
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.94
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.94
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.94
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.94
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.94
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.94
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.94
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.94
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.94
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.94
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.94
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.94
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.94
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.94
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.94
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.94
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.94
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.94
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.94
3bhy_A	283	Death-associated protein kinase 3; death associate	99.94
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.94
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.94
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.94
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.94
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.94
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.94
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.94
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.94
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.94
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.94
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.94
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.94
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.94
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.94
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.94
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.94
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.94
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.94
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.94
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.94
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.94
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.94
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.94
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.94
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.93
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.93
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.93
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.93
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.93
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.93
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.93
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.93
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.93
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.93
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.93
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.93
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.93
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.93
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.93
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.93
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.93
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.93
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.93
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.93
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.93
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.93
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.93
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.93
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.93
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.93
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.93
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.93
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.93
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.93
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.93
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.93
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.93
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.93
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.93
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.93
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.93
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.93
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.93
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.93
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.93
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.93
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.93
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.93
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.93
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.93
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.93
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.93
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.93
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.93
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.93
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.93
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.93
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.93
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.93
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.92
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.92
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.92
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.92
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.92
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.92
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.92
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.92
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.92
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.92
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.92
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.92
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.92
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.92
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.92
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.92
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.92
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.92
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.92
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.91
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.91
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.91
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.91
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.91
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.91
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.91
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.91
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.91
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.91
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.91
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.91
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.91
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.9
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.9
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.89
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.89
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.89
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.88
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.86
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.83
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.76
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.39
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.25
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.17
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.66
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.66
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.57
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.38
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.34
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	98.22
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.18
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.17
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.06
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.99
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.93
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.9
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.52
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.11
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.87
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.83
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.77
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.77
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.58
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.34
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.26
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	96.03
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.79
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	95.02
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	94.8
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.6
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.11
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	91.9
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	90.9
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	90.24
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	89.98
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	88.6
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	87.81
2k9y_A	41	Ephrin type-A receptor 2; receptor tyrosine kinase	87.5
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	86.67
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	86.67
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	86.44
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	86.22
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	85.35
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	84.61
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	84.55
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	83.88
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	83.1
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	82.81
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	82.72
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	82.41
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	82.37
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	82.36
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	82.34
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	82.23
3m19_A	251	Variable lymphocyte receptor A diversity region; a	81.91
3e6j_A	229	Variable lymphocyte receptor diversity region; var	80.92
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	80.36

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.2e-37  Score=263.88  Aligned_cols=144  Identities=26%  Similarity=0.420  Sum_probs=126.2

Q ss_pred             CCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEE
Q 023282          134 FSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      +...+.||+|+||+||+|++.      +++.||||+++........++|.+|+.++++++|||||+++|+|...+..++|
T Consensus        28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV  107 (308)
T 4gt4_A           28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI  107 (308)
T ss_dssp             EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence            445678999999999999863      46789999997655555566899999999999999999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCc
Q 023282          208 YPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  275 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~  275 (284)
                      ||||++|+|.++|+....            ....++|.+++.++.|||+||+|||+.   +||||||||+|||+|+++.+
T Consensus       108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~  184 (308)
T 4gt4_A          108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNV  184 (308)
T ss_dssp             EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred             EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCE
Confidence            999999999999975421            123589999999999999999999999   99999999999999999999


Q ss_pred             chhhh
Q 023282          276 SSKTI  280 (284)
Q Consensus       276 ~~~df  280 (284)
                      ||+||
T Consensus       185 Ki~DF  189 (308)
T 4gt4_A          185 KISDL  189 (308)
T ss_dssp             EECCS
T ss_pred             EECCc
Confidence            99998

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.6e-37  Score=262.56  Aligned_cols=145  Identities=28%  Similarity=0.481  Sum_probs=125.8

Q ss_pred             cCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  205 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~  205 (284)
                      ++|...+.||+|+||+||+|++.      ++..||||+++.. .....++|.+|+++|++++|||||+++|+|.+.+..+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            45667789999999999999863      4678999999643 2333457999999999999999999999999999999


Q ss_pred             EEEeCCCCCChHHHHhhcC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcc
Q 023282          206 LVYPYMTNGSVASRLRERQ---------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  276 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~  276 (284)
                      +|||||++|+|.++|+...         .....++|.+++.++.|+|.||+|||++   +|+||||||+|||+|+++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence            9999999999999998642         2234699999999999999999999998   999999999999999999999


Q ss_pred             hhhh
Q 023282          277 SKTI  280 (284)
Q Consensus       277 ~~df  280 (284)
                      |+||
T Consensus       169 i~DF  172 (299)
T 4asz_A          169 IGDF  172 (299)
T ss_dssp             ECCC
T ss_pred             ECCc
Confidence            9998

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=262.64  Aligned_cols=145  Identities=31%  Similarity=0.497  Sum_probs=127.1

Q ss_pred             cCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  205 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~  205 (284)
                      ++|...+.||+|+||+||+|++.      ++..||||+++.. .....++|.+|+++|++++|||||+++|+|.+.+..+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            34556688999999999999864      4678999999643 2333457999999999999999999999999999999


Q ss_pred             EEEeCCCCCChHHHHhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCC
Q 023282          206 LVYPYMTNGSVASRLRERQS-----------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  274 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~  274 (284)
                      +|||||++|+|.++++....           ...+++|.+++.|+.|+|+||+|||+.   +|+||||||+|||+|.++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence            99999999999999986432           124699999999999999999999998   9999999999999999999


Q ss_pred             cchhhh
Q 023282          275 QSSKTI  280 (284)
Q Consensus       275 ~~~~df  280 (284)
                      +||+||
T Consensus       197 ~Ki~DF  202 (329)
T 4aoj_A          197 VKIGDF  202 (329)
T ss_dssp             EEECCC
T ss_pred             EEEccc
Confidence            999998

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-36  Score=257.65  Aligned_cols=143  Identities=29%  Similarity=0.436  Sum_probs=125.0

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEE
Q 023282          129 VATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       129 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      +..+++...+.||+|+||+||+|++.+  .||||+++..... ...+.|.+|+.++++++|||||+++|+|.. +..++|
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV  109 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV  109 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence            344667778899999999999998753  5999999744332 234579999999999999999999998864 578999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||||++|+|.++|+...   ..++|.+++.|+.|+|+||+|||+.   +||||||||+|||+|+++.+||+||
T Consensus       110 mEy~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DF  176 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDF  176 (307)
T ss_dssp             EECCSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCC
T ss_pred             EEcCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeec
Confidence            99999999999997643   2589999999999999999999998   9999999999999999999999999

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.7e-35  Score=256.23  Aligned_cols=144  Identities=21%  Similarity=0.327  Sum_probs=123.3

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++..... .....+.+|+.++++++|||||++++++.+.+..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5788889999999999999986 47899999999754433 234469999999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||++|+|.++|.....  ..+++.+...++.|++.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus       104 y~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DF  169 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDF  169 (350)
T ss_dssp             CCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECST
T ss_pred             CCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEccc
Confidence            9999999999976432  2478899999999999999999999   9999999999999999999999999

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.8e-35  Score=252.96  Aligned_cols=140  Identities=25%  Similarity=0.366  Sum_probs=127.1

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +.|+..+.||+|+||+||+|+.. +|+.||||+++.... .....+.+|+.+|+.++|||||++++++...+..|+||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            45777889999999999999864 799999999965432 3344688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |++|+|.+++...     .+++.+...++.|++.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus       153 ~~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DF  214 (346)
T 4fih_A          153 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDF  214 (346)
T ss_dssp             CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred             CCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecC
Confidence            9999999999753     489999999999999999999999   9999999999999999999999998

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.7e-35  Score=250.14  Aligned_cols=142  Identities=27%  Similarity=0.358  Sum_probs=128.7

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc--CcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|+..+.||+|+||+||+|+. .+++.||||++....  .......+.+|+++++.++|||||++++++.+.+..++||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4588889999999999999985 478999999996442  2233457899999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.++++...    .+++.+...++.|++.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus       112 Ey~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DF  176 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDF  176 (311)
T ss_dssp             CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred             ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEc
Confidence            9999999999998753    489999999999999999999999   9999999999999999999999998

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=7e-35  Score=249.47  Aligned_cols=139  Identities=28%  Similarity=0.410  Sum_probs=118.8

Q ss_pred             CCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC----eeeEEEe
Q 023282          134 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT----EKLLVYP  209 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~----~~~lv~e  209 (284)
                      +...+.||+|+||+||+|++ +|+.||||+++...  .....+..|+..+.+++|||||+++|+|...+    ..+||||
T Consensus         5 i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             EEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            55668899999999999998 58899999996432  11223445666677899999999999998754    5799999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC-----DPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~-----~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||++|+|.++|+..     .++|..+.+++.|+++||+|||+++     .++|+||||||+|||+|.++++||+||
T Consensus        82 y~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF  152 (303)
T 3hmm_A           82 YHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             CCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             CCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence            99999999999864     4899999999999999999999863     568999999999999999999999999

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.3e-34  Score=247.03  Aligned_cols=145  Identities=21%  Similarity=0.331  Sum_probs=123.4

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC--------
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT--------  202 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~--------  202 (284)
                      ++|+..+.||+|+||+||+|+.. +++.||||+++........+.+.+|+.+|++++|||||++++++...+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            35788899999999999999864 789999999975443333457899999999999999999999987544        


Q ss_pred             ----eeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchh
Q 023282          203 ----EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  278 (284)
Q Consensus       203 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~  278 (284)
                          ..++|||||++|+|.+++.... .....++.....++.|+++||+|||++   +|+||||||+|||++.++.+||+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence                3689999999999999998643 223456778899999999999999999   99999999999999999999999


Q ss_pred             hh
Q 023282          279 TI  280 (284)
Q Consensus       279 df  280 (284)
                      ||
T Consensus       161 DF  162 (299)
T 4g31_A          161 DF  162 (299)
T ss_dssp             CC
T ss_pred             cC
Confidence            98

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.7e-35  Score=256.33  Aligned_cols=156  Identities=28%  Similarity=0.391  Sum_probs=134.8

Q ss_pred             ccHHHHHHHhcCCCCCCeecccCceEEEEEEeCC------CcEEEEEEeecccCcccHHHHHHHHHHHhcCCC-CCceee
Q 023282          122 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVH-RNLLRL  194 (284)
Q Consensus       122 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h-~niv~l  194 (284)
                      +..++|++..++|+..+.||+|+||+||+|++..      ++.||||.++........+.|.+|+.+|++++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            4556778888899999999999999999998532      357999999765544455679999999999965 899999


Q ss_pred             eeEEeeC-CeeeEEEeCCCCCChHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeC
Q 023282          195 YGFCTTV-TEKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRD  261 (284)
Q Consensus       195 ~g~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrd  261 (284)
                      +|+|... ...++|||||++|+|.++|+....            ....++|.+++.++.|||+||+|||++   +|||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence            9999775 468999999999999999986422            123589999999999999999999999   999999


Q ss_pred             CCCCCeeeCCCCCcchhhh
Q 023282          262 VKAANILLDEDADQSSKTI  280 (284)
Q Consensus       262 lk~~NiLld~~~~~~~~df  280 (284)
                      |||+|||+++++.+||+||
T Consensus       211 LK~~NILl~~~~~vKi~DF  229 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDF  229 (353)
T ss_dssp             CSGGGEEECGGGCEEECCC
T ss_pred             cCccceeeCCCCCEEECcc
Confidence            9999999999999999998

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.6e-34  Score=254.25  Aligned_cols=140  Identities=25%  Similarity=0.366  Sum_probs=127.7

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +.|+..+.||+|+||.||+|+.. +|+.||||++..... .....+.+|+.+|+.++|||||++++++...+..|+||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            46888899999999999999864 789999999965432 3344689999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |++|+|.+++...     .+++.++..++.|++.||+|||++   +|+||||||+||||+.++.+||+||
T Consensus       230 ~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DF  291 (423)
T 4fie_A          230 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDF  291 (423)
T ss_dssp             CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCC
T ss_pred             CCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecC
Confidence            9999999999753     389999999999999999999999   9999999999999999999999998

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.1e-34  Score=241.62  Aligned_cols=141  Identities=26%  Similarity=0.399  Sum_probs=120.9

Q ss_pred             CCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcc-cHHHHHHHHHHHhcCCCCCceeeeeEEee----CCeeeEEE
Q 023282          135 SNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTT----VTEKLLVY  208 (284)
Q Consensus       135 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~g~~~~----~~~~~lv~  208 (284)
                      ...+.||+|+||+||+|... ++..||+|.+....... ....|.+|++++++++|||||++++++..    ....++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            34567999999999999864 68899999997544332 33469999999999999999999999865    24579999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC-CCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~-~~~~~~~df  280 (284)
                      |||++|+|.++++...    .+++..+..++.|++.||+|||++ .++|+||||||+|||++. ++.+||+||
T Consensus       109 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DF  176 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDL  176 (290)
T ss_dssp             ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCT
T ss_pred             eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeC
Confidence            9999999999998653    489999999999999999999997 224999999999999984 789999998

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.2e-34  Score=246.31  Aligned_cols=136  Identities=24%  Similarity=0.302  Sum_probs=122.8

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +.|...+.||+|+||.||+|+.. +|+.||||+++.+..      ..+|+.+++.++|||||++++++.+.+..++||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            34666788999999999999964 689999999975322      24799999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC-Ccchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~-~~~~~df  280 (284)
                      |++|+|.++++...    .+++.+...++.|++.||+|||++   +|+||||||+|||++.++ .+||+||
T Consensus       132 ~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DF  195 (336)
T 4g3f_A          132 LEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDF  195 (336)
T ss_dssp             CTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCC
T ss_pred             cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeC
Confidence            99999999998653    489999999999999999999999   999999999999999998 5999998

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=7.2e-34  Score=238.81  Aligned_cols=141  Identities=23%  Similarity=0.418  Sum_probs=122.7

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc--ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|+..+.||+|+||+||+|+. .+++.||||+++.....  .....+.+|+++++.++|||||++++++.+.+..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            5799999999999999999985 47899999999654322  23456999999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+ +|+|.+++....    .+++.+...++.|++.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        93 Ey~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DF  156 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADF  156 (275)
T ss_dssp             ECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCS
T ss_pred             eCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeec
Confidence            999 689999997643    589999999999999999999999   9999999999999999999999998

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.2e-34  Score=246.81  Aligned_cols=142  Identities=27%  Similarity=0.332  Sum_probs=121.7

Q ss_pred             cCCCCCCeecccCceEEEEEEeC----CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~l  206 (284)
                      ++|+..+.||+|+||+||+|+..    +++.||||+++..... .....+.+|++++++++|||||++++++.+.+..++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            45888899999999999999752    4679999999654322 223368899999999999999999999999999999


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||||++|+|.+++....    .+++.+...++.|++.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus       104 vmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DF  170 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDF  170 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESS
T ss_pred             EEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEeccc
Confidence            999999999999998753    489999999999999999999999   9999999999999999999999998

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.98  E-value=4.4e-32  Score=234.33  Aligned_cols=172  Identities=81%  Similarity=1.252  Sum_probs=148.1

Q ss_pred             CChhhhhhcccccccHHHHHHHhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCC
Q 023282          109 EDDSELQLGQLKRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH  188 (284)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h  188 (284)
                      ........+....+++.++....++|...+.||+|+||.||+|+..+++.||||++...........+.+|+.+++.++|
T Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h   86 (326)
T 3uim_A            7 EEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVH   86 (326)
T ss_dssp             --------CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCC
T ss_pred             ccCcccccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccC
Confidence            33444455667789999999999999999999999999999999878999999999765444444478999999999999


Q ss_pred             CCceeeeeEEeeCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCee
Q 023282          189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL  268 (284)
Q Consensus       189 ~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiL  268 (284)
                      |||+++++++......++||||+++|+|.+++.........++|..+..++.|++.||+|||+.+.++|+||||||+|||
T Consensus        87 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil  166 (326)
T 3uim_A           87 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANIL  166 (326)
T ss_dssp             TTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEE
T ss_pred             CCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEE
Confidence            99999999999999999999999999999999876655567999999999999999999999988889999999999999


Q ss_pred             eCCCCCcchhhh
Q 023282          269 LDEDADQSSKTI  280 (284)
Q Consensus       269 ld~~~~~~~~df  280 (284)
                      ++.++.++|+||
T Consensus       167 ~~~~~~~kl~Df  178 (326)
T 3uim_A          167 LDEEFEAVVGDF  178 (326)
T ss_dssp             ECTTCCEEECCC
T ss_pred             ECCCCCEEeccC
Confidence            999999999998

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.97  E-value=1.3e-31  Score=236.78  Aligned_cols=141  Identities=23%  Similarity=0.412  Sum_probs=123.6

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeC------Ce
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV------TE  203 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~------~~  203 (284)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++..... ...+.+.+|+++|+.++|||||++++++...      ..
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            4688889999999999999986 47999999999654332 2234688999999999999999999987643      56


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .++|||||+ |+|.+++....    .+++.++..++.|++.||.|||++   +|+||||||+|||++.++.+|++||
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~----~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DF  202 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ----PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDF  202 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEeCCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeec
Confidence            899999996 78999997542    589999999999999999999999   9999999999999999999999998

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.97  E-value=1.1e-30  Score=228.48  Aligned_cols=139  Identities=20%  Similarity=0.352  Sum_probs=123.6

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEeC----CCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCCe
Q 023282          129 VATDGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTE  203 (284)
Q Consensus       129 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~  203 (284)
                      ...+.|+..+.||+|+||+||+|+.+    +++.||+|.+...   .....+.+|+++++.+ +|||||++++++...+.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~---~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT---SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT---SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc---cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            34577999999999999999999742    4678999998543   2344688999999988 69999999999999999


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCC-CCcchhhh
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTI  280 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~-~~~~~~df  280 (284)
                      .++||||+++|+|.+++.       .+++.+...++.|++.||+|||++   +|+||||||+|||++.+ +.+||+||
T Consensus        95 ~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DF  162 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDF  162 (361)
T ss_dssp             EEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             EEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcC
Confidence            999999999999999984       278999999999999999999999   99999999999999987 78999998

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.97  E-value=1.5e-30  Score=240.66  Aligned_cols=143  Identities=28%  Similarity=0.390  Sum_probs=124.5

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHH---HHHHHHHhcCCCCCceeeeeEEeeCCee
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQF---QTEVKIISMAVHRNLLRLYGFCTTVTEK  204 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~---~~e~~~l~~~~h~niv~l~g~~~~~~~~  204 (284)
                      .++|+..++||+|+||+||+|+.. +|+.||||+++....  .......   ..++.+++.++|||||++++++.+.+..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            457888999999999999999864 789999999964321  1122223   3446777889999999999999999999


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++||||+++|+|.++|....    .+++.....++.||+.||+|||++   +||||||||+|||||.++.+||+||
T Consensus       268 ylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DF  336 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDL  336 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEeccc
Confidence            99999999999999998753    489999999999999999999999   9999999999999999999999998

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.96  E-value=7.2e-30  Score=235.78  Aligned_cols=143  Identities=20%  Similarity=0.342  Sum_probs=127.0

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      .++|+..+.||+|+||.||+|+. .+|+.||+|.+.... ......+.+|+.+|+.++|||||++++++......++|||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E  234 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  234 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            35788899999999999999986 478999999986533 2234468899999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCC--CCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED--ADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~--~~~~~~df  280 (284)
                      ||++|+|.++|....   ..+++.+...++.|++.||.|||++   +|+||||||+|||++.+  +.+||+||
T Consensus       235 ~~~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DF  301 (573)
T 3uto_A          235 FMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDF  301 (573)
T ss_dssp             CCCCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred             ecCCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeec
Confidence            999999999996532   2589999999999999999999999   99999999999999865  78999998

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.96  E-value=1e-29  Score=219.13  Aligned_cols=151  Identities=44%  Similarity=0.735  Sum_probs=134.9

Q ss_pred             HHHHHhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeee
Q 023282          126 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  205 (284)
Q Consensus       126 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~  205 (284)
                      ++...+++|...+.||+|+||.||+|+..++..||+|.+.... ......+.+|+.+++.++||||+++++++...+..+
T Consensus        33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  111 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI  111 (321)
T ss_dssp             CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred             HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            3445668899999999999999999998889999999886542 233457899999999999999999999999999999


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +||||+++|+|.+++.........++|..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+||
T Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCC
T ss_pred             EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeec
Confidence            99999999999999976544444689999999999999999999998   9999999999999999999999998

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.96  E-value=3.9e-29  Score=220.02  Aligned_cols=143  Identities=31%  Similarity=0.451  Sum_probs=127.7

Q ss_pred             cCCCCCCeecccCceEEEEEEeC----CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      ++|+..+.||+|+||.||+|+..    ++..||||.++..........|.+|+.++++++||||+++++++......++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            46888999999999999999854    46789999997554334455799999999999999999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||+++|+|.++++...   ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus       125 ~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df  191 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDF  191 (373)
T ss_dssp             EECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             EeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcC
Confidence            99999999999997643   2589999999999999999999999   9999999999999999999999998

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.96  E-value=6.2e-29  Score=218.52  Aligned_cols=147  Identities=28%  Similarity=0.453  Sum_probs=128.4

Q ss_pred             hcCCCCCCeecccCceEEEEEEe--------CCCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEeeC
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL--------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  201 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~  201 (284)
                      .++|...+.||+|+||.||+|+.        .++..||||+++..........+.+|+.+++.+ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            35677889999999999999975        234579999997654434445799999999999 899999999999999


Q ss_pred             CeeeEEEeCCCCCChHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeee
Q 023282          202 TEKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  269 (284)
Q Consensus       202 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLl  269 (284)
                      +..++||||+++|+|.+++.....            ....+++..+..++.|++.||+|||+.   +|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence            999999999999999999986432            123589999999999999999999999   99999999999999


Q ss_pred             CCCCCcchhhh
Q 023282          270 DEDADQSSKTI  280 (284)
Q Consensus       270 d~~~~~~~~df  280 (284)
                      +.++.+||+||
T Consensus       237 ~~~~~~kl~DF  247 (370)
T 2psq_A          237 TENNVMKIADF  247 (370)
T ss_dssp             CTTCCEEECCC
T ss_pred             CCCCCEEEccc
Confidence            99999999998

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.96  E-value=1e-28  Score=213.21  Aligned_cols=145  Identities=21%  Similarity=0.333  Sum_probs=125.7

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC--------
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT--------  202 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~--------  202 (284)
                      ++|+..+.||+|+||.||+|+.. +++.||||+++..........+.+|+.+++.++||||+++++++....        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            45778899999999999999975 789999999975544444567999999999999999999999986543        


Q ss_pred             -------------------------------------------------eeeEEEeCCCCCChHHHHhhcCCCCCCCCHH
Q 023282          203 -------------------------------------------------EKLLVYPYMTNGSVASRLRERQSSLPPLDWP  233 (284)
Q Consensus       203 -------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~  233 (284)
                                                                       ..+++|||+++|+|.+++..... ....++.
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~  164 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREHG  164 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhhH
Confidence                                                             27999999999999999986532 3346778


Q ss_pred             HHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          234 TRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       234 ~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus       165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  208 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDF  208 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeec
Confidence            8999999999999999999   9999999999999999999999998

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.96  E-value=3.6e-29  Score=220.61  Aligned_cols=147  Identities=30%  Similarity=0.458  Sum_probs=130.1

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeE
Q 023282          128 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       128 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~l  206 (284)
                      ....++|...+.||+|+||.||+|+.. +++.||||.++..........|.+|+.+++.++||||+++++++...+..++
T Consensus       110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  189 (377)
T 3cbl_A          110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI  189 (377)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence            334556777899999999999999975 7889999998754333333468899999999999999999999999899999


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||||+++|+|.++++....   .+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+||
T Consensus       190 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~Df  257 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDF  257 (377)
T ss_dssp             EEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCG
T ss_pred             EEEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcC
Confidence            9999999999999986432   478999999999999999999999   9999999999999999999999998

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.96  E-value=7.5e-29  Score=214.29  Aligned_cols=143  Identities=29%  Similarity=0.415  Sum_probs=127.3

Q ss_pred             cCCCCCCeecccCceEEEEEEeC----CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      ++|...+.||+|+||.||+|...    .+..||||.++..........+.+|+.+++.++||||+++++++......++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            45677799999999999999864    34569999997654444455799999999999999999999999998899999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||+++|+|.++++...   ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus       129 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df  195 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDF  195 (325)
T ss_dssp             EECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             eeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCC
Confidence            99999999999997543   2589999999999999999999999   9999999999999999999999998

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.96  E-value=4.2e-29  Score=223.77  Aligned_cols=152  Identities=20%  Similarity=0.290  Sum_probs=133.3

Q ss_pred             cHHHHHHHhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEe
Q 023282          123 SLRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCT  199 (284)
Q Consensus       123 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~  199 (284)
                      .+.++....++|+..++||+|+||+||+|+.. +++.||+|+++....  ......+.+|..++..++||||+++++++.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            34556667789999999999999999999975 578999999964321  112234889999999999999999999999


Q ss_pred             eCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhh
Q 023282          200 TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKT  279 (284)
Q Consensus       200 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~d  279 (284)
                      ..+..++||||+++|+|.+++....   ..+++..+..++.|++.||.|||+.   +|+||||||+|||+|.++.+||+|
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D  218 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD  218 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence            9999999999999999999997632   2489999999999999999999999   999999999999999999999999


Q ss_pred             h
Q 023282          280 I  280 (284)
Q Consensus       280 f  280 (284)
                      |
T Consensus       219 F  219 (437)
T 4aw2_A          219 F  219 (437)
T ss_dssp             C
T ss_pred             h
Confidence            8

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.96  E-value=1.6e-28  Score=212.53  Aligned_cols=143  Identities=24%  Similarity=0.401  Sum_probs=128.8

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      .++|...+.||+|+||.||+|+. .+|+.||||++...... .....+.+|+++++.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            45688889999999999999986 57899999999654332 23346889999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        94 e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DF  158 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADF  158 (328)
T ss_dssp             CCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECST
T ss_pred             ECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeec
Confidence            9999999999997653    488999999999999999999999   9999999999999999999999998

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.96  E-value=2.2e-28  Score=209.72  Aligned_cols=142  Identities=25%  Similarity=0.453  Sum_probs=127.3

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ++|...+.||+|+||+||++... ++..||+|.+... .......+.+|+++++.++||||+++++++......++||||
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            45777899999999999999864 6889999988542 223345799999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++|+|.+++.....   .++|..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        89 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df  152 (310)
T 3s95_A           89 IKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADF  152 (310)
T ss_dssp             CTTCBHHHHHHHCCT---TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCC
T ss_pred             cCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeec
Confidence            999999999986432   589999999999999999999999   9999999999999999999999998

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.96  E-value=4.4e-28  Score=206.83  Aligned_cols=141  Identities=22%  Similarity=0.363  Sum_probs=128.1

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      .++|...+.||+|+||+||+|.. .+++.||+|.+..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            45788899999999999999985 5789999999865432 334568899999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++|+|.+++...     .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus        98 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Df  160 (297)
T 3fxz_A           98 YLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDF  160 (297)
T ss_dssp             CCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred             CCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeC
Confidence            99999999999764     378999999999999999999999   9999999999999999999999998

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.96  E-value=7.7e-28  Score=205.89  Aligned_cols=157  Identities=43%  Similarity=0.707  Sum_probs=139.1

Q ss_pred             cccccHHHHHHHhcCCCCC------CeecccCceEEEEEEeCCCcEEEEEEeecccC---cccHHHHHHHHHHHhcCCCC
Q 023282          119 LKRFSLRELQVATDGFSNK------NILGRGGFGKVYKGRLADGKLVAVKRLKEERT---SGGELQFQTEVKIISMAVHR  189 (284)
Q Consensus       119 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~~h~  189 (284)
                      ...+++.++...+++|...      +.||+|+||.||+|.. ++..||+|.+.....   ......+.+|+.+++.++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            4568899999999999887      8999999999999987 578999999864322   22245689999999999999


Q ss_pred             CceeeeeEEeeCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeee
Q 023282          190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  269 (284)
Q Consensus       190 niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLl  269 (284)
                      ||+++++++...+..+++|||+++|+|.+++..... ..+++|..+..++.|++.||.|||+.   +++||||||+||++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili  166 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL  166 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence            999999999999999999999999999999975322 23689999999999999999999999   99999999999999


Q ss_pred             CCCCCcchhhh
Q 023282          270 DEDADQSSKTI  280 (284)
Q Consensus       270 d~~~~~~~~df  280 (284)
                      +.++.++|+||
T Consensus       167 ~~~~~~kl~Df  177 (307)
T 2nru_A          167 DEAFTAKISDF  177 (307)
T ss_dssp             CTTCCEEECCC
T ss_pred             cCCCcEEEeec
Confidence            99999999998

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.95  E-value=5.8e-28  Score=208.36  Aligned_cols=151  Identities=22%  Similarity=0.308  Sum_probs=132.3

Q ss_pred             cccHHHHHHHhcC----------CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCC
Q 023282          121 RFSLRELQVATDG----------FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR  189 (284)
Q Consensus       121 ~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~  189 (284)
                      .++++++..+++.          |+..+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.+++.++||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCCT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCC
Confidence            4566666666653          555678999999999999975 79999999986543 33445688999999999999


Q ss_pred             CceeeeeEEeeCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeee
Q 023282          190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  269 (284)
Q Consensus       190 niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLl  269 (284)
                      ||+++++++...+..++||||+++|+|.+++...     .++|..+..++.|++.||.|||+.   +|+||||||+|||+
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll  174 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL  174 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEE
Confidence            9999999999999999999999999999998643     489999999999999999999998   99999999999999


Q ss_pred             CCCCCcchhhh
Q 023282          270 DEDADQSSKTI  280 (284)
Q Consensus       270 d~~~~~~~~df  280 (284)
                      +.++.++|+||
T Consensus       175 ~~~~~~kl~Df  185 (321)
T 2c30_A          175 TLDGRVKLSDF  185 (321)
T ss_dssp             CTTCCEEECCC
T ss_pred             CCCCcEEEeee
Confidence            99999999998

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.95  E-value=7.5e-29  Score=215.33  Aligned_cols=151  Identities=30%  Similarity=0.490  Sum_probs=131.9

Q ss_pred             HHHHhcCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEee
Q 023282          127 LQVATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT  200 (284)
Q Consensus       127 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~  200 (284)
                      +....++|...+.||+|+||.||+|+..      +++.||+|.++..........+.+|+.+++.++||||+++++++..
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            3445678888999999999999999863      3478999999755443445579999999999999999999999999


Q ss_pred             CCeeeEEEeCCCCCChHHHHhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeee
Q 023282          201 VTEKLLVYPYMTNGSVASRLRERQSS--------------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHR  260 (284)
Q Consensus       201 ~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHr  260 (284)
                      .+..++||||+++|+|.+++......                    ...+++.++..++.|+++||.|||+.   +|+||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~  198 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR  198 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence            99999999999999999999864211                    14689999999999999999999999   99999


Q ss_pred             CCCCCCeeeCCCCCcchhhh
Q 023282          261 DVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       261 dlk~~NiLld~~~~~~~~df  280 (284)
                      ||||+|||++.++.++|+||
T Consensus       199 Dlkp~NIl~~~~~~~kl~Df  218 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADF  218 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCC
T ss_pred             CCCcceEEECCCCeEEEeec
Confidence            99999999999999999998

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.95  E-value=8.1e-29  Score=220.25  Aligned_cols=149  Identities=23%  Similarity=0.325  Sum_probs=131.6

Q ss_pred             HHHHHHHhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEee
Q 023282          124 LRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTT  200 (284)
Q Consensus       124 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~  200 (284)
                      +.++....++|...+.||+|+||+||+++.. +++.||+|+++....  ......+.+|+.+++.++||||+++++++..
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            4455666788999999999999999999965 688999999964321  1223358899999999999999999999999


Q ss_pred             CCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          201 VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       201 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ....++||||+++|+|.++++..     .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF  212 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF  212 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence            99999999999999999999763     378999999999999999999999   9999999999999999999999998

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.95  E-value=2.5e-28  Score=211.95  Aligned_cols=142  Identities=25%  Similarity=0.342  Sum_probs=127.8

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--CcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|+..+.||+|+||.||+++.. +++.||+|+++...  .......+.+|+.+++.++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            56788899999999999999865 68999999997542  2233456889999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        85 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DF  149 (337)
T 1o6l_A           85 EYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF  149 (337)
T ss_dssp             ECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeec
Confidence            9999999999997643    488999999999999999999999   9999999999999999999999998

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.95  E-value=1.7e-28  Score=211.94  Aligned_cols=142  Identities=25%  Similarity=0.392  Sum_probs=125.2

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ++|+..+.||+|+||.||+|+.. +++.||+|++...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            56888899999999999999865 78899999986544444445689999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus        87 ~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Df  149 (323)
T 3tki_A           87 CSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDF  149 (323)
T ss_dssp             CTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             CCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEe
Confidence            99999999986532    489999999999999999999999   9999999999999999999999998

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.95  E-value=9e-29  Score=220.10  Aligned_cols=153  Identities=21%  Similarity=0.283  Sum_probs=134.1

Q ss_pred             ccHHHHHHHhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEE
Q 023282          122 FSLRELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFC  198 (284)
Q Consensus       122 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~  198 (284)
                      +.+++.....++|+..++||+|+||.||+++.. +++.||+|+++....  ......+.+|..++..++||||+++++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            345566667788999999999999999999964 789999999964321  11223588999999999999999999999


Q ss_pred             eeCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchh
Q 023282          199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  278 (284)
Q Consensus       199 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~  278 (284)
                      ...+..++||||+++|+|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+|||+|.++.+||+
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~  204 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSKFGE---RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLA  204 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEe
Confidence            999999999999999999999986432   489999999999999999999999   99999999999999999999999


Q ss_pred             hh
Q 023282          279 TI  280 (284)
Q Consensus       279 df  280 (284)
                      ||
T Consensus       205 DF  206 (412)
T 2vd5_A          205 DF  206 (412)
T ss_dssp             CC
T ss_pred             ec
Confidence            98

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.95  E-value=3.6e-28  Score=212.27  Aligned_cols=145  Identities=29%  Similarity=0.430  Sum_probs=127.3

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--CcccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCCee
Q 023282          129 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEK  204 (284)
Q Consensus       129 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~  204 (284)
                      ...++|+..++||+|+||.||+++.. +++.||+|+++...  .......+..|..++..+ +||||+++++++...+..
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            34578889999999999999999864 68899999997542  122344678899999887 699999999999999999


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++||||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus       100 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DF  168 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADF  168 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccc
Confidence            99999999999999998653    489999999999999999999999   9999999999999999999999998

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.95  E-value=6.7e-29  Score=217.03  Aligned_cols=156  Identities=28%  Similarity=0.408  Sum_probs=133.3

Q ss_pred             ccHHHHHHHhcCCCCCCeecccCceEEEEEEe------CCCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceee
Q 023282          122 FSLRELQVATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRL  194 (284)
Q Consensus       122 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l  194 (284)
                      +...+++...++|...+.||+|+||.||+|++      .+++.||||.++..........+.+|++++..+ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            34556677788899999999999999999973      245789999997654444455799999999999 79999999


Q ss_pred             eeEEeeCCe-eeEEEeCCCCCChHHHHhhcCCC-----------------------------------------------
Q 023282          195 YGFCTTVTE-KLLVYPYMTNGSVASRLRERQSS-----------------------------------------------  226 (284)
Q Consensus       195 ~g~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~-----------------------------------------------  226 (284)
                      ++++...+. .++||||+++|+|.++++.....                                               
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            999987654 89999999999999999864321                                               


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          227 ---------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       227 ---------------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                                     ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Df  237 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDF  237 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEec
Confidence                           11288999999999999999999999   9999999999999999999999998

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.95  E-value=2.3e-28  Score=214.73  Aligned_cols=146  Identities=32%  Similarity=0.424  Sum_probs=127.1

Q ss_pred             cCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  205 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~  205 (284)
                      ++|...+.||+|+||.||+|+..      ++..||||+++..........+.+|+.+++.++||||+++++++......+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            45777899999999999999843      456899999975544445557899999999999999999999999999999


Q ss_pred             EEEeCCCCCChHHHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC---Ccchhh
Q 023282          206 LVYPYMTNGSVASRLRERQS---SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSKT  279 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~---~~~~~d  279 (284)
                      +||||+++|+|.+++.....   ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence            99999999999999987532   224589999999999999999999999   999999999999999655   499999


Q ss_pred             h
Q 023282          280 I  280 (284)
Q Consensus       280 f  280 (284)
                      |
T Consensus       228 F  228 (367)
T 3l9p_A          228 F  228 (367)
T ss_dssp             C
T ss_pred             C
Confidence            8

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.95  E-value=6e-28  Score=202.81  Aligned_cols=142  Identities=27%  Similarity=0.442  Sum_probs=128.2

Q ss_pred             hcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      .++|...+.||+|+||.||++...++..||+|++....  ....++.+|++++++++||||+++++++......++||||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   86 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc--cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence            35677789999999999999998888899999997543  2345789999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++|+|.+++....   ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+||
T Consensus        87 ~~~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Df  150 (269)
T 4hcu_A           87 MEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDF  150 (269)
T ss_dssp             CTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCT
T ss_pred             CCCCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccc
Confidence            99999999997643   2589999999999999999999999   9999999999999999999999998

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.95  E-value=8.6e-28  Score=204.70  Aligned_cols=142  Identities=23%  Similarity=0.309  Sum_probs=127.3

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCccc--HHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|...+.||+|+||.||+++.. ++..||+|.+........  ...+.+|+.+++.++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            46778899999999999999854 688999999864433222  346899999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++....    ++++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus        91 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Df  155 (294)
T 4eqm_A           91 EYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDF  155 (294)
T ss_dssp             ECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeC
Confidence            9999999999998653    489999999999999999999999   9999999999999999999999998

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.95  E-value=9.2e-28  Score=206.67  Aligned_cols=146  Identities=27%  Similarity=0.450  Sum_probs=115.6

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      .++|+..+.||+|+||.||+|... +++.||+|.++..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            356888899999999999999854 6899999999765444444578899999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQ--SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |++ |+|.+++....  .....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df  152 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDF  152 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcC
Confidence            998 69999987542  2223589999999999999999999999   9999999999999999999999998

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.95  E-value=6.2e-28  Score=207.89  Aligned_cols=142  Identities=30%  Similarity=0.435  Sum_probs=127.3

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|...+.||+|+||.||+++.. +++.||+|+++....  ......+.+|..+++.++||||+++++++......++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            56778899999999999999864 789999999975422  233446889999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++....    .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        86 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Df  150 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDF  150 (318)
T ss_dssp             CCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeec
Confidence            9999999999998643    488999999999999999999999   9999999999999999999999998

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.95  E-value=1.5e-27  Score=208.98  Aligned_cols=143  Identities=24%  Similarity=0.339  Sum_probs=127.1

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcc-----cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCee
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-----GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  204 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~  204 (284)
                      .+.|...+.||+|+||.||+++.. +|+.||+|.++......     ....+.+|+.+++.++||||+++++++......
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            356788899999999999999865 68999999997543321     235789999999999999999999999999999


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC----Ccchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA----DQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~----~~~~~df  280 (284)
                      ++||||+++|+|.+++....    .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++    .+||+||
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            99999999999999997532    589999999999999999999999   999999999999998887    7999998

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.95  E-value=7.1e-28  Score=213.17  Aligned_cols=143  Identities=26%  Similarity=0.363  Sum_probs=126.1

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcc--cHHHHHHHHHHHhcC-CCCCceeeeeEEeeCCeeeE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG--GELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~~l  206 (284)
                      .++|+..++||+|+||.||+++.. +++.||+|+++......  ....+..|..++..+ +||||+++++++......++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            456888899999999999999965 67899999997553322  223578899998776 89999999999999999999


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus       131 V~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF  197 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDY  197 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeec
Confidence            999999999999998653    489999999999999999999999   9999999999999999999999998

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.95  E-value=5.4e-28  Score=213.39  Aligned_cols=147  Identities=29%  Similarity=0.423  Sum_probs=128.5

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC--------CCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEeeC
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA--------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  201 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~  201 (284)
                      .++|...+.||+|+||.||+|+..        .+..||+|+++..........+.+|+++++.+ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            356777899999999999999842        23579999997654444446789999999999 899999999999999


Q ss_pred             CeeeEEEeCCCCCChHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeee
Q 023282          202 TEKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  269 (284)
Q Consensus       202 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLl  269 (284)
                      +..++||||+++|+|.+++.....            ....+++..+..++.|++.||.|||+.   +|+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence            999999999999999999987532            123589999999999999999999999   99999999999999


Q ss_pred             CCCCCcchhhh
Q 023282          270 DEDADQSSKTI  280 (284)
Q Consensus       270 d~~~~~~~~df  280 (284)
                      +.++.+||+||
T Consensus       225 ~~~~~~kL~DF  235 (382)
T 3tt0_A          225 TEDNVMKIADF  235 (382)
T ss_dssp             CTTCCEEECSC
T ss_pred             cCCCcEEEccc
Confidence            99999999998

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.95  E-value=1.1e-27  Score=201.04  Aligned_cols=142  Identities=28%  Similarity=0.437  Sum_probs=128.4

Q ss_pred             hcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      .++|...+.||+|+||.||++...++..||+|.++...  ....++.+|++++..++||||+++++++......++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT--BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC--CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            45677789999999999999998888899999996543  2345689999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++++|.+++.....   .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+||
T Consensus        85 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Df  148 (268)
T 3sxs_A           85 ISNGCLLNYLRSHGK---GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDF  148 (268)
T ss_dssp             CTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCT
T ss_pred             cCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccC
Confidence            999999999986432   489999999999999999999999   9999999999999999999999998

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.95  E-value=1.2e-27  Score=208.40  Aligned_cols=142  Identities=27%  Similarity=0.370  Sum_probs=126.5

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCccc--HHHHHHHHHHHhcC-CCCCceeeeeEEeeCCeeeEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG--ELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~~lv  207 (284)
                      ++|+..+.||+|+||.||+++.. +++.||+|+++.......  ...+.+|..++..+ +||||+++++++......++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            46777899999999999999965 688999999975543222  33578899999887 899999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        89 ~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DF  154 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDY  154 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCG
T ss_pred             EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEec
Confidence            99999999999997643    489999999999999999999999   9999999999999999999999998

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.95  E-value=7.1e-28  Score=210.31  Aligned_cols=146  Identities=20%  Similarity=0.275  Sum_probs=126.6

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc----CcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER----TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~l  206 (284)
                      +.|...+.||+|+||.||++... +++.||||++....    .......+.+|+.+++.++||||+++++++...+..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            45778899999999999999864 68999999986432    11234578999999999999999999999999999999


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCC---cchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD---QSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~---~~~~df  280 (284)
                      ||||+++|+|.+.+.........+++..+..++.|++.||.|||+.   +|+||||||+|||++.+++   +||+||
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Df  177 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGF  177 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecC
Confidence            9999999999988876433334589999999999999999999999   9999999999999987765   899998

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.95  E-value=1.7e-28  Score=210.54  Aligned_cols=150  Identities=28%  Similarity=0.423  Sum_probs=129.4

Q ss_pred             HHHHHhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCee
Q 023282          126 ELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  204 (284)
Q Consensus       126 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~  204 (284)
                      ++....++|...+.||+|+||+||+|+. +++.||||++...... .....+.+|++++++++||||+++++++...+..
T Consensus        31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 3p86_A           31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL  109 (309)
T ss_dssp             -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred             cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence            3344556788889999999999999987 5788999998654332 2234689999999999999999999999999999


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK--IIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~--ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+.   +  |+||||||+|||++.++.+||+||
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Df  183 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDF  183 (309)
T ss_dssp             EEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred             EEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCC
Confidence            999999999999999975321 12378999999999999999999998   7  999999999999999999999998

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.95  E-value=1.7e-27  Score=210.64  Aligned_cols=144  Identities=22%  Similarity=0.312  Sum_probs=128.8

Q ss_pred             cCCCCCCeeccc--CceEEEEEEeC-CCcEEEEEEeecccCccc-HHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEE
Q 023282          132 DGFSNKNILGRG--GFGKVYKGRLA-DGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       132 ~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      ++|...+.||+|  +||.||+++.. +++.||||+++....... ...+.+|+.+++.++||||+++++++...+..++|
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  104 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV  104 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence            457788999999  99999999965 789999999975543322 34688899999999999999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||+++|+|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus       105 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~df  172 (389)
T 3gni_B          105 TSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGL  172 (389)
T ss_dssp             EECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCG
T ss_pred             EEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccc
Confidence            999999999999986422  2489999999999999999999999   9999999999999999999999999

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.95  E-value=6.4e-28  Score=210.02  Aligned_cols=146  Identities=25%  Similarity=0.425  Sum_probs=127.5

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCCe
Q 023282          128 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTE  203 (284)
Q Consensus       128 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~  203 (284)
                      ....++|...+.||+|+||.||+|+.. +++.||+|.++....  ......+..|..++..+ +||||+++++++.....
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            445678889999999999999999965 688999999975421  23344678889888866 89999999999999999


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .++||||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DF  162 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADF  162 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEC
Confidence            999999999999999998643    489999999999999999999999   9999999999999999999999998

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.95  E-value=9.4e-28  Score=206.10  Aligned_cols=142  Identities=25%  Similarity=0.433  Sum_probs=124.2

Q ss_pred             cCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCccc-HHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ++|...+.||+|+||+||+|+..+++.||+|+++....... ...+.+|+++++.++||||+++++++......++||||
T Consensus        21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  100 (311)
T 3niz_A           21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF  100 (311)
T ss_dssp             CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred             hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence            56778899999999999999988899999999965433322 34688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++ |+|.+++....   ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       101 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Df  163 (311)
T 3niz_A          101 ME-KDLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADF  163 (311)
T ss_dssp             CS-EEHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             CC-CCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccC
Confidence            98 58888887543   2489999999999999999999999   9999999999999999999999998

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.95  E-value=8.7e-28  Score=207.77  Aligned_cols=143  Identities=25%  Similarity=0.346  Sum_probs=122.0

Q ss_pred             hcCCCCCCeecccCceEEEEEEe----CCCcEEEEEEeecccC---cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCe
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL----ADGKLVAVKRLKEERT---SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  203 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~  203 (284)
                      .++|+..+.||+|+||.||+++.    .+++.||+|+++....   ......+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            35678889999999999999986    4788999999975432   1223357889999999999999999999999999


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .++||||+++|+|.+++....    .+++.....++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Df  165 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDF  165 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCC
T ss_pred             EEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeC
Confidence            999999999999999997643    478999999999999999999999   9999999999999999999999998

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.95  E-value=4.9e-28  Score=207.59  Aligned_cols=148  Identities=30%  Similarity=0.445  Sum_probs=128.7

Q ss_pred             HhcCCCCCCeecccCceEEEEEEe------CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCe
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  203 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~  203 (284)
                      ..++|...+.||+|+||.||++..      .++..||+|.++..........+.+|+++++.++||||+++++++...+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            345677789999999999999975      24578999999755444444578999999999999999999999999999


Q ss_pred             eeEEEeCCCCCChHHHHhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCC
Q 023282          204 KLLVYPYMTNGSVASRLRERQS--------------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVK  263 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk  263 (284)
                      .++||||+++|+|.+++.....                    ....+++..+..++.|+++||.|||+.   +|+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccc
Confidence            9999999999999999986432                    112478999999999999999999999   99999999


Q ss_pred             CCCeeeCCCCCcchhhh
Q 023282          264 AANILLDEDADQSSKTI  280 (284)
Q Consensus       264 ~~NiLld~~~~~~~~df  280 (284)
                      |+|||++.++.++|+||
T Consensus       178 p~NIli~~~~~~kl~Df  194 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDF  194 (314)
T ss_dssp             GGGEEEETTTEEEECCC
T ss_pred             hheEEEcCCCCEEEccc
Confidence            99999999999999998

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.95  E-value=6e-28  Score=217.78  Aligned_cols=148  Identities=22%  Similarity=0.373  Sum_probs=130.1

Q ss_pred             HHHHHHhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCee
Q 023282          125 RELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  204 (284)
Q Consensus       125 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~  204 (284)
                      .+++...++|...+.||+|+||.||+|...++..||||.++...  .....|.+|+.+++.++||||+++++++. .+..
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~  257 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI  257 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence            34455667788889999999999999999888899999997543  34567999999999999999999999986 5678


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++||||+++|+|.++++....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DF  328 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADF  328 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECST
T ss_pred             EEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeC
Confidence            999999999999999975321  1378899999999999999999999   9999999999999999999999998

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.95  E-value=6.8e-28  Score=212.53  Aligned_cols=142  Identities=25%  Similarity=0.358  Sum_probs=127.4

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--CcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|...+.||+|+||.||+++.. +++.||+|.+....  .......+.+|+.+++.++||||+++++++......++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            56778899999999999999864 68899999986433  2233457889999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++....    .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus        95 e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DF  159 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNV----HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDF  159 (384)
T ss_dssp             CCCTTEEHHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             ecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEecc
Confidence            9999999999997642    489999999999999999999999   9999999999999999999999998

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.95  E-value=1.1e-27  Score=208.95  Aligned_cols=142  Identities=24%  Similarity=0.323  Sum_probs=127.6

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--CcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|+..+.||+|+||.||+++.. +++.||+|+++...  .......+.+|+.+++.++||||+++++++......++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            46778899999999999999965 68999999996442  1233456889999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++....    .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       121 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DF  185 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDF  185 (350)
T ss_dssp             ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEccc
Confidence            9999999999998643    489999999999999999999999   9999999999999999999999998

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.95  E-value=1.4e-27  Score=201.95  Aligned_cols=143  Identities=27%  Similarity=0.430  Sum_probs=125.9

Q ss_pred             HhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      ..++|...+.||+|+||.||++...++..||+|+++...  ....++.+|++++..++||||+++++++......++|||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   99 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   99 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC--CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence            345677789999999999999999888899999997543  234578999999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++|+|.+++.....   .+++..+..++.|++.||.|||+.   +++||||||+|||++.++.++|+||
T Consensus       100 ~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Df  164 (283)
T 3gen_A          100 YMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDF  164 (283)
T ss_dssp             CCTTCBHHHHHHCGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECST
T ss_pred             ccCCCcHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccc
Confidence            9999999999976322   489999999999999999999999   9999999999999999999999998

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.95  E-value=8.3e-28  Score=203.84  Aligned_cols=146  Identities=21%  Similarity=0.322  Sum_probs=128.8

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ++|...+.||+|+||.||++... ++..+|+|.+...........+.+|+++++.++||||+++++++......++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            35777899999999999999864 68899999997665555566899999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeee---CCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLl---d~~~~~~~~df  280 (284)
                      +++|+|.+++.........+++..+..++.|++.||+|||+.   +|+||||||+|||+   +.++.++|+||
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Df  171 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDF  171 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEee
Confidence            999999999975432234589999999999999999999999   99999999999999   55678999998

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.95  E-value=1.6e-27  Score=202.34  Aligned_cols=142  Identities=24%  Similarity=0.447  Sum_probs=126.1

Q ss_pred             cCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ++|...+.||+|+||.||+|+..+++.||+|.++..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            457778999999999999999888999999998644322 2235688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++ +|.+++....   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        82 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df  144 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADF  144 (288)
T ss_dssp             CSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCT
T ss_pred             cCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeEC
Confidence            985 9999987542   2588999999999999999999999   9999999999999999999999998

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.95  E-value=1.3e-27  Score=205.68  Aligned_cols=145  Identities=23%  Similarity=0.329  Sum_probs=127.2

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC--eeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT--EKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~--~~~lv~  208 (284)
                      ++|...+.||+|+||+||+|+.. +++.||||+++..........+.+|+++++.++||||+++++++....  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            45777899999999999999965 588999999976554455567889999999999999999999998755  679999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeee----CCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL----DEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLl----d~~~~~~~~df  280 (284)
                      ||+++|+|.+++..... ...+++..+..++.|++.||+|||+.   +|+||||||+|||+    +.++.+||+||
T Consensus        89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Df  160 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDF  160 (319)
T ss_dssp             ECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred             eCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccC
Confidence            99999999999986432 22489999999999999999999999   99999999999999    88888999998

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=2.1e-27  Score=204.91  Aligned_cols=141  Identities=21%  Similarity=0.334  Sum_probs=125.9

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ++|...+.||+|+||.||++... ++..+|+|.++..  ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            56788899999999999999865 6889999998643  22344688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC--CCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE--DADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~--~~~~~~~df  280 (284)
                      +++|+|.+++....   ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.  ++.+|++||
T Consensus        83 ~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Df  148 (321)
T 1tki_A           83 ISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEF  148 (321)
T ss_dssp             CCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred             CCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEEC
Confidence            99999999997542   2589999999999999999999999   9999999999999997  789999998

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.95  E-value=1.7e-27  Score=214.53  Aligned_cols=143  Identities=28%  Similarity=0.449  Sum_probs=126.8

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC-eeeEE
Q 023282          129 VATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT-EKLLV  207 (284)
Q Consensus       129 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~-~~~lv  207 (284)
                      ...++|...+.||+|+||.||+|... ++.||||.++...   ....|.+|+.++++++||||+++++++.... ..++|
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv  265 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV  265 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence            34566778899999999999999885 7799999997543   3457999999999999999999999987765 78999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||+++|+|.++++....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus       266 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~Df  333 (450)
T 1k9a_A          266 TEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDF  333 (450)
T ss_dssp             EECCTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeC
Confidence            999999999999987532  2478999999999999999999999   9999999999999999999999998

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=4e-28  Score=211.01  Aligned_cols=150  Identities=27%  Similarity=0.427  Sum_probs=127.0

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEe------CCCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEee
Q 023282          128 QVATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  200 (284)
Q Consensus       128 ~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~  200 (284)
                      +...++|...+.||+|+||.||+|..      .++..||+|.++..........+.+|+.++.++ +||||+++++++..
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            34556788889999999999999985      245689999997554444455799999999999 89999999999999


Q ss_pred             CCeeeEEEeCCCCCChHHHHhhcCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeC
Q 023282          201 VTEKLLVYPYMTNGSVASRLRERQSS-------------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRD  261 (284)
Q Consensus       201 ~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrd  261 (284)
                      .+..++||||+++|+|.+++......                   ...+++..+..++.|++.||.|||+.   +|+|||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~D  197 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD  197 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence            99999999999999999999864321                   13479999999999999999999999   999999


Q ss_pred             CCCCCeeeCCCCCcchhhh
Q 023282          262 VKAANILLDEDADQSSKTI  280 (284)
Q Consensus       262 lk~~NiLld~~~~~~~~df  280 (284)
                      |||+|||++.++.++|+||
T Consensus       198 ikp~NIll~~~~~~kL~Df  216 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDF  216 (344)
T ss_dssp             CSGGGEEEETTTEEEECCC
T ss_pred             CChhhEEEcCCCcEEeCCC
Confidence            9999999999999999998

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.95  E-value=7.8e-28  Score=219.22  Aligned_cols=147  Identities=27%  Similarity=0.402  Sum_probs=130.3

Q ss_pred             HHHHhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeee
Q 023282          127 LQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  205 (284)
Q Consensus       127 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~  205 (284)
                      ++...++|...+.||+|+||.||+|... ++..||||.++...  ....+|.+|+.++++++||||++++++|......+
T Consensus       215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  292 (495)
T 1opk_A          215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY  292 (495)
T ss_dssp             CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence            3444556777889999999999999976 47899999997542  23557999999999999999999999999999999


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +||||+++|+|.++++....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus       293 lv~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DF  362 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADF  362 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCT
T ss_pred             EEEEccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeec
Confidence            99999999999999986432  3589999999999999999999999   9999999999999999999999998

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.95  E-value=2.7e-27  Score=204.57  Aligned_cols=142  Identities=26%  Similarity=0.338  Sum_probs=126.3

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcc-----cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-----GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  205 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~  205 (284)
                      +.|...+.||+|+||.||++... ++..||+|.++......     ....+.+|+.+++.++||||+++++++......+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            34777899999999999999865 68899999986543221     2457899999999999999999999999999999


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC----Ccchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA----DQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~----~~~~~df  280 (284)
                      +||||+++|+|.+++...    ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++    .+||+||
T Consensus        91 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            999999999999999753    2589999999999999999999999   999999999999999888    7999998

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.95  E-value=1.4e-27  Score=209.48  Aligned_cols=144  Identities=16%  Similarity=0.248  Sum_probs=124.2

Q ss_pred             HhcCCCCCCeecccCceEEEEEE------eCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCC---CCCceeeeeEEee
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGR------LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV---HRNLLRLYGFCTT  200 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~---h~niv~l~g~~~~  200 (284)
                      ..++|...+.||+|+||+||+|.      ..+++.||+|+++..    ...++..|++++..++   |+||+++++++..
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            34567888999999999999994      446889999998643    3446778888887777   9999999999999


Q ss_pred             CCeeeEEEeCCCCCChHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC--------
Q 023282          201 VTEKLLVYPYMTNGSVASRLRERQS-SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE--------  271 (284)
Q Consensus       201 ~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~--------  271 (284)
                      .+..++||||+++|+|.+++..... ....++|..+..++.|++.||+|||+.   +|+||||||+|||++.        
T Consensus       139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~  215 (365)
T 3e7e_A          139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDE  215 (365)
T ss_dssp             SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC---
T ss_pred             CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccc
Confidence            9999999999999999999975322 234689999999999999999999998   9999999999999999        


Q ss_pred             ---CCCcchhhh
Q 023282          272 ---DADQSSKTI  280 (284)
Q Consensus       272 ---~~~~~~~df  280 (284)
                         ++.+||+||
T Consensus       216 ~~~~~~~kl~DF  227 (365)
T 3e7e_A          216 DDLSAGLALIDL  227 (365)
T ss_dssp             ---CTTEEECCC
T ss_pred             ccccCCEEEeeC
Confidence               899999998

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.95  E-value=2e-27  Score=202.75  Aligned_cols=142  Identities=27%  Similarity=0.451  Sum_probs=122.9

Q ss_pred             CCCCCCeecccCceEEEEEEe-----CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeC--Ceee
Q 023282          133 GFSNKNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKL  205 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~--~~~~  205 (284)
                      .|+..+.||+|+||.||++++     .+++.||+|.++..........+.+|+.+++.++||||+++++++...  ...+
T Consensus        22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  101 (302)
T 4e5w_A           22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK  101 (302)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred             hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence            466678999999999999983     367899999997655445556799999999999999999999999876  5689


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +||||+++|+|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus       102 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Df  170 (302)
T 4e5w_A          102 LIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDF  170 (302)
T ss_dssp             EEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCC
T ss_pred             EEEEeCCCCcHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcc
Confidence            99999999999999966432   489999999999999999999999   9999999999999999999999998

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.95  E-value=1.9e-27  Score=206.12  Aligned_cols=148  Identities=28%  Similarity=0.457  Sum_probs=127.8

Q ss_pred             HhcCCCCCCeecccCceEEEEEEeC--------CCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEee
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRLA--------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  200 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~  200 (284)
                      ..++|...+.||+|+||.||+|+..        ++..||+|.++..........+.+|+.+++.+ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3466788899999999999999863        46789999997554434445789999999999 89999999999999


Q ss_pred             CCeeeEEEeCCCCCChHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCee
Q 023282          201 VTEKLLVYPYMTNGSVASRLRERQSS------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL  268 (284)
Q Consensus       201 ~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiL  268 (284)
                      .+..++||||+++|+|.+++......            ...+++..+..++.|++.||.|||+.   +|+||||||+|||
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence            99999999999999999999864321            12489999999999999999999999   9999999999999


Q ss_pred             eCCCCCcchhhh
Q 023282          269 LDEDADQSSKTI  280 (284)
Q Consensus       269 ld~~~~~~~~df  280 (284)
                      ++.++.+||+||
T Consensus       190 l~~~~~~kL~Df  201 (334)
T 2pvf_A          190 VTENNVMKIADF  201 (334)
T ss_dssp             ECTTCCEEECCC
T ss_pred             EcCCCCEEEccc
Confidence            999999999998

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.95  E-value=1.7e-27  Score=207.92  Aligned_cols=145  Identities=24%  Similarity=0.330  Sum_probs=127.7

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCCee
Q 023282          129 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEK  204 (284)
Q Consensus       129 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~  204 (284)
                      ...++|...+.||+|+||.||+++.. +++.||+|+++....  ......+..|..++..+ +||||+++++++...+..
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            34567888999999999999999975 578999999975431  23344688999999887 799999999999999999


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++||||+++|+|.+++....    .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        97 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DF  165 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADF  165 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeC
Confidence            99999999999999998643    489999999999999999999999   9999999999999999999999998

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.95  E-value=1.2e-27  Score=204.05  Aligned_cols=142  Identities=25%  Similarity=0.364  Sum_probs=120.1

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcc-------------------------cHHHHHHHHHHHh
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-------------------------GELQFQTEVKIIS  184 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-------------------------~~~~~~~e~~~l~  184 (284)
                      .++|...+.||+|+||.||+|+.. +++.||||++.......                         ....+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            356888899999999999999864 68899999986442111                         1235889999999


Q ss_pred             cCCCCCceeeeeEEee--CCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCC
Q 023282          185 MAVHRNLLRLYGFCTT--VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV  262 (284)
Q Consensus       185 ~~~h~niv~l~g~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdl  262 (284)
                      .++||||+++++++..  ....++||||+++++|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl  163 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI  163 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence            9999999999999986  5678999999999999876542     2589999999999999999999999   9999999


Q ss_pred             CCCCeeeCCCCCcchhhh
Q 023282          263 KAANILLDEDADQSSKTI  280 (284)
Q Consensus       263 k~~NiLld~~~~~~~~df  280 (284)
                      ||+|||++.++.+||+||
T Consensus       164 kp~Nil~~~~~~~kl~Df  181 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADF  181 (298)
T ss_dssp             CGGGEEECTTSCEEECCC
T ss_pred             CHHHEEECCCCCEEEecC
Confidence            999999999999999998

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.95  E-value=9e-28  Score=216.15  Aligned_cols=144  Identities=25%  Similarity=0.334  Sum_probs=120.1

Q ss_pred             HhcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc--CcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeE
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~l  206 (284)
                      ..++|...+.||+|+||.||++.. .+++.||||+++...  .......+.+|+.+++.++||||+++++++...+..++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            345688889999999999999985 478899999997542  22233467889999999999999999999999999999


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||||+++|+|.+++....    .+++..+..++.|++.||+|||+ .   +|+||||||+|||++.++.+||+||
T Consensus       226 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DF  293 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDF  293 (446)
T ss_dssp             EECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCC
T ss_pred             EEeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccC
Confidence            999999999999997643    48999999999999999999998 7   8999999999999999999999998

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.95  E-value=2.3e-27  Score=198.95  Aligned_cols=145  Identities=26%  Similarity=0.393  Sum_probs=125.5

Q ss_pred             cCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeC--CeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~--~~~~lv~  208 (284)
                      ++|...+.||+|+||.||+|+.. +..+|+|.++..... .....+.+|+.+++.++||||+++++++...  ...++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            46777899999999999999985 888999999754322 2334699999999999999999999999887  6789999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++.....  ..+++..+..++.|++.||.|||+. .++++||||||+|||++.++.++++||
T Consensus        89 e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~  157 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMA  157 (271)
T ss_dssp             ECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred             cccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEec
Confidence            99999999999986432  2589999999999999999999998 122999999999999999999998876

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.95  E-value=2.8e-27  Score=200.06  Aligned_cols=140  Identities=26%  Similarity=0.416  Sum_probs=119.7

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCCeeeEE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~~lv  207 (284)
                      .++|...+.||+|+||.||+|... +++.||+|.++..... ....++.+|+..+..+ +||||+++++++...+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            356788899999999999999965 7899999999754332 2345688999999888 899999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  273 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~  273 (284)
                      |||+++|+|.+++.........+++..+..++.|++.||.|||+.   +|+||||||+|||++.++
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~  152 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTS  152 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCC
Confidence            999999999999986432223589999999999999999999999   999999999999999544

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.95  E-value=3e-27  Score=200.67  Aligned_cols=140  Identities=10%  Similarity=-0.016  Sum_probs=122.5

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCccc--HHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|...+.||+|+||.||+|+.. +++.||+|.+........  ...+.+|+..+..++||||+++++++...+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            45777899999999999999975 588999999975543322  256899999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++++|.+++...      ....+...++.|++.||.|||+.   +|+||||||+|||++.++.++|+++
T Consensus       111 e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~  173 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYP  173 (286)
T ss_dssp             ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSC
T ss_pred             EecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEec
Confidence            999999999999542      24557889999999999999999   9999999999999999999998754

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.95  E-value=5.9e-28  Score=206.99  Aligned_cols=148  Identities=29%  Similarity=0.401  Sum_probs=129.2

Q ss_pred             HhcCCCCCCeecccCceEEEEEEe------CCCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCC
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVT  202 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~  202 (284)
                      ..++|...+.||+|+||.||+|+.      .++..||+|.++..........+.+|+.+++.+ +||||+++++++...+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            345677889999999999999974      246789999997554334445799999999999 8999999999999999


Q ss_pred             eeeEEEeCCCCCChHHHHhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCee
Q 023282          203 EKLLVYPYMTNGSVASRLRERQSS--------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL  268 (284)
Q Consensus       203 ~~~lv~e~~~~g~L~~~l~~~~~~--------------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiL  268 (284)
                      ..++||||+++|+|.+++......              ...+++..+..++.|++.||.|||+.   +++||||||+||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEE
Confidence            999999999999999999865321              22489999999999999999999999   9999999999999


Q ss_pred             eCCCCCcchhhh
Q 023282          269 LDEDADQSSKTI  280 (284)
Q Consensus       269 ld~~~~~~~~df  280 (284)
                      ++.++.++|+||
T Consensus       178 ~~~~~~~kl~Df  189 (313)
T 1t46_A          178 LTHGRITKICDF  189 (313)
T ss_dssp             EETTTEEEECCC
T ss_pred             EcCCCCEEEccc
Confidence            999999999998

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.94  E-value=3.6e-27  Score=206.71  Aligned_cols=143  Identities=22%  Similarity=0.320  Sum_probs=126.4

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      .++|...+.||+|+||.||++... ++..||+|.+...... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            456888899999999999999864 6889999999754332 23346889999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC---Ccchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~---~~~~~df  280 (284)
                      ||+++|+|.+++....    .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++   .+||+||
T Consensus       108 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Df  175 (362)
T 2bdw_A          108 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADF  175 (362)
T ss_dssp             CCCCSCBHHHHHTTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeec
Confidence            9999999999997542    489999999999999999999999   999999999999998765   4999998

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.94  E-value=4.2e-27  Score=200.03  Aligned_cols=142  Identities=20%  Similarity=0.407  Sum_probs=124.4

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCccc-HHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      ++|...+.||+|+||+||+|+.. +++.||+|+++....... ...+.+|+.+++.++||||+++++++......++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46777899999999999999864 688999999975543332 3568899999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++ ++.+.+....   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        82 ~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Df  145 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANF  145 (292)
T ss_dssp             CCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence            9985 6666665432   2589999999999999999999999   9999999999999999999999998

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.94  E-value=7.7e-28  Score=207.23  Aligned_cols=153  Identities=27%  Similarity=0.435  Sum_probs=132.1

Q ss_pred             HHHHHHhcCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEE
Q 023282          125 RELQVATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC  198 (284)
Q Consensus       125 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~  198 (284)
                      ++++...++|...+.||+|+||.||+|...      ++..||+|.+...........+.+|+.+++.++||||+++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            444555677888999999999999999753      36789999997554434445689999999999999999999999


Q ss_pred             eeCCeeeEEEeCCCCCChHHHHhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCC
Q 023282          199 TTVTEKLLVYPYMTNGSVASRLRERQ------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED  272 (284)
Q Consensus       199 ~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~  272 (284)
                      ...+..++||||+++|+|.+++....      .....+++..+..++.|++.||.|||+.   +|+||||||+|||++.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED  174 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCC
Confidence            99999999999999999999997532      1123578999999999999999999999   99999999999999999


Q ss_pred             CCcchhhh
Q 023282          273 ADQSSKTI  280 (284)
Q Consensus       273 ~~~~~~df  280 (284)
                      +.++|+||
T Consensus       175 ~~~kl~Df  182 (322)
T 1p4o_A          175 FTVKIGDF  182 (322)
T ss_dssp             CCEEECCT
T ss_pred             CeEEECcC
Confidence            99999998

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.94  E-value=1.2e-27  Score=206.34  Aligned_cols=142  Identities=30%  Similarity=0.438  Sum_probs=122.8

Q ss_pred             hcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC----eeeE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT----EKLL  206 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~----~~~l  206 (284)
                      .++|...+.||+|+||.||+|+.. ++.||||+++...  .....+..|+.+++.++||||+++++++....    ..++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            356778899999999999999875 7899999986432  22335667899999999999999999998754    3699


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-------CCCeeeeCCCCCCeeeCCCCCcchhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC-------DPKIIHRDVKAANILLDEDADQSSKT  279 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~-------~~~ivHrdlk~~NiLld~~~~~~~~d  279 (284)
                      ||||+++|+|.++++..     .++|..+..++.|++.||+|||+.+       .++|+||||||+|||++.++.+||+|
T Consensus       100 v~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D  174 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD  174 (322)
T ss_dssp             EEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred             EEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence            99999999999999764     3899999999999999999999862       34899999999999999999999999


Q ss_pred             h
Q 023282          280 I  280 (284)
Q Consensus       280 f  280 (284)
                      |
T Consensus       175 F  175 (322)
T 3soc_A          175 F  175 (322)
T ss_dssp             C
T ss_pred             C
Confidence            8

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.94  E-value=1.5e-27  Score=206.26  Aligned_cols=142  Identities=26%  Similarity=0.480  Sum_probs=119.1

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCc----EEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~l  206 (284)
                      ++|+..+.||+|+||+||+|+.. +++    .||+|.++..........+.+|+.++++++||||++++++|... ..++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence            45777899999999999999853 444    36888886554445556799999999999999999999999875 4789


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++||+++|+|.+++.....   .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        94 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Df  161 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDF  161 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTT---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCT
T ss_pred             EEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccC
Confidence            9999999999999987432   489999999999999999999999   9999999999999999999999998

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.94  E-value=2.4e-27  Score=205.70  Aligned_cols=141  Identities=25%  Similarity=0.434  Sum_probs=125.8

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|...+.||+|+||.||+|.. .+++.||+|++.....  ......+.+|+.+++.++||||+++++++......++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5677889999999999999996 5789999999864321  222346899999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+ +|+|.+++....    .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        89 E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DF  152 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADF  152 (336)
T ss_dssp             CCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCS
T ss_pred             ECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEe
Confidence            999 689999987653    489999999999999999999999   9999999999999999999999998

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.94  E-value=9e-28  Score=204.40  Aligned_cols=142  Identities=26%  Similarity=0.462  Sum_probs=124.0

Q ss_pred             cCCCCCCeecccCceEEEEEEe-----CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeC--Cee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEK  204 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~--~~~  204 (284)
                      ++|+..+.||+|+||.||++++     .+++.||||++... .......+.+|+++++.++||||+++++++...  ...
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            4577789999999999999984     25789999998643 223335789999999999999999999998653  458


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++||||+++|+|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Df  158 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDF  158 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGG---GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCC
T ss_pred             EEEEEeCCCCCHHHHHHhccc---ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccC
Confidence            999999999999999986432   489999999999999999999999   9999999999999999999999998

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.94  E-value=1.3e-27  Score=215.39  Aligned_cols=146  Identities=27%  Similarity=0.434  Sum_probs=128.5

Q ss_pred             HHHHhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeE
Q 023282          127 LQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       127 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~l  206 (284)
                      ++...++|...+.||+|+||.||+|...++..||||.++...  ....+|.+|+.++++++||||+++++++.. +..++
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i  255 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  255 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence            344556677888999999999999999888889999997543  234579999999999999999999999876 67899


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||||+++|+|.++++....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus       256 v~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~Df  324 (452)
T 1fmk_A          256 VTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF  324 (452)
T ss_dssp             EECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             EehhhcCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCC
Confidence            9999999999999975321  2488999999999999999999999   9999999999999999999999998

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.94  E-value=1.7e-27  Score=199.51  Aligned_cols=141  Identities=28%  Similarity=0.440  Sum_probs=127.8

Q ss_pred             cCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      ++|...+.||+|+||.||++...++..||+|.++....  ....+.+|+++++.++||||+++++++...+..+++|||+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            46777899999999999999988888999999975432  3457899999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++++|.+++.....   .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++++||
T Consensus        86 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~df  148 (267)
T 3t9t_A           86 EHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDF  148 (267)
T ss_dssp             TTCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCT
T ss_pred             CCCcHHHHHhhCcc---cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccc
Confidence            99999999986432   478999999999999999999999   9999999999999999999999998

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.94  E-value=1.2e-27  Score=205.44  Aligned_cols=142  Identities=25%  Similarity=0.370  Sum_probs=125.1

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCccc--HHHHHHHHHHHhcCCCCCceeeeeEEeeCCe----e
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTTVTE----K  204 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~----~  204 (284)
                      ++|...+.||+|+||.||+++. .+++.||+|+++.......  ...+.+|+.+++.++||||+++++++.....    .
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   91 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   91 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence            5678889999999999999995 5788999999975433322  2468899999999999999999999876543    3


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++||||+++|+|.++++...    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        92 ~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df  160 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF  160 (311)
T ss_dssp             EEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCC
T ss_pred             EEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeec
Confidence            99999999999999998643    489999999999999999999999   9999999999999999999999998

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.94  E-value=4.2e-27  Score=206.20  Aligned_cols=141  Identities=24%  Similarity=0.286  Sum_probs=126.2

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      .++|...+.||+|+||+||+++.. +++.||+|++.....  ....+.+|+.+++.++||||+++++++......++|||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            356788899999999999999965 788999999965432  23468899999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCC--cchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD--QSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~--~~~~df  280 (284)
                      |+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.  +||+||
T Consensus        97 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Df  162 (361)
T 3uc3_A           97 YASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDF  162 (361)
T ss_dssp             CCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCC
T ss_pred             eCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeec
Confidence            999999999997643    489999999999999999999999   9999999999999998776  999998

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.94  E-value=3.3e-27  Score=216.25  Aligned_cols=146  Identities=31%  Similarity=0.443  Sum_probs=130.0

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|...++||+|+||.||+++.. +|+.||+|++.....  ......+..|+.+++.++||||+++++++......++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            56778889999999999999975 689999999965432  223456889999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++.........+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DF  333 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDL  333 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeec
Confidence            99999999999987544344689999999999999999999999   9999999999999999999999998

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.94  E-value=4e-27  Score=203.40  Aligned_cols=146  Identities=29%  Similarity=0.502  Sum_probs=125.1

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcE--EEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCCeeeEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKL--VAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~~lv  207 (284)
                      ++|...+.||+|+||.||+|+.. ++..  +|+|.++..........+.+|+++++++ +||||+++++++...+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            46777899999999999999854 5554  4999987544444455789999999999 899999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCc
Q 023282          208 YPYMTNGSVASRLRERQ------------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  275 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~  275 (284)
                      |||+++|+|.+++....            .....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence            99999999999997643            2234689999999999999999999999   99999999999999999999


Q ss_pred             chhhh
Q 023282          276 SSKTI  280 (284)
Q Consensus       276 ~~~df  280 (284)
                      +|+||
T Consensus       182 kL~Df  186 (327)
T 1fvr_A          182 KIADF  186 (327)
T ss_dssp             EECCT
T ss_pred             EEccc
Confidence            99998

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.94  E-value=1.2e-27  Score=206.18  Aligned_cols=150  Identities=26%  Similarity=0.401  Sum_probs=119.8

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEeCC-C---cEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC
Q 023282          128 QVATDGFSNKNILGRGGFGKVYKGRLAD-G---KLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT  202 (284)
Q Consensus       128 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~  202 (284)
                      ....++|...+.||+|+||.||+|+... +   ..||||.++..... .....+.+|+++++.++||||+++++++....
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            3445678889999999999999998643 3   27999999754322 33457999999999999999999999998766


Q ss_pred             ee------eEEEeCCCCCChHHHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCC
Q 023282          203 EK------LLVYPYMTNGSVASRLRERQ--SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  274 (284)
Q Consensus       203 ~~------~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~  274 (284)
                      ..      +++|||+++|+|.+++....  .....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCC
Confidence            54      99999999999999997543  2223589999999999999999999999   9999999999999999999


Q ss_pred             cchhhh
Q 023282          275 QSSKTI  280 (284)
Q Consensus       275 ~~~~df  280 (284)
                      ++|+||
T Consensus       176 ~kl~Df  181 (323)
T 3qup_A          176 VCVADF  181 (323)
T ss_dssp             EEECCC
T ss_pred             EEEeec
Confidence            999998

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.94  E-value=2.1e-27  Score=200.81  Aligned_cols=143  Identities=23%  Similarity=0.324  Sum_probs=123.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEeCC----CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~l  206 (284)
                      .++|...+.||+|+||.||+|....    +..||+|.++..........+.+|+.+++.++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4567778999999999999998642    45799999865433333457899999999999999999999984 567899


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||||+++|+|.+++....   ..+++..+..++.|++.||.|||+.   +++||||||+|||++.++.++|+||
T Consensus        93 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df  160 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDF  160 (281)
T ss_dssp             EEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-
T ss_pred             EEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcc
Confidence            999999999999998643   2489999999999999999999999   9999999999999999999999998

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.94  E-value=3.6e-28  Score=210.32  Aligned_cols=151  Identities=27%  Similarity=0.378  Sum_probs=130.0

Q ss_pred             HHHHhcCCCCCCeecccCceEEEEEEeC-CC-----cEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEe
Q 023282          127 LQVATDGFSNKNILGRGGFGKVYKGRLA-DG-----KLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCT  199 (284)
Q Consensus       127 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~  199 (284)
                      ++...++|...+.||+|+||.||+|... .+     ..||+|.++..........+.+|+.+++.+ +||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            4455677888999999999999999864 22     479999997654434455799999999999 8999999999999


Q ss_pred             eCCeeeEEEeCCCCCChHHHHhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeee
Q 023282          200 TVTEKLLVYPYMTNGSVASRLRERQS----------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL  269 (284)
Q Consensus       200 ~~~~~~lv~e~~~~g~L~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLl  269 (284)
                      ..+..++||||+++|+|.+++.....          ....+++..+..++.|++.||.|||+.   +|+||||||+|||+
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLL  197 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEE
Confidence            99999999999999999999975321          123578999999999999999999999   99999999999999


Q ss_pred             CCCCCcchhhh
Q 023282          270 DEDADQSSKTI  280 (284)
Q Consensus       270 d~~~~~~~~df  280 (284)
                      +.++.++|+||
T Consensus       198 ~~~~~~kl~Df  208 (333)
T 2i1m_A          198 TNGHVAKIGDF  208 (333)
T ss_dssp             EGGGEEEBCCC
T ss_pred             CCCCeEEECcc
Confidence            99999999998

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.94  E-value=4.5e-27  Score=216.13  Aligned_cols=145  Identities=27%  Similarity=0.371  Sum_probs=128.6

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--CcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      .++|...++||+|+||.||+++.. +|+.||+|++....  .......+.+|+.+++.++||||+++++++...+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            456888899999999999999864 78999999996432  123344688999999999999999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||+++|+|.+++....  ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       263 mEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DF  330 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDL  330 (576)
T ss_dssp             ECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             EEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEec
Confidence            99999999999997643  22489999999999999999999999   9999999999999999999999998

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.94  E-value=5.9e-27  Score=199.67  Aligned_cols=137  Identities=28%  Similarity=0.422  Sum_probs=117.9

Q ss_pred             hcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhc--CCCCCceeeeeEEeeC----Cee
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM--AVHRNLLRLYGFCTTV----TEK  204 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--~~h~niv~l~g~~~~~----~~~  204 (284)
                      .++|...+.||+|+||+||+|+. +++.||||++...    ....+..|.+++..  ++||||+++++++...    ...
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            35688889999999999999988 6889999998542    23345566666655  8999999999987643    457


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeeeeCCCCCCeeeCCCCCcc
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH--------EHCDPKIIHRDVKAANILLDEDADQS  276 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH--------~~~~~~ivHrdlk~~NiLld~~~~~~  276 (284)
                      ++||||+++|+|.++++..     .+++..+..++.|++.||+|||        +.   +|+||||||+|||++.++.+|
T Consensus        82 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             EEEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEE
T ss_pred             EEehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEE
Confidence            8999999999999999643     4899999999999999999999        66   999999999999999999999


Q ss_pred             hhhh
Q 023282          277 SKTI  280 (284)
Q Consensus       277 ~~df  280 (284)
                      |+||
T Consensus       154 l~Df  157 (301)
T 3q4u_A          154 IADL  157 (301)
T ss_dssp             ECCC
T ss_pred             EeeC
Confidence            9998

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=3.5e-27  Score=204.48  Aligned_cols=143  Identities=29%  Similarity=0.475  Sum_probs=125.6

Q ss_pred             cCCCCCCeecccCceEEEEEEeCC-----CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLAD-----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~l  206 (284)
                      ++|...+.||+|+||.||+|....     +..||+|.++..........+.+|+.+++.++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            345667899999999999998532     236999999755443444578999999999999999999999999999999


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||||+++|+|.+++....   ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus       124 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Df  191 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDF  191 (333)
T ss_dssp             EEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             EEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCC
Confidence            999999999999997643   2589999999999999999999999   9999999999999999999999998

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.94  E-value=4.2e-27  Score=202.02  Aligned_cols=142  Identities=24%  Similarity=0.225  Sum_probs=121.2

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhc-CCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISM-AVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~-~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|...+.||+|+||+||+|+.. +++.||||++...... .....+..|+..+.. .+||||+++++++...+..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            46888899999999999999975 7899999988643322 222345556655544 48999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+ +++|.+++.....   .++|..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus       137 e~~-~~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DF  201 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGA---SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDF  201 (311)
T ss_dssp             ECC-CCBHHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCC
T ss_pred             ecc-CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccc
Confidence            999 6799999876532   589999999999999999999999   9999999999999999999999998

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.94  E-value=4e-27  Score=212.98  Aligned_cols=142  Identities=25%  Similarity=0.447  Sum_probs=127.4

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|...+.||+|+||.||+|+.. +|+.||||++.....  .+....+.+|+.+++.++||||+++++++...+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            46777899999999999999965 789999999964422  223446899999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        96 E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DF  160 (476)
T 2y94_A           96 EYVSGGELFDYICKNG----RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF  160 (476)
T ss_dssp             ECCSSEEHHHHTTSSS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEec
Confidence            9999999999997532    489999999999999999999999   9999999999999999999999998

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.94  E-value=1.9e-27  Score=218.55  Aligned_cols=144  Identities=27%  Similarity=0.438  Sum_probs=126.5

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          129 VATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       129 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ...++|...+.||+|+||.||+|.+.++..||||+++...  ...++|.+|+++|++++||||+++++++.. ...++||
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~  340 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT  340 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence            3444566678899999999999999888889999997543  234579999999999999999999999876 6789999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.++++....  ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus       341 e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DF  407 (535)
T 2h8h_A          341 EYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF  407 (535)
T ss_dssp             CCCTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCT
T ss_pred             ehhcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccc
Confidence            99999999999975321  2488999999999999999999999   9999999999999999999999998

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.94  E-value=4.5e-27  Score=208.50  Aligned_cols=145  Identities=23%  Similarity=0.329  Sum_probs=127.0

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC--eeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT--EKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~--~~~lv~  208 (284)
                      ++|...+.||+|+||.||+|+.. +++.||||+++..........+.+|+++++.++||||+++++++....  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            45777899999999999999965 589999999976554455567889999999999999999999998755  679999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeee----CCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL----DEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLl----d~~~~~~~~df  280 (284)
                      ||+++|+|.+++..... ...+++..+..++.|++.||+|||+.   +|+||||||+|||+    +.++.+||+||
T Consensus        89 e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DF  160 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDF  160 (396)
T ss_dssp             CCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred             ecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecC
Confidence            99999999999976432 22489999999999999999999999   99999999999999    77888999998

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.94  E-value=2.9e-27  Score=207.88  Aligned_cols=142  Identities=27%  Similarity=0.360  Sum_probs=118.3

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc--ccHHHHHHHHHH-HhcCCCCCceeeeeEEeeCCeeeEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKI-ISMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~-l~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      ++|+..+.||+|+||.||+++.. +++.||+|+++.....  .....+..|..+ ++.++||||+++++++...+..++|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            45777899999999999999965 6889999999755432  223356677776 5788999999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||+++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus       118 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DF  183 (373)
T 2r5t_A          118 LDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDF  183 (373)
T ss_dssp             EECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeC
Confidence            99999999999998643    478899999999999999999999   9999999999999999999999998

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.94  E-value=4.8e-27  Score=198.32  Aligned_cols=143  Identities=32%  Similarity=0.488  Sum_probs=127.1

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      .++|...+.||+|+||.||++... ++..||+|++.....  ......+.+|+.+++.++||||+++++++......++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            456788899999999999999865 677999999864321  12245688999999999999999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||+++|+|.+++....    .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus        88 ~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Df  153 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADF  153 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSC
T ss_pred             EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEec
Confidence            99999999999997653    488999999999999999999998   9999999999999999999999998

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.94  E-value=1.1e-26  Score=199.95  Aligned_cols=139  Identities=29%  Similarity=0.445  Sum_probs=123.4

Q ss_pred             CCCCCeecccCceEEEEEEeC-----CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeC--CeeeE
Q 023282          134 FSNKNILGRGGFGKVYKGRLA-----DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV--TEKLL  206 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~--~~~~l  206 (284)
                      |...+.||+|+||+||++.+.     +++.||||+++..........+.+|+++++.++||||+++++++...  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            367789999999999988642     57889999997654334455799999999999999999999999874  57899


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||||+++|+|.+++...     .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus       113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Df  178 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDF  178 (318)
T ss_dssp             EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCG
T ss_pred             EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCc
Confidence            99999999999999764     389999999999999999999999   9999999999999999999999998

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.94  E-value=5.5e-27  Score=201.47  Aligned_cols=146  Identities=26%  Similarity=0.381  Sum_probs=125.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEee----CCeee
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT----VTEKL  205 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~----~~~~~  205 (284)
                      .++|...+.||+|+||.||+++. .+++.||+|.+... .......+.+|+.+++.++||||+++++++..    ....+
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            35678889999999999999986 57899999998643 22334568999999999999999999999873    34788


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +||||+++|+|.+++.........+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~df  178 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDL  178 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEec
Confidence            99999999999999986433345689999999999999999999999   9999999999999999999999998

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.94  E-value=5.6e-27  Score=197.38  Aligned_cols=142  Identities=25%  Similarity=0.390  Sum_probs=128.4

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ++|+..+.||+|+||.||+|... +++.||+|.+...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            46778899999999999999865 78899999997554444456789999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++++|.+++...    ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++++||
T Consensus        87 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  149 (276)
T 2yex_A           87 CSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDF  149 (276)
T ss_dssp             CTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeC
Confidence            9999999998653    2489999999999999999999999   9999999999999999999999998

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.94  E-value=6.1e-27  Score=210.28  Aligned_cols=143  Identities=19%  Similarity=0.281  Sum_probs=124.9

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      .++|...+.||+|+||.||++.. .+++.+|+|.+...... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            45688889999999999999985 47889999998754332 23346899999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeC---CCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD---EDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld---~~~~~~~~df  280 (284)
                      ||+++|+|.+.+....    .+++..+..++.|++.||.|||+.   +|+||||||+|||++   .++.+||+||
T Consensus        90 E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DF  157 (444)
T 3soa_A           90 DLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADF  157 (444)
T ss_dssp             CCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCC
T ss_pred             EeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccC
Confidence            9999999999998653    489999999999999999999999   999999999999999   4578999998

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=2.9e-27  Score=208.07  Aligned_cols=141  Identities=33%  Similarity=0.503  Sum_probs=121.7

Q ss_pred             CCCCCeecccCceEEEEEEeC--CC--cEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEee-CCeeeEEE
Q 023282          134 FSNKNILGRGGFGKVYKGRLA--DG--KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTEKLLVY  208 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~-~~~~~lv~  208 (284)
                      |...+.||+|+||.||+|...  ++  ..||+|.++..........+.+|+.++++++||||+++++++.. .+..++||
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~  170 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  170 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence            455688999999999999853  22  36899998654444445679999999999999999999999765 45789999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.++++...   ..+++..+..++.|+++||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       171 e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DF  236 (373)
T 3c1x_A          171 PYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADF  236 (373)
T ss_dssp             ECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             ECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeec
Confidence            9999999999997543   2478999999999999999999999   9999999999999999999999998

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.94  E-value=2.4e-26  Score=197.42  Aligned_cols=141  Identities=25%  Similarity=0.349  Sum_probs=123.9

Q ss_pred             cCCCC-CCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhc-CCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSN-KNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISM-AVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~-~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      +.|.. .+.||+|+||.||++.. .+++.||||++.... ......+.+|++++.+ .+||||+++++++...+..++||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            34555 37899999999999985 478999999996543 3345578899999988 57999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCC---cchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD---QSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~---~~~~df  280 (284)
                      ||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.   +||+||
T Consensus        91 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Df  158 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDF  158 (316)
T ss_dssp             ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCT
T ss_pred             EcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEc
Confidence            9999999999998653    488999999999999999999999   9999999999999998876   899998

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.94  E-value=1.4e-27  Score=204.95  Aligned_cols=156  Identities=28%  Similarity=0.408  Sum_probs=132.8

Q ss_pred             ccHHHHHHHhcCCCCCCeecccCceEEEEEEe------CCCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceee
Q 023282          122 FSLRELQVATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRL  194 (284)
Q Consensus       122 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l  194 (284)
                      +...++....++|...+.||+|+||.||+|+.      .+++.||+|.++..........+.+|+.++..+ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            44556666778899999999999999999974      346789999997654444445789999999999 69999999


Q ss_pred             eeEEeeCC-eeeEEEeCCCCCChHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeC
Q 023282          195 YGFCTTVT-EKLLVYPYMTNGSVASRLRERQSS------------LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRD  261 (284)
Q Consensus       195 ~g~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrd  261 (284)
                      ++++...+ ..+++|||+++|+|.+++......            ...+++..+..++.|++.||.|||+.   +|+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence            99988755 489999999999999999865321            12378999999999999999999999   999999


Q ss_pred             CCCCCeeeCCCCCcchhhh
Q 023282          262 VKAANILLDEDADQSSKTI  280 (284)
Q Consensus       262 lk~~NiLld~~~~~~~~df  280 (284)
                      |||+||+++.++.++|+||
T Consensus       174 ikp~Nil~~~~~~~kl~Df  192 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDF  192 (316)
T ss_dssp             CSGGGEEECGGGCEEECCC
T ss_pred             CccceEEECCCCCEEECCC
Confidence            9999999999999999998

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.94  E-value=1e-26  Score=205.36  Aligned_cols=142  Identities=20%  Similarity=0.327  Sum_probs=125.3

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +.|...+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            56888899999999999999864 68899999986432 22334688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC--CCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE--DADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~--~~~~~~~df  280 (284)
                      +++|+|.+++....   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.  ++.+||+||
T Consensus       130 ~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DF  195 (387)
T 1kob_A          130 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDF  195 (387)
T ss_dssp             CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCC
T ss_pred             CCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEec
Confidence            99999999997532   2489999999999999999999999   9999999999999985  467999998

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.94  E-value=7.6e-27  Score=196.92  Aligned_cols=143  Identities=29%  Similarity=0.477  Sum_probs=127.5

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|...+.||+|+||.||+|+. .+++.||+|.+.....  ......+.+|+.+++.++||||+++++++...+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            4677889999999999999986 5789999999964322  122356899999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++++|.+++....   ..+++..+..++.|+++||.|||+.   +++||||||+||+++.++.++|+||
T Consensus        91 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~df  156 (278)
T 3cok_A           91 EMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADF  156 (278)
T ss_dssp             ECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCC
T ss_pred             ecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEee
Confidence            9999999999998642   3589999999999999999999999   9999999999999999999999998

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.94  E-value=4.9e-27  Score=199.08  Aligned_cols=142  Identities=26%  Similarity=0.398  Sum_probs=124.1

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CC-------cEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCe
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DG-------KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  203 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~  203 (284)
                      ++|...+.||+|+||.||+|... ++       ..||+|.+.... ......+.+|+.+++.++||||+++++++...+.
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            45777899999999999999854 33       479999986432 2344579999999999999999999999999999


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCC--------c
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD--------Q  275 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~--------~  275 (284)
                      .++||||+++|+|.+++.....   .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.        +
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             CEEEEECCCCCCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999986432   378999999999999999999999   9999999999999999987        8


Q ss_pred             chhhh
Q 023282          276 SSKTI  280 (284)
Q Consensus       276 ~~~df  280 (284)
                      +++||
T Consensus       161 kl~Df  165 (289)
T 4fvq_A          161 KLSDP  165 (289)
T ss_dssp             EECCC
T ss_pred             eeccC
Confidence            88887

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.94  E-value=4.8e-27  Score=219.05  Aligned_cols=135  Identities=24%  Similarity=0.366  Sum_probs=120.9

Q ss_pred             eecccCceEEEEEEeC---CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCCC
Q 023282          139 ILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS  215 (284)
Q Consensus       139 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g~  215 (284)
                      .||+|+||.||+|...   ++..||||+++.........++.+|+++++.++||||+++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999753   4567999999765444456689999999999999999999999976 56899999999999


Q ss_pred             hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          216 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       216 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |.+++....   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus       422 L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DF  480 (613)
T 2ozo_A          422 LHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDF  480 (613)
T ss_dssp             HHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCC
T ss_pred             HHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeec
Confidence            999997542   3589999999999999999999999   9999999999999999999999998

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.94  E-value=6.8e-27  Score=203.93  Aligned_cols=140  Identities=29%  Similarity=0.372  Sum_probs=119.5

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      .+.|...+.||+|+||.||+|+.. +++.||+|+++...   ....+.+|++++++++||||+++++++......++|||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            356778899999999999999975 57899999997532   23468899999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC---CCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~---~~~~~~~df  280 (284)
                      |+++|+|.+++....    .+++..+..++.|++.||.|||+.   +|+||||||+|||++.   ++.+||+||
T Consensus       129 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Df  195 (349)
T 2w4o_A          129 LVTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADF  195 (349)
T ss_dssp             CCCSCBHHHHHTTCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             eCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccC
Confidence            999999999997542    489999999999999999999999   9999999999999976   889999998

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=3.4e-27  Score=206.31  Aligned_cols=142  Identities=27%  Similarity=0.344  Sum_probs=125.5

Q ss_pred             cCCCCCCeecccCceEEEEEEe----CCCcEEEEEEeecccC---cccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCCe
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL----ADGKLVAVKRLKEERT---SGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTE  203 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~  203 (284)
                      ++|...+.||+|+||.||+++.    .+++.||||+++....   ......+.+|++++..+ +||||+++++++.....
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            4677889999999999999986    3688999999864321   12234577899999998 69999999999999999


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .++||||+++|+|.+++....    .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df  203 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDF  203 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCS
T ss_pred             EEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeC
Confidence            999999999999999998653    488999999999999999999999   9999999999999999999999998

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.94  E-value=5.5e-27  Score=204.46  Aligned_cols=141  Identities=31%  Similarity=0.455  Sum_probs=124.2

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcc--cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          133 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG--GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      .|...+.||+|+||.||+|+. .+++.||||++.......  ....+.+|+++++.++||||+++++++...+..++|||
T Consensus        55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  134 (348)
T 1u5q_A           55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME  134 (348)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence            467778999999999999985 578899999996543222  22468899999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |++ |+|.+++....   ..+++..+..++.|+++||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       135 ~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  198 (348)
T 1u5q_A          135 YCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDF  198 (348)
T ss_dssp             CCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCC
T ss_pred             cCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeec
Confidence            997 68888886543   2589999999999999999999999   9999999999999999999999998

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.94  E-value=1.1e-26  Score=199.00  Aligned_cols=142  Identities=23%  Similarity=0.363  Sum_probs=126.0

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCccc-HHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      ++|...+.||+|+||.||+|+.. +++.||+|++........ ...+.+|+.+++.++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            56778899999999999999965 589999998865433222 3468899999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++++|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus        83 ~~~~~~l~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df  146 (311)
T 4agu_A           83 YCDHTVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDF  146 (311)
T ss_dssp             CCSEEHHHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             eCCCchHHHHHhhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeC
Confidence            999999999887542    489999999999999999999999   9999999999999999999999998

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.94  E-value=1.5e-26  Score=197.49  Aligned_cols=141  Identities=31%  Similarity=0.475  Sum_probs=128.3

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +.|...+.||+|+||.||+|.. .+++.||+|.+...........+.+|+.+++.++||||+++++++......++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            4577789999999999999985 468899999997655455556799999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++++|.+++...     .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+||
T Consensus       102 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Df  163 (303)
T 3a7i_A          102 LGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADF  163 (303)
T ss_dssp             CTTEEHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeec
Confidence            9999999999642     489999999999999999999999   9999999999999999999999998

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.94  E-value=3e-27  Score=204.11  Aligned_cols=142  Identities=25%  Similarity=0.430  Sum_probs=121.4

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcE----EEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKL----VAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~l  206 (284)
                      ++|...+.||+|+||.||+|... +++.    ||+|.+...........+.+|+.+++.++||||+++++++. ....++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            45777899999999999999854 4443    78888754433333446788999999999999999999886 467889


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||||+++|+|.+++....   ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus        92 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Df  159 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADF  159 (325)
T ss_dssp             EEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSC
T ss_pred             EEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCC
Confidence            999999999999997642   2478889999999999999999999   9999999999999999999999998

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.94  E-value=3.5e-27  Score=203.67  Aligned_cols=142  Identities=26%  Similarity=0.453  Sum_probs=122.7

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ++|...+.||+|+||.||+|+.. +++.||+|.++..........+.+|+.+++.++||||+++++++......++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            46777899999999999999965 78899999986543332223456799999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++ |+|.+++.....   .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus        82 ~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Df  144 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGN---IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADF  144 (324)
T ss_dssp             CS-EEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSS
T ss_pred             cc-cCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccC
Confidence            97 599999876432   488999999999999999999999   9999999999999999999999998

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.94  E-value=1.3e-26  Score=202.84  Aligned_cols=151  Identities=23%  Similarity=0.350  Sum_probs=131.2

Q ss_pred             cHHHHHHHhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCccc----------HHHHHHHHHHHhcCCCCCce
Q 023282          123 SLRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG----------ELQFQTEVKIISMAVHRNLL  192 (284)
Q Consensus       123 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~e~~~l~~~~h~niv  192 (284)
                      .+.++....++|...+.||+|+||.||+|...++..||||++........          ...+.+|+++++.++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            45677888899999999999999999999988899999999864332211          25689999999999999999


Q ss_pred             eeeeEEeeC-----CeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCe
Q 023282          193 RLYGFCTTV-----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANI  267 (284)
Q Consensus       193 ~l~g~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~Ni  267 (284)
                      ++++++...     ...++||||++ |+|.+++....   ..+++..+..++.|++.||.|||+.   +|+||||||+||
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI  165 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI  165 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence            999998543     35799999998 68988887532   2589999999999999999999999   999999999999


Q ss_pred             eeCCCCCcchhhh
Q 023282          268 LLDEDADQSSKTI  280 (284)
Q Consensus       268 Lld~~~~~~~~df  280 (284)
                      |++.++.++|+||
T Consensus       166 l~~~~~~~kl~Df  178 (362)
T 3pg1_A          166 LLADNNDITICDF  178 (362)
T ss_dssp             EECTTCCEEECCT
T ss_pred             EEcCCCCEEEEec
Confidence            9999999999998

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.94  E-value=6.3e-27  Score=204.79  Aligned_cols=144  Identities=26%  Similarity=0.359  Sum_probs=128.4

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      .++|...+.||+|+||.||++... ++..||+|.++..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            346888899999999999999865 6889999999765433344578999999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++|+|.+++....    .+++..+..++.|++.||.|||+.+  +|+||||||+|||++.++.++|+||
T Consensus       112 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Df  176 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDF  176 (360)
T ss_dssp             CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCC
T ss_pred             CCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEEC
Confidence            999999999998753    4789999999999999999999831  7999999999999999999999998

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.94  E-value=3e-27  Score=199.51  Aligned_cols=144  Identities=29%  Similarity=0.437  Sum_probs=126.2

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          129 VATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       129 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ...++|...+.||+|+||.||+|...++..||+|.++...  .....+.+|+++++.++||||+++++++. .+..++||
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   86 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIIT   86 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEE
Confidence            3445677889999999999999998888899999986532  23457899999999999999999999986 45689999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++++|.+++.....  ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+||
T Consensus        87 e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Df  153 (279)
T 1qpc_A           87 EYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADF  153 (279)
T ss_dssp             ECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred             ecCCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCC
Confidence            99999999999975321  1488999999999999999999999   9999999999999999999999998

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=1.1e-26  Score=197.60  Aligned_cols=141  Identities=28%  Similarity=0.402  Sum_probs=121.9

Q ss_pred             CCCCCeecccCceEEEEEEeC-CC---cEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCee-eEEE
Q 023282          134 FSNKNILGRGGFGKVYKGRLA-DG---KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK-LLVY  208 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~-~lv~  208 (284)
                      |...++||+|+||+||+|... ++   ..+|+|.+...........+.+|+.+++.++||||+++++++...+.. ++++
T Consensus        23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  102 (298)
T 3pls_A           23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL  102 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence            444588999999999999842 33   379999986544434445789999999999999999999999876655 9999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+.+|+|.+++....   ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.++|+||
T Consensus       103 e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Df  168 (298)
T 3pls_A          103 PYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADF  168 (298)
T ss_dssp             CCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCT
T ss_pred             ecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcC
Confidence            9999999999997632   3578999999999999999999999   9999999999999999999999998

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.94  E-value=9.5e-27  Score=198.26  Aligned_cols=142  Identities=33%  Similarity=0.477  Sum_probs=122.3

Q ss_pred             CCCCCCeecccCceEEEEEEeCC----CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEee-CCeeeEE
Q 023282          133 GFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTEKLLV  207 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~-~~~~~lv  207 (284)
                      .|...+.||+|+||.||+|...+    ...+|+|.++..........+.+|+.++++++||||+++++++.. .+..+++
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  105 (298)
T 3f66_A           26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  105 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence            46677899999999999998542    236899998654443444578999999999999999999999754 5578999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||+++|+|.+++....   ..+++..+..++.|++.||.|||+.   +++||||||+|||++.++.++|+||
T Consensus       106 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Df  172 (298)
T 3f66_A          106 LPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADF  172 (298)
T ss_dssp             EECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSC
T ss_pred             EeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcc
Confidence            99999999999997532   2478999999999999999999999   9999999999999999999999998

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.94  E-value=1.4e-26  Score=199.60  Aligned_cols=142  Identities=25%  Similarity=0.349  Sum_probs=126.5

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcc-----cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-----GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  205 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~  205 (284)
                      +.|...+.||+|+||.||+++.. +++.||+|.++......     ....+.+|+.+++.++||||+++++++......+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            45777899999999999999865 68899999997543322     2456899999999999999999999999999999


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC----Ccchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA----DQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~----~~~~~df  280 (284)
                      +||||+++++|.+++....    .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++    .++|+||
T Consensus        92 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEECCCCSCBHHHHHHTCS----CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            9999999999999997532    488999999999999999999999   999999999999999988    7999998

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.94  E-value=5.1e-27  Score=200.13  Aligned_cols=150  Identities=28%  Similarity=0.383  Sum_probs=114.9

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeE
Q 023282          128 QVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       128 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~l  206 (284)
                      ....++|...+.||+|+||.||++.. .+++.||+|.+..........++.+|+.+++.++||||+++++++...+..++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            44567888999999999999999985 47889999998654433344568899999999999999999999999999999


Q ss_pred             EEeCCCCCChHHHHhhc----CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRER----QSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~----~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||||+++++|.+++...    ......+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+||
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  165 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADF  165 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCC
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEec
Confidence            99999999999999742    11233589999999999999999999999   9999999999999999999999998

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.94  E-value=2.3e-26  Score=195.59  Aligned_cols=142  Identities=23%  Similarity=0.345  Sum_probs=126.5

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc--ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|...+.||+|+||.||++... +++.+|+|.+......  .....+.+|+.+++.++||||+++++++...+..+++|
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            45677899999999999999965 5789999998654322  22346889999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++++|.+++....    .+++..+..++.|+++||+|||+.   +++||||||+||+++.++.++|+||
T Consensus        95 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  159 (294)
T 2rku_A           95 ELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDF  159 (294)
T ss_dssp             ECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             ecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEec
Confidence            9999999999987643    489999999999999999999999   9999999999999999999999998

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.94  E-value=2e-26  Score=194.21  Aligned_cols=141  Identities=23%  Similarity=0.339  Sum_probs=126.5

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ++|...+.||+|+||.||+|... ++..+|+|.+..... .....+.+|+++++.++||||+++++++......++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            45777899999999999999865 577999999865433 3455789999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeee---CCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLl---d~~~~~~~~df  280 (284)
                      +++++|.+++....    .+++..+..++.|++.||.|||+.   +++||||||+|||+   +.++.++++||
T Consensus        88 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Df  153 (277)
T 3f3z_A           88 CTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDF  153 (277)
T ss_dssp             CCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEec
Confidence            99999999997643    489999999999999999999999   99999999999999   88899999998

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.94  E-value=2.6e-26  Score=194.10  Aligned_cols=142  Identities=27%  Similarity=0.370  Sum_probs=126.5

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcc-----cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-----GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  205 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~  205 (284)
                      ++|...+.||+|+||.||+++.. +++.||+|.++......     ....+.+|+.+++.++||||+++++++......+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            45777899999999999999975 68899999987543221     2457899999999999999999999999999999


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC----Ccchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA----DQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~----~~~~~df  280 (284)
                      +||||+++++|.+++....    .+++..+..++.|++.||.|||+.   +++||||||+||+++.++    .++|+||
T Consensus        85 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df  156 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF  156 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence            9999999999999997643    489999999999999999999999   999999999999999887    7999998

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.94  E-value=5.7e-27  Score=197.71  Aligned_cols=146  Identities=23%  Similarity=0.348  Sum_probs=126.2

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEee--CCeeeEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEKLLV  207 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~--~~~~~lv  207 (284)
                      ++|...+.||+|+||.||++... +++.||+|.+...... .....+.+|+.+++.++||||+++++++..  ....++|
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   85 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   85 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence            56778899999999999999865 7899999999754332 233468999999999999999999998854  5678999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-----eeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK-----IIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~-----ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||+++|+|.+++.........+++..+..++.|++.||.|||+.   +     ++||||||+||+++.++.++|+||
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~df  160 (279)
T 2w5a_A           86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDF  160 (279)
T ss_dssp             EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCC
T ss_pred             EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence            999999999999986543344589999999999999999999998   6     999999999999999999999998

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.94  E-value=7.8e-27  Score=205.35  Aligned_cols=137  Identities=25%  Similarity=0.362  Sum_probs=116.7

Q ss_pred             CCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCCCC
Q 023282          137 KNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGS  215 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~g~  215 (284)
                      .+.||+|+||.||+|.. .+++.||+|+++.... .....+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            46799999999999986 4689999999975432 334578999999999999999999999999999999999999999


Q ss_pred             hHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeee--CCCCCcchhhh
Q 023282          216 VASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL--DEDADQSSKTI  280 (284)
Q Consensus       216 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLl--d~~~~~~~~df  280 (284)
                      |.+++....   ..+++..+..++.|++.||.|||+.   +|+||||||+|||+  +.++.+||+||
T Consensus       173 L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DF  233 (373)
T 2x4f_A          173 LFDRIIDES---YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDF  233 (373)
T ss_dssp             EHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCC
T ss_pred             HHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeC
Confidence            999997542   2488999999999999999999999   99999999999999  66778999998

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.94  E-value=7.1e-27  Score=210.98  Aligned_cols=141  Identities=20%  Similarity=0.324  Sum_probs=114.2

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeC-----Cee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TEK  204 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~-----~~~  204 (284)
                      ++|...+.||+|+||+||+|+.. +++.||||++...... .....+.+|+.+++.++||||+++++++...     ...
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            56888899999999999999854 7889999998643322 2234688999999999999999999998543     468


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++||||+. |+|.+++....    .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       133 ~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DF  200 (458)
T 3rp9_A          133 YVVLEIAD-SDFKKLFRTPV----YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDF  200 (458)
T ss_dssp             EEEECCCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEeccc-cchhhhcccCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeeccc
Confidence            99999985 79999997542    489999999999999999999999   9999999999999999999999998

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=1.1e-26  Score=196.88  Aligned_cols=141  Identities=23%  Similarity=0.354  Sum_probs=122.8

Q ss_pred             CCCCCC-eecccCceEEEEEEeC---CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          133 GFSNKN-ILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       133 ~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      +|...+ .||+|+||.||+|...   ++..||+|.++..........+.+|+++++.++||||+++++++ ..+..++||
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~   88 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM   88 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred             HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence            344444 8999999999999753   57789999997654334455799999999999999999999999 556789999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++++|.+++....   ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+||
T Consensus        89 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Df  154 (287)
T 1u59_A           89 EMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDF  154 (287)
T ss_dssp             ECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCC
T ss_pred             EeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcc
Confidence            9999999999997532   3589999999999999999999999   9999999999999999999999998

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.94  E-value=2.2e-26  Score=199.54  Aligned_cols=142  Identities=23%  Similarity=0.345  Sum_probs=126.3

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc--ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|...+.||+|+||.||++... +++.+|+|.+......  .....+.+|+.+++.++||||+++++++...+..++||
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            34667789999999999999965 5789999998654322  22346889999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++++|.+++....    .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus       121 e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Df  185 (335)
T 2owb_A          121 ELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDF  185 (335)
T ss_dssp             CCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCC
T ss_pred             ecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeec
Confidence            9999999999987643    489999999999999999999999   9999999999999999999999998

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.94  E-value=3.1e-26  Score=193.72  Aligned_cols=143  Identities=22%  Similarity=0.322  Sum_probs=126.6

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      .++|...+.||+|+||.||+|... +++.||+|++...... .....+.+|+.+++.++||||+++++++...+..+++|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            467888899999999999999864 6889999999754433 22346889999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCC---cchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD---QSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~---~~~~df  280 (284)
                      ||+++++|.+.+....    .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.   ++|+||
T Consensus        85 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Df  152 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADF  152 (284)
T ss_dssp             CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCC
T ss_pred             ecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeec
Confidence            9999999999987653    489999999999999999999999   9999999999999987766   899998

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.94  E-value=1.8e-26  Score=197.66  Aligned_cols=146  Identities=20%  Similarity=0.314  Sum_probs=126.4

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc--ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|...+.||+|+||.||+|.. .++..||+|.++.....  .....+.+|+.+++.++||||+++++++...+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            4577789999999999999985 57899999998653322  22346889999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++.........+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+||
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Df  180 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDL  180 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEec
Confidence            99999999999975333334589999999999999999999999   9999999999999999999999998

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.94  E-value=2.1e-27  Score=201.26  Aligned_cols=146  Identities=28%  Similarity=0.411  Sum_probs=129.3

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeE
Q 023282          128 QVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       128 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~l  206 (284)
                      +...++|+..+.||+|+||.||+|... ++..||+|.+...  ......+.+|+.+++.++||||+++++++......++
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   86 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   86 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC--STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence            344567788899999999999999965 5889999998643  2234578999999999999999999999999999999


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||||+++++|.+++....  ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+||
T Consensus        87 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Df  155 (288)
T 3kfa_A           87 ITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADF  155 (288)
T ss_dssp             EEECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             EEEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccC
Confidence            999999999999998643  23589999999999999999999999   9999999999999999999999998

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.94  E-value=3e-28  Score=211.28  Aligned_cols=141  Identities=20%  Similarity=0.228  Sum_probs=117.1

Q ss_pred             hcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccC-------cccHHHHHHHHHHHhcCC---------CCCceee
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERT-------SGGELQFQTEVKIISMAV---------HRNLLRL  194 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~~~---------h~niv~l  194 (284)
                      .++|...+.||+|+||+||+|+. +++.||||+++....       ......+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            34577789999999999999998 689999999975432       122356888999888775         7777777


Q ss_pred             eeEEe------------------------------eCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 023282          195 YGFCT------------------------------TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR  244 (284)
Q Consensus       195 ~g~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~  244 (284)
                      .+.+.                              .....++||||+++|++.+.+..     ..+++..+..++.|++.
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence            77643                              15789999999999987777643     24789999999999999


Q ss_pred             HHHHHH-cCCCCCeeeeCCCCCCeeeCCCC--------------------Ccchhhh
Q 023282          245 GLSYLH-EHCDPKIIHRDVKAANILLDEDA--------------------DQSSKTI  280 (284)
Q Consensus       245 gl~yLH-~~~~~~ivHrdlk~~NiLld~~~--------------------~~~~~df  280 (284)
                      ||+||| +.   +|+||||||+|||++.++                    .+||+||
T Consensus       173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DF  226 (336)
T 2vuw_A          173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDY  226 (336)
T ss_dssp             HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCC
T ss_pred             HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeec
Confidence            999999 88   999999999999999987                    8999998

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.94  E-value=2.1e-26  Score=193.95  Aligned_cols=143  Identities=24%  Similarity=0.414  Sum_probs=127.9

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--CcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      .++|...+.||+|+||.||+|... +++.||+|.+....  .......+.+|+.+++.++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            356778899999999999999975 78999999986432  123345788999999999999999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||+++++|.+++....    .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++++||
T Consensus        90 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~df  155 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF  155 (276)
T ss_dssp             EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCC
T ss_pred             EeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeec
Confidence            99999999999997653    488999999999999999999999   9999999999999999999999998

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.94  E-value=5.6e-27  Score=203.39  Aligned_cols=143  Identities=26%  Similarity=0.322  Sum_probs=126.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcc-------cHHHHHHHHHHHhcCCCCCceeeeeEEeeCC
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-------GELQFQTEVKIISMAVHRNLLRLYGFCTTVT  202 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~  202 (284)
                      .++|...+.||+|+||.||+|+. .+++.||||.++......       ....+.+|+.+++.++||||+++++++...+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            45688889999999999999985 478899999997543211       2235778999999999999999999999999


Q ss_pred             eeeEEEeCCCCC-ChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          203 EKLLVYPYMTNG-SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       203 ~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ..++||||+..| +|.+++....    .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence            999999999877 9999997643    489999999999999999999999   9999999999999999999999998

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.94  E-value=2.5e-26  Score=194.61  Aligned_cols=141  Identities=31%  Similarity=0.604  Sum_probs=122.1

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccH------HHHHHHHHHHhcCCCCCceeeeeEEeeCCee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGE------LQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  204 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~------~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~  204 (284)
                      ++|...+.||+|+||.||+|+. .+++.||+|.+.........      ..+.+|+.+++.++||||+++++++....  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            5677789999999999999986 47889999998654332221      46899999999999999999999986544  


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeeeCCCCCCeeeCCCCC-----cch
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK--IIHRDVKAANILLDEDAD-----QSS  277 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~--ivHrdlk~~NiLld~~~~-----~~~  277 (284)
                      ++||||+++|+|.+.+....   ..+++..+..++.|++.||+|||+.   +  ++||||||+|||++.++.     ++|
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence            79999999999999987543   2589999999999999999999998   7  999999999999998887     899


Q ss_pred             hhh
Q 023282          278 KTI  280 (284)
Q Consensus       278 ~df  280 (284)
                      +||
T Consensus       171 ~Df  173 (287)
T 4f0f_A          171 ADF  173 (287)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            998

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.94  E-value=2.4e-26  Score=197.04  Aligned_cols=143  Identities=23%  Similarity=0.318  Sum_probs=128.0

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCccc--HHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      .++|...+.||+|+||.||++... +++.||+|.+........  ...+.+|+.+++.++||||+++++++...+..+++
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            367888899999999999999965 688999999965433222  34688999999999999999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||+++++|.+++....    .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus       113 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Df  178 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDF  178 (309)
T ss_dssp             EECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSC
T ss_pred             EEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecC
Confidence            99999999999998643    489999999999999999999999   9999999999999999999999998

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.94  E-value=1.5e-26  Score=199.86  Aligned_cols=147  Identities=31%  Similarity=0.415  Sum_probs=124.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEe------CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCee
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  204 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~  204 (284)
                      .++|...+.||+|+||.||+|+.      .++..||||.+...........+.+|+.+++.++||||+++++++......
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            45688889999999999999984      246789999996544444455789999999999999999999999999999


Q ss_pred             eEEEeCCCCCChHHHHhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCC---CCcchh
Q 023282          205 LLVYPYMTNGSVASRLRERQSS---LPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED---ADQSSK  278 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~---~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~---~~~~~~  278 (284)
                      ++||||+++|+|.+++......   ...+++..+..++.|++.||.|||+.   +++||||||+|||++.+   ..++|+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence            9999999999999999875321   23589999999999999999999999   99999999999999954   459999


Q ss_pred             hh
Q 023282          279 TI  280 (284)
Q Consensus       279 df  280 (284)
                      ||
T Consensus       186 Df  187 (327)
T 2yfx_A          186 DF  187 (327)
T ss_dssp             CC
T ss_pred             cc
Confidence            97

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.94  E-value=1.2e-26  Score=200.75  Aligned_cols=139  Identities=19%  Similarity=0.261  Sum_probs=123.5

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCCeeeEEEe
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      ++|...+.||+|+||.||+|+. .+++.||||.+.....   ...+.+|+.+++.+ +||||+++++++......++|||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            5678889999999999999985 5788999999864422   23588999999999 89999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCC-----cchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD-----QSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~-----~~~~df  280 (284)
                      |+ +++|.+++....   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.     ++|+||
T Consensus        86 ~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DF  154 (330)
T 2izr_A           86 LL-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDF  154 (330)
T ss_dssp             CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred             eC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence            99 999999998642   2589999999999999999999999   9999999999999999887     999998

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.94  E-value=3.8e-26  Score=197.30  Aligned_cols=133  Identities=20%  Similarity=0.337  Sum_probs=118.5

Q ss_pred             CCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCC-CCCceeeeeEEeeCCeeeEEEeCCCCC
Q 023282          137 KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPYMTNG  214 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~~~~~~lv~e~~~~g  214 (284)
                      .+.||+|+||.||++... +++.||||.+...    ....+.+|+.++..+. ||||+++++++......++||||+++|
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~   91 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG   91 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence            478999999999999864 6889999998542    3346789999999997 999999999999999999999999999


Q ss_pred             ChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC---Ccchhhh
Q 023282          215 SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSKTI  280 (284)
Q Consensus       215 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~---~~~~~df  280 (284)
                      +|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++   .++|+||
T Consensus        92 ~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Df  153 (325)
T 3kn6_A           92 ELFERIKKKK----HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDF  153 (325)
T ss_dssp             BHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCC
T ss_pred             cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEecc
Confidence            9999998743    589999999999999999999999   999999999999998766   7999998

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.94  E-value=2.2e-26  Score=194.77  Aligned_cols=142  Identities=29%  Similarity=0.462  Sum_probs=126.8

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|...+.||+|+||.||+|... ++..||+|.+.....  ......+.+|+++++.++||||+++++++...+..+++|
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            56778899999999999999865 678999999864321  223456899999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++....    .+++.....++.|++.||.|||+.   +++||||||+||+++.++.++|+||
T Consensus        94 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Df  158 (284)
T 2vgo_A           94 EFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADF  158 (284)
T ss_dssp             CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred             EeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecc
Confidence            9999999999998653    488999999999999999999998   9999999999999999999999998

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.94  E-value=1.6e-26  Score=199.83  Aligned_cols=142  Identities=26%  Similarity=0.480  Sum_probs=124.2

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCc----EEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~l  206 (284)
                      ++|...+.||+|+||.||+|+.. +++    .||+|.+...........+.+|+.+++.++||||+++++++... ..++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-CceE
Confidence            56778899999999999999853 444    35778776554455566899999999999999999999999875 4789


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++||+++|+|.+++.....   .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus        94 v~~~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~Df  161 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDF  161 (327)
T ss_dssp             EECCCSSCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCT
T ss_pred             EEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccC
Confidence            9999999999999987532   489999999999999999999999   9999999999999999999999998

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.94  E-value=5.9e-27  Score=203.58  Aligned_cols=150  Identities=21%  Similarity=0.260  Sum_probs=125.1

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc----CcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC
Q 023282          128 QVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER----TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT  202 (284)
Q Consensus       128 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~  202 (284)
                      ....++|...+.||+|+||.||+|.. .++..||+|++....    .......+.+|+.+++.++||||+++++++...+
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            34456788899999999999999986 468899999986432    2233457999999999999999999999999999


Q ss_pred             eeeEEEeCCCCCChHHHHhhcCCC------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 023282          203 EKLLVYPYMTNGSVASRLRERQSS------------------------------------LPPLDWPTRKKIALGSARGL  246 (284)
Q Consensus       203 ~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~i~~gl  246 (284)
                      ..++||||+++|+|.+++......                                    ...+++.....++.|++.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            999999999999999999531100                                    11235667888999999999


Q ss_pred             HHHHcCCCCCeeeeCCCCCCeeeCCCC--Ccchhhh
Q 023282          247 SYLHEHCDPKIIHRDVKAANILLDEDA--DQSSKTI  280 (284)
Q Consensus       247 ~yLH~~~~~~ivHrdlk~~NiLld~~~--~~~~~df  280 (284)
                      +|||+.   +|+||||||+|||++.++  .+||+||
T Consensus       182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Df  214 (345)
T 3hko_A          182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDF  214 (345)
T ss_dssp             HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCC
T ss_pred             HHHHHC---CccccCCChhhEEEecCCCceEEEeec
Confidence            999999   999999999999998777  8999998

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.94  E-value=3.7e-26  Score=208.70  Aligned_cols=143  Identities=22%  Similarity=0.373  Sum_probs=123.4

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc------------ccHHHHHHHHHHHhcCCCCCceeeeeE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS------------GGELQFQTEVKIISMAVHRNLLRLYGF  197 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~e~~~l~~~~h~niv~l~g~  197 (284)
                      .++|...+.||+|+||+||+|+.. ++..+|+|+++.....            .....+.+|+.+++.++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            356888899999999999999965 6789999998654321            224568999999999999999999999


Q ss_pred             EeeCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC---C
Q 023282          198 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---D  274 (284)
Q Consensus       198 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~---~  274 (284)
                      +......++||||+++|+|.+++....    .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++   .
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence            999999999999999999999997653    489999999999999999999999   999999999999999876   5


Q ss_pred             cchhhh
Q 023282          275 QSSKTI  280 (284)
Q Consensus       275 ~~~~df  280 (284)
                      +||+||
T Consensus       188 ~kl~Df  193 (504)
T 3q5i_A          188 IKIVDF  193 (504)
T ss_dssp             EEECCC
T ss_pred             EEEEEC
Confidence            899998

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.94  E-value=1.8e-26  Score=199.23  Aligned_cols=142  Identities=26%  Similarity=0.407  Sum_probs=124.1

Q ss_pred             cCCCCCCeecccCceEEEEEEe-----CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEee--CCee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEK  204 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~--~~~~  204 (284)
                      ++|+..+.||+|+||.||+++.     .++..||+|++.... ......+.+|+++++.++||||+++++++..  ....
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            4577789999999999999984     357899999986432 2334468999999999999999999999874  4568


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++||||+++++|.+++.....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Df  171 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADF  171 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCG
T ss_pred             EEEEeecCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccc
Confidence            899999999999999986432   489999999999999999999999   9999999999999999999999998

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.94  E-value=2.1e-26  Score=216.78  Aligned_cols=145  Identities=24%  Similarity=0.330  Sum_probs=127.1

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--CcccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCCee
Q 023282          129 VATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEK  204 (284)
Q Consensus       129 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~  204 (284)
                      ...++|...++||+|+||.||+++.. +++.||||+++...  .......+..|..++..+ +||+|+++++++...+..
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            34567888899999999999999864 68899999997542  223344678899999887 699999999999999999


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++||||+++|+|.++++...    .+++..+..++.|++.||+|||+.   +|+||||||+|||+|.++.+||+||
T Consensus       418 ~lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DF  486 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADF  486 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCC
T ss_pred             EEEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeec
Confidence            99999999999999998753    489999999999999999999999   9999999999999999999999998

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.93  E-value=9.1e-27  Score=199.83  Aligned_cols=151  Identities=26%  Similarity=0.443  Sum_probs=122.7

Q ss_pred             HHHHhcCCCCCCeecccCceEEEEEEeC----CCcEEEEEEeecccCcc-cHHHHHHHHHHHhcCCCCCceeeeeEEeeC
Q 023282          127 LQVATDGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTV  201 (284)
Q Consensus       127 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~g~~~~~  201 (284)
                      +....++|...+.||+|+||.||+|...    ++..||+|.++...... ....+.+|+.+++.++||||+++++++...
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            3344566788899999999999999753    34589999987543322 234689999999999999999999999875


Q ss_pred             Ce-----eeEEEeCCCCCChHHHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCC
Q 023282          202 TE-----KLLVYPYMTNGSVASRLRERQ--SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  274 (284)
Q Consensus       202 ~~-----~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~  274 (284)
                      ..     .+++|||+++|+|.+++....  .....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSC
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCc
Confidence            43     499999999999999996432  2234689999999999999999999999   9999999999999999999


Q ss_pred             cchhhh
Q 023282          275 QSSKTI  280 (284)
Q Consensus       275 ~~~~df  280 (284)
                      ++|+||
T Consensus       186 ~kl~Df  191 (313)
T 3brb_A          186 VCVADF  191 (313)
T ss_dssp             EEECSC
T ss_pred             EEEeec
Confidence            999998

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.93  E-value=2.8e-26  Score=195.60  Aligned_cols=143  Identities=25%  Similarity=0.414  Sum_probs=125.5

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      .+.|+..+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            356778899999999999999975 58899999986442 3345578999999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++++|.+++.....   .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+||
T Consensus        97 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df  161 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADF  161 (302)
T ss_dssp             CCTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCC
T ss_pred             eCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEEC
Confidence            9999999999876432   489999999999999999999999   9999999999999999999999998

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.93  E-value=2.3e-26  Score=206.20  Aligned_cols=141  Identities=26%  Similarity=0.349  Sum_probs=124.0

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeC-----Cee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TEK  204 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~-----~~~  204 (284)
                      ++|...+.||+|+||.||+|+.. +++.||||+++..... .....+.+|+.+++.++||||+++++++...     ...
T Consensus        26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  105 (432)
T 3n9x_A           26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL  105 (432)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence            56888899999999999999864 6889999999654322 2234689999999999999999999998765     568


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++||||++ |+|.+++...    ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       106 ~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DF  173 (432)
T 3n9x_A          106 YIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDF  173 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEecCC-cCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccC
Confidence            99999997 5999999753    2489999999999999999999999   9999999999999999999999998

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.93  E-value=1.7e-26  Score=206.27  Aligned_cols=143  Identities=24%  Similarity=0.342  Sum_probs=121.6

Q ss_pred             HhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-------ccHHHHHHHHHHHhcCCCCCceeeeeEEeeC
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-------GGELQFQTEVKIISMAVHRNLLRLYGFCTTV  201 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~  201 (284)
                      ..++|...+.||+|+||.||+|... +++.||||++......       .....+.+|+.++++++||||+++++++. .
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence            4578889999999999999999864 6889999998643211       11224889999999999999999999975 4


Q ss_pred             CeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC---Ccchh
Q 023282          202 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSK  278 (284)
Q Consensus       202 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~---~~~~~  278 (284)
                      +..++||||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++   .+||+
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             CceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence            5689999999999999988653    2589999999999999999999999   999999999999997655   49999


Q ss_pred             hh
Q 023282          279 TI  280 (284)
Q Consensus       279 df  280 (284)
                      ||
T Consensus       285 DF  286 (419)
T 3i6u_A          285 DF  286 (419)
T ss_dssp             CS
T ss_pred             ec
Confidence            98

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.93  E-value=2.6e-26  Score=192.85  Aligned_cols=143  Identities=29%  Similarity=0.455  Sum_probs=119.7

Q ss_pred             cCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCc---ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS---GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|+..+.||+|+||.||+|... ++.+|||.++.....   .....+.+|+.+++.++||||+++++++...+..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            56777899999999999999974 789999998654322   22356889999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC--------CCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE--------DADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~--------~~~~~~~df  280 (284)
                      ||+++++|.+++...     .+++..+..++.|++.||.|||+....+++||||||+|||++.        ++.++++||
T Consensus        86 e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           86 EFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             ECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            999999999999642     4899999999999999999999983233999999999999996        677999998

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.93  E-value=9.9e-26  Score=191.51  Aligned_cols=144  Identities=24%  Similarity=0.368  Sum_probs=124.4

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +.+....+||+|+||.||+|.. .++..||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  100 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ  100 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence            3455567999999999999985 468899999986543 23345789999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC-CCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-DADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~-~~~~~~~df  280 (284)
                      +++++|.+++..... ...+++..+..++.|++.||.|||+.   +++||||||+||+++. ++.++|+||
T Consensus       101 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Df  167 (295)
T 2clq_A          101 VPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDF  167 (295)
T ss_dssp             CSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCT
T ss_pred             CCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeec
Confidence            999999999986432 23467889999999999999999999   9999999999999998 889999998

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.93  E-value=4.5e-26  Score=207.09  Aligned_cols=142  Identities=27%  Similarity=0.451  Sum_probs=126.6

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|...+.||+|+||.||+++.. +++.||||++.....  ......+.+|+.+++.++||||+++++++......++||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            45777899999999999999865 789999999865432  234557999999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeee---CCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLl---d~~~~~~~~df  280 (284)
                      ||+++|+|.+++....    .+++..+..++.|++.||.|||+.   +|+||||||+|||+   +.++.+||+||
T Consensus       106 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  173 (484)
T 3nyv_A          106 EVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDF  173 (484)
T ss_dssp             CCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCT
T ss_pred             ecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEee
Confidence            9999999999997643    489999999999999999999999   99999999999999   56788999998

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.93  E-value=2e-26  Score=203.36  Aligned_cols=144  Identities=21%  Similarity=0.306  Sum_probs=119.0

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeC-----
Q 023282          128 QVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----  201 (284)
Q Consensus       128 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~-----  201 (284)
                      ....++|...+.||+|+||+||+|+. .+++.||+|++.....     ...+|+++++.++||||+++++++...     
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            34566788899999999999999985 5789999999864322     234799999999999999999998543     


Q ss_pred             ---------------------------------CeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 023282          202 ---------------------------------TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY  248 (284)
Q Consensus       202 ---------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~y  248 (284)
                                                       ...++||||++ |+|.+.+.........+++..+..++.|+++||+|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                             23789999998 58888887532233468999999999999999999


Q ss_pred             HHcCCCCCeeeeCCCCCCeeeC-CCCCcchhhh
Q 023282          249 LHEHCDPKIIHRDVKAANILLD-EDADQSSKTI  280 (284)
Q Consensus       249 LH~~~~~~ivHrdlk~~NiLld-~~~~~~~~df  280 (284)
                      ||+.   +|+||||||+|||++ .++.+||+||
T Consensus       157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Df  186 (383)
T 3eb0_A          157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDF  186 (383)
T ss_dssp             HHTT---TEECSCCCGGGEEEETTTTEEEECCC
T ss_pred             HHHC---cCccCccCHHHEEEcCCCCcEEEEEC
Confidence            9998   999999999999998 5789999998

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=7.6e-26  Score=195.80  Aligned_cols=143  Identities=29%  Similarity=0.426  Sum_probs=121.8

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhc--CCCCCceeeeeEEeeC----
Q 023282          128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM--AVHRNLLRLYGFCTTV----  201 (284)
Q Consensus       128 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--~~h~niv~l~g~~~~~----  201 (284)
                      ....++|...+.||+|+||.||+|+.. ++.||||++...    ....+..|.+++..  ++||||+++++++...    
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            344567899999999999999999885 889999998532    22345556666554  4899999999999887    


Q ss_pred             CeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeeeeCCCCCCeeeCCCCCcc
Q 023282          202 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC-----DPKIIHRDVKAANILLDEDADQS  276 (284)
Q Consensus       202 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~-----~~~ivHrdlk~~NiLld~~~~~~  276 (284)
                      ...++||||+++|+|.++++..     .+++..+..++.|++.||.|||+.+     .++|+||||||+|||++.++.+|
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence            6789999999999999999764     4899999999999999999999752     34899999999999999999999


Q ss_pred             hhhh
Q 023282          277 SKTI  280 (284)
Q Consensus       277 ~~df  280 (284)
                      |+||
T Consensus       183 l~Df  186 (337)
T 3mdy_A          183 IADL  186 (337)
T ss_dssp             ECCC
T ss_pred             EEeC
Confidence            9998

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.93  E-value=6.7e-26  Score=198.84  Aligned_cols=149  Identities=23%  Similarity=0.320  Sum_probs=130.1

Q ss_pred             HHHHHHhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCccc-------HHHHHHHHHHHhcC-CCCCceeee
Q 023282          125 RELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG-------ELQFQTEVKIISMA-VHRNLLRLY  195 (284)
Q Consensus       125 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-------~~~~~~e~~~l~~~-~h~niv~l~  195 (284)
                      .......++|...+.||+|+||.||+|+.. +|+.||||++........       ...+.+|+.+++.+ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            334445567888999999999999999975 789999999865432111       23578899999998 799999999


Q ss_pred             eEEeeCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCc
Q 023282          196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  275 (284)
Q Consensus       196 g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~  275 (284)
                      +++......++||||+++++|.+++....    .+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i  239 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI  239 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence            99999999999999999999999998643    489999999999999999999999   99999999999999999999


Q ss_pred             chhhh
Q 023282          276 SSKTI  280 (284)
Q Consensus       276 ~~~df  280 (284)
                      +++||
T Consensus       240 kl~Df  244 (365)
T 2y7j_A          240 RLSDF  244 (365)
T ss_dssp             EECCC
T ss_pred             EEEec
Confidence            99998

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.93  E-value=1.4e-26  Score=201.51  Aligned_cols=144  Identities=26%  Similarity=0.354  Sum_probs=127.2

Q ss_pred             hcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCccc----------------HHHHHHHHHHHhcCCCCCceee
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG----------------ELQFQTEVKIISMAVHRNLLRL  194 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----------------~~~~~~e~~~l~~~~h~niv~l  194 (284)
                      .++|...+.||+|+||.||+|.. +++.||+|.+........                ...+.+|+.+++.++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            35788889999999999999998 899999999864432211                1679999999999999999999


Q ss_pred             eeEEeeCCeeeEEEeCCCCCChHHH------HhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeeeCCCCCCe
Q 023282          195 YGFCTTVTEKLLVYPYMTNGSVASR------LRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANI  267 (284)
Q Consensus       195 ~g~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~ivHrdlk~~Ni  267 (284)
                      ++++...+..++||||+++|+|.++      +...  ....+++..+..++.|++.||.|||+ .   +++||||||+||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni  183 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI  183 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence            9999999999999999999999998      5432  13468999999999999999999998 7   999999999999


Q ss_pred             eeCCCCCcchhhh
Q 023282          268 LLDEDADQSSKTI  280 (284)
Q Consensus       268 Lld~~~~~~~~df  280 (284)
                      +++.++.++|+||
T Consensus       184 l~~~~~~~kl~df  196 (348)
T 2pml_X          184 LMDKNGRVKLSDF  196 (348)
T ss_dssp             EECTTSCEEECCC
T ss_pred             EEcCCCcEEEecc
Confidence            9999999999998

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.93  E-value=1.6e-26  Score=202.12  Aligned_cols=153  Identities=20%  Similarity=0.266  Sum_probs=131.0

Q ss_pred             ccccHHHHHHHhcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCC-----CCCcee
Q 023282          120 KRFSLRELQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-----HRNLLR  193 (284)
Q Consensus       120 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-----h~niv~  193 (284)
                      ..+++.+.....++|...+.||+|+||.||+|+. .+++.||||+++..  ......+..|+.++..+.     ||||++
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            3445555566678899999999999999999986 47889999998632  223345778999998886     999999


Q ss_pred             eeeEEeeCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC--
Q 023282          194 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE--  271 (284)
Q Consensus       194 l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~--  271 (284)
                      +++++...+..++||||+ +++|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.  
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~  174 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPY  174 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTT
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccc
Confidence            999999999999999999 8999999986432  2489999999999999999999999   9999999999999986  


Q ss_pred             -----------------------CCCcchhhh
Q 023282          272 -----------------------DADQSSKTI  280 (284)
Q Consensus       272 -----------------------~~~~~~~df  280 (284)
                                             ++.+||+||
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DF  206 (360)
T 3llt_A          175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF  206 (360)
T ss_dssp             CCEEEEEEECTTTCCEEEEEEESCCCEEECCC
T ss_pred             ccccccchhcccccccccccccCCCCEEEEec
Confidence                                   788999998

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.93  E-value=1.8e-26  Score=195.56  Aligned_cols=147  Identities=22%  Similarity=0.274  Sum_probs=121.9

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHH-HHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~-~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      .++|+..+.||+|+||.||+++. .+++.||+|.++.........+ +.++...++.++||||+++++++...+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            45678889999999999999986 5788999999975433333333 445555688899999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||++ |+|.+++.........+++..+..++.|++.||+|||+.+  +++||||||+|||++.++.++|+||
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Df  154 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDF  154 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeec
Confidence            9997 5898888653233346899999999999999999999842  7999999999999999999999998

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.93  E-value=3.1e-26  Score=214.22  Aligned_cols=135  Identities=26%  Similarity=0.379  Sum_probs=119.0

Q ss_pred             CeecccCceEEEEEEeC---CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCC
Q 023282          138 NILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  213 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~  213 (284)
                      +.||+|+||.||+|.+.   .+..||||+++..... ....++.+|+++++.++|||||++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999642   4678999999754332 234579999999999999999999999864 568899999999


Q ss_pred             CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          214 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       214 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus       454 g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DF  513 (635)
T 4fl3_A          454 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDF  513 (635)
T ss_dssp             EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCT
T ss_pred             CCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEc
Confidence            99999997643    489999999999999999999999   9999999999999999999999998

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.93  E-value=1.8e-26  Score=195.01  Aligned_cols=143  Identities=24%  Similarity=0.359  Sum_probs=124.1

Q ss_pred             hcCCCCCCeecccCceEEEEEEeCC----CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~l  206 (284)
                      .++|...+.||+|+||.||+|...+    +..||+|.++..........+.+|+.+++.++||||+++++++.. +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            4567778999999999999998532    336999998765444445679999999999999999999999764 56789


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||||+++++|.+++.....   .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+||
T Consensus        90 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df  157 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDF  157 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCC
T ss_pred             EEecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCcc
Confidence            9999999999999976432   488999999999999999999999   9999999999999999999999998

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.93  E-value=2.9e-26  Score=198.34  Aligned_cols=142  Identities=25%  Similarity=0.435  Sum_probs=125.4

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCccc-HHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      ++|...+.||+|+||.||+++.. +++.||+|++........ ...+.+|+.+++.++||||+++++++...+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            45777889999999999999965 588999999865433222 3457899999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++++|.+++....    .+++..+..++.|++.||.|||+.   +++||||||+|||++.++.++|+||
T Consensus       105 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Df  168 (331)
T 4aaa_A          105 FVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDF  168 (331)
T ss_dssp             CCSEEHHHHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             cCCcchHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeC
Confidence            999999988876432    489999999999999999999999   9999999999999999999999998

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.93  E-value=4.9e-26  Score=207.40  Aligned_cols=142  Identities=23%  Similarity=0.393  Sum_probs=120.8

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC-cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      +.|...+.||+|+||+||+|+.. ++..+|+|+++.... ......+.+|+.+++.++||||+++++++......++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            34777899999999999999965 688999999975432 2334578999999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC---Ccchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~---~~~~~df  280 (284)
                      |+++|+|.+.+....    .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++   .+||+||
T Consensus       117 ~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  183 (494)
T 3lij_A          117 CYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDF  183 (494)
T ss_dssp             CCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEEC
Confidence            999999999987653    489999999999999999999999   999999999999998754   4899998

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.93  E-value=4.3e-26  Score=201.61  Aligned_cols=142  Identities=23%  Similarity=0.400  Sum_probs=115.9

Q ss_pred             HhcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCC-CCCceeeeeEEeeCC--ee
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAV-HRNLLRLYGFCTTVT--EK  204 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~~~--~~  204 (284)
                      ..++|...+.||+|+||.||+|.. .+++.||||++...... .....+.+|+.++..+. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            356788899999999999999985 47899999998643222 23346789999999997 999999999997654  68


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++||||++ |+|.++++..     .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        87 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DF  153 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADF  153 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCC
Confidence            99999998 6899999763     488999999999999999999999   9999999999999999999999998

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.93  E-value=2.7e-26  Score=193.88  Aligned_cols=139  Identities=25%  Similarity=0.452  Sum_probs=122.5

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEee----------
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT----------  200 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~----------  200 (284)
                      .+|+..+.||+|+||.||+|... +++.||+|.++...     ..+.+|+++++.++||||+++++++..          
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            45778899999999999999975 78999999986432     257789999999999999999998854          


Q ss_pred             ------CCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCC
Q 023282          201 ------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  274 (284)
Q Consensus       201 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~  274 (284)
                            ....++||||+++|+|.+++.....  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCC
Confidence                  3457999999999999999976432  2589999999999999999999999   9999999999999999999


Q ss_pred             cchhhh
Q 023282          275 QSSKTI  280 (284)
Q Consensus       275 ~~~~df  280 (284)
                      ++|+||
T Consensus       161 ~kl~Df  166 (284)
T 2a19_B          161 VKIGDF  166 (284)
T ss_dssp             EEECCC
T ss_pred             EEECcc
Confidence            999998

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.93  E-value=4.2e-26  Score=196.94  Aligned_cols=142  Identities=26%  Similarity=0.460  Sum_probs=123.4

Q ss_pred             cCCCCCCeecccCceEEEEEEe-----CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC--ee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-----ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT--EK  204 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~--~~  204 (284)
                      ++|...+.||+|+||.||+++.     .+++.||+|.+... .......+.+|+.+++.++||||+++++++...+  ..
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            4567788999999999999984     36889999998653 2233457899999999999999999999987644  68


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++||||+++|+|.+++.....   .+++..+..++.|++.||.|||+.   +++||||||+|||++.++.++|+||
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Df  189 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDF  189 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTT---SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCC
T ss_pred             EEEEECCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecC
Confidence            999999999999999986532   489999999999999999999999   9999999999999999999999998

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.93  E-value=9.1e-26  Score=191.53  Aligned_cols=140  Identities=25%  Similarity=0.395  Sum_probs=121.5

Q ss_pred             CCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEee----CCeeeEE
Q 023282          134 FSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT----VTEKLLV  207 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~----~~~~~lv  207 (284)
                      |...+.||+|+||.||+|... ++..||+|.+...... .....+.+|+.+++.++||||+++++++..    ....++|
T Consensus        28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  107 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence            555678999999999999864 6789999998754433 234468999999999999999999999865    3457999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeeeCCCCCCeeeC-CCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK--IIHRDVKAANILLD-EDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~--ivHrdlk~~NiLld-~~~~~~~~df  280 (284)
                      |||+++|+|.+++....    .+++..+..++.|++.||.|||+.   +  ++||||||+|||++ .++.++|+||
T Consensus       108 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Df  176 (290)
T 1t4h_A          108 TELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDL  176 (290)
T ss_dssp             EECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred             EEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence            99999999999998643    488999999999999999999998   6  99999999999998 7889999998

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=3.4e-26  Score=199.18  Aligned_cols=144  Identities=28%  Similarity=0.432  Sum_probs=119.9

Q ss_pred             HhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcc----cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCee
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG----GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  204 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~  204 (284)
                      ..++|...+.||+|+||.||+|+.. +++.||+|.++......    ....+.+|+.+++.++||||+++++++......
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            3467888999999999999999964 68999999986432221    123688999999999999999999999999999


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++||||+++ +|.+++....   ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Df  156 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADF  156 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEec
Confidence            999999986 8988887542   2478889999999999999999999   9999999999999999999999998

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.93  E-value=3e-26  Score=198.23  Aligned_cols=143  Identities=22%  Similarity=0.362  Sum_probs=121.1

Q ss_pred             HhcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcc-cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEE
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      ..++|...+.||+|+||+||+++. .+++.||+|+++...... ....+.+|+.+++.++||||+++++++......++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            345788889999999999999985 478899999996543322 234578999999999999999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeC-----CCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-----EDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld-----~~~~~~~~df  280 (284)
                      |||++ |+|.+++....    .+++..+..++.|++.||.|||+.   +|+||||||+|||++     .++.+||+||
T Consensus       112 ~e~~~-~~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df  181 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDF  181 (329)
T ss_dssp             EECCS-EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred             EecCC-CCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcC
Confidence            99998 59999997643    489999999999999999999999   999999999999995     4445999998

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.93  E-value=3.5e-26  Score=194.12  Aligned_cols=142  Identities=30%  Similarity=0.472  Sum_probs=122.0

Q ss_pred             HhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcc-cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ..++|...+.||+|+||.||+|+..+  .+|+|.++...... ....+.+|+.+++.++||||+++++++ .....++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            34678888999999999999998643  59999986544332 234689999999999999999999965 456789999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++++|.+++....   ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus        99 e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Df  164 (289)
T 3og7_A           99 QWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDF  164 (289)
T ss_dssp             ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCC
T ss_pred             EecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccc
Confidence            9999999999997543   3589999999999999999999999   9999999999999999999999998

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.93  E-value=4.7e-27  Score=207.04  Aligned_cols=146  Identities=16%  Similarity=0.189  Sum_probs=118.2

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccC--cccHHHHHHHH---HHHhcCCCCCceeee-------eE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT--SGGELQFQTEV---KIISMAVHRNLLRLY-------GF  197 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~---~~l~~~~h~niv~l~-------g~  197 (284)
                      .++|...+.||+|+||+||+|+. .+++.||||++.....  ....+.+.+|+   +.++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            35577789999999999999995 5789999999974322  22345788999   556667899999998       55


Q ss_pred             EeeCC-----------------eeeEEEeCCCCCChHHHHhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 023282          198 CTTVT-----------------EKLLVYPYMTNGSVASRLRERQSS---LPPLDWPTRKKIALGSARGLSYLHEHCDPKI  257 (284)
Q Consensus       198 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~~---~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~i  257 (284)
                      +...+                 ..+++|||+ +|+|.+++......   ...++|..+..++.|++.||+|||+.   +|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            55443                 278999999 68999999863211   12344688889999999999999999   99


Q ss_pred             eeeCCCCCCeeeCCCCCcchhhh
Q 023282          258 IHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       258 vHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +||||||+|||++.++.+||+||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DF  250 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGF  250 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCG
T ss_pred             ecCCCCHHHEEEcCCCCEEEEec
Confidence            99999999999999999999998

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.93  E-value=8.3e-26  Score=192.44  Aligned_cols=143  Identities=22%  Similarity=0.457  Sum_probs=123.6

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      ++|+..+.||+|+||.||+|+.. +++.||+|.++..... .....+.+|+.++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (299)
T 2r3i_A            3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence            56778899999999999999865 7899999998654322 223568899999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |++ |+|.+++.....  ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+||
T Consensus        83 ~~~-~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~df  147 (299)
T 2r3i_A           83 FLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADF  147 (299)
T ss_dssp             CCS-EEHHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECST
T ss_pred             ccc-CCHHHHHHhhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHeEEcCCCCEEECcc
Confidence            998 699999976432  3478999999999999999999999   9999999999999999999999998

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.93  E-value=1.1e-25  Score=195.22  Aligned_cols=140  Identities=28%  Similarity=0.416  Sum_probs=123.9

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhc--CCCCCceeeeeEEeeCC---
Q 023282          128 QVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM--AVHRNLLRLYGFCTTVT---  202 (284)
Q Consensus       128 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--~~h~niv~l~g~~~~~~---  202 (284)
                      ....++|...+.||+|+||.||+|+. +++.||+|.+...    ....+.+|.+++..  ++||||+++++++....   
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~  112 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW  112 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence            44456799999999999999999998 5889999998532    33467788888876  78999999999998775   


Q ss_pred             -eeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeeeeCCCCCCeeeCCCC
Q 023282          203 -EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH--------EHCDPKIIHRDVKAANILLDEDA  273 (284)
Q Consensus       203 -~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH--------~~~~~~ivHrdlk~~NiLld~~~  273 (284)
                       ..++||||+++|+|.+++...     .+++..+..++.|++.||.|||        +.   +|+||||||+|||++.++
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~  184 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNG  184 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTS
T ss_pred             ceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCC
Confidence             789999999999999999763     4899999999999999999999        66   999999999999999999


Q ss_pred             Ccchhhh
Q 023282          274 DQSSKTI  280 (284)
Q Consensus       274 ~~~~~df  280 (284)
                      .++|+||
T Consensus       185 ~~kL~Df  191 (342)
T 1b6c_B          185 TCCIADL  191 (342)
T ss_dssp             CEEECCC
T ss_pred             CEEEEEC
Confidence            9999998

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.93  E-value=3.6e-26  Score=194.64  Aligned_cols=142  Identities=24%  Similarity=0.408  Sum_probs=123.7

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEee---------
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT---------  200 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~---------  200 (284)
                      .++|+..+.||+|+||.||+|+. .+++.||+|.+...  ......+.+|+.+++.++||||+++++++..         
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            34677889999999999999996 47899999998542  2233568899999999999999999998865         


Q ss_pred             ----CCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcc
Q 023282          201 ----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  276 (284)
Q Consensus       201 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~  276 (284)
                          ....++||||+++|+|.+++....   ..+++.....++.|++.||+|||+.   +++||||||+|||++.++.++
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence                346789999999999999998642   2467889999999999999999999   999999999999999999999


Q ss_pred             hhhh
Q 023282          277 SKTI  280 (284)
Q Consensus       277 ~~df  280 (284)
                      ++||
T Consensus       157 l~df  160 (303)
T 1zy4_A          157 IGDF  160 (303)
T ss_dssp             ECCC
T ss_pred             EeeC
Confidence            9998

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.93  E-value=2.5e-26  Score=196.81  Aligned_cols=142  Identities=30%  Similarity=0.484  Sum_probs=121.1

Q ss_pred             cCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      ++|+..+.||+|+||.||+++.. ++.||+|.+...   .....+.+|++++++++||||+++++++.  +..++||||+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~   81 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA   81 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence            45677889999999999999874 678999998532   33457899999999999999999999876  4589999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCC-cchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD-QSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~-~~~~df  280 (284)
                      ++|+|.+++.... ....+++..+..++.|+++||+|||+.+..+|+||||||+|||++.++. +||+||
T Consensus        82 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Df  150 (307)
T 2eva_A           82 EGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDF  150 (307)
T ss_dssp             TTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCC
T ss_pred             CCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccc
Confidence            9999999998643 2234788999999999999999999942238999999999999998887 799998

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.93  E-value=1.8e-26  Score=196.03  Aligned_cols=141  Identities=25%  Similarity=0.366  Sum_probs=120.7

Q ss_pred             cCCCCCC-eecccCceEEEEEEe---CCCcEEEEEEeecccCccc-HHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeE
Q 023282          132 DGFSNKN-ILGRGGFGKVYKGRL---ADGKLVAVKRLKEERTSGG-ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       132 ~~~~~~~-~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~l  206 (284)
                      ++|...+ .||+|+||.||+|..   ..+..||||.++....... ...+.+|+.+++.++||||+++++++ ..+..++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            4566666 899999999999954   2467899999975433222 45799999999999999999999999 5677899


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||||+++++|.+++....    .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+||
T Consensus        95 v~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Df  161 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDF  161 (291)
T ss_dssp             EEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCC
T ss_pred             EEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccC
Confidence            999999999999998643    489999999999999999999999   9999999999999999999999998

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.93  E-value=8.8e-26  Score=193.30  Aligned_cols=145  Identities=29%  Similarity=0.453  Sum_probs=120.4

Q ss_pred             HhcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc----ccHHHHHHHHHHHhcC---CCCCceeeeeEEeeC
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS----GGELQFQTEVKIISMA---VHRNLLRLYGFCTTV  201 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~~---~h~niv~l~g~~~~~  201 (284)
                      ..++|...+.||+|+||+||+|+. .+++.||+|.++.....    .....+.+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            456899999999999999999995 57899999998643211    1123567777777665   499999999999875


Q ss_pred             C-----eeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcc
Q 023282          202 T-----EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  276 (284)
Q Consensus       202 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~  276 (284)
                      .     ..+++|||+. |+|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence            5     4789999997 699999986432  2489999999999999999999999   999999999999999999999


Q ss_pred             hhhh
Q 023282          277 SKTI  280 (284)
Q Consensus       277 ~~df  280 (284)
                      |+||
T Consensus       161 l~Df  164 (308)
T 3g33_A          161 LADF  164 (308)
T ss_dssp             ECSC
T ss_pred             EeeC
Confidence            9998

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.93  E-value=4.2e-26  Score=198.38  Aligned_cols=140  Identities=22%  Similarity=0.294  Sum_probs=123.4

Q ss_pred             cCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcc-cHHHHHHHHHHHhcCCC--CCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVH--RNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h--~niv~l~g~~~~~~~~~lv~  208 (284)
                      +.|...+.||+|+||.||++...+++.||||++....... ....+.+|+.++..++|  |||+++++++......++||
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~   88 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM   88 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence            4577789999999999999998889999999987543322 23468999999999986  99999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      | +.+|+|.+++....    .+++..+..++.|++.||.|||+.   +|+||||||+|||++ ++.+||+||
T Consensus        89 e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DF  151 (343)
T 3dbq_A           89 E-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDF  151 (343)
T ss_dssp             C-CCSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCC
T ss_pred             e-CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeec
Confidence            9 56789999998743    489999999999999999999999   999999999999997 678999998

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.93  E-value=7.5e-26  Score=193.38  Aligned_cols=141  Identities=25%  Similarity=0.408  Sum_probs=123.9

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ++|...+.||+|+||.||+++.. +++.||+|.++.... .....+.+|+.+++.++||||+++++++......++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            45777899999999999999864 789999999975432 2234688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeee---CCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLl---d~~~~~~~~df  280 (284)
                      +++++|.+++....    .+++.....++.|++.||.|||+.   +++||||||+||++   +.++.++++||
T Consensus        88 ~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Df  153 (304)
T 2jam_A           88 VSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDF  153 (304)
T ss_dssp             CCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSC
T ss_pred             CCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccC
Confidence            99999999997643    488999999999999999999999   99999999999999   78889999998

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.93  E-value=7.8e-26  Score=192.50  Aligned_cols=143  Identities=29%  Similarity=0.325  Sum_probs=126.5

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc--------ccHHHHHHHHHHHhcCC-CCCceeeeeEEee
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--------GGELQFQTEVKIISMAV-HRNLLRLYGFCTT  200 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~  200 (284)
                      .++|...+.||+|+||.||+|... +++.||+|.++.....        .....+.+|+.+++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            467888899999999999999965 6889999998644311        11235789999999996 9999999999999


Q ss_pred             CCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          201 VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       201 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ....++||||+++++|.+++....    .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             CCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence            999999999999999999998643    489999999999999999999999   9999999999999999999999998

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=3.7e-26  Score=200.62  Aligned_cols=140  Identities=24%  Similarity=0.362  Sum_probs=116.4

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC------e
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT------E  203 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~------~  203 (284)
                      ++|...+.||+|+||.||+|.. .+|+.||||++...... .....+.+|+.+++.++||||+++++++....      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            4677789999999999999986 47899999998543322 22346889999999999999999999997653      4


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .++||||+ +++|.+++...     .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       105 ~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df  172 (367)
T 1cm8_A          105 FYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF  172 (367)
T ss_dssp             CEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEee
Confidence            59999999 78999999763     488999999999999999999999   9999999999999999999999998

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.93  E-value=5.6e-26  Score=198.01  Aligned_cols=141  Identities=22%  Similarity=0.377  Sum_probs=123.7

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeC-----Cee
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TEK  204 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~-----~~~  204 (284)
                      .++|...+.||+|+||.||+|... +++.||||.+...........+.+|+.+++.++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            356788899999999999999965 68899999996443333345688999999999999999999988754     578


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++|||++ |+|.+++...     .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus        90 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Df  156 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDF  156 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEec
Confidence            99999997 6999998763     489999999999999999999999   9999999999999999999999998

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.93  E-value=6.4e-26  Score=201.29  Aligned_cols=137  Identities=23%  Similarity=0.296  Sum_probs=116.4

Q ss_pred             CCCCC-CeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHH-hcCCCCCceeeeeEEee----CCeee
Q 023282          133 GFSNK-NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLRLYGFCTT----VTEKL  205 (284)
Q Consensus       133 ~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l-~~~~h~niv~l~g~~~~----~~~~~  205 (284)
                      +|... ++||+|+||+||++... +++.||||+++..      ..+.+|++++ +..+||||+++++++..    ....+
T Consensus        62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            44444 68999999999999864 6889999998531      3567888876 55689999999998865    45689


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC---CCCcchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~---~~~~~~~df  280 (284)
                      +||||+++|+|.+++....  ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.   ++.+||+||
T Consensus       136 lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEec
Confidence            9999999999999998642  23589999999999999999999998   9999999999999998   788999998

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.93  E-value=5.5e-26  Score=206.63  Aligned_cols=142  Identities=25%  Similarity=0.424  Sum_probs=125.9

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC-cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      ++|...+.||+|+||+||+++.. +++.||||++..... ......+.+|+++++.++||||+++++++......++|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            45778899999999999999865 788999999864332 2345578999999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeC---CCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD---EDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld---~~~~~~~~df  280 (284)
                      |+++|+|.+.+....    .+++..+..++.|++.||.|||+.   +|+||||||+|||++   .++.+||+||
T Consensus       102 ~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  168 (486)
T 3mwu_A          102 LYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDF  168 (486)
T ss_dssp             CCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSC
T ss_pred             cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEEC
Confidence            999999999997653    489999999999999999999999   999999999999995   4567999998

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.93  E-value=1.2e-25  Score=192.92  Aligned_cols=142  Identities=30%  Similarity=0.462  Sum_probs=122.2

Q ss_pred             HhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ..+.|+..+.||+|+||.||+|... +++.||+|.+....   ....+.+|+.+++.++||||+++++++......++||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            4467888899999999999999865 58999999986532   3346889999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++++|.+++....   ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+||
T Consensus       104 e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  169 (314)
T 3com_A          104 EYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADF  169 (314)
T ss_dssp             ECCTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred             ecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeec
Confidence            9999999999997432   2589999999999999999999999   9999999999999999999999998

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.93  E-value=6.8e-26  Score=198.65  Aligned_cols=140  Identities=21%  Similarity=0.315  Sum_probs=123.3

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeC-----Ceee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TEKL  205 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~-----~~~~  205 (284)
                      ++|...+.||+|+||.||++... ++..||+|++...........+.+|++++..++||||+++++++...     ...+
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            46888899999999999999864 68899999997543333345789999999999999999999999765     3689


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +||||++ |+|.+++...     .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus       107 iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Df  172 (364)
T 3qyz_A          107 IVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDF  172 (364)
T ss_dssp             EEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeC
Confidence            9999997 5999999763     389999999999999999999999   9999999999999999999999998

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.93  E-value=6.4e-26  Score=195.42  Aligned_cols=141  Identities=25%  Similarity=0.358  Sum_probs=119.4

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC-------cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCe
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-------SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  203 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~  203 (284)
                      ++|...+.||+|+||.||+|... +++.||||.+.....       ......+.+|+++++.++||||+++++++.... 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            46788899999999999999864 678999999864321       112235889999999999999999999987654 


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCC---cchhhh
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD---QSSKTI  280 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~---~~~~df  280 (284)
                      .++||||+++|+|.+++...    ..+++.....++.|++.||.|||+.   +|+||||||+|||++.+++   ++|+||
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             eEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccC
Confidence            89999999999999999753    2589999999999999999999999   9999999999999987765   999998

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.93  E-value=4.6e-26  Score=205.86  Aligned_cols=140  Identities=23%  Similarity=0.305  Sum_probs=120.5

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeC------C
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV------T  202 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~------~  202 (284)
                      .++|...+.||+|+||+||+|... +++.||||++...... .....+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            356888899999999999999854 6889999999654322 2244688999999999999999999999654      3


Q ss_pred             eeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          203 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       203 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ..++||||+++ +|.+.+..      .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DF  208 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  208 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEE
Confidence            56999999976 57777643      378999999999999999999999   9999999999999999999999998

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.93  E-value=1.7e-25  Score=191.09  Aligned_cols=144  Identities=23%  Similarity=0.336  Sum_probs=122.2

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccC---cccHHHHHHHHHHHhcCCCCCceeeeeEEe--eCCee
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERT---SGGELQFQTEVKIISMAVHRNLLRLYGFCT--TVTEK  204 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~~h~niv~l~g~~~--~~~~~  204 (284)
                      .++|...+.||+|+||.||++.. .++..+|+|.++....   ......+.+|+.+++.++||||+++++++.  .....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            36788999999999999999996 4688999999964321   233457999999999999999999999984  44578


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++||||++++ |.+++....  ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++++||
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~df  153 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISAL  153 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecc
Confidence            9999999876 777776543  23589999999999999999999999   9999999999999999999999998

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.93  E-value=3.4e-26  Score=200.54  Aligned_cols=143  Identities=16%  Similarity=0.223  Sum_probs=117.9

Q ss_pred             hcCCCCCCeecccCceEEEEEEeCC------CcEEEEEEeecccCcc----------cHHHHHHHHHHHhcCCCCCceee
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLAD------GKLVAVKRLKEERTSG----------GELQFQTEVKIISMAVHRNLLRL  194 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~~~h~niv~l  194 (284)
                      .++|...+.||+|+||.||+|....      ++.||||++.......          ....+..|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            3467888999999999999998754      4689999986442110          01124456667788899999999


Q ss_pred             eeEEeeC----CeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeC
Q 023282          195 YGFCTTV----TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD  270 (284)
Q Consensus       195 ~g~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld  270 (284)
                      ++++...    ...++||||+ +++|.+++....   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~  186 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence            9998764    4579999999 999999998642   2589999999999999999999999   999999999999999


Q ss_pred             --CCCCcchhhh
Q 023282          271 --EDADQSSKTI  280 (284)
Q Consensus       271 --~~~~~~~~df  280 (284)
                        .++.+||+||
T Consensus       187 ~~~~~~~kl~DF  198 (364)
T 3op5_A          187 YKNPDQVYLVDY  198 (364)
T ss_dssp             SSCTTCEEECCC
T ss_pred             cCCCCeEEEEEC
Confidence              8899999998

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.93  E-value=8.4e-26  Score=196.48  Aligned_cols=138  Identities=20%  Similarity=0.309  Sum_probs=119.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCCeeeEEE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      .++|+..+.||+|+||.||++... +++.||+|.++....     ...+|++++.++ +||||+++++++......++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            456888899999999999999865 688999999965422     234678888776 7999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCC-C---Ccchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-A---DQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~-~---~~~~~df  280 (284)
                      ||+++|+|.+++....    .+++..+..++.|++.||.|||+.   +|+||||||+|||+..+ +   .+||+||
T Consensus        96 E~~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Df  164 (342)
T 2qr7_A           96 ELMKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDF  164 (342)
T ss_dssp             CCCCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCC
T ss_pred             eCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEEC
Confidence            9999999999997642    489999999999999999999999   99999999999998543 3   3899998

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.93  E-value=3.1e-26  Score=197.55  Aligned_cols=149  Identities=31%  Similarity=0.469  Sum_probs=128.9

Q ss_pred             HHHHHHhcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEee--
Q 023282          125 RELQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT--  200 (284)
Q Consensus       125 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~--  200 (284)
                      .++....++|...+.||+|+||.||+|+. .+++.||+|.+....  .....+.+|+.+++.+ +||||+++++++..  
T Consensus        17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   94 (326)
T 2x7f_A           17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN   94 (326)
T ss_dssp             CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred             hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence            33444567788899999999999999996 478899999986432  2345788999999988 79999999999976  


Q ss_pred             ----CCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcc
Q 023282          201 ----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQS  276 (284)
Q Consensus       201 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~  276 (284)
                          ....++||||+++|+|.+++....  ...+++.....++.|++.||.|||+.   +++||||||+|||++.++.++
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~k  169 (326)
T 2x7f_A           95 PPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVK  169 (326)
T ss_dssp             --CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEE
T ss_pred             CccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEE
Confidence                457899999999999999998642  12588999999999999999999999   999999999999999999999


Q ss_pred             hhhh
Q 023282          277 SKTI  280 (284)
Q Consensus       277 ~~df  280 (284)
                      |+||
T Consensus       170 l~Df  173 (326)
T 2x7f_A          170 LVDF  173 (326)
T ss_dssp             ECCC
T ss_pred             EeeC
Confidence            9998

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.93  E-value=1e-25  Score=196.36  Aligned_cols=142  Identities=29%  Similarity=0.481  Sum_probs=122.9

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeC--------
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV--------  201 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~--------  201 (284)
                      ++|...+.||+|+||.||+|+. .+++.||+|++...... .....+.+|+.+++.++||||+++++++...        
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            4677889999999999999996 57899999998654332 2244688999999999999999999998773        


Q ss_pred             CeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          202 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       202 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +..++||||+++ +|.+.+....   ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df  168 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  168 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             ceEEEEEeccCC-CHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence            468999999985 7888876542   2489999999999999999999999   9999999999999999999999998

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.93  E-value=2.4e-25  Score=189.43  Aligned_cols=140  Identities=18%  Similarity=0.230  Sum_probs=123.7

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCCeeeEEE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      .++|...+.||+|+||.||+|.. .+++.||+|.+....   ....+.+|+.++..+ +|+|++++++++......++||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC---ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            35688889999999999999985 578899999986432   223578899999998 7999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCC-----cchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD-----QSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~-----~~~~df  280 (284)
                      ||+ +++|.+++.....   .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.     ++|+||
T Consensus        86 e~~-~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df  155 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDF  155 (298)
T ss_dssp             ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             Eec-CCCHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence            999 9999999986432   489999999999999999999998   9999999999999988876     999998

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.93  E-value=1.1e-25  Score=199.24  Aligned_cols=140  Identities=22%  Similarity=0.288  Sum_probs=122.9

Q ss_pred             cCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCC--CCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAV--HRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~--h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ..|...+.||+|+||.||++...+++.||||++...... .....+.+|+.+++.++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            347888999999999999999878999999998654332 23356899999999986  599999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      | +.+++|.+++....    .+++..+..++.|++.||.|||+.   +|+||||||+|||++ ++.+||+||
T Consensus       136 E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DF  198 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDF  198 (390)
T ss_dssp             E-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCC
T ss_pred             e-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEec
Confidence            9 56889999998643    478899999999999999999999   999999999999996 588999998

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.93  E-value=4e-26  Score=192.58  Aligned_cols=141  Identities=28%  Similarity=0.449  Sum_probs=122.2

Q ss_pred             hcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeC-CeeeEEEe
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV-TEKLLVYP  209 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~-~~~~lv~e  209 (284)
                      .++|+..+.||+|+||.||++... ++.||+|.++...   ....+.+|+.+++.++||||+++++++... +..++|||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            456778899999999999999874 7899999986432   345789999999999999999999997654 47899999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++|+|.+++.....  ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+||
T Consensus        96 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Df  161 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDF  161 (278)
T ss_dssp             CCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCC
T ss_pred             cCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeec
Confidence            9999999999976421  1378889999999999999999999   9999999999999999999999998

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.93  E-value=7.7e-26  Score=212.29  Aligned_cols=146  Identities=23%  Similarity=0.328  Sum_probs=125.6

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEeCC----CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCe
Q 023282          128 QVATDGFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  203 (284)
Q Consensus       128 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~  203 (284)
                      ....++|...+.||+|+||.||+|....    +..||+|.++..........+.+|+.+++.++||||+++++++. .+.
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~  464 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP  464 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence            3344567778899999999999998642    45799999865433333457999999999999999999999985 467


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .++||||+++|+|.+++....   ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       465 ~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DF  535 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDF  535 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCC
T ss_pred             eEEEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEec
Confidence            899999999999999998643   2489999999999999999999999   9999999999999999999999998

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.93  E-value=2.6e-25  Score=189.68  Aligned_cols=138  Identities=23%  Similarity=0.315  Sum_probs=119.4

Q ss_pred             cCCCCC-CeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHH-hcCCCCCceeeeeEEee----CCee
Q 023282          132 DGFSNK-NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKII-SMAVHRNLLRLYGFCTT----VTEK  204 (284)
Q Consensus       132 ~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l-~~~~h~niv~l~g~~~~----~~~~  204 (284)
                      ++|... ++||+|+||.||++.. .+++.||+|.++.      ...+.+|++++ +..+||||+++++++..    ....
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            345554 7799999999999986 4788999999853      23567888887 67799999999999876    5678


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC---CCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~---~~~~~~~df  280 (284)
                      ++||||+++|+|.+++.....  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.   ++.++|+||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Df  164 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  164 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecc
Confidence            999999999999999987432  3589999999999999999999999   9999999999999998   788999998

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.93  E-value=2.1e-25  Score=192.69  Aligned_cols=135  Identities=23%  Similarity=0.320  Sum_probs=120.6

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCC-CCCceeeeeEEee--CCeeeEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTT--VTEKLLV  207 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~--~~~~~lv  207 (284)
                      ++|+..+.||+|+||.||+|+. .+++.||+|+++.    .....+.+|+.+++.++ ||||+++++++..  ....+++
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            4577789999999999999985 5788999999863    23457899999999997 9999999999987  5678999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC-Ccchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~-~~~~~df  280 (284)
                      |||+++++|.+++..       +++..+..++.|++.||+|||+.   +|+||||||+|||++.++ .++|+||
T Consensus       112 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Df  175 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDW  175 (330)
T ss_dssp             EECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             EeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeC
Confidence            999999999999853       78889999999999999999999   999999999999999777 8999998

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.93  E-value=5.9e-26  Score=214.39  Aligned_cols=139  Identities=21%  Similarity=0.350  Sum_probs=119.7

Q ss_pred             cCCCCCCeecccCceEEEEEEeC--CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCe-----e
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA--DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE-----K  204 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~-----~  204 (284)
                      ++|...+.||+|+||.||++...  +++.||||.+...........+.+|+.+++.++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            56788899999999999999864  5889999998654333334568899999999999999999999987665     6


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++||||+++++|.+++..      .++|.++..++.|++.||.|||+.   +|+||||||+|||++.+ .+||+||
T Consensus       160 ~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DF  225 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDL  225 (681)
T ss_dssp             EEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCC
T ss_pred             EEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEec
Confidence            999999999999987753      489999999999999999999999   99999999999999986 8999998

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.93  E-value=3.4e-25  Score=187.81  Aligned_cols=143  Identities=24%  Similarity=0.409  Sum_probs=126.7

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC-cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT-SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      .++|...+.||+|+||.||+++.. +++.||+|.+..... ......+.+|+.++++++||||+++++++......++++
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            356888899999999999999965 788999999865433 234557899999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC---Ccchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA---DQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~---~~~~~df  280 (284)
                      ||+++++|.+++....    .+++..+..++.|++.||.|||+.   +++||||||+||+++.++   .++|+||
T Consensus       101 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Df  168 (287)
T 2wei_A          101 ELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDF  168 (287)
T ss_dssp             CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred             EccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEecc
Confidence            9999999999987643    489999999999999999999999   999999999999997654   6999998

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.92  E-value=2.6e-25  Score=192.47  Aligned_cols=140  Identities=34%  Similarity=0.527  Sum_probs=115.9

Q ss_pred             hcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHH--HhcCCCCCceeeeeEEee-----CCe
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKI--ISMAVHRNLLRLYGFCTT-----VTE  203 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~--l~~~~h~niv~l~g~~~~-----~~~  203 (284)
                      .++|...+.||+|+||.||+|+. +++.||||++....    ...+..|.++  +..++||||+++++.+..     ...
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            45788889999999999999987 67899999986432    2234444444  556899999999986543     225


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC------CCCeeeeCCCCCCeeeCCCCCcch
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC------DPKIIHRDVKAANILLDEDADQSS  277 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~------~~~ivHrdlk~~NiLld~~~~~~~  277 (284)
                      .++||||+++|+|.+++....     .+|..+..++.|++.||.|||+.+      .++|+||||||+|||++.++.+||
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             EEEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence            689999999999999997642     588999999999999999999873      338999999999999999999999


Q ss_pred             hhh
Q 023282          278 KTI  280 (284)
Q Consensus       278 ~df  280 (284)
                      +||
T Consensus       162 ~DF  164 (336)
T 3g2f_A          162 SDF  164 (336)
T ss_dssp             CCC
T ss_pred             eec
Confidence            998

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.92  E-value=2e-25  Score=196.17  Aligned_cols=139  Identities=22%  Similarity=0.306  Sum_probs=121.3

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC------e
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVT------E  203 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~------~  203 (284)
                      ++|...+.||+|+||.||+|... +++.||||++...... .....+.+|+.+++.++||||+++++++....      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            56888899999999999999854 6889999999754322 22346889999999999999999999997654      6


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .++||||++ |+|.+.+..      .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       105 ~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df  171 (371)
T 2xrw_A          105 VYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  171 (371)
T ss_dssp             EEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             eEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEe
Confidence            799999997 578888853      378999999999999999999999   9999999999999999999999998

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.92  E-value=1.5e-25  Score=193.61  Aligned_cols=148  Identities=22%  Similarity=0.288  Sum_probs=126.7

Q ss_pred             HHHhcCCCCC-CeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCC-CCCceeeeeEEeeCCe
Q 023282          128 QVATDGFSNK-NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTE  203 (284)
Q Consensus       128 ~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~~~~  203 (284)
                      +...+.|... +.||+|+||.||++... +++.||+|.++..... .....+.+|+.++..+. ||||+++++++.....
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            3444455555 78999999999999865 6899999999754433 23457899999999885 6999999999999999


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC---CCCcchhhh
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTI  280 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~---~~~~~~~df  280 (284)
                      .++||||+++|+|.+++....  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.   ++.++|+||
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Df  178 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDF  178 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred             EEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeC
Confidence            999999999999999986532  23589999999999999999999999   9999999999999998   789999998

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.92  E-value=1.1e-25  Score=197.53  Aligned_cols=140  Identities=25%  Similarity=0.367  Sum_probs=113.6

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeC------Ce
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV------TE  203 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~------~~  203 (284)
                      ++|...+.||+|+||.||+|.. .+|+.||||++...... .....+.+|+.+++.++||||+++++++...      ..
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            5688889999999999999985 47889999998643322 2334688999999999999999999998654      56


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .++++||+ +++|.+++...     .+++..+..++.|+++||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       109 ~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DF  176 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF  176 (367)
T ss_dssp             CEEEEECC-CEECC-----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-
T ss_pred             EEEEeccc-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeec
Confidence            79999999 68999988642     489999999999999999999999   9999999999999999999999998

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.92  E-value=3.7e-25  Score=190.71  Aligned_cols=145  Identities=29%  Similarity=0.503  Sum_probs=121.6

Q ss_pred             HhcCCCCCCeecccCceEEEEEEe--CCCcEEEEEEeecccCcc-cHHHHHHHHHHHhcC---CCCCceeeeeEEe----
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRL--ADGKLVAVKRLKEERTSG-GELQFQTEVKIISMA---VHRNLLRLYGFCT----  199 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~---~h~niv~l~g~~~----  199 (284)
                      ..++|...+.||+|+||.||+|+.  .+++.||+|.++...... ....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            346788889999999999999987  467899999986543222 223566777776655   8999999999987    


Q ss_pred             -eCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchh
Q 023282          200 -TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  278 (284)
Q Consensus       200 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~  278 (284)
                       .....++||||++ |+|.+++.....  ..+++..+..++.|++.||.|||+.   +++||||||+|||++.++.++|+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence             4567899999998 699999986432  2489999999999999999999999   99999999999999999999999


Q ss_pred             hh
Q 023282          279 TI  280 (284)
Q Consensus       279 df  280 (284)
                      ||
T Consensus       163 Df  164 (326)
T 1blx_A          163 DF  164 (326)
T ss_dssp             SC
T ss_pred             cC
Confidence            98

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.92  E-value=3e-25  Score=190.48  Aligned_cols=139  Identities=26%  Similarity=0.391  Sum_probs=114.9

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEe-----------
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCT-----------  199 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~-----------  199 (284)
                      ++|...+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.           
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            46777899999999999999975 58899999986432 233456889999999999999999999874           


Q ss_pred             ---eCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeC-CCCCc
Q 023282          200 ---TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-EDADQ  275 (284)
Q Consensus       200 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld-~~~~~  275 (284)
                         .....++||||++ |+|.+++...     .+++..+..++.|++.||+|||+.   +|+||||||+|||++ .++.+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG-----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC-----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeE
Confidence               3457899999998 6999999642     488999999999999999999999   999999999999997 56689


Q ss_pred             chhhh
Q 023282          276 SSKTI  280 (284)
Q Consensus       276 ~~~df  280 (284)
                      ||+||
T Consensus       161 kl~Df  165 (320)
T 2i6l_A          161 KIGDF  165 (320)
T ss_dssp             EECCC
T ss_pred             EEccC
Confidence            99998

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.92  E-value=1.2e-25  Score=190.58  Aligned_cols=142  Identities=35%  Similarity=0.451  Sum_probs=115.1

Q ss_pred             cCCCCCCeecccCceEEEEEEeC--CCc--EEEEEEeecccCc--ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA--DGK--LVAVKRLKEERTS--GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  205 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~  205 (284)
                      ++|+..+.||+|+||+||+|++.  ++.  .||+|.++.....  .....+.+|+.+++.++||||+++++++.... .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            45777899999999999999852  333  6899988654322  23457899999999999999999999998754 88


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +|+||+++|+|.+++.....   .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+||
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Df  165 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDF  165 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCC
T ss_pred             eeEecccCCCHHHHHHhccC---CcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccc
Confidence            99999999999999986432   478999999999999999999999   9999999999999999999999998

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.92  E-value=4.7e-26  Score=195.74  Aligned_cols=147  Identities=24%  Similarity=0.457  Sum_probs=125.5

Q ss_pred             HHHHHHhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCe
Q 023282          125 RELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  203 (284)
Q Consensus       125 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~  203 (284)
                      .++....++|...+.||+|+||.||+|...+  .+|+|.++..... .....+.+|+.+++.++||||+++++++...+.
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence            4445556788899999999999999998754  4999998654322 223457889999999999999999999999999


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .+++|||+++++|.+++....   ..+++..+..++.|++.||+|||+.   +++||||||+|||++ ++.++|+||
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Df  173 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDF  173 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCC
T ss_pred             eEEEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeec
Confidence            999999999999999997643   2588999999999999999999999   999999999999998 679999998

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.92  E-value=2.3e-25  Score=198.95  Aligned_cols=139  Identities=29%  Similarity=0.446  Sum_probs=114.3

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeC----C--eee
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV----T--EKL  205 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~----~--~~~  205 (284)
                      .|...+.||+|+||.||+|+.. +++.||||++.....     .+.+|+++++.++||||+++++++...    +  ..+
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            4666789999999999999975 689999999864321     234799999999999999999998542    1  367


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCC-CCcchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~-~~~~~~df  280 (284)
                      +||||+++ ++.+.+.........+++..+..++.|+++||+|||+.   +|+||||||+|||++.+ +.+||+||
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DF  201 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDF  201 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccc
Confidence            89999985 67776654222234689999999999999999999998   99999999999999966 46799998

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.92  E-value=3.4e-25  Score=194.76  Aligned_cols=139  Identities=22%  Similarity=0.367  Sum_probs=121.3

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcc-cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCee-----
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK-----  204 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~-----  204 (284)
                      ++|...+.||+|+||.||+|... +++.||+|++....... ....+.+|+.+++.++||||+++++++...+..     
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            46777899999999999999864 68899999996543322 234688999999999999999999999876654     


Q ss_pred             -eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 -LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 -~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                       ++||||+. ++|.+.+..      .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus       122 ~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Df  188 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF  188 (371)
T ss_dssp             CEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECST
T ss_pred             EEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEec
Confidence             99999998 688888743      389999999999999999999999   9999999999999999999999998

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.92  E-value=2.2e-25  Score=192.68  Aligned_cols=143  Identities=27%  Similarity=0.380  Sum_probs=121.1

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCC-CCCceeeeeEEee--------C
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTT--------V  201 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~--------~  201 (284)
                      .+|...+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.++..+. ||||+++++++..        .
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            45777899999999999999964 78899999985432 233446889999999996 9999999999842        3


Q ss_pred             CeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeeeCCCCCCeeeCCCCCcchhh
Q 023282          202 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK--IIHRDVKAANILLDEDADQSSKT  279 (284)
Q Consensus       202 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~--ivHrdlk~~NiLld~~~~~~~~d  279 (284)
                      ...+++|||+. |+|.+++..... ...+++..+..++.|++.||.|||+.   +  |+||||||+|||++.++.++|+|
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence            34789999996 799999875322 23589999999999999999999998   6  99999999999999999999999


Q ss_pred             h
Q 023282          280 I  280 (284)
Q Consensus       280 f  280 (284)
                      |
T Consensus       182 f  182 (337)
T 3ll6_A          182 F  182 (337)
T ss_dssp             C
T ss_pred             C
Confidence            8

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.92  E-value=1.9e-25  Score=196.28  Aligned_cols=140  Identities=11%  Similarity=0.021  Sum_probs=103.9

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc--ccHHHHHHHH---HHHhcCCCCCceeee-------eEEe
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS--GGELQFQTEV---KIISMAVHRNLLRLY-------GFCT  199 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~---~~l~~~~h~niv~l~-------g~~~  199 (284)
                      .|...+.||+|+||.||+|+.. +++.||||+++.....  .....+.+|+   ..++. +||||++++       +++.
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhee
Confidence            4677889999999999999964 7889999999765432  2233577774   55566 799988755       4443


Q ss_pred             eC-----------------CeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHH------HHHHHHHHHHHHHHHcCCCCC
Q 023282          200 TV-----------------TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTR------KKIALGSARGLSYLHEHCDPK  256 (284)
Q Consensus       200 ~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~------~~i~~~i~~gl~yLH~~~~~~  256 (284)
                      ..                 ...++||||++ |+|.+++.....   .+.+..+      ..++.|++.||+|||+.   +
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~  214 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSK---G  214 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence            32                 23799999999 899999986422   2344455      78889999999999999   9


Q ss_pred             eeeeCCCCCCeeeCCCCCcchhhh
Q 023282          257 IIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       257 ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+||||||+|||++.++.+||+||
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DF  238 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDV  238 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCG
T ss_pred             CccCcCCHHHEEECCCCCEEEEec
Confidence            999999999999999999999998

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.92  E-value=1.4e-25  Score=195.31  Aligned_cols=141  Identities=18%  Similarity=0.193  Sum_probs=115.3

Q ss_pred             cCCCCCCeecccCceEEEEEEeC----CCcEEEEEEeecccCcc----------cHHHHHHHHHHHhcCCCCCceeeeeE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSG----------GELQFQTEVKIISMAVHRNLLRLYGF  197 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~~~h~niv~l~g~  197 (284)
                      ++|...+.||+|+||.||+|...    ++..+|+|.+.......          ....+.+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            45777899999999999999865    56789999986442210          11236678889999999999999999


Q ss_pred             Eee----CCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC
Q 023282          198 CTT----VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  273 (284)
Q Consensus       198 ~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~  273 (284)
                      +..    ....++||||+ +++|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence            987    67889999999 999999997643    589999999999999999999999   999999999999999888


Q ss_pred             --Ccchhhh
Q 023282          274 --DQSSKTI  280 (284)
Q Consensus       274 --~~~~~df  280 (284)
                        .++|+||
T Consensus       189 ~~~~kL~Df  197 (345)
T 2v62_A          189 PDQVYLADY  197 (345)
T ss_dssp             TTSEEECCC
T ss_pred             CCcEEEEeC
Confidence              9999998

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.92  E-value=6e-25  Score=191.98  Aligned_cols=150  Identities=21%  Similarity=0.294  Sum_probs=113.0

Q ss_pred             HHHHHHhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCe
Q 023282          125 RELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE  203 (284)
Q Consensus       125 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~  203 (284)
                      .+.....++|...+.||+|+||.||+|+.. ++..||||++......  ...+.+|++.++.++||||+++++++.....
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC--CCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc--cHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            344566788999999999999999999964 6889999988643322  2346678888889999999999999976443


Q ss_pred             -------eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCCeeeeCCCCCCeeeCC-CC
Q 023282          204 -------KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH--EHCDPKIIHRDVKAANILLDE-DA  273 (284)
Q Consensus       204 -------~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH--~~~~~~ivHrdlk~~NiLld~-~~  273 (284)
                             .++||||+++ +|.+.+.........+++..+..++.|++.||.|||  +.   +|+||||||+|||++. ++
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred             ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence                   7899999985 666555542223346889999999999999999999  76   9999999999999997 89


Q ss_pred             Ccchhhh
Q 023282          274 DQSSKTI  280 (284)
Q Consensus       274 ~~~~~df  280 (284)
                      .+||+||
T Consensus       170 ~~kl~Df  176 (360)
T 3e3p_A          170 TLKLCDF  176 (360)
T ss_dssp             EEEECCC
T ss_pred             cEEEeeC
Confidence            9999998

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.92  E-value=4.9e-25  Score=195.27  Aligned_cols=139  Identities=25%  Similarity=0.404  Sum_probs=114.1

Q ss_pred             CCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCe------eeE
Q 023282          133 GFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTE------KLL  206 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~------~~l  206 (284)
                      +|...++||+|+||.||+|+...+..+|+|++......     ..+|+++++.++||||+++++++.....      .++
T Consensus        41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            46778999999999999999877777999988543221     2369999999999999999999865433      789


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeC-CCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-EDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld-~~~~~~~~df  280 (284)
                      ||||++++ +.+.+.........+++..+..++.|+++||+|||+.   +|+||||||+|||++ .++.+||+||
T Consensus       116 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DF  186 (394)
T 4e7w_A          116 VLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDF  186 (394)
T ss_dssp             EEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             EeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeC
Confidence            99999865 4444432212223589999999999999999999999   999999999999999 7899999998

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.92  E-value=7.5e-25  Score=196.13  Aligned_cols=141  Identities=21%  Similarity=0.310  Sum_probs=121.0

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcC------CCCCceeeeeEEeeCCee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMA------VHRNLLRLYGFCTTVTEK  204 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~------~h~niv~l~g~~~~~~~~  204 (284)
                      .+|...+.||+|+||.||+|... +++.||||+++...  .....+.+|+.++..+      +|+||+++++++......
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            45788899999999999999864 68899999996432  2234567787777655      678999999999999999


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCC--cchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD--QSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~--~~~~df  280 (284)
                      ++||||+. ++|.+++.....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.  +||+||
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DF  246 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDF  246 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred             EEEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeec
Confidence            99999996 699999986432  3489999999999999999999999   9999999999999999987  899998

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.92  E-value=1.3e-25  Score=195.98  Aligned_cols=137  Identities=20%  Similarity=0.245  Sum_probs=119.0

Q ss_pred             cCCCCCCeecccCceEEEEEEeCC---------CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCcee---------
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLAD---------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR---------  193 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~---------  193 (284)
                      ++|...+.||+|+||.||+|+...         ++.||+|.+...      ..+.+|+++++.++||||++         
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            467788999999999999998653         788999998643      25789999999999999988         


Q ss_pred             ------eeeEEee-CCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCC
Q 023282          194 ------LYGFCTT-VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN  266 (284)
Q Consensus       194 ------l~g~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~N  266 (284)
                            +++++.. ....++||||+ +++|.+++....  ...+++..+..++.|++.||.|||+.   +|+||||||+|
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N  189 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN  189 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence                  6777776 67889999999 999999998642  12589999999999999999999999   99999999999


Q ss_pred             eeeCCCC--Ccchhhh
Q 023282          267 ILLDEDA--DQSSKTI  280 (284)
Q Consensus       267 iLld~~~--~~~~~df  280 (284)
                      ||++.++  .++|+||
T Consensus       190 Il~~~~~~~~~kl~Df  205 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGY  205 (352)
T ss_dssp             EEEETTEEEEEEECCG
T ss_pred             EEEcCCCCceEEEecC
Confidence            9999998  8999998

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.92  E-value=4.6e-25  Score=192.48  Aligned_cols=139  Identities=22%  Similarity=0.362  Sum_probs=120.5

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcc-cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCe------
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTE------  203 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~------  203 (284)
                      ++|...+.||+|+||.||+|... +|+.||||.+....... ....+.+|+.+++.++||||+++++++.....      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            46777899999999999999864 68899999986543222 23468899999999999999999999987654      


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .+++|||++ |+|.+++..      .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus       104 ~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Df  170 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF  170 (353)
T ss_dssp             CEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECST
T ss_pred             EEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeec
Confidence            499999997 688877742      388999999999999999999999   9999999999999999999999998

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.92  E-value=1.6e-25  Score=191.97  Aligned_cols=146  Identities=23%  Similarity=0.367  Sum_probs=117.7

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcc-----cHHHHHHHHHHHhcC----CCCCceeeeeE
Q 023282          128 QVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-----GELQFQTEVKIISMA----VHRNLLRLYGF  197 (284)
Q Consensus       128 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~~----~h~niv~l~g~  197 (284)
                      ....++|...+.||+|+||.||+|+. .+++.||+|.+.......     ....+.+|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            34456789999999999999999985 478899999996443211     122466788888887    89999999999


Q ss_pred             EeeCCeeeEEEeC-CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeC-CCCCc
Q 023282          198 CTTVTEKLLVYPY-MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-EDADQ  275 (284)
Q Consensus       198 ~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld-~~~~~  275 (284)
                      +...+..++++|| +++++|.+++....    .+++..+..++.|++.||.|||+.   +|+||||||+||+++ .++.+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence            9988999999999 78999999998643    489999999999999999999999   999999999999999 88899


Q ss_pred             chhhh
Q 023282          276 SSKTI  280 (284)
Q Consensus       276 ~~~df  280 (284)
                      +|+||
T Consensus       180 kl~df  184 (312)
T 2iwi_A          180 KLIDF  184 (312)
T ss_dssp             EECCC
T ss_pred             EEEEc
Confidence            99998

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.91  E-value=7.6e-25  Score=189.02  Aligned_cols=147  Identities=23%  Similarity=0.338  Sum_probs=122.2

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHH-HHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVK-IISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~-~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      .++|...+.||+|+||.||++... +++.||||.++.........++..|+. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            467788899999999999999964 788999999975543333445666666 778899999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQ-SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~-~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++ +|.+++.... .....+++..+..++.|++.||.|||+..  +++||||||+|||++.++.+||+||
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Df  170 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDF  170 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCC
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccC
Confidence            99985 8888776311 11235899999999999999999999842  7999999999999999999999998

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.91  E-value=7.3e-25  Score=194.78  Aligned_cols=140  Identities=24%  Similarity=0.357  Sum_probs=111.2

Q ss_pred             CCC-CCeecccCceEEEEEEeC---CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEee--CCeeeEE
Q 023282          134 FSN-KNILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEKLLV  207 (284)
Q Consensus       134 ~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~--~~~~~lv  207 (284)
                      |.. .++||+|+||.||+|+..   ++..||+|.+....   ....+.+|+.+++.++||||+++++++..  ....++|
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS---CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC---CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            443 468999999999999864   57789999986432   23468899999999999999999999964  6678999


Q ss_pred             EeCCCCCChHHHHhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeee----CCCCCcchh
Q 023282          208 YPYMTNGSVASRLRERQ-----SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL----DEDADQSSK  278 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLl----d~~~~~~~~  278 (284)
                      |||++ |+|.+++....     .....+++..+..++.|++.||+|||+.   +|+||||||+|||+    +.++.+||+
T Consensus        99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            99997 58888876321     1122489999999999999999999999   99999999999999    778899999


Q ss_pred             hh
Q 023282          279 TI  280 (284)
Q Consensus       279 df  280 (284)
                      ||
T Consensus       175 Df  176 (405)
T 3rgf_A          175 DM  176 (405)
T ss_dssp             CT
T ss_pred             EC
Confidence            98

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.91  E-value=4.8e-25  Score=189.93  Aligned_cols=144  Identities=22%  Similarity=0.358  Sum_probs=125.0

Q ss_pred             HhcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcc-----cHHHHHHHHHHHhcCC--CCCceeeeeEEeeC
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-----GELQFQTEVKIISMAV--HRNLLRLYGFCTTV  201 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~~~--h~niv~l~g~~~~~  201 (284)
                      ..++|...+.||+|+||.||+|.. .+++.||||.++......     ....+.+|+.+++.++  |+||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            346688889999999999999985 478899999997543322     1235778999999886  59999999999999


Q ss_pred             CeeeEEEeCCCC-CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeC-CCCCcchhh
Q 023282          202 TEKLLVYPYMTN-GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-EDADQSSKT  279 (284)
Q Consensus       202 ~~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld-~~~~~~~~d  279 (284)
                      +..++++||+.+ ++|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++ .++.+||+|
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred             CcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEee
Confidence            999999999976 89999998643    488999999999999999999999   999999999999999 778999999


Q ss_pred             h
Q 023282          280 I  280 (284)
Q Consensus       280 f  280 (284)
                      |
T Consensus       194 f  194 (320)
T 3a99_A          194 F  194 (320)
T ss_dssp             C
T ss_pred             C
Confidence            8

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.91  E-value=2.2e-24  Score=183.13  Aligned_cols=140  Identities=22%  Similarity=0.283  Sum_probs=118.1

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEE-eeCCeeeEEE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC-TTVTEKLLVY  208 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~-~~~~~~~lv~  208 (284)
                      .++|...+.||+|+||.||+|+. .+++.||+|++.....   ...+.+|+.+++.++|++++..++++ ......+++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            46788899999999999999985 5788999998754322   22578899999999998888777766 5567789999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeee---CCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLl---d~~~~~~~~df  280 (284)
                      ||+ +++|.+++.....   .+++..+..++.|++.||.|||+.   +|+||||||+|||+   +.++.+||+||
T Consensus        85 e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Df  152 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDF  152 (296)
T ss_dssp             ECC-CCBHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCC
T ss_pred             Ecc-CCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecC
Confidence            999 9999999975322   489999999999999999999999   99999999999999   78899999998

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.91  E-value=3.6e-24  Score=181.95  Aligned_cols=140  Identities=22%  Similarity=0.283  Sum_probs=120.4

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEE-eeCCeeeEEE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC-TTVTEKLLVY  208 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~-~~~~~~~lv~  208 (284)
                      .++|...+.||+|+||.||+|+. .+++.||+|++.....   ...+.+|+.+++.++|++++..++++ ......++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            35688889999999999999995 5789999999864332   23588999999999998877777665 5566789999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeee---CCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLl---d~~~~~~~~df  280 (284)
                      ||+ +++|.+++.....   .+++..+..++.|++.||.|||+.   +|+||||||+|||+   +.++.+||+||
T Consensus        85 e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df  152 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDF  152 (296)
T ss_dssp             ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred             Eec-CCCHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence            999 8999999975332   589999999999999999999999   99999999999999   58889999998

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.91  E-value=4.5e-24  Score=185.08  Aligned_cols=139  Identities=23%  Similarity=0.289  Sum_probs=113.8

Q ss_pred             cCCCCC-CeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEee----CCeee
Q 023282          132 DGFSNK-NILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT----VTEKL  205 (284)
Q Consensus       132 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~----~~~~~  205 (284)
                      ++|... ++||+|+||.||+|... +++.||+|++...     .....+....+..++||||+++++++..    ....+
T Consensus        28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            456663 57999999999999865 6899999998542     1122223334677899999999999876    34579


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCC---CCcchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED---ADQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~---~~~~~~df  280 (284)
                      +||||+++|+|.+++.....  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.+   +.++|+||
T Consensus       103 lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Df  175 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDF  175 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             EEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecc
Confidence            99999999999999986432  3589999999999999999999999   99999999999999874   45999998

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.91  E-value=1e-24  Score=201.39  Aligned_cols=131  Identities=15%  Similarity=0.139  Sum_probs=103.1

Q ss_pred             ecccCceEEEEEE-eCCCcEEEEEEeecccCc---------ccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCCeeeEEE
Q 023282          140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTS---------GGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       140 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---------~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      .+.|++|.+..++ .-.|+.+|||.+......         ...++|.+|+++|+++ .|+||+++++++.+....||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4455555555443 234788999999654211         1123699999999999 6999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||++|++|.+.|....    +++..   +|+.||+.||+|+|++   +||||||||+|||++.++.+||+||
T Consensus       322 Eyv~G~~L~d~i~~~~----~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DF  383 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE----EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDF  383 (569)
T ss_dssp             ECCCSEEHHHHHHTTC----CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCC
T ss_pred             ecCCCCcHHHHHHhCC----CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeec
Confidence            9999999999998643    35543   5889999999999999   9999999999999999999999999

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.91  E-value=1.7e-24  Score=185.77  Aligned_cols=142  Identities=21%  Similarity=0.276  Sum_probs=123.9

Q ss_pred             HhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCC--CCCceeeeeEEeeCCeeeE
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAV--HRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~--h~niv~l~g~~~~~~~~~l  206 (284)
                      ..++|...+.||+|+||.||++...+++.||+|.+...... .....+.+|+.++..++  ||||+++++++...+..++
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            34567888999999999999999888999999998654332 23346899999999997  5999999999999999999


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +|| +.+++|.+++....    .+++..+..++.|+++||.|||+.   +++||||||+|||+++ +.+||+||
T Consensus       106 v~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Df  170 (313)
T 3cek_A          106 VME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDF  170 (313)
T ss_dssp             EEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCC
T ss_pred             EEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeec
Confidence            999 56889999998643    488999999999999999999999   9999999999999974 88999998

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.91  E-value=2.6e-24  Score=185.96  Aligned_cols=141  Identities=22%  Similarity=0.328  Sum_probs=121.1

Q ss_pred             cCCCCCCeecccCceEEEEEEe--CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCC------CceeeeeEEeeCCe
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL--ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR------NLLRLYGFCTTVTE  203 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~------niv~l~g~~~~~~~  203 (284)
                      ++|...+.||+|+||.||++..  .+++.||+|+++..  ......+.+|+.++..++|+      +++++++++...+.
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            5678889999999999999986  36789999998642  12234678899888877655      49999999999999


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC------------
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE------------  271 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~------------  271 (284)
                      .++||||+ +++|.+++.....  .++++..+..++.|++.||+|||+.   +|+||||||+|||++.            
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             EEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccc
Confidence            99999999 8899999986432  3588999999999999999999999   9999999999999998            


Q ss_pred             -------CCCcchhhh
Q 023282          272 -------DADQSSKTI  280 (284)
Q Consensus       272 -------~~~~~~~df  280 (284)
                             ++.++|+||
T Consensus       166 ~~~~~~~~~~~kl~Df  181 (339)
T 1z57_A          166 RDERTLINPDIKVVDF  181 (339)
T ss_dssp             CEEEEESCCCEEECCC
T ss_pred             cccccccCCCceEeeC
Confidence                   667999998

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.91  E-value=6.2e-24  Score=192.47  Aligned_cols=140  Identities=20%  Similarity=0.253  Sum_probs=119.8

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCC-CCceeeeeEEeeCCeeeEEE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH-RNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h-~niv~l~g~~~~~~~~~lv~  208 (284)
                      .++|...+.||+|+||.||+|+. .+++.||||++.....   ..++..|++++..++| +++..+..++......++||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            35788899999999999999985 5789999998864432   2257899999999987 55556666667788899999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeee---CCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL---DEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLl---d~~~~~~~~df  280 (284)
                      ||+ +++|.+++.....   .+++..++.++.|++.||.|||+.   +|+||||||+|||+   +.++.+||+||
T Consensus        83 e~~-g~sL~~ll~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DF  150 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDF  150 (483)
T ss_dssp             ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCC
T ss_pred             ECC-CCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeC
Confidence            999 9999999975322   589999999999999999999999   99999999999999   68899999998

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.91  E-value=4.2e-25  Score=205.40  Aligned_cols=145  Identities=26%  Similarity=0.368  Sum_probs=123.6

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEee------CCee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT------VTEK  204 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~------~~~~  204 (284)
                      ++|...+.||+|+||.||+|.. .++..||||.++..........+.+|+++++.++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            6789999999999999999986 46889999998755444445578999999999999999999998755      5678


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCC---cchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD---QSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~---~~~~df  280 (284)
                      ++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.   ++|+||
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             EEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence            999999999999999986432 23578889999999999999999998   9999999999999998776   788887

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.91  E-value=1.9e-24  Score=191.06  Aligned_cols=135  Identities=25%  Similarity=0.364  Sum_probs=112.1

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCC--------CCCceeeeeEEe---
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV--------HRNLLRLYGFCT---  199 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~--------h~niv~l~g~~~---  199 (284)
                      ++|...+.||+|+||+||+|+. .+++.||+|+++..  ......+.+|+.+++.++        |+||+++++++.   
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            5688889999999999999985 46889999998642  223346889999998875        788999999987   


Q ss_pred             -eCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC
Q 023282          200 -TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA  273 (284)
Q Consensus       200 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~  273 (284)
                       .....++||||+ +++|.+.+....  ...+++..+..++.|++.||.|||+++  +|+||||||+|||++.++
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~  184 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccc
Confidence             455789999999 567777776532  235899999999999999999999864  799999999999999875

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.91  E-value=4e-24  Score=183.49  Aligned_cols=143  Identities=24%  Similarity=0.381  Sum_probs=112.2

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHH-HHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~-~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      .++|+..+.||+|+||.||+|... +++.||||.+..........+ +.++..+++.++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            356777889999999999999975 789999999975543333333 444555788899999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+ ++.+..+.....   ..+++..+..++.|+++||.|||+ .   +++||||||+||+++.++.++|+||
T Consensus       104 e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~df  169 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDF  169 (318)
T ss_dssp             CCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             ecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEEC
Confidence            999 445555544322   258999999999999999999998 5   7999999999999999999999998

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.90  E-value=2e-24  Score=193.72  Aligned_cols=138  Identities=25%  Similarity=0.234  Sum_probs=111.0

Q ss_pred             CCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCCeeeEEEeCCCC
Q 023282          135 SNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPYMTN  213 (284)
Q Consensus       135 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~~lv~e~~~~  213 (284)
                      ...++||+|+||+||.+...+|+.||||++...    ....+.+|+.++..+ +||||+++++++......++||||+. 
T Consensus        18 ~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-   92 (434)
T 2rio_A           18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-   92 (434)
T ss_dssp             EEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred             eccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence            345789999999998766668999999998643    234578899999875 89999999999999999999999996 


Q ss_pred             CChHHHHhhcCCCCCC---CCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCC-------------CCcch
Q 023282          214 GSVASRLRERQSSLPP---LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-------------ADQSS  277 (284)
Q Consensus       214 g~L~~~l~~~~~~~~~---l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~-------------~~~~~  277 (284)
                      |+|.+++.........   .++..+..++.|++.||+|||+.   +|+||||||+|||++.+             +.++|
T Consensus        93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL  169 (434)
T 2rio_A           93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI  169 (434)
T ss_dssp             EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred             CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence            6999999864322111   13334578999999999999999   99999999999999754             47899


Q ss_pred             hhh
Q 023282          278 KTI  280 (284)
Q Consensus       278 ~df  280 (284)
                      +||
T Consensus       170 ~DF  172 (434)
T 2rio_A          170 SDF  172 (434)
T ss_dssp             CCC
T ss_pred             ccc
Confidence            998

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.90  E-value=7.9e-24  Score=189.55  Aligned_cols=138  Identities=22%  Similarity=0.287  Sum_probs=113.1

Q ss_pred             cCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      .+|...++||+|+||+||.....+++.||||++.....    ..+.+|+.+++.+ +||||+++++++......++||||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            35777789999999996655556789999999864322    2356899999988 799999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCC-----CCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-----ADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~-----~~~~~~df  280 (284)
                      ++ |+|.+++......   ..+.....++.|++.||.|||+.   +|+||||||+|||++.+     ..++|+||
T Consensus       100 ~~-g~L~~~l~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DF  167 (432)
T 3p23_A          100 CA-ATLQEYVEQKDFA---HLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDF  167 (432)
T ss_dssp             CS-EEHHHHHHSSSCC---CCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred             CC-CCHHHHHHhcCCC---ccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence            96 6999999865432   33445678999999999999999   99999999999999532     35679998

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=1.3e-23  Score=177.70  Aligned_cols=138  Identities=13%  Similarity=0.072  Sum_probs=110.2

Q ss_pred             HHHHHHHhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcc-----------------cHHHHHHHHHHHhcC
Q 023282          124 LRELQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSG-----------------GELQFQTEVKIISMA  186 (284)
Q Consensus       124 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~~e~~~l~~~  186 (284)
                      +..+......|...+.||+|+||.||+|...+|+.||+|.++......                 ....+.+|+.+++.+
T Consensus        82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l  161 (282)
T 1zar_A           82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL  161 (282)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence            344455555667779999999999999998779999999986432211                 134588999999999


Q ss_pred             CCCCceeeeeEEeeCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCC
Q 023282          187 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAAN  266 (284)
Q Consensus       187 ~h~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~N  266 (284)
                      +  | +++.+++.. +..++||||+++|+|.+ +..          .....++.|++.||.|||+.   +|+||||||+|
T Consensus       162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~N  223 (282)
T 1zar_A          162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYN  223 (282)
T ss_dssp             T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred             c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHH
Confidence            8  5 677775544 56799999999999988 421          12457999999999999999   99999999999


Q ss_pred             eeeCCCCCcchhhh
Q 023282          267 ILLDEDADQSSKTI  280 (284)
Q Consensus       267 iLld~~~~~~~~df  280 (284)
                      ||++ ++.++|+||
T Consensus       224 ILl~-~~~vkl~DF  236 (282)
T 1zar_A          224 VLVS-EEGIWIIDF  236 (282)
T ss_dssp             EEEE-TTEEEECCC
T ss_pred             EEEE-CCcEEEEEC
Confidence            9999 999999998

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.89  E-value=2e-23  Score=184.05  Aligned_cols=145  Identities=23%  Similarity=0.310  Sum_probs=120.0

Q ss_pred             HhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCC-CC-----CceeeeeEEeeCC
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HR-----NLLRLYGFCTTVT  202 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~-----niv~l~g~~~~~~  202 (284)
                      ..++|...+.||+|+||+||+|... +++.||||+++...  ....++..|+.++..++ |+     +++++++++...+
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            3567888899999999999999865 68899999996421  22345777888887775 44     4999999999999


Q ss_pred             eeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeC--CCCCcchhhh
Q 023282          203 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD--EDADQSSKTI  280 (284)
Q Consensus       203 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld--~~~~~~~~df  280 (284)
                      ..++||||++ |+|.+++.....  ..+++..+..++.|++.||.|||++ ..+|+||||||+|||++  .++.+||+||
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             ceEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            9999999996 599999986432  3489999999999999999999953 23899999999999994  5778999998

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.89  E-value=2e-23  Score=181.66  Aligned_cols=141  Identities=19%  Similarity=0.328  Sum_probs=119.4

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CC-cEEEEEEeecccCcccHHHHHHHHHHHhcCCCCC------ceeeeeEEeeCCe
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DG-KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN------LLRLYGFCTTVTE  203 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n------iv~l~g~~~~~~~  203 (284)
                      ++|...+.||+|+||.||++... ++ ..||+|+++..  ......+.+|+.+++.++|++      ++.+.+++...+.
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            56788899999999999999864 44 68999998642  223346788999998887665      8999999999999


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeee--------------
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILL--------------  269 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLl--------------  269 (284)
                      .++||||+ ++++.+++....  ...+++..+..++.|++.||+|||+.   +|+||||||+|||+              
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             EEEEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccc
Confidence            99999999 677888876643  23589999999999999999999998   99999999999999              


Q ss_pred             -----CCCCCcchhhh
Q 023282          270 -----DEDADQSSKTI  280 (284)
Q Consensus       270 -----d~~~~~~~~df  280 (284)
                           +.++.++|+||
T Consensus       171 ~~~~~~~~~~~kl~Df  186 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADF  186 (355)
T ss_dssp             CCEEEESCCCEEECCC
T ss_pred             ccccccCCCcEEEeec
Confidence                 66789999998

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.89  E-value=2.9e-23  Score=190.60  Aligned_cols=127  Identities=15%  Similarity=0.253  Sum_probs=101.9

Q ss_pred             CCCeecccCceEEEEEEeCCCcEEEEEEeecccCccc-------HHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          136 NKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGG-------ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       136 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ..++||+|+||.||++.. .+..+++|..........       .+.+.+|++++++++||||+++..++...+..++||
T Consensus       340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            356899999999999954 567889998644322111       234799999999999999997777777888889999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++..            +..++.|+++||.|||++   +|+||||||+|||++.  .+||+||
T Consensus       419 E~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DF  473 (540)
T 3en9_A          419 SYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDF  473 (540)
T ss_dssp             ECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCC
T ss_pred             ECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEEC
Confidence            99999999999964            357899999999999999   9999999999999998  9999998

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.88  E-value=2e-23  Score=183.16  Aligned_cols=142  Identities=19%  Similarity=0.333  Sum_probs=118.7

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCC-----------CCCceeeeeEEe
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-----------HRNLLRLYGFCT  199 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-----------h~niv~l~g~~~  199 (284)
                      ++|...+.||+|+||.||+|+. .+++.||||.+....  .....+.+|+.+++.++           ||||+++++++.
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            4677889999999999999986 578899999986422  22346788999888776           899999999987


Q ss_pred             eCC----eeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeC-----
Q 023282          200 TVT----EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-----  270 (284)
Q Consensus       200 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld-----  270 (284)
                      ..+    ..+++|||+ +++|.+++.....  ..+++..+..++.|++.||+|||+.+  +|+||||||+|||++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCC
Confidence            644    689999999 8999999986432  24899999999999999999999853  799999999999994     


Q ss_pred             -CCCCcchhhh
Q 023282          271 -EDADQSSKTI  280 (284)
Q Consensus       271 -~~~~~~~~df  280 (284)
                       ..+.++|+||
T Consensus       172 ~~~~~~kl~Df  182 (373)
T 1q8y_A          172 ENLIQIKIADL  182 (373)
T ss_dssp             TTEEEEEECCC
T ss_pred             cCcceEEEccc
Confidence             4447899998

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.86  E-value=1.3e-22  Score=180.78  Aligned_cols=144  Identities=17%  Similarity=0.196  Sum_probs=107.3

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc--ccHHHHHHHHHHHhcCCC-CCceee---------eeE--
Q 023282          133 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVH-RNLLRL---------YGF--  197 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~~~h-~niv~l---------~g~--  197 (284)
                      .|...++||+|+||+||+|+. .+|+.||||+++.....  ...+.+.+|+.+++.++| +|....         ...  
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            355678899999999999995 57899999998733222  224578999999999987 322111         111  


Q ss_pred             ----------Eee-----CCeeeEEEeCCCCCChHHHHhhc---CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeee
Q 023282          198 ----------CTT-----VTEKLLVYPYMTNGSVASRLRER---QSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIH  259 (284)
Q Consensus       198 ----------~~~-----~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH  259 (284)
                                ...     ....+++|+++ +++|.+++...   ......++|..++.++.|+++||+|||+.   +|+|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiH  234 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH  234 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence                      111     12346666655 68999988521   12223578889999999999999999999   9999


Q ss_pred             eCCCCCCeeeCCCCCcchhhh
Q 023282          260 RDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       260 rdlk~~NiLld~~~~~~~~df  280 (284)
                      |||||+|||++.++.+||+||
T Consensus       235 rDiKp~NILl~~~~~~kL~DF  255 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGF  255 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCG
T ss_pred             CCcccceEEEecCCeEEEEec
Confidence            999999999999999999998

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.83  E-value=5.6e-21  Score=159.57  Aligned_cols=131  Identities=18%  Similarity=0.192  Sum_probs=99.7

Q ss_pred             CCCCCeecccCceEEEEEEe-CCCcE--EEEEEeecccCcc-----------------------cHHHHHHHHHHHhcCC
Q 023282          134 FSNKNILGRGGFGKVYKGRL-ADGKL--VAVKRLKEERTSG-----------------------GELQFQTEVKIISMAV  187 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~~-----------------------~~~~~~~e~~~l~~~~  187 (284)
                      |...+.||+|+||.||+|.. .+|+.  ||||+++......                       ....+.+|+..+..++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            45678899999999999987 67888  9999875432110                       0125788999999998


Q ss_pred             CCCc--eeeeeEEeeCCeeeEEEeCCCC-C----ChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeee
Q 023282          188 HRNL--LRLYGFCTTVTEKLLVYPYMTN-G----SVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH-EHCDPKIIH  259 (284)
Q Consensus       188 h~ni--v~l~g~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH-~~~~~~ivH  259 (284)
                      |+++  ..++++    ...++||||+.+ |    +|.++...       .++.....++.|++.||.||| +.   +|+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH  194 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH  194 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence            8764  333332    357899999942 4    66665432       123356789999999999999 87   9999


Q ss_pred             eCCCCCCeeeCCCCCcchhhh
Q 023282          260 RDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       260 rdlk~~NiLld~~~~~~~~df  280 (284)
                      |||||+|||++.  .++|+||
T Consensus       195 rDlkp~NILl~~--~~~liDF  213 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDM  213 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCC
T ss_pred             CCCCHHHEEEcC--cEEEEEC
Confidence            999999999998  8999998

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.76  E-value=1.3e-19  Score=158.01  Aligned_cols=139  Identities=16%  Similarity=0.121  Sum_probs=95.3

Q ss_pred             HHHHhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCc-------------ccHHHH--------HHHHHHHhc
Q 023282          127 LQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-------------GGELQF--------QTEVKIISM  185 (284)
Q Consensus       127 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~--------~~e~~~l~~  185 (284)
                      +.....-|.+.+.||+|+||.||+|...+|+.||||+++.....             ......        ..|...|.+
T Consensus        90 L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r  169 (397)
T 4gyi_A           90 HAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA  169 (397)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence            33333347888999999999999999889999999987532111             001111        234555555


Q ss_pred             CCCCCceeeeeEEeeCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCC
Q 023282          186 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAA  265 (284)
Q Consensus       186 ~~h~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~  265 (284)
                      +.+.++....-+..  ...++||||+++++|..+...          .....++.|++.+|.|||..   +||||||||.
T Consensus       170 L~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~  234 (397)
T 4gyi_A          170 LYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNEF  234 (397)
T ss_dssp             HHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTT
T ss_pred             HHhcCCCCCeeeec--cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHH
Confidence            54333321111111  234799999999888654321          12356789999999999998   9999999999


Q ss_pred             CeeeCCCCC----------cchhhh
Q 023282          266 NILLDEDAD----------QSSKTI  280 (284)
Q Consensus       266 NiLld~~~~----------~~~~df  280 (284)
                      |||++++++          +.|.||
T Consensus       235 NILl~~dgd~~d~~~~~~~~~iID~  259 (397)
T 4gyi_A          235 NILIREEKDAEDPSSITLTPIIIXF  259 (397)
T ss_dssp             SEEEEEEECSSCTTSEEEEEEECCC
T ss_pred             HEEEeCCCCcccccccccceEEEEe
Confidence            999998875          567776

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.39  E-value=8.7e-13  Score=109.80  Aligned_cols=141  Identities=12%  Similarity=0.054  Sum_probs=106.8

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCC-CCCceeeeeEEeeCCeeeEE
Q 023282          129 VATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       129 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~~~~~~lv  207 (284)
                      ...++|.....++.|+.+.||+.... +..+++|....... .....+.+|+++++.+. +..+.++++++...+..++|
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            34456777777888888999998754 67899998864321 12235888999998774 67788899999888899999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC----------------------------------
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC----------------------------------  253 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~----------------------------------  253 (284)
                      |||+++.+|.+.+...         .....++.+++++|+.||+..                                  
T Consensus        89 ~e~i~G~~l~~~~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           89 MSEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EECCSSEEHHHHCCTT---------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             EEecCCeehhhccCCc---------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            9999999988764211         123478889999999999810                                  


Q ss_pred             ----------------------CCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          254 ----------------------DPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       254 ----------------------~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                                            .+.++|+|++|.|||++.+....|.||
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDw  208 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDL  208 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCC
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEc
Confidence                                  135899999999999987655567776

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.25  E-value=5.7e-12  Score=104.37  Aligned_cols=124  Identities=14%  Similarity=0.048  Sum_probs=90.7

Q ss_pred             cccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCC--ceeeeeEEeeCCeeeEEEeCCCCCChHH
Q 023282          141 GRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN--LLRLYGFCTTVTEKLLVYPYMTNGSVAS  218 (284)
Q Consensus       141 g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n--iv~l~g~~~~~~~~~lv~e~~~~g~L~~  218 (284)
                      +.|..+.||+....+|..+++|.....    ....+..|+.+++.+.+.+  +.+++++....+..++||||+++.++. 
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence            456679999998777788999987543    1235778888888776444  456888887777889999999998884 


Q ss_pred             HHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------------------
Q 023282          219 RLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC---------------------------------------------  253 (284)
Q Consensus       219 ~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~---------------------------------------------  253 (284)
                       ...       .+   ...++.++++.|..||+..                                             
T Consensus       104 -~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (264)
T 1nd4_A          104 -SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  172 (264)
T ss_dssp             -TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             -cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence             211       11   2356777788888888641                                             


Q ss_pred             ----------CCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          254 ----------DPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       254 ----------~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                                .+.++|+|++|.|||++.+....+.||
T Consensus       173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~  209 (264)
T 1nd4_A          173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDC  209 (264)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCC
T ss_pred             HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcc
Confidence                      113999999999999987765668876

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.17  E-value=4.7e-11  Score=103.96  Aligned_cols=137  Identities=11%  Similarity=0.184  Sum_probs=98.7

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEee--cccCcccHHHHHHHHHHHhcCC--CCCceeeeeEEeeC---CeeeEEEe
Q 023282          137 KNILGRGGFGKVYKGRLADGKLVAVKRLK--EERTSGGELQFQTEVKIISMAV--HRNLLRLYGFCTTV---TEKLLVYP  209 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~e~~~l~~~~--h~niv~l~g~~~~~---~~~~lv~e  209 (284)
                      .+.++.|.++.||+....+ ..+++|+..  ..........+.+|+.+++.+.  +..+.++++++...   +..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            4678999999999988754 577888765  3221122336788999998876  45678888888765   34899999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC------------------------------------
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC------------------------------------  253 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~------------------------------------  253 (284)
                      |+++..+.+..      ...++..++..++.++++.|+.||+..                                    
T Consensus       122 ~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          122 FVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             CCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             ecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            99987774311      123677888899999999999999731                                    


Q ss_pred             -------------------CCCeeeeCCCCCCeeeCCCCC--cchhhh
Q 023282          254 -------------------DPKIIHRDVKAANILLDEDAD--QSSKTI  280 (284)
Q Consensus       254 -------------------~~~ivHrdlk~~NiLld~~~~--~~~~df  280 (284)
                                         .+.++|+|+++.|||++.++.  ..|.||
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDw  243 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDW  243 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCC
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECc
Confidence                               247999999999999998764  467775

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.57  E-value=1e-07  Score=80.85  Aligned_cols=131  Identities=20%  Similarity=0.159  Sum_probs=88.8

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCC-CCC--ceeeeeEEeeCC---eeeEEEeC
Q 023282          137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRN--LLRLYGFCTTVT---EKLLVYPY  210 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~n--iv~l~g~~~~~~---~~~lv~e~  210 (284)
                      .+.++.|....||+..    ..+++|.....   .....+.+|.++++.+. +..  +.+++.......   ..++|||+
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            4668999999999853    45788875422   22346889999987763 333  334444433222   35889999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC--------------------------------------
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH--------------------------------------  252 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~--------------------------------------  252 (284)
                      +++.++.+....      .++..++..++.++++.|+.||+.                                      
T Consensus        98 i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           98 IKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             CCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             cCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            999888654322      256666777788888888877751                                      


Q ss_pred             -----------------CCCCeeeeCCCCCCeeeCCC--CCcchhhh
Q 023282          253 -----------------CDPKIIHRDVKAANILLDED--ADQSSKTI  280 (284)
Q Consensus       253 -----------------~~~~ivHrdlk~~NiLld~~--~~~~~~df  280 (284)
                                       ..+.++|+|+++.||+++.+  ....+.||
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~  218 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDF  218 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCC
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeC
Confidence                             12458999999999999984  44667776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.38  E-value=1.8e-06  Score=73.17  Aligned_cols=75  Identities=12%  Similarity=0.086  Sum_probs=52.5

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCC---CceeeeeEEe-eCCeeeEEEeCCC
Q 023282          137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR---NLLRLYGFCT-TVTEKLLVYPYMT  212 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~---niv~l~g~~~-~~~~~~lv~e~~~  212 (284)
                      .+.++.|....||+.    +..+++|.-..   ......+..|.+++..+.+.   .+.+++.++. ..+..+++|||++
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            356888888899987    45677887421   12234688999999888642   3455666664 3455789999999


Q ss_pred             CCChHH
Q 023282          213 NGSVAS  218 (284)
Q Consensus       213 ~g~L~~  218 (284)
                      +..+.+
T Consensus        97 G~~l~~  102 (306)
T 3tdw_A           97 GQILGE  102 (306)
T ss_dssp             SEECHH
T ss_pred             CeECch
Confidence            988765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.34  E-value=2.8e-06  Score=70.42  Aligned_cols=129  Identities=18%  Similarity=0.135  Sum_probs=86.0

Q ss_pred             ecccCce-EEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCC-CCCceeeeeEEeeCCeeeEEEeCCCCCCh
Q 023282          140 LGRGGFG-KVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKLLVYPYMTNGSV  216 (284)
Q Consensus       140 lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~~~~~~lv~e~~~~g~L  216 (284)
                      +..|..| .||+.... ++..+.+|.-...    ....+.+|...++.+. +-.+-++++++...+..++|||++++.++
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            4445554 68987754 4567888876432    2335788888887664 34466788888888999999999999887


Q ss_pred             HHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcC--------------------------------------------
Q 023282          217 ASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH--------------------------------------------  252 (284)
Q Consensus       217 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~--------------------------------------------  252 (284)
                      .+......        .....++.++++.|.-||..                                            
T Consensus       108 ~~~~~~~~--------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          108 FQVLEEYP--------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             HHHHHHCG--------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             cccccCCH--------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            76543211        11233444555555555531                                            


Q ss_pred             -----------CCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          253 -----------CDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       253 -----------~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                                 ..+.++|+|+.+.|||++.+..+-|.||
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDw  218 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDV  218 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCC
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEEC
Confidence                       1123799999999999998766667775

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=98.22  E-value=4.1e-07  Score=86.91  Aligned_cols=46  Identities=48%  Similarity=0.814  Sum_probs=41.7

Q ss_pred             CccEEEccCCCCcccCCCCCCCCccCcccccCCcCCCCCCCCCCCCC
Q 023282            1 MTALRDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCSG   47 (284)
Q Consensus         1 ~~~~~dlS~N~lsG~iP~~~~~~~~~~~s~~gN~~lcg~~~~~~c~~   47 (284)
                      .|+.||||+|+|+|+||..++|.+|+..+|.||++|||.+.. +|..
T Consensus       705 ~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~  750 (768)
T 3rgz_A          705 MLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDP  750 (768)
T ss_dssp             CCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCS
T ss_pred             CCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCCC
Confidence            478999999999999999999999999999999999998765 7753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.17  E-value=2.5e-06  Score=73.80  Aligned_cols=80  Identities=8%  Similarity=-0.019  Sum_probs=52.2

Q ss_pred             Cee-cccCceEEEEEEeC-------CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCC-C--CCceeeeeEEeeC---
Q 023282          138 NIL-GRGGFGKVYKGRLA-------DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAV-H--RNLLRLYGFCTTV---  201 (284)
Q Consensus       138 ~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~-h--~niv~l~g~~~~~---  201 (284)
                      +.| +.|....+|+....       ++..+++|.......  ......+..|+.+++.+. +  ..+.++++++...   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            557 88888999988754       256788887643220  101134677888877664 2  3466777777554   


Q ss_pred             CeeeEEEeCCCCCChH
Q 023282          202 TEKLLVYPYMTNGSVA  217 (284)
Q Consensus       202 ~~~~lv~e~~~~g~L~  217 (284)
                      +..++||||+++..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3568999999876553

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.06  E-value=1.8e-05  Score=67.73  Aligned_cols=137  Identities=16%  Similarity=0.228  Sum_probs=73.8

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhc-----CCCCCceeee-e--EEeeCCeeeEEEe
Q 023282          138 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISM-----AVHRNLLRLY-G--FCTTVTEKLLVYP  209 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-----~~h~niv~l~-g--~~~~~~~~~lv~e  209 (284)
                      +.|+.|..+.||+....++ .+++|.....     ...+..|..++..     +..|.++... |  +....+..+++||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC-----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC-----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            4466677889999887655 4888987541     1223334444432     2234444311 1  1223567789999


Q ss_pred             CCCCCChH--------------HHHhhcCCCC----------CCCCHHHHH-----------------------------
Q 023282          210 YMTNGSVA--------------SRLRERQSSL----------PPLDWPTRK-----------------------------  236 (284)
Q Consensus       210 ~~~~g~L~--------------~~l~~~~~~~----------~~l~~~~~~-----------------------------  236 (284)
                      |+++..+.              ..+|......          ..-.|....                             
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986542              1222211100          012343211                             


Q ss_pred             --HHHHHHHHHHHHHHc----------CCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          237 --KIALGSARGLSYLHE----------HCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       237 --~i~~~i~~gl~yLH~----------~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                        .+...+.+++.+|+.          ...+.++|+|+++.|||++.++.+.+.||
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDf  247 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDL  247 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCC
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEeh
Confidence              011123345666653          02348999999999999988888888887

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.99  E-value=2.4e-05  Score=68.65  Aligned_cols=76  Identities=9%  Similarity=0.022  Sum_probs=47.7

Q ss_pred             CCeecccCceEEEEEEeC-CCcEEEEEEeecccC------cccHHHHHHHHHHHhcCCC--CC-ceeeeeEEeeCCeeeE
Q 023282          137 KNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT------SGGELQFQTEVKIISMAVH--RN-LLRLYGFCTTVTEKLL  206 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~e~~~l~~~~h--~n-iv~l~g~~~~~~~~~l  206 (284)
                      .+.+|.|.++.||++... ++..+++|.......      ......+..|.++++.+..  +. +.+++.+  ..+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            357899999999999754 467899997643211      0112346778888876532  33 3345543  3456789


Q ss_pred             EEeCCCCC
Q 023282          207 VYPYMTNG  214 (284)
Q Consensus       207 v~e~~~~g  214 (284)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.93  E-value=4.2e-05  Score=64.94  Aligned_cols=138  Identities=16%  Similarity=0.181  Sum_probs=89.0

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCC---CCCceeeeeEEeeCCeeeEEEeCCCC
Q 023282          137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV---HRNLLRLYGFCTTVTEKLLVYPYMTN  213 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~---h~niv~l~g~~~~~~~~~lv~e~~~~  213 (284)
                      .+.|+.|....+|+... ++..+++|.....    ....+..|.+.|+.+.   ...+.+++.++...+..++||||+++
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            45689999999999876 4667888876432    2345788888887663   35677888888777889999999998


Q ss_pred             CChH-----------HHHhhcCC-CC---------C--------CCCHHHHH---HHHH--H--------------HHHH
Q 023282          214 GSVA-----------SRLRERQS-SL---------P--------PLDWPTRK---KIAL--G--------------SARG  245 (284)
Q Consensus       214 g~L~-----------~~l~~~~~-~~---------~--------~l~~~~~~---~i~~--~--------------i~~g  245 (284)
                      ..+.           -.||.... ..         +        .-+|....   ++..  +              +.+.
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            7642           12333211 00         0        12465432   1111  1              1111


Q ss_pred             -HHHHHc-CCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          246 -LSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       246 -l~yLH~-~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                       ...|.. ...|.++|+|+.+.|++++.++ +.|.|+
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~  231 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNP  231 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcC
Confidence             223421 2357899999999999999887 777775

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.90  E-value=3.3e-05  Score=64.66  Aligned_cols=78  Identities=17%  Similarity=0.220  Sum_probs=53.7

Q ss_pred             CCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCC---CCceeeeeEEeeCCeeeEEEeC
Q 023282          134 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH---RNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h---~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +...+.+|.|..+.||+.+..+|+.+.+|+-..... .....|..|.+.|+.+.-   -.+.+++++    +..+++|||
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~-~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~   91 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP-ALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW   91 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC-CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc-chhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence            344567899999999999999999999998653322 222357889888876642   223344443    235789999


Q ss_pred             CCCCCh
Q 023282          211 MTNGSV  216 (284)
Q Consensus       211 ~~~g~L  216 (284)
                      ++.+..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.52  E-value=0.00032  Score=61.92  Aligned_cols=74  Identities=14%  Similarity=0.097  Sum_probs=44.5

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEeecccC---c-----ccHHHHHHHHHHHh-cCCCCCceeeeeEEeeCCeeeEE
Q 023282          137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERT---S-----GGELQFQTEVKIIS-MAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~-----~~~~~~~~e~~~l~-~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      .+.+|.|..+.||+... ++..++||.......   .     .....+..|+..+. ......+.+++.+.  .+..++|
T Consensus        39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv  115 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG  115 (420)
T ss_dssp             EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred             EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence            46789999999999865 466889995322110   0     02223444444332 22233455666654  5678999


Q ss_pred             EeCC-CC
Q 023282          208 YPYM-TN  213 (284)
Q Consensus       208 ~e~~-~~  213 (284)
                      |||+ ++
T Consensus       116 ~e~l~~g  122 (420)
T 2pyw_A          116 MRYLEPP  122 (420)
T ss_dssp             ECCCCTT
T ss_pred             EeecCCc
Confidence            9999 76

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.11  E-value=0.0018  Score=54.30  Aligned_cols=71  Identities=8%  Similarity=0.022  Sum_probs=41.1

Q ss_pred             CCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCc-eeeeeEEeeCCeeeEEEeCC-CCC
Q 023282          137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL-LRLYGFCTTVTEKLLVYPYM-TNG  214 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni-v~l~g~~~~~~~~~lv~e~~-~~g  214 (284)
                      .+.|+.|....+|+.     ..+.+|.-.......  .....|..+++.+....+ .+++++  ..+.-++++||+ ++.
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~--~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY--INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----C--CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccce--eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence            577889999999998     447778764321111  123456666655432222 344443  344467899999 554


Q ss_pred             Ch
Q 023282          215 SV  216 (284)
Q Consensus       215 ~L  216 (284)
                      ++
T Consensus        94 ~l   95 (301)
T 3dxq_A           94 TM   95 (301)
T ss_dssp             EC
T ss_pred             cC
Confidence            33

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.87  E-value=0.0021  Score=54.61  Aligned_cols=27  Identities=30%  Similarity=0.372  Sum_probs=22.1

Q ss_pred             CCCeeeeCCCCCCeeeCCC----CCcchhhh
Q 023282          254 DPKIIHRDVKAANILLDED----ADQSSKTI  280 (284)
Q Consensus       254 ~~~ivHrdlk~~NiLld~~----~~~~~~df  280 (284)
                      .+.++|+|+.+.|||++.+    ..+.+.||
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf  212 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDF  212 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCC
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeC
Confidence            3479999999999999875    56677776

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.83  E-value=0.0025  Score=56.44  Aligned_cols=71  Identities=18%  Similarity=0.260  Sum_probs=45.7

Q ss_pred             CeecccCceEEEEEEeCC--------CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCc-eeeeeEEeeCCeeeEEE
Q 023282          138 NILGRGGFGKVYKGRLAD--------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL-LRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni-v~l~g~~~~~~~~~lv~  208 (284)
                      +.|+.|....+|+....+        +..+.+|+....   .....+..|..++..+...++ .++++.+.  +  .+|+
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~  151 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE  151 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence            567888889999998653        467888876321   111345578888776643333 45666543  2  3899


Q ss_pred             eCCCCCC
Q 023282          209 PYMTNGS  215 (284)
Q Consensus       209 e~~~~g~  215 (284)
                      ||+++.+
T Consensus       152 e~l~G~~  158 (429)
T 1nw1_A          152 EYIPSRP  158 (429)
T ss_dssp             CCCCEEE
T ss_pred             EEeCCcc
Confidence            9998533

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.77  E-value=0.011  Score=50.02  Aligned_cols=75  Identities=19%  Similarity=0.111  Sum_probs=45.6

Q ss_pred             CeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCC--CCceeeeeE-----EeeCCeeeEEEeC
Q 023282          138 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH--RNLLRLYGF-----CTTVTEKLLVYPY  210 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h--~niv~l~g~-----~~~~~~~~lv~e~  210 (284)
                      ..++ |....||+....+|+.+++|.......  ....+..|..++..+..  -.+.+++..     ....+..++++||
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            4466 777889988776777789998853321  23346667776655431  123334332     1224556789999


Q ss_pred             CCCCC
Q 023282          211 MTNGS  215 (284)
Q Consensus       211 ~~~g~  215 (284)
                      +++..
T Consensus       109 i~G~~  113 (328)
T 1zyl_A          109 VGGRQ  113 (328)
T ss_dssp             CCCEE
T ss_pred             cCCCC
Confidence            98744

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.77  E-value=0.011  Score=49.81  Aligned_cols=153  Identities=9%  Similarity=0.058  Sum_probs=78.0

Q ss_pred             HHHHHHHhcCCCC-----CCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCC-----CCCcee
Q 023282          124 LRELQVATDGFSN-----KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-----HRNLLR  193 (284)
Q Consensus       124 ~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-----h~niv~  193 (284)
                      .+++......|..     .+.|+.|....+|+....++ .+++|.......   ...+..|..++..+.     -|.++.
T Consensus         9 ~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~vP~~~~   84 (322)
T 2ppq_A            9 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLPLP   84 (322)
T ss_dssp             HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             HHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCCCcccC
Confidence            3444444444543     23466788889999887665 577887754211   123455666665443     233322


Q ss_pred             ee-e--EEeeCCeeeEEEeCCCCCChH--------------HHHhhcCCC--CC---C---CCHHHHHHH----------
Q 023282          194 LY-G--FCTTVTEKLLVYPYMTNGSVA--------------SRLRERQSS--LP---P---LDWPTRKKI----------  238 (284)
Q Consensus       194 l~-g--~~~~~~~~~lv~e~~~~g~L~--------------~~l~~~~~~--~~---~---l~~~~~~~i----------  238 (284)
                      .. |  +....+..+++++|+++..+.              ..+|.....  ..   .   ..|.....-          
T Consensus        85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~  164 (322)
T 2ppq_A           85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  164 (322)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence            11 1  112235678999999875431              112221110  00   0   124331111          


Q ss_pred             --HHHHHHHHHHHHcC----CCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          239 --ALGSARGLSYLHEH----CDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       239 --~~~i~~gl~yLH~~----~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                        ...+.+.++++...    ..+.++|+|+.+.|||++.+....+.||
T Consensus       165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf  212 (322)
T 2ppq_A          165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDF  212 (322)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCC
T ss_pred             hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecc
Confidence              11244455666531    1347999999999999987655567776

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.58  E-value=0.013  Score=52.27  Aligned_cols=73  Identities=15%  Similarity=0.177  Sum_probs=44.4

Q ss_pred             CeecccCceEEEEEEeCC-CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCc-eeeeeEEeeCCeeeEEEeCCCCCC
Q 023282          138 NILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL-LRLYGFCTTVTEKLLVYPYMTNGS  215 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni-v~l~g~~~~~~~~~lv~e~~~~g~  215 (284)
                      +.|+.|-...+|+....+ +..+.+|+.......  ..+-..|..++..+...++ .++++.+.  +  .+||||+++..
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~--~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE--IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS--CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh--hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            567888889999998765 467888876432111  1112477777777764444 46666652  2  35999998643


Q ss_pred             h
Q 023282          216 V  216 (284)
Q Consensus       216 L  216 (284)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.34  E-value=0.014  Score=50.79  Aligned_cols=137  Identities=14%  Similarity=0.152  Sum_probs=74.2

Q ss_pred             CeecccCceEEEEEEeCC--------CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCC-ceeeeeEEeeCCeeeEEE
Q 023282          138 NILGRGGFGKVYKGRLAD--------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN-LLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n-iv~l~g~~~~~~~~~lv~  208 (284)
                      +.+..|-...+|+....+        +..+.+|+....  ........+|.++++.+.-.+ ..++++++..    .+||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            456677778899988642        467888875221  122345668888887664222 2456665532    2999


Q ss_pred             eCCCCCChHH-----------------HHhhcCCC-CCCCC--HHHHHHHHHHHH-------------------HHHHHH
Q 023282          209 PYMTNGSVAS-----------------RLRERQSS-LPPLD--WPTRKKIALGSA-------------------RGLSYL  249 (284)
Q Consensus       209 e~~~~g~L~~-----------------~l~~~~~~-~~~l~--~~~~~~i~~~i~-------------------~gl~yL  249 (284)
                      ||+++..|..                 .||..... .....  |.+..++..++.                   +.+.+|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            9998754421                 11221111 11122  444444443332                   123333


Q ss_pred             H----c-CCCCCeeeeCCCCCCeeeCCC----CCcchhhh
Q 023282          250 H----E-HCDPKIIHRDVKAANILLDED----ADQSSKTI  280 (284)
Q Consensus       250 H----~-~~~~~ivHrdlk~~NiLld~~----~~~~~~df  280 (284)
                      .    . .....++|+|+.+.|||++.+    +.+.+.||
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDw  249 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDF  249 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCC
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEec
Confidence            2    2 123468999999999999887    57777776

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.26  E-value=0.0051  Score=53.12  Aligned_cols=72  Identities=7%  Similarity=0.029  Sum_probs=40.0

Q ss_pred             CeecccCceEEEEEEeCC---------CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCC-ceeeeeEEeeCCeeeEE
Q 023282          138 NILGRGGFGKVYKGRLAD---------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN-LLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n-iv~l~g~~~~~~~~~lv  207 (284)
                      +.++.|....+|+....+         +..+.+|+.......  ..+...|.+++..+...+ ..++++..    .-++|
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~--~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v  112 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE--LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI  112 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG--TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc--eecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence            457778888999988654         257888876432111  112356777666554223 33555443    23789


Q ss_pred             EeCCCCCC
Q 023282          208 YPYMTNGS  215 (284)
Q Consensus       208 ~e~~~~g~  215 (284)
                      |||+++..
T Consensus       113 ~e~i~G~~  120 (369)
T 3c5i_A          113 EEWLYGDP  120 (369)
T ss_dssp             EECCCSEE
T ss_pred             EEEecCCc
Confidence            99998743

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=96.03  E-value=0.0028  Score=61.05  Aligned_cols=36  Identities=28%  Similarity=0.517  Sum_probs=27.4

Q ss_pred             CccEEEccCCCCcccCCCCCCCCccCcccccCCcCCCC
Q 023282            1 MTALRDLSNNRLSGPVPDNGSFSQFTPISFENNLNLCG   38 (284)
Q Consensus         1 ~~~~~dlS~N~lsG~iP~~~~~~~~~~~s~~gN~~lcg   38 (284)
                      +|+.||||+|+|+|.+|..  |.++....+.||+..|.
T Consensus       527 ~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~  562 (844)
T 3j0a_A          527 NLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICE  562 (844)
T ss_dssp             CCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCS
T ss_pred             cccEEECCCCcCCCCChhH--hCCcCEEEecCCCcccc
Confidence            4678888888888888764  55677777888988873

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.79  E-value=0.044  Score=46.68  Aligned_cols=26  Identities=19%  Similarity=0.276  Sum_probs=23.1

Q ss_pred             CCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          255 PKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       255 ~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +.++|+|+.+.||+++.++.+.+.||
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~  231 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDW  231 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCC
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEEC
Confidence            47999999999999998777888887

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=95.02  E-value=0.0065  Score=34.83  Aligned_cols=32  Identities=22%  Similarity=0.152  Sum_probs=17.8

Q ss_pred             CcchhhhhHHHHHHHHHHhheeEEEEeccCCC
Q 023282           69 NAAIPVGVALGAALLFAVPVIGFAYWRRTRPH  100 (284)
Q Consensus        69 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  100 (284)
                      ...|..+++.|+++++++.+..++++||++.+
T Consensus        10 ~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~   41 (44)
T 2ks1_B           10 IPSIATGMVGALLLLLVVALGIGLFMRRRHIV   41 (44)
T ss_dssp             SSSSTHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cceEEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence            34455666665665555555555556665543

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=94.80  E-value=0.0067  Score=34.69  Aligned_cols=32  Identities=28%  Similarity=0.273  Sum_probs=18.4

Q ss_pred             CcchhhhhHHHHHHHHHHhheeEEEEeccCCC
Q 023282           69 NAAIPVGVALGAALLFAVPVIGFAYWRRTRPH  100 (284)
Q Consensus        69 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  100 (284)
                      ...|..+++.|+++++++.+..++++|||+.+
T Consensus         9 ~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A            9 TPLIAAGVIGGLFILVIVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             SHHHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred             cceEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence            34566666666666555555555666665543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.11  E-value=0.34  Score=42.58  Aligned_cols=73  Identities=4%  Similarity=0.020  Sum_probs=43.3

Q ss_pred             CeecccCceEEEEEEeCC--------CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCC-ceeeeeEEeeCCeeeEEE
Q 023282          138 NILGRGGFGKVYKGRLAD--------GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN-LLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~n-iv~l~g~~~~~~~~~lv~  208 (284)
                      +.+..|-...+|+....+        +..+.+|+.......  ..+..+|..+++.+...+ ..++++.+    .-++|+
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~--~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~  149 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK--FYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE  149 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C--CCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch--hcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence            456677788899988653        567888875332211  112346777666554222 34455433    237899


Q ss_pred             eCCCCCCh
Q 023282          209 PYMTNGSV  216 (284)
Q Consensus       209 e~~~~g~L  216 (284)
                      ||+++..|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99997553

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=91.90  E-value=0.02  Score=51.08  Aligned_cols=61  Identities=7%  Similarity=0.009  Sum_probs=17.7

Q ss_pred             CCeecccCceEEEEEEeCC-CcEEEE------EEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEee
Q 023282          137 KNILGRGGFGKVYKGRLAD-GKLVAV------KRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT  200 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~~~-~~~vav------K~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~  200 (284)
                      .+.||   ||.||+|.+.. ..+|||      |..+..... +....+.+|..+++..+|||+++.+++...
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            45566   99999998754 367888      776543322 223468889999999999999999887653

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=90.90  E-value=0.21  Score=37.73  Aligned_cols=34  Identities=26%  Similarity=0.310  Sum_probs=23.1

Q ss_pred             CccEEEccCCCCcccCCCC-CCCCccCcccccCCc
Q 023282            1 MTALRDLSNNRLSGPVPDN-GSFSQFTPISFENNL   34 (284)
Q Consensus         1 ~~~~~dlS~N~lsG~iP~~-~~~~~~~~~s~~gN~   34 (284)
                      +|+.||||+|+|++..|.. ..+.++....+.+|.
T Consensus        55 ~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~   89 (170)
T 3g39_A           55 QLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ   89 (170)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             cCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence            4788999999999765543 345555556666664

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=90.24  E-value=0.26  Score=37.40  Aligned_cols=34  Identities=15%  Similarity=0.204  Sum_probs=23.7

Q ss_pred             CccEEEccCCCCcccCCCC-CCCCccCcccccCCc
Q 023282            1 MTALRDLSNNRLSGPVPDN-GSFSQFTPISFENNL   34 (284)
Q Consensus         1 ~~~~~dlS~N~lsG~iP~~-~~~~~~~~~s~~gN~   34 (284)
                      +|+.||||+|+|++-.|.. ..+.++....+.+|.
T Consensus        58 ~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~   92 (174)
T 2r9u_A           58 NLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH   92 (174)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence            4889999999999854432 345566666666664

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=89.98  E-value=0.23  Score=38.27  Aligned_cols=34  Identities=12%  Similarity=0.116  Sum_probs=23.0

Q ss_pred             CccEEEccCCCCcccCCCC-CCCCccCcccccCCc
Q 023282            1 MTALRDLSNNRLSGPVPDN-GSFSQFTPISFENNL   34 (284)
Q Consensus         1 ~~~~~dlS~N~lsG~iP~~-~~~~~~~~~s~~gN~   34 (284)
                      .|+.||||+|+|++..|.. ..+.++....+.+|.
T Consensus        79 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  113 (192)
T 1w8a_A           79 HIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQ  113 (192)
T ss_dssp             TCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSC
T ss_pred             cCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCc
Confidence            4788899999998877753 334555555566663

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=88.60  E-value=0.064  Score=30.55  Aligned_cols=29  Identities=14%  Similarity=0.169  Sum_probs=12.9

Q ss_pred             chhhhhHHHHHHHHHHhheeEEEEeccCC
Q 023282           71 AIPVGVALGAALLFAVPVIGFAYWRRTRP   99 (284)
Q Consensus        71 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~   99 (284)
                      ..+++.++|+++++++.+..+.++|||+.
T Consensus        12 ~~Ia~~vVGvll~vi~~l~~~~~~RRR~~   40 (44)
T 2jwa_A           12 TSIISAVVGILLVVVLGVVFGILIKRRQQ   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHHCS
T ss_pred             cchHHHHHHHHHHHHHHHHHHhheehhhh
Confidence            33444444544444444444444555543

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=87.81  E-value=1.6  Score=34.48  Aligned_cols=78  Identities=10%  Similarity=0.004  Sum_probs=55.7

Q ss_pred             CCCCceeeeeEEeeCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHH-HHHcCCCCCeeeeCCCCC
Q 023282          187 VHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS-YLHEHCDPKIIHRDVKAA  265 (284)
Q Consensus       187 ~h~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~-yLH~~~~~~ivHrdlk~~  265 (284)
                      .||..  -...-...+...+.|+--+++.=...++.       ++...+++++..++.-.. +++.     -+|--|.|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-------~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-------TTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-------SCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-------cCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence            46776  33444566777777776555444444542       577889999888877666 5554     478889999


Q ss_pred             CeeeCCCCCcchh
Q 023282          266 NILLDEDADQSSK  278 (284)
Q Consensus       266 NiLld~~~~~~~~  278 (284)
                      |+++|.++.|++.
T Consensus       114 NL~f~~~~~p~i~  126 (219)
T 4ano_A          114 NLMFNRALEPFFL  126 (219)
T ss_dssp             GEEECTTCCEEES
T ss_pred             eEEEeCCCcEEEE
Confidence            9999999999875

>2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens}

Probab=87.50  E-value=0.26  Score=27.66  Aligned_cols=27  Identities=41%  Similarity=0.625  Sum_probs=11.5

Q ss_pred             cchhhhhHHHHHHHHHHhheeEEEEec
Q 023282           70 AAIPVGVALGAALLFAVPVIGFAYWRR   96 (284)
Q Consensus        70 ~~i~~~~~~~~~~~~~~~~~~~~~~~~   96 (284)
                      ..++.+++.|.++++++..+.++++||
T Consensus        13 ~~I~~~vv~Gv~ll~~iv~~~~~~~rR   39 (41)
T 2k9y_A           13 LAVIGGVAVGVVLLLVLAGVGFFIHRR   39 (41)
T ss_dssp             THHHHHHHHHHHHHHHHHHHHHSSSSS
T ss_pred             EEEEeehhHHHHHHHHHHHHheeEeee
Confidence            445555555544433233333333443

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=86.67  E-value=0.53  Score=33.88  Aligned_cols=36  Identities=19%  Similarity=0.277  Sum_probs=22.6

Q ss_pred             CccEEEccCCCCcccCCCC--CCCCccCcccccCCcCCC
Q 023282            1 MTALRDLSNNRLSGPVPDN--GSFSQFTPISFENNLNLC   37 (284)
Q Consensus         1 ~~~~~dlS~N~lsG~iP~~--~~~~~~~~~s~~gN~~lc   37 (284)
                      +|+.||||+|+|+. ||..  ..+.++....+.+|+-.|
T Consensus        32 ~l~~L~Ls~N~l~~-l~~~~f~~l~~L~~L~L~~NP~~C   69 (130)
T 3rfe_A           32 DTTELVLTGNNLTA-LPPGLLDALPALRTAHLGANPWRC   69 (130)
T ss_dssp             TCSEEECTTSCCSS-CCTTTGGGCTTCCEEECCSSCCBC
T ss_pred             CCCEEECCCCcCCc-cChhhhhhccccCEEEecCCCeec
Confidence            47888888888886 4543  123334445667777666

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=86.67  E-value=0.45  Score=37.48  Aligned_cols=34  Identities=21%  Similarity=0.121  Sum_probs=23.3

Q ss_pred             CccEEEccCCCCcccCCCC-CCCCccCcccccCCc
Q 023282            1 MTALRDLSNNRLSGPVPDN-GSFSQFTPISFENNL   34 (284)
Q Consensus         1 ~~~~~dlS~N~lsG~iP~~-~~~~~~~~~s~~gN~   34 (284)
                      +|+.||||+|++++..|.. ..+.++....+.+|.
T Consensus       106 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  140 (220)
T 2v70_A          106 SLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQ  140 (220)
T ss_dssp             SCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSC
T ss_pred             CCCEEECCCCcCCeECHhHcCCCccCCEEECCCCc
Confidence            4789999999999987764 234445555565653

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=86.44  E-value=1.1  Score=35.35  Aligned_cols=81  Identities=7%  Similarity=0.013  Sum_probs=56.9

Q ss_pred             CCCCCceeeeeEEeeCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCC
Q 023282          186 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAA  265 (284)
Q Consensus       186 ~~h~niv~l~g~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~  265 (284)
                      ..||+.+.. .+-...+...+.|+.-+.+-=...++       .++...+++++..++.-..+++..     +|--|.|+
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik-------~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~  108 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK-------SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPD  108 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG-------GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGG
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH-------hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecc
Confidence            357888765 45555566666666544322222233       257788999999998888777654     78889999


Q ss_pred             CeeeCCCCCcchhh
Q 023282          266 NILLDEDADQSSKT  279 (284)
Q Consensus       266 NiLld~~~~~~~~d  279 (284)
                      |+++|.++.|++..
T Consensus       109 NL~f~~~~~p~i~~  122 (215)
T 4ann_A          109 ELFFTRDGLPIAKT  122 (215)
T ss_dssp             GEEECTTSCEEESC
T ss_pred             eEEEcCCCCEEEEE
Confidence            99999999988763

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=86.22  E-value=0.27  Score=46.64  Aligned_cols=17  Identities=35%  Similarity=0.700  Sum_probs=10.0

Q ss_pred             ccEEEccCCCCcccCCC
Q 023282            2 TALRDLSNNRLSGPVPD   18 (284)
Q Consensus         2 ~~~~dlS~N~lsG~iP~   18 (284)
                      |+.||||+|+|+|.||.
T Consensus       658 L~~L~Ls~N~l~g~ip~  674 (768)
T 3rgz_A          658 LFILNLGHNDISGSIPD  674 (768)
T ss_dssp             CCEEECCSSCCCSCCCG
T ss_pred             CCEEeCcCCccCCCCCh
Confidence            45566666666666654

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=85.35  E-value=0.57  Score=36.87  Aligned_cols=34  Identities=18%  Similarity=0.163  Sum_probs=23.5

Q ss_pred             CccEEEccCCCCcccCCCC-CCCCccCcccccCCc
Q 023282            1 MTALRDLSNNRLSGPVPDN-GSFSQFTPISFENNL   34 (284)
Q Consensus         1 ~~~~~dlS~N~lsG~iP~~-~~~~~~~~~s~~gN~   34 (284)
                      +|+.|||++|++++..|.. ..+.++....+.+|.
T Consensus       105 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  139 (220)
T 2v9t_B          105 SLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNK  139 (220)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCc
Confidence            4789999999999987764 234445555566664

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=84.61  E-value=0.79  Score=38.61  Aligned_cols=17  Identities=18%  Similarity=0.092  Sum_probs=10.2

Q ss_pred             ccEEEccCCCCcccCCC
Q 023282            2 TALRDLSNNRLSGPVPD   18 (284)
Q Consensus         2 ~~~~dlS~N~lsG~iP~   18 (284)
                      |+.||||+|+|+|..|.
T Consensus        58 L~~L~l~~N~l~~~~~~   74 (347)
T 2ifg_A           58 LRNLTIVKSGLRFVAPD   74 (347)
T ss_dssp             CSEEECCSSCCCEECTT
T ss_pred             CCEEECCCCccceeCHH
Confidence            55666666666665554

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=84.55  E-value=0.49  Score=39.92  Aligned_cols=14  Identities=29%  Similarity=0.150  Sum_probs=7.5

Q ss_pred             ccEEEccCCCCccc
Q 023282            2 TALRDLSNNRLSGP   15 (284)
Q Consensus         2 ~~~~dlS~N~lsG~   15 (284)
                      |+.||||+|+|++.
T Consensus        82 L~~L~l~~N~l~~~   95 (347)
T 2ifg_A           82 LSRLNLSFNALESL   95 (347)
T ss_dssp             CCEEECCSSCCSCC
T ss_pred             CCEEeCCCCcccee
Confidence            45555555555543

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=83.88  E-value=0.98  Score=33.89  Aligned_cols=34  Identities=15%  Similarity=0.234  Sum_probs=24.2

Q ss_pred             CccEEEccCCCCcccCCCC-CCCCccCcccccCCc
Q 023282            1 MTALRDLSNNRLSGPVPDN-GSFSQFTPISFENNL   34 (284)
Q Consensus         1 ~~~~~dlS~N~lsG~iP~~-~~~~~~~~~s~~gN~   34 (284)
                      +|+.|||++|++++..|.. ..+.++....+.+|.
T Consensus        77 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~  111 (177)
T 2o6r_A           77 KLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQ  111 (177)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             ccCEEECCCCCccccCHHHhhCCcccCEEECcCCc
Confidence            4889999999999876653 345556666666663

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=83.10  E-value=0.99  Score=33.81  Aligned_cols=34  Identities=24%  Similarity=0.357  Sum_probs=25.6

Q ss_pred             CccEEEccCCCCcccCCCC-CCCCccCcccccCCc
Q 023282            1 MTALRDLSNNRLSGPVPDN-GSFSQFTPISFENNL   34 (284)
Q Consensus         1 ~~~~~dlS~N~lsG~iP~~-~~~~~~~~~s~~gN~   34 (284)
                      .|+.|||++|++++..|.. ..+.++....+.+|.
T Consensus        31 ~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~   65 (170)
T 3g39_A           31 TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQ   65 (170)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSC
T ss_pred             CCcEEEcCCCcCCccChhhhcCcccCCEEECCCCC
Confidence            4789999999999988864 345566666676764

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=82.81  E-value=0.86  Score=35.02  Aligned_cols=34  Identities=24%  Similarity=0.174  Sum_probs=24.0

Q ss_pred             CccEEEccCCCCcccCCCC-CCCCccCcccccCCc
Q 023282            1 MTALRDLSNNRLSGPVPDN-GSFSQFTPISFENNL   34 (284)
Q Consensus         1 ~~~~~dlS~N~lsG~iP~~-~~~~~~~~~s~~gN~   34 (284)
                      .|+.||||+|+|++..|.. ..+.++....+.+|.
T Consensus        79 ~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~  113 (193)
T 2wfh_A           79 QLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGND  113 (193)
T ss_dssp             TCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCC
Confidence            4889999999999977753 334555555666664

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=82.72  E-value=0.9  Score=41.40  Aligned_cols=17  Identities=12%  Similarity=0.014  Sum_probs=10.5

Q ss_pred             ccEEEccCCCCcccCCC
Q 023282            2 TALRDLSNNRLSGPVPD   18 (284)
Q Consensus         2 ~~~~dlS~N~lsG~iP~   18 (284)
                      |+.||||+|+|++..|.
T Consensus       520 L~~L~Ls~N~l~~l~~~  536 (635)
T 4g8a_A          520 LQVLNMSHNNFFSLDTF  536 (635)
T ss_dssp             CCEEECTTSCCCBCCCG
T ss_pred             CCEEECCCCcCCCCChh
Confidence            56666666666665543

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=82.41  E-value=1.1  Score=34.29  Aligned_cols=32  Identities=22%  Similarity=0.303  Sum_probs=17.8

Q ss_pred             ccEEEccCCCCcccCCC--CCCCCccCcccccCC
Q 023282            2 TALRDLSNNRLSGPVPD--NGSFSQFTPISFENN   33 (284)
Q Consensus         2 ~~~~dlS~N~lsG~iP~--~~~~~~~~~~s~~gN   33 (284)
                      |+.|+|++|++++..|.  ...+.++....+.+|
T Consensus        31 l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N   64 (192)
T 1w8a_A           31 TTELLLNDNELGRISSDGLFGRLPHLVKLELKRN   64 (192)
T ss_dssp             CSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSS
T ss_pred             CCEEECCCCcCCccCCccccccCCCCCEEECCCC
Confidence            56777777777665553  223444444445554

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=82.37  E-value=1.1  Score=33.77  Aligned_cols=34  Identities=18%  Similarity=0.204  Sum_probs=25.6

Q ss_pred             CccEEEccCCCCcccCCCC-CCCCccCcccccCCc
Q 023282            1 MTALRDLSNNRLSGPVPDN-GSFSQFTPISFENNL   34 (284)
Q Consensus         1 ~~~~~dlS~N~lsG~iP~~-~~~~~~~~~s~~gN~   34 (284)
                      .|+.||||+|+|++..|.. ..+.++....+.+|.
T Consensus        34 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~   68 (174)
T 2r9u_A           34 DKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNK   68 (174)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCC
Confidence            4789999999999988864 345566666677773

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=82.36  E-value=0.79  Score=41.23  Aligned_cols=32  Identities=22%  Similarity=0.312  Sum_probs=20.9

Q ss_pred             CccEEEccCCCCcccCCCCCCCCccCcccccCC
Q 023282            1 MTALRDLSNNRLSGPVPDNGSFSQFTPISFENN   33 (284)
Q Consensus         1 ~~~~~dlS~N~lsG~iP~~~~~~~~~~~s~~gN   33 (284)
                      +|+.||||+|+|+ .||....+.++....+.+|
T Consensus       452 ~L~~L~Ls~N~l~-~ip~~~~l~~L~~L~Ls~N  483 (549)
T 2z81_A          452 RLQELYISRNKLK-TLPDASLFPVLLVMKISRN  483 (549)
T ss_dssp             TCCEEECCSSCCS-SCCCGGGCTTCCEEECCSS
T ss_pred             hhcEEECCCCccC-cCCCcccCccCCEEecCCC
Confidence            3677888888887 6776544555555555555

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=82.34  E-value=1.3  Score=35.91  Aligned_cols=34  Identities=21%  Similarity=0.173  Sum_probs=22.5

Q ss_pred             CccEEEccCCCCcccCCCC-CCCCccCcccccCCc
Q 023282            1 MTALRDLSNNRLSGPVPDN-GSFSQFTPISFENNL   34 (284)
Q Consensus         1 ~~~~~dlS~N~lsG~iP~~-~~~~~~~~~s~~gN~   34 (284)
                      +|+.||+++|++++..|.. ..+.++....+.+|.
T Consensus       158 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~  192 (272)
T 3rfs_A          158 NLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ  192 (272)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             cCCEEECCCCCcCccCHHHhcCCccCCEEECCCCc
Confidence            4788899999998766543 334555555566653

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=82.23  E-value=1.4  Score=33.91  Aligned_cols=33  Identities=15%  Similarity=0.149  Sum_probs=21.3

Q ss_pred             CccEEEccCCCCcccCCCC-CCCCccCcccccCC
Q 023282            1 MTALRDLSNNRLSGPVPDN-GSFSQFTPISFENN   33 (284)
Q Consensus         1 ~~~~~dlS~N~lsG~iP~~-~~~~~~~~~s~~gN   33 (284)
                      +|+.|||++|++++..|.. ..+.++....+.+|
T Consensus       101 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  134 (208)
T 2o6s_A          101 QLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQN  134 (208)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CCCEEEcCCCcCcccCHhHhccCCcCCEEECCCC
Confidence            4788899999888765542 33445555555565

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=81.91  E-value=1.2  Score=35.53  Aligned_cols=34  Identities=15%  Similarity=0.161  Sum_probs=23.0

Q ss_pred             CccEEEccCCCCcccCCC-CCCCCccCcccccCCc
Q 023282            1 MTALRDLSNNRLSGPVPD-NGSFSQFTPISFENNL   34 (284)
Q Consensus         1 ~~~~~dlS~N~lsG~iP~-~~~~~~~~~~s~~gN~   34 (284)
                      +|+.||||+|+|++..|. ...+.++....+.+|.
T Consensus       132 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  166 (251)
T 3m19_A          132 KLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQ  166 (251)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             cccEEECcCCcCCccCHHHcCcCcCCCEEECCCCc
Confidence            478899999999976663 2344555556666663

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=80.92  E-value=1.4  Score=34.79  Aligned_cols=32  Identities=16%  Similarity=0.312  Sum_probs=21.2

Q ss_pred             CccEEEccCCCCcccCCCC-CCCCccCcccccCC
Q 023282            1 MTALRDLSNNRLSGPVPDN-GSFSQFTPISFENN   33 (284)
Q Consensus         1 ~~~~~dlS~N~lsG~iP~~-~~~~~~~~~s~~gN   33 (284)
                      +|+.||||+|+|+ .||.. ..+.++....+.+|
T Consensus       113 ~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N  145 (229)
T 3e6j_A          113 HLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN  145 (229)
T ss_dssp             TCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSS
T ss_pred             hhCeEeccCCccc-ccCcccccCCCCCEEECCCC
Confidence            4788999999998 67754 22344445555565

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=80.36  E-value=0.58  Score=38.34  Aligned_cols=34  Identities=21%  Similarity=0.166  Sum_probs=23.3

Q ss_pred             CccEEEccCCCCcc--cCCCC-CCCCccCcccccCCc
Q 023282            1 MTALRDLSNNRLSG--PVPDN-GSFSQFTPISFENNL   34 (284)
Q Consensus         1 ~~~~~dlS~N~lsG--~iP~~-~~~~~~~~~s~~gN~   34 (284)
                      +|+.||||+|+|+|  .+|.. ..+.++....+.+|.
T Consensus       171 ~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~  207 (267)
T 3rw6_A          171 ELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNE  207 (267)
T ss_dssp             TCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSC
T ss_pred             CCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCc
Confidence            48899999999999  67643 124455555565653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	284
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-41
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-38
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-38
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-37
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-37
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-37
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-37
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-36
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-36
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-36
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-36
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-36
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-36
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-36
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	9e-36
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-35
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-35
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	7e-35
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	9e-35
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-34
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-34
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	9e-34
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-33
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-33
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-32
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-32
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-32
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-31
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-31
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-31
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-31
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-30
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-30
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-30
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-30
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-30
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-30
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-30
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-30
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-29
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-29
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-28
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-28
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-27
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-27
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-27
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	7e-27
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-26
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-26
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-25
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-25
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-24
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-24
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-24
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	9e-24
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-23
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-23
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-22
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-22
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	8e-22
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-20
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-19
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-18
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-09

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 2e-41
 Identities = 37/147 (25%), Positives = 67/147 (45%), Gaps = 7/147 (4%)

Query: 127 LQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISM 185
           +++  D F   + LG G  G V+K      G ++A K +  E       Q   E++++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 186 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 245
                ++  YG   +  E  +   +M  GS+   L++       +      K+++   +G
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKG 116

Query: 246 LSYLHEHCDPKIIHRDVKAANILLDED 272
           L+YL E    KI+HRDVK +NIL++  
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSR 141

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  135 bits (341), Expect = 1e-38
 Identities = 44/164 (26%), Positives = 70/164 (42%), Gaps = 19/164 (11%)

Query: 122 FSLRELQVATDGFSNK---------NILGRGGFGKVYKGRLA----DGKLVAVKRLKEER 168
           F+  +   A   F+ +          ++G G FG+V  G L         VA+K LK   
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 169 TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP 228
           T      F +E  I+    H N++ L G  T  T  +++  +M NGS+ S LR+      
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND---G 123

Query: 229 PLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
                    +  G A G+ YL +      +HRD+ A NIL++ +
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSN 164

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 4e-38
 Identities = 42/140 (30%), Positives = 63/140 (45%), Gaps = 8/140 (5%)

Query: 132 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 191
           +       LG G FG+V+ G       VAVK LK+   S     F  E  ++    H+ L
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRL 70

Query: 192 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 251
           +RLY   T      ++  YM NGS+   L+        L       +A   A G++++ E
Sbjct: 71  VRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE 127

Query: 252 HCDPKIIHRDVKAANILLDE 271
                 IHRD++AANIL+ +
Sbjct: 128 RN---YIHRDLRAANILVSD 144

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 1e-37
 Identities = 37/152 (24%), Positives = 62/152 (40%), Gaps = 11/152 (7%)

Query: 125 RELQVATDGFSNKNI-LGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEV 180
           ++L +  D     +I LG G FG V +G          VA+K LK+        +   E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 181 KIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIAL 240
           +I+    +  ++RL G C      +LV      G +   L  ++  +P        ++  
Sbjct: 61  QIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIP---VSNVAELLH 116

Query: 241 GSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
             + G+ YL E      +HRD+ A N+LL   
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNR 145

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 1e-37
 Identities = 43/162 (26%), Positives = 64/162 (39%), Gaps = 24/162 (14%)

Query: 132 DGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIIS- 184
           +  S    LG G FGKV +              VAVK LK            +E+K++S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP--------------PL 230
           +  H N++ L G CT     L++  Y   G + + LR ++ S                 L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 231 DWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           D       +   A+G+++L        IHRD+ A NILL   
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHG 181

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 2e-37
 Identities = 44/140 (31%), Positives = 66/140 (47%), Gaps = 10/140 (7%)

Query: 134 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLL 192
            +    +G G FG VYKG+      VAVK L     +  +LQ F+ EV ++    H N+L
Sbjct: 10  ITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
              G+ T   +  +V  +    S+   L   ++     +      IA  +A+G+ YLH  
Sbjct: 68  LFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK 123

Query: 253 CDPKIIHRDVKAANILLDED 272
               IIHRD+K+ NI L ED
Sbjct: 124 S---IIHRDLKSNNIFLHED 140

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 2e-37
 Identities = 43/140 (30%), Positives = 62/140 (44%), Gaps = 10/140 (7%)

Query: 134 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
                 +G+G FG V  G    G  VAVK +K + T+     F  E  +++   H NL++
Sbjct: 9   LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQ 64

Query: 194 LYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
           L G        L +V  YM  GS+   LR R  S   L      K +L     + YL  +
Sbjct: 65  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEGN 122

Query: 253 CDPKIIHRDVKAANILLDED 272
                +HRD+ A N+L+ ED
Sbjct: 123 ---NFVHRDLAARNVLVSED 139

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 1e-36
 Identities = 37/147 (25%), Positives = 60/147 (40%), Gaps = 6/147 (4%)

Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHR 189
           + +     +G G +G+  K R  +DGK++  K L     +  E Q   +EV ++    H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 190 NLLRLYGFCTTVTEKLL--VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           N++R Y      T   L  V  Y   G +AS + +       LD     ++       L 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 248 YLHEH--CDPKIIHRDVKAANILLDED 272
             H        ++HRD+K AN+ LD  
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGK 150

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  129 bits (326), Expect = 2e-36
 Identities = 46/176 (26%), Positives = 73/176 (41%), Gaps = 29/176 (16%)

Query: 123 SLRELQVATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQF 176
            L  L+   +       +G G FG+V++ R           +VAVK LKEE ++  +  F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 177 QTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSL--------- 227
           Q E  +++   + N+++L G C       L++ YM  G +   LR               
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 228 -----------PPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
                      PPL    +  IA   A G++YL E    K +HRD+   N L+ E+
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGEN 176

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (324), Expect = 2e-36
 Identities = 36/142 (25%), Positives = 58/142 (40%), Gaps = 8/142 (5%)

Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
           + +     LG G +G+V         + VAVK +  +R        + E+ I  M  H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
           +++ YG       + L   Y + G +  R+         +  P  ++       G+ YLH
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLH 120

Query: 251 EHCDPKIIHRDVKAANILLDED 272
                 I HRD+K  N+LLDE 
Sbjct: 121 GIG---ITHRDIKPENLLLDER 139

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 2e-36
 Identities = 39/160 (24%), Positives = 62/160 (38%), Gaps = 29/160 (18%)

Query: 139 ILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNL 191
           +LG G FGKV                VAVK LKE+  S       +E+K+++    H N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 192 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLP-------------------PLDW 232
           + L G CT      L++ Y   G + + LR ++                        L +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 233 PTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
                 A   A+G+ +L        +HRD+ A N+L+   
Sbjct: 164 EDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHG 200

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 3e-36
 Identities = 41/139 (29%), Positives = 67/139 (48%), Gaps = 8/139 (5%)

Query: 134 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
            +    +G G FG V+ G   +   VA+K ++E   S  E  F  E +++    H  L++
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQ 64

Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           LYG C       LV+ +M +G ++  LR ++         T   + L    G++YL E C
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEAC 121

Query: 254 DPKIIHRDVKAANILLDED 272
              +IHRD+ A N L+ E+
Sbjct: 122 ---VIHRDLAARNCLVGEN 137

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  128 bits (324), Expect = 4e-36
 Identities = 42/145 (28%), Positives = 63/145 (43%), Gaps = 10/145 (6%)

Query: 131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV 187
              FS+   +G G FG VY  R + + ++VA+K++        E       EV+ +    
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           H N ++  G         LV  Y    +       ++    PL       +  G+ +GL+
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLA 129

Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           YLH H    +IHRDVKA NILL E 
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEP 151

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 6e-36
 Identities = 41/145 (28%), Positives = 65/145 (44%), Gaps = 17/145 (11%)

Query: 137 KNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYG 196
           +  +G+G FG+V++G+   G+ VAVK              + E+    M  H N+L    
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIA 64

Query: 197 FCT----TVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
                  T T+  LV  Y  +GS+   L         +      K+AL +A GL++LH  
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHME 119

Query: 253 C-----DPKIIHRDVKAANILLDED 272
                  P I HRD+K+ NIL+ ++
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKN 144

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 9e-36
 Identities = 39/139 (28%), Positives = 61/139 (43%), Gaps = 8/139 (5%)

Query: 134 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLR 193
            +    LG G FG V  G+      VA+K +KE   S  E +F  E K++    H  L++
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQ 63

Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           LYG CT      ++  YM NG + + LRE +            ++       + YL    
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESKQ 120

Query: 254 DPKIIHRDVKAANILLDED 272
               +HRD+ A N L+++ 
Sbjct: 121 ---FLHRDLAARNCLVNDQ 136

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  126 bits (318), Expect = 2e-35
 Identities = 42/154 (27%), Positives = 69/154 (44%), Gaps = 8/154 (5%)

Query: 120 KRFSLRELQVATDGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQT 178
              +  + ++     + K+ LG G +G+VY+G        VAVK LKE+     E  F  
Sbjct: 5   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLK 62

Query: 179 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI 238
           E  ++    H NL++L G CT      ++  +MT G++   LRE       +       +
Sbjct: 63  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYM 120

Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           A   +  + YL +      IHRD+ A N L+ E+
Sbjct: 121 ATQISSAMEYLEKK---NFIHRDLAARNCLVGEN 151

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 7e-35
 Identities = 40/143 (27%), Positives = 65/143 (45%), Gaps = 8/143 (5%)

Query: 131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR 189
            D +     LG G FGKVYK +      L A K +  +     E  +  E+ I++   H 
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-DYMVEIDILASCDHP 69

Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           N+++L           ++  +   G+V + + E +    PL     + +   +   L+YL
Sbjct: 70  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYL 126

Query: 250 HEHCDPKIIHRDVKAANILLDED 272
           H++   KIIHRD+KA NIL   D
Sbjct: 127 HDN---KIIHRDLKAGNILFTLD 146

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 7e-35
 Identities = 46/156 (29%), Positives = 72/156 (46%), Gaps = 17/156 (10%)

Query: 120 KRFSLRELQVATDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER--TSGGELQF 176
           ++++L + ++          LG+G FG VY  R      ++A+K L + +   +G E Q 
Sbjct: 1   RQWALEDFEI-------GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53

Query: 177 QTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRK 236
           + EV+I S   H N+LRLYG+    T   L+  Y   G+V   L++        D     
Sbjct: 54  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL----SKFDEQRTA 109

Query: 237 KIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
                 A  LSY H     ++IHRD+K  N+LL   
Sbjct: 110 TYITELANALSYCHSK---RVIHRDIKPENLLLGSA 142

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 9e-35
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 19/157 (12%)

Query: 132 DGFSNKNILGRGGFGKVYKGRLADGKL---VAVKRLKEERTSGGELQFQTEVKIIS-MAV 187
           +    ++++G G FG+V K R+    L    A+KR+KE  +      F  E++++  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ------------SSLPPLDWPTR 235
           H N++ L G C       L   Y  +G++   LR+ +            S+   L     
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 236 KKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
              A   ARG+ YL +    + IHRD+ A NIL+ E+
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 163

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (311), Expect = 1e-34
 Identities = 38/142 (26%), Positives = 65/142 (45%), Gaps = 11/142 (7%)

Query: 137 KNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQ-FQTEVKIISMAVHRNLLRL 194
              +GRG F  VYKG   +    VA   L++ + +  E Q F+ E +++    H N++R 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 195 YGFCTTVTEK----LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
           Y    +  +     +LV   MT+G++ + L+  +     +     +       +GL +LH
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLH 129

Query: 251 EHCDPKIIHRDVKAANILLDED 272
               P IIHRD+K  NI +   
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGP 150

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 5e-34
 Identities = 42/150 (28%), Positives = 68/150 (45%), Gaps = 11/150 (7%)

Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLADG-----KLVAVKRLKEERTSGGELQFQTEVKI 182
           ++     + + ++G G FG+VYKG L          VA+K LK   T    + F  E  I
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62

Query: 183 ISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGS 242
           +    H N++RL G  +     +++  YM NG++   LRE+              +  G 
Sbjct: 63  MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGI 119

Query: 243 ARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           A G+ YL        +HRD+ A NIL++ +
Sbjct: 120 AAGMKYLANMN---YVHRDLAARNILVNSN 146

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 9e-34
 Identities = 45/141 (31%), Positives = 59/141 (41%), Gaps = 11/141 (7%)

Query: 137 KNILGRGGFGKVYKGRLADGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
             ++GRG FG VY G L D        AVK L      G   QF TE  I+    H N+L
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 193 RLYGFCTTV-TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 251
            L G C       L+V PYM +G + + +R                  L  A+G   +  
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKG---MKF 145

Query: 252 HCDPKIIHRDVKAANILLDED 272
               K +HRD+ A N +LDE 
Sbjct: 146 LASKKFVHRDLAARNCMLDEK 166

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 2e-33
 Identities = 40/141 (28%), Positives = 65/141 (46%), Gaps = 8/141 (5%)

Query: 132 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL 191
           +    +  LG+G FG+V+ G       VA+K LK    S     F  E +++    H  L
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKL 74

Query: 192 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE 251
           ++LY   +      +V  YM+ GS+   L+        L  P    +A   A G++Y+  
Sbjct: 75  VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER 131

Query: 252 HCDPKIIHRDVKAANILLDED 272
                 +HRD++AANIL+ E+
Sbjct: 132 MN---YVHRDLRAANILVGEN 149

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 4e-33
 Identities = 35/139 (25%), Positives = 55/139 (39%), Gaps = 12/139 (8%)

Query: 138 NILGRGGFGKVYKGRLAD---GKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVHRNLLR 193
             LG G FG V KG        K VAVK LK E        +   E  ++    +  ++R
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           + G C      +LV      G +   L++ +     +      ++    + G+ YL E  
Sbjct: 73  MIGICEA-ESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES- 126

Query: 254 DPKIIHRDVKAANILLDED 272
               +HRD+ A N+LL   
Sbjct: 127 --NFVHRDLAARNVLLVTQ 143

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 2e-32
 Identities = 42/159 (26%), Positives = 71/159 (44%), Gaps = 15/159 (9%)

Query: 126 ELQVATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTE 179
           E +VA +  +    LG+G FG VY+G             VA+K + E  +    ++F  E
Sbjct: 14  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73

Query: 180 VKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLR------ERQSSLPPLDWP 233
             ++      +++RL G  +     L++   MT G + S LR           L P    
Sbjct: 74  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133

Query: 234 TRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
              ++A   A G++YL+ +   K +HRD+ A N ++ ED
Sbjct: 134 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 169

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  119 bits (299), Expect = 4e-32
 Identities = 33/150 (22%), Positives = 60/150 (40%), Gaps = 8/150 (5%)

Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
           D +     LG G FG V++    A G++   K +            + E+ I++   H  
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPK 87

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
           L+ L+       E +L+  +++ G +  R+         +           +  GL ++H
Sbjct: 88  LINLHDAFEDKYEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMH 144

Query: 251 EHCDPKIIHRDVKAANILLDEDADQSSKTI 280
           EH    I+H D+K  NI+ +     S K I
Sbjct: 145 EH---SIVHLDIKPENIMCETKKASSVKII 171

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  119 bits (298), Expect = 6e-32
 Identities = 31/144 (21%), Positives = 61/144 (42%), Gaps = 8/144 (5%)

Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRN 190
           D +     LG G FG V++    A G   A K +     S  E   + E++ +S+  H  
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-TVRKEIQTMSVLRHPT 84

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
           L+ L+       E +++Y +M+ G +  ++ +  +    +      +      +GL ++H
Sbjct: 85  LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMH 141

Query: 251 EHCDPKIIHRDVKAANILLDEDAD 274
           E+     +H D+K  NI+      
Sbjct: 142 ENN---YVHLDLKPENIMFTTKRS 162

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 1e-31
 Identities = 32/143 (22%), Positives = 63/143 (44%), Gaps = 10/143 (6%)

Query: 131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR 189
              ++    +G+G  G VY    +A G+ VA++++  ++    E     E+ ++    + 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNP 77

Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           N++          E  +V  Y+  GS+   + E       +D      +     + L +L
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFL 132

Query: 250 HEHCDPKIIHRDVKAANILLDED 272
           H +   ++IHRD+K+ NILL  D
Sbjct: 133 HSN---QVIHRDIKSDNILLGMD 152

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 1e-31
 Identities = 43/162 (26%), Positives = 64/162 (39%), Gaps = 24/162 (14%)

Query: 132 DGFSNKNILGRGGFGKVYKGRL--------ADGKLVAVKRLKEERTSGGELQFQTEVKII 183
           D       LG G FG+V                  VAVK LK + T        +E++++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 184 SMAV-HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRER------------QSSLPPL 230
            M   H+N++ L G CT      ++  Y + G++   L+ R             +    L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 231 DWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
                   A   ARG+ YL      K IHRD+ A N+L+ ED
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTED 171

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  117 bits (293), Expect = 3e-31
 Identities = 40/146 (27%), Positives = 66/146 (45%), Gaps = 13/146 (8%)

Query: 132 DGFSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGE-----LQFQTEVKIISM 185
           + FS   I+GRGGFG+VY  R AD GK+ A+K L ++R    +     L  +  + ++S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 186 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 245
                ++ +     T  +   +   M  G +   L +             +  A     G
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILG 119

Query: 246 LSYLHEHCDPKIIHRDVKAANILLDE 271
           L ++H      +++RD+K ANILLDE
Sbjct: 120 LEHMHNRF---VVYRDLKPANILLDE 142

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 4e-31
 Identities = 33/137 (24%), Positives = 57/137 (41%), Gaps = 11/137 (8%)

Query: 139 ILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRL 194
            +G G FG V++G           VA+K  K   +     +F  E   +    H ++++L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 195 YGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCD 254
            G  T      ++    T G + S L+ R+     LD  +    A   +  L+YL     
Sbjct: 74  IGVITE-NPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK-- 127

Query: 255 PKIIHRDVKAANILLDE 271
            + +HRD+ A N+L+  
Sbjct: 128 -RFVHRDIAARNVLVSS 143

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 1e-30
 Identities = 48/139 (34%), Positives = 60/139 (43%), Gaps = 13/139 (9%)

Query: 140 LGRGGFGKVYKGRL----ADGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAVHRNLLR 193
           LG G FG V +G           VAVK LK +  S  E    F  EV  +    HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 194 LYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC 253
           LYG   T     +V      GS+  RLR+ Q         T  + A+  A G+ YL    
Sbjct: 76  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESKR 131

Query: 254 DPKIIHRDVKAANILLDED 272
               IHRD+ A N+LL   
Sbjct: 132 ---FIHRDLAARNLLLATR 147

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  113 bits (284), Expect = 2e-30
 Identities = 42/151 (27%), Positives = 61/151 (40%), Gaps = 17/151 (11%)

Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK--------EERTSGGELQFQTEVKI 182
           + +  K ILGRG    V +       K  AVK +          E           EV I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 183 IS-MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALG 241
           +  ++ H N+++L     T T   LV+  M  G +   L E+      L     +KI   
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRA 118

Query: 242 SARGLSYLHEHCDPKIIHRDVKAANILLDED 272
               +  LH+     I+HRD+K  NILLD+D
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDD 146

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 3e-30
 Identities = 46/161 (28%), Positives = 69/161 (42%), Gaps = 23/161 (14%)

Query: 132 DGFSNKNILGRGGFGKVYKGR------LADGKLVAVKRLKEERTSGGELQFQTEVKIISM 185
           D       LGRG FG+V +         A  + VAVK LKE  T        +E+KI+  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 186 AVHR-NLLRLYGFCTTVTEKL-LVYPYMTNGSVASRLRERQSSLPP------------LD 231
             H  N++ L G CT     L ++  +   G++++ LR +++   P            L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 232 WPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
                  +   A+G+ +L      K IHRD+ A NILL E 
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK 170

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (282), Expect = 3e-30
 Identities = 39/144 (27%), Positives = 54/144 (37%), Gaps = 10/144 (6%)

Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTS--GGELQFQTEVKIISMAVH 188
           + F    ILG G F  V   R LA  +  A+K L++              E  ++S   H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 248
              ++LY       +      Y  NG     L +    +   D    +         L Y
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALEY 123

Query: 249 LHEHCDPKIIHRDVKAANILLDED 272
           LH      IIHRD+K  NILL+ED
Sbjct: 124 LHGKG---IIHRDLKPENILLNED 144

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 3e-30
 Identities = 29/143 (20%), Positives = 58/143 (40%), Gaps = 5/143 (3%)

Query: 131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHR 189
              ++N + +G G +G V       +   VA+K++          +   E+KI+    H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           N++ +       T + +   Y+    + + L +   +   L             RGL Y+
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYI 125

Query: 250 HEHCDPKIIHRDVKAANILLDED 272
           H      ++HRD+K +N+LL+  
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTT 145

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 4e-30
 Identities = 33/142 (23%), Positives = 64/142 (45%), Gaps = 9/142 (6%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 198
           LGRG FG V++    +  K    K +K + T   ++  + E+ I+++A HRN+L L+   
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLHESF 70

Query: 199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKII 258
            ++ E ++++ +++   +  R+         L+              L +LH H    I 
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIG 124

Query: 259 HRDVKAANILLDEDADQSSKTI 280
           H D++  NI+       + K I
Sbjct: 125 HFDIRPENIIYQTRRSSTIKII 146

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (282), Expect = 6e-30
 Identities = 38/148 (25%), Positives = 70/148 (47%), Gaps = 13/148 (8%)

Query: 130 ATDGFSNKNILGRGGFGKVYKGR-LADGKL----VAVKRLKEERTSGGELQFQTEVKIIS 184
            T+ F    +LG G FG VYKG  + +G+     VA+K L+E  +     +   E  +++
Sbjct: 8   ETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66

Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
              + ++ RL G C T +   L+   M  G +   +RE +     +         +  A+
Sbjct: 67  SVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAK 122

Query: 245 GLSYLHEHCDPKIIHRDVKAANILLDED 272
           G++YL +    +++HRD+ A N+L+   
Sbjct: 123 GMNYLEDR---RLVHRDLAARNVLVKTP 147

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  112 bits (281), Expect = 7e-30
 Identities = 31/151 (20%), Positives = 64/151 (42%), Gaps = 8/151 (5%)

Query: 125 RELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKII 183
           ++ +   D +  +++LG G F +V         KLVA+K + ++   G E   + E+ ++
Sbjct: 2   KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61

Query: 184 SMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 243
               H N++ L     +     L+   ++ G +  R+ E+             ++     
Sbjct: 62  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQVL 117

Query: 244 RGLSYLHEHCDPKIIHRDVKAANILLDEDAD 274
             + YLH+     I+HRD+K  N+L     +
Sbjct: 118 DAVKYLHDLG---IVHRDLKPENLLYYSLDE 145

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 6e-29
 Identities = 42/146 (28%), Positives = 68/146 (46%), Gaps = 16/146 (10%)

Query: 134 FSNKNILGRGGFGKVYKGRLAD-GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL 192
           +++  ++G G FG VY+ +L D G+LVA+K++ +++          E++I+    H N++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 76

Query: 193 RLYGFCTTVTEK------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
           RL  F  +  EK       LV  Y+         R    +   L     K       R L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 247 SYLHEHCDPKIIHRDVKAANILLDED 272
           +Y+H      I HRD+K  N+LLD D
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPD 158

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 6e-29
 Identities = 40/143 (27%), Positives = 63/143 (44%), Gaps = 11/143 (7%)

Query: 138 NILGRGGFGKVYKGR--LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAV---HRNL 191
             +G G +GKV+K R     G+ VA+KR++ +    G  L    EV ++       H N+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 192 LRLYGFCTTVTEKLLVYPYMTNGSVASRLRE--RQSSLPPLDWPTRKKIALGSARGLSYL 249
           +RL+  CT           +    V   L     +   P +   T K +     RGL +L
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 250 HEHCDPKIIHRDVKAANILLDED 272
           H H   +++HRD+K  NIL+   
Sbjct: 133 HSH---RVVHRDLKPQNILVTSS 152

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  106 bits (266), Expect = 6e-28
 Identities = 33/136 (24%), Positives = 63/136 (46%), Gaps = 8/136 (5%)

Query: 138 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYG 196
             +G G +G VYK +   G+  A+K+++ E+   G       E+ I+    H N+++LY 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 197 FCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPK 256
              T    +LV+ ++                  L+  T K   L    G++Y H+    +
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHDR---R 120

Query: 257 IIHRDVKAANILLDED 272
           ++HRD+K  N+L++ +
Sbjct: 121 VLHRDLKPQNLLINRE 136

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 8e-28
 Identities = 31/144 (21%), Positives = 56/144 (38%), Gaps = 17/144 (11%)

Query: 139 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYG 196
           +LG G  GKV +       +  A+K L++        + + EV++   A    +++R+  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRIVD 72

Query: 197 FCTTVTEK----LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
               +       L+V   +  G + SR+++R             +I       + YLH  
Sbjct: 73  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI 130

Query: 253 CDPKIIHRDVKAANILLDEDADQS 276
               I HRDVK  N+L       +
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNA 151

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  105 bits (264), Expect = 2e-27
 Identities = 40/154 (25%), Positives = 66/154 (42%), Gaps = 17/154 (11%)

Query: 122 FSLRELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL--QFQT 178
           +SL++ Q+          LG G FG+V+  R   +G+  A+K LK+E     +       
Sbjct: 1   YSLQDFQI-------LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND 53

Query: 179 EVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKI 238
           E  ++S+  H  ++R++G      +  ++  Y+        L            P  K  
Sbjct: 54  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFY 109

Query: 239 ALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           A      L YLH      II+RD+K  NILLD++
Sbjct: 110 AAEVCLALEYLHSKD---IIYRDLKPENILLDKN 140

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  104 bits (261), Expect = 3e-27
 Identities = 38/148 (25%), Positives = 68/148 (45%), Gaps = 14/148 (9%)

Query: 131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEE--RTSGGELQFQTEVKIISMAV 187
           +D +    ILG GG  +V+  R L   + VAVK L+ +  R     L+F+ E +  +   
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 188 HRNLLRLYGFCTTVTEKL----LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 243
           H  ++ +Y      T       +V  Y+   +    LR+   +  P+      ++   + 
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVT----LRDIVHTEGPMTPKRAIEVIADAC 121

Query: 244 RGLSYLHEHCDPKIIHRDVKAANILLDE 271
           + L++ H++    IIHRDVK ANI++  
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISA 146

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 3e-27
 Identities = 35/143 (24%), Positives = 68/143 (47%), Gaps = 8/143 (5%)

Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHR 189
           + F     +G G +G VYK R    G++VA+K+++ +  T G       E+ ++    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 190 NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYL 249
           N+++L     T  +  LV+ ++       +     S+L  +  P  K       +GL++ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118

Query: 250 HEHCDPKIIHRDVKAANILLDED 272
           H H    ++HRD+K  N+L++ +
Sbjct: 119 HSHR---VLHRDLKPQNLLINTE 138

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 7e-27
 Identities = 37/145 (25%), Positives = 61/145 (42%), Gaps = 11/145 (7%)

Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL--QFQTEVKIISMAV- 187
           + F    +LG+G FGKV+        +  A+K LK++     +       E +++S+A  
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 188 HRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           H  L  ++    T      V  Y+  G +   ++         D       A     GL 
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQ 117

Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           +LH      I++RD+K  NILLD+D
Sbjct: 118 FLHSK---GIVYRDLKLDNILLDKD 139

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 1e-26
 Identities = 41/140 (29%), Positives = 64/140 (45%), Gaps = 12/140 (8%)

Query: 138 NILGRGGFGKVYKGR-LADGKLVAVKRLK----EERTSGGELQFQTEVKIISMAVHRNLL 192
           + LG G F  VYK R     ++VA+K++K     E   G       E+K++    H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 193 RLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEH 252
            L       +   LV+ +M            + +   L     K   L + +GL YLH+H
Sbjct: 64  GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119

Query: 253 CDPKIIHRDVKAANILLDED 272
               I+HRD+K  N+LLDE+
Sbjct: 120 W---ILHRDLKPNNLLLDEN 136

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  104 bits (260), Expect = 1e-26
 Identities = 38/168 (22%), Positives = 65/168 (38%), Gaps = 11/168 (6%)

Query: 109 EDDSELQLGQLKRFSLRELQVAT-DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKE 166
           E  ++ +   LK++       A  D F     LG G FG+V   +    G   A+K L +
Sbjct: 17  EFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76

Query: 167 ERTSGGEL--QFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQ 224
           ++    +       E +I+       L++L       +   +V  Y+  G + S LR   
Sbjct: 77  QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG 136

Query: 225 SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
                   P  +  A        YLH      +I+RD+K  N+L+D+ 
Sbjct: 137 ----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQ 177

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  100 bits (250), Expect = 2e-25
 Identities = 33/148 (22%), Positives = 53/148 (35%), Gaps = 11/148 (7%)

Query: 126 ELQVATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS 184
           EL+V  + +     +G G FG +Y G  +A G+ VA+K    +       Q   E KI  
Sbjct: 2   ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYK 57

Query: 185 MAVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSAR 244
           M      +    +C    +  ++   +   S+                 T   +A     
Sbjct: 58  MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS---RKFSLKTVLLLADQMIS 114

Query: 245 GLSYLHEHCDPKIIHRDVKAANILLDED 272
            + Y+H       IHRDVK  N L+   
Sbjct: 115 RIEYIHSK---NFIHRDVKPDNFLMGLG 139

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 2e-25
 Identities = 38/163 (23%), Positives = 65/163 (39%), Gaps = 21/163 (12%)

Query: 122 FSLRELQVATDGFSNK----NILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL-Q 175
           F  +E+                +G G +G V        G  VA+K+L     S     +
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 176 FQTEVKIISMAVHRNLLRLYGFCTT------VTEKLLVYPYMTNGSVASRLRERQSSLPP 229
              E++++    H N++ L    T        T+  LV P+M  G+   +L + +     
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE----K 117

Query: 230 LDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
           L     + +     +GL Y+H      IIHRD+K  N+ ++ED
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNED 157

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.9 bits (243), Expect = 1e-24
 Identities = 36/153 (23%), Positives = 57/153 (37%), Gaps = 13/153 (8%)

Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL-----QFQTEVKIISM 185
           D +     LG G F  V K R  + G   A K +K+ RT            + EV I+  
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 186 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 245
             H N++ L+      T+ +L+   +  G     L +  +    L      +       G
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILNG 125

Query: 246 LSYLHEHCDPKIIHRDVKAANILLDEDADQSSK 278
           + YLH      I H D+K  NI+L +      +
Sbjct: 126 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPR 155

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 96.8 bits (240), Expect = 3e-24
 Identities = 26/143 (18%), Positives = 51/143 (35%), Gaps = 12/143 (8%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLL-RLYGF 197
           +G G FG +++G  L + + VA+K       +    Q + E +   +      +  +Y F
Sbjct: 13  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP---QLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 198 CTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKI 257
                  +LV   +      S               T    A      +  +HE     +
Sbjct: 70  GQEGLHNVLVIDLLGP----SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SL 122

Query: 258 IHRDVKAANILLDEDADQSSKTI 280
           ++RD+K  N L+     +++  I
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMI 145

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.9 bits (238), Expect = 5e-24
 Identities = 30/142 (21%), Positives = 56/142 (39%), Gaps = 14/142 (9%)

Query: 139 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGE-----LQFQTEVKIISM--AVHRN 190
           +LG GGFG VY G  ++D   VA+K ++++R S         +   EV ++    +    
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 191 LLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
           ++RL  +       +L+                +     L     +         + + H
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCH 127

Query: 251 EHCDPKIIHRDVKAANILLDED 272
                 ++HRD+K  NIL+D +
Sbjct: 128 NC---GVLHRDIKDENILIDLN 146

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.4 bits (239), Expect = 9e-24
 Identities = 36/147 (24%), Positives = 58/147 (39%), Gaps = 10/147 (6%)

Query: 129 VATDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL--QFQTEVKIISM 185
           V  + F    +LG+G FGKV   R  A G+  A+K L++E     +      TE +++  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 186 AVHRNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARG 245
             H  L  L     T      V  Y   G +   L   +           +      A  
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYG---AEI 114

Query: 246 LSYLHEHCDPKIIHRDVKAANILLDED 272
           +S L       +++RD+K  N++LD+D
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKD 141

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 95.7 bits (237), Expect = 2e-23
 Identities = 31/145 (21%), Positives = 59/145 (40%), Gaps = 18/145 (12%)

Query: 132 DGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHR 189
           D +     LGRG + +V++   + + + V VK LK  +      + + E+KI+  +    
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK----KIKREIKILENLRGGP 90

Query: 190 NLLRLYGFCTTVTEKL--LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLS 247
           N++ L         +   LV+ ++ N       +        L     +       + L 
Sbjct: 91  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALD 143

Query: 248 YLHEHCDPKIIHRDVKAANILLDED 272
           Y H      I+HRDVK  N+++D +
Sbjct: 144 YCHSMG---IMHRDVKPHNVMIDHE 165

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.3 bits (236), Expect = 2e-23
 Identities = 38/149 (25%), Positives = 65/149 (43%), Gaps = 17/149 (11%)

Query: 134 FSNKNILGRGGFGKVYKGR-LADGKLVAVKRL-KEERTSGGELQFQTEVKIISMAVHRNL 191
           +     +G+G FG+V+K R    G+ VA+K++  E    G  +    E+KI+ +  H N+
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 192 LRLYGFCTTVTEK--------LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSA 243
           + L   C T             LV+ +  +           + L        K++     
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDL----AGLLSNVLVKFTLSEIKRVM---Q 124

Query: 244 RGLSYLHEHCDPKIIHRDVKAANILLDED 272
             L+ L+     KI+HRD+KAAN+L+  D
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITRD 153

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 89.5 bits (221), Expect = 2e-22
 Identities = 24/143 (16%), Positives = 41/143 (28%), Gaps = 19/143 (13%)

Query: 138 NILGRGGFGKVYKGRLADGKLVAVKRLKEERTS---------GGELQFQTEVKIISMAVH 188
            ++G G    V+           VK  K   TS          G+L F       +    
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 248
           R L +L G             Y   G+           L  +      ++       ++ 
Sbjct: 66  RALQKLQGLAV-------PKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118

Query: 249 LHEHCDPKIIHRDVKAANILLDE 271
            +      I+H D+   N+L+ E
Sbjct: 119 FYHRG---IVHGDLSQYNVLVSE 138

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.8 bits (224), Expect = 5e-22
 Identities = 29/137 (21%), Positives = 60/137 (43%), Gaps = 9/137 (6%)

Query: 138 NILGRGGFGKVYKGR-LADGKLVAVKRLK-EERTSGGELQFQTEVKIISMAVHRNLLRLY 195
             +G G +G V+K +     ++VA+KR++ ++   G       E+ ++    H+N++RL+
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 196 GFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDP 255
               +  +  LV+ +          +   S    LD    K       + L  L      
Sbjct: 68  DVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFL---FQLLKGLGFCHSR 120

Query: 256 KIIHRDVKAANILLDED 272
            ++HRD+K  N+L++ +
Sbjct: 121 NVLHRDLKPQNLLINRN 137

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.7 bits (224), Expect = 8e-22
 Identities = 39/153 (25%), Positives = 64/153 (41%), Gaps = 15/153 (9%)

Query: 128 QVATDGFSNKNILGRGGFGKVYKGRLA----DGKLVAVKRLKEERTSGGEL---QFQTEV 180
           +V  + F    +LG G +GKV+  R       GKL A+K LK+             +TE 
Sbjct: 20  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79

Query: 181 KIISMAVHR-NLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIA 239
           +++        L+ L+    T T+  L+  Y+  G + + L +R+            +I 
Sbjct: 80  QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI- 138

Query: 240 LGSARGLSYLHEHCDPKIIHRDVKAANILLDED 272
                 +  L       II+RD+K  NILLD +
Sbjct: 139 ------VLALEHLHKLGIIYRDIKLENILLDSN 165

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.3 bits (215), Expect = 2e-20
 Identities = 31/143 (21%), Positives = 53/143 (37%), Gaps = 5/143 (3%)

Query: 131 TDGFSNKNILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVH 188
            + + N + +G G +G V        G  VAVK+L     S     +   E++++    H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 189 RNLLRLYGFCTTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSY 248
            N++ L    T                +             L     + +     RGL Y
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 249 LHEHCDPKIIHRDVKAANILLDE 271
           +H      IIHRD+K +N+ ++E
Sbjct: 137 IHSAD---IIHRDLKPSNLAVNE 156

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.8 bits (206), Expect = 4e-19
 Identities = 30/142 (21%), Positives = 50/142 (35%), Gaps = 18/142 (12%)

Query: 139 ILGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGEL-QFQTEVKIISMAVHRNLLRLYG 196
            +G G  G V         + VA+K+L     +     +   E+ ++    H+N++ L  
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 197 FCTT------VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLH 250
             T         +  LV   M          E        D      +      G+ +LH
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHERMSYLLYQMLCGIKHLH 136

Query: 251 EHCDPKIIHRDVKAANILLDED 272
                 IIHRD+K +NI++  D
Sbjct: 137 SAG---IIHRDLKPSNIVVKSD 155

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 80.1 bits (196), Expect = 9e-18
 Identities = 27/146 (18%), Positives = 53/146 (36%), Gaps = 17/146 (11%)

Query: 140 LGRGGFGKVYKGR-LADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFC 198
           LG G F  V+  + + +   VA+K ++ ++        + E+K++      +  +     
Sbjct: 21  LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY--TEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 199 TTVTEKLLVYPY------------MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGL 246
                KLL +                          ++     +     K+I+     GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 247 SYLHEHCDPKIIHRDVKAANILLDED 272
            Y+H  C   IIH D+K  N+L++  
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIV 162

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 55.5 bits (132), Expect = 2e-09
 Identities = 14/48 (29%), Positives = 23/48 (47%), Gaps = 3/48 (6%)

Query: 1   MTALR--DLSNNRLSGPVPDNGSFSQFTPISFENNLNLCGPNTKKPCS 46
           +  L   ++S N L G +P  G+  +F   ++ NN  LCG      C+
Sbjct: 267 LKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS-PLPACT 313

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	284
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.98
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.98
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.98
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.98
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.98
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.97
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.97
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.97
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.97
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.97
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.97
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.97
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.97
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.97
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.97
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.97
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.97
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.97
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.97
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.97
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.97
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.97
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.97
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.97
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.97
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.97
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.97
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.96
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.96
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.96
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.96
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.96
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.96
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.95
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.95
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.95
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.95
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.95
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.94
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.94
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.93
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.86
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.37
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.82
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.61
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.14
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.05
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.23
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	90.05
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	89.98
d2ifga3	156	High affinity nerve growth factor receptor, N-term	83.28
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	81.11
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	80.37

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.6e-36  Score=251.51  Aligned_cols=148  Identities=28%  Similarity=0.403  Sum_probs=131.5

Q ss_pred             HHHHHhcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCee
Q 023282          126 ELQVATDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEK  204 (284)
Q Consensus       126 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~  204 (284)
                      +++...++|+..+.||+|+||+||+|+.. +++.||||+++.+.  ...++|.+|+.++++++|||||+++|+|...+..
T Consensus        11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (287)
T d1opja_          11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   88 (287)
T ss_dssp             TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence            34444567888899999999999999865 58899999986543  3345799999999999999999999999999999


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++||||+++|+|.+++....  ...++|..+..++.|++.||+|||++   +|+||||||+|||+|.++.+||+||
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DF  159 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADF  159 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             EEEeecccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccc
Confidence            99999999999999997643  23689999999999999999999999   9999999999999999999999998

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-35  Score=246.04  Aligned_cols=143  Identities=25%  Similarity=0.391  Sum_probs=126.2

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      .++|+..+.||+|+||+||+|+. .+++.||||+++.....+..+.+.+|++++++++|||||++++++...+..++|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            35688889999999999999986 47899999999755444444568999999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++|+|.+++....    .+++.++..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        84 y~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DF  147 (271)
T d1nvra_          84 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDF  147 (271)
T ss_dssp             CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCC
T ss_pred             ccCCCcHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccc
Confidence            999999999996532    589999999999999999999999   9999999999999999999999998

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-35  Score=244.14  Aligned_cols=141  Identities=28%  Similarity=0.445  Sum_probs=128.5

Q ss_pred             cCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      ++|+..+.||+|+||+||+|++.+++.||||+++...  ...++|.+|++++++++|||||+++|+|...+..++||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            4577788999999999999999888899999996532  33457999999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++|+|.+++....   ..++|..+..++.|+|.||.|||+.   +|+||||||+|||+|.++.+||+||
T Consensus        83 ~~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DF  145 (263)
T d1sm2a_          83 EHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDF  145 (263)
T ss_dssp             TTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSC
T ss_pred             CCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEeccc
Confidence            9999999987643   2589999999999999999999999   9999999999999999999999998

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.9e-35  Score=248.51  Aligned_cols=143  Identities=29%  Similarity=0.452  Sum_probs=126.0

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CC---cEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DG---KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      ++|+..++||+|+||+||+|+.. ++   ..||||.+.........++|.+|+++|++++|||||+++|+|...+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            44666789999999999999864 23   368999886554444456799999999999999999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||+++|+|.+++....   ..++|.+++.++.|+++||+|||+.   +|+||||||+|||+|.++.+||+||
T Consensus       106 ~Ey~~~g~L~~~~~~~~---~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DF  172 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDF  172 (299)
T ss_dssp             EECCTTEEHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             EEecCCCcceeeecccc---CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCc
Confidence            99999999999987643   2589999999999999999999998   9999999999999999999999998

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-35  Score=245.80  Aligned_cols=143  Identities=29%  Similarity=0.456  Sum_probs=125.6

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEE
Q 023282          129 VATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       129 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      ...++|+..+.||+|+||+||+|+..+  .||||+++..... ...+.|.+|+.++++++|||||+++|++.. +..++|
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv   81 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV   81 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence            345678889999999999999998643  5999999754433 334579999999999999999999998754 568999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||+++|+|.++++....   .++|..++.++.|+++||+|||+.   +|+||||||+|||+|.++.+||+||
T Consensus        82 ~Ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DF  148 (276)
T d1uwha_          82 TQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDF  148 (276)
T ss_dssp             EECCCEEEHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCC
T ss_pred             EecCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccc
Confidence            999999999999976432   589999999999999999999998   9999999999999999999999998

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-35  Score=246.81  Aligned_cols=144  Identities=29%  Similarity=0.440  Sum_probs=126.7

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          129 VATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       129 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      +..++|+..+.||+|+||.||+|+++++..||||+++...  ...+.|.+|++++++++|||||+++|++.. +..++||
T Consensus        10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~   86 (272)
T d1qpca_          10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (272)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence            3445677789999999999999999888899999996532  334579999999999999999999998754 5679999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++.....  ..++|.+++.++.|+++||.|||+.   +|+||||||+|||+|.++.+||+||
T Consensus        87 Ey~~~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DF  153 (272)
T d1qpca_          87 EYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADF  153 (272)
T ss_dssp             ECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred             EeCCCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccc
Confidence            99999999998865322  2489999999999999999999998   9999999999999999999999998

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-34  Score=235.53  Aligned_cols=141  Identities=27%  Similarity=0.437  Sum_probs=129.3

Q ss_pred             cCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      ++|+..+.||+|+||+||+|+.+++..||||+++...  ....+|.+|+.++++++||||++++|+|...+..++||||+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~--~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS--SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc--CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            5788999999999999999999888899999997543  23457999999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++|+|.+++.....   .++|..+.+++.|+++||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        82 ~~g~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~Df  144 (258)
T d1k2pa_          82 ANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDF  144 (258)
T ss_dssp             TTEEHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCC
T ss_pred             CCCcHHHhhhcccc---CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcc
Confidence            99999999875433   478999999999999999999998   9999999999999999999999998

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-34  Score=239.07  Aligned_cols=140  Identities=22%  Similarity=0.365  Sum_probs=127.7

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|++++++++|||||++++++...+..++||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC-hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            4689999999999999999985 5799999999875432 3345789999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++|+|.+++...     .+++.++..++.|++.||+|||++   +|+||||||+|||++.++++||+||
T Consensus        99 ~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DF  160 (293)
T d1yhwa1          99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDF  160 (293)
T ss_dssp             CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred             cCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccc
Confidence            9999999988753     489999999999999999999999   9999999999999999999999998

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-34  Score=241.00  Aligned_cols=142  Identities=28%  Similarity=0.425  Sum_probs=127.9

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +.|+..+.||+|+||+||+|+. .++..||||+++... ....+.+.+|++++++++|||||++++++...+..++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            4577789999999999999986 478899999996542 33345789999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++|+|.+++.+...   ++++.++..++.|++.||.|||++   +|+||||||+|||++.++++||+||
T Consensus        91 ~~~g~L~~~~~~~~~---~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DF  154 (288)
T d2jfla1          91 CAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADF  154 (288)
T ss_dssp             CTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEec
Confidence            999999999876432   589999999999999999999999   9999999999999999999999998

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-34  Score=248.04  Aligned_cols=143  Identities=27%  Similarity=0.378  Sum_probs=129.8

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      .++|+..+.||+|+||+||+|+. .+|+.||+|+++..........+.+|+.+++.++|||||++++++...+..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            46788899999999999999996 47899999999765444445578999999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++|+|.+++.+..    .+++..+..++.|++.||.|||+ +   +|+||||||+|||++.++.+||+||
T Consensus        85 y~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DF  149 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDF  149 (322)
T ss_dssp             CCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeC
Confidence            999999999998653    48999999999999999999997 5   7999999999999999999999998

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-34  Score=240.62  Aligned_cols=149  Identities=23%  Similarity=0.340  Sum_probs=120.3

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcc-cHHHHHHHHHHHhcCCCCCceeeeeEEee--CCeeeEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTT--VTEKLLV  207 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~g~~~~--~~~~~lv  207 (284)
                      ++|+..+.||+|+||+||+|+. .+|+.||+|.++.....+ ....+.+|++++++++|||||++++++..  ....++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5688889999999999999986 478999999996544332 23468999999999999999999999865  4567999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC--DPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~--~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||+++|+|.+++.........+++..+..++.|++.||.|||+..  ..+|+||||||+|||++.++.+||+||
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF  158 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  158 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence            9999999999999754333346899999999999999999999862  125999999999999999999999998

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-34  Score=236.63  Aligned_cols=142  Identities=32%  Similarity=0.494  Sum_probs=128.1

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|+..+.||+|+||+||+|+.. +++.||+|++.....  ......+.+|+.+++.++|||||++++++.+.+..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46888899999999999999964 688999999864322  233456899999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++....    .+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        86 Ey~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DF  150 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADF  150 (263)
T ss_dssp             ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             eecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeeccc
Confidence            9999999999998653    489999999999999999999999   9999999999999999999999998

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-34  Score=240.22  Aligned_cols=142  Identities=25%  Similarity=0.379  Sum_probs=123.1

Q ss_pred             cCCCCCCe-ecccCceEEEEEEeC---CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEE
Q 023282          132 DGFSNKNI-LGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       132 ~~~~~~~~-lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      +++...+. ||+|+||+||+|...   ++..||||+++........++|.+|++++++++|||||+++|++.. +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            34455564 999999999999753   3557999999765444445679999999999999999999999865 568999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||+++|+|.+++....   ..++|.++..++.|+++||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        87 mE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DF  153 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDF  153 (285)
T ss_dssp             EECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCC
T ss_pred             EEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccc
Confidence            99999999999986543   2589999999999999999999999   9999999999999999999999998

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-34  Score=239.24  Aligned_cols=143  Identities=29%  Similarity=0.482  Sum_probs=126.9

Q ss_pred             cCCCCCCeecccCceEEEEEEeCCC-----cEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLADG-----KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~l  206 (284)
                      +.|+..++||+|+||.||+|.+++.     ..||||+++.........+|.+|+.++++++|||||+++|++...+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4567789999999999999986432     37999999765444445579999999999999999999999999999999


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||||+.+|++.+.+.....   .++|.++..++.|++.||+|||+.   +|+||||||+|||+|.++.+||+||
T Consensus        87 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DF  154 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDF  154 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             EEEecccCcchhhhhcccc---cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEccc
Confidence            9999999999998876432   589999999999999999999998   9999999999999999999999998

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-34  Score=240.35  Aligned_cols=142  Identities=27%  Similarity=0.432  Sum_probs=126.7

Q ss_pred             hcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      .++|+..+.||+|+||+||+|+.+++..||||+++...  ...+.|.+|+.++++++|||||+++|+|. .+..++||||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey   92 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY   92 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEe
Confidence            45688889999999999999999888889999996443  33457999999999999999999999985 4678999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++|+|..++.....  ..++|.+++.++.|+++||+|||+.   +|+||||||+|||+|.++++||+||
T Consensus        93 ~~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~Df  157 (285)
T d1fmka3          93 MSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF  157 (285)
T ss_dssp             CTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             cCCCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEccc
Confidence            999999999876432  2489999999999999999999999   9999999999999999999999998

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.5e-34  Score=240.40  Aligned_cols=154  Identities=30%  Similarity=0.487  Sum_probs=134.7

Q ss_pred             HHHHHHHhcCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeE
Q 023282          124 LRELQVATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGF  197 (284)
Q Consensus       124 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~  197 (284)
                      +.+++.+.++|+..+.||+|+||+||+|+..      +++.||||+++.....+...+|.+|+++++.++||||++++++
T Consensus         5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~   84 (301)
T d1lufa_           5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV   84 (301)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence            3456667788999999999999999999853      3568999999765544445679999999999999999999999


Q ss_pred             EeeCCeeeEEEeCCCCCChHHHHhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 023282          198 CTTVTEKLLVYPYMTNGSVASRLRERQS--------------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKI  257 (284)
Q Consensus       198 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~i  257 (284)
                      |......+++|||+++|+|.++++....                    ....++|..++.++.|++.||+|||+.   ++
T Consensus        85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i  161 (301)
T d1lufa_          85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF  161 (301)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred             eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence            9999999999999999999999975321                    123588999999999999999999999   99


Q ss_pred             eeeCCCCCCeeeCCCCCcchhhh
Q 023282          258 IHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       258 vHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +||||||+|||+|.++++||+||
T Consensus       162 vHrDlKp~NILld~~~~~Kl~DF  184 (301)
T d1lufa_         162 VHRDLATRNCLVGENMVVKIADF  184 (301)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCC
T ss_pred             EeeEEcccceEECCCCcEEEccc
Confidence            99999999999999999999998

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-33  Score=239.58  Aligned_cols=141  Identities=29%  Similarity=0.420  Sum_probs=125.5

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCccc--HHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          133 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      .|+..+.||+|+||+||+|+. .+++.||||+++.......  ...+.+|+.++++++|||||++++++...+..++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            477789999999999999985 4788999999975443222  2468999999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||++|+|..++....    ++++.++..++.|++.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus        96 ~~~~g~l~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DF  159 (309)
T d1u5ra_          96 YCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDF  159 (309)
T ss_dssp             CCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCC
T ss_pred             ecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeec
Confidence            999999977765532    589999999999999999999999   9999999999999999999999998

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-33  Score=242.40  Aligned_cols=149  Identities=27%  Similarity=0.428  Sum_probs=125.1

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEeCC-C-----cEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEeeC
Q 023282          129 VATDGFSNKNILGRGGFGKVYKGRLAD-G-----KLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  201 (284)
Q Consensus       129 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~  201 (284)
                      ...++|+..++||+|+||+||+|+... +     ..||+|.+...........+.+|+.++.++ +|||||+++|++...
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            345678888999999999999998532 2     369999986554444455789999999887 899999999999999


Q ss_pred             CeeeEEEeCCCCCChHHHHhhcCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCC
Q 023282          202 TEKLLVYPYMTNGSVASRLRERQS-------------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDV  262 (284)
Q Consensus       202 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdl  262 (284)
                      +..++||||+++|+|.++|+....                   ....++|..++.++.|+++||+|||+.   +|+||||
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl  190 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL  190 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence            999999999999999999986432                   123589999999999999999999999   9999999


Q ss_pred             CCCCeeeCCCCCcchhhh
Q 023282          263 KAANILLDEDADQSSKTI  280 (284)
Q Consensus       263 k~~NiLld~~~~~~~~df  280 (284)
                      ||+|||++.++.+||+||
T Consensus       191 Kp~Nill~~~~~~Kl~DF  208 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDF  208 (325)
T ss_dssp             SGGGEEEETTTEEEECCC
T ss_pred             chhccccccCCeEEEeec
Confidence            999999999999999998

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-33  Score=235.52  Aligned_cols=142  Identities=27%  Similarity=0.358  Sum_probs=128.1

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc--CcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|+..+.||+|+||+||+|+. .+++.||||+++...  .......+.+|++++++++||||+++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            4588889999999999999986 478999999996432  1233456899999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||+++++.+||+||
T Consensus        88 Ey~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DF  152 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDF  152 (288)
T ss_dssp             CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred             EccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEeccc
Confidence            9999999999988653    489999999999999999999999   9999999999999999999999998

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=6.6e-33  Score=232.25  Aligned_cols=135  Identities=26%  Similarity=0.374  Sum_probs=116.8

Q ss_pred             CeecccCceEEEEEEeC---CCcEEEEEEeecccCcc-cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCCCC
Q 023282          138 NILGRGGFGKVYKGRLA---DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYMTN  213 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~~~  213 (284)
                      +.||+|+||+||+|.++   .++.||||+++...... ..++|.+|+.++++++|||||+++|+|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            46999999999999854   34689999996543322 23479999999999999999999999864 567899999999


Q ss_pred             CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          214 GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       214 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+|.++++...    .++|..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|++||
T Consensus        92 g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DF  151 (277)
T d1xbba_          92 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDF  151 (277)
T ss_dssp             EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCC
T ss_pred             CcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccch
Confidence            99999998643    489999999999999999999998   9999999999999999999999998

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.98  E-value=1.2e-32  Score=230.53  Aligned_cols=142  Identities=29%  Similarity=0.335  Sum_probs=127.4

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCccc--------HHHHHHHHHHHhcCC-CCCceeeeeEEeeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGG--------ELQFQTEVKIISMAV-HRNLLRLYGFCTTV  201 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~--------~~~~~~e~~~l~~~~-h~niv~l~g~~~~~  201 (284)
                      ++|+..+.||+|+||+||+|+. .+++.||||+++.......        ...+.+|+.++++++ ||||+++++++.+.
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            5788899999999999999986 5788999999965432211        125889999999997 99999999999999


Q ss_pred             CeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          202 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       202 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +..++||||+++|+|.++++...    .+++.++..++.|+++||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DF  154 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF  154 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             cceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccc
Confidence            99999999999999999998653    489999999999999999999999   9999999999999999999999998

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.98  E-value=6.2e-33  Score=235.62  Aligned_cols=142  Identities=23%  Similarity=0.383  Sum_probs=122.3

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +.|+..+.||+|+||+||+|+.. +++.||||++...........+.+|+.+++.++|||||++++++...+..++||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            55888899999999999999864 68999999997554444445688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeC---CCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD---EDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld---~~~~~~~~df  280 (284)
                      +++|+|.+++....    .+++.....++.|++.||+|||+.   +|+||||||+|||+.   .++.+||+||
T Consensus        89 ~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DF  154 (307)
T d1a06a_          89 VSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDF  154 (307)
T ss_dssp             CCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred             cCCCcHHHhhhccc----CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEecc
Confidence            99999999997642    589999999999999999999999   999999999999994   5788999998

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.7e-32  Score=228.80  Aligned_cols=140  Identities=26%  Similarity=0.406  Sum_probs=119.9

Q ss_pred             CCCeecccCceEEEEEEeC-CCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEee----CCeeeEEEe
Q 023282          136 NKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT----VTEKLLVYP  209 (284)
Q Consensus       136 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~----~~~~~lv~e  209 (284)
                      ..+.||+|+||+||+|+.. ++..||+|.+...... ...+.|.+|++++++++|||||++++++..    ....++|||
T Consensus        13 ~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE   92 (270)
T d1t4ha_          13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE   92 (270)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred             eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEe
Confidence            3467999999999999864 6889999998754433 233468999999999999999999999865    345789999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeC-CCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD-EDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld-~~~~~~~~df  280 (284)
                      |+++|+|.+++....    .+++..+..++.|+++||+|||++ .++|+||||||+|||++ +++.+||+||
T Consensus        93 ~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DF  159 (270)
T d1t4ha_          93 LMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDL  159 (270)
T ss_dssp             CCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred             CCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeec
Confidence            999999999998653    489999999999999999999998 22399999999999996 5789999998

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=2.4e-32  Score=230.77  Aligned_cols=142  Identities=26%  Similarity=0.332  Sum_probs=126.9

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc-----ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-----GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  205 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~  205 (284)
                      +.|+..+.||+|+||+||+|+. .+|+.||||+++.....     .....+.+|+.++++++|||||++++++.+.+..+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            5688889999999999999996 47899999998644322     12457999999999999999999999999999999


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCC----cchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD----QSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~----~~~~df  280 (284)
                      +||||+++|+|.+++....    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.    +|++||
T Consensus        90 iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence            9999999999999998753    489999999999999999999999   9999999999999998874    899997

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.8e-32  Score=235.31  Aligned_cols=143  Identities=25%  Similarity=0.345  Sum_probs=129.1

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc--CcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEE
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      .++|+..+.||+|+||.||+|+. .+++.||||+++...  .......+.+|+.+|+.++||||+++++++.+.+..++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            35788899999999999999986 579999999997542  223345688999999999999999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||+++|+|.+++....    .+++.....++.|++.||+|||++   +|+||||||+|||+|.++.+||+||
T Consensus        84 ~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DF  149 (337)
T d1o6la_          84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF  149 (337)
T ss_dssp             EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             eeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeec
Confidence            99999999999998754    478889999999999999999999   9999999999999999999999998

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2e-32  Score=232.95  Aligned_cols=146  Identities=29%  Similarity=0.498  Sum_probs=125.0

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCc--EEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEeeCCeeeEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGK--LVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~~~~~lv  207 (284)
                      ++|+..++||+|+||.||+|++. ++.  .||||.++.....+..+.|.+|+++++++ +|||||+++|+|...+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            56777899999999999999864 444  57888886554444455799999999998 799999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCc
Q 023282          208 YPYMTNGSVASRLRERQ------------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQ  275 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~  275 (284)
                      |||+++|+|.++|+...            .....++|..+..++.|+++||.|||+.   +|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence            99999999999997541            2234689999999999999999999999   99999999999999999999


Q ss_pred             chhhh
Q 023282          276 SSKTI  280 (284)
Q Consensus       276 ~~~df  280 (284)
                      ||+||
T Consensus       167 kl~Df  171 (309)
T d1fvra_         167 KIADF  171 (309)
T ss_dssp             EECCT
T ss_pred             EEccc
Confidence            99998

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.97  E-value=2.6e-32  Score=232.69  Aligned_cols=142  Identities=30%  Similarity=0.434  Sum_probs=127.7

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc--CcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++...  .....+.+.+|+.+++.++|||||++++++...+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5688889999999999999996 468999999996432  2233457899999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+++|+|..++....    .+++.....++.|++.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        84 E~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DF  148 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDF  148 (316)
T ss_dssp             CCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             eecCCccccccccccc----cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecC
Confidence            9999999999998653    378888999999999999999999   9999999999999999999999998

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.97  E-value=2.8e-32  Score=235.46  Aligned_cols=142  Identities=20%  Similarity=0.347  Sum_probs=126.3

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ++|+..+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+.++++++|||||++++++...+..++||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            5788889999999999999986 478999999996432 22345689999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC--CCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE--DADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~--~~~~~~~df  280 (284)
                      +++|+|.+++....   ..+++..+..++.|++.||.|||++   +|+||||||+|||++.  ++.+||+||
T Consensus       105 ~~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DF  170 (350)
T d1koaa2         105 MSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDF  170 (350)
T ss_dssp             CCSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCC
T ss_pred             CCCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeec
Confidence            99999999996532   2589999999999999999999999   9999999999999964  578999998

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.97  E-value=3.4e-32  Score=235.05  Aligned_cols=142  Identities=21%  Similarity=0.337  Sum_probs=126.3

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      +.|+..+.||+|+||.||+|+. .+|+.||||+++... ......+.+|+.++++++|||||++++++...+..++||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            4688889999999999999986 479999999986543 22344688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeC--CCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLD--EDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld--~~~~~~~~df  280 (284)
                      +++|+|.+++....   ..+++.+...++.|++.||.|||+.   +|+||||||+|||++  .++.+||+||
T Consensus       108 ~~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DF  173 (352)
T d1koba_         108 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDF  173 (352)
T ss_dssp             CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCC
T ss_pred             CCCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeec
Confidence            99999999886532   2589999999999999999999999   999999999999998  5688999998

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=7.5e-33  Score=235.46  Aligned_cols=151  Identities=27%  Similarity=0.434  Sum_probs=130.6

Q ss_pred             HHHHhcCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEee
Q 023282          127 LQVATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT  200 (284)
Q Consensus       127 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~  200 (284)
                      +++..++|+..+.||+|+||.||+|.+.      ++..||||+++..........|.+|+.++++++|||||+++|+|..
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            3444567788899999999999999753      2568999999755444444569999999999999999999999999


Q ss_pred             CCeeeEEEeCCCCCChHHHHhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCC
Q 023282          201 VTEKLLVYPYMTNGSVASRLRERQ------SSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDAD  274 (284)
Q Consensus       201 ~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~  274 (284)
                      .+..++||||+++|+|.+++....      .....++|..+..++.|+++||.|||+.   +|+||||||+|||+|.++.
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCce
Confidence            999999999999999999987532      2234579999999999999999999998   9999999999999999999


Q ss_pred             cchhhh
Q 023282          275 QSSKTI  280 (284)
Q Consensus       275 ~~~~df  280 (284)
                      +||+||
T Consensus       172 ~Kl~DF  177 (308)
T d1p4oa_         172 VKIGDF  177 (308)
T ss_dssp             EEECCT
T ss_pred             EEEeec
Confidence            999998

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=7.7e-33  Score=231.58  Aligned_cols=144  Identities=23%  Similarity=0.322  Sum_probs=124.4

Q ss_pred             HhcCCCCCCeecccCceEEEEEEeCC----CcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeee
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRLAD----GKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  205 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~  205 (284)
                      ..++|+..+.||+|+||.||+|+...    +..||||.++..........|.+|+.++++++|||||+++|++. .+..+
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~   83 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   83 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence            34568888999999999999998642    34689998865444444457999999999999999999999985 46789


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +||||+++|+|.+++....   ..+++..++.++.|+++||.|||+.   +|+||||||+||+++.++.+||+||
T Consensus        84 iv~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~Df  152 (273)
T d1mp8a_          84 IIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDF  152 (273)
T ss_dssp             EEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-
T ss_pred             EEEEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccc
Confidence            9999999999999887643   2589999999999999999999999   9999999999999999999999998

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8.9e-32  Score=228.90  Aligned_cols=138  Identities=33%  Similarity=0.509  Sum_probs=120.4

Q ss_pred             CCeecccCceEEEEEEeCCC----cEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEee-CCeeeEEEeCC
Q 023282          137 KNILGRGGFGKVYKGRLADG----KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTEKLLVYPYM  211 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~-~~~~~lv~e~~  211 (284)
                      .++||+|+||+||+|++.++    ..||||.++.........+|.+|++++++++|||||+++|++.. ....++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999986432    36899999754444444679999999999999999999999876 45789999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++|+|.++++....   .+++..++.++.|++.||.|||+.   +|+||||||+|||+|+++.+||+||
T Consensus       112 ~~g~l~~~~~~~~~---~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DF  174 (311)
T d1r0pa_         112 KHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADF  174 (311)
T ss_dssp             TTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSS
T ss_pred             ecCchhhhhccccc---cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecc
Confidence            99999999986432   478889999999999999999998   9999999999999999999999998

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8.2e-32  Score=230.11  Aligned_cols=141  Identities=21%  Similarity=0.325  Sum_probs=125.1

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ++|...+.||+|+||+||+|... +++.||||.++...  .+...+.+|+++|+.++|||||++++++.+.+..++||||
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            56788899999999999999864 68899999996532  2334688999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC--Ccchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA--DQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~--~~~~~df  280 (284)
                      |++|+|.+++....   ..+++.+...++.|++.||.|||+.   +|+||||||+|||++.++  .++++||
T Consensus        83 ~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DF  148 (321)
T d1tkia_          83 ISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEF  148 (321)
T ss_dssp             CCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred             CCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEccc
Confidence            99999999997643   2489999999999999999999999   999999999999998654  7889998

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5e-32  Score=231.28  Aligned_cols=142  Identities=26%  Similarity=0.486  Sum_probs=121.6

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCc----EEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGK----LVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLL  206 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~l  206 (284)
                      ++|+..++||+|+||+||+|... +|+    .||+|.++........++|.+|+.++++++|||||+++|+|.. +..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence            35788899999999999999864 444    5899988765555556689999999999999999999999976 45678


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++||+.+|+|.+++.....   .++|..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        88 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DF  155 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDF  155 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCC
T ss_pred             EEEeccCCccccccccccc---CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeecc
Confidence            8999999999999886533   589999999999999999999998   9999999999999999999999998

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8.5e-33  Score=229.61  Aligned_cols=141  Identities=28%  Similarity=0.452  Sum_probs=122.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEee-CCeeeEEEe
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTT-VTEKLLVYP  209 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~-~~~~~lv~e  209 (284)
                      .++|+..+.||+|+||.||+|+.. |..||||+++.+   ...++|.+|++++++++||||++++|+|.. .+..++|||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e   81 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   81 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence            345677889999999999999984 778999999643   234579999999999999999999999865 456799999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++|+|.+++.....  ..++|..+++++.|++.||.|||+.   +|+||||||+|||++.++.+|++||
T Consensus        82 y~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~df  147 (262)
T d1byga_          82 YMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDF  147 (262)
T ss_dssp             CCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCC
T ss_pred             ccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeeccc
Confidence            9999999999976421  1479999999999999999999998   9999999999999999999999998

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.8e-32  Score=232.27  Aligned_cols=149  Identities=28%  Similarity=0.395  Sum_probs=129.7

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEe------CCCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEeeC
Q 023282          129 VATDGFSNKNILGRGGFGKVYKGRL------ADGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTTV  201 (284)
Q Consensus       129 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~~  201 (284)
                      ...++|+..+.||+|+||.||+|++      .++..||||+++..........|.+|+.+++++ +|||||+++|+|...
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            3446777889999999999999975      245689999997655444455799999999988 699999999999999


Q ss_pred             CeeeEEEeCCCCCChHHHHhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCe
Q 023282          202 TEKLLVYPYMTNGSVASRLRERQS--------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANI  267 (284)
Q Consensus       202 ~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~Ni  267 (284)
                      +..+++|||+++|+|.++++....              ....+++..+..++.|++.||+|||++   +++||||||+||
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI  176 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI  176 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccc
Confidence            999999999999999999986431              123589999999999999999999999   999999999999


Q ss_pred             eeCCCCCcchhhh
Q 023282          268 LLDEDADQSSKTI  280 (284)
Q Consensus       268 Lld~~~~~~~~df  280 (284)
                      |++.++.++++||
T Consensus       177 l~~~~~~~ki~Df  189 (311)
T d1t46a_         177 LLTHGRITKICDF  189 (311)
T ss_dssp             EEETTTEEEECCC
T ss_pred             cccccCccccccc
Confidence            9999999999998

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.97  E-value=1.5e-31  Score=224.15  Aligned_cols=143  Identities=24%  Similarity=0.332  Sum_probs=126.2

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCccc--HHHHHHHHHHHhcCCCCCceeeeeEEeeCC----ee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTTVT----EK  204 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~~h~niv~l~g~~~~~~----~~  204 (284)
                      ++|+..+.||+|+||+||+|+. .+++.||||+++.....+.  ...+.+|+++++.++|||||++++++...+    ..
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            5688889999999999999985 5789999999975543332  346899999999999999999999987654    37


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  281 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df~  281 (284)
                      ++||||+++|+|.+++....    .+++.++..++.|++.||+|||+.   +|+||||||+|||++.++..+++||-
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~  156 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFG  156 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCT
T ss_pred             EEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhh
Confidence            89999999999999987653    489999999999999999999999   99999999999999999999999874

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.5e-31  Score=226.52  Aligned_cols=143  Identities=23%  Similarity=0.473  Sum_probs=122.1

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      ++|+..+.||+|+||+||+|+. .+++.||||+++..... ....++.+|++++++++|||||++++++.+.+..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5788899999999999999986 57899999999654322 224578999999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+.+ ++.+++....  ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++..|++||
T Consensus        82 ~~~~-~~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DF  146 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADF  146 (298)
T ss_dssp             CCSE-EHHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECST
T ss_pred             ecCC-chhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccC
Confidence            9975 4555554322  23589999999999999999999999   9999999999999999999999998

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.6e-32  Score=230.42  Aligned_cols=154  Identities=28%  Similarity=0.387  Sum_probs=125.1

Q ss_pred             HHHHHHHhcCCCCCCeecccCceEEEEEEeC------CCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeee
Q 023282          124 LRELQVATDGFSNKNILGRGGFGKVYKGRLA------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYG  196 (284)
Q Consensus       124 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g  196 (284)
                      .++++...++|+..+.||+|+||.||+|+..      +++.||||+++........+.+.+|...+.++ +|+||+.+++
T Consensus         5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1           5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence            3455556678889999999999999999852      24689999997655444555788888877665 6899999999


Q ss_pred             EEeeCC-eeeEEEeCCCCCChHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCC
Q 023282          197 FCTTVT-EKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVK  263 (284)
Q Consensus       197 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk  263 (284)
                      ++...+ ..++||||+++|+|.++++....            ....++|.++..++.|+++||.|||++   +|+|||||
T Consensus        85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlK  161 (299)
T d1ywna1          85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA  161 (299)
T ss_dssp             EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCC
T ss_pred             eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCC
Confidence            987654 68999999999999999976432            123588999999999999999999999   99999999


Q ss_pred             CCCeeeCCCCCcchhhh
Q 023282          264 AANILLDEDADQSSKTI  280 (284)
Q Consensus       264 ~~NiLld~~~~~~~~df  280 (284)
                      |+|||++.++.+||+||
T Consensus       162 p~NILl~~~~~~Kl~DF  178 (299)
T d1ywna1         162 ARNILLSEKNVVKICDF  178 (299)
T ss_dssp             GGGEEECGGGCEEECC-
T ss_pred             ccceeECCCCcEEEccC
Confidence            99999999999999998

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=2.3e-31  Score=229.82  Aligned_cols=142  Identities=24%  Similarity=0.323  Sum_probs=128.1

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeeccc--CcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEER--TSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~  208 (284)
                      ++|+..+.||+|+||.||+|+. .+|+.||||++....  .......+.+|+.+++.++|||||++++++......++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            4688889999999999999986 479999999986432  2233456899999999999999999999999999999999


Q ss_pred             eCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          209 PYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       209 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ||+.+|+|.+++....    .+++.....++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       121 e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DF  185 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDF  185 (350)
T ss_dssp             ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             ccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeec
Confidence            9999999999997653    489999999999999999999999   9999999999999999999999998

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.97  E-value=1.5e-31  Score=225.11  Aligned_cols=142  Identities=23%  Similarity=0.405  Sum_probs=126.4

Q ss_pred             cCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeC
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPY  210 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~  210 (284)
                      ++|+..+.||+|+||+||+|+..+|+.||||+++..... .....+.+|+.++++++|||||++++++...+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            568888999999999999999989999999999654322 2345799999999999999999999999999999999999


Q ss_pred             CCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          211 MTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       211 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +.++.+..+....    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|++||
T Consensus        82 ~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~Df  144 (286)
T d1ob3a_          82 LDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADF  144 (286)
T ss_dssp             CSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCT
T ss_pred             ehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEeccc
Confidence            9887666665433    3589999999999999999999998   9999999999999999999999998

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.5e-32  Score=229.19  Aligned_cols=148  Identities=29%  Similarity=0.421  Sum_probs=123.4

Q ss_pred             HhcCCCCCCeecccCceEEEEEEeC--------CCcEEEEEEeecccCcccHHHHHHHHHHHhcC-CCCCceeeeeEEee
Q 023282          130 ATDGFSNKNILGRGGFGKVYKGRLA--------DGKLVAVKRLKEERTSGGELQFQTEVKIISMA-VHRNLLRLYGFCTT  200 (284)
Q Consensus       130 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~-~h~niv~l~g~~~~  200 (284)
                      ..++|...+.||+|+||.||+|+..        ++..||||+++.+.......++.+|...+.++ +|||||+++++|..
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            4467778899999999999999742        12479999997665544556788899888777 79999999999999


Q ss_pred             CCeeeEEEeCCCCCChHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCee
Q 023282          201 VTEKLLVYPYMTNGSVASRLRERQS------------SLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANIL  268 (284)
Q Consensus       201 ~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiL  268 (284)
                      .+..++||||+++|+|.++++....            ....++|.+++.++.|++.||+|||+.   +|+||||||+|||
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiL  167 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL  167 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccccee
Confidence            9999999999999999999976532            124589999999999999999999999   9999999999999


Q ss_pred             eCCCCCcchhhh
Q 023282          269 LDEDADQSSKTI  280 (284)
Q Consensus       269 ld~~~~~~~~df  280 (284)
                      ++.++.+||+||
T Consensus       168 l~~~~~~kl~df  179 (299)
T d1fgka_         168 VTEDNVMKIADF  179 (299)
T ss_dssp             ECTTCCEEECST
T ss_pred             ecCCCCeEeccc
Confidence            999999999998

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.3e-31  Score=226.12  Aligned_cols=142  Identities=25%  Similarity=0.407  Sum_probs=124.9

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeeccc--CcccHHHHHHHHHHHh-cCCCCCceeeeeEEeeCCeeeEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEER--TSGGELQFQTEVKIIS-MAVHRNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~-~~~h~niv~l~g~~~~~~~~~lv  207 (284)
                      ++|...+.||+|+||+||+|+.. +++.||||+++...  .......+..|..++. .++|||||++++++...+..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            56888899999999999999864 78999999996432  1233345667777664 78999999999999999999999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |||+++|+|.+++....    .+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+|++||
T Consensus        82 mEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DF  147 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADF  147 (320)
T ss_dssp             EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             EeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceecccc
Confidence            99999999999998754    478899999999999999999999   9999999999999999999999998

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.97  E-value=3.6e-31  Score=229.73  Aligned_cols=143  Identities=28%  Similarity=0.383  Sum_probs=124.0

Q ss_pred             hcCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccC--cccHHHHH---HHHHHHhcCCCCCceeeeeEEeeCCee
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERT--SGGELQFQ---TEVKIISMAVHRNLLRLYGFCTTVTEK  204 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~---~e~~~l~~~~h~niv~l~g~~~~~~~~  204 (284)
                      .++|+..++||+|+||.||+|+.. +|+.||||++.....  ......+.   .|+.+++.++|||||++++++...+..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            367888999999999999999864 789999999864321  11222333   446778888999999999999999999


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++||||+++|+|.+++....    .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DF  151 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDL  151 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCC
T ss_pred             EEEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeee
Confidence            99999999999999998653    478999999999999999999999   9999999999999999999999998

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.3e-31  Score=224.66  Aligned_cols=139  Identities=28%  Similarity=0.410  Sum_probs=116.5

Q ss_pred             CCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC----eeeEEEe
Q 023282          134 FSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT----EKLLVYP  209 (284)
Q Consensus       134 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~----~~~lv~e  209 (284)
                      |...+.||+|+||.||+|+. +|+.||||+++...  .....+..|+..+..++|||||+++|+|...+    ..++|||
T Consensus         5 ~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E   81 (303)
T d1vjya_           5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             EEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence            45568899999999999997 57899999985432  11112334555667889999999999998654    5789999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC-----DPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~-----~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      |+++|+|.+++++.     .++|..+..++.|+|.||+|||+.+     .++|+||||||+|||+|.++.+||+||
T Consensus        82 y~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF  152 (303)
T d1vjya_          82 YHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             CCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             cccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence            99999999999864     4899999999999999999999731     358999999999999999999999998

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.1e-31  Score=224.20  Aligned_cols=142  Identities=34%  Similarity=0.438  Sum_probs=115.0

Q ss_pred             cCCCCCCeecccCceEEEEEEeC--CC--cEEEEEEeecccCccc--HHHHHHHHHHHhcCCCCCceeeeeEEeeCCeee
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA--DG--KLVAVKRLKEERTSGG--ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKL  205 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~~~--~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~  205 (284)
                      ++|+..+.||+|+||.||+|+..  ++  ..||||+++.......  .++|.+|+.++++++|||||+++|++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            45777889999999999999853  23  3789999875543332  3479999999999999999999999965 5678


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +||||+++|++.+.+.....   .++|..++.++.|+++||.|||++   +|+||||||+|||++.++++|++||
T Consensus        87 lv~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~Df  155 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDF  155 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCC
T ss_pred             eeeeeecCcchhhhhhcccC---CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccc
Confidence            99999999999998876532   489999999999999999999998   9999999999999999999999998

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3e-31  Score=224.69  Aligned_cols=137  Identities=29%  Similarity=0.411  Sum_probs=116.5

Q ss_pred             CCeecccCceEEEEEEe-CCCcEEEEEEeecccCccc----HHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEeCC
Q 023282          137 KNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGG----ELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYPYM  211 (284)
Q Consensus       137 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~----~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e~~  211 (284)
                      .++||+|+||+||+|+. .+|+.||||+++.......    ...+.+|+.+++.++|||||++++++...+..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            47899999999999996 4689999999864432211    236889999999999999999999999999999999999


Q ss_pred             CCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          212 TNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       212 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++++..+....    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        83 ~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DF  144 (299)
T d1ua2a_          83 ETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADF  144 (299)
T ss_dssp             SEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             cchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccC
Confidence            988776665432    2478888999999999999999999   9999999999999999999999998

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=6.9e-30  Score=215.42  Aligned_cols=142  Identities=20%  Similarity=0.348  Sum_probs=127.3

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcc-cHHHHHHHHHHHhcCCCCCceeeeeEEeeCCeeeEEEe
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~~~~lv~e  209 (284)
                      ++|+..+.||+|+||+||+|+. .+++.||||+++...... ...++.+|+.+++.++||||+++++++......++++|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            4678889999999999999996 578899999997554333 34578999999999999999999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ++.++++..++....    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+|++||
T Consensus        82 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DF  145 (292)
T d1unla_          82 FCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANF  145 (292)
T ss_dssp             CCSEEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred             ecccccccccccccc----ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeec
Confidence            999999888876542    478999999999999999999999   9999999999999999999999998

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.3e-30  Score=223.40  Aligned_cols=141  Identities=21%  Similarity=0.313  Sum_probs=119.2

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeCC----eeeE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTVT----EKLL  206 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~----~~~l  206 (284)
                      ++|...+.||+|+||+||+|+. .+|+.||||+++........+.+.+|+++|+.++||||+++++++....    ..++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            4577889999999999999985 5899999999965443334457899999999999999999999997643    2345


Q ss_pred             EEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          207 VYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       207 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      +++|+.+|+|.+++...     .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        88 l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~Df  153 (345)
T d1pmea_          88 LVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDF  153 (345)
T ss_dssp             EEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEccc
Confidence            55677799999999753     489999999999999999999999   9999999999999999999999998

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=8.3e-30  Score=218.76  Aligned_cols=138  Identities=23%  Similarity=0.297  Sum_probs=117.5

Q ss_pred             cCCCCC-CeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHh-cCCCCCceeeeeEEee----CCee
Q 023282          132 DGFSNK-NILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIIS-MAVHRNLLRLYGFCTT----VTEK  204 (284)
Q Consensus       132 ~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~-~~~h~niv~l~g~~~~----~~~~  204 (284)
                      ++|... ++||+|+||+||+|+. .+++.||||+++.      ...+.+|++++. ..+|||||++++++..    ....
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            467665 4699999999999985 5789999999853      235778998865 5589999999999865    3568


Q ss_pred             eEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC---CCCcchhhh
Q 023282          205 LLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTI  280 (284)
Q Consensus       205 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~---~~~~~~~df  280 (284)
                      ++|||||++|+|.+++....  ...+++.+...++.|++.||+|||+.   +|+||||||+|||++.   ++.+|++||
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             EEEEECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccc
Confidence            99999999999999998642  23589999999999999999999999   9999999999999986   446899998

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.2e-30  Score=214.74  Aligned_cols=142  Identities=23%  Similarity=0.363  Sum_probs=122.2

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcc-----cHHHHHHHHHHHhcCC--CCCceeeeeEEeeCCe
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-----GELQFQTEVKIISMAV--HRNLLRLYGFCTTVTE  203 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~~e~~~l~~~~--h~niv~l~g~~~~~~~  203 (284)
                      ++|...++||+|+||+||+|+. .+++.||||+++......     ....+.+|+.++++++  |||||++++++...+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            4678889999999999999985 478999999997543221     1224678999999886  8999999999999999


Q ss_pred             eeEEEeCCCC-CChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCC-CCcchhhh
Q 023282          204 KLLVYPYMTN-GSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDED-ADQSSKTI  280 (284)
Q Consensus       204 ~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~-~~~~~~df  280 (284)
                      .++||||+.+ +++.+++....    .+++.++..++.|+++||+|||+.   +|+||||||+|||++.+ +.+|++||
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             EEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcc
Confidence            9999999975 67888887643    489999999999999999999999   99999999999999965 68999998

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.3e-29  Score=219.11  Aligned_cols=139  Identities=28%  Similarity=0.427  Sum_probs=114.2

Q ss_pred             CCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeeeeEEeeC------Ceee
Q 023282          133 GFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLYGFCTTV------TEKL  205 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~------~~~~  205 (284)
                      +|+..++||+|+||+||+|+.. +|+.||||+++....     .+.+|++++++++||||+++++++...      ...+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            3666789999999999999964 789999999965432     234799999999999999999998643      2468


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC-Ccchhhh
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTI  280 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~-~~~~~df  280 (284)
                      +||||++++.+ +.+.........+++.++..++.|++.||+|||++   +|+||||||+|||++.++ .+||+||
T Consensus        96 lv~Ey~~~~~~-~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DF  167 (350)
T d1q5ka_          96 LVLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDF  167 (350)
T ss_dssp             EEEECCSEEHH-HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCC
T ss_pred             EEEeccCCccH-HHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecc
Confidence            99999986644 44432222234689999999999999999999998   999999999999999875 8899998

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3e-29  Score=216.58  Aligned_cols=142  Identities=23%  Similarity=0.355  Sum_probs=116.6

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcc-cHHHHHHHHHHHhcCCCCCceeeeeEEeeCC------
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTVT------  202 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~g~~~~~~------  202 (284)
                      .++|+..+.||+|+||+||+|+. .+|+.||||+++...... ..+.+.+|+.+|+.++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            35688889999999999999986 479999999997543322 2346889999999999999999999997654      


Q ss_pred             eeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhhh
Q 023282          203 EKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  281 (284)
Q Consensus       203 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df~  281 (284)
                      ..++||||+ +.+|..+.+..     .+++..+..++.|++.||.|||++   +|+||||||+|||++.++..|++||-
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg  166 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  166 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             eEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccc
Confidence            469999999 56777777543     489999999999999999999999   99999999999999999999999984

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.95  E-value=4.8e-29  Score=213.73  Aligned_cols=135  Identities=23%  Similarity=0.322  Sum_probs=118.2

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCC-CCCceeeeeEEeeC--CeeeEE
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTV--TEKLLV  207 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~~--~~~~lv  207 (284)
                      ++|+..+.||+|+||+||+|+. .+++.||||+++..    ...++.+|+++|+.++ ||||+++++++...  ...++|
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            5688889999999999999996 57899999998632    3456889999999985 99999999998754  468999


Q ss_pred             EeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCC-Ccchhhh
Q 023282          208 YPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDA-DQSSKTI  280 (284)
Q Consensus       208 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~-~~~~~df  280 (284)
                      |||+++++|..+.+       .+++..+..++.|++.||+|||++   +|+||||||+|||++.++ .++++||
T Consensus       111 ~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DF  174 (328)
T d3bqca1         111 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDW  174 (328)
T ss_dssp             EECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCG
T ss_pred             EeecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccc
Confidence            99999999876542       488999999999999999999999   999999999999999766 5899998

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=5.2e-29  Score=215.17  Aligned_cols=143  Identities=22%  Similarity=0.330  Sum_probs=122.9

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEeeC-----Ce
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTTV-----TE  203 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~~-----~~  203 (284)
                      .++|+..+.||+|+||+||+|+. .+|+.||||+++..... ...+.+.+|+++++.++|||+|++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            35688889999999999999985 57999999999754332 2234688999999999999999999998643     34


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhhh
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  281 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df~  281 (284)
                      .+++++|+.+|+|.+++...     .+++..+..++.|++.||+|||++   +|+||||||+|||++.++..+++||-
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg  166 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG  166 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred             eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccc
Confidence            46777888899999999643     489999999999999999999999   99999999999999999999999983

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=9.3e-29  Score=209.80  Aligned_cols=144  Identities=28%  Similarity=0.466  Sum_probs=117.1

Q ss_pred             hcCCCCCCeecccCceEEEEEEe-CC-CcEEEEEEeecccCcc-cHHHHHHHHHHHhc---CCCCCceeeeeEEee----
Q 023282          131 TDGFSNKNILGRGGFGKVYKGRL-AD-GKLVAVKRLKEERTSG-GELQFQTEVKIISM---AVHRNLLRLYGFCTT----  200 (284)
Q Consensus       131 ~~~~~~~~~lg~G~~g~V~~~~~-~~-~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~---~~h~niv~l~g~~~~----  200 (284)
                      .++|+..+.||+|+||+||+|+. .+ ++.||||+++...... ....+.+|+.+++.   .+||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46788899999999999999986 34 6679999996543322 22346677777655   489999999999853    


Q ss_pred             -CCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhh
Q 023282          201 -VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKT  279 (284)
Q Consensus       201 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~d  279 (284)
                       ....+++|||+.++++.......   ...+++.....++.|++.||+|||++   +|+||||||+|||++.++.+|++|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCceEEEEEEeccCCchhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence             24678999999987766554432   23588999999999999999999999   999999999999999999999999


Q ss_pred             h
Q 023282          280 I  280 (284)
Q Consensus       280 f  280 (284)
                      |
T Consensus       160 f  160 (305)
T d1blxa_         160 F  160 (305)
T ss_dssp             C
T ss_pred             h
Confidence            8

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=5.4e-29  Score=212.59  Aligned_cols=142  Identities=27%  Similarity=0.346  Sum_probs=124.8

Q ss_pred             cCCCCCCeecccCceEEEEEEe----CCCcEEEEEEeecccC---cccHHHHHHHHHHHhcCCC-CCceeeeeEEeeCCe
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL----ADGKLVAVKRLKEERT---SGGELQFQTEVKIISMAVH-RNLLRLYGFCTTVTE  203 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~~~h-~niv~l~g~~~~~~~  203 (284)
                      ++|+..+.||+|+||+||+|+.    .+|+.||||.++....   ......+.+|++++++++| |||+++++++.....
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5688899999999999999974    2478999999864322   1223468899999999976 899999999999999


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .+++|||+.+|+|.+++....    .+.......++.|++.||.|||+.   +|+||||||+|||+|.++.++|+||
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DF  173 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDF  173 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCS
T ss_pred             eeeeeecccccHHHHHHHhcc----cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeec
Confidence            999999999999999998754    367788899999999999999999   9999999999999999999999998

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.1e-28  Score=210.50  Aligned_cols=142  Identities=27%  Similarity=0.444  Sum_probs=118.1

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCc-ccHHHHHHHHHHHhcCCCCCceeeeeEEee--------C
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTS-GGELQFQTEVKIISMAVHRNLLRLYGFCTT--------V  201 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~~~h~niv~l~g~~~~--------~  201 (284)
                      ++|+..+.||+|+||+||+|+. .+|+.||||++...... ....++.+|+.+|++++|||++++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            5688889999999999999996 57999999998644332 234568899999999999999999998865        3


Q ss_pred             CeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          202 TEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       202 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      ...+++|||++++.+.......    ..++......++.|+++||.|||+.   +|+||||||+|||++.++.+|++||
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             ceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence            4578999999887665544332    2478889999999999999999999   9999999999999999999999997

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=5.7e-28  Score=209.12  Aligned_cols=140  Identities=23%  Similarity=0.297  Sum_probs=118.1

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcc-cHHHHHHHHHHHhcCCCCCceeeeeEEeeC------Ce
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSG-GELQFQTEVKIISMAVHRNLLRLYGFCTTV------TE  203 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~~~h~niv~l~g~~~~~------~~  203 (284)
                      ++|+..++||+|+||+||+|+.. +|+.||||+++...... ....+.+|+.+++.++|||||++++++...      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            56888899999999999999964 69999999997554332 234688999999999999999999999643      57


Q ss_pred             eeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchhhhh
Q 023282          204 KLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSKTIL  281 (284)
Q Consensus       204 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~df~  281 (284)
                      .++||||+.++ +.+.+..      .+++.....++.|++.||.|||+.   +|+||||||+|||++.++..+++||-
T Consensus        97 ~~iv~Ey~~~~-l~~~~~~------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~  164 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_dssp             EEEEEECCSEE-HHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             eEEEEeccchH-HHHhhhc------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechh
Confidence            89999999764 5555532      378999999999999999999999   99999999999999999999999983

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.94  E-value=6.6e-27  Score=197.12  Aligned_cols=139  Identities=18%  Similarity=0.235  Sum_probs=120.1

Q ss_pred             cCCCCCCeecccCceEEEEEEeC-CCcEEEEEEeecccCcccHHHHHHHHHHHhcCCC-CCceeeeeEEeeCCeeeEEEe
Q 023282          132 DGFSNKNILGRGGFGKVYKGRLA-DGKLVAVKRLKEERTSGGELQFQTEVKIISMAVH-RNLLRLYGFCTTVTEKLLVYP  209 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h-~niv~l~g~~~~~~~~~lv~e  209 (284)
                      ++|...+.||+|+||+||+|+.. +++.||||++.....   ...+.+|++.++.+.| +|++.+++++......++|||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            46788899999999999999954 688999998864332   2347788899988875 899999999999999999999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC-----CCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE-----DADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~-----~~~~~~~df  280 (284)
                      |+ +|+|.++++....   .+++.+...++.|++.||+|||+.   +|+||||||+|||++.     ++.++++||
T Consensus        82 ~~-~~~l~~~~~~~~~---~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DF  150 (293)
T d1csna_          82 LL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDF  150 (293)
T ss_dssp             CC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             ec-CCCHHHHHHhhcc---chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEccc
Confidence            99 6899999876432   489999999999999999999999   9999999999999975     567899998

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.93  E-value=2.2e-26  Score=194.46  Aligned_cols=139  Identities=22%  Similarity=0.226  Sum_probs=113.5

Q ss_pred             cCCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCceeee-eEEeeCCeeeEEEe
Q 023282          132 DGFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNLLRLY-GFCTTVTEKLLVYP  209 (284)
Q Consensus       132 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~niv~l~-g~~~~~~~~~lv~e  209 (284)
                      ++|+..+.||+|+||.||+|+. .+++.||||++.....   ..++..|+++++.++|+|++..+ ++....+..++|||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            4578889999999999999986 5688999998865322   23578999999999887766555 45566778899999


Q ss_pred             CCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCC---CCCcchhhh
Q 023282          210 YMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDE---DADQSSKTI  280 (284)
Q Consensus       210 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~---~~~~~~~df  280 (284)
                      |+ +|++.+.+....   ..+++..+..++.|++.||+|||++   +|+||||||+|||++.   +..++++||
T Consensus        84 ~~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DF  150 (299)
T d1ckia_          84 LL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDF  150 (299)
T ss_dssp             CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred             Ec-CCchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeecc
Confidence            99 456777665432   2589999999999999999999999   9999999999998764   456899998

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=2.9e-23  Score=163.80  Aligned_cols=126  Identities=13%  Similarity=0.115  Sum_probs=97.9

Q ss_pred             CCCeecccCceEEEEEEeCCCcEEEEEEeecccCc----c-------------cHHHHHHHHHHHhcCCCCCceeeeeEE
Q 023282          136 NKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTS----G-------------GELQFQTEVKIISMAVHRNLLRLYGFC  198 (284)
Q Consensus       136 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~-------------~~~~~~~e~~~l~~~~h~niv~l~g~~  198 (284)
                      ..+.||+|+||+||+|+..+|+.||||+++.....    .             .......|...+.++.|.+++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            45789999999999999888999999987532111    0             011345688889999999999887653


Q ss_pred             eeCCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeeeCCCCCCeeeCCCCCcchh
Q 023282          199 TTVTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHCDPKIIHRDVKAANILLDEDADQSSK  278 (284)
Q Consensus       199 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivHrdlk~~NiLld~~~~~~~~  278 (284)
                          ..+++|||+++..+.+           +++.....++.|+++||.|||+.   +|+||||||+|||++++ .++++
T Consensus        84 ----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          84 ----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             ----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred             ----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence                2479999998765432           22234567899999999999999   99999999999999965 48888


Q ss_pred             hh
Q 023282          279 TI  280 (284)
Q Consensus       279 df  280 (284)
                      ||
T Consensus       145 DF  146 (191)
T d1zara2         145 DF  146 (191)
T ss_dssp             CC
T ss_pred             EC
Confidence            98

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.86  E-value=1.6e-22  Score=174.89  Aligned_cols=143  Identities=20%  Similarity=0.254  Sum_probs=109.6

Q ss_pred             CCCCCCeecccCceEEEEEEe-CCCcEEEEEEeecccCcccHHHHHHHHHHHhcCC-----------CCCceeeeeEEee
Q 023282          133 GFSNKNILGRGGFGKVYKGRL-ADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-----------HRNLLRLYGFCTT  200 (284)
Q Consensus       133 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-----------h~niv~l~g~~~~  200 (284)
                      +|+..+.||+|+||+||+|+. .+|+.||||+++....  ....+.+|+.+++.++           |+||+++++++..
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~--~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc--chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            478889999999999999996 5799999999964321  2235778888887664           5789999998764


Q ss_pred             --CCeeeEEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeeeCCCCCCeeeCCCCC---
Q 023282          201 --VTEKLLVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHE-HCDPKIIHRDVKAANILLDEDAD---  274 (284)
Q Consensus       201 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~ivHrdlk~~NiLld~~~~---  274 (284)
                        ....+++++++..+......... .....+++..+..++.|++.||+|||+ .   +|+||||||+|||++.++.   
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTT
T ss_pred             ccccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccc
Confidence              45566777766655443333322 223357889999999999999999998 5   8999999999999987764   


Q ss_pred             ---cchhhhh
Q 023282          275 ---QSSKTIL  281 (284)
Q Consensus       275 ---~~~~df~  281 (284)
                         ++++||-
T Consensus       168 ~~~~kl~dfg  177 (362)
T d1q8ya_         168 LIQIKIADLG  177 (362)
T ss_dssp             EEEEEECCCT
T ss_pred             cceeeEeecc
Confidence               7788773

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.37  E-value=2.2e-06  Score=68.65  Aligned_cols=143  Identities=12%  Similarity=0.053  Sum_probs=86.8

Q ss_pred             HHHHhcCCCCCCeecccCceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCC-CCCceeeeeEEeeCCeee
Q 023282          127 LQVATDGFSNKNILGRGGFGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV-HRNLLRLYGFCTTVTEKL  205 (284)
Q Consensus       127 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~-h~niv~l~g~~~~~~~~~  205 (284)
                      +......|...+..+-++.+.||+... +++.+.+|+....... ....+.+|...+..+. +--+.+++.+....+..+
T Consensus         9 l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~-~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCccc-chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            333344454434333344568998865 4556677876433221 2224677887766543 434567788888888899


Q ss_pred             EEEeCCCCCChHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--------------------------------
Q 023282          206 LVYPYMTNGSVASRLRERQSSLPPLDWPTRKKIALGSARGLSYLHEHC--------------------------------  253 (284)
Q Consensus       206 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~--------------------------------  253 (284)
                      +||+++++.++.+.....      ..   ...++.++++.++.||+..                                
T Consensus        87 lv~~~l~G~~~~~~~~~~------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDE------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEECCSSEEHHHHTTTC------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred             EEEEeccccccccccccc------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence            999999988776544221      01   2223444444445454310                                


Q ss_pred             ------------------------CCCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          254 ------------------------DPKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       254 ------------------------~~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                                              .+.++|+|+.|.|||++++...-+.||
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDw  208 (263)
T d1j7la_         158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDL  208 (263)
T ss_dssp             GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCC
T ss_pred             ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeec
Confidence                                    123799999999999998766667775

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.82  E-value=2.1e-05  Score=62.41  Aligned_cols=73  Identities=12%  Similarity=0.023  Sum_probs=49.6

Q ss_pred             ecccC-ceEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCC--CCCceeeeeEEeeCCeeeEEEeCCCCCCh
Q 023282          140 LGRGG-FGKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAV--HRNLLRLYGFCTTVTEKLLVYPYMTNGSV  216 (284)
Q Consensus       140 lg~G~-~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~--h~niv~l~g~~~~~~~~~lv~e~~~~g~L  216 (284)
                      +..|. -+.||+...+++..+.+|.-....    ...+..|...++.+.  .-.+.+++.+....+..++||+|+++-++
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            34444 367899988778778888764332    123566777665443  33456778887888888999999987554

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.61  E-value=8.5e-05  Score=63.03  Aligned_cols=76  Identities=11%  Similarity=0.041  Sum_probs=45.5

Q ss_pred             CeecccCceEEEEEEeCC-CcEEEEEEeeccc------CcccHHHHHHHHHHHhcCC-C--CCceeeeeEEeeCCeeeEE
Q 023282          138 NILGRGGFGKVYKGRLAD-GKLVAVKRLKEER------TSGGELQFQTEVKIISMAV-H--RNLLRLYGFCTTVTEKLLV  207 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~------~~~~~~~~~~e~~~l~~~~-h--~niv~l~g~~~~~~~~~lv  207 (284)
                      +.||.|....||+....+ +..+.+|.-....      ......+...|.+.++.+. +  ..+.+++.+  ..+..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            468999999999998654 6678888643211      1111123455777765442 2  334455543  45667899


Q ss_pred             EeCCCCCC
Q 023282          208 YPYMTNGS  215 (284)
Q Consensus       208 ~e~~~~g~  215 (284)
                      |||+++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.14  E-value=0.0033  Score=51.41  Aligned_cols=66  Identities=18%  Similarity=0.176  Sum_probs=41.7

Q ss_pred             eEEEEEEeCCCcEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCc-----eeee--eEEeeCCeeeEEEeCCCC
Q 023282          146 GKVYKGRLADGKLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL-----LRLY--GFCTTVTEKLLVYPYMTN  213 (284)
Q Consensus       146 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni-----v~l~--g~~~~~~~~~lv~e~~~~  213 (284)
                      -.||+.+.++|..+++|..+...-  ...++..|...+..+....+     +..-  ......+..+.+++++++
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            579999999999999998765432  23456777777655432111     1111  122345667889999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.05  E-value=0.011  Score=49.39  Aligned_cols=72  Identities=18%  Similarity=0.255  Sum_probs=45.2

Q ss_pred             CeecccCceEEEEEEeCCC--------cEEEEEEeecccCcccHHHHHHHHHHHhcCCCCCc-eeeeeEEeeCCeeeEEE
Q 023282          138 NILGRGGFGKVYKGRLADG--------KLVAVKRLKEERTSGGELQFQTEVKIISMAVHRNL-LRLYGFCTTVTEKLLVY  208 (284)
Q Consensus       138 ~~lg~G~~g~V~~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~e~~~l~~~~h~ni-v~l~g~~~~~~~~~lv~  208 (284)
                      +.|+.|-.-.+|+...+++        ..|.+++.- ..  .......+|..+++.+.-.++ .++++++.    -.+|+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~  120 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP--ETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLE  120 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEE
Confidence            5688888899999986542        356666543 21  222345678888776643334 46777664    26889


Q ss_pred             eCCCCCCh
Q 023282          209 PYMTNGSV  216 (284)
Q Consensus       209 e~~~~g~L  216 (284)
                      ||+++-.+
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99986433

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.23  E-value=0.23  Score=39.46  Aligned_cols=26  Identities=19%  Similarity=0.240  Sum_probs=22.4

Q ss_pred             CCeeeeCCCCCCeeeCCCCCcchhhh
Q 023282          255 PKIIHRDVKAANILLDEDADQSSKTI  280 (284)
Q Consensus       255 ~~ivHrdlk~~NiLld~~~~~~~~df  280 (284)
                      .++||+|+.+.|++++.+...-|.||
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF  208 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDF  208 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCC
T ss_pred             cccccCCcchhhhhcccccceeEecc
Confidence            37999999999999998876677776

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=90.05  E-value=0.11  Score=40.26  Aligned_cols=32  Identities=16%  Similarity=0.218  Sum_probs=15.1

Q ss_pred             ccEEEccCCCCcccCCCC-CCCCccCcccccCC
Q 023282            2 TALRDLSNNRLSGPVPDN-GSFSQFTPISFENN   33 (284)
Q Consensus         2 ~~~~dlS~N~lsG~iP~~-~~~~~~~~~s~~gN   33 (284)
                      |+.+++++|+|++..|.. ..+.++....+.+|
T Consensus       150 l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N  182 (266)
T d1p9ag_         150 LEKLSLANNNLTELPAGLLNGLENLDTLLLQEN  182 (266)
T ss_dssp             CCEEECTTSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred             chhcccccccccccCccccccccccceeecccC
Confidence            455666666666544432 22333334444444

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=89.98  E-value=0.059  Score=43.02  Aligned_cols=37  Identities=30%  Similarity=0.480  Sum_probs=24.6

Q ss_pred             CccEEEccCCCCcccCCCC-CCCCccCcccccCCcCCCC
Q 023282            1 MTALRDLSNNRLSGPVPDN-GSFSQFTPISFENNLNLCG   38 (284)
Q Consensus         1 ~~~~~dlS~N~lsG~iP~~-~~~~~~~~~s~~gN~~lcg   38 (284)
                      +|+.||||+|+|+|.||+. ..+.++....+.+|. ++|
T Consensus       245 ~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~-l~g  282 (313)
T d1ogqa_         245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN-LCG  282 (313)
T ss_dssp             TCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSE-EEE
T ss_pred             ccccccCccCeecccCChHHhCCCCCCEEECcCCc-ccc
Confidence            4778899999999999874 234445555556663 444

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=83.28  E-value=0.55  Score=33.08  Aligned_cols=34  Identities=12%  Similarity=0.059  Sum_probs=17.8

Q ss_pred             CccEEEccCCCCcccCCCC-CCCCccCcccccCCc
Q 023282            1 MTALRDLSNNRLSGPVPDN-GSFSQFTPISFENNL   34 (284)
Q Consensus         1 ~~~~~dlS~N~lsG~iP~~-~~~~~~~~~s~~gN~   34 (284)
                      +|+.|+||+|+|+.--|.. ..+.++....+.+|.
T Consensus        57 ~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~   91 (156)
T d2ifga3          57 ELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA   91 (156)
T ss_dssp             CCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred             ccCcceeeccccCCcccccccccccccceeccCCC
Confidence            3667777777777644432 223333444455553

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=81.11  E-value=0.15  Score=40.46  Aligned_cols=18  Identities=28%  Similarity=0.556  Sum_probs=11.2

Q ss_pred             ccEEEccC-CCCcccCCCC
Q 023282            2 TALRDLSN-NRLSGPVPDN   19 (284)
Q Consensus         2 ~~~~dlS~-N~lsG~iP~~   19 (284)
                      |++||||+ |+|+|.||..
T Consensus        78 L~~L~Ls~~N~l~g~iP~~   96 (313)
T d1ogqa_          78 LNFLYIGGINNLVGPIPPA   96 (313)
T ss_dssp             CSEEEEEEETTEESCCCGG
T ss_pred             ccccccccccccccccccc
Confidence            56666664 6666666653

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=80.37  E-value=0.58  Score=33.18  Aligned_cols=31  Identities=23%  Similarity=0.415  Sum_probs=18.1

Q ss_pred             ccEEEccCCCCcccCCCC-CCCCccCcccccCC
Q 023282            2 TALRDLSNNRLSGPVPDN-GSFSQFTPISFENN   33 (284)
Q Consensus         2 ~~~~dlS~N~lsG~iP~~-~~~~~~~~~s~~gN   33 (284)
                      |+.|||++|+++. ||.. ..+..+....+.+|
T Consensus        20 lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N   51 (162)
T d1a9na_          20 DRELDLRGYKIPV-IENLGATLDQFDAIDFSDN   51 (162)
T ss_dssp             CEEEECTTSCCCS-CCCGGGGTTCCSEEECCSS
T ss_pred             CcEEECCCCCCCc-cCccccccccCCEEECCCC
Confidence            5678888888765 3543 22444555556666